
<html lang="en"     class="pb-page"  data-request-id="a3e1f389-34c9-4be0-b546-1edabe58148b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2010.53.issue-11;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm9018756;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Emerging Targets in Osteoporosis Disease Modification" /></meta><meta name="dc.Creator" content="John G.  Allen" /></meta><meta name="dc.Creator" content="Christopher  Fotsch" /></meta><meta name="dc.Creator" content="Philip  Babij" /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 10, 2010" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm9018756" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm9018756" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm9018756" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm9018756" /></link>
        
    
    

<title>Emerging Targets in Osteoporosis Disease Modification | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm9018756" /></meta><meta property="og:title" content="Emerging Targets in Osteoporosis Disease Modification" /></meta><meta property="og:image" content="https://pubs.acs.org/pb-assets/images/CoverImages_2by1Scaled/jmcmar-1595795902140.png" /></meta><meta property="og:description" content="" /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm9018756"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm9018756">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm9018756&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm9018756&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm9018756&amp;href=/doi/10.1021/jm9018756" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4332-4353</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901024b" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm9013899" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Emerging Targets in Osteoporosis Disease Modification</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+G.++Allen">John G. Allen</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Fotsch">Christopher Fotsch</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philip++Babij">Philip Babij</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Chemistry Research and Discovery, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Metabolic Disorders, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: 805-313-5257. Fax: 805-480-1337. E-mail: <a href="/cdn-cgi/l/email-protection#bdd7d2d5dcd1d1d8d3fddcd0dad8d393ded2d0"><span class="__cf_email__" data-cfemail="f69c999e979a9a9398b6979b919398d895999b">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm9018756&amp;href=/doi/10.1021%2Fjm9018756" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4332–4353</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 10, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 December 2009</li><li><span class="item_label"><b>Published</b> online</span>10 March 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 June 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm9018756" title="DOI URL">https://doi.org/10.1021/jm9018756</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4332%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJohn%2BG.%2BAllen%252C%2BChristopher%2BFotsch%252C%2BPhilip%2BBabij%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D11%26contentID%3Djm9018756%26title%3DEmerging%2BTargets%2Bin%2BOsteoporosis%2BDisease%2BModification%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4353%26publicationDate%3DJune%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm9018756"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3705</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">24</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm9018756" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Emerging Targets in Osteoporosis Disease Modification&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;G. Allen&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Fotsch&quot;},{&quot;first_name&quot;:&quot;Philip&quot;,&quot;last_name&quot;:&quot;Babij&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;4332-4353&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm9018756&quot;},&quot;abstract&quot;:&quot;&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9018756&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9018756" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9018756&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9018756" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9018756&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9018756" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm9018756&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9018756&amp;href=/doi/10.1021/jm9018756" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm9018756" /></input><a href="/doi/pdf/10.1021/jm9018756" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm9018756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm9018756%26sid%3Dliteratum%253Aachs%26pmid%3D20218623%26genre%3Darticle%26aulast%3DAllen%26date%3D2010%26atitle%3DEmerging%2BTargets%2Bin%2BOsteoporosis%2BDisease%2BModification%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D11%26spage%3D4332%26epage%3D4353%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72233" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72233" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Bone health in adult life depends on the coordinated activities of bone forming osteoblasts and bone resorbing osteoclasts that function together in a basic multicellular unit (BMU<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a>) <div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: BMU, basic multicellular unit; BMD, bone mineral density; OPG, osteoprotegerin; RANK, receptor activator of nuclear factor κB; SERM, selective estrogen receptor modulator; SARM, selective androgen receptor modulator; PTH, parathyroid hormone; RGD, arginine−glycine−aspartate; DXA, dual energy X-ray absorptiometry; CTX-I, C-terminal telopeptides of type I collagen; NTX-I, N-terminal telopeptides of type I collagen; FPPS, farnesyl diphosphate synthase; MSC, mesenchymal stem cell; CAT, cathepsin; OVX, ovariectomized; mAb, monoclonal antibody; HSA, human serum albumin; BMP, bone morphogenic protein; TGF, transforming growth factor; IGF, insulin-like growth factor; FGF, fibroblast growth factor; WNT, wingless-type MMTV integration site; LRP5/6, lipoprotein receptor-related protein 5/6; RUNX2, runt-related transcription factor 2; ATF4, activating transcripton factor 4; OC, osteocalcin; ALP, alkaline phosphatase; PINP, N-terminal cross-linking propeptide of type I procollagen; PICP, C-terminal cross-linking propeptide of type I procollagen; PTH1R, parathryoid hormone receptor; MMTV, mouse mammary tumor virus; DSH, disheveled; GSK, glycogen synthase kinase; APC, adenomatous polyposis coli; TCF, T-cell factor; LEF, lymphoid enhancer-binding factor; SOST, sclerostin; DKK-1, dickkopf-1; sFRP-1, secreted frizzled related protein-1; WIF, wingless-type MMTV integration site inhibitory factor-1; FZD, frizzled receptor; CREB, cyclic adenosine monophosphate response element binding protein; COL1, type-1 collagen; HMG-CoA, 3-hydroxy-3-methylglutaryl coenzyme A; GPCR, G-protein-coupled receptor; EP, prostaglandin receptor; PG, prostaglandin; cAMP, cyclic adenosine monophosphate; BMC, bone mineral content; CB, cannabinoid; SRC, sarcoma proto-oncogene; PBMC, primary bone marrow cells; CDK, cyclin dependent kinase; LCK, leukocyte-specific protein tyrosine kinase; YES, Yamaguchi sarcoma viral oncogene homologue; ABL, Abelson murine leukemia viral oncogene homologue 2; KIT, Hardy−Zuckerman 4 feline sarcoma viral oncogene homologue; CSK, carboxy-terminal SRC kinase; PYK, proline-rich tyrosine kinase; FAK, focal adhesion kinase; BMM, bone marrow macrophage; EGCG, (−)-epigallocatechin gallate; NFkB, nuclear factor κ-light-chain-enhancer of activated B cells; m-CSF, macrophage colony-stimulating factor; SPA, scintillation proximity assay; TPH, tryptophan hydroxylase; HTR, hydroxytryptamine receptor; ADR2β, β2 adrenergic receptor; SSRI, selective serotonin reuptake inhibitor; SHN3, schnurri3; WWP1, WW domain−containing protein 1; SMURF1, small mothers against decapentaplegic ubiquitin regulatory factor 1; SMAD, small mothers against decapentaplegic.</p></div>on the bone surface.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Bone turnover reflects a balance between these anabolic and catabolic cellular functions and ensures that the mature skeleton can repair itself when damaged and sustain its endocrine function by release of minerals such as calcium and phosphorus into the circulation. In addition, the skeleton can adapt to changes in physical activity and alter its size in response to cellular signaling in osteocytes (specialized osteoblasts surrounded by mineralized bone) which likely act as mechanosensors in bone that sense changes in mechanical load.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Normal bone turnover can be altered, however, in many disease states resulting in increases or decreases in bone mass or changes in bone quality linked to mineralization defects that can compromise strength and increase the risk of fracture.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Gradual loss of bone mineral density (BMD) referred to as osteopenia and severe loss of bone known as osteoporosis may represent the early and late manifestations of alterations in bone turnover that result in bone disease.</div><div class="NLM_p">The peak bone mass attained by the skeleton during adolescent growth may predict the risk for development of osteoporosis in later life.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In fact the accumulation of bone during growth is strongly heritable with genetic differences accounting for as much as 50−85% of the variation in BMD.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> With advancing age, however, the BMU creates an environment in bone where the amount of bone resorbed typically exceeds its replacement capacity leading to a net decrease in BMD. Although normal age-dependent loss of bone mass occurs in both men and women, the rapid loss of bone associated with estrogen deficiency following menopause in women accounts for the majority of clinical cases of osteoporosis. Other major disease-related causes of osteoporosis in addition to hypogonadism include but are not limited to endocrine disorders such as Cushing’s syndrome (and the related secondary loss of bone associated with the use of steroids for other medical conditions) and renal insufficiency.<a onclick="showRef(event, 'ref3 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref6">(3, 6)</a></div><div class="NLM_p">The general principles involved in bone remodeling and the role of the BMU are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. The normally quiescent bone surface lined by inactive osteoblasts is thought to receive activating signals, possibly including those from underlying osteocytes, which trigger initiation of bone resorption via osteoclasts. A cascade of events leads to the formation of mature multinucleated osteoclasts from osteoclast precursor cells in the bone marrow that attach to the bone surface. Significant progress has been made over the past decade or so that establishes a fundamental role for OPG/RANKL interactions in regulating the level of osteoclast bone resorbing activity.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Binding of osteoprotegerin (OPG) to RANKL prevents RANKL-dependent activation of the receptor activator of nuclear factor κB (RANK) receptor on osteoclasts, thus limiting the potential for resorptive activity. The etching effect of osteoclast action and degradation of bone matrix result in the formation of resorption pits, which is then followed by apoptosis of the invading osteoclasts. In normal bone, the demineralized space becomes occupied by bone forming osteoblasts that synthesize new bone matrix to repair the pitted surfaces. Signals from osteoclasts themselves could be involved in the osteoblast recruitment phase. The new matrix (osteoid) deposited by osteoblasts is then mineralized, and the loss of old bone is effectively balanced by replacement of new bone. In postmenopausal osteoporosis, however, the loss of estrogen that can normally inhibit RANKL expression tips the OPG/RANKL ratio in favor of RANKL-stimulated osteoclast activity and accelerated bone resorption. Although bone formation also increases, it does so at a relatively slower rate where the bone forming capacity of osteoblasts fails to totally replace the lost bone. Thus, a net loss of bone occurs over time that can be associated with increased fracture risk. An understanding of the central role of RANKL in driving bone resorption led to the development of the fully human anti-RANKL antibody denosumab (Prolia) by Amgen, which is currently under review in the U.S. and Europe for osteoporosis and other bone-related indications.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a></div><figure id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Role of OPG/RANKL and emerging new targets in bone remodeling. OPG and RANKL are expressed in many tissues and cell types including osteoblasts. Cellular locations of emerging antiresorptive, anabolic, and potential dual-acting agents are shown and described in the text. Abbreviations are as follows: BLC, bone lining cell; OY, osteocyte; OC, osteoclast; OB, osteoblast.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Among current marketed osteoporosis drugs, the bisphosphonate class of oral small molecule antiresorptives celebrated 40 years of clinical use in 2009 for the treatment and prevention of osteoporosis. Bisphosphonates arguably represent the current standard of care for osteoporosis, and several classes of bisphosphonates are available<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> including, for example, Novartis’ recently approved Reclast (zoledronic acid) as a once a year infusion. Calcium and vitamin D supplementation represents an additional mainstay of osteoporosis treatment. Other therapies are available that address the hypogonadal function associated with low bone mass in women including use of estrogen and selective estrogen receptor modulators (SERMs).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Calcitonin is another approved antiresorptive for the treatment of osteoporosis. Whereas bisphosphonates represent the first line treatment for osteoporosis, approved therapies associated with osteoblast anabolic function are also available. These include Eli Lilly’s PTH-related anabolic agent Forteo (teriparatide) which was approved as a biological agent in 2002 and Nycomed’s PTH molecule Preotact which was approved in Europe in 2006. However, while indicated for treatment of osteoporosis via enhanced bone-forming activity, the Forteo label limits its use to 2 years because of the risk of osteosarcoma. Other compound classes with potential anabolic activity that have received particular attention include the selective androgen receptor modulators (SARMs)<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and Servier’s Protelos (strontium ranelate) which, although approved in Europe for osteoporosis, has a less well understood mechanism of action.</div><div class="NLM_p last">The emerging understanding of osteoclast and osteoblast biology has led to the identification of several new targets with potential antiresorptive, anabolic, and dual action properties. The focus of the current Perspective is to describe progress in the advancement of bone antiresorptive or anabolic small molecule programs described in the last five years (or since recent reviews).<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15-17)</a> We have placed an emphasis on targets with a known biochemical mechanism in bone metabolism, and that have been validated by testing with selective small molecule agents in cell culture or in vivo. However, compounds discovered in cell based and natural products screening with unknown biochemical mechanism are also included.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Assessment of Bone Mass and Use of Serum Biomarkers</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24838" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24838" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Bone is constructed of both outer cortical material that is dense and compact with superior strength and inner trabecular material that forms a porous network with a large surface area that is in contact with the marrow. Bone tissue can vary in the proportion of cortical and trabecular material present and regional changes in bone mass, and the effects of bone modulating agents can be monitored in a number of ways. Direct assessment of BMD is typically made noninvasively by dual energy X-ray absorptiometry (DXA), whereas measurement of serum biomarkers is used to indirectly evaluate changes in the rates of bone formation and resorption. In preclinical studies and in patients taking antiresorptive medications, serum or urine C-terminal and N-terminal cross-linking telopeptides of type I collagen (CTX-I and NTX-I) represent examples of several biomarkers used to assess bone resorption. Enhanced osteogenesis is associated with increased differentiation and activity of osteoblast cells, as characterized by the secretion of proteins associated with mineralization and the production of new collagen. These changes can be monitored in preclinical studies and in patients on medication using serum biomarkers including osteocalcin (OC), bone-specific alkaline phosphatase (ALP), and N-terminal and C-terminal cross-linking propeptides of type I procollagen (PINP and PICP respectively).</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Bone Antiresorptive Targets</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64625" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64625" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Bone remodeling is initiated by the activity of osteoclasts as they migrate to the bone surface.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Bisphosphonates inhibit osteoclast activity via stimulation of apoptosis and inhibition of farnesyl diphosphate synthase (FPPS), which is required for prenylation of small GTPases and osteoclast survival.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Osteoclasts attach to proteins containing an arginine−glycine−aspartate (RGD) sequence in the extracellular matrix of mineralized bone largely via α<sub>v</sub>β<sub>3</sub> integrin receptor interactions. The activated osteoclasts establish a sealing zone next to bone that allows for acidification by hydrochloric acid secretion and breakdown of the mineral component. This localized production of hydrochloric acid depends on the activities of an H<sup>+</sup>ATPase, Cl<sup>−</sup> channel, and HCO<sub>3</sub><sup>−</sup> exchanger. The type I collagen exposed during demineralization becomes a substrate for the protease cathepsin K, and the loss of collagen results in the formation of a resorption pit leading to erosion of the bone surface. Recent progress is described below on the development of small molecule inhibitors of cathepsin K and α<sub>v</sub>β<sub>3</sub> integrin as novel antiresorptive agents.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Cathepsin K</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35338" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35338" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cathepsin K is one of 11 human cysteine proteases in the papain family. Expressed primarily and at high levels in osteoclasts, cathepsin K plays an important role in the breakdown of type 1 collagen in bone matrix. Loss of the cathepsin K gene results in pcynodysostosis in humans<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and osteopetrosis in mouse models,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> conditions characterized by short dense bones, providing genetic evidence for the role of cathepsin K in osteoclast function. Recent developments have been reviewed,<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20-22)</a> and advanced compounds from several groups have been published including four clinical candidates that have provided valuable data on cathepsin K inhibition in humans (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Early tool compounds used in preclinical studies of cathepsin K pharmacology were irreversible covalent inhibitors that resulted in antigenic and immunologic complications in vivo. Reversible covalent binders were next developed, followed by noncovalent inhibitors. Decreased affinity of the noncovalent binders for cathepsin K was compensated for by incorporating basic functionality in the S3 pocket. Subsequently it was recognized that inhibitors containing basic functionality may be lysosomotropic and could reach concentrations in acidic subcellular organelles sufficient to cause inhibition of other cysteine proteases or cause other off-target effects despite excellent biochemical selectivity. By optimization of other interactions in neutral scaffolds, potency was improved and lysosomal accumulation was avoided. Data on each class of cathepsin K inhibitor have been recently published and are summarized below (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><figure id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cathepsin K inhibitors in various stages of development.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibitor Enzymatic Potency on CAT K and Isoform Selectivity</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th align="center"> </th><th colspan="6" align="center"><i>n</i>-fold</th></tr><tr valign="top"><th align="center">compd</th><th align="center">IC<sub>50</sub> (nM)<br /></br>CAT K</th><th align="center">CAT B</th><th align="center">CAT L</th><th align="center">CAT S</th><th align="center">CAT V</th><th align="center">CAT H</th><th align="center">CAT F</th></tr></thead><tbody><tr valign="top"><td align="left"><b>1</b></td><td align="left">34.5</td><td align="left">8</td><td align="left">17</td><td align="left">5</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>2</b></td><td align="left">4.8<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td align="left">71</td><td align="left">500</td><td align="left">3542</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>3</b></td><td align="left">1.4</td><td align="left">3428</td><td align="left">359</td><td align="left">46429</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>4</b></td><td align="left"><1.0</td><td align="left"> </td><td align="left">>1000</td><td align="left">>10000</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>5</b></td><td align="left">1.7<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td align="left">>882</td><td align="left">>882</td><td align="left">>882</td><td align="left">>882</td><td align="left">>882</td><td align="left">397</td></tr><tr valign="top"><td align="left"><b>6</b></td><td align="left">2.5<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td align="left">>4000</td><td align="left">>40000</td><td align="left">>40000</td><td align="left"> </td><td align="left">>4000</td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>7</b></td><td align="left">0.041<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td align="left">317</td><td align="left">1.65</td><td align="left">39</td><td align="left">1.54</td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>8</b></td><td align="left">0.2</td><td align="left">5170</td><td align="left">14975</td><td align="left">300</td><td align="left">3810</td><td align="left">>50000</td><td align="left">3975</td></tr><tr valign="top"><td align="left"><b>9</b></td><td align="left">0.62<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td align="left">>16000</td><td align="left">4700</td><td align="left">4300</td><td align="left">1100</td><td align="left">>140000</td><td align="left">110</td></tr><tr valign="top"><td align="left"><b>10</b></td><td align="left">10.1<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td align="left">>990</td><td align="left">>347</td><td align="left">>446</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>11</b></td><td align="left">18</td><td align="left">>556</td><td align="left">111</td><td align="left">31</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>12</b></td><td align="left">4.8</td><td align="left">>4167</td><td align="left">>4167</td><td align="left">2083</td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">K<sub>i</sub>′.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last"><i>K</i><sub>i</sub><sup>app</sup>.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Biochemical data determined using humanized rabbit enzyme.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last"><i>K</i><sub>i</sub>.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last"><i>K</i><sub>i</sub><sup>ss</sup>.</p></div></div></div><div class="NLM_p">The cathepsin K active site (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) is characterized by the Cys25-His159-Asn175 triad containing the catalytic cysteine Cys25 that forms a reversible or irreversible covalent bond with many reported inhibitors via an epoxide, hydrazide, semicarbazone, vinylsulfone, aldehyde, amide, ketone, or nitrile. Flanking Cys25 are binding sites S and S′, the former of which has been divided into the S1, S2, and S3 pockets and is occupied by the corresponding P1, P2, and P3 inhibitor substituents.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> For example, corresponding to S2, the P2 substituent makes van der Waals contacts with Leu157, Leu205, and Tyr67. 1-Amino-1-cyclohexanecarboxylic acid and leucine derivatives are two P2 groups that have provided high levels of cathepsin K selectivity while maintaining potency. The carbonyl and amine of the P2 group satisfy critical hydrogen bonds with Gly66. The S1 and S′ pockets may or may not be occupied, and the S3 pocket is defined by Tyr67 and Asp61 and appears to tolerate π-stacking aromatic or basic substituents that form ionic interactions.</div><figure id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic representation of the cathepsin K active site.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An example of an irreversible covalent inhibitor of cathepsin K is VEL-0230 (<b>1</b>), developed by Velcura and Nippon Chemiphar (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The carboxylate epoxysuccinyl group binds in the region of the Cys25 and His159 and reacts irreversibly with the catalytic Cys25, providing a moderately potent and selective cathepsin K inhibitor (CAT K IC<sub>50</sub> (nM), 34.5; selectivity (fold), CAT B, 8; CAT L, 17; CAT S, 5). Compound <b>1</b> significantly inhibited osteoclast-dependent resorption pit formation on dentin slices and CTX-I release by mature osteoclasts at 1 μM.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In addition to the antiresorptive behavior known for other cathepsin K inhibitors, <b>1</b> has also been reported to show osteogenic properties,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> possibly via stimulation of differentiation of mesenchymal stem cells (MSC) into osteoblasts.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Velcura has reported the completion of phase Ia clinical trials of <b>1</b> at 150−450 mg in which a significant reduction of CTX-I compared to placebo was observed within 15 min of dosing and persisted over 12 h. Approximately 80% inhibition of CTX-I was observed at 6 h.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Velcura reported in May 2008<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> initiation of phase I clinical trials for the treatment of rheumatoid arthritis, metastatic bone diseases, myeloma, and osteoporosis.</div><div class="NLM_p">Basic substituents in the S3 pocket have been positioned in order to form a highly favorable ionic bonding interaction with Asp61. 3,4-Disubstituted azetidinones, exemplified by compound <b>2</b>, recently published by Celera Genomics, form a covalent thioester bond on reaction with the cathepsin K active site, in a mechanism analogous to β-lactam reaction with serine proteases.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> A similar thioester bond was shown to hydrolyze in vitro with <i>t</i><sub>1/2</sub> = 26 min for another analogue. Compound <b>2</b> was potent and selective (CAT K <i>K</i><sub>i</sub>′ (nM), 4.8; selectivity (fold), CAT B, 71; CAT S, 3542; CAT L, 500), but rat pharmacokinetics were poor, and further optimization was discontinued. Also containing a piperazine group, AAE581 (<b>3</b>) from Novartis was potent and selective<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> (CAT K IC<sub>50</sub> (nM), 1.4; selectivity (fold), CAT B, 3428; CAT L, 359; CAT S, 46429). In phase II clinical trials, a 50 mg dose of compound <b>3</b> decreased bone resorption markers serum CTX-I (61%) and urinary NTX-I (55%) as normalized to creatine at 1 month.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Furthermore, 50 mg of <b>3</b> provided 4.46% and 2.25% increases in BMD at lumbar spine and hip, respectively, compared to 0.25% and 0.25% for placebo at 1 year.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Novartis has reportedly stopped development of this compound,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> since skin adverse events (mainly pruritus) were observed as well as a small number of patients experiencing scleredema or morphea-like skin changes.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Noting the basic piperazine group in the molecule, these adverse findings may have been linked to inhibition of other cathepsins or CAT K itself following lysosomal accumulation of <b>3</b>.<a onclick="showRef(event, 'ref31 ref33'); return false;" href="javascript:void(0);" class="ref ref31 ref33">(31, 33)</a> For example, cathepsins B, K, L, and G are all expressed in skin and skin-derived cells, and their inhibition could lead to excessive deposition of extracellular matrix proteins in the dermis and thereby account for the adverse events.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">A second series of inhibitors based on a novel pyrrolopyrimidine-2-carbonitrile scaffold has been published more recently by Novarits.<a onclick="showRef(event, 'ref35 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref35 ref36 ref37">(35-37)</a> Compound <b>4</b><a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> was potent and selective (CAT K IC<sub>50</sub> (nM), <1.0; selectivity (fold) CAT S, >10000; CAT L, >1000). In rats, <b>4</b> showed high clearance and high volume of distribution ( <i>F</i>, 98%; CL, 14.3 (L/h)/kg; Vd<sub>ss</sub> 97.2 L/kg). It was noted that compounds in this series accumulated in bone marrow, the site of action (compound <b>4</b> had bone marrow/serum concentration ratio of 34.9 after 11 days of dosing 100 mg/kg po in rats). This bone marrow partitioning may lead to improved efficacy. Following administration of 2 mg/kg po q.d. for 14 days to cynomolgus monkeys, <b>4</b> significantly reduced CTX-I levels over the entire 24 h cycle and throughout the 14-day study.</div><div class="NLM_p">Another compound to enter clinical trials was MV-701 (<b>5</b>, structure not disclosed), developed by Medivir AB. Compound <b>5</b> is a selective and potent inhibitor of cathepsin K (CAT K <i>K</i><sub>i</sub> (nM), 1.7; selectivity (fold), CAT L, S, B, V, and H >882; CAT F, 397), and oral administration to male cynomolgus monkeys (16 mg/kg) resulted in a rapid reduction in CTX-I levels within 2 h to a maximum of 80% after 4−8 h. Similar inhibition of CTX-I was seen in multiple day dosing po q.d., and inhibition was reversible, returning to pretreatment levels within 48 h. In a phase I clinical study, CTX-1 was also reduced by >50% at trough concentration between doses following 300 mg po q.d. for 14 days.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Although the structure of <b>5</b> has not been released, a compound recently published by this group is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, MV061194 (<b>6</b>). This compound bears some similarity to <b>2</b> and features a reversible ketone electrophile and a piperazine S3 substituent. Compound <b>6</b> is potent and selective (CAT K <i>K</i><sub>i</sub> (nM), 2.5; selectivity (fold) CAT L and S, >40000; CAT B and H, >4000).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a></div><div class="NLM_p">Another example of a ketone electrophile was the clinical compound developed by GSK, SB-462795 (<b>7</b>). This compound placed a large 7-methylazepanone group in the S1 pocket and occupied the S′ pocket with a pyridin-2-ylsulfonamide group. The azepanone<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> was able to lock in the inhibitor’s bioactive conformation, and with the addition of the C7 <i>S</i>-methyl group, the azepane chair conformation required for binding was favored, thereby improving potency.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> In addition, the stereogenic center adjacent to the reactive ketone was more configurationally stable in the azepane than in smaller ring or acyclic<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> analogues, and the azepane was also observed to improve rat pharmacokinetic properties. X-ray cocrystallography showed that the benzofuran carboxamide formed an edge-to-face π−π stacking interaction with Tyr67 in the S3 pocket. The pyridine-2-ylsulfonamide group occupied the S′ binding pocket with one of the sulfonamide oxygens forming a hydrogen bond with the indole N−H of Trp184.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Compound <b>7</b> was a very potent and reasonably selective cathepsin K inhibitor (CAT K <i>K</i><sub>i,app</sub> (nM), 0.041; selectivity (fold) CAT L, 1.65; CAT V, 1.54; CAT S, 39; CAT B, 317) that showed cellular inhibition of osteoclast resorption (IC<sub>50</sub> ≈ 70 nM). Pharmacokinetics in rat (CL = 19.5 (mL/min)/kg, Vd<sub>ss</sub> = 1.79 L/kg, <i>F</i> = 89%) and cynomolgus monkey (CL = 11.7 (mL/min)/kg, Vd<sub>ss</sub> = 0.95 L/kg, <i>F</i> = 28%)<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> were acceptable. A single dose of <b>7</b> at 10 mg/kg or five daily doses at 3 mg/kg po in cynomolgus monkeys showed a significant decrease in urinary and serum NTX-I of up to 57%. A year of daily dosing in male cynomolgus monkeys at 10, 30, and 1000 mg/kg was well tolerated, although exposure in the 1000 mg/kg group was only 4 times that in the 30 mg/kg cohort. Compared to control, at 30 and 1000 mg/kg doses BMD was significantly increased at lumbar spine, femoral neck, and distal radius (predominantly trabecular bone), and in midfemur and proximal radius (predominantly cortical bone). In addition, bone strength was significantly increased (42% and 49% at 30 and 1000 mg/kg, respectively) in lumbar vertebrae.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Although clinical trials were reported<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> to have started in 2007, no human data have been published. GSK has also recently published a less potent series of semicarbazone-based cathepsin K inhibitors.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a></div><div class="NLM_p">In a series of publications, Merck in collaboration with Celera Genomics discussed their discovery and optimization of odanacatib (MK-0822, <b>8</b>),<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> which was reported to be in phase III clinical trials.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> This compound was designed from a known dipeptide using structural data with the strategy of improving contacts with cathepsin K and replacing peptidic bonds with bioisosteres.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Early lead compounds containing P2 leucine<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> or 1-amino-1-cyclohexanecarboxylic acid<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> were potent (CAT K IC<sub>50</sub> = 0.2 nM), but much of the potency was driven by an ionic interaction with Asp61 via an S3 pocket piperidine. Basic functionality was soon recognized to lead to lysosomotropic compounds.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The S3 piperazine was replaced with methylsulfone, resulting in an approximately 40-fold loss of potency.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> However, replacing the amide link between P3 and P2 with a trifluoroethylamine resulted in a 10- to 20-fold increase in potency on cathepsin K and also improved metabolic stability.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The trifluoroethylamine was itself nonbasic and was able to maintain and enhance the crucial P2−Gly66 hydrogen bonding interaction. A fluorine atom was introduced into the P2 leucine group in order to block oxidative metabolism. P1−P2 amide hydrolysis was reduced by incorporation of a cyclopropyl group into P1 as 1-amino-1-cyanocyclopropane.</div><div class="NLM_p">Compound <b>8</b> showed excellent biochemical potency and selectivity (CAT K IC<sub>50</sub> (nM), 0.2; selectivity (fold), CAT B, 5170; CAT L, 14975; CAT S, 300; CAT F, 3975; CAT V, 3810; CAT C, H, Z >50 000) and was reported to show excellent pharmacokinetics in the dog (<i>F</i> up to 100%) and rat (<i>F</i> up to 38%) with long half-lives.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> In humans weekly 50 mg doses po over 24 months significantly increased BMD at lumbar spine (5.5%) and total hip (3.2%) compared to almost no change for placebo. Treatment at the same dose decreased the bone resorption marker NTX-I in urine by 52%.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div><div class="NLM_p">Primary amides<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> and ketones,<a onclick="showRef(event, 'ref55 ref56'); return false;" href="javascript:void(0);" class="ref ref55 ref56">(55, 56)</a> which allowed exploration of the S′ pocket, as replacements of the nitrile electrophile of <b>8</b> have resulted in selective but somewhat less potent inhibitors. Continued studies<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> on bioisosteric replacement of the P2−P3 amide resulted in a second series that yielded another nonbasic lead compound, MK-1256 (<b>9</b>). The pyrazole core<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> served as an isosteric replacement in the region of the P2−P3 amide and was selected to avoid a steric clash with Asn158 in S2 and to provide additional polar functionality. Increased molecular polarity had a beneficial effect on cell shift in moving from biochemical to cell based measures of potency. The addition of the <i>N</i>-(2,2,2-trifluoroethyl) group blocked metabolic dealkylation, and the <i>gem</i>-dichloro group on the cyclohexyl ring blocked oxidative metabolism while improving potency. As was seen in the optimization of <b>8</b>, the S3 methylsulfone and S1 cyclopropyl groups improved metabolic stability. Compound <b>9</b> was a potent and selective cathepsin K inhibitor (humanized rabbit CAT K IC<sub>50</sub> (nM), 0.62; selectivity (fold), CAT B, >16000; L, 4700; S, 4300; C, 6000; H, >140000; V, 1100; Z, 1700; F, 110), with excellent pharmacokinetics in rat (CL, 7.8 (mL/min)/kg; <i>V</i><sub>d</sub>, 2.8 L/kg; <i>F</i>, 105%) and rhesus monkey (<i>F</i>, 104%. CL, 5 (mL/min)/kg; <i>t</i><sub>1/2</sub>, 13 h; <i>V</i><sub>d</sub>, 3.4 L/kg).<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> When dosed at 1 mg/kg daily for 1 week in ovariectomized (OVX) rhesus monkeys, a mean 72% reduction in urinary NTX-I normalized to creatine was achieved.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div><div class="NLM_p">Amura Pharmaceuticals published a novel nonbasic cis-fused 5,5-bicyclic ketone cathepsin K inhibitor, <b>10</b>, which was made configurationally stable by virtue of its cis-fusion and was able to access both S and S′ binding sites (CAT K <i>K</i><sub>i</sub><sup>ss</sup> (nM), 10.1; selectivity (fold), CAT L, >347; CAT S, >446; CAT B, >990). Compound <b>10</b> inhibited human osteoclast bone resorption in vitro (CTX-I 75% I at 100 nM).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div><div class="NLM_p">A nitrile-based inhibitor was recently published by AstraZeneca (<b>11</b>).<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> This compound was optimized for reduced electrophilicity toward glutathione on the premise that less reactive electrophiles may be more selective for cathepsin K. The isobutyl group occupied S1, the morpholino group occupied S2, and although the 5-amino group was directed toward S3, this position was not further substituted in order to reduce nitrile electrophilicity. Thus, there were no contacts in the S3 pocket. Nevertheless, with minimal molecular recognition elements, <b>11</b> achieved good potency and selectivity (CAT K IC<sub>50</sub> (nM), 18; selectivity (fold), CAT S, 31; CAT L, 111; CAT B >556), and its low molecular weight resulted in favorable rat pharmacokinetic properties.</div><div class="NLM_p last">A series of noncovalent reversible inhibitors related to an earlier series from Novartis has been published recently by Sankyo (<b>12</b>).<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> The 3-biphenylamino, cyclohexyl, ethyl, and acetic acid groups of <b>12</b> occupied the S3, S2, S1, and S′ pockets, respectively. Perhaps because of the lack of a covalent interaction with the catalytic cysteine, good selectivity was achieved (selectivity (fold): CAT S, 2083; CAT B, L, >4167), and potency was maintained on both human and rat (CAT K IC<sub>50</sub> (nM), 4.8 and 58, respectively). With biochemical potency on the rat protein and reasonable PK following 50 mg/kg oral dosing (<i>C</i><sub>max</sub> = 9.2 μg/mL; AUC = 103.9 μgh/mL), <b>12</b> showed a trend toward increased BMD in OVX rat femur following b.i.d. dosing for 42 days, although the improvement was not statistically significant. In addition to the clinical programs listed above, Ono Pharmaceuticals has an ongoing phase II clinical trial to investigate a cathepsin K inhibitor in osteoporosis,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> but no structure, biological, or clinical data have been published. Additional clinical data describing the efficacy of cathepsin K inhibitors in the treatment of osteoporosis are expected in due course.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Integrin α<sub>v</sub>β<sub>3</sub></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61533" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61533" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Integrin α<sub>v</sub>β<sub>3</sub> interacts with many RGD-containing proteins in different cell types but is relatively highly expressed in osteoclasts. Binding of integrin α<sub>v</sub>β<sub>3</sub> to bone matrix proteins such as osteopontin and bone sialoprotein in a noncovalent manner is a key step in the initiation of bone resorption.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Soluble integrin α<sub>v</sub>β<sub>3</sub> binders such as vitronectin, echistatin, and the synthetic cyclic pentapeptide cilengitide (<b>13</b>)<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> inhibit osteoclast activity in culture and prevent bone loss in OVX mice and rats.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Up-regulation of the integrin α<sub>v</sub>β<sub>3</sub> receptor has been associated with osteoporosis. There has been much interest in this target over the years, and the literature has been recently reviewed from a chemistry perspective.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> A humanized mAb to integrin α<sub>v</sub>β<sub>3</sub>, Vitaxin (MEDI-522), is in phase II clinical trials most recently in combination with bevacizumab for the antiangiogenic treatment of metastatic kidney cancer. Related to its inhibition of osteoclast activity in vitro,<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Vitaxin was also reported for possible use in rheumatoid arthritis and related diseases.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div><div class="NLM_p">Small molecule drug-discovery efforts toward integrin α<sub>v</sub>β<sub>3</sub> inhibitors have focused on nonpeptidic RGD mimetics and were accelerated by structural data available from recent crystal structures of the native and cilengitide-bound α<sub>v</sub>β<sub>3</sub> receptor extracellular domain.<a onclick="showRef(event, 'ref70 ref71'); return false;" href="javascript:void(0);" class="ref ref70 ref71">(70, 71)</a> In the cilengitide cocrystal structure, binding interactions were mostly electrostatic, with minor hydrophobic interactions observed. Cilengitide was shown to span a pocket near the extracellular N-termini of the α<sub>V</sub> and β<sub>3</sub> subunits. The guanidine group formed a bidentate salt bridge with α<sub>V</sub>-Asp218 and α<sub>V</sub>-Asp150, and the aspartic acid group bound a Ca<sup>2+</sup> or Mn<sup>2+</sup> metal ion closely associated with the β<sub>3</sub> subunit and formed hydrogen bonds to β<sub>3</sub>-Arg214 and the backbone amide of β<sub>3</sub>-Asn215 and β<sub>3</sub>-Tyr122. The aspartic acid C-β and arginine C-ζ were separated by ∼13.8 Å, an important element in the pharmacophore of α<sub>v</sub>β<sub>3</sub> peptidomimetics.</div><div class="NLM_p">Ligand complementarity to the highly charged α<sub>v</sub>β<sub>3</sub> binding pocket has resulted in analogues with challenging issues of poor oral bioavailability and high plasma protein binding. A common strategy has been to discover lipophilic isosteres of RGD arginine and aspartate functionality. For example, as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, research at Merck resulted in the advanced compound L-000845704 (<b>14</b>) that replaced the guanidine group with less basic, more lipophilic tetrahydronaphthyridine (α<sub>v</sub>β<sub>3</sub> IC<sub>50</sub> = 0.08 nM).<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> Tetrahydronaphthyridine also improved selectivity for the integrin α<sub>v</sub>β<sub>3</sub> isoform (α<sub>v</sub>β<sub>5</sub>, 125-fold selective). The peptide backbone could be replaced with alkylimidazolidinone,<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> increasing lipophilicity and increasing conformational constraint.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> The polarity and basicity of the 3-substituent (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) were modified in order to reduce protein binding (human plasma protein binding, 88%) and improve oral bioavailability, clearance, and half-life. Pharmacokinetic properties of <b>14</b> were determined in rat (<i>F</i>, 26%; CL, 47 (mL/min)/kg; <i>t</i><sub>1/2</sub>, 3 h), dog (<i>F</i>, 64%; CL, 6.4 (mL/min)/kg; <i>t</i><sub>1/2</sub>, 3.5 h), and monkey, and increased BMD was observed at the distal femoral metaphysis relative to cortex in OVX rats at 10 mg/kg (8.9% over vehicle) and 30 mg/kg (12.8% over vehicle) b.i.d. for 28 days.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Urinary NTX-I in OVX rhesus monkeys was reduced by 39% following 15 mg/kg q.d. for 14 days.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a> Dosing in postmenopausal osteoporotic women for 12 months at 200 mg b.i.d. was generally well tolerated and increased BMD at the lumbar spine (3.5%), hip (1.7%), and femoral neck (2.4%).<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div><div class="NLM_p">An alternative approach to reducing plasma protein binding in the same series was to hydroxylate the aliphatic tether between the guanidine mimetic and carboxylic acid groups. On binding α<sub>v</sub>β<sub>3</sub>, the alcohol group was predicted to lie in a solvent exposed region. Compound <b>15</b> showed good potency (α<sub>v</sub>β<sub>3</sub> IC<sub>50</sub> = 0.24 nM), pharmacokinetic properties (dog PK: <i>F</i>, 60%; CL, 2.5 (mL/min)/kg; <i>t</i><sub>1/2</sub>, 6.1 h; human plasma protein binding, 93%), and good selectivity versus the closely related target α<sub>IIb</sub>β<sub>3</sub>.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a></div><div class="NLM_p">A group at Johnson and Johnson took a similar approach in order to improve free fraction and thereby in vivo efficacy. Polar functionality was investigated in a series of alkyltetrahydronaphthyridine substituted indole-based α<sub>v</sub>β<sub>3</sub>/α<sub>v</sub>β<sub>5</sub> dual inhibitors that were directed at oncology and osteoporosis applications.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Introduction of <i>N</i>,<i>N</i>-dimethylaminomethyl to the unsubstituted pyridine ring of an earlier lead resulted in <b>16</b> with good potency (IC<sub>50</sub> α<sub>v</sub>β<sub>3</sub>, 0.29 nM; α<sub>v</sub>β<sub>5</sub>, 0.16 nM; α<sub>v</sub>β<sub>5</sub>, 5.3 nM; α<sub>IIb</sub>β<sub>IIIa</sub>, >1 μM) and reduced human serum albumin (HSA) binding (lead compound HSA bound fraction, 96.5%; <b>16</b>, 40%). Reduced lipophilicity also improved microsomal stability. Interestingly, the indole isomer <b>17</b> was designed on the basis of docking studies using the published α<sub>v</sub>β<sub>3</sub> cilengitide cocrystal structure<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> and was found to have similar potency as <b>16</b> (ELISA IC<sub>50</sub> α<sub>v</sub>β<sub>3</sub>, 0.5 nM; α<sub>v</sub>β<sub>5</sub>, 0.96 nM; α<sub>5</sub>β<sub>1</sub>, 250 nM; α<sub>IIb</sub>β<sub>IIIa</sub>, >1 μM) and good CACO-2 permeability.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div><figure id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Examples of integrin α<sub>v</sub>β<sub>3</sub> inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A Pfizer approach took the strategy of replacing the amide backbone of peptidomimetic α<sub>v</sub>β<sub>3</sub> antagonists with the known amide isostere 1,2,4-oxadiazole.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Compound <b>18</b> contained a tetrahydronaphthyridine guanidine isostere to reduce the basicity of the molecule and was a potent inhibitor of α<sub>v</sub>β<sub>3</sub> (IC<sub>50</sub> = 0.4 nM) and selective over α<sub>IIb</sub>β<sub>3</sub> (67-fold). Adhesion of α<sub>v</sub>β<sub>3</sub>-expressing 293 cells was blocked at 0.65 nM <b>18</b>, but adhesion of α<sub>v</sub>β<sub>1</sub>- and α<sub>v</sub>β<sub>5</sub>-expressing HEK-293 cells was blocked at 2.6 and 1.7 nM, respectively, indicating modest selectivity. Adhesion of α<sub>v</sub>β<sub>6</sub>-expressing HT29 cells was blocked at 2.7 μM. Good rat bioavailability was observed (<i>F</i>, 95%), but clearance was high and <i>t</i><sub>1/2</sub> was reduced (CL, 10.9 (mL/min)/kg; <i>t</i><sub>1/2</sub>, 1.4 h). A second effort from Pfizer directed toward oncology applications identified <b>19</b> that inhibited adhesion of α<sub>v</sub>β<sub>3</sub>-expressing HEK-293 cells at 1 nM and of α<sub>v</sub>β<sub>6</sub>-expressing HT29 cells at 366 nM, indicating good selectivity. Mouse pharmacokinetic properties, however, were poor (<i>F</i>, 5.9%; <i>t</i><sub>1/2</sub>, 2 h).<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></div><div class="NLM_p">In a series of papers from Meiji Seika Kaisha, Ltd., studies of amide <b>20</b>, a dual α<sub>v</sub>β<sub>3</sub>/α<sub>IIb</sub>β<sub>3</sub> inhibitor for the treatment of ischemic diseases, were described. The scaffold was reportedly designed on the basis of structure and literature data and optimized for dual inhibition.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> Aqueous solubility and α<sub>v</sub>β<sub>3</sub> potency were improved by methoxy substitution on the central phenyl ring because of improved contacts in the binding site and torsion around the phenylpiperidine linkage: IC<sub>50</sub> α<sub>v</sub>β<sub>3</sub>, 0.19 nM; α<sub>IIb</sub>β<sub>3</sub>, 0.44 nM; inhibition of aortic smooth muscle cells binding to vitronectin, 110 nM. Rat pharmacokinetic and solubility properties were amenable to intravenous infusion: rat <i>t</i><sub>1/2</sub>, 46 min; CL, 47 (mL/min)/kg; aqueous solubility, 1.3 mg/mL.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> This compound was reported to be under license for preclinical development as MN-447.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a></div><div class="NLM_p last">Other recent developments in α<sub>v</sub>β<sub>3</sub> integrin inhibitors include a hexahydroindolizin-5(1<i>H</i>)-one scaffold with moderate potency for α<sub>v</sub>β<sub>3</sub> and selectivity over α<sub>v</sub>β<sub>5</sub> (<b>21</b>, competitive binding IC<sub>50</sub> 304 nM, α<sub>v</sub>β<sub>5</sub>, 3.5-fold).<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> The discovery was reported of a potent 3-methylthiazolidin-4-one-based α<sub>v</sub>β<sub>3</sub> inhibitor through pharmacophore virtual screening followed by similarity searching among commercial compounds. The most potent α<sub>v</sub>β<sub>3</sub> binder was <b>22</b> (competitive binding IC<sub>50</sub> of 0.03 nM). Compound <b>22</b> showed inhibition of cell growth at 20 μM in several cancer cell lines, but biochemical selectivity data were not provided.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> A series of phenybiguanides was reported that was also discovered by virtual screening followed by SAR analysis of a screening hit. The most potent analogue <b>23</b> inhibited α<sub>v</sub>β<sub>3</sub>-mediated cell adhesion (IC<sub>50</sub> 33.5 nM), but selectivity data was not provided.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Bone Anabolic Targets</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05361" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05361" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Whereas antiresorptive agents inhibit osteoclast function, a complementary approach that targets enhancement of osteoblast function underlies the basis for development of bone anabolic agents. Following activation and resorption of bone by invading osteoclasts, the eroded surfaces become occupied by osteoblasts within the BMU that subsequently engage in the deposition of new matrix in a “coupling” process designed to complete the cycle of new bone formation.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Although the development of pharmacological agents that stimulate bone formation is less advanced compared to antiresorptive therapies, several pathways are known to facilitate osteoblast function including activity via bone morphogenic proteins (BMPs), transforming growth factor β (TGFβ), parathyroid hormone (PTH), insulin-like growth factor (IGF), fibroblast growth factor (FGF), and wingless-type MMTV integration site (WNT) signaling.<a onclick="showRef(event, 'ref2 ref6'); return false;" href="javascript:void(0);" class="ref ref2 ref6">(2, 6)</a> The transcription factor runt-related transcription factor 2 (RUNX2) acts a master regulator that orchestrates many of the downstream effects of these pathways and in its absence the skeleton will not mineralize. Other transcription factors such as osterix and activating transcripton factor 4 (ATF4) also contribute to the expression of osteoblast-specific genes.</div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Parathyroid Hormone Receptor (PTH1R)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15221" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15221" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Analogues of parathyroid hormone (PTH) peptide are the only class of bone anabolic agents currently approved for the treatment of osteoporosis. PTH has been clinically shown to increase bone formation rates, increase bone mineral density, and reduce the incidence of bone fractures.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> In response to low levels of serum calcium, the parathyroid gland normally secretes PTH, which acts on the parathryoid hormone receptor (PTH1R) in bone to release calcium. Prolonged exposure to PTH can cause excessive bone resorption,<a onclick="showRef(event, 'ref87 ref88'); return false;" href="javascript:void(0);" class="ref ref87 ref88">(87, 88)</a> but when dosed intermittently, PTH has anabolic effects on bone in part by preventing osteoblast apoptosis.<a onclick="showRef(event, 'ref89 ref90'); return false;" href="javascript:void(0);" class="ref ref89 ref90">(89, 90)</a> Therefore, approaches have been taken to develop orally active compounds based on identification of small molecule PTH mimetics and compounds that act directly on the parathyroid gland to stimulate secretion of PTH.</div><div class="NLM_p">Given the size of PTH (∼9.5 KDa), it was originally thought unlikely that small molecule mimetics could elicit similar pharmacological responses compared to the natural peptide ligand. Nevertheless, scientists at GlaxoSmithKline were able to identify a small molecule mimic of PTH (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) that contained the pyrimidine 2,4,6-trione core.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Compound AH3960 (<b>24</b>), identified through high-throughput screening, had EC<sub>50</sub> = 1.5 μM for cAMP production and EC<sub>50</sub> = 3.2 μM for intracellular mobilization in HEK293 cells overexpressing PTH1R. In the same assays, hPTH(1−34) had EC<sub>50</sub> values of 0.3 and 1 nM, respectively. In human MSC, both compounds inhibited adipogenesis after intermittent dosing and they also increased ALP, providing evidence for osteoblastic differentiation. The mechanism through which <b>24</b> acts on the PTH1R was not reported, and no further work on this compound has been disclosed. However, two patents (published in 2005)<a onclick="showRef(event, 'ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref92 ref93">(92, 93)</a> from GlaxoSmithKline cover small molecule PTH agonists and disclose structures related to <b>24</b> (see Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, <b>25</b> and <b>26</b>).</div><figure id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0014.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Parathyroid hormone mimetics.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Calcium Sensing Receptor (CaSR)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28776" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28776" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">PTH secretion from the parathyroid gland is regulated by the calcium sensing receptor (CaSR). Binding of calcium to CaSR normally inhibits secretion of PTH. However, compounds that antagonize the effect of Ca<sup>2+</sup> (calcilytics) disrupt CaSR signaling, which results in a release of PTH into the circulation. The first calcilytic reported was NPS 2143 (<b>27</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), a compound containing a central amino alcohol core discovered at NPS Pharmaceuticals and GlaxoSmithKline.<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94, 95)</a> Compound <b>27</b> had IC<sub>50</sub> = 43 nM in HEK 293 cells expressing human CaSR. In cultured bovine parathyroid cells, <b>27</b> was shown to have the desired effect of increasing PTH secretion with EC<sub>50</sub> = 41 nM. This effect was mimicked in rats, where <b>27</b> raised plasma PTH 4-fold during a 2 h infusion. Compound <b>27</b> was also tested in OVX rats.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> After being dosed for 8 weeks, <b>27</b> raised PTH levels but did not produce a significant improvement in BMD in the proximal tibia. In contrast, OVX rats treated with PTH for 8 weeks showed an increase in BMD in the proximal tibia that matched the sham/vehicle treated rats. One explanation for the difference in BMD between <b>27</b> and PTH was thought to be related to the duration of PTH elevation. Compound <b>27</b> elevated PTH levels for at least 4 h, whereas PTH treated animals had elevated hormone levels for only 1 h. The authors suggested that the longer elevated PTH observed with <b>27</b> may result in activation of bone resorptive mechanisms. These data suggested that a shorter acting calcilytic may be beneficial for treating osteoporosis.</div><div class="NLM_p">In an effort to transiently raise PTH levels and thus mitigate the potential for bone resorptive effects, efforts have been made to identify calcilytics with a shorter half-life compared to <b>27</b>. Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> summarizes some compounds where in vivo effects on PTH have been reported. NPS Pharmaceuticals published on a series of calcilytics that contained either a quinazolinone (<b>31</b>)<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> or pyrimidinone (<b>32</b>)<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> core, functionality that is not present on <b>27</b>. Representative examples from this new series of compounds were shown to elevate PTH levels in normal rats for only 5−10 min (<b>31</b>, 10 μmol/kg iv, PTH <i>C</i><sub>max</sub> ≈ 400 pg/mL; <b>32</b>, 3 μmol/kg iv, PTH <i>C</i><sub>max</sub> ≈ 600 pg/mL). In addition to this work, Bristol-Myers Squibb identified a series of calcilytics that contained an aminopyridine core (<b>33</b>).<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> One example from this series was shown to elevate PTH levels with a maximal effect at 2 min (7 μmol/kg iv, 1100 pg/mL), returning to baseline after 10 min in normal rats. While these groups have identified compounds that raise PTH transiently, efficacy in models of osteoporosis has yet to be reported.</div><figure id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Calcium sensing receptor antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The strongest evidence for a calcilytic achieving a PTH profile beneficial for bone formation comes from data reported on ronacaleret (<b>28</b>), a drug co-developed by GlaxoSmithKline and NPS Pharmaceuticals, which had entered the clinic for osteoporosis. Ronacaleret was shown to increase PTH when given orally at 30, 60, or 120 mg/kg to OVX rats (PTH <i>C</i><sub>max</sub> of 33, 66, and 68 pM, respectively).<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Bone formation rates and increases in osteoid perimeter at the lumbar spine were observed in the 120 mg/kg treated animals, but the PTH profile associated with these results has not yet been published. In addition results from a phase I study in healthy postmenopausal women were reported showing that after 28 days of dosing at 475 mg, <b>28</b> significantly increased biomarkers for bone formation (OC, 63%; PINP, 79%; ALP, 35% relative to placebo).<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> According to GlaxoSmithKline’s Web site, <b>28</b> is currently in phase II clinical studies.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> Japan Tobacco and Novartis<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> have also reported having calcilytics in the clinic (JTT-305 and ATF-936, respectively); however, the structures of these compounds have not yet been disclosed.</div><div class="NLM_p">Analogues of <b>28</b> have also recently been described by GSK and NPS. The carboxylic acid SB-423562 (<b>29</b>) was a potent CaSR antagonist (IC<sub>50</sub> = 73 nM) but had high clearance (rat CL = 89 (mL/min)/kg), was poorly absorbed, and suffered high first pass hepatic extraction.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> The corresponding ethyl ester SB-423557 (<b>30</b>) was well absorbed and readily cleaved to the acid in vivo. Thus, <b>30</b>, when dosed in vivo, resulted in dose-dependent and transient systemic levels of the acid <b>29</b>, while the ester was not detected. Accordingly, PTH stimulation with <b>30</b> was dose dependent and short-lived, returning to baseline levels within 2 h following 5, 15, or 50 mg/kg po doses in rats.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> In OVX rats, 50 mg/kg dosed daily po increased BMD and strength of the lumbar spine to near sham surgery control levels but not as well as 1 μg/kg sc PTH(1−34). Pharmacokinetic properties were similar in humans, with short half-life (1.4−3.7 h). Furthermore, the <i>t</i><sub>max</sub> (1−2 h) and duration of PTH elevation (0.5−6.5 h) after oral administration of <b>30</b> in humans closely matched the profile observed after intermittent sc dosing of PTH(1−34).<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> This suggested that oral adminstration of <b>30</b> might improve BMD in humans. The risk of hypercalcemia associated with calcilytics does not appear to be a concern with <b>30</b>, since after a dose of 400 mg in healthy volunteers, the increase in serum ionized calcium was considered to be within the normal range.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a></div><div class="NLM_p last">In a publication by Pfizer scientists, use of GSK’s <b>28</b> was shown to have modest activity against the human CaSR (IC<sub>50</sub> = 150 nM), with an oral bioavailability of 12% in rats.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> In an effort to improve on <b>28</b>, this group prepared analogues that contained more hydrophobic substituents adjacent to the carboxylic acid moiety and replaced the phenoxy ring with a benzyloxy group.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Their work led to compound <b>34</b>, which had CaSR IC<sub>50</sub> = 25 nM and rat oral bioavailability of 60%. The PTH response with compound <b>34</b> in Sprague−Dawley rats was considered robust, but a time course profile was not reported.</div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Wingless-Type MMTV Integration Site (WNT) Pathway</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33246" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33246" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The wingless-type MMTV integration site (WNT) family of ligands is required in a variety of developmental and regenerative processes.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> In bone, activation of the canonical WNT signaling pathway is associated with differentiation, proliferation, and survival of osteoblasts.<a onclick="showRef(event, 'ref107 ref108 ref109'); return false;" href="javascript:void(0);" class="ref ref107 ref108 ref109">(107-109)</a> The role of the WNT co-receptor lipoprotein receptor-related protein 5/6 (LRP5/6) in the regulation of bone mass has received particular attention over the past few years. In humans, loss or gain of function mutations in the LRP5 gene is associated with low and high bone mass phenotypes, respectively. Binding of WNTs to LRP5/6 and frizzled receptor (FZD) results in LRP5/6 phosphorylation and the formation of a complex containing disheveled (DSH), glycogen synthase kinase-3β (GSK-3β), axin, and adenomatous polyposis coli (APC).<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> As part of this complex, GSK-3β is unable to phosphorylate β-catenin which can subsequently translocate to the nucleus, bind to T-cell factor (TCF)/lymphoid enhancer-binding factor (LEF) transcription factors, and activate transcription of bone related genes. Importantly, however, genetic studies of β-catenin mice with gain and loss of function mutations in osteoblasts suggest that, unlike LRP5 mutations that can affect bone formation parameters, β-catenin impacts bone mass via effects on resorption mediated by changes in OPG expression.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> These contrasting genetic findings suggest that LRP5 and β-catenin may not be linked directly via WNT signaling to the control of bone mass. Nevertheless, canonical WNT signaling is regulated by several types of WNT inhibitors such as sclerostin (SOST), dickkopf-1 (DKK1), secreted frizzled related protein-1 (sFRP1), and WNT inhibitory factor-1 (WIF-1), which are known to have profound inhibitory effects on bone mass.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> As such, this pathway has opened up new opportunities for therapeutics to treat bone diseases.</div><div class="NLM_p">Targeted approaches for activating the canonical WNT signaling pathway include (1) blocking the antagonists that bind to the LRP5/6−FZD complex, (2) inhibiting the proteins that sequester WNTs and neutralize WNT activity, and (3) increasing intracellular β-catenin levels by inhibiting the kinase GSK-3β (see below). Monoclonal antibodies against sclerostin, developed by Amgen and UCB, had marked bone anabolic effects in preclinical rodent models of postmenopausal osteoporosis<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> and inflammation-induced bone loss.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> In a follow-on human study, administration of a sclerostin-neutralizing monoclonal antibody in healthy postmenopausal women resulted in dose-dependent increases in biochemical markers of bone formation.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Amgen also reported on a monoclonal antibody to DKK1 which showed efficacy in rodents and also in a mouse model of rheumatoid arthritis.<a onclick="showRef(event, 'ref115 ref116'); return false;" href="javascript:void(0);" class="ref ref115 ref116">(115, 116)</a> A human anti-DKK1 neutralizing antibody (BHQ880) was recently shown to stimulate bone formation in mouse myeloma models,<a onclick="showRef(event, 'ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref117 ref118">(117, 118)</a> and Novartis has initiated a clinical trial for osteolytic bone loss associated with multiple myeloma.</div><div class="NLM_p">Recently, Wyeth reported a small molecule with a 2-aminopyrimidine structure that showed evidence of WNT signaling agonist activity in osteosarcoma cells. WAY-262611 (<b>35</b>) was reported to have micromolar cellular activity and furthermore showed increased trabecular bone formation rate in the tibia in OVX rats (10 mg/kg po q.d., 28 days, 1.5 (μm<sup>2</sup>/μm)/day).<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Importantly, <b>35</b> did not appear to inhibit GSK-3β, suggesting that the compound may act by enhancing WNT/LRP5/FZD interactions at the cell membrane. More recently naphthylpyrimidine <b>36</b> was developed from a high-throughput screening campaign. Compound <b>36</b> had EC<sub>50</sub> = 6.8 μM (4.9-fold induction at 20 μM) in a Wnt3a and DKK1-dependent TCF-luciferase cellular assay. Furthermore, C57BL/6 mice given a local subcutaneous injection (0.1 mg/kg <b>36</b>, q.d., 7 days) over the right side of the calvaria showed a dose-dependent increase in mineral apposition rate (∼150%) used as a measure of in vivo bone anabolic activity.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Since compounds showed minimal effects on GSK-3β, it was proposed that agonistic activity was mediated via WNT3a/DKK1 interaction.</div><div class="NLM_p">In a different approach, Wyeth identified two series of sulfonamides that disrupted the binding of WNT to sFRP-1.<a onclick="showRef(event, 'ref121 ref122'); return false;" href="javascript:void(0);" class="ref ref121 ref122">(121, 122)</a> By use of human U2OS osteosarcoma cells overexpressing sFRP-1 and WNT-3a, compound <b>37</b> containing a bis-phenylsulfone core was obtained from a high throughput screening campaign (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Compound <b>37</b> showed EC<sub>50</sub> = 3.9 μM in a TCF-luciferase assay, a measure of WNT signaling pathway activation, and a 2.5-fold induction of TCF-luciferase gene expression at 15 μM. Through SAR studies, compound <b>38</b> was obtained which had a higher EC<sub>50</sub> of 7 μM and showed a 3-fold increase in TCF-luciferase gene expression at 15 μM. At 5 μM, <b>38</b> also increased the total bone area (∼150%) and the number of osteoblasts (∼130%) in an ex vivo mouse calvarial study used as a secondary assay to assess effects on bone formation.</div><figure id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. WNT pathway inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a second related sulfonamide series, Wyeth compound WAY-316606 (<b>39</b>) demonstrated an EC<sub>50</sub> = 0.65 μM in the TCF-luciferase assay,<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> and at 10 μM, <b>39</b> caused an 8.7-fold increase in gene expression.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Compound <b>39</b> also increased total bone area 60% in the ex vivo mouse calvarial assay at 10 nM.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Through extensive SAR studies, compound <b>40</b> was identified which had an EC<sub>50</sub> = 30 nM and was able to cause a 4-fold increase in WNT-Luc gene expression at this concentration.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> In the ex vivo mouse calvarial assay, <b>40</b> increased total bone area 75% at 1 nM. While compounds like <b>39</b> and <b>40</b> increased bone formation in an ex vivo model, the compounds lacked sufficient exposure in vivo and data were not reported from preclinical models of osteoporosis. Nonetheless, this set of sFRP-1 inhibitors illustrates how relatively low-molecular-weight compounds can be identified with the potential for disrupting protein/protein interactions in the WNT-signaling pathway.</div><div class="NLM_p last">Other series disclosed by Wyeth include a series of iminooxothiazolidines that also inhibited sFRP-1. Methyl ester <b>41</b> was discovered in a cell-based screen of Wnt-pathway activation and was shown to selectively bind sFRP-1 with <i>K</i><sub>D</sub> = 0.72 μM based on changes in protein tryptophan fluorescence. The corresponding ethyl ester (<b>42</b>) showed a 2.3-fold increase in TCF-luciferase gene expression at 15 μM in transfected U2OS cells and increased total bone area (∼120%) and the number of osteoblasts (∼140%) in an ex vivo calvarial bone formation assay at the same concentration.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a></div></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Glycogen Synthase Kinase 3 (GSK3)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31785" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31785" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">GSK3 has been implicated in a number of diseases including neurological disorders,<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> cancer,<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> and diabetes.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> The GSK-3α and related GSK-3β genes are expressed ubiquitously in tissues but are not functionally redundant. The β isoform of GSK3 and more recently the α isoform<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> have been shown to interrupt canonical WNT signaling by lowering the intracellular levels of β-catenin via phosphorylation, which leads to removal of β-catenin by proteasomal degradation. Since canonical WNT signaling appears to be important for regulation of bone mass,<a onclick="showRef(event, 'ref107 ref108 ref109 ref110'); return false;" href="javascript:void(0);" class="ref ref107 ref108 ref109 ref110">(107-110)</a> inhibitors of GSK3 in principle have the potential to act as bone anabolic agents.</div><div class="NLM_p">While many groups have published on potent GSK3 inhibitors, there are relatively few examples where GSK3 inhibitors have been used in preclinical models of osteoporosis. Lithium chloride is known to weakly inhibit GSK-3β (<i>K</i><sub>i</sub> = 2 mM).<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Nevertheless, when normal C57BL/6, osteopenic SAMP6, and <i>Lrp5</i><sup><i>−/−</i></sup> mice were dosed with lithium chloride (200 mg/kg po q.d., for 1 month), bone volume and bone formation rates were increased in all strains. The anabolic responses to lithium were greatest in the <i>Lrp5</i><sup>−/−</sup> and SAMP6 mice where bone formation rates increased ∼130% compared to ∼30% in C57BL/6 mice.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> These interesting results therefore suggested that the bone anabolic effects of lithium were occurring via canonical WNT signaling but downstream of the LRP5 WNT co-receptor. It was proposed that prospective studies of patients receiving lithium therapy might demonstrate a link with increased bone mass.</div><div class="NLM_p">A group from Eli Lilly indentified a dual GSK-3α and GSK-3β inhibitor, compound <b>43</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), through SAR work on a series of bis-arylmaleimides, a compound class present in other GSK3 inhibitors.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> Compound <b>43</b> had an IC<sub>50</sub> = 1.3 nM on GSK-3β and was 500-fold selective over a panel of 11 other kinases.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> In mouse mesenchymal C3H10T1/2 cells, <b>43</b> was shown to dose-dependently increase the levels of β-catenin (1.5-fold at 1 μM). In the same cell line, WNT signaling measured by TCF-luciferase gene expression increased by 7-fold at 0.1 μM but decreased to about 2-fold at 10 μM. Increased expression of genes associated with osteoblast differentiation and activity such as ALP and OC was also observed in C3H10T1/2 cells treated with <b>43</b>. In a 2-month study with OVX rats, compound <b>43</b> dosed 3 mg/kg q.d., po, was also shown to restore both mineral apposition rate in tibia and mechanical properties of L5 vertebrae to levels similar to those of sham control.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></div><figure id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Eli Lilly GSK inhibitor <b>43</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">While the preclinical observations with GSK3 inhibitors on bone formation are promising, there is concern that inhibition of GSK3 may be tumor promoting.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> GSK3 suppresses not only WNT signaling but also hedgehog and notch pathways which play fundamental roles in cell growth, differentiation, and proliferation. Inhibition of GSK3 may activate these pathways, causing an increase in cell proliferation.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> However, GSK3 inhibitors have been shown to inhibit the growth and proliferation of pancreatic<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> and colorectal tumors.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a></div></div><div id="sec11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Whole Cell Screening</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80555" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80555" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In addition to targeting specific mechanisms of bone anabolism, research groups have also screened compounds in whole cell assays that provide functional assessments of osteogenesis. In a proof of concept study from the Schultz group,<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> ∼100 000 compounds were screened in mouse C3H10T1/2 cells using ALP as a marker of osteogenesis. This work led to the identification of a purine analogue, purmorphamine (<b>44</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), that increased ALP activity at concentrations as low as 1 μM. Osteoblast differentiation was confirmed in <b>44</b> treated cells by increased expression of the bone-specific transcription factor RUNX2. Compound <b>44</b> was also shown to increase ALP activity synergistically with bone morphorgenetic protein-4 (BMP-4), a growth factor that induces C3H10T1/2 differentiation. Additional work<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> demonstrated that <b>44</b> activated the hedgehog signaling pathway and that smoothened was the specific protein target in the hedgehog pathway.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a></div><figure id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Osteogenic compounds identified through whole cell screening.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">At Amgen,<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> ∼45 000 compounds were screened in a mouse MC3T3-E1 osteoblast cell line, using ALP and OC as markers of osteogenesis and calcium as a marker of mineralization. Two of the most potent compounds identified from this screen, AMG0892 (<b>45</b>) and AMG0309 (<b>46</b>), increased ALP (15- and 25-fold, respectively), OC (6- and 5-fold, respectively), and calcium (2.5-fold) with EC<sub>50</sub> values between 30 and 100 nM. These two compounds also increased the expression of RUNX2, confirming osteoblast differentiation. The underlying mechanism responsible for the osteogenic activity of <b>45</b> and <b>46</b> was also examined. Both compounds inhibited MC3T3-E1 cell growth and had no effect on apoptosis, suggesting a link between growth inhibition and increased osteogenesis. In cell-based studies using luciferase reporter gene assays driven by BMP, WNT, and CREB response elements, <b>45</b> and <b>46</b> were shown to activate the CREB pathway but not the BMP or WNT signaling pathways.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> These results suggested that the osteogenic effects seen with <b>45</b> and <b>46</b> were due to CREB pathway activation, a pathway that has been implicated in osteoblast biology.<a onclick="showRef(event, 'ref140 ref141'); return false;" href="javascript:void(0);" class="ref ref140 ref141">(140, 141)</a></div><div class="NLM_p">Compounds affecting osteogenesis were also identified in a high-throughput screen in MCT3-E1 cells using a green fluorescence protein reporter gene assay, driven by the type I collagen promoter (Col1a1GFP).<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> After the screening of ∼2500 compounds, a natural product obtained from the licorice plant <i>Glycyrrhiza glabra</i> was identified, named glabrisoflavone (<b>47</b>), which increased expression of GFP and transcription of OC (∼58% over control) and ALP (∼58% over control) mRNA at 30 μM. The osteogenic activity of glabrisoflavone was also confirmed in mouse primary osteoblasts. Mechanistic studies were conducted in luciferase assays containing BMP, WNT, or RUNX2 response elements. Glabrisoflavone had no significant effect in these settings, which suggested that the osteogenic effects of glabrisoflavone operated independently of the BMP, WNT, or RUNX2 pathway.</div><div class="NLM_p last">Finally, a high-throughput screen in MCT3-E1 osteoblast cells was performed for compounds that increased activity of the BMP-2 promoter.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Benzthiophene <b>48</b> was shown to induce BMP-2 expression by 35.6% at 4 μM. HMG-CoA reductase inhibitors are also known to increase BMP-2 expression,<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> and in this report 0.4 μM lovastatin was shown to increase BMP-2 expression 20.9%. When compound <b>48</b> was dosed orally at 15 and 30 mg/kg for 90 days in OVX rats, it significantly increased trabecular bone volume (19.4% and 21.0%, respectively) compared to vehicle treatment and it returned bone resorption surface to levels close to those seen in sham operated animals.</div></div><div id="sec12" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Dual Antiresorptive and Anabolic Targets</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Some targets appear to be expressed in both osteoblasts and osteoclasts and may hold promise for a synergistic effect in treating osteoporosis. Prostaglandin and cannabinoid receptors and SRC and PYK2 kinase pathways in osteoclasts and osteoblasts have been targeted for potential dual antiresorptive and anabolic treatments of osteoporosis.</div></div><div id="sec13" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Prostaglandin E2 Receptors EP2 and EP4</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04588" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04588" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Prostaglandin E2 (PGE2, <b>49</b>) signals through at least four known receptors (EP1−4). Local administration of <b>49</b> in animals stimulates new bone formation and increases bone mass and strength, although therapeutic use is limited by side effects that include diarrhea, lethargy, and hypotension. These side effects may be due to <b>49</b> activity<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> at EP1 and EP3 receptors;<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> thus, isoform selective agonists of EP2 and/or EP4 receptors could be valuable as anabolic treatments of osteoporosis.<a onclick="showRef(event, 'ref147 ref148 ref149'); return false;" href="javascript:void(0);" class="ref ref147 ref148 ref149">(147-149)</a> The relative importance of EP2 and EP4 receptors in regulating bone mass was recently reviewed,<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> suggesting that the evidence for a role of both receptors in bone formation was more consistent than a direct role for either on osteoclastogenesis. Both EP2 and EP4 receptors appeared to be important for bone formation in animal models, but a role for the human EP2 receptor remains to be confirmed.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a></div><div class="NLM_p">Pfizer previously initiated programs on both EP2 and EP4 receptor agonists for bone disease. An EP4 selective agonist based on a scaffold related to the natural ligand <b>49</b> was developed from a screening effort. Introduction of a thiophene ring into the N-linked alkanoic acid side chain blocked a β-oxidation clearance pathway, improving metabolic stability. The aryl ring in the C-linked side chain was optimized for selectivity and potency, resulting in CP432 (<b>50</b>, rat IC<sub>50</sub> values EP4, 6 nM; EP2, 483 nM; EC<sub>50</sub> cAMP activation in HEK-293 expressing rat EP4, 0.5 nM, 102% of <b>49</b> response, Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>).<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Rat oral pharmacokinetics were poor (CL, 70 (mL/min)/kg; <i>F</i>, 1%; <i>t</i><sub>1/2</sub>, 0.2 h), but 1 mg/kg dosed daily sc to 12-month-old ovariectomized rats for 6 weeks increased total bone mineral content (20.6%) and total BMD (22.9%) over vehicle and was well tolerated. Increased mineralizing surface and mineral apposition rate indicated increased recruitment and activity of osteoblasts.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a></div><figure id="fig10" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Prostaglandin E2 receptor EP2 and EP4 agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In a parallel program, Pfizer designed CP-533,536 (<b>51</b>) based on an earlier published sulfonamide that was known to be EP2 selective. Phenoxyacetic acid was introduced as an isostere of <b>49</b> heptenoate and provided an attractive balance of EP2 potency and EP4 selectivity. Arylsulfonamide and 3-pyridyl in particular provided good functional potency while maintaining selectivity. The <i>tert</i>-butylphenyl group, being highly metabolized, was added to prevent systemic exposure of the compound following local administration by injection into the bone marrow cavity. These studies resulted in <b>51</b> (rat IC<sub>50</sub> values EP2, 50 nM; EP4, >3200; EC<sub>50</sub> cAMP activation in HEK-293 expressing rat EP2, 0.3 nM, full agonist compared to <b>49</b>)<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> that was selective among seven other prostanoid receptors<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> and did indeed show a short plasma half-life (1 mg/kg iv rat CL, 56 (mL/min)/kg; <i>t</i><sub>1/2</sub>, 0.33 h). In a model of bone growth,<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a><b>51</b> (0.3 mg/kg) was injected directly into the rat periosteum in an extended release formulation. After 2 weeks volumetric bone mineral content (BMC) and bone area were found to be increased 18% and 25%, respectively, over vehicle. In a model of fracture healing, the rat femur was fractured and <b>51</b> (0.5 mg) injected directly into the fracture site. After 3 weeks, total callus area was found to be increased 19% over vehicle and mean force to failure by torsional testing was increased by 34%.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Recently, this compound entered a phase II clinical trial for tibial shaft fracture healing.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a></div><div class="NLM_p last">Ono Pharmaceuticals has also developed an EP4 agonist, ONO-4819 (<b>52</b>). Introduction of sulfur in the α-chain was found to improve potency, and its position in the chain was important for selectivity and chemical stability.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Installation of phenyl in the ω-chain improved selectivity but reduced EP4 potency. Potency was recovered by meta-substitution with methoxymethyl. Compound <b>52</b> was brought forward as the methyl ester of <b>53</b> (data for <b>52</b>: mouse competitive binding <i>K</i><sub>i</sub> values, EP4, 0.70 nM; EP2, 620 nM; EP3, 56 nM; five other receptors >10 μM; c-AMP production in CHO cells expressing mouse EP4 EC<sub>50</sub>, 1.6 nM)<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> because of increased chemical stability of the ester. Compound <b>52</b> has been shown to accelerate BMP-induced osteoblast differentiation<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> and to augment the BMP-dependent bone mineralization in mice. Polymer discs containing BMP (5 μg) and <b>52</b> (300 μg) implanted in the dorsal muscle pouch in mice were mineralized to a greater extent (BMC ∼3-fold higher) than discs containing BMP alone after 3 weeks.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> Furthermore, in OVX rats, <b>52</b> at 3 μg/kg sc b.i.d. for 11 weeks restored trabecular BMD from 220 mg/cm<sup>3</sup> (OVX vehicle) to 378 mg/cm<sup>3</sup>.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a></div></div><div id="sec14" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Cannabinoid Type 1 and Type 2 Receptors (CB1 and CB2)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18088" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18088" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Differentiated osteoblasts and osteoclasts express cannabinoid type 2 receptors (CB2) on their surfaces<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> and produce the endocannabinoids 2-arachidonoylglycerol and anandamide.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> Mouse gene knockout data and in vitro cellular studies using selective agonists and antagonists indicated that CB2 signaling was important in osteoblastic colony formation, ALP activity, and matrix mineralization. CB2 signaling may also suppress osteoclast differentiation.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> In vivo, <i>Cb2</i> knockout animals showed high bone turnover with overall bone loss at 1 year and increased bone loss compared to wild-type following ovariectomy.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> In humans polymorphisms in the <i>CNR2</i> gene that encodes CB2 have been associated with osteoporosis. On the other hand, CB1 is highly expressed in bone sympathetic nerve terminals and may function by suppressing norepinephrine release in the vicinity of osteoblasts, possibly leading to increased bone formation.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> However, <i>Cb1</i> knockout studies in mice<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> have demonstrated low bone mass, normal bone mass, or high bone mass phenotypes depending on gender and mouse background strain.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a></div><div class="NLM_p">Selective and nonselective CB1 and CB2 small molecule agonists and antagonists have been made available through their development for the treatment of central and peripheral neurological disorders and have been important tools in the elucidation of cannabinoid receptor pharmacology in bone metabolism (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>). Bone anabolic effects were associated with CB1 and CB2 dual agonists, and antiresoptive effects were demonstrated for CB2-selective antagonists. CP55,940 (<b>54</b>),<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> a nonselective CB agonist, stimulated bone nodule formation in MSC cultures at 100 nM. In contrast, bone nodule formation was inhibited by AM251 (<b>55</b>),<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> a selective CB1 antagonist, at 100 nM.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> AM630 (<b>56</b>),<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> a selective CB2 antagonist, inhibited osteoclast differentiation (IC<sub>50</sub> = 0.33 μM) and activity (IC<sub>50</sub> = 7.2 μM) in vitro. Furthermore, <b>56</b> at 1 mg/kg restored bone volume in OVX wild-type mice compared to sham/vehicle treated animals.<a onclick="showRef(event, 'ref162 ref168'); return false;" href="javascript:void(0);" class="ref ref162 ref168">(162, 168)</a> CB2 selective agonists JWH-133 (<b>57</b>)<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> and HU308 (<b>58</b>)<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> promoted osteoclast differentiation at concentrations from 10 to 300 nM.</div><div class="NLM_p">Recent reports of other small molecule cannabinoid receptor ligands have appeared but have not included data associated with bone metabolism. Benzimidazole derivatives as CB2 agonists have been recently disclosed by Astra-Zeneca.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> Diverse CB2 partial agonists, antagonists, and inverse agonists of moderate affinity were discovered by virtual screening.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> A series of 1-alkyl-2-aryl-4-(1-naphthoyl)pyrroles as CB1 and CB2 dual binders have also been described.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a></div><div class="NLM_p">A new report suggested a potential role for the CB receptor-related molecule GPR55 in regulating osteoclast activity and bone mass.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> GPR55 was found to be expressed in both osteoclasts and osteoblasts, and in Gpr55 knockout mice bone volume was increased in the tibia and femur (136% and 149%, respectively) of 12-week-old male (but not female) mice. The increased bone mass was associated with impaired osteoclast function, despite increased osteoclast numbers and no change in bone formation parameters. Cannabidiol (<b>59</b>) has a low affinity for CB1 and CB2 receptors (<i>K</i><sub>i</sub> from 2.4 to 10 μM)<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> but is an antagonist of GPR55 (EC<sub>50</sub> = 445 nM). When tested on human osteoclasts cultured on dentin discs for 5 days, <b>59</b> inhibited osteoclast activity induced by the GPR55 agonist O-1602. Moreover, treatment of male mice for 8 weeks with 10 mg/kg cannabidiol (3 times per week) decreased bone resorption (serum CTX-I, −18%) and was associated with a nonsignificant increase (10%) in bone volume.</div><figure id="fig11" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0006.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Cannabinoid CB1 and CB2 binders and GPR55 antagonist <b>59</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec15" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Sarcoma Proto-Oncogene (SRC) Tyrosine Kinase</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12400" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12400" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Sarcoma proto-oncogene (SRC) kinase is a well recognized target in oncology with several inhibitors or dual SRC/Abelson murine leukemia viral oncogene (ABL) inhibitors in advanced clinical trials or marketed (KX2-391, phase I; AZD-0530 (<b>60</b>), phase II; dasatinib, launched). Previously <i>Src</i><sup>−/−</sup> mice<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> were demonstrated to present an unusual osteoclast morphology with an inability to resorb bone<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> and an osteopetrotic phenotype. SRC also negatively regulates osteoblast differentiation, and inhibitors may have a complementary effect in both cell types.<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a></div><div class="NLM_p">Although under development for oncology applications, the effect of <b>60</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>) on osteoclasts in vitro and in vivo has been studied. Compound <b>60</b> binds the SRC kinase ATP binding site where the tetrahydropyran-4-yloxy group occupies the ribose pocket improving selectivity, and the chlorobenzodioxolyl group makes important hydrophobic contacts in the SRC selectivity pocket (IC<sub>50</sub> values: SRC, 2.7 nM; LCK, <4 nM; YES, 4 nM; ABLl, 30 nM; KIT, 200 nM; CSK, 840 nM; 18 other kinases reported were >2 μM).<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> Compound <b>60</b> inhibited formation and activity of human osteoclasts in vitro. Bone resorption on bovine cortical bone in PBMC/osteoclast culture was completely blocked by 1 μM <b>60</b> over 3 weeks.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> In men, markers of bone resorption reported from a multiple ascending dose study of <b>60</b> were reduced following 10−14 days dosing at 250 mg (serum CTX-I, −88%; urinary NTX-I, −67%).<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a></div><div class="NLM_p">One series of SRC inhibitors has been specifically developed for applications in osteoporosis. AP23451 (<b>61</b>) was developed from a known series of purine-based cyclin-dependent kinase (CDK) inhibitors.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> The diphosphonic acid group was included in order to target the inhibitor to active sites of bone remodeling, was predicted by modeling to be projected into solvent on binding to SRC, and was shown not to interfere with binding. The carbon linked <i>trans</i>-4-aminocyclohexyl group particularly improved SRC kinase potency.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> Compound <b>61</b> was equipotent on SRC and ABL (IC<sub>50</sub>, 68 nM) but at least 30-fold selective over CDK2 and a panel of 35 other kinases. In a mouse model of osteoclast activation and bone resorption, <b>61</b> (3 or 10 mg/kg sc b.i.d. for 5 days) reduced serum calcium levels in mice treated with PTH (20 μg/kg q.i.d. for 3 days) to levels at or below those of untreated animals. [<sup>14</sup>C]<b>61</b> was effectively localized to bone and retained there for several weeks.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> However, it is difficult to differentiate effects due to specific SRC inhibition from those due to bisphosphonate-type osteoclast inhibition.</div><figure id="fig12" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0007.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. SRC tyrosine kinase inhbitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec16" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Proline-Rich Tyrosine Kinase 2 (PYK2)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12286" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12286" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Proline-rich tyrosine kinase 2 (PYK2) is another enzyme implicated in the regulation of both osteoblast and osteoclast activity.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> Several studies point toward a role for PYK2 in the osteoclast sealing zone and its ability to alter bone resorption. In fact osteopetrosis and impaired osteoclast function are phenotypic features of <i>Pyk2</i><sup>−/−</sup> mice.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> Moreover, an independent study of <i>Pyk2</i><sup>−/−</sup> mice also showed that increases in osteoblast number and activity contributed to increased bone mass, raising the possibility of a dual role for PYK2 in bone biology.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> In this latter study, PF-431396 (<b>62</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>) was developed as a combined PYK2/FAK inhibitor (IC<sub>50</sub> values: PYK2, 11−32 nM; FAK, 1.5 nM) and over 28 days of dosing (30 mg/kg, po) was able to maintain total bone content and total bone density in OVX rats. Increased mineralizing surface (30.4% OVX plus vehicle versus 40.6% OVX plus <b>62</b>) and mineral apposition rate (1.43 μm/day OVX plus vehicle versus 1.96 μm/day OVX plus <b>62</b>) in proximal tibia cancellous bone were consistent with increased osteoblast activity. Because of the lack of kinase selectivity, it is difficult to know the contribution of PYK2 or FAK inhibition to in vivo efficacy. Another compound from this series PF-562271 (IC<sub>50</sub> values: PYK2, 14 nM; FAK, 1.5 nM) has completed a phase I study in oncology applications.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> More recently PF-4618433 (<b>63</b>) was published as part of a structural analysis and although less potent on PYK2 (IC<sub>50</sub> 637 nM) may provide a more selective starting point for optimization.<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a></div><figure id="fig13" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0008.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. PYK2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Screening at Amgen identified a pyridinone series of compounds (<b>64</b> and <b>65</b>) as PYK2 inhibitors (IC<sub>50</sub> values 35 and 53 nM, respectively) that did not inhibit FAK (IC<sub>50</sub> values of 17 and >125 μM, respectively).<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> Modeling studies indicated that selectivity may have been achieved by an unusual binding conformation wherein <b>64</b> simultaneously occupied both the DFG-in ATP pocket and the protein substrate binding cleft. These compounds increased ALP, OC, and calcium in MC3T3 cells cultured over 3 weeks (EC<sub>50</sub> ≈ 10 nM).<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> Selectivity was demonstrated over a limited number of other high homology kinases (IC<sub>50</sub> values of >1 μM), but nonselective effects via inhibition of other kinases could not be ruled out.</div></div><div id="sec17" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Natural Products</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45678" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45678" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">While most of the compounds for osteoporosis have been generated using a targeted based approach, a number of researchers have identified natural products that inhibit osteoclasts or activate osteoblasts in vitro (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>). These natural products have frequently been isolated from traditional remedies and folk medicines where anecdotal evidence suggested that they may improve BMD. For example, green tea, used as a curative for many ailments,<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> contains polyphenol natural products that may help in treating osteoporosis. One compound extracted from green tea, <span class="smallcaps smallerCapital">d</span>-catechin (<b>66</b>), is known to inhibit bone resorption in embryonic mouse calvaria.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> A related analogue, (−)-epigallocatechin gallate (EGCG, <b>67</b>), was shown to induce apoptosis in osteoclasts. More recently, <b>67</b> was shown to inhibit RANKL-induced differentiation of mouse osteoclasts in culture (17% at 10 μM, 32% at 20 μM).<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> The authors suggest that <b>67</b> may block RANKL mediated NF-κB transcriptional activation that would result in decreased osteoclastogenesis.</div><figure id="fig14" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0009.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Natural products that modify bone metabolism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Flavonoids, a class of compounds related to the catechins, have also been isolated from plants used in folk medicines. For example, the compound naringin (<b>68</b>), which was isolated from <i>Drynaria fortunei</i>, a plant used in traditional Chinese medicine, was found to stimulate proliferative activity (∼150% at 1 nM) in the ROS 17/2.8 osteosarcoma cell line.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> In a more recent publication,<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> researchers reported the isolation of another flavonoid (<b>69</b>) from <i>D. fortunei</i> that showed increased proliferation in the rat osteosarcoma cell line UMR106 (10 nM, 35.9%). More complex flavonoids, like the biflavonoid sciadopitysin, were also shown to have beneficial effects on osteoblasts. Isolated from the leaves and twigs of the traditional Korean medicinal plant <i>Cephalotaxus koreana</i>, sciadopitysin (<b>70</b>) was shown to increase ALP activity (121% at 1 μM) in primary mouse osteoblasts.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a></div><div class="NLM_p">The anthracene glycosides <b>71</b> and <b>72</b> were isolated from the traditional Vietnamese medicinal plant <i>Rhodomyrtus tomentosa</i> and were shown to increase ALP activity (<b>71</b>, 135% at 0.01 μM), collagen synthesis (<b>72</b>, 111% at 0.01 μM), and mineralization (<b>71</b>, ∼115%; <b>72</b>, ∼125% at 1 μM) of the murine osteoblast cell line, MC3T3.<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a> Another plant used in traditional Vietnamese medicine is <i>Manglietia phuthoensis</i>, which has been extracted to yield a phenyl glycoside and a lignan glycoside that stimulate osteoblasts.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> These two compounds, named mangliesides B (<b>73</b>) and E (<b>74</b>), respectively, also increased ALP activity (<b>73</b>, ∼114%; <b>74</b>, ∼112% at 0.03 μM), collagen synthesis (<b>73</b>, ∼123%; <b>74</b>, ∼118% at 0.03 μM), and mineralization (<b>73</b>, ∼118%; <b>74</b>, ∼109% at 0.03 μM) in MC3T3-E1 cells.</div><div class="NLM_p last">Besides polyphenols and polyhydroxylated compounds, a few terpenes have been isolated from folk medicines and have been shown to either stimulate osteoblasts or inhibit osteoclastogensis. A compound from the class of diterpenes known as the cembranoids, compound <b>75</b>, was isolated from the soft coral <i>Sarcophyton mililatensis</i> and was shown to increase ALP activity (127.8% at 0.3 μM), collagen content (108.2% at 0.3 μM), and mineralization (110.6% at 0.3 μM) in MC3T3-E1 cells.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> A diterpenoid, ent-trachylobane acid (<b>76</b>), isolated from a plant used in Tibetan folk medicine, <i>Euphorbia wallichii</i>, inhibited osteoclastogenesis induced by M-CSF and RANKL (IC<sub>50</sub> of 4 μM).<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> Finally, the triterpene 25-acetylcimigenol xylopyranoside (<b>77</b>), isolated from the roots and rhizome of black cohosh, a traditional Native American medicine, was shown to fully inhibit RANKL induced osteoclastogenesis at 10 μM.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a></div></div><div id="sec18" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Perspective</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40081" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40081" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Antiresorptive therapy represents the current standard of care for treatment of osteoporosis.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Branded bisphosphonates have been used with great success to treat patients with primary and secondary forms of osteoporosis, and the recent availability of generic bisphosphonates will likely continue this trend. In addition to advances in the understanding of the mechanism of action of bisphosphonates, other recent key findings in osteoclast biology have been described that have created new therapeutic opportunities to treat bone disease. As mentioned earlier, over the past several years the critical role of the OPG/RANKL system in regulating osteoclast activity and bone mass has been elucidated.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> The discovery of this essential pathway has led to advances in the development of fully human antibodies against RANKL (denosumab) as a potential new option for the treatment of osteoporosis and other bone-related diseases.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a></div><div class="NLM_p">Nevertheless, it has been proposed that availability of additional anabolic agents would also make a contribution to osteoporosis treatment.<a onclick="showRef(event, 'ref202 ref203'); return false;" href="javascript:void(0);" class="ref ref202 ref203">(202, 203)</a> Thus, therapeutic agents capable of stimulating bone formation would arguably enhance the options for treating osteoporosis. New anabolic therapies may allow combination with antiresorptive therapies in ways that could prolong efficacy and provide sustained protection against the risk of fracture. Indeed, dual acting single agent therapeutics may have improved convenience and safety in use and improved efficacy.</div><div class="NLM_p">Recently the peripheral and central effects of serotonin signaling on bone mass regulation were described suggesting potential opportunities for the design of new therapeutics for the treatment of osteoporosis. The production of serotonin by tryptophan hydroxylase 1 (TPH1) in gut enterochromaffin cells was proposed as a new mechanism whereby its release into the circulation as a hormone was important for regulation of bone mass.<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a> Several lines of mouse genetic evidence pointed to serotonin’s peripheral inhibition of bone formation via the hydroxytryptamine receptor 1b (HTR1b) serotonin receptor expressed on osteoblasts. Thus, inhibition of TPH1 may be an attractive new target for enhancing bone formation. Although most serotonin is produced peripherally, additional new work suggested that the ∼5% synthesized in the brain appeared to play a dominant and opposite role in the control of bone mass. Remarkably, the serotonin produced by TPH2 in brainstem neurons was shown to signal to HTR2c receptors in the ventromedial hypothalamus, leading to a decreased peripheral sympathetic tone.<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a> It was proposed that reduction in sympathetic activity mediated by β2 adrenergic receptors (ADR2β) receptors expressed on osteoblasts was responsible for stimulation of bone mass. Patients taking selective serotonin reuptake inhibitors (SSRIs) show evidence of osteoporosis, suggesting a link between sertotonin signaling and bone mass.<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a></div><div class="NLM_p">Other potential bone anabolic targets reported in the literature are supported by mouse genetic or biochemical data but currently lack pharmacological validation. For example, a remarkable high bone phenotype driven by increases in bone formation was observed in Schnurri3 (Shn3) knockout mice.<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a> In this study it was proposed that Shn3 participated in the ubiquitination and degradation of Runx2 by the E3 ubiquitin ligase WW domain-containing protein 1 (WWP1). Thus, inhibition of SHN3/WWP1 activity could potentially provide an opportunity to develop bone anabolic treatments. Similarly, small mothers against decapentaplegic (SMAD) ubiquitin regulatory factor 1 (SMURF1) E3 ubiquitin ligase<a onclick="showRef(event, 'ref208 ref209'); return false;" href="javascript:void(0);" class="ref ref208 ref209">(208, 209)</a> was also shown to be involved in the regulation of osteoblast activity, suggesting that E3 ubiquitin ligases may present a new target class for further investigation. However, current work in the field of ligase inhibitors has highlighted the difficulties associated with small molecule tractability of this target class. SMURF1 and WWP1 are involved in ubiquitination of several proteins associated with BMP and TGFβ signaling including a number of SMAD regulatory proteins. The central role of SMAD signaling in the regulation of bone mass was recently reported from a new angle where bone formation was shown to be induced in mice following treatment with a soluble activin type IIA receptor.<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a> These results suggested that inhibition of activin signaling via SMAD2/3 led to enhanced osteoblast activity. Acceleron’s fully human ActRIIA:Fc fusion protein (ACE-011) is currently in phase I clinical trials for osteoporosis.<a onclick="showRef(event, 'ref211'); return false;" href="javascript:void(0);" class="ref ref211">(211)</a></div><div class="NLM_p last">While the search for new bone anabolic targets continues, there is a growing interest in the potential for small molecules to be used as therapeutic inducers of cell fate during tissue repair and cell regeneration.<a onclick="showRef(event, 'ref212'); return false;" href="javascript:void(0);" class="ref ref212">(212)</a> As such, new compounds could see applications in, for example, the differentiation of osteoblast cells to enhance bone formation for indications such as osteoporosis and fracture healing. In a recent example, the compound reversine was shown to stimulate the differentiation of committed C2C12 myoblasts into osteoblasts.<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a> Similarly, when the proteasome inhibitor bortezomib was administered to mice, it induced MSCs to differentiate into osteoblasts and also increased bone formation in a mouse OVX model of osteoporosis.<a onclick="showRef(event, 'ref214'); return false;" href="javascript:void(0);" class="ref ref214">(214)</a> It is therefore theoretically possible that MSCs located in the periosteum and bone marrow, for example, could be coaxed into an osteoblast phenotype with selective small molecules. Other recent work showed that PTH stimulation of osteoblasts was associated with an increase in hematopoietic cells within the hematopoietic stem cell niche located on bone marrow endosteal surfaces.<a onclick="showRef(event, 'ref215 ref216'); return false;" href="javascript:void(0);" class="ref ref215 ref216">(215, 216)</a> These results raise the possibility of using small molecule approaches for altering stem cell activity that may benefit treatment of bone diseases and other related diseases.</div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00100" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00100" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John G. Allen</span> - <span class="hlFld-Affiliation affiliation">Chemistry Research and Discovery, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#9af0f5f2fbf6f6fff4dafbf7fdfff4b4f9f5f7"><span class="__cf_email__" data-cfemail="3f5550575e53535a517f5e52585a51115c5052">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Fotsch</span> - <span class="hlFld-Affiliation affiliation">Chemistry Research and Discovery, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philip Babij</span> - <span class="hlFld-Affiliation affiliation">Metabolic Disorders, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm9018756" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="bio"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54556" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54556" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>John G. Allen</b> is Principal Scientist at Amgen, Inc. He obtained his B.S. (1993) at Queen’s University, Kingston, Ontario, Canada, and his Ph.D. (1998) at Duke University. He was NIH Fellow at Memorial Sloan Kettering Cancer Center, 1998−2000. He joined Eli Lilly and Co. in 2000 and moved to Amgen, Inc., in 2005. He has led project teams in lead discovery, validation, and optimization efforts in oncology, inflammation, and metabolic disease.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Christopher Fotsch</b>, Ph.D., is Director of Research at Amgen, Inc. He obtained his Ph.D. from the University of California, Irvine, and did postdoctoral work at The Scripps Research Institute. His research interests include the development of novel therapies for unmet medical needs, structure based drug design, and enzyme catalyzed organic synthesis.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id="><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Philip Babij</b> obtained his Ph.D. from Kings College London. After postdoctoral fellowships at UTHSC Houston and the University of Vermont he joined the faculty at University College London as Assistant Professor. He moved to Wyeth-Ayerst Research before joining Amgen where he is currently Principal Scientist involved in drug research and development in bone and metabolic disorders.</p></figure></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54764" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54764" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Dr. Andrew Tasker for his critical review.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63183" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63183" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 216 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Riggs, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parfitt, A. M.</span><span> </span><span class="NLM_article-title">Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1359%2FJBMR.041114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=15647810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFarsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=177-184&author=B.+L.+Riggsauthor=A.+M.+Parfitt&title=Drugs+used+to+treat+osteoporosis%3A+the+critical+need+for+a+uniform+nomenclature+based+on+their+action+on+bone+remodeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling</span></div><div class="casAuthors">Riggs, B. Lawrence; Parfitt, A. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-184</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">A review.  There continues to be uncertainty about the classification of available drugs for treating osteoporosis.  We find that grouping them into anti-catabolic and anabolic classes based on the mechanisms of their action on bone remodeling and fracture redn. removes ambiguities and provides a relatively straightforward classification.  The recent introduction of teriparatide into clin. practice initiated the era of anabolic therapy for osteoporosis, but it is still unclear how to define an anabolic drug.  All drugs that increase bone mass do so by affecting bone remodeling.  When their mechanisms of action on bone remodeling and on fracture redn. are considered, we find that anti-osteoporotic drugs fall naturally into either anti-catabolic or anabolic classes.  Anti-catabolic drugs increase bone strength and reduce fractures mainly by decreasing the no. of bone multicellular units (BMUs).  This reduces perforative resorption and preserves skeletal microarchitecture (by preventing further structural damage to trabecular bone and increased porosity in cortical bone induced by high bone remodeling).  Redn. in bone remodeling by anti-catabolic drugs may increase bone mass moderately during the interval in which previously initiated BMUs are completing mineralization.  Some anti-catabolic drugs may also enhance the formation phase of the remodeling cycle, but their major action is to reduce overall bone turnover (i.e., the no. of BMUs in bone).  In contrast, anabolic drugs increase bone strength and reduce fractures by substantially increasing bone mass as a result of an overall increase in the no. of BMUs combined with a pos. BMU balance (the magnitude of the formation phase is greater than that of the resorption phase).  Some anabolic drugs also induce renewed modeling, increase periosteal apposition and repair of trabecular microstructure.  We hope that this classification will serve as a starting point for continued discussion on the important issue of nomenclature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplvXiQnmgRwbVg90H21EOLACvtfcHk0lj8KifCIZspXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFarsr8%253D&md5=68dbfe2d250d2632369191d4ef6a9804</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1359%2FJBMR.041114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252FJBMR.041114%26sid%3Dliteratum%253Aachs%26aulast%3DRiggs%26aufirst%3DB.%2BL.%26aulast%3DParfitt%26aufirst%3DA.%2BM.%26atitle%3DDrugs%2520used%2520to%2520treat%2520osteoporosis%253A%2520the%2520critical%2520need%2520for%2520a%2520uniform%2520nomenclature%2520based%2520on%2520their%2520action%2520on%2520bone%2520remodeling%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2005%26volume%3D20%26spage%3D177%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellido, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khosla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recker, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaney, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papapoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldring, S. R.</span><span> </span><span class="NLM_article-title">Targeting bone remodeling for the treatment of osteoporosis: summary of the proceedings of an ASBMR workshop</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">385</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1359%2Fjbmr.090105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19260805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A280%3ADC%252BD1M7osF2qtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=373-385&author=J.+P.+Bilezikianauthor=T.+Matsumotoauthor=T.+Bellidoauthor=S.+Khoslaauthor=J.+Martinauthor=R.+R.+Reckerauthor=R.+Heaneyauthor=E.+Seemanauthor=S.+Papapoulosauthor=S.+R.+Goldring&title=Targeting+bone+remodeling+for+the+treatment+of+osteoporosis%3A+summary+of+the+proceedings+of+an+ASBMR+workshop"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting bone remodeling for the treatment of osteoporosis: summary of the proceedings of an ASBMR workshop</span></div><div class="casAuthors">Bilezikian John P; Matsumoto Toshio; Bellido Teresita; Khosla Sundeep; Martin Jack; Recker Robert R; Heaney Robert; Seeman Ego; Papapoulos Socrates; Goldring Steven R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">373-85</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSq7pzmphErRhJ5E29YNGvQfW6udTcc2ebRZOUyLF0X8bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7osF2qtQ%253D%253D&md5=20a66f1cf0c30690c059ea2a7238176e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.090105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.090105%26sid%3Dliteratum%253Aachs%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DBellido%26aufirst%3DT.%26aulast%3DKhosla%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DJ.%26aulast%3DRecker%26aufirst%3DR.%2BR.%26aulast%3DHeaney%26aufirst%3DR.%26aulast%3DSeeman%26aufirst%3DE.%26aulast%3DPapapoulos%26aufirst%3DS.%26aulast%3DGoldring%26aufirst%3DS.%2BR.%26atitle%3DTargeting%2520bone%2520remodeling%2520for%2520the%2520treatment%2520of%2520osteoporosis%253A%2520summary%2520of%2520the%2520proceedings%2520of%2520an%2520ASBMR%2520workshop%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2009%26volume%3D24%26spage%3D373%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Eastell, R.</span><span> </span><span class="NLM_article-title">Treatment of postmenopausal osteoporosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">736</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1056%2FNEJM199803123381107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=9494151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADyaK1cXitFars70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=1998&pages=736-746&author=R.+Eastell&title=Treatment+of+postmenopausal+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of postmenopausal osteoporosis</span></div><div class="casAuthors">Eastell, Richard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">736-746</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review with 95 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNnI99Uw6Lv7Vg90H21EOLACvtfcHk0lhTxipijAwfpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitFars70%253D&md5=01c6d630a7e327295829b5cb1129e233</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJM199803123381107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199803123381107%26sid%3Dliteratum%253Aachs%26aulast%3DEastell%26aufirst%3DR.%26atitle%3DTreatment%2520of%2520postmenopausal%2520osteoporosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1998%26volume%3D338%26spage%3D736%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Seeman, E.</span><span> </span><span class="NLM_article-title">Invited review: pathogenesis of osteoporosis</span> <span class="citation_source-journal">J. Appl. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2142</span><span class="NLM_x">–</span> <span class="NLM_lpage">2151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2003&pages=2142-2151&author=E.+Seeman&title=Invited+review%3A+pathogenesis+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeeman%26aufirst%3DE.%26atitle%3DInvited%2520review%253A%2520pathogenesis%2520of%2520osteoporosis%26jtitle%3DJ.%2520Appl.%2520Physiol.%26date%3D2003%26volume%3D95%26spage%3D2142%26epage%3D2151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Ralston, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Crombrugghe, B.</span><span> </span><span class="NLM_article-title">Genetic regulation of bone mass and susceptibility to osteoporosis</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2492</span><span class="NLM_x">–</span> <span class="NLM_lpage">2506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=2492-2506&author=S.+H.+Ralstonauthor=B.+de+Crombrugghe&title=Genetic+regulation+of+bone+mass+and+susceptibility+to+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRalston%26aufirst%3DS.%2BH.%26aulast%3Dde%2BCrombrugghe%26aufirst%3DB.%26atitle%3DGenetic%2520regulation%2520of%2520bone%2520mass%2520and%2520susceptibility%2520to%2520osteoporosis%26jtitle%3DGenes%2520Dev.%26date%3D2006%26volume%3D20%26spage%3D2492%26epage%3D2506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Lewiecki, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeBoff, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P. D.</span><span> </span><span class="NLM_article-title">2008 Santa Fe Bone Symposium: update on osteoporosis</span> <span class="citation_source-journal">J. Clin. Densitom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.jocd.2009.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19426925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A280%3ADC%252BD1MzjtlSjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=135-157&author=E.+M.+Lewieckiauthor=S.+Baimauthor=J.+P.+Bilezikianauthor=R.+Eastellauthor=M.+S.+LeBoffauthor=P.+D.+Miller&title=2008+Santa+Fe+Bone+Symposium%3A+update+on+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">2008 Santa Fe Bone Symposium: update on osteoporosis</span></div><div class="casAuthors">Lewiecki E Michael; Baim Sanford; Bilezikian John P; Eastell Richard; LeBoff Meryl S; Miller Paul D</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-57</span>
        ISSN:<span class="NLM_cas:issn">1094-6950</span>.
    </div><div class="casAbstract">The Ninth Annual Santa Fe Bone Symposium was held on August 1-2, 2008, in Santa Fe, New Mexico, USA.  The symposium faculty presented the current best evidence on selected topics of clinical relevance in the fields of osteoporosis, metabolic bone disease, and assessment of skeletal health.  The educational venues were in the form of didactic presentations, panel discussions, challenging cases, and numerous interactive discussions.  Knowledge of basic science and clinical trials was applied to real-world patient scenarios that were discussed by faculty experts and clinician participants.  Topics included an update on the rationale and development of new agents for the treatment of osteoporosis, the use of bone turnover markers in clinical practice, hospital-based pathways for the management of hip fracture patients, injectable bisphosphonates for the treatment of osteoporosis, combination therapy with anabolic and antiresorptive agents, and assessment of skeletal health with devices other than central dual-energy X-ray absorptiometry.  This is a collection of scientific essays based on presentations and discussions at the 2008 Santa Fe Bone Symposium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxgtfX2XicQUNoizSOkG_FfW6udTcc2ebRZOUyLF0X8bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MzjtlSjtg%253D%253D&md5=e19e58bcedb43def6a2973b693fc93c9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.jocd.2009.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jocd.2009.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DLewiecki%26aufirst%3DE.%2BM.%26aulast%3DBaim%26aufirst%3DS.%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26aulast%3DEastell%26aufirst%3DR.%26aulast%3DLeBoff%26aufirst%3DM.%2BS.%26aulast%3DMiller%26aufirst%3DP.%2BD.%26atitle%3D2008%2520Santa%2520Fe%2520Bone%2520Symposium%253A%2520update%2520on%2520osteoporosis%26jtitle%3DJ.%2520Clin.%2520Densitom.%26date%3D2009%26volume%3D12%26spage%3D135%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Boyle, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonet, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacey, D. L.</span><span> </span><span class="NLM_article-title">Osteoclast differentiation and activation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">423</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1038%2Fnature01658" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=12748652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1ynu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=423&publication_year=2003&pages=337-342&author=W.+J.+Boyleauthor=W.+S.+Simonetauthor=D.+L.+Lacey&title=Osteoclast+differentiation+and+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoclast differentiation and activation</span></div><div class="casAuthors">Boyle, William J.; Simonet, W. Scott; Lacey, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">423</span>
        (<span class="NLM_cas:issue">6937</span>),
    <span class="NLM_cas:pages">337-342</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Osteoclasts are specialized cells derived from the monocyte/macrophage hematopoietic lineage that develop and adhere to bone matrix, then secrete acid and lytic enzymes that degrade it in a specialized, extracellular compartment.  Discovery of the RANK signaling pathway in the osteoclast has provided insight into the mechanisms of osteoclastogenesis and activation of bone resorption, and how hormonal signals impact bone structure and mass.  Further study of this pathway is providing the mol. basis for developing therapeutics to treat osteoporosis and other diseases of bone loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9r8QN5mP3a7Vg90H21EOLACvtfcHk0ljB_Ao7727Hkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1ynu7g%253D&md5=0d6ef73c5aa7c17f6abeb533fe31f39a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature01658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01658%26sid%3Dliteratum%253Aachs%26aulast%3DBoyle%26aufirst%3DW.%2BJ.%26aulast%3DSimonet%26aufirst%3DW.%2BS.%26aulast%3DLacey%26aufirst%3DD.%2BL.%26atitle%3DOsteoclast%2520differentiation%2520and%2520activation%26jtitle%3DNature%26date%3D2003%26volume%3D423%26spage%3D337%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kearns, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khosla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostenuik, P. J.</span><span> </span><span class="NLM_article-title">Receptor activator of nuclear factor kB ligand and osteoprotegerin regulation of bone remodeling in health and disease</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1210%2Fer.2007-0014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18057140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlOhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=155-192&author=A.+E.+Kearnsauthor=S.+Khoslaauthor=P.+J.+Kostenuik&title=Receptor+activator+of+nuclear+factor+kB+ligand+and+osteoprotegerin+regulation+of+bone+remodeling+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor activator of nuclear factor κB ligand and osteoprotegerin regulation of bone remodeling in health and disease</span></div><div class="casAuthors">Kearns, Ann E.; Khosla, Sundeep; Kostenuik, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-192</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Osteoclasts and osteoblasts dictate skeletal mass, structure, and strength via their resp. roles in resorbing and forming bone.  Bone remodeling is a spatially coordinated lifelong process whereby old bone is removed by osteoclasts and replaced by bone-forming osteoblasts.  The refilling of resorption cavities is incomplete in many pathol. states, which leads to a net loss of bone mass with each remodeling cycle.  Postmenopausal osteoporosis and other conditions are assocd. with an increased rate of bone remodeling, which leads to accelerated bone loss and increased risk of fracture.  Bone resorption is dependent on a cytokine known as RANKL (receptor activator of nuclear factor κB ligand), a TNF family member that is essential for osteoclast formation, activity, and survival in normal and pathol. states of bone remodeling.  The catabolic effects of RANKL are prevented by osteoprotegerin (OPG), a TNF receptor family member that binds RANKL and thereby prevents activation of its single cognate receptor called RANK.  Osteoclast activity is likely to depend, at least in part, on the relative balance of RANKL and OPG.  Studies in numerous animal models of bone disease show that RANKL inhibition leads to marked suppression of bone resorption and increases in cortical and cancelous bone vol., d., and strength.  RANKL inhibitors also prevent focal bone loss that occurs in animal models of rheumatoid arthritis and bone metastasis.  Clin. trials are exploring the effects of denosumab, a fully human anti-RANKL antibody, on bone loss in patients with osteoporosis, bone metastasis, myeloma, and rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG6-aul71sSLVg90H21EOLACvtfcHk0ljB_Ao7727Hkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlOhsr0%253D&md5=0d30b55f492ce4f438654f1fa8418495</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1210%2Fer.2007-0014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2007-0014%26sid%3Dliteratum%253Aachs%26aulast%3DKearns%26aufirst%3DA.%2BE.%26aulast%3DKhosla%26aufirst%3DS.%26aulast%3DKostenuik%26aufirst%3DP.%2BJ.%26atitle%3DReceptor%2520activator%2520of%2520nuclear%2520factor%2520kB%2520ligand%2520and%2520osteoprotegerin%2520regulation%2520of%2520bone%2520remodeling%2520in%2520health%2520and%2520disease%26jtitle%3DEndocr.%2520Rev.%26date%3D2008%26volume%3D29%26spage%3D155%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Smith, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egerdie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toriz, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tammela, T. L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heracek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szwedowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leder, B. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goessl, C.</span><span> </span><span class="NLM_article-title">Denosumab in men receiving androgen-deprivation therapy for prostate cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1056%2FNEJMoa0809003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19671656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWls7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=745-755&author=M.+R.+Smithauthor=B.+Egerdieauthor=N.+H.+Torizauthor=R.+Feldmanauthor=T.+L.+J.+Tammelaauthor=F.+Saadauthor=J.+Heracekauthor=M.+Szwedowskiauthor=C.+Keauthor=A.+Kupicauthor=B.+Z.+Lederauthor=C.+Goessl&title=Denosumab+in+men+receiving+androgen-deprivation+therapy+for+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Denosumab in men receiving androgen-deprivation therapy for prostate cancer</span></div><div class="casAuthors">Smith, Matthew R.; Egerdie, Blair; Toriz, Narciso Hernandez; Feldman, Robert; Tammela, Teuvo L. J.; Saad, Fred; Heracek, Jiri; Szwedowski, Maciej; Ke, Chunlei; Kupic, Amy; Leder, Benjamin Z.; Goessl, Carsten</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">745-755</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Androgen-deprivation therapy is well-established for treating prostate cancer but is assocd. with bone loss and an increased risk of fracture.  We investigated the effects of Denosumab, a fully human monoclonal antibody against receptor activator of nuclear factor-κB ligand, on bone mineral d. and fractures in men receiving androgen-deprivation therapy for nonmetastatic prostate cancer.  In this double-blind, multicenter study, we randomly assigned patients to receive Denosumab at a dose of 60 mg s.c. every 6 mo or placebo (734 patients in each group).  The primary end point was percent change in bone mineral d. at the lumbar spine at 24 mo.  Key secondary end points included percent change in bone mineral densities at the femoral neck and total hip at 24 mo and at all three sites at 36 mo, as well as incidence of new vertebral fractures.  At 24 mo, bone mineral d. of the lumbar spine had increased by 5.60% in the Denosumab group as compared with a loss of 1.0% in the placebo group (P < 0.001); significant differences between the two groups were seen at as early as 1 mo and sustained through 36 mo.  Denosumab therapy was also assocd. with significant increases in bone mineral d. at the total hip, femoral neck, and distal third of the radius at all time points.  Patients who received Denosumab had a decreased incidence of new vertebral fractures at 36 mo (1.5%, vs. 3.9% with placebo) (relative risk, 0.38; 95% confidence interval, 0.19 to 0.78; P = 0.006).  Rates of adverse events were similar between the two groups.  Denosumab was assocd. with increased bone mineral d. at all sites and a redn. in the incidence of new vertebral fractures among men receiving androgen-deprivation therapy for nonmetastatic prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoorugOPElZobVg90H21EOLACvtfcHk0ljJ9iVNpu0iIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWls7rF&md5=b96aa8f8eefa61f0d8d01763630dfe09</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0809003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0809003%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%2BR.%26aulast%3DEgerdie%26aufirst%3DB.%26aulast%3DToriz%26aufirst%3DN.%2BH.%26aulast%3DFeldman%26aufirst%3DR.%26aulast%3DTammela%26aufirst%3DT.%2BL.%2BJ.%26aulast%3DSaad%26aufirst%3DF.%26aulast%3DHeracek%26aufirst%3DJ.%26aulast%3DSzwedowski%26aufirst%3DM.%26aulast%3DKe%26aufirst%3DC.%26aulast%3DKupic%26aufirst%3DA.%26aulast%3DLeder%26aufirst%3DB.%2BZ.%26aulast%3DGoessl%26aufirst%3DC.%26atitle%3DDenosumab%2520in%2520men%2520receiving%2520androgen-deprivation%2520therapy%2520for%2520prostate%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D745%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Cummings, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Martin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClung, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siris, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoog, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutilek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanchetta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libanati, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddhanti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, C.</span><span> </span><span class="NLM_article-title">Denosumab for prevention of fractures in postmenopausal women with osteoporosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">756</span><span class="NLM_x">–</span> <span class="NLM_lpage">765</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1056%2FNEJMoa0809493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19671655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWls7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=756-765&author=S.+R.+Cummingsauthor=J.+San+Martinauthor=M.+R.+McClungauthor=E.+S.+Sirisauthor=R.+Eastellauthor=I.+R.+Reidauthor=P.+Delmasauthor=H.+B.+Zoogauthor=M.+Austinauthor=A.+Wangauthor=S.+Kutilekauthor=S.+Adamiauthor=J.+Zanchettaauthor=C.+Libanatiauthor=S.+Siddhantiauthor=C.+Christiansen&title=Denosumab+for+prevention+of+fractures+in+postmenopausal+women+with+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Denosumab for prevention of fractures in postmenopausal women with osteoporosis</span></div><div class="casAuthors">Cummings, Steven R.; San Martin, Javier; McClung, Michael R.; Siris, Ethel S.; Eastell, Richard; Reid, Ian R.; Delmas, Pierre; Zoog, Holly B.; Austin, Matt; Wang, Andrea; Kutilek, Stepan; Adami, Silvano; Zanchetta, Jose; Libanati, Cesar; Siddhanti, Suresh; Christiansen, Claus</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">756-765</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Denosumab is a fully human monoclonal antibody to the receptor activator of nuclear factor-κB ligand (RANKL) that blocks its binding to RANK, inhibiting the development and activity of osteoclasts, decreasing bone resorption, and increasing bone d.  Given its unique actions, Denosumab may be useful in the treatment of osteoporosis.  The authors enrolled 7868 women between the ages of 60 and 90 years who had a bone mineral d. T score of less than -2.5 but not less than -4.0 at the lumbar spine or total hip.  Subjects were randomly assigned to receive either 60 mg of Denosumab or placebo s.c. every 6 mo for 36 mo.  The primary end point was new vertebral fracture.  Secondary end points included nonvertebral and hip fractures.  As compared with placebo, Denosumab reduced the risk of new radiog. vertebral fracture, with a cumulative incidence of 2.3% in the Denosumab group, vs. 7.2% in the placebo group (risk ratio, 0.32; 95% confidence interval [CI], 0.26 to 0.41; P < 0.001) - a relative decrease of 68%.  Denosumab reduced the risk of hip fracture, with a cumulative incidence of 0.7% in the Denosumab group, vs. 1.2% in the placebo group (hazard ratio, 0.60; 95% CI, 0.37 to 0.97; P = 0.04) - a relative decrease of 40%.  Denosumab also reduced the risk of nonvertebral fracture, with a cumulative incidence of 6.5% in the Denosumab group, vs. 8.0% in the placebo group (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P = 0.01) - a relative decrease of 20%.  There was no increase in the risk of cancer, infection, cardiovascular disease, delayed fracture healing, or hypocalcemia, and there were no cases of osteonecrosis of the jaw and no adverse reactions to the injection of Denosumab.  Denosumab given s.c. twice yearly for 36 mo was assocd. with a redn. in the risk of vertebral, nonvertebral, and hip fractures in women with osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNRIIi_v86Q7Vg90H21EOLACvtfcHk0ljJ9iVNpu0iIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWls7nF&md5=cb12769a605cf79727596902520bd865</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0809493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0809493%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DS.%2BR.%26aulast%3DSan%2BMartin%26aufirst%3DJ.%26aulast%3DMcClung%26aufirst%3DM.%2BR.%26aulast%3DSiris%26aufirst%3DE.%2BS.%26aulast%3DEastell%26aufirst%3DR.%26aulast%3DReid%26aufirst%3DI.%2BR.%26aulast%3DDelmas%26aufirst%3DP.%26aulast%3DZoog%26aufirst%3DH.%2BB.%26aulast%3DAustin%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DKutilek%26aufirst%3DS.%26aulast%3DAdami%26aufirst%3DS.%26aulast%3DZanchetta%26aufirst%3DJ.%26aulast%3DLibanati%26aufirst%3DC.%26aulast%3DSiddhanti%26aufirst%3DS.%26aulast%3DChristiansen%26aufirst%3DC.%26atitle%3DDenosumab%2520for%2520prevention%2520of%2520fractures%2520in%2520postmenopausal%2520women%2520with%2520osteoporosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D756%26epage%3D765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Chapurlat, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmas, P. D.</span><span> </span><span class="NLM_article-title">Drug insight: bisphosphonates for postmenopausal osteoporosis</span> <span class="citation_source-journal">Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFSrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=211-219&author=R.+D.+Chapurlatauthor=P.+D.+Delmas&title=Drug+insight%3A+bisphosphonates+for+postmenopausal+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Drug insight: bisphosphonates for postmenopausal osteoporosis</span></div><div class="casAuthors">Chapurlat, Roland D.; Delmas, Pierre D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Endocrinology & Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">211-219</span>CODEN:
                <span class="NLM_cas:coden">NCPEDB</span>;
        ISSN:<span class="NLM_cas:issn">1745-8366</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Bisphosphonates are potent antiresorptive agents, which have largely been used for the treatment of postmenopausal osteoporosis during the past 10 years.  When embedded in bone matrix, bisphosphonates are taken up by osteoclasts engaged in bone resorption, leading-mainly by inhibition of farnesyl diphosphate synthase, a key enzyme of the mevalonate pathway-to osteoclast apoptosis.  Bone resorption decreases, with consequent improvement in the mech. properties of bone and a reduced risk of fracture.  Alendronate and risedronate are oral nitrogen-contg. bisphosphonates.  Several randomized, placebo-controlled trials have shown the ability of these bisphosphonates to halve the risk of vertebral fracture when taken daily for 3 years.  Nonvertebral fracture risk, including that at the hip, was also significantly decreased.  Weekly regimens have simplified the administration of bisphosphonates and, probably, improved adherence to treatment.  A significant redn. in the risk of vertebral fracture has also been demonstrated with an intermittent regimen of ibandronate, which is a new, potent, nitrogen-contg. bisphosphonate.  Ibandronate was recently marketed for use in an oral, once-monthly dose of 150 mg, with the goal of improving compliance.  Bisphosphonates are usually well tolerated in the long term.  I.v. administration of bisphosphonates in women with osteoporosis, which is currently under investigation, might be an interesting future option for women who cannot tolerate oral regimens, and for enhancing compliance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO6jSyazonebVg90H21EOLACvtfcHk0ljJ9iVNpu0iIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFSrtLY%253D&md5=f47925a8a7424f026776f5c8ddd4a67b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChapurlat%26aufirst%3DR.%2BD.%26aulast%3DDelmas%26aufirst%3DP.%2BD.%26atitle%3DDrug%2520insight%253A%2520bisphosphonates%2520for%2520postmenopausal%2520osteoporosis%26jtitle%3DEndocrinol.%2520Metab.%26date%3D2006%26volume%3D2%26spage%3D211%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Yasothan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kar, S.</span><span> </span><span class="NLM_article-title">Osteoporosis: overview and pipeline</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=725-726&author=U.+Yasothanauthor=S.+Kar&title=Osteoporosis%3A+overview+and+pipeline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYasothan%26aufirst%3DU.%26aulast%3DKar%26aufirst%3DS.%26atitle%3DOsteoporosis%253A%2520overview%2520and%2520pipeline%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D725%26epage%3D726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Raisz, L. G.</span><span> </span><span class="NLM_article-title">Pathogenesis of osteoporosis: concepts, conflicts, and prospects</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">3318</span><span class="NLM_x">–</span> <span class="NLM_lpage">3325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1172%2FJCI27071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16322775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=3318-3325&author=L.+G.+Raisz&title=Pathogenesis+of+osteoporosis%3A+concepts%2C+conflicts%2C+and+prospects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis of osteoporosis: Concepts, conflicts, and prospects</span></div><div class="casAuthors">Raisz, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3318-3325</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Osteoporosis is a disorder in which loss of bone strength leads to fragility fractures.  This review examines the fundamental pathogenetic mechanisms underlying this disorder, which include: (a) failure to achieve a skeleton of optimal strength during growth and development; (b) excessive bone resorption resulting in loss of bone mass and disruption of architecture; and (c) failure to replace lost bone due to defects in bone formation.  Estrogen deficiency is known to play a crit. role in the development of osteoporosis, while calcium and vitamin D deficiencies and secondary hyperparathyroidism also contribute.  There are multiple mechanisms underlying the regulation of bone remodeling, and these involve not only the osteoblastic and osteoclastic cell lineages but also other marrow cells, in addn. to the interaction of systemic hormones, local cytokines, growth factors, and transcription factors.  Polymorphisms of a large no. of genes have been assocd. with differences in bone mass and fragility.  It is now possible to diagnose osteoporosis, assess fracture risk, and reduce that risk with antiresorptive or other available therapies.  However, new and more effective approaches are likely to emerge from a better understanding of the regulators of bone cell function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr4gmjg9pMWrVg90H21EOLACvtfcHk0lh92OT0rt3Rbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLzJ&md5=77de4d8a09119f8178d1277e441e1bff</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1172%2FJCI27071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI27071%26sid%3Dliteratum%253Aachs%26aulast%3DRaisz%26aufirst%3DL.%2BG.%26atitle%3DPathogenesis%2520of%2520osteoporosis%253A%2520concepts%252C%2520conflicts%252C%2520and%2520prospects%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26spage%3D3318%26epage%3D3325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Mohler, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohl, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coss, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span> </span><span class="NLM_article-title">Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3597</span><span class="NLM_x">–</span> <span class="NLM_lpage">3617</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900280m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3597-3617&author=M.+L.+Mohlerauthor=C.+E.+Bohlauthor=A.+Jonesauthor=C.+C.+Cossauthor=R.+Narayananauthor=Y.+Heauthor=D.+J.+Hwangauthor=J.+T.+Daltonauthor=D.+D.+Miller&title=Nonsteroidal+selective+androgen+receptor+modulators+%28SARMs%29%3A+dissociating+the+anabolic+and+androgenic+activities+of+the+androgen+receptor+for+therapeutic+benefit"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm900280m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900280m%26sid%3Dliteratum%253Aachs%26aulast%3DMohler%26aufirst%3DM.%2BL.%26aulast%3DBohl%26aufirst%3DC.%2BE.%26aulast%3DJones%26aufirst%3DA.%26aulast%3DCoss%26aufirst%3DC.%2BC.%26aulast%3DNarayanan%26aufirst%3DR.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DHwang%26aufirst%3DD.%2BJ.%26aulast%3DDalton%26aufirst%3DJ.%2BT.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3DNonsteroidal%2520selective%2520androgen%2520receptor%2520modulators%2520%2528SARMs%2529%253A%2520dissociating%2520the%2520anabolic%2520and%2520androgenic%2520activities%2520of%2520the%2520androgen%2520receptor%2520for%2520therapeutic%2520benefit%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3597%26epage%3D3617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Mathoo, J. M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumbhare, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, J. D.</span><span> </span><span class="NLM_article-title">Therapeutic advances in the treatment of osteoporosis</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1517%2F13543776.17.3.277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFSjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=277-285&author=J.+M.+R.+Mathooauthor=L.+Beckerauthor=D.+Kumbhareauthor=J.+D.+Adachi&title=Therapeutic+advances+in+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic advances in the treatment of osteoporosis</span></div><div class="casAuthors">Mathoo, Julian M. R.; Becker, Lisa; Kumbhare, Dinesh; Adachi, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-285</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Until recently, pharmacol. options for the treatment of osteoporosis have been limited to antiresorptive agents, including the oral bisphosphonates.  Evidence from randomized controlled trials and meta-analyses support the efficacy and safety of oral bisphosphonates as first-line pharmacol. agents in the prevention and treatment of osteoporosis.  However, advances in parenteral bisphosphonate therapy, the development of antireceptor activator of NF-κB ligand (anti-RANKL) therapy, the development of anabolic agents, namely parathyroid hormone and related peptides, as well as the emergence of strontium ranelate as a novel therapeutic agent with both anabolic and antiresporptive properties, have dramatically expanded our pharmacol. armamentarium of antiosteoporosis treatments.  Effective treatment options now exist for patients in whom older agents were either contraindicated or not tolerated.  This review will focus on recent developments in osteoporosis treatments in advanced phases of development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq0C-Hht7lx7Vg90H21EOLACvtfcHk0lh92OT0rt3Rbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFSjtbc%253D&md5=0e5b0fba3831d4891d2693f40eb18608</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F13543776.17.3.277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.17.3.277%26sid%3Dliteratum%253Aachs%26aulast%3DMathoo%26aufirst%3DJ.%2BM.%2BR.%26aulast%3DBecker%26aufirst%3DL.%26aulast%3DKumbhare%26aufirst%3DD.%26aulast%3DAdachi%26aufirst%3DJ.%2BD.%26atitle%3DTherapeutic%2520advances%2520in%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2007%26volume%3D17%26spage%3D277%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Grey, A.</span><span> </span><span class="NLM_article-title">Emerging pharmacologic therapies for osteoporosis</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">508</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1517%2F14728214.12.3.493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17874975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCit77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=493-508&author=A.+Grey&title=Emerging+pharmacologic+therapies+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging pharmacologic therapies for osteoporosis</span></div><div class="casAuthors">Grey, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">493-508</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Osteoporotic fractures are an important public health problem, contributing substantially to morbidity and mortality in an ageing world population and consuming considerable health resources.  Presently available pharmacol. therapies for prevention of fragility fractures are limited in scope, efficacy and acceptability to patients.  Considerable efforts are being made to develop new, more effective treatments for osteoporosis, and to refine/optimize existing therapies.  These novel treatments include an expanding array of drugs that primarily inhibit osteoclastic bone resorption: estrogenic compds., bisphosphonates, inhibitors of receptor activator of NF-κB ligand signaling, cathepsin K inhibitors, c-src kinase inhibitors, integrin inhibitors and chloride channel inhibitors.  The advent of intermittent parathyroid hormone (PTH) therapy has provided proof-of-principle that osteoblast-targeted (anabolic) agents can effectively prevent osteoporotic fractures, and is likely to be followed by the introduction of other therapies based on PTH (orally active PTH analogs, antagonists of the calcium sensing receptor, PTH-related peptide analogs) and/or agents that induce osteoblast anabolism by means of pathways involving key, recently identified, mol. targets (wnt-low-d. lipoprotein receptor-related protein 5 signaling, sclerostin and matrix extracellular phosphoglycoprotein).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1sq6IuCjXrbVg90H21EOLACvtfcHk0li7baomOmHFLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCit77K&md5=f6e04bffc4c2167b74eb914811256f76</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1517%2F14728214.12.3.493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.12.3.493%26sid%3Dliteratum%253Aachs%26aulast%3DGrey%26aufirst%3DA.%26atitle%3DEmerging%2520pharmacologic%2520therapies%2520for%2520osteoporosis%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2007%26volume%3D12%26spage%3D493%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Sun, S.</span><span> </span><span class="NLM_article-title">Bone disease drug discovery: examining the interactions between osteoblast and osteoclast</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1517%2F14728222.12.2.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18208371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFCqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=239-251&author=S.+Sun&title=Bone+disease+drug+discovery%3A+examining+the+interactions+between+osteoblast+and+osteoclast"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Bone disease drug discovery: examining the interactions between osteoblast and osteoclast</span></div><div class="casAuthors">Sun, Sengen</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">239-251</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Existing drugs, including bisphosphonates and calcitonin, cannot meet the strong demand for a possible cure of bone diseases, the prevailing cause of human disabilities.  To understand on-going drug discovery activities, new trends and different opinions in the treatment of bone diseases, the recent literature up to August 2007 related to osteoporosis and joint diseases was searched, summarized, and analyzed.  The drug discovery based on the mol. mechanism of bone remodeling has made some progress, but there are challenges, difficulties and different opinions.  Bone resorption by osteoclasts is directly regulated by osteoblasts via the receptor activator of NF-κB/receptor activator of NF-κB ligand/osteoprotegerin signaling pathway, whereas the regulation of bone formation is poorly understood.  Several aspects, including the present state and future trends, are commented on as the expert opinions in this paper.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSx8IbypuL7rVg90H21EOLACvtfcHk0li7baomOmHFLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFCqtA%253D%253D&md5=1ee153044909a68690ec5b5abbc93264</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F14728222.12.2.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.12.2.239%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26atitle%3DBone%2520disease%2520drug%2520discovery%253A%2520examining%2520the%2520interactions%2520between%2520osteoblast%2520and%2520osteoclast%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2008%26volume%3D12%26spage%3D239%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Gelb, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, G.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desnick, R. J.</span><span> </span><span class="NLM_article-title">Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">1236</span><span class="NLM_x">–</span> <span class="NLM_lpage">1238</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1996&pages=1236-1238&author=B.+D.+Gelbauthor=G.-P.+Shiauthor=H.+A.+Chapmanauthor=R.+J.+Desnick&title=Pycnodysostosis%2C+a+lysosomal+disease+caused+by+cathepsin+K+deficiency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGelb%26aufirst%3DB.%2BD.%26aulast%3DShi%26aufirst%3DG.-P.%26aulast%3DChapman%26aufirst%3DH.%2BA.%26aulast%3DDesnick%26aufirst%3DR.%2BJ.%26atitle%3DPycnodysostosis%252C%2520a%2520lysosomal%2520disease%2520caused%2520by%2520cathepsin%2520K%2520deficiency%26jtitle%3DScience%26date%3D1996%26volume%3D273%26spage%3D1236%26epage%3D1238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunziker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehmeyer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommerskirch, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von Figura, K.</span><span> </span><span class="NLM_article-title">Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">13453</span><span class="NLM_x">–</span> <span class="NLM_lpage">13458</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=13453-13458&author=P.+Saftigauthor=E.+Hunzikerauthor=O.+Wehmeyerauthor=S.+Jonesauthor=A.+Boydeauthor=W.+Rommerskirchauthor=J.+D.+Moritzauthor=P.+Schuauthor=K.+Von+Figura&title=Impaired+osteoclastic+bone+resorption+leads+to+osteopetrosis+in+cathepsin-K-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DHunziker%26aufirst%3DE.%26aulast%3DWehmeyer%26aufirst%3DO.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DBoyde%26aufirst%3DA.%26aulast%3DRommerskirch%26aufirst%3DW.%26aulast%3DMoritz%26aufirst%3DJ.%2BD.%26aulast%3DSchu%26aufirst%3DP.%26aulast%3DVon%2BFigura%26aufirst%3DK.%26atitle%3DImpaired%2520osteoclastic%2520bone%2520resorption%2520leads%2520to%2520osteopetrosis%2520in%2520cathepsin-K-deficient%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D13453%26epage%3D13458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Kim, T.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A. S.</span><span> </span><span class="NLM_article-title">Non-covalent cathepsin K inhibitors for the treatment of osteoporosis</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.2174%2F156802606776287036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16611147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVahsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=355-360&author=T.-S.+Kimauthor=A.+S.+Tasker&title=Non-covalent+cathepsin+K+inhibitors+for+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Non-covalent cathepsin K inhibitors for the treatment of osteoporosis</span></div><div class="casAuthors">Kim, Tae-Seong; Tasker, Andrew S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-360</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cathepsin K is a cysteine protease that plays an important role in the pathol. process of bone resorption.  Selective cathepsin K inhibitors may thus provide great potential in the treatment of osteoporosis.  Pharmaceutical interest in this area is highlighted by the rising no. of publications and patent applications.  Most recently, the interim results of 3 clin. trials conducted by Novartis, GlaxoSmithKline, and Merck have strengthened the validation of the target for the therapeutic intervention of osteoporosis.  Here we report a series of Cbz-leucyl-(4-piperidinylphenyl)aminoethyl amides based on dipeptidyl anilines for cathepsin K inhibition.  These new non-covalent inhibitors exhibit single digit nM inhibition of the cathepsin family.  Mol. modeling studies on the interactions responsible for the potency of these inhibitors for cathepsin K will be also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQqiDzuZl3EbVg90H21EOLACvtfcHk0li7baomOmHFLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVahsbw%253D&md5=05adceb5089c3f01187638ed00aab36e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F156802606776287036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606776287036%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DT.-S.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26atitle%3DNon-covalent%2520cathepsin%2520K%2520inhibitors%2520for%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D355%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Bromme, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecaille, F.</span><span> </span><span class="NLM_article-title">Cathepsin K inhibitors for osteoporosis and potential off-target effects</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">585</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=585-600&author=D.+Brommeauthor=F.+Lecaille&title=Cathepsin+K+inhibitors+for+osteoporosis+and+potential+off-target+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBromme%26aufirst%3DD.%26aulast%3DLecaille%26aufirst%3DF.%26atitle%3DCathepsin%2520K%2520inhibitors%2520for%2520osteoporosis%2520and%2520potential%2520off-target%2520effects%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D585%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Vasiljeva, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinheckel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B.</span><span> </span><span class="NLM_article-title">Emerging roles of cysteine cathepsins in disease and their potential as drug targets</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.2174%2F138161207780162962" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17311556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvVyltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=387-403&author=O.+Vasiljevaauthor=T.+Reinheckelauthor=C.+Petersauthor=D.+Turkauthor=V.+Turkauthor=B.+Turk&title=Emerging+roles+of+cysteine+cathepsins+in+disease+and+their+potential+as+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging roles of cysteine cathepsins in disease and their potential as drug targets</span></div><div class="casAuthors">Vasiljeva, Olga; Reinheckel, Thomas; Peters, Christoph; Turk, Dusan; Turk, Vito; Turk, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">387-403</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The general view on Cys cathepsins, which were long believed to be primarily involved in intracellular protein turnover, has dramatically changed in last 10 to 15 years.  The discovery of new cathepsins, such as cathepsins K, V, X, F and O, and their tissue distribution suggested that at least some of them are involved in very specific cellular processes.  Moreover, gene ablation expts. revealed that cathepsins play a vital role in numerous physiol. processes, such as antigen processing and presentation, bone remodeling, prohormone processing and wound healing.  Their involvement in several pathologies, including osteoporosis, rheumatoid arthritis, osteoarthritis, bronchial asthma and cancer were also confirmed and today several of them were validated as relevant targets for therapies.  Compds. targeting cathepsins S and K are already in clin. evaluation, whereas others are in exptl. phases.  The cathepsin K inhibitor AAE-581 (balicatib) as the most advanced of them passed Phase II clin. trials in 2005.  In this review, we discuss the current view on cathepsins as an emerging group of targets for several diseases and the development of cathepsin K and S inhibitors for treatment of osteoporosis and various immune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpl43svUGSDrVg90H21EOLACvtfcHk0lh1M6n6BEzuBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvVyltrg%253D&md5=50a14bd3146b8c29e745f4bb3af85af7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F138161207780162962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161207780162962%26sid%3Dliteratum%253Aachs%26aulast%3DVasiljeva%26aufirst%3DO.%26aulast%3DReinheckel%26aufirst%3DT.%26aulast%3DPeters%26aufirst%3DC.%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DTurk%26aufirst%3DV.%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DEmerging%2520roles%2520of%2520cysteine%2520cathepsins%2520in%2520disease%2520and%2520their%2520potential%2520as%2520drug%2520targets%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2007%26volume%3D13%26spage%3D387%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">McGrath, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromme, D.</span><span> </span><span class="NLM_article-title">Crystal structure of human cathepsin K complexed with a potent inhibitor</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1997&pages=105-109&author=M.+E.+McGrathauthor=J.+L.+Klausauthor=M.+G.+Barnesauthor=D.+Bromme&title=Crystal+structure+of+human+cathepsin+K+complexed+with+a+potent+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DKlaus%26aufirst%3DJ.%2BL.%26aulast%3DBarnes%26aufirst%3DM.%2BG.%26aulast%3DBromme%26aufirst%3DD.%26atitle%3DCrystal%2520structure%2520of%2520human%2520cathepsin%2520K%2520complexed%2520with%2520a%2520potent%2520inhibitor%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D1997%26volume%3D4%26spage%3D105%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Asagiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunigami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gober, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golenbock, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayanagi, H.</span><span> </span><span class="NLM_article-title">Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2008&pages=624-627&author=M.+Asagiriauthor=T.+Hiraiauthor=T.+Kunigamiauthor=S.+Kamanoauthor=H.-J.+Goberauthor=K.+Okamotoauthor=K.+Nishikawaauthor=E.+Latzauthor=D.+T.+Golenbockauthor=K.+Aokiauthor=K.+Ohyaauthor=Y.+Imaiauthor=Y.+Morishitaauthor=K.+Miyazonoauthor=S.+Katoauthor=P.+Saftigauthor=H.+Takayanagi&title=Cathepsin+K-dependent+toll-like+receptor+9+signaling+revealed+in+experimental+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsagiri%26aufirst%3DM.%26aulast%3DHirai%26aufirst%3DT.%26aulast%3DKunigami%26aufirst%3DT.%26aulast%3DKamano%26aufirst%3DS.%26aulast%3DGober%26aufirst%3DH.-J.%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DNishikawa%26aufirst%3DK.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DGolenbock%26aufirst%3DD.%2BT.%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DOhya%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DMorishita%26aufirst%3DY.%26aulast%3DMiyazono%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DTakayanagi%26aufirst%3DH.%26atitle%3DCathepsin%2520K-dependent%2520toll-like%2520receptor%25209%2520signaling%2520revealed%2520in%2520experimental%2520arthritis%26jtitle%3DScience%26date%3D2008%26volume%3D319%26spage%3D624%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Westover, A. J.; Chagnovich, D.; Long, M. W.</span><span> </span><span class="NLM_article-title">Dual-action cathepsin K inhibitors: modulation of human osteoclast function</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span>), Abstract M389.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&issue=Suppl.+1&author=A.+J.+Westover&author=D.+Chagnovich&author=M.+W.+Long&title=Dual-action+cathepsin+K+inhibitors%3A+modulation+of+human+osteoclast+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWestover%26aufirst%3DA.%2BJ.%26atitle%3DDual-action%2520cathepsin%2520K%2520inhibitors%253A%2520modulation%2520of%2520human%2520osteoclast%2520function%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2007%26volume%3D22%26issue%3DSuppl.%25201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Twomey, T.; Chagnovich, D.; Zielenski, J.; Long, M. W.</span><span> </span><span class="NLM_article-title">Dual-action cathepsin K inhibitors: regulation of human mesenchymal stem cell (MSC) lineage commitment</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span>), Abstract W315.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&issue=Suppl.+1&author=T.+Twomey&author=D.+Chagnovich&author=J.+Zielenski&author=M.+W.+Long&title=Dual-action+cathepsin+K+inhibitors%3A+regulation+of+human+mesenchymal+stem+cell+%28MSC%29+lineage+commitment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTwomey%26aufirst%3DT.%26atitle%3DDual-action%2520cathepsin%2520K%2520inhibitors%253A%2520regulation%2520of%2520human%2520mesenchymal%2520stem%2520cell%2520%2528MSC%2529%2520lineage%2520commitment%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2007%26volume%3D22%26issue%3DSuppl.%25201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Chagnovich, D.; Fellows, J.; Dyer, R. D.; Long, M. W.</span><span> </span><span class="NLM_article-title">A role for cathepsin K inhibitors in rheumatoid arthritis: VEL-0230 phase I clinical trial results</span>.  <span class="citation_source-journal">Inflammation Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span>), Abstract A108.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&issue=Suppl.+2&author=D.+Chagnovich&author=J.+Fellows&author=R.+D.+Dyer&author=M.+W.+Long&title=A+role+for+cathepsin+K+inhibitors+in+rheumatoid+arthritis%3A+VEL-0230+phase+I+clinical+trial+results"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChagnovich%26aufirst%3DD.%26atitle%3DA%2520role%2520for%2520cathepsin%2520K%2520inhibitors%2520in%2520rheumatoid%2520arthritis%253A%2520VEL-0230%2520phase%2520I%2520clinical%2520trial%2520results%26jtitle%3DInflammation%2520Res.%26date%3D2008%26volume%3D57%26issue%3DSuppl.%25202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span>Velcura Therapeutics. <a href="http://www.velcura.com/" class="extLink">http://www.velcura.com/</a> (accessed May 8,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Velcura+Therapeutics.+http%3A%2F%2Fwww.velcura.com%2F+%28accessed+May+8%2C+2008%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Setti, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J.</span><span> </span><span class="NLM_article-title">3,4-Disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P2 elements for selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2051</span><span class="NLM_x">–</span> <span class="NLM_lpage">2053</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2051-2053&author=E.+L.+Settiauthor=D.+Davisauthor=T.+Chungauthor=J.+McCarter&title=3%2C4-Disubstituted+azetidinones+as+selective+inhibitors+of+the+cysteine+protease+cathepsin+K.+Exploring+P2+elements+for+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSetti%26aufirst%3DE.%2BL.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DChung%26aufirst%3DT.%26aulast%3DMcCarter%26aufirst%3DJ.%26atitle%3D3%252C4-Disubstituted%2520azetidinones%2520as%2520selective%2520inhibitors%2520of%2520the%2520cysteine%2520protease%2520cathepsin%2520K.%2520Exploring%2520P2%2520elements%2520for%2520selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2051%26epage%3D2053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Setti, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janc, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffery, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span> </span><span class="NLM_article-title">3,4-Disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1529</span><span class="NLM_x">–</span> <span class="NLM_lpage">1534</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1529-1534&author=E.+L.+Settiauthor=D.+Davisauthor=J.+W.+Jancauthor=D.+A.+Jefferyauthor=H.+Cheungauthor=W.+Yu&title=3%2C4-Disubstituted+azetidinones+as+selective+inhibitors+of+the+cysteine+protease+cathepsin+K.+Exploring+P3+elements+for+potency+and+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSetti%26aufirst%3DE.%2BL.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DJanc%26aufirst%3DJ.%2BW.%26aulast%3DJeffery%26aufirst%3DD.%2BA.%26aulast%3DCheung%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DW.%26atitle%3D3%252C4-Disubstituted%2520azetidinones%2520as%2520selective%2520inhibitors%2520of%2520the%2520cysteine%2520protease%2520cathepsin%2520K.%2520Exploring%2520P3%2520elements%2520for%2520potency%2520and%2520selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1529%26epage%3D1534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khougaz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toulmond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span> </span><span class="NLM_article-title">Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7535</span><span class="NLM_x">–</span> <span class="NLM_lpage">7543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0504961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7535-7543&author=J.-P.+Falgueyretauthor=S.+Desmaraisauthor=R.+Oballaauthor=W.+C.+Blackauthor=W.+Cromlishauthor=K.+Khougazauthor=S.+Lamontagneauthor=F.+Masseauthor=D.+Riendeauauthor=S.+Toulmondauthor=M.+D.+Percival&title=Lysosomotropism+of+basic+cathepsin+K+inhibitors+contributes+to+increased+cellular+potencies+against+off-target+cathepsins+and+reduced+functional+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity</span></div><div class="casAuthors">Falgueyret, Jean-Pierre; Desmarais, Sylvie; Oballa, Renata; Black, W. Cameron; Cromlish, Wanda; Khougaz, Karine; Lamontagne, Sonia; Masse, Frederic; Riendeau, Denis; Toulmond, Sylvie; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7535-7543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lysosomal cysteine protease cathepsin K is a target for osteoporosis therapy.  The aryl-piperazine-contg. cathepsin K inhibitor CRA-013783/L-006235 (1) displays greater than 4000-fold selectivity against the lysosomal/endosomal antitargets cathepsin B, L, and S.  However, 1 and other aryl-piperazine-contg. analogs, including balicatib (10), are ∼10-100-fold more potent in cell-based enzyme occupancy assays than against each purified enzyme.  This phenomenon arises from their basic, lipophilic nature, which results in lysosomal trapping.  Consistent with its lysosomotropic nature, 1 accumulates in cells and in rat tissues of high lysosome content.  In contrast, nonbasic aryl-morpholino-contg. analogs do not exhibit lysosomotropic properties.  Increased off-target activities of basic cathepsin K inhibitors were obsd. in a cell-based cathepsin S antigen presentation assay.  No potency increases of basic inhibitors in a functional cathepsin K bone resorption whole cell assay were detected.  Therefore, basic cathepsin K inhibitors, such as 1, suffer from reduced functional selectivities compared to those predicted using purified enzyme assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1NUHyZtwrwLVg90H21EOLACvtfcHk0lipU_2OlUFqvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE&md5=9522026bb34984bc66b462b2e95fcbb0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm0504961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504961%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DKhougaz%26aufirst%3DK.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DToulmond%26aufirst%3DS.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DLysosomotropism%2520of%2520basic%2520cathepsin%2520K%2520inhibitors%2520contributes%2520to%2520increased%2520cellular%2520potencies%2520against%2520off-target%2520cathepsins%2520and%2520reduced%2520functional%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7535%26epage%3D7543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Adami, S.; Supronik, J.; Hala, T.; Brown, J. P.; Garnero, P.; Haemmerle, S.; Ortmann, C. E.; Bouisset, F.; Trechsel, U.</span><span> </span><span class="NLM_article-title">Effect of one year treatment with the cathepsin-K inhibitor, balicatib, on bone mineral density (BMD) in postmenopausal women with osteopenia/osteoporosis</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span>, Abstract 1085.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&author=S.+Adami&author=J.+Supronik&author=T.+Hala&author=J.+P.+Brown&author=P.+Garnero&author=S.+Haemmerle&author=C.+E.+Ortmann&author=F.+Bouisset&author=U.+Trechsel&title=Effect+of+one+year+treatment+with+the+cathepsin-K+inhibitor%2C+balicatib%2C+on+bone+mineral+density+%28BMD%29+in+postmenopausal+women+with+osteopenia%2Fosteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdami%26aufirst%3DS.%26atitle%3DEffect%2520of%2520one%2520year%2520treatment%2520with%2520the%2520cathepsin-K%2520inhibitor%252C%2520balicatib%252C%2520on%2520bone%2520mineral%2520density%2520%2528BMD%2529%2520in%2520postmenopausal%2520women%2520with%2520osteopenia%252Fosteoporosis%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2006%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tawa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickarski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span> </span><span class="NLM_article-title">Effect of cathepsin K inhibitor basicity on in vivo off-target activities</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1124%2Fmol.107.039511" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17940194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslCqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=147-156&author=S.+Desmaraisauthor=W.+C.+Blackauthor=R.+Oballaauthor=S.+Lamontagneauthor=D.+Riendeauauthor=P.+Tawaauthor=L.+T.+Duongauthor=M.+Pickarskiauthor=M.+D.+Percival&title=Effect+of+cathepsin+K+inhibitor+basicity+on+in+vivo+off-target+activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of cathepsin K inhibitor basicity on in vivo off-target activities</span></div><div class="casAuthors">Desmarais, Sylvie; Black, W. Cameron; Oballa, Renata; Lamontagne, Sonia; Riendeau, Denis; Tawa, Paul; Duong, Le Thi; Pickarski, Maureen; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">147-156</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cathepsin K is a lysosomal cysteine protease that is a pharmacol. target for the treatment of osteoporosis.  Previous studies showed that basic, lipophilic cathepsin K inhibitors are lysosomotropic and have greater activities in cell-based assays against cathepsin K, as well as the physiol. important lysosomal cysteine cathepsins B, L, and S, than expected based on their potencies against these isolated enzymes.  Long-term administration of the basic cathepsin K inhibitors N-(1-(((cyanomethyl)amino)carbonyl)cyclohexyl)-4-(2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl)benzamide (L-006235) and balicatib to rats at a supratherapeutic dose of 500 mg/kg/day for 4 wk resulted in increased tissue protein levels of cathepsin B and L but had no effect on cathepsin B and L message.  This is attributed to the inhibitor engagement of these off-target enzymes and their stabilization to proteolytic degrdn.  No such increase in these tissue cathepsins was detected at the same dose of L-873724, a potent nonbasic cathepsin K inhibitor with a similar off-target profile, although all three inhibitors provided similar plasma exposures.  Using an activity-based probe, 125I-BIL-DMK, in vivo inhibition of cathepsins B, L, and S was detected in tissues of mice given a single oral dose of L-006235 and balicatib, but not in mice given L-873724.  In each case, similar tissue levels were achieved by all three compds., thereby demonstrating the in vivo cathepsin selectivity of L-873724.  In conclusion, basic cathepsin K inhibitors demonstrate increased off-target cysteine cathepsin activities than their nonbasic analogs and potentially have a greater risk of adverse effects assocd. with inhibition of these cathepsins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE1Ff2aKlZ57Vg90H21EOLACvtfcHk0lgIySrM7U64XA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslCqtg%253D%253D&md5=53c20d61bd9b84db2d0cc4fe071040f4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fmol.107.039511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.107.039511%26sid%3Dliteratum%253Aachs%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DTawa%26aufirst%3DP.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DPickarski%26aufirst%3DM.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DEffect%2520of%2520cathepsin%2520K%2520inhibitor%2520basicity%2520on%2520in%2520vivo%2520off-target%2520activities%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D147%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Peroni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braga, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colato, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girolomoni, G.</span><span> </span><span class="NLM_article-title">Drug-induced morphea: report of a case induced by balicatib and review of the literature</span> <span class="citation_source-journal">J. Am. Acad. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.jaad.2008.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18410981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A280%3ADC%252BD1czpvVGjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2008&pages=125-129&author=A.+Peroniauthor=A.+Ziniauthor=V.+Bragaauthor=C.+Colatoauthor=S.+Adamiauthor=G.+Girolomoni&title=Drug-induced+morphea%3A+report+of+a+case+induced+by+balicatib+and+review+of+the+literature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced morphea: report of a case induced by balicatib and review of the literature</span></div><div class="casAuthors">Peroni Anna; Zini Antonio; Braga Vania; Colato Chiara; Adami Silvano; Girolomoni Giampiero</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Academy of Dermatology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Drug-induced scleroderma has been rarely reported, mostly with the features of diffuse scleroderma or acrosclerosis, and exceptionally with the characteristics of morphea.  We report the case of an adult white woman, enrolled in a double-blind, placebo-controlled, multicentric trial evaluating the efficacy and safety of the cathepsin K inhibitor balicatib for osteoporosis.  Typical morphea lesions developed on the patient's trunk 9 months after the beginning of therapy.  Lesions completely resolved after drug withdrawal and a single brief course of systemic steroids.  No recurrence occurred in a 2-year follow-up.  Fifteen cases of drug-induced morphea could be retrieved from the literature.  Drug withdrawal determined complete remission in only a few patients.  Different drug classes have been implicated.  Some of these, including balicatib, alter directly connective tissue metabolism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7h78HCX_qQIUSrryheKE6fW6udTcc2ea6i26VcbThv7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czpvVGjsA%253D%253D&md5=61fd8e59d3f450f6263ae45f59767616</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.jaad.2008.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaad.2008.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DPeroni%26aufirst%3DA.%26aulast%3DZini%26aufirst%3DA.%26aulast%3DBraga%26aufirst%3DV.%26aulast%3DColato%26aufirst%3DC.%26aulast%3DAdami%26aufirst%3DS.%26aulast%3DGirolomoni%26aufirst%3DG.%26atitle%3DDrug-induced%2520morphea%253A%2520report%2520of%2520a%2520case%2520induced%2520by%2520balicatib%2520and%2520review%2520of%2520the%2520literature%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D2008%26volume%3D59%26spage%3D125%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Altmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aichholz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betschart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irie, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tintelnot-Blomley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Missbach, M.</span><span> </span><span class="NLM_article-title">2-Cyano-pyrimidines: a new chemotype for inhibitors of the cysteine protease cathepsin K</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0613525" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=591-594&author=E.+Altmannauthor=R.+Aichholzauthor=C.+Betschartauthor=T.+Buhlauthor=J.+Greenauthor=O.+Irieauthor=N.+Tenoauthor=R.+Lattmannauthor=M.+Tintelnot-Blomleyauthor=M.+Missbach&title=2-Cyano-pyrimidines%3A+a+new+chemotype+for+inhibitors+of+the+cysteine+protease+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm0613525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0613525%26sid%3Dliteratum%253Aachs%26aulast%3DAltmann%26aufirst%3DE.%26aulast%3DAichholz%26aufirst%3DR.%26aulast%3DBetschart%26aufirst%3DC.%26aulast%3DBuhl%26aufirst%3DT.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DIrie%26aufirst%3DO.%26aulast%3DTeno%26aufirst%3DN.%26aulast%3DLattmann%26aufirst%3DR.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DMissbach%26aufirst%3DM.%26atitle%3D2-Cyano-pyrimidines%253A%2520a%2520new%2520chemotype%2520for%2520inhibitors%2520of%2520the%2520cysteine%2520protease%2520cathepsin%2520K%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D591%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Teno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irie, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitomi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gohda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umemura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kometani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasaki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan-Jacob, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Missbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betschart, C.</span><span> </span><span class="NLM_article-title">Novel scaffold for cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6096</span><span class="NLM_x">–</span> <span class="NLM_lpage">6100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.bmcl.2007.09.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17911019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOjt77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6096-6100&author=N.+Tenoauthor=T.+Miyakeauthor=T.+Eharaauthor=O.+Irieauthor=J.+Sakakiauthor=O.+Ohmoriauthor=H.+Gunjiauthor=N.+Matsuuraauthor=K.+Masuyaauthor=Y.+Hitomiauthor=K.+Nonomuraauthor=M.+Horiuchiauthor=K.+Gohdaauthor=A.+Iwasakiauthor=I.+Umemuraauthor=S.+Tadaauthor=M.+Kometaniauthor=G.+Iwasakiauthor=S.+W.+Cowan-Jacobauthor=M.+Missbachauthor=R.+Lattmannauthor=C.+Betschart&title=Novel+scaffold+for+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Novel scaffold for cathepsin K inhibitors</span></div><div class="casAuthors">Teno, Naoki; Miyake, Takahiro; Ehara, Takeru; Irie, Osamu; Sakaki, Junichi; Ohmori, Osamu; Gunji, Hiroki; Matsuura, Naoko; Masuya, Keiichi; Hitomi, Yuko; Nonomura, Kazuhiko; Horiuchi, Miyuki; Gohda, Keigo; Iwasaki, Atsuko; Umemura, Ichiro; Tada, Sachiyo; Kometani, Motohiko; Iwasaki, Genji; Cowan-Jacob, Sandra W.; Missbach, Martin; Lattmann, Rene; Betschart, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6096-6100</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pyrrolopyrimidine, a novel scaffold, allows to adjust interactions within the S3 subsite of cathepsin K.  The core intermediate 10 (I) facilitated the P3 optimization and identified highly potent and selective cathepsin K inhibitors 11-20.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovAekeL5ajUrVg90H21EOLACvtfcHk0ljGKLt565BGUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOjt77N&md5=9320305ef6bd02c637ffb0dd1afd367d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.09.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.09.047%26sid%3Dliteratum%253Aachs%26aulast%3DTeno%26aufirst%3DN.%26aulast%3DMiyake%26aufirst%3DT.%26aulast%3DEhara%26aufirst%3DT.%26aulast%3DIrie%26aufirst%3DO.%26aulast%3DSakaki%26aufirst%3DJ.%26aulast%3DOhmori%26aufirst%3DO.%26aulast%3DGunji%26aufirst%3DH.%26aulast%3DMatsuura%26aufirst%3DN.%26aulast%3DMasuya%26aufirst%3DK.%26aulast%3DHitomi%26aufirst%3DY.%26aulast%3DNonomura%26aufirst%3DK.%26aulast%3DHoriuchi%26aufirst%3DM.%26aulast%3DGohda%26aufirst%3DK.%26aulast%3DIwasaki%26aufirst%3DA.%26aulast%3DUmemura%26aufirst%3DI.%26aulast%3DTada%26aufirst%3DS.%26aulast%3DKometani%26aufirst%3DM.%26aulast%3DIwasaki%26aufirst%3DG.%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26aulast%3DMissbach%26aufirst%3DM.%26aulast%3DLattmann%26aufirst%3DR.%26aulast%3DBetschart%26aufirst%3DC.%26atitle%3DNovel%2520scaffold%2520for%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6096%26epage%3D6100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Teno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irie, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gohda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kometani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasaki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betschart, C.</span><span> </span><span class="NLM_article-title">New chemotypes for cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2599</span><span class="NLM_x">–</span> <span class="NLM_lpage">2603</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.bmcl.2008.03.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18375120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1akt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2599-2603&author=N.+Tenoauthor=O.+Irieauthor=T.+Miyakeauthor=K.+Gohdaauthor=M.+Horiuchiauthor=S.+Tadaauthor=K.+Nonomuraauthor=M.+Kometaniauthor=G.+Iwasakiauthor=C.+Betschart&title=New+chemotypes+for+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">New chemotypes for cathepsin K inhibitors</span></div><div class="casAuthors">Teno, Naoki; Irie, Osamu; Miyake, Takahiro; Gohda, Keigo; Horiuchi, Miyuki; Tada, Sachiyo; Nonomura, Kazuhiko; Kometani, Motohiko; Iwasaki, Genji; Betschart, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2599-2603</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Alkynyl- and tert-aminopyrimidinecarbonitriles were prepd. and tested for inhibitory activities against cathepsin K and the highly homologous cathepsins L and S.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS5QY0yeimmrVg90H21EOLACvtfcHk0ljGKLt565BGUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1akt74%253D&md5=88877c6dea5e08af2b0fafead6998e68</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.03.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.03.036%26sid%3Dliteratum%253Aachs%26aulast%3DTeno%26aufirst%3DN.%26aulast%3DIrie%26aufirst%3DO.%26aulast%3DMiyake%26aufirst%3DT.%26aulast%3DGohda%26aufirst%3DK.%26aulast%3DHoriuchi%26aufirst%3DM.%26aulast%3DTada%26aufirst%3DS.%26aulast%3DNonomura%26aufirst%3DK.%26aulast%3DKometani%26aufirst%3DM.%26aulast%3DIwasaki%26aufirst%3DG.%26aulast%3DBetschart%26aufirst%3DC.%26atitle%3DNew%2520chemotypes%2520for%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2599%26epage%3D2603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Teno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irie, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitomi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umemura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasaki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukaya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toriyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kometani, M.</span><span> </span><span class="NLM_article-title">Effect of cathepsin K inhibitors on bone resorption</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5459</span><span class="NLM_x">–</span> <span class="NLM_lpage">5462</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800626a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5459-5462&author=N.+Tenoauthor=K.+Masuyaauthor=T.+Eharaauthor=T.+Kosakaauthor=T.+Miyakeauthor=O.+Irieauthor=Y.+Hitomiauthor=N.+Matsuuraauthor=I.+Umemuraauthor=G.+Iwasakiauthor=H.+Fukayaauthor=K.+Toriyamaauthor=N.+Uchiyamaauthor=K.+Nonomuraauthor=I.+Sugiyamaauthor=M.+Kometani&title=Effect+of+cathepsin+K+inhibitors+on+bone+resorption"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Cathepsin K Inhibitors on Bone Resorption</span></div><div class="casAuthors">Teno, Naoki; Masuya, Keiichi; Ehara, Takeru; Kosaka, Takatoshi; Miyake, Takahiro; Irie, Osamu; Hitomi, Yuko; Matsuura, Naoko; Umemura, Ichiro; Iwasaki, Genji; Fukaya, Hiroaki; Toriyama, Kazuhiro; Uchiyama, Noriko; Nonomura, Kazuhiko; Sugiyama, Ikuo; Kometani, Motohiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5459-5462</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of the pyrrolopyrimidine core structure that was previously discovered, cathepsin K inhibitors having a spiro amine at the P3 have been explored to enhance the target, bone marrow, tissue distribution.  Several spiro structures were identified with improved distribution toward bone marrow.  The representative inhibitor 7 of this series revealed in vivo redn. in C-terminal telopeptide of type I collagen in rats and monkeys.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUGSZEmNpl4rVg90H21EOLACvtfcHk0liVaTujzW1kww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurbE&md5=ff9f7cce2fc32fa0cb8fe692f6bb5bac</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm800626a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800626a%26sid%3Dliteratum%253Aachs%26aulast%3DTeno%26aufirst%3DN.%26aulast%3DMasuya%26aufirst%3DK.%26aulast%3DEhara%26aufirst%3DT.%26aulast%3DKosaka%26aufirst%3DT.%26aulast%3DMiyake%26aufirst%3DT.%26aulast%3DIrie%26aufirst%3DO.%26aulast%3DHitomi%26aufirst%3DY.%26aulast%3DMatsuura%26aufirst%3DN.%26aulast%3DUmemura%26aufirst%3DI.%26aulast%3DIwasaki%26aufirst%3DG.%26aulast%3DFukaya%26aufirst%3DH.%26aulast%3DToriyama%26aufirst%3DK.%26aulast%3DUchiyama%26aufirst%3DN.%26aulast%3DNonomura%26aufirst%3DK.%26aulast%3DSugiyama%26aufirst%3DI.%26aulast%3DKometani%26aufirst%3DM.%26atitle%3DEffect%2520of%2520cathepsin%2520K%2520inhibitors%2520on%2520bone%2520resorption%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5459%26epage%3D5462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Böttiger, D.; Darpö, B.; Grabowska, U.; Shiroo, M.; Chambers, T. J.; Samuelsson, B.</span><span> </span><span class="NLM_article-title">Cathepsin K inhibitor, MIV-701, suppresses bone resorption markers in healthy PMW: results of a phase I clinical trial</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span>), Abstract F433.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&issue=Suppl.+1&author=D.+B%C3%B6ttiger&author=B.+Darp%C3%B6&author=U.+Grabowska&author=M.+Shiroo&author=T.+J.+Chambers&author=B.+Samuelsson&title=Cathepsin+K+inhibitor%2C+MIV-701%2C+suppresses+bone+resorption+markers+in+healthy+PMW%3A+results+of+a+phase+I+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25B6ttiger%26aufirst%3DD.%26atitle%3DCathepsin%2520K%2520inhibitor%252C%2520MIV-701%252C%2520suppresses%2520bone%2520resorption%2520markers%2520in%2520healthy%2520PMW%253A%2520results%2520of%2520a%2520phase%2520I%2520clinical%2520trial%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2008%26volume%3D23%26issue%3DSuppl.%25201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Fuller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grabowska, U. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiroo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, T. J.</span><span> </span><span class="NLM_article-title">Cathepsin K inhibitors prevent matrix-derived growth factor degradation by human osteoclasts</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2008&pages=200-211&author=K.+Fullerauthor=K.+M.+Lawrenceauthor=J.+L.+Rossauthor=U.+B.+Grabowskaauthor=M.+Shirooauthor=B.+Samuelssonauthor=T.+J.+Chambers&title=Cathepsin+K+inhibitors+prevent+matrix-derived+growth+factor+degradation+by+human+osteoclasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuller%26aufirst%3DK.%26aulast%3DLawrence%26aufirst%3DK.%2BM.%26aulast%3DRoss%26aufirst%3DJ.%2BL.%26aulast%3DGrabowska%26aufirst%3DU.%2BB.%26aulast%3DShiroo%26aufirst%3DM.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DChambers%26aufirst%3DT.%2BJ.%26atitle%3DCathepsin%2520K%2520inhibitors%2520prevent%2520matrix-derived%2520growth%2520factor%2520degradation%2520by%2520human%2520osteoclasts%26jtitle%3DBone%26date%3D2008%26volume%3D42%26spage%3D200%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Marquis, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ru, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoCastro, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erhard, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszek, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salyers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proksch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haltiwanger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trescher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemling, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQueney, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D'Alessio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzulli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodds, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gress, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lark, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span> </span><span class="NLM_article-title">Azepanone-based inhibitors of human and rat cathepsin K</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1380</span><span class="NLM_x">–</span> <span class="NLM_lpage">1395</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000481x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1380-1395&author=R.+W.+Marquisauthor=Y.+Ruauthor=S.+M.+LoCastroauthor=J.+Zengauthor=D.+S.+Yamashitaauthor=H.-J.+Ohauthor=K.+F.+Erhardauthor=L.+D.+Davisauthor=T.+A.+Tomaszekauthor=D.+Tewauthor=K.+Salyersauthor=J.+Prokschauthor=K.+Wardauthor=B.+Smithauthor=M.+Levyauthor=M.+D.+Cummingsauthor=R.+C.+Haltiwangerauthor=G.+Trescherauthor=B.+Wangauthor=M.+E.+Hemlingauthor=C.+J.+Quinnauthor=H.+Y.+Chengauthor=F.+Linauthor=W.+W.+Smithauthor=C.+A.+Jansonauthor=B.+Zhaoauthor=M.+S.+McQueneyauthor=K.+D%27Alessioauthor=C.-P.+Leeauthor=A.+Marzulliauthor=R.+A.+Doddsauthor=S.+Blakeauthor=S.-M.+Hwangauthor=I.+E.+Jamesauthor=C.+J.+Gressauthor=B.+R.+Bradleyauthor=M.+W.+Larkauthor=M.+Gowenauthor=D.+F.+Veber&title=Azepanone-based+inhibitors+of+human+and+rat+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm000481x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000481x%26sid%3Dliteratum%253Aachs%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DRu%26aufirst%3DY.%26aulast%3DLoCastro%26aufirst%3DS.%2BM.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DYamashita%26aufirst%3DD.%2BS.%26aulast%3DOh%26aufirst%3DH.-J.%26aulast%3DErhard%26aufirst%3DK.%2BF.%26aulast%3DDavis%26aufirst%3DL.%2BD.%26aulast%3DTomaszek%26aufirst%3DT.%2BA.%26aulast%3DTew%26aufirst%3DD.%26aulast%3DSalyers%26aufirst%3DK.%26aulast%3DProksch%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DLevy%26aufirst%3DM.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DHaltiwanger%26aufirst%3DR.%2BC.%26aulast%3DTrescher%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DHemling%26aufirst%3DM.%2BE.%26aulast%3DQuinn%26aufirst%3DC.%2BJ.%26aulast%3DCheng%26aufirst%3DH.%2BY.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DMcQueney%26aufirst%3DM.%2BS.%26aulast%3DD%2527Alessio%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DC.-P.%26aulast%3DMarzulli%26aufirst%3DA.%26aulast%3DDodds%26aufirst%3DR.%2BA.%26aulast%3DBlake%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DS.-M.%26aulast%3DJames%26aufirst%3DI.%2BE.%26aulast%3DGress%26aufirst%3DC.%2BJ.%26aulast%3DBradley%26aufirst%3DB.%2BR.%26aulast%3DLark%26aufirst%3DM.%2BW.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26atitle%3DAzepanone-based%2520inhibitors%2520of%2520human%2520and%2520rat%2520cathepsin%2520K%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D1380%26epage%3D1395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Yamashita, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nidamarthy, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erhard, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roethke, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevins, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haltiwanger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narducci Sarjeant, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liable-Sands, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQueney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gress, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zembryki, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lark, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span> </span><span class="NLM_article-title">Structure activity relationships of 5-, 6-, and 7-methyl-substituted azepan-3-one cathepsin K inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1597</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050915u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1597-1612&author=D.+S.+Yamashitaauthor=R.+W.+Marquisauthor=R.+Xieauthor=S.+D.+Nidamarthyauthor=H.-J.+Ohauthor=J.+U.+Jeongauthor=K.+F.+Erhardauthor=K.+W.+Wardauthor=T.+J.+Roethkeauthor=B.+R.+Smithauthor=H.-Y.+Chengauthor=X.+Gengauthor=F.+Linauthor=P.+H.+Offenauthor=B.+Wangauthor=N.+Nevinsauthor=M.+S.+Headauthor=R.+C.+Haltiwangerauthor=A.+A.+Narducci+Sarjeantauthor=L.+M.+Liable-Sandsauthor=B.+Zhaoauthor=W.+W.+Smithauthor=C.+A.+Jansonauthor=E.+Gaoauthor=T.+Tomaszekauthor=M.+McQueneyauthor=I.+E.+Jamesauthor=C.+J.+Gressauthor=D.+L.+Zembrykiauthor=M.+W.+Larkauthor=D.+F.+Veber&title=Structure+activity+relationships+of+5-%2C+6-%2C+and+7-methyl-substituted+azepan-3-one+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm050915u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050915u%26sid%3Dliteratum%253Aachs%26aulast%3DYamashita%26aufirst%3DD.%2BS.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DXie%26aufirst%3DR.%26aulast%3DNidamarthy%26aufirst%3DS.%2BD.%26aulast%3DOh%26aufirst%3DH.-J.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DErhard%26aufirst%3DK.%2BF.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DRoethke%26aufirst%3DT.%2BJ.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DCheng%26aufirst%3DH.-Y.%26aulast%3DGeng%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DOffen%26aufirst%3DP.%2BH.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DNevins%26aufirst%3DN.%26aulast%3DHead%26aufirst%3DM.%2BS.%26aulast%3DHaltiwanger%26aufirst%3DR.%2BC.%26aulast%3DNarducci%2BSarjeant%26aufirst%3DA.%2BA.%26aulast%3DLiable-Sands%26aufirst%3DL.%2BM.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DGao%26aufirst%3DE.%26aulast%3DTomaszek%26aufirst%3DT.%26aulast%3DMcQueney%26aufirst%3DM.%26aulast%3DJames%26aufirst%3DI.%2BE.%26aulast%3DGress%26aufirst%3DC.%2BJ.%26aulast%3DZembryki%26aufirst%3DD.%2BL.%26aulast%3DLark%26aufirst%3DM.%2BW.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26atitle%3DStructure%2520activity%2520relationships%2520of%25205-%252C%25206-%252C%2520and%25207-methyl-substituted%2520azepan-3-one%2520cathepsin%2520K%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1597%26epage%3D1612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Barrett, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catalano, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deaton, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFadyen, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells-Knecht, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.-Q. Q.</span><span> </span><span class="NLM_article-title">Acyclic, orally bioavailable ketone-based cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=22-27&author=D.+G.+Barrettauthor=J.+G.+Catalanoauthor=D.+N.+Deatonauthor=S.+T.+Longauthor=R.+B.+McFadyenauthor=A.+B.+Millerauthor=L.+R.+Millerauthor=V.+Samanoauthor=F.+X.+Tavaresauthor=K.+J.+Wells-Knechtauthor=L.+L.+Wrightauthor=H.-Q.+Q.+Zhou&title=Acyclic%2C+orally+bioavailable+ketone-based+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DD.%2BG.%26aulast%3DCatalano%26aufirst%3DJ.%2BG.%26aulast%3DDeaton%26aufirst%3DD.%2BN.%26aulast%3DLong%26aufirst%3DS.%2BT.%26aulast%3DMcFadyen%26aufirst%3DR.%2BB.%26aulast%3DMiller%26aufirst%3DA.%2BB.%26aulast%3DMiller%26aufirst%3DL.%2BR.%26aulast%3DSamano%26aufirst%3DV.%26aulast%3DTavares%26aufirst%3DF.%2BX.%26aulast%3DWells-Knecht%26aufirst%3DK.%2BJ.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DZhou%26aufirst%3DH.-Q.%2BQ.%26atitle%3DAcyclic%252C%2520orally%2520bioavailable%2520ketone-based%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D22%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Kumar, S.; Rehm, S.; Boyce, R.; Birmingham, J.; Stroup, G.; Jerome, C.; Weir, P.</span><span> </span><span class="NLM_article-title">Treatment of young male monkeys for 12 months with a highly potent inhibitor of cathepsin K inhibits bone resorption, and increases bone mineral density and strength</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span>), Abstract F232.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&issue=Suppl.+1&author=S.+Kumar&author=S.+Rehm&author=R.+Boyce&author=J.+Birmingham&author=G.+Stroup&author=C.+Jerome&author=P.+Weir&title=Treatment+of+young+male+monkeys+for+12+months+with+a+highly+potent+inhibitor+of+cathepsin+K+inhibits+bone+resorption%2C+and+increases+bone+mineral+density+and+strength"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26atitle%3DTreatment%2520of%2520young%2520male%2520monkeys%2520for%252012%2520months%2520with%2520a%2520highly%2520potent%2520inhibitor%2520of%2520cathepsin%2520K%2520inhibits%2520bone%2520resorption%252C%2520and%2520increases%2520bone%2520mineral%2520density%2520and%2520strength%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2005%26volume%3D20%26issue%3DSuppl.%25201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Adkison, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deaton, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gampe, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFadyen, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewchuk, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells-Knecht, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willard, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span> </span><span class="NLM_article-title">Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">978</span><span class="NLM_x">–</span> <span class="NLM_lpage">983</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=978-983&author=K.+K.+Adkisonauthor=D.+G.+Barrettauthor=D.+N.+Deatonauthor=R.+T.+Gampeauthor=A.+M.+Hassellauthor=S.+T.+Longauthor=R.+B.+McFadyenauthor=A.+B.+Millerauthor=L.+R.+Millerauthor=J.+A.+Payneauthor=L.+M.+Shewchukauthor=K.+J.+Wells-Knechtauthor=D.+H.+Willardauthor=L.+L.+Wright&title=Semicarbazone-based+inhibitors+of+cathepsin+K%2C+are+they+prodrugs+for+aldehyde+inhibitors%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdkison%26aufirst%3DK.%2BK.%26aulast%3DBarrett%26aufirst%3DD.%2BG.%26aulast%3DDeaton%26aufirst%3DD.%2BN.%26aulast%3DGampe%26aufirst%3DR.%2BT.%26aulast%3DHassell%26aufirst%3DA.%2BM.%26aulast%3DLong%26aufirst%3DS.%2BT.%26aulast%3DMcFadyen%26aufirst%3DR.%2BB.%26aulast%3DMiller%26aufirst%3DA.%2BB.%26aulast%3DMiller%26aufirst%3DL.%2BR.%26aulast%3DPayne%26aufirst%3DJ.%2BA.%26aulast%3DShewchuk%26aufirst%3DL.%2BM.%26aulast%3DWells-Knecht%26aufirst%3DK.%2BJ.%26aulast%3DWillard%26aufirst%3DD.%2BH.%26aulast%3DWright%26aufirst%3DL.%2BL.%26atitle%3DSemicarbazone-based%2520inhibitors%2520of%2520cathepsin%2520K%252C%2520are%2520they%2520prodrugs%2520for%2520aldehyde%2520inhibitors%253F%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D978%26epage%3D983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeRiche, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, V.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venuti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span> </span><span class="NLM_article-title">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">928</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.bmcl.2007.12.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18226527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=923-928&author=J.+Y.+Gauthierauthor=N.+Chauretauthor=W.+Cromlishauthor=S.+Desmaraisauthor=L.+T.+Duongauthor=J.-P.+Falgueyretauthor=D.+B.+Kimmelauthor=S.+Lamontagneauthor=S.+Legerauthor=T.+LeRicheauthor=C.+S.+Liauthor=F.+Masseauthor=D.+J.+McKayauthor=D.+A.+Nicoll-Griffithauthor=R.+M.+Oballaauthor=J.+T.+Palmerauthor=M.+D.+Percivalauthor=D.+Riendeauauthor=J.+Robichaudauthor=G.+A.+Rodanauthor=S.+B.+Rodanauthor=C.+Setoauthor=M.+Therienauthor=V.-L.+Truongauthor=M.+C.+Venutiauthor=G.+Wesolowskiauthor=R.+N.+Youngauthor=R.+Zamboniauthor=W.+C.+Black&title=The+discovery+of+odanacatib+%28MK-0822%29%2C+a+selective+inhibitor+of+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span></div><div class="casAuthors">Gauthier, Jacques Yves; Chauret, Nathalie; Cromlish, Wanda; Desmarais, Sylvie; Duong, Le T.; Falgueyret, Jean-Pierre; Kimmel, Donald B.; Lamontagne, Sonia; Leger, Serge; LeRiche, Tammy; Li, Chun Sing; Masse, Frederic; McKay, Daniel J.; Nicoll-Griffith, Deborah A.; Oballa, Renata M.; Palmer, James T.; Percival, M. David; Riendeau, Denis; Robichaud, Joel; Rodan, Gideon A.; Rodan, Sevgi B.; Seto, Carmai; Therien, Michel; Truong, Vouy-Linh; Venuti, Michael C.; Wesolowski, Gregg; Young, Robert N.; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">923-928</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Odanacatib is a potent, selective, and neutral cathepsin K inhibitor which was developed to address the metabolic liabilities of the Cat K inhibitor L-873724.  Substituting P1 and modifying the P2 side chain led to a metabolically robust inhibitor with a long half-life in preclin. species.  Odanacatib was more selective in whole cell assays than the published Cat K inhibitors balicatib and relacatib.  Evaluation in dermal fibroblast culture showed minimal intracellular collagen accumulation relative to less selective Cat K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7ytNI-SBgarVg90H21EOLACvtfcHk0lg8McTaABF2EQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D&md5=e432a420a3ec99c784117750b9bbeda8</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.047%26sid%3Dliteratum%253Aachs%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DLeRiche%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DSeto%26aufirst%3DC.%26aulast%3DTherien%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.-L.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DThe%2520discovery%2520of%2520odanacatib%2520%2528MK-0822%2529%252C%2520a%2520selective%2520inhibitor%2520of%2520cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D923%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span> </span><span class="NLM_article-title">Cathepsin K: a new molecular target for osteoporosis</span> <span class="citation_source-journal">IBMS BoneKEy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=16-24&author=S.+B.+Rodanauthor=L.+T.+Duong&title=Cathepsin+K%3A+a+new+molecular+target+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26atitle%3DCathepsin%2520K%253A%2520a%2520new%2520molecular%2520target%2520for%2520osteoporosis%26jtitle%3DIBMS%2520BoneKEy%26date%3D2008%26volume%3D5%26spage%3D16%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Setti, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of tetracyclic nonpeptidic biaryl nitrile inhibitors of cathepsin K</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4296</span><span class="NLM_x">–</span> <span class="NLM_lpage">4299</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4296-4299&author=E.+L.+Settiauthor=S.+Venkatramanauthor=J.+T.+Palmerauthor=X.+Xieauthor=H.+Cheungauthor=W.+Yuauthor=G.+Wesolowskiauthor=J.+Robichaud&title=Design+and+synthesis+of+tetracyclic+nonpeptidic+biaryl+nitrile+inhibitors+of+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSetti%26aufirst%3DE.%2BL.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DCheung%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DRobichaud%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520tetracyclic%2520nonpeptidic%2520biaryl%2520nitrile%2520inhibitors%2520of%2520cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4296%26epage%3D4299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span> </span><span class="NLM_article-title">A novel class of nonpeptidic biaryl inhibitors of human cathepsin K</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3709</span><span class="NLM_x">–</span> <span class="NLM_lpage">3727</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0301078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3709-3727&author=J.+Robichaudauthor=R.+Oballaauthor=P.+Prasitauthor=J.-P.+Falgueyretauthor=M.+D.+Percivalauthor=G.+Wesolowskiauthor=S.+B.+Rodanauthor=D.+Kimmelauthor=C.+Johnsonauthor=C.+Bryantauthor=S.+Venkatramanauthor=E.+Settiauthor=R.+Mendoncaauthor=J.+T.+Palmer&title=A+novel+class+of+nonpeptidic+biaryl+inhibitors+of+human+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm0301078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0301078%26sid%3Dliteratum%253Aachs%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DKimmel%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DC.%26aulast%3DBryant%26aufirst%3DC.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DSetti%26aufirst%3DE.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26atitle%3DA%2520novel%2520class%2520of%2520nonpeptidic%2520biaryl%2520inhibitors%2520of%2520human%2520cathepsin%2520K%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3709%26epage%3D3727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setti, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydzewski, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Z.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrill, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janc, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somoza, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enriquez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickley, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venuti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G.</span><span> </span><span class="NLM_article-title">Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7520</span><span class="NLM_x">–</span> <span class="NLM_lpage">7534</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058198r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7520-7534&author=J.+T.+Palmerauthor=C.+Bryantauthor=D.-X.+Wangauthor=D.+E.+Davisauthor=E.+L.+Settiauthor=R.+M.+Rydzewskiauthor=S.+Venkatramanauthor=Z.-Q.+Tianauthor=L.+C.+Burrillauthor=R.+V.+Mendoncaauthor=E.+Springmanauthor=J.+McCarterauthor=T.+Chungauthor=H.+Cheungauthor=J.+W.+Jancauthor=M.+McGrathauthor=J.+R.+Somozaauthor=P.+Enriquezauthor=Z.+W.+Yuauthor=R.+M.+Strickleyauthor=L.+Liuauthor=M.+C.+Venutiauthor=M.+D.+Percivalauthor=J.-P.+Falgueyretauthor=P.+Prasitauthor=R.+Oballaauthor=D.+Riendeauauthor=R.+N.+Youngauthor=G.+Wesolowskiauthor=S.+B.+Rodanauthor=C.+Johnsonauthor=D.+B.+Kimmelauthor=G.+Rodan&title=Design+and+synthesis+of+tri-ring+P3+benzamide-containing+aminonitriles+as+potent%2C+selective%2C+orally+effective+inhibitors+of+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm058198r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058198r%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DBryant%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DD.-X.%26aulast%3DDavis%26aufirst%3DD.%2BE.%26aulast%3DSetti%26aufirst%3DE.%2BL.%26aulast%3DRydzewski%26aufirst%3DR.%2BM.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DZ.-Q.%26aulast%3DBurrill%26aufirst%3DL.%2BC.%26aulast%3DMendonca%26aufirst%3DR.%2BV.%26aulast%3DSpringman%26aufirst%3DE.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DT.%26aulast%3DCheung%26aufirst%3DH.%26aulast%3DJanc%26aufirst%3DJ.%2BW.%26aulast%3DMcGrath%26aufirst%3DM.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DEnriquez%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DZ.%2BW.%26aulast%3DStrickley%26aufirst%3DR.%2BM.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DJohnson%26aufirst%3DC.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DRodan%26aufirst%3DG.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520tri-ring%2520P3%2520benzamide-containing%2520aminonitriles%2520as%2520potent%252C%2520selective%252C%2520orally%2520effective%2520inhibitors%2520of%2520cathepsin%2520K%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7520%26epage%3D7534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Li, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschenes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, V.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span> </span><span class="NLM_article-title">Identification of a potent and selective non-basic cathepsin K inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1985</span><span class="NLM_x">–</span> <span class="NLM_lpage">1989</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.bmcl.2005.12.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16413777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVyqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1985-1989&author=C.+S.+Liauthor=D.+Deschenesauthor=S.+Desmaraisauthor=J.-P.+Falgueyretauthor=J.+Y.+Gauthierauthor=D.+B.+Kimmelauthor=S.+Legerauthor=F.+Masseauthor=M.+E.+McGrathauthor=D.+J.+McKayauthor=M.+D.+Percivalauthor=D.+Riendeauauthor=S.+B.+Rodanauthor=M.+Therienauthor=V.-L.+Truongauthor=G.+Wesolowskiauthor=R.+Zamboniauthor=W.+C.+Black&title=Identification+of+a+potent+and+selective+non-basic+cathepsin+K+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a potent and selective non-basic cathepsin K inhibitor</span></div><div class="casAuthors">Li, Chun Sing; Deschenes, Denis; Desmarais, Sylvie; Falgueyret, Jean-Pierre; Gauthier, Jacques Yves; Kimmel, Donald. B.; Leger, Serge; Masse, Frederic; McGrath, Mary E.; McKay, Daniel J.; Percival, M. David; Riendeau, Denis; Rodan, Sevgi B.; Therien, Michel; Truong, Vouy-Linh; Wesolowski, Gregg; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1985-1989</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Based on our previous study with trifluoroethylamine as a P2-P3 amide isostere of cathepsin K inhibitor, further optimization led to identification of L-873724 (I) as a potent and selective non-basic cathepsin K inhibitor.  This compd. showed excellent pharmacokinetics and efficacy in an ovariectomized (OVX) rhesus monkey model.  The vols. of distribution close to unity were consistent with this compd. not being lysosomotropic, which is a characteristic of basic cathepsin K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbVLlTt9kYhrVg90H21EOLACvtfcHk0li033KdgECbxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVyqs74%253D&md5=e63e471204893774e5a617993ed9be18</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.12.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.12.071%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DDeschenes%26aufirst%3DD.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DTherien%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.-L.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DIdentification%2520of%2520a%2520potent%2520and%2520selective%2520non-basic%2520cathepsin%2520K%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1985%26epage%3D1989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span> </span><span class="NLM_article-title">Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4741</span><span class="NLM_x">–</span> <span class="NLM_lpage">4744</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.bmcl.2005.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16154747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVanu7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4741-4744&author=W.+C.+Blackauthor=C.+I.+Baylyauthor=D.+E.+Davisauthor=S.+Desmaraisauthor=J.-P.+Falgueyretauthor=S.+Legerauthor=C.+S.+Liauthor=F.+Masseauthor=D.+J.+McKayauthor=J.+T.+Palmerauthor=M.+D.+Percivalauthor=J.+Robichaudauthor=N.+Tsouauthor=R.+Zamboni&title=Trifluoroethylamines+as+amide+isosteres+in+inhibitors+of+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K</span></div><div class="casAuthors">Black, W. Cameron; Bayly, Christopher I.; Davis, Dana E.; Desmarais, Sylvie; Falgueyret, Jean-Pierre; Leger, Serge; Li, Chun Sing; Masse, Frederic; McKay, Daniel J.; Palmer, James T.; Percival, M. David; Robichaud, Joel; Tsou, Nancy; Zamboni, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4741-4744</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The P2-P3 amide of dipeptide cathepsin K inhibitors can be replaced by the metabolically stable trifluoroethylamine group.  The nonbasic nature of the nitrogen allows the important hydrogen bond to Gly66 to be made.  The resulting compds. are 10- to 20-fold more potent than the corresponding amide derivs.  Compd. (I) is a 5 pM inhibitor of human cathepsin K with >10,000-fold selectivity over other cathepsins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKJDCfyMa_crVg90H21EOLACvtfcHk0li033KdgECbxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVanu7%252FE&md5=c2ffc9bde9fbee7bb432d3c2485cfc62</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DDavis%26aufirst%3DD.%2BE.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DTsou%26aufirst%3DN.%26aulast%3DZamboni%26aufirst%3DR.%26atitle%3DTrifluoroethylamines%2520as%2520amide%2520isosteres%2520in%2520inhibitors%2520of%2520cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4741%26epage%3D4744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">McClung, M.; Bone, H.; Cosman, F.; Roux, C.; Verbruggen, N.; Hustad, C.; DaSilva, C.; Santora, A.; Ince, A.</span><span> </span><span class="NLM_article-title">A randomized, double-blind, placebo-controlled study of odanacatib (MK-822) in the treatment of postmenopausal women with low bone mineral density: 24-month results</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span>), Abstract 1291.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&issue=Suppl.+1&author=M.+McClung&author=H.+Bone&author=F.+Cosman&author=C.+Roux&author=N.+Verbruggen&author=C.+Hustad&author=C.+DaSilva&author=A.+Santora&author=A.+Ince&title=A+randomized%2C+double-blind%2C+placebo-controlled+study+of+odanacatib+%28MK-822%29+in+the+treatment+of+postmenopausal+women+with+low+bone+mineral+density%3A+24-month+results"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcClung%26aufirst%3DM.%26atitle%3DA%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520study%2520of%2520odanacatib%2520%2528MK-822%2529%2520in%2520the%2520treatment%2520of%2520postmenopausal%2520women%2520with%2520low%2520bone%2520mineral%2520density%253A%252024-month%2520results%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2008%26volume%3D23%26issue%3DSuppl.%25201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truchon, J.-F.</span><span> </span><span class="NLM_article-title">Primary amides as selective inhibitors of cathepsin K</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4328</span><span class="NLM_x">–</span> <span class="NLM_lpage">4332</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4328-4332&author=S.+Legerauthor=C.+I.+Baylyauthor=W.+C.+Blackauthor=S.+Desmaraisauthor=J.-P.+Falgueyretauthor=F.+Masseauthor=M.+D.+Percivalauthor=J.-F.+Truchon&title=Primary+amides+as+selective+inhibitors+of+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DTruchon%26aufirst%3DJ.-F.%26atitle%3DPrimary%2520amides%2520as%2520selective%2520inhibitors%2520of%2520cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4328%26epage%3D4332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Boyd, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheigetz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span> </span><span class="NLM_article-title">Investigation of ketone warheads as alternatives to the nitrile for preparation of potent and selective cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=675-679&author=M.+J.+Boydauthor=S.+N.+Craneauthor=J.+Robichaudauthor=J.+Scheigetzauthor=W.+C.+Blackauthor=N.+Chauretauthor=Q.+Wangauthor=F.+Masseauthor=R.+M.+Oballa&title=Investigation+of+ketone+warheads+as+alternatives+to+the+nitrile+for+preparation+of+potent+and+selective+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DM.%2BJ.%26aulast%3DCrane%26aufirst%3DS.%2BN.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DScheigetz%26aufirst%3DJ.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26atitle%3DInvestigation%2520of%2520ketone%2520warheads%2520as%2520alternatives%2520to%2520the%2520nitrile%2520for%2520preparation%2520of%2520potent%2520and%2520selective%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D675%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirschbein, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janc, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span> </span><span class="NLM_article-title">Keto-1,3,4-oxadiazoles as cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2909</span><span class="NLM_x">–</span> <span class="NLM_lpage">2914</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2909-2914&author=J.+T.+Palmerauthor=B.+L.+Hirschbeinauthor=H.+Cheungauthor=J.+McCarterauthor=J.+W.+Jancauthor=Z.+W.+Yuauthor=G.+Wesolowski&title=Keto-1%2C3%2C4-oxadiazoles+as+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DHirschbein%26aufirst%3DB.%2BL.%26aulast%3DCheung%26aufirst%3DH.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DJanc%26aufirst%3DJ.%2BW.%26aulast%3DYu%26aufirst%3DZ.%2BW.%26aulast%3DWesolowski%26aufirst%3DG.%26atitle%3DKeto-1%252C3%252C4-oxadiazoles%2520as%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2909%26epage%3D2914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Crane, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somoza, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheigetz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouellet, M.</span><span> </span><span class="NLM_article-title">β-Substituted cyclohexanecarboxamide: a nonpeptidic framework for the design of potent inhibitors of cathepsin K</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1066</span><span class="NLM_x">–</span> <span class="NLM_lpage">1079</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051059p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1066-1079&author=S.+N.+Craneauthor=W.+C.+Blackauthor=J.+T.+Palmerauthor=D.+E.+Davisauthor=E.+Settiauthor=J.+Robichaudauthor=J.+Paquetauthor=R.+M.+Oballaauthor=C.+I.+Baylyauthor=D.+J.+McKayauthor=J.+R.+Somozaauthor=N.+Chauretauthor=C.+Setoauthor=J.+Scheigetzauthor=G.+Wesolowskiauthor=F.+Masseauthor=S.+Desmaraisauthor=M.+Ouellet&title=%CE%B2-Substituted+cyclohexanecarboxamide%3A+a+nonpeptidic+framework+for+the+design+of+potent+inhibitors+of+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm051059p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051059p%26sid%3Dliteratum%253Aachs%26aulast%3DCrane%26aufirst%3DS.%2BN.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DDavis%26aufirst%3DD.%2BE.%26aulast%3DSetti%26aufirst%3DE.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DPaquet%26aufirst%3DJ.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DSeto%26aufirst%3DC.%26aulast%3DScheigetz%26aufirst%3DJ.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DOuellet%26aufirst%3DM.%26atitle%3D%25CE%25B2-Substituted%2520cyclohexanecarboxamide%253A%2520a%2520nonpeptidic%2520framework%2520for%2520the%2520design%2520of%2520potent%2520inhibitors%2520of%2520cathepsin%2520K%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1066%26epage%3D1079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truchon, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, S. N.</span><span> </span><span class="NLM_article-title">β-Substituted cyclohexanecarboxamide cathepsin K inhibitors: modification of the 1,2-disubstituted aromatic core</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3146</span><span class="NLM_x">–</span> <span class="NLM_lpage">3151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3146-3151&author=J.+Robichaudauthor=C.+I.+Baylyauthor=W.+C.+Blackauthor=S.+Desmaraisauthor=S.+Legerauthor=F.+Masseauthor=D.+J.+McKayauthor=R.+M.+Oballaauthor=J.+Paquetauthor=M.+D.+Percivalauthor=J.-F.+Truchonauthor=G.+Wesolowskiauthor=S.+N.+Crane&title=%CE%B2-Substituted+cyclohexanecarboxamide+cathepsin+K+inhibitors%3A+modification+of+the+1%2C2-disubstituted+aromatic+core"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DPaquet%26aufirst%3DJ.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DTruchon%26aufirst%3DJ.-F.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DCrane%26aufirst%3DS.%2BN.%26atitle%3D%25CE%25B2-Substituted%2520cyclohexanecarboxamide%2520cathepsin%2520K%2520inhibitors%253A%2520modification%2520of%2520the%25201%252C2-disubstituted%2520aromatic%2520core%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3146%26epage%3D3151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isabel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, S. N.</span><span> </span><span class="NLM_article-title">Identification of a nonbasic, nitrile-containing cathepsin K inhibitor (MK-1256) that is efficacious in a monkey model of osteoporosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6410</span><span class="NLM_x">–</span> <span class="NLM_lpage">6420</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800610j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6410-6420&author=J.+Robichaudauthor=W.+C.+Blackauthor=M.+Therienauthor=J.+Paquetauthor=R.+M.+Oballaauthor=C.+I.+Baylyauthor=D.+J.+McKayauthor=Q.+Wangauthor=E.+Isabelauthor=S.+Legerauthor=C.+Mellonauthor=D.+B.+Kimmelauthor=G.+Wesolowskiauthor=M.+D.+Percivalauthor=F.+Masseauthor=S.+Desmaraisauthor=J.-P.+Falgueyretauthor=S.+N.+Crane&title=Identification+of+a+nonbasic%2C+nitrile-containing+cathepsin+K+inhibitor+%28MK-1256%29+that+is+efficacious+in+a+monkey+model+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm800610j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800610j%26sid%3Dliteratum%253Aachs%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DTherien%26aufirst%3DM.%26aulast%3DPaquet%26aufirst%3DJ.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DIsabel%26aufirst%3DE.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DMellon%26aufirst%3DC.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DCrane%26aufirst%3DS.%2BN.%26atitle%3DIdentification%2520of%2520a%2520nonbasic%252C%2520nitrile-containing%2520cathepsin%2520K%2520inhibitor%2520%2528MK-1256%2529%2520that%2520is%2520efficacious%2520in%2520a%2520monkey%2520model%2520of%2520osteoporosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6410%26epage%3D6420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Quibell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flinn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramjee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, J.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of <i>cis</i>-hexahydropyrrolo[3,2-<i>b</i>]pyrrol-3-one peptidomimetic inhibitors of CAC1 cysteinyl proteinases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=609-625&author=M.+Quibellauthor=A.+Bennauthor=N.+Flinnauthor=T.+Monkauthor=M.+Ramjeeauthor=P.+Rayauthor=Y.+Wangauthor=J.+Watts&title=Synthesis+and+evaluation+of+cis-hexahydropyrrolo%5B3%2C2-b%5Dpyrrol-3-one+peptidomimetic+inhibitors+of+CAC1+cysteinyl+proteinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuibell%26aufirst%3DM.%26aulast%3DBenn%26aufirst%3DA.%26aulast%3DFlinn%26aufirst%3DN.%26aulast%3DMonk%26aufirst%3DT.%26aulast%3DRamjee%26aufirst%3DM.%26aulast%3DRay%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWatts%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520cis-hexahydropyrrolo%255B3%252C2-b%255Dpyrrol-3-one%2520peptidomimetic%2520inhibitors%2520of%2520CAC1%2520cysteinyl%2520proteinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D609%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Morley, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heald, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacFaul, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porres, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, T. J.</span><span> </span><span class="NLM_article-title">5-Aminopyrimidin-2-ylnitriles as cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1658</span><span class="NLM_x">–</span> <span class="NLM_lpage">1661</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1658-1661&author=A.+D.+Morleyauthor=P.+W.+Kennyauthor=B.+Burtonauthor=R.+A.+Healdauthor=P.+A.+MacFaulauthor=J.+Mullettauthor=K.+Pageauthor=S.+S.+Porresauthor=L.+R.+Ribeiroauthor=P.+Smithauthor=S.+Wardauthor=T.+J.+Wilkinson&title=5-Aminopyrimidin-2-ylnitriles+as+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorley%26aufirst%3DA.%2BD.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DHeald%26aufirst%3DR.%2BA.%26aulast%3DMacFaul%26aufirst%3DP.%2BA.%26aulast%3DMullett%26aufirst%3DJ.%26aulast%3DPage%26aufirst%3DK.%26aulast%3DPorres%26aufirst%3DS.%2BS.%26aulast%3DRibeiro%26aufirst%3DL.%2BR.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DWard%26aufirst%3DS.%26aulast%3DWilkinson%26aufirst%3DT.%2BJ.%26atitle%3D5-Aminopyrimidin-2-ylnitriles%2520as%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1658%26epage%3D1661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Shinozuka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamane, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuka, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohhata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naito, S.</span><span> </span><span class="NLM_article-title">Potent and selective cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6789</span><span class="NLM_x">–</span> <span class="NLM_lpage">6806</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=6789-6806&author=T.+Shinozukaauthor=K.+Shimadaauthor=S.+Matsuiauthor=T.+Yamaneauthor=M.+Amaauthor=T.+Fukudaauthor=M.+Takiauthor=Y.+Takedaauthor=E.+Otsukaauthor=M.+Yamatoauthor=S.+Mochizukiauthor=K.+Ohhataauthor=S.+Naito&title=Potent+and+selective+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShinozuka%26aufirst%3DT.%26aulast%3DShimada%26aufirst%3DK.%26aulast%3DMatsui%26aufirst%3DS.%26aulast%3DYamane%26aufirst%3DT.%26aulast%3DAma%26aufirst%3DM.%26aulast%3DFukuda%26aufirst%3DT.%26aulast%3DTaki%26aufirst%3DM.%26aulast%3DTakeda%26aufirst%3DY.%26aulast%3DOtsuka%26aufirst%3DE.%26aulast%3DYamato%26aufirst%3DM.%26aulast%3DMochizuki%26aufirst%3DS.%26aulast%3DOhhata%26aufirst%3DK.%26aulast%3DNaito%26aufirst%3DS.%26atitle%3DPotent%2520and%2520selective%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D6789%26epage%3D6806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span>ClinicalTrials.Gov Identifier NCT00532337. http://clinicaltrials.gov/ct2/show/NCT00532337 (updated June 15,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.Gov+Identifier+NCT00532337.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00532337+%28updated+June+15%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Reinholt, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultenby, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinegaard, D.</span><span> </span><span class="NLM_article-title">Osteopontin, a possible anchor of osteoclasts to bone</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">4473</span><span class="NLM_x">–</span> <span class="NLM_lpage">4475</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1990&pages=4473-4475&author=F.+P.+Reinholtauthor=K.+Hultenbyauthor=A.+Oldbergauthor=D.+Heinegaard&title=Osteopontin%2C+a+possible+anchor+of+osteoclasts+to+bone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReinholt%26aufirst%3DF.%2BP.%26aulast%3DHultenby%26aufirst%3DK.%26aulast%3DOldberg%26aufirst%3DA.%26aulast%3DHeinegaard%26aufirst%3DD.%26atitle%3DOsteopontin%252C%2520a%2520possible%2520anchor%2520of%2520osteoclasts%2520to%2520bone%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1990%26volume%3D87%26spage%3D4473%26epage%3D4475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Dechantsreiter, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathae, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohof, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelzemann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonczyk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, H.</span><span> </span><span class="NLM_article-title">N-Methylated cyclic RGDpeptides as highly active and selective αVβ3 integrin antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3033</span><span class="NLM_x">–</span> <span class="NLM_lpage">3040</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970832g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=3033-3040&author=M.+A.+Dechantsreiterauthor=E.+Plankerauthor=B.+Mathaeauthor=E.+Lohofauthor=G.+Hoelzemannauthor=A.+Jonczykauthor=S.+L.+Goodmanauthor=H.+Kessler&title=N-Methylated+cyclic+RGDpeptides+as+highly+active+and+selective+%CE%B1V%CE%B23+integrin+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm970832g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970832g%26sid%3Dliteratum%253Aachs%26aulast%3DDechantsreiter%26aufirst%3DM.%2BA.%26aulast%3DPlanker%26aufirst%3DE.%26aulast%3DMathae%26aufirst%3DB.%26aulast%3DLohof%26aufirst%3DE.%26aulast%3DHoelzemann%26aufirst%3DG.%26aulast%3DJonczyk%26aufirst%3DA.%26aulast%3DGoodman%26aufirst%3DS.%2BL.%26aulast%3DKessler%26aufirst%3DH.%26atitle%3DN-Methylated%2520cyclic%2520RGDpeptides%2520as%2520highly%2520active%2520and%2520selective%2520%25CE%25B1V%25CE%25B23%2520integrin%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D3033%26epage%3D3040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seedor, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leu, C.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span> </span><span class="NLM_article-title">The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">1411</span><span class="NLM_x">–</span> <span class="NLM_lpage">1419</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=1998&pages=1411-1419&author=M.+Yamamotoauthor=J.+E.+Fisherauthor=M.+Gentileauthor=J.+G.+Seedorauthor=C.-T.+Leuauthor=S.+B.+Rodanauthor=G.+A.+Rodan&title=The+integrin+ligand+echistatin+prevents+bone+loss+in+ovariectomized+mice+and+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DFisher%26aufirst%3DJ.%2BE.%26aulast%3DGentile%26aufirst%3DM.%26aulast%3DSeedor%26aufirst%3DJ.%2BG.%26aulast%3DLeu%26aufirst%3DC.-T.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26atitle%3DThe%2520integrin%2520ligand%2520echistatin%2520prevents%2520bone%2520loss%2520in%2520ovariectomized%2520mice%2520and%2520rats%26jtitle%3DEndocrinology%26date%3D1998%26volume%3D139%26spage%3D1411%26epage%3D1419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Meyer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auernheimer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modlinger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, H.</span><span> </span><span class="NLM_article-title">Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging and targeting</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2723</span><span class="NLM_x">–</span> <span class="NLM_lpage">2747</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.2174%2F138161206777947740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16918408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28Xotlalsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=2723-2747&author=A.+Meyerauthor=J.+Auernheimerauthor=A.+Modlingerauthor=H.+Kessler&title=Targeting+RGD+recognizing+integrins%3A+drug+development%2C+biomaterial+research%2C+tumor+imaging+and+targeting"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging and targeting</span></div><div class="casAuthors">Meyer, A.; Auernheimer, J.; Modlinger, A.; Kessler, H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2723-2747</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Integrins constitute an important class of cell adhesion receptors responsible not only for cell-matrix adhesion but also for signaling bidirectionally across the membrane.  Integrins are involved in many biol. processes such as angiogenesis, thrombosis, inflammation, osteoporosis and cancer.  Integrins thus play a key role in many severe human diseases.  In this review the authors will describe recent research and development of RGD-contg. integrin ligands for medical applications including drug design, radiolabeling, drug targeting, as well as biomaterial research.  Many ligands were developed for targeting the αvβ3 integrin to block angiogenesis or osteoporosis, but there are also other integrins like αvβ5 and α5β1 which become more and more interesting for similar purposes.  αIIbβ3 constitutes a potent target in thrombosis therapy; but the search for suitable ligands is still ongoing.  The authors will reconstruct the drug development process for these integrin subtypes considering selected examples with focus on structure based design.  Different structural requirements are pointed out concerning integrin activity and particularly the selectivity towards the distinct integrin types.  Furthermore, the authors will show recent progress in tumor and thrombosis imaging based on radiolabeled RGD-contg. ligands binding αvβ3 or αIIβ3, resp.  Addnl. further advances in biomaterial research are presented.  The authors describe the coating of different implant materials with various αvβ3 recognizing ligands for the purpose of increasing cell attachment and biocompatibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZglS_7z7bJrVg90H21EOLACvtfcHk0lgksQ_A5xi_9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xotlalsbk%253D&md5=9d0a773a6565c32ea6a23c8a28af8df0</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.2174%2F138161206777947740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206777947740%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DAuernheimer%26aufirst%3DJ.%26aulast%3DModlinger%26aufirst%3DA.%26aulast%3DKessler%26aufirst%3DH.%26atitle%3DTargeting%2520RGD%2520recognizing%2520integrins%253A%2520drug%2520development%252C%2520biomaterial%2520research%252C%2520tumor%2520imaging%2520and%2520targeting%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D2723%26epage%3D2747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Gramoun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shorey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bashutski, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heersche, J. N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manolson, M. F.</span><span> </span><span class="NLM_article-title">Effects of Vitaxin, a novel therapeutic in trial for metastatic bone tumors, on osteoclast functions in vitro</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=341-352&author=A.+Gramounauthor=S.+Shoreyauthor=J.+D.+Bashutskiauthor=S.+J.+Dixonauthor=S.+M.+Simsauthor=J.+N.+M.+Heerscheauthor=M.+F.+Manolson&title=Effects+of+Vitaxin%2C+a+novel+therapeutic+in+trial+for+metastatic+bone+tumors%2C+on+osteoclast+functions+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGramoun%26aufirst%3DA.%26aulast%3DShorey%26aufirst%3DS.%26aulast%3DBashutski%26aufirst%3DJ.%2BD.%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26aulast%3DSims%26aufirst%3DS.%2BM.%26aulast%3DHeersche%26aufirst%3DJ.%2BN.%2BM.%26aulast%3DManolson%26aufirst%3DM.%2BF.%26atitle%3DEffects%2520of%2520Vitaxin%252C%2520a%2520novel%2520therapeutic%2520in%2520trial%2520for%2520metastatic%2520bone%2520tumors%252C%2520on%2520osteoclast%2520functions%2520in%2520vitro%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2007%26volume%3D102%26spage%3D341%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Wilder, R. L.</span><span> </span><span class="NLM_article-title">Integrin αvβ3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">ii96</span><span class="NLM_x">–</span> <span class="NLM_lpage">ii99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=12379637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFagtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2002&pages=ii96-ii99&author=R.+L.+Wilder&title=Integrin+%CE%B1v%CE%B23+as+a+target+for+treatment+of+rheumatoid+arthritis+and+related+rheumatic+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases</span></div><div class="casAuthors">Wilder, R. L.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">ii96-ii99</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">A review.  A substantial and persuasive body of data now exists that supports the view that integrin alpha V beta 3 plays a crit. part in activated macrophage dependent inflammation, osteoclast development, migration, and bone resorption, and inflammatory angiogenesis.  All of these processes play an important part in the pathogenesis of rheumatoid arthritis (RA) and related athropathies.  Animal arthritis model data further support these concepts and also suggest that therapeutic antagonism of integrin alpha V beta 3 is worthy of further investigation in RA and related arthropathies.  To this end, Vitaxin, also known as MEDI-522, has been developed.  Vitaxin is a humanized monoclonal IgG1 antibody that specifically binds a conformational epitope formed by both the integrin alpha V and beta 3 subunits.  It blocks the interaction of alpha V beta 3 with various ligands such as osteopontin and vitronectin.  Clin. trials with Vitaxin in patients with RA are in progress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTbIIw2DS4vrVg90H21EOLACvtfcHk0lj9paVO8YfeEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFagtbY%253D&md5=6dca01ff730ae3125afce124a15bd05e</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilder%26aufirst%3DR.%2BL.%26atitle%3DIntegrin%2520%25CE%25B1v%25CE%25B23%2520as%2520a%2520target%2520for%2520treatment%2520of%2520rheumatoid%2520arthritis%2520and%2520related%2520rheumatic%2520diseases%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2002%26volume%3D61%26spage%3Dii96%26epage%3Dii99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Xiong, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stehle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diefenbach, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnaout, M. A.</span><span> </span><span class="NLM_article-title">Crystal structure of the extracellular segment of integrin αvβ3</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1126%2Fscience.1064535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=11546839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsFGqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2001&pages=339-345&author=J.+P.+Xiongauthor=T.+Stehleauthor=B.+Diefenbachauthor=R.+Zhangauthor=R.+Dunkerauthor=D.+L.+Scottauthor=A.+Joachimiakauthor=S.+L.+Goodmanauthor=M.+A.+Arnaout&title=Crystal+structure+of+the+extracellular+segment+of+integrin+%CE%B1v%CE%B23"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the extracellular segment of integrin αVβ3</span></div><div class="casAuthors">Xiong, Jian-Ping; Stehle, Thilo; Diefenbach, Beate; Zhang, Rongguang; Dunker, Reinhardt; Scott, David L.; Joachimiak, Andrzej; Goodman, Simon L.; Arnaout, M. Amin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">5541</span>),
    <span class="NLM_cas:pages">339-345</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Integrins are αβ heterodimeric receptors that mediate divalent cation-dependent cell-cell and cell-matrix adhesion through tightly regulated interactions with ligands.  We have solved the crystal structure of the extracellular portion of integrin αVβ3 at 3.1 Å resoln.  Its 12 domains assemble into an ovoid "head" and two "tails.".  In the crystal, αVβ3 is severely bent at a defined region in its tails, reflecting an unusual flexibility that may be linked to integrin regulation.  The main intersubunit interface lies within the head, between a seven-bladed β-propeller from αV and an A domain from β3, and bears a striking resemblance to the Gα/Gβ interface in G proteins.  A metal ion-dependent adhesion site (MIDAS) in the βA domain is positioned to participate in a ligand-binding interface formed of loops from the propeller and βA domains.  MIDAS lies adjacent to a calcium-binding site with a potential regulatory function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryjkcgYhppB7Vg90H21EOLACvtfcHk0lj9paVO8YfeEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsFGqsb4%253D&md5=cae2f78e7d2db79bb4c5c77c488a552d</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1126%2Fscience.1064535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1064535%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DJ.%2BP.%26aulast%3DStehle%26aufirst%3DT.%26aulast%3DDiefenbach%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DDunker%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DD.%2BL.%26aulast%3DJoachimiak%26aufirst%3DA.%26aulast%3DGoodman%26aufirst%3DS.%2BL.%26aulast%3DArnaout%26aufirst%3DM.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520the%2520extracellular%2520segment%2520of%2520integrin%2520%25CE%25B1v%25CE%25B23%26jtitle%3DScience%26date%3D2001%26volume%3D294%26spage%3D339%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Xiong, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stehle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frech, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnaout, M. A.</span><span> </span><span class="NLM_article-title">Crystal structure of the extracellular segment of integrin αvβ3 in complex with an Arg-Gly-Asp ligand</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1126%2Fscience.1069040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=11884718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD38XivVWjsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=151-155&author=J.-P.+Xiongauthor=T.+Stehleauthor=R.+Zhangauthor=A.+Joachimiakauthor=M.+Frechauthor=S.+L.+Goodmanauthor=M.+A.+Arnaout&title=Crystal+structure+of+the+extracellular+segment+of+integrin+%CE%B1v%CE%B23+in+complex+with+an+Arg-Gly-Asp+ligand"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the extracellular segment of integrin αvβ3 in complex with an Arg-Gly-Asp ligand</span></div><div class="casAuthors">Xiong, Jian-Ping; Stehle, Thilo; Zhang, Rongguang; Joachimiak, Andrzej; Frech, Matthias; Goodman, Simon L.; Arnaout, M. Amin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5565</span>),
    <span class="NLM_cas:pages">151-155</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The structural basis for the divalent cation-dependent binding of heterodimeric αβ integrins to their Ligands, which contain the prototypical Arg-Gly-Asp sequence, is unknown.  Interaction with ligands triggers tertiary and quaternary structural rearrangements in integrins that are needed for cell signaling.  Here we report the crystal structure of the extracellular segment of integrin αVβ3 in complex with a cyclic peptide presenting the Arg-Gly-Asp sequence.  The ligand binds at the major interface between the αV and β3 subunits and makes extensive contacts with both.  Both tertiary and quaternary changes are obsd. in the presence of ligand.  The tertiary rearrangements take place in βA, the ligand-binding domain of β3; in the complex, βA acquires two cations, one of which contacts the ligand Asp directly and the other stabilizes the ligand-binding surface.  Ligand binding induces small changes in the orientation of αV relative to β3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo22hT2wzRg0bVg90H21EOLACvtfcHk0lgE33-Ruab5kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivVWjsLo%253D&md5=9f7d93de3bbe8dbeb0d860c12213de81</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1126%2Fscience.1069040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1069040%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DJ.-P.%26aulast%3DStehle%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DJoachimiak%26aufirst%3DA.%26aulast%3DFrech%26aufirst%3DM.%26aulast%3DGoodman%26aufirst%3DS.%2BL.%26aulast%3DArnaout%26aufirst%3DM.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520the%2520extracellular%2520segment%2520of%2520integrin%2520%25CE%25B1v%25CE%25B23%2520in%2520complex%2520with%2520an%2520Arg-Gly-Asp%2520ligand%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D151%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Meissner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihle, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leu, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagy, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor-Olsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitman, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span> </span><span class="NLM_article-title">Nonpeptide αvβ3 antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=25-29&author=R.+S.+Meissnerauthor=J.+J.+Perkinsauthor=L.+T.+Duongauthor=G.+D.+Hartmanauthor=W.+F.+Hoffmanauthor=J.+R.+Huffauthor=N.+C.+Ihleauthor=C.+T.+Leuauthor=R.+M.+Nagyauthor=A.+Naylor-Olsenauthor=G.+A.+Rodanauthor=S.+B.+Rodanauthor=D.+B.+Whitmanauthor=G.+A.+Wesolowskiauthor=M.+E.+Duggan&title=Nonpeptide+%CE%B1v%CE%B23+antagonists.+Part+2%3A+constrained+glycyl+amides+derived+from+the+RGD+tripeptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeissner%26aufirst%3DR.%2BS.%26aulast%3DPerkins%26aufirst%3DJ.%2BJ.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHoffman%26aufirst%3DW.%2BF.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DIhle%26aufirst%3DN.%2BC.%26aulast%3DLeu%26aufirst%3DC.%2BT.%26aulast%3DNagy%26aufirst%3DR.%2BM.%26aulast%3DNaylor-Olsen%26aufirst%3DA.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DWhitman%26aufirst%3DD.%2BB.%26aulast%3DWesolowski%26aufirst%3DG.%2BA.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26atitle%3DNonpeptide%2520%25CE%25B1v%25CE%25B23%2520antagonists.%2520Part%25202%253A%2520constrained%2520glycyl%2520amides%2520derived%2520from%2520the%2520RGD%2520tripeptide%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D25%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Askew, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitman, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leu, C.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Metzler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merkle, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span> </span><span class="NLM_article-title">Non-peptide αvβ3 antagonists. Part 4: Potent and orally bioavailable chain-shortened RGD mimetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2463</span><span class="NLM_x">–</span> <span class="NLM_lpage">2465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2463-2465&author=P.+J.+Colemanauthor=B.+C.+Askewauthor=J.+H.+Hutchinsonauthor=D.+B.+Whitmanauthor=J.+J.+Perkinsauthor=G.+D.+Hartmanauthor=G.+A.+Rodanauthor=C.-T.+Leuauthor=T.+Prueksaritanontauthor=C.+Fernandez-Metzlerauthor=K.+M.+Merkleauthor=R.+Lynchauthor=J.+J.+Lynchauthor=S.+B.+Rodanauthor=M.+E.+Duggan&title=Non-peptide+%CE%B1v%CE%B23+antagonists.+Part+4%3A+Potent+and+orally+bioavailable+chain-shortened+RGD+mimetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DAskew%26aufirst%3DB.%2BC.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DWhitman%26aufirst%3DD.%2BB.%26aulast%3DPerkins%26aufirst%3DJ.%2BJ.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DLeu%26aufirst%3DC.-T.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DFernandez-Metzler%26aufirst%3DC.%26aulast%3DMerkle%26aufirst%3DK.%2BM.%26aulast%3DLynch%26aufirst%3DR.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26atitle%3DNon-peptide%2520%25CE%25B1v%25CE%25B23%2520antagonists.%2520Part%25204%253A%2520Potent%2520and%2520orally%2520bioavailable%2520chain-shortened%2520RGD%2520mimetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2463%26epage%3D2465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halczenko, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashear, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Metzler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leu, C.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meissner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merkle, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennypacker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zartman, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span> </span><span class="NLM_article-title">Nonpeptide αvβ3 antagonists. 8. In vitro and in vivo evaluation of a potent αvβ3 antagonist for the prevention and treatment of osteoporosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4790</span><span class="NLM_x">–</span> <span class="NLM_lpage">4798</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030306r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4790-4798&author=J.+H.+Hutchinsonauthor=W.+Halczenkoauthor=K.+M.+Brashearauthor=M.+J.+Breslinauthor=P.+J.+Colemanauthor=L.+T.+Duongauthor=C.+Fernandez-Metzlerauthor=M.+A.+Gentileauthor=J.+E.+Fisherauthor=G.+D.+Hartmanauthor=J.+R.+Huffauthor=D.+B.+Kimmelauthor=C.-T.+Leuauthor=R.+S.+Meissnerauthor=K.+Merkleauthor=R.+Nagyauthor=B.+Pennypackerauthor=J.+J.+Perkinsauthor=T.+Prueksaritanontauthor=G.+A.+Rodanauthor=S.+L.+Vargaauthor=G.+A.+Wesolowskiauthor=A.+E.+Zartmanauthor=S.+B.+Rodanauthor=M.+E.+Duggan&title=Nonpeptide+%CE%B1v%CE%B23+antagonists.+8.+In+vitro+and+in+vivo+evaluation+of+a+potent+%CE%B1v%CE%B23+antagonist+for+the+prevention+and+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm030306r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030306r%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DHalczenko%26aufirst%3DW.%26aulast%3DBrashear%26aufirst%3DK.%2BM.%26aulast%3DBreslin%26aufirst%3DM.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DFernandez-Metzler%26aufirst%3DC.%26aulast%3DGentile%26aufirst%3DM.%2BA.%26aulast%3DFisher%26aufirst%3DJ.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLeu%26aufirst%3DC.-T.%26aulast%3DMeissner%26aufirst%3DR.%2BS.%26aulast%3DMerkle%26aufirst%3DK.%26aulast%3DNagy%26aufirst%3DR.%26aulast%3DPennypacker%26aufirst%3DB.%26aulast%3DPerkins%26aufirst%3DJ.%2BJ.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DVarga%26aufirst%3DS.%2BL.%26aulast%3DWesolowski%26aufirst%3DG.%2BA.%26aulast%3DZartman%26aufirst%3DA.%2BE.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26atitle%3DNonpeptide%2520%25CE%25B1v%25CE%25B23%2520antagonists.%25208.%2520In%2520vitro%2520and%2520in%2520vivo%2520evaluation%2520of%2520a%2520potent%2520%25CE%25B1v%25CE%25B23%2520antagonist%2520for%2520the%2520prevention%2520and%2520treatment%2520of%2520osteoporosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4790%26epage%3D4798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Murphy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerchio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoch, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesdiener, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recker, R.</span><span> </span><span class="NLM_article-title">Effect of L-000845704, an αvβ3 integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">2022</span><span class="NLM_x">–</span> <span class="NLM_lpage">2028</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1210%2Fjc.2004-2126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=15687321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsFWjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2005&pages=2022-2028&author=M.+G.+Murphyauthor=K.+Cerchioauthor=S.+A.+Stochauthor=K.+Gottesdienerauthor=M.+Wuauthor=R.+Recker&title=Effect+of+L-000845704%2C+an+%CE%B1v%CE%B23+integrin+antagonist%2C+on+markers+of+bone+turnover+and+bone+mineral+density+in+postmenopausal+osteoporotic+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of L-000845704, an αvβ3 integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women</span></div><div class="casAuthors">Murphy, M. G.; Cerchio, K.; Stoch, S. A.; Gottesdiener, K.; Wu, M.; Recker, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2022-2028</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The αvβ3 integrin (vitronectin receptor) plays a pivotal role in bone resorption.  We hypothesized that L-000845704, an αvβ3 integrin antagonist, would potently inhibit bone resorption, thereby increasing bone mass as assessed by bone mineral d. (BMD) in women with postmenopausal osteoporosis.  In a multicenter, randomized, double-blind, placebo-controlled, 12-mo study, 227 women (av. 63 yr) with low lumbar spine or femoral neck BMD were randomly assigned to receive 100 or 400 mg L-000845704 once daily (qd), 200 mg L-000845704 twice daily (bid), or placebo.  L-000845704 increased lumbar spine BMD (2.1, 3.1, and 3.5% for the 100-mg-qd, 400-mg-qd, and 200-mg-bid treatment groups, resp., vs. -0.1% for placebo; P < 0.01 all treatments vs. placebo).  Only 200 mg L-000845704 bid significantly increased BMD at the hip (1.7 vs. 0.3% for placebo; P < 0.03) and femoral neck (2.4 vs. 0.7% for placebo; P < 0.05).  No L-000845704 group increased total body BMD.  All doses of L-000845704 resulted in a similar approx. 42% decrease from baseline of N-telopeptide cross-links (P < 0.001 vs. placebo).  L-000845704 was generally well tolerated; adverse events resulting in discontinuation from the study were relatively infrequent.  In conclusion, the antiresorptive effect of the αvβ3 integrin antagonist L-000845704 translated into significant increases in lumbar spine BMD.  Furthermore, 200 mg L-000845704 bid provided efficacy at the hip sites.  These data suggest that the αvβ3 integrin antagonist L-000845704 could be developed as an effective therapeutic agent for osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCPinJOVULILVg90H21EOLACvtfcHk0lg5o7Mu9VL0tA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsFWjt7o%253D&md5=5849438d1122ca31d921cf67d907a001</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1210%2Fjc.2004-2126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2004-2126%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DM.%2BG.%26aulast%3DCerchio%26aufirst%3DK.%26aulast%3DStoch%26aufirst%3DS.%2BA.%26aulast%3DGottesdiener%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DRecker%26aufirst%3DR.%26atitle%3DEffect%2520of%2520L-000845704%252C%2520an%2520%25CE%25B1v%25CE%25B23%2520integrin%2520antagonist%252C%2520on%2520markers%2520of%2520bone%2520turnover%2520and%2520bone%2520mineral%2520density%2520in%2520postmenopausal%2520osteoporotic%2520women%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2005%26volume%3D90%26spage%3D2022%26epage%3D2028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Zartman, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Metzler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leu, C.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meissner, R. S.</span><span> </span><span class="NLM_article-title">Nonpeptide αvβ3 antagonists: identification of potent, chain-shortened 7-oxo RGD mimetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1647</span><span class="NLM_x">–</span> <span class="NLM_lpage">1650</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1647-1650&author=A.+E.+Zartmanauthor=L.+T.+Duongauthor=C.+Fernandez-Metzlerauthor=G.+D.+Hartmanauthor=C.-T.+Leuauthor=T.+Prueksaritanontauthor=G.+A.+Rodanauthor=S.+B.+Rodanauthor=M.+E.+Dugganauthor=R.+S.+Meissner&title=Nonpeptide+%CE%B1v%CE%B23+antagonists%3A+identification+of+potent%2C+chain-shortened+7-oxo+RGD+mimetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZartman%26aufirst%3DA.%2BE.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DFernandez-Metzler%26aufirst%3DC.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DLeu%26aufirst%3DC.-T.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DMeissner%26aufirst%3DR.%2BS.%26atitle%3DNonpeptide%2520%25CE%25B1v%25CE%25B23%2520antagonists%253A%2520identification%2520of%2520potent%252C%2520chain-shortened%25207-oxo%2520RGD%2520mimetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1647%26epage%3D1650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DesJarlais, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattanze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaikin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manthey, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomczuk, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marugan, J. J.</span><span> </span><span class="NLM_article-title">Identification of novel short chain 4-substituted indoles as potent αvβ3 antagonist using structure-based drug design</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">343</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=334-343&author=P.+Raboissonauthor=R.+L.+DesJarlaisauthor=R.+Reedauthor=J.+Lattanzeauthor=M.+Chaikinauthor=C.+L.+Mantheyauthor=B.+E.+Tomczukauthor=J.+J.+Marugan&title=Identification+of+novel+short+chain+4-substituted+indoles+as+potent+%CE%B1v%CE%B23+antagonist+using+structure-based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DDesJarlais%26aufirst%3DR.%2BL.%26aulast%3DReed%26aufirst%3DR.%26aulast%3DLattanze%26aufirst%3DJ.%26aulast%3DChaikin%26aufirst%3DM.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26aulast%3DTomczuk%26aufirst%3DB.%2BE.%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26atitle%3DIdentification%2520of%2520novel%2520short%2520chain%25204-substituted%2520indoles%2520as%2520potent%2520%25CE%25B1v%25CE%25B23%2520antagonist%2520using%2520structure-based%2520drug%2520design%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2007%26volume%3D42%26spage%3D334%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Boys, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schretzman, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrakumar, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tollefson, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohler, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penning, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenmark, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spangler, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engleman, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanneke, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keene, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klover, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickols, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickols, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steininger, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norring, S. A.</span><span> </span><span class="NLM_article-title">Convergent, parallel synthesis of a series of β-substituted 1,2,4-oxadiazole butanoic acids as potent and selective αvβ3 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=839-844&author=M.+L.+Boysauthor=L.+A.+Schretzmanauthor=N.+S.+Chandrakumarauthor=M.+B.+Tollefsonauthor=S.+B.+Mohlerauthor=V.+L.+Downsauthor=T.+D.+Penningauthor=M.+A.+Russellauthor=J.+A.+Wendtauthor=B.+B.+Chenauthor=H.+G.+Stenmarkauthor=H.+Wuauthor=D.+P.+Spanglerauthor=M.+Clareauthor=B.+N.+Desaiauthor=I.+K.+Khannaauthor=M.+N.+Nguyenauthor=T.+Duffinauthor=V.+W.+Englemanauthor=M.+B.+Finnauthor=S.+K.+Freemanauthor=M.+L.+Hannekeauthor=J.+L.+Keeneauthor=J.+A.+Kloverauthor=G.+A.+Nickolsauthor=M.+A.+Nickolsauthor=C.+N.+Steiningerauthor=M.+Westlinauthor=W.+Westlinauthor=Y.+X.+Yuauthor=Y.+Wangauthor=C.+R.+Daltonauthor=S.+A.+Norring&title=Convergent%2C+parallel+synthesis+of+a+series+of+%CE%B2-substituted+1%2C2%2C4-oxadiazole+butanoic+acids+as+potent+and+selective+%CE%B1v%CE%B23+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoys%26aufirst%3DM.%2BL.%26aulast%3DSchretzman%26aufirst%3DL.%2BA.%26aulast%3DChandrakumar%26aufirst%3DN.%2BS.%26aulast%3DTollefson%26aufirst%3DM.%2BB.%26aulast%3DMohler%26aufirst%3DS.%2BB.%26aulast%3DDowns%26aufirst%3DV.%2BL.%26aulast%3DPenning%26aufirst%3DT.%2BD.%26aulast%3DRussell%26aufirst%3DM.%2BA.%26aulast%3DWendt%26aufirst%3DJ.%2BA.%26aulast%3DChen%26aufirst%3DB.%2BB.%26aulast%3DStenmark%26aufirst%3DH.%2BG.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DSpangler%26aufirst%3DD.%2BP.%26aulast%3DClare%26aufirst%3DM.%26aulast%3DDesai%26aufirst%3DB.%2BN.%26aulast%3DKhanna%26aufirst%3DI.%2BK.%26aulast%3DNguyen%26aufirst%3DM.%2BN.%26aulast%3DDuffin%26aufirst%3DT.%26aulast%3DEngleman%26aufirst%3DV.%2BW.%26aulast%3DFinn%26aufirst%3DM.%2BB.%26aulast%3DFreeman%26aufirst%3DS.%2BK.%26aulast%3DHanneke%26aufirst%3DM.%2BL.%26aulast%3DKeene%26aufirst%3DJ.%2BL.%26aulast%3DKlover%26aufirst%3DJ.%2BA.%26aulast%3DNickols%26aufirst%3DG.%2BA.%26aulast%3DNickols%26aufirst%3DM.%2BA.%26aulast%3DSteininger%26aufirst%3DC.%2BN.%26aulast%3DWestlin%26aufirst%3DM.%26aulast%3DWestlin%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DY.%2BX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDalton%26aufirst%3DC.%2BR.%26aulast%3DNorring%26aufirst%3DS.%2BA.%26atitle%3DConvergent%252C%2520parallel%2520synthesis%2520of%2520a%2520series%2520of%2520%25CE%25B2-substituted%25201%252C2%252C4-oxadiazole%2520butanoic%2520acids%2520as%2520potent%2520and%2520selective%2520%25CE%25B1v%25CE%25B23%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D839%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Nagarajan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devadas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malecha, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruminski, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rico, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrufo, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleine, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lantz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landis, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffin, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engleman, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griggs, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickols, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steininger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickols, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keene, J. L.</span><span> </span><span class="NLM_article-title"><i>R</i>-Isomers of Arg-Gly-Asp (RGD) mimics as potent αvβ3 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3783</span><span class="NLM_x">–</span> <span class="NLM_lpage">3800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=3783-3800&author=S.+R.+Nagarajanauthor=B.+Devadasauthor=J.+W.+Malechaauthor=H.-F.+Luauthor=P.+G.+Ruminskiauthor=J.+G.+Ricoauthor=T.+E.+Rogersauthor=L.+D.+Marrufoauthor=J.+T.+Collinsauthor=H.+P.+Kleineauthor=M.+K.+Lantzauthor=J.+Zhuauthor=N.+F.+Greenauthor=M.+A.+Russellauthor=B.+H.+Landisauthor=L.+M.+Millerauthor=D.+M.+Meyerauthor=T.+D.+Duffinauthor=V.+W.+Englemanauthor=M.+B.+Finnauthor=S.+K.+Freemanauthor=D.+W.+Griggsauthor=M.+L.+Williamsauthor=M.+A.+Nickolsauthor=J.+A.+Peggauthor=K.+E.+Shannonauthor=C.+Steiningerauthor=M.+M.+Westlinauthor=G.+A.+Nickolsauthor=J.+L.+Keene&title=R-Isomers+of+Arg-Gly-Asp+%28RGD%29+mimics+as+potent+%CE%B1v%CE%B23+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNagarajan%26aufirst%3DS.%2BR.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DMalecha%26aufirst%3DJ.%2BW.%26aulast%3DLu%26aufirst%3DH.-F.%26aulast%3DRuminski%26aufirst%3DP.%2BG.%26aulast%3DRico%26aufirst%3DJ.%2BG.%26aulast%3DRogers%26aufirst%3DT.%2BE.%26aulast%3DMarrufo%26aufirst%3DL.%2BD.%26aulast%3DCollins%26aufirst%3DJ.%2BT.%26aulast%3DKleine%26aufirst%3DH.%2BP.%26aulast%3DLantz%26aufirst%3DM.%2BK.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DGreen%26aufirst%3DN.%2BF.%26aulast%3DRussell%26aufirst%3DM.%2BA.%26aulast%3DLandis%26aufirst%3DB.%2BH.%26aulast%3DMiller%26aufirst%3DL.%2BM.%26aulast%3DMeyer%26aufirst%3DD.%2BM.%26aulast%3DDuffin%26aufirst%3DT.%2BD.%26aulast%3DEngleman%26aufirst%3DV.%2BW.%26aulast%3DFinn%26aufirst%3DM.%2BB.%26aulast%3DFreeman%26aufirst%3DS.%2BK.%26aulast%3DGriggs%26aufirst%3DD.%2BW.%26aulast%3DWilliams%26aufirst%3DM.%2BL.%26aulast%3DNickols%26aufirst%3DM.%2BA.%26aulast%3DPegg%26aufirst%3DJ.%2BA.%26aulast%3DShannon%26aufirst%3DK.%2BE.%26aulast%3DSteininger%26aufirst%3DC.%26aulast%3DWestlin%26aufirst%3DM.%2BM.%26aulast%3DNickols%26aufirst%3DG.%2BA.%26aulast%3DKeene%26aufirst%3DJ.%2BL.%26atitle%3DR-Isomers%2520of%2520Arg-Gly-Asp%2520%2528RGD%2529%2520mimics%2520as%2520potent%2520%25CE%25B1v%25CE%25B23%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D3783%26epage%3D3800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Kubota, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hachisu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajito, K.</span><span> </span><span class="NLM_article-title">Tricyclic pharmacophore-based molecules as novel integrin αvβ3 antagonists. Part 1: design and synthesis of a lead compound exhibiting αvβ3/αIIbβ3 dual antagonistic activity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2089</span><span class="NLM_x">–</span> <span class="NLM_lpage">2108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=2089-2108&author=D.+Kubotaauthor=M.+Ishikawaauthor=M.+Yamamotoauthor=S.+Murakamiauthor=M.+Hachisuauthor=K.+Katanoauthor=K.+Ajito&title=Tricyclic+pharmacophore-based+molecules+as+novel+integrin+%CE%B1v%CE%B23+antagonists.+Part+1%3A+design+and+synthesis+of+a+lead+compound+exhibiting+%CE%B1v%CE%B23%2F%CE%B1IIb%CE%B23+dual+antagonistic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKubota%26aufirst%3DD.%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DMurakami%26aufirst%3DS.%26aulast%3DHachisu%26aufirst%3DM.%26aulast%3DKatano%26aufirst%3DK.%26aulast%3DAjito%26aufirst%3DK.%26atitle%3DTricyclic%2520pharmacophore-based%2520molecules%2520as%2520novel%2520integrin%2520%25CE%25B1v%25CE%25B23%2520antagonists.%2520Part%25201%253A%2520design%2520and%2520synthesis%2520of%2520a%2520lead%2520compound%2520exhibiting%2520%25CE%25B1v%25CE%25B23%252F%25CE%25B1IIb%25CE%25B23%2520dual%2520antagonistic%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D2089%26epage%3D2108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyanagi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajito, K.</span><span> </span><span class="NLM_article-title">Tricyclic pharmacophore-based molecules as novel integrin αvβ3 antagonists. Part 2: synthesis of potent αvβ3/αIIbβ3 dual antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2109</span><span class="NLM_x">–</span> <span class="NLM_lpage">2130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=2109-2130&author=M.+Ishikawaauthor=D.+Kubotaauthor=M.+Yamamotoauthor=C.+Kurodaauthor=M.+Iguchiauthor=A.+Koyanagiauthor=S.+Murakamiauthor=K.+Ajito&title=Tricyclic+pharmacophore-based+molecules+as+novel+integrin+%CE%B1v%CE%B23+antagonists.+Part+2%3A+synthesis+of+potent+%CE%B1v%CE%B23%2F%CE%B1IIb%CE%B23+dual+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DKubota%26aufirst%3DD.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKuroda%26aufirst%3DC.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKoyanagi%26aufirst%3DA.%26aulast%3DMurakami%26aufirst%3DS.%26aulast%3DAjito%26aufirst%3DK.%26atitle%3DTricyclic%2520pharmacophore-based%2520molecules%2520as%2520novel%2520integrin%2520%25CE%25B1v%25CE%25B23%2520antagonists.%2520Part%25202%253A%2520synthesis%2520of%2520potent%2520%25CE%25B1v%25CE%25B23%252F%25CE%25B1IIb%25CE%25B23%2520dual%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D2109%26epage%3D2130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajito, K.</span><span> </span><span class="NLM_article-title">Synthesis of potent αvβ3/αIIbβ3 dual antagonists tricyclic pharmacophore-based molecules and their selectivity control</span> <span class="citation_source-journal">J. Synth. Org. Chem., Jpn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.5059%2Fyukigoseikyokaishi.66.1093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlyrtL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2008&pages=1093-1104&author=M.+Ishikawaauthor=D.+Kubotaauthor=K.+Ajito&title=Synthesis+of+potent+%CE%B1v%CE%B23%2F%CE%B1IIb%CE%B23+dual+antagonists+tricyclic+pharmacophore-based+molecules+and+their+selectivity+control"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of potent αvβ3/αIIbβ3 dual antagonists tricyclic pharmacophore-based molecules and their selectivity control</span></div><div class="casAuthors">Ishikawa, Minoru; Kubota, Dai; Ajito, Keiichi</div><div class="citationInfo"><span class="NLM_cas:title">Yuki Gosei Kagaku Kyokaishi</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1093-1104</span>CODEN:
                <span class="NLM_cas:coden">YGKKAE</span>;
        ISSN:<span class="NLM_cas:issn">0037-9980</span>.
    
            (<span class="NLM_cas:orgname">Yuki Gosei Kagaku Kyokai</span>)
        </div><div class="casAbstract">The blockade of α11bβ3 binding to fibrinogen is known to provide a potent antiplatelet activity.  We have focused on the adhesion and migration of integrin αvβ3 in vascular smooth muscle cells and leukocytes.  An injectable αvβ3/α11bβ3 dual antagonist would be a novel drug candidate for acute ischemic diseases.  For the mol. design of novel non-peptide integrin αvβ3 antagonists, we focused on spatial screening and mimetics of the RGD tripeptide, which was a key recognition site.  The first piperazine analog (4) exhibited strong α11bβ3 activity, and replacement of piperazine by 4-aminopiperidine afforded the αvβ3/α11bβ3 dual antagonist (30).  Paying attention to enhancement of activity and improvement of soly., optimization of 30 gave some preliminary candidates modified at the central arom. or the C-terminus.  Backup compds. possessing the (3S)-aminopiperidine moiety with further improvement of soly. were synthesized.  These preliminary candidates exhibited preferable ADME in rats, and some of them showed acceptable water soly., which did not provide detectable toxicity in vitro or in mice.  We also generated αvβ3 selective antagonists with tricyclic pharmacophore, in order to prove that in vivo efficacy of the dual antagonist was superior to that of the αvβ3 selective antagonist.  Finally, excellent in vivo efficacy of the candidate (81) was demonstrated in both canine ACS and PTCA models by independent groups.  Regarding development of 81, a partnership was established in 2006, and a clin. trial of 81 is now being prepd. in the US and Canada.  The selection of an integrin research program, strategies for competing with big pharmaceutical companies, and speedy medicinal chem. are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA9RQmrFIRd7Vg90H21EOLACvtfcHk0lgnOTt55aPKug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlyrtL7J&md5=7597e80137cc9857220d2a3804d47912</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.5059%2Fyukigoseikyokaishi.66.1093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5059%252Fyukigoseikyokaishi.66.1093%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DKubota%26aufirst%3DD.%26aulast%3DAjito%26aufirst%3DK.%26atitle%3DSynthesis%2520of%2520potent%2520%25CE%25B1v%25CE%25B23%252F%25CE%25B1IIb%25CE%25B23%2520dual%2520antagonists%2520tricyclic%2520pharmacophore-based%2520molecules%2520and%2520their%2520selectivity%2520control%26jtitle%3DJ.%2520Synth.%2520Org.%2520Chem.%252C%2520Jpn.%26date%3D2008%26volume%3D66%26spage%3D1093%26epage%3D1104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Manzoni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassanini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belvisi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scolastico, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castorina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisano, C.</span><span> </span><span class="NLM_article-title">Nonpeptide integrin antagonists: RGD mimetics incorporating substituted azabicycloalkanes as amino acid replacements</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">1309</span><span class="NLM_x">–</span> <span class="NLM_lpage">1317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=1309-1317&author=L.+Manzoniauthor=M.+Bassaniniauthor=L.+Belvisiauthor=I.+Mottoauthor=C.+Scolasticoauthor=M.+Castorinaauthor=C.+Pisano&title=Nonpeptide+integrin+antagonists%3A+RGD+mimetics+incorporating+substituted+azabicycloalkanes+as+amino+acid+replacements"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManzoni%26aufirst%3DL.%26aulast%3DBassanini%26aufirst%3DM.%26aulast%3DBelvisi%26aufirst%3DL.%26aulast%3DMotto%26aufirst%3DI.%26aulast%3DScolastico%26aufirst%3DC.%26aulast%3DCastorina%26aufirst%3DM.%26aulast%3DPisano%26aufirst%3DC.%26atitle%3DNonpeptide%2520integrin%2520antagonists%253A%2520RGD%2520mimetics%2520incorporating%2520substituted%2520azabicycloalkanes%2520as%2520amino%2520acid%2520replacements%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2007%26spage%3D1309%26epage%3D1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Dayam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garofalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Discovery of small molecule integrin αvβ3 antagonists as novel anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4526</span><span class="NLM_x">–</span> <span class="NLM_lpage">4534</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051296s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4526-4534&author=R.+Dayamauthor=F.+Aielloauthor=J.+Dengauthor=Y.+Wuauthor=A.+Garofaloauthor=X.+Chenauthor=N.+Neamati&title=Discovery+of+small+molecule+integrin+%CE%B1v%CE%B23+antagonists+as+novel+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm051296s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051296s%26sid%3Dliteratum%253Aachs%26aulast%3DDayam%26aufirst%3DR.%26aulast%3DAiello%26aufirst%3DF.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520small%2520molecule%2520integrin%2520%25CE%25B1v%25CE%25B23%2520antagonists%2520as%2520novel%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4526%26epage%3D4534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span> </span><span class="NLM_article-title">Discovery of small molecule inhibitors of integrin αvβ3 through structure-based virtual screening</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5878</span><span class="NLM_x">–</span> <span class="NLM_lpage">5882</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5878-5882&author=Y.+Zhouauthor=H.+Pengauthor=Q.+Jiauthor=J.+Qiauthor=Z.+Zhuauthor=C.+Yang&title=Discovery+of+small+molecule+inhibitors+of+integrin+%CE%B1v%CE%B23+through+structure-based+virtual+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DQ.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520small%2520molecule%2520inhibitors%2520of%2520integrin%2520%25CE%25B1v%25CE%25B23%2520through%2520structure-based%2520virtual%2520screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5878%26epage%3D5882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Pleiner-Duxneuner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwettler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paschalis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roschger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nell-Duxneuner, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaushofer, K.</span><span> </span><span class="NLM_article-title">Treatment of osteoporosis with parathyroid hormone and teriparatide</span> <span class="citation_source-journal">Calcif. Tissue Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1007%2Fs00223-009-9218-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19189037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVWksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2009&pages=159-170&author=J.+Pleiner-Duxneunerauthor=E.+Zwettlerauthor=E.+Paschalisauthor=P.+Roschgerauthor=V.+Nell-Duxneunerauthor=K.+Klaushofer&title=Treatment+of+osteoporosis+with+parathyroid+hormone+and+teriparatide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of osteoporosis with parathyroid hormone and teriparatide</span></div><div class="casAuthors">Pleiner-Duxneuner, Johannes; Zwettler, Elisabeth; Paschalis, Eleftherios; Roschger, Paul; Nell-Duxneuner, Valerie; Klaushofer, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Calcified Tissue International</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">159-170</span>CODEN:
                <span class="NLM_cas:coden">CTINDZ</span>;
        ISSN:<span class="NLM_cas:issn">0171-967X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Nowadays osteoporosis treatment is based primarily on therapy with antiresorptive agents, like the bisphosphonates.  Parathyroid hormone (Preotact) and human recombinant parathyroid hormone peptide 1-34 (Teriparatide) are relatively new for the treatment of osteoporosis and belong to the group of anabolic agents.  Both agents demonstrated an increase in bone mineral d. and a significant redn. in vertebral fractures in postmenopausal women with osteoporosis when given for 18-24 mo.  Data on nonvertebral fractures are, however, not clear-cut, and so far only bisphosphonates and strontium ranelate have been demonstrated to reduce all types of fractures and therefore remain the front-line option for treatment of osteoporosis.  As the safety, tolerability, and cost of the therapy also influence the choice of therapy, Preotact and Teriparatide might be useful addns. to the armamentarium for (second-line) treatment of osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSlgQ_XUDVzLVg90H21EOLACvtfcHk0lgnOTt55aPKug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVWksL4%253D&md5=0622adf720cd263638c0de2c2017ca3c</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1007%2Fs00223-009-9218-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00223-009-9218-x%26sid%3Dliteratum%253Aachs%26aulast%3DPleiner-Duxneuner%26aufirst%3DJ.%26aulast%3DZwettler%26aufirst%3DE.%26aulast%3DPaschalis%26aufirst%3DE.%26aulast%3DRoschger%26aufirst%3DP.%26aulast%3DNell-Duxneuner%26aufirst%3DV.%26aulast%3DKlaushofer%26aufirst%3DK.%26atitle%3DTreatment%2520of%2520osteoporosis%2520with%2520parathyroid%2520hormone%2520and%2520teriparatide%26jtitle%3DCalcif.%2520Tissue%2520Int.%26date%3D2009%26volume%3D84%26spage%3D159%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Frolik, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cain, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satterwhite, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown-Augsburger, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hock, J. M.</span><span> </span><span class="NLM_article-title">Anabolic and catabolic bone effects of human parathyroid hormone (1−34) are predicted by duration of hormone exposure</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2003&pages=372-379&author=C.+A.+Frolikauthor=E.+C.+Blackauthor=R.+L.+Cainauthor=J.+H.+Satterwhiteauthor=P.+L.+Brown-Augsburgerauthor=M.+Satoauthor=J.+M.+Hock&title=Anabolic+and+catabolic+bone+effects+of+human+parathyroid+hormone+%281%E2%88%9234%29+are+predicted+by+duration+of+hormone+exposure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrolik%26aufirst%3DC.%2BA.%26aulast%3DBlack%26aufirst%3DE.%2BC.%26aulast%3DCain%26aufirst%3DR.%2BL.%26aulast%3DSatterwhite%26aufirst%3DJ.%2BH.%26aulast%3DBrown-Augsburger%26aufirst%3DP.%2BL.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DHock%26aufirst%3DJ.%2BM.%26atitle%3DAnabolic%2520and%2520catabolic%2520bone%2520effects%2520of%2520human%2520parathyroid%2520hormone%2520%25281%25E2%2588%259234%2529%2520are%2520predicted%2520by%2520duration%2520of%2520hormone%2520exposure%26jtitle%3DBone%26date%3D2003%26volume%3D33%26spage%3D372%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Ma, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cain, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miles, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onyia, J. E.</span><span> </span><span class="NLM_article-title">Catabolic effects of continuous human PTH (1−38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">4047</span><span class="NLM_x">–</span> <span class="NLM_lpage">4054</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2001&pages=4047-4054&author=Y.+L.+Maauthor=R.+L.+Cainauthor=D.+L.+Halladayauthor=X.+Yangauthor=Q.+Zengauthor=R.+R.+Milesauthor=S.+Chandrasekharauthor=T.+J.+Martinauthor=J.+E.+Onyia&title=Catabolic+effects+of+continuous+human+PTH+%281%E2%88%9238%29+in+vivo+is+associated+with+sustained+stimulation+of+RANKL+and+inhibition+of+osteoprotegerin+and+gene-associated+bone+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DY.%2BL.%26aulast%3DCain%26aufirst%3DR.%2BL.%26aulast%3DHalladay%26aufirst%3DD.%2BL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DMiles%26aufirst%3DR.%2BR.%26aulast%3DChandrasekhar%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DT.%2BJ.%26aulast%3DOnyia%26aufirst%3DJ.%2BE.%26atitle%3DCatabolic%2520effects%2520of%2520continuous%2520human%2520PTH%2520%25281%25E2%2588%259238%2529%2520in%2520vivo%2520is%2520associated%2520with%2520sustained%2520stimulation%2520of%2520RANKL%2520and%2520inhibition%2520of%2520osteoprotegerin%2520and%2520gene-associated%2520bone%2520formation%26jtitle%3DEndocrinology%26date%3D2001%26volume%3D142%26spage%3D4047%26epage%3D4054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Jilka, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellido, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parfitt, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manolagas, S. C.</span><span> </span><span class="NLM_article-title">Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=1999&pages=439-446&author=R.+L.+Jilkaauthor=R.+S.+Weinsteinauthor=T.+Bellidoauthor=P.+Robersonauthor=A.+M.+Parfittauthor=S.+C.+Manolagas&title=Increased+bone+formation+by+prevention+of+osteoblast+apoptosis+with+parathyroid+hormone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJilka%26aufirst%3DR.%2BL.%26aulast%3DWeinstein%26aufirst%3DR.%2BS.%26aulast%3DBellido%26aufirst%3DT.%26aulast%3DRoberson%26aufirst%3DP.%26aulast%3DParfitt%26aufirst%3DA.%2BM.%26aulast%3DManolagas%26aufirst%3DS.%2BC.%26atitle%3DIncreased%2520bone%2520formation%2520by%2520prevention%2520of%2520osteoblast%2520apoptosis%2520with%2520parathyroid%2520hormone%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1999%26volume%3D104%26spage%3D439%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Jilka, R. L.</span><span> </span><span class="NLM_article-title">Molecular and cellular mechanisms of the anabolic effect of intermittent PTH</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1434</span><span class="NLM_x">–</span> <span class="NLM_lpage">1446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=1434-1446&author=R.+L.+Jilka&title=Molecular+and+cellular+mechanisms+of+the+anabolic+effect+of+intermittent+PTH"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJilka%26aufirst%3DR.%2BL.%26atitle%3DMolecular%2520and%2520cellular%2520mechanisms%2520of%2520the%2520anabolic%2520effect%2520of%2520intermittent%2520PTH%26jtitle%3DBone%26date%3D2007%26volume%3D40%26spage%3D1434%26epage%3D1446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Rickard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Rojas, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trice, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votta, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroup, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuttall, M. E.</span><span> </span><span class="NLM_article-title">Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1361</span><span class="NLM_x">–</span> <span class="NLM_lpage">1372</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2006&pages=1361-1372&author=D.+J.+Rickardauthor=F.-L.+Wangauthor=A.-M.+Rodriguez-Rojasauthor=Z.+Wuauthor=W.+J.+Triceauthor=S.+J.+Hoffmanauthor=B.+Vottaauthor=G.+B.+Stroupauthor=S.+Kumarauthor=M.+E.+Nuttall&title=Intermittent+treatment+with+parathyroid+hormone+%28PTH%29+as+well+as+a+non-peptide+small+molecule+agonist+of+the+PTH1+receptor+inhibits+adipocyte+differentiation+in+human+bone+marrow+stromal+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRickard%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DF.-L.%26aulast%3DRodriguez-Rojas%26aufirst%3DA.-M.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DTrice%26aufirst%3DW.%2BJ.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DVotta%26aufirst%3DB.%26aulast%3DStroup%26aufirst%3DG.%2BB.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DNuttall%26aufirst%3DM.%2BE.%26atitle%3DIntermittent%2520treatment%2520with%2520parathyroid%2520hormone%2520%2528PTH%2529%2520as%2520well%2520as%2520a%2520non-peptide%2520small%2520molecule%2520agonist%2520of%2520the%2520PTH1%2520receptor%2520inhibits%2520adipocyte%2520differentiation%2520in%2520human%2520bone%2520marrow%2520stromal%2520cells%26jtitle%3DBone%26date%3D2006%26volume%3D39%26spage%3D1361%26epage%3D1372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Cowan, D. J.; Navas, F.,  III; Oplinger, J. A.</span><span> </span><span class="NLM_article-title">Preparation of Uracil-Derived Compounds as Parathyroid Hormone Type I Receptor Agonists for Use against Osteoporosis</span>. 2005-US3248, 2005077918, 20050203,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=D.+J.+Cowan&author=F.+Navas&author=J.+A.+Oplinger&title=Preparation+of+Uracil-Derived+Compounds+as+Parathyroid+Hormone+Type+I+Receptor+Agonists+for+Use+against+Osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCowan%26aufirst%3DD.%2BJ.%26atitle%3DPreparation%2520of%2520Uracil-Derived%2520Compounds%2520as%2520Parathyroid%2520Hormone%2520Type%2520I%2520Receptor%2520Agonists%2520for%2520Use%2520against%2520Osteoporosis%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Spearing, P. K.</span><span> </span><span class="NLM_article-title">Preparation of Isothiazolopyrimidinediones as Parathyroid Hormone Type I Receptor (PTH1R) Agonists for Treatment of Osteoporosis</span>. 2005-US3247, 005077959, 20050203,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=P.+K.+Spearing&title=Preparation+of+Isothiazolopyrimidinediones+as+Parathyroid+Hormone+Type+I+Receptor+%28PTH1R%29+Agonists+for+Treatment+of+Osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSpearing%26aufirst%3DP.%2BK.%26atitle%3DPreparation%2520of%2520Isothiazolopyrimidinediones%2520as%2520Parathyroid%2520Hormone%2520Type%2520I%2520Receptor%2520%2528PTH1R%2529%2520Agonists%2520for%2520Treatment%2520of%2520Osteoporosis%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmar, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Calcilytic compounds: potent and selective Ca<sup>2+</sup> receptor antagonists that stimulate secretion of parathyroid hormone</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=11561095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFWltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=323-331&author=E.+F.+Nemethauthor=E.+G.+Delmarauthor=W.+L.+Heatonauthor=M.+A.+Millerauthor=L.+D.+Lambertauthor=R.+L.+Conklinauthor=M.+Gowenauthor=J.+G.+Gleasonauthor=P.+K.+Bhatnagarauthor=J.+Fox&title=Calcilytic+compounds%3A+potent+and+selective+Ca2%2B+receptor+antagonists+that+stimulate+secretion+of+parathyroid+hormone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone</span></div><div class="casAuthors">Nemeth, Edward F.; Delmar, Eric G.; Heaton, William L.; Miller, Michael A.; Lambert, Lyssa D.; Conklin, Rebecca L.; Gowen, Maxine; Gleason, John G.; Bhatnagar, Pradip K.; Fox, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">323-331</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Despite the discovery of many ions and mols. that activate the Ca2+ receptor, there are no known ligands that block this receptor.  Reported here are the pharmacodynamic properties of a small mol., NPS 2143, which acts as an antagonist at the Ca2+ receptor.  This compd. blocked (IC50 of 43 nM) increases in cytoplasmic Ca2+ concns. [Ca2+]i elicited by activating the Ca2+ receptor in HEK 293 cells expressing the human Ca2+ receptor.  NPS 2143, even when tested at much higher concns. (3 μM), did not affect the activity of a no. of other G protein-coupled receptors, including those most structurally homologous to the Ca2+ receptor.  NPS 2143 stimulated parathyroid hormone (PTH) secretion from bovine parathyroid cells (EC50 of 41 nM) over a range of extracellular Ca2+ concns. and reversed the effects of the calcimimetic compd. NPS R-467 on [Ca2+]i and on secretion of PTH.  When infused i.v. in normal rats, NPS 2143 caused a rapid and large increase in plasma levels of PTH.  Ca2+ receptor antagonists are termed calcilytics and NPS 2143 is the first substance (either at. or mol.) shown to possess such activity.  The pharmacodynamic properties of NPS 2143 together with the recently demonstrated effects of this compd. on bone formation support the view that orally active calcilytic compds. might provide a novel anabolic therapy for osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5irxzzwLOvbVg90H21EOLACvtfcHk0lg399LnfzGApg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFWltbk%253D&md5=14cedbe167bc3f0de96cec16d9ce73b4</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DDelmar%26aufirst%3DE.%2BG.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DLambert%26aufirst%3DL.%2BD.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DGleason%26aufirst%3DJ.%2BG.%26aulast%3DBhatnagar%26aufirst%3DP.%2BK.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DCalcilytic%2520compounds%253A%2520potent%2520and%2520selective%2520Ca2%252B%2520receptor%2520antagonists%2520that%2520stimulate%2520secretion%2520of%2520parathyroid%2520hormone%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D323%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Marquis, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trout, R. E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelMar, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Wagenen, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roethke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P.</span><span> </span><span class="NLM_article-title">Antagonists of the calcium receptor I. Amino alcohol-based parathyroid hormone secretagogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3982</span><span class="NLM_x">–</span> <span class="NLM_lpage">3993</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900364m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvVSgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3982-3993&author=R.+W.+Marquisauthor=A.+M.+Lagoauthor=J.+F.+Callahanauthor=R.+E.+L.+Troutauthor=M.+Gowenauthor=E.+G.+DelMarauthor=B.+C.+Van+Wagenenauthor=S.+Loganauthor=S.+Shimizuauthor=J.+Foxauthor=E.+F.+Nemethauthor=Z.+Yangauthor=T.+Roethkeauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=J.+Leeauthor=R.+M.+Keenanauthor=P.+Bhatnagar&title=Antagonists+of+the+calcium+receptor+I.+Amino+alcohol-based+parathyroid+hormone+secretagogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonists of the Calcium Receptor I. Amino Alcohol-Based Parathyroid Hormone Secretagogues</span></div><div class="casAuthors">Marquis, Robert W.; Lago, Amparo M.; Callahan, James F.; Trout, Robert E. Lee; Gowen, Maxine; DelMar, Eric G.; Van Wagenen, Bradford C.; Logan, Sarah; Shimizu, Scott; Fox, John; Nemeth, Edward F.; Yang, Zheng; Roethke, Theresa; Smith, Brian R.; Ward, Keith W.; Lee, John; Keenan, Richard M.; Bhatnagar, Pradip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3982-3993</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Functional screening of the former SmithKline Beecham compd. collection against the human calcium receptor (CaR) resulted in the identification of the amino alc.-based hit 2 (IC50 = 11 μM).  Structure-activity studies of 2 focused on the optimization of the right- and left-hand side arom. moieties as well as the amino alc. linker region.  Crit. to the optimization of this antagonist template was the discovery that the chirality of the C-2 secondary alc. played a key role in enhancing both CaR potency as well as selectivity over the β-adrenergic receptor subtypes.  These SAR studies ultimately led to the identification of 38 (NPS 2143; SB-262470A), a potent and orally active CaR antagonist.  Pharmacokinetic characterization of 38 in the rat revealed that this mol. had a large vol. of distribution (11 L/kg), which resulted in a prolonged systemic exposure, protracted increases in the plasma levels of PTH, and an overall lack of net bone formation effect in a rodent model of osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEH_JHFpGSM7Vg90H21EOLACvtfcHk0lg399LnfzGApg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvVSgtL0%253D&md5=7737a92f22bb30886f925395753243fd</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fjm900364m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900364m%26sid%3Dliteratum%253Aachs%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DLago%26aufirst%3DA.%2BM.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DTrout%26aufirst%3DR.%2BE.%2BL.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DDelMar%26aufirst%3DE.%2BG.%26aulast%3DVan%2BWagenen%26aufirst%3DB.%2BC.%26aulast%3DLogan%26aufirst%3DS.%26aulast%3DShimizu%26aufirst%3DS.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DRoethke%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKeenan%26aufirst%3DR.%2BM.%26aulast%3DBhatnagar%26aufirst%3DP.%26atitle%3DAntagonists%2520of%2520the%2520calcium%2520receptor%2520I.%2520Amino%2520alcohol-based%2520parathyroid%2520hormone%2520secretagogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3982%26epage%3D3993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroup, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodds, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votta, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelMar, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1595</span><span class="NLM_x">–</span> <span class="NLM_lpage">1604</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2000&pages=1595-1604&author=M.+Gowenauthor=G.+B.+Stroupauthor=R.+A.+Doddsauthor=I.+E.+Jamesauthor=B.+J.+Vottaauthor=B.+R.+Smithauthor=P.+K.+Bhatnagarauthor=A.+M.+Lagoauthor=J.+F.+Callahanauthor=E.+G.+DelMarauthor=M.+A.+Millerauthor=E.+F.+Nemethauthor=J.+Fox&title=Antagonizing+the+parathyroid+calcium+receptor+stimulates+parathyroid+hormone+secretion+and+bone+formation+in+osteopenic+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DStroup%26aufirst%3DG.%2BB.%26aulast%3DDodds%26aufirst%3DR.%2BA.%26aulast%3DJames%26aufirst%3DI.%2BE.%26aulast%3DVotta%26aufirst%3DB.%2BJ.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DBhatnagar%26aufirst%3DP.%2BK.%26aulast%3DLago%26aufirst%3DA.%2BM.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DDelMar%26aufirst%3DE.%2BG.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DAntagonizing%2520the%2520parathyroid%2520calcium%2520receptor%2520stimulates%2520parathyroid%2520hormone%2520secretion%2520and%2520bone%2520formation%2520in%2520osteopenic%2520rats%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D105%26spage%3D1595%26epage%3D1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Shcherbakova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghatak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span> </span><span class="NLM_article-title">3H-Quinazolin-4-ones as a new calcilytic template for the potential treatment of osteoporosis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1557</span><span class="NLM_x">–</span> <span class="NLM_lpage">1560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1557-1560&author=I.+Shcherbakovaauthor=M.+F.+Balandrinauthor=J.+Foxauthor=A.+Ghatakauthor=W.+L.+Heatonauthor=R.+L.+Conklin&title=3H-Quinazolin-4-ones+as+a+new+calcilytic+template+for+the+potential+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DGhatak%26aufirst%3DA.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26atitle%3D3H-Quinazolin-4-ones%2520as%2520a%2520new%2520calcilytic%2520template%2520for%2520the%2520potential%2520treatment%2520of%2520osteoporosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1557%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Shcherbakova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoffroy, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swierczek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span> </span><span class="NLM_article-title">Design, new synthesis, and calcilytic activity of substituted 3H-pyrimidin-4-ones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2537</span><span class="NLM_x">–</span> <span class="NLM_lpage">2540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2537-2540&author=I.+Shcherbakovaauthor=G.+Huangauthor=O.+J.+Geoffroyauthor=S.+K.+Nairauthor=K.+Swierczekauthor=M.+F.+Balandrinauthor=J.+Foxauthor=W.+L.+Heatonauthor=R.+L.+Conklin&title=Design%2C+new+synthesis%2C+and+calcilytic+activity+of+substituted+3H-pyrimidin-4-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DGeoffroy%26aufirst%3DO.%2BJ.%26aulast%3DNair%26aufirst%3DS.%2BK.%26aulast%3DSwierczek%26aufirst%3DK.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26atitle%3DDesign%252C%2520new%2520synthesis%252C%2520and%2520calcilytic%2520activity%2520of%2520substituted%25203H-pyrimidin-4-ones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2537%26epage%3D2540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Kirk, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arey, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J. K.</span><span> </span><span class="NLM_article-title">Discovery and structure−activity relationships of trisubstituted pyrimidines/pyridines as novel calcium-sensing receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1204</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801178c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1204-1208&author=W.+Yangauthor=Z.+Ruanauthor=Y.+Wangauthor=K.+Van+Kirkauthor=Z.+Maauthor=B.+J.+Areyauthor=C.+B.+Cooperauthor=R.+Seethalaauthor=J.+H.+M.+Feyenauthor=J.+K.+Dickson&title=Discovery+and+structure%E2%88%92activity+relationships+of+trisubstituted+pyrimidines%2Fpyridines+as+novel+calcium-sensing+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Fjm801178c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801178c%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DRuan%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DVan%2BKirk%26aufirst%3DK.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DArey%26aufirst%3DB.%2BJ.%26aulast%3DCooper%26aufirst%3DC.%2BB.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DDickson%26aufirst%3DJ.%2BK.%26atitle%3DDiscovery%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%2520trisubstituted%2520pyrimidines%252Fpyridines%2520as%2520novel%2520calcium-sensing%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1204%26epage%3D1208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Hoffman, S. J.; Caprjotti, C. A.; Vasko, J. A.; Liang, X.; Stroup, G. B.; Casillas, L. N.; Marquis, R. W.; Kumar, S.</span><span> </span><span class="NLM_article-title">The bone-building effects of the oral calcium-sensing receptor antagonist, ronacaleret, in ovariectomized rats</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span>(S) S336, SEP 2008, abstract number Su372, volume 23.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+J.+Hoffman&author=C.+A.+Caprjotti&author=J.+A.+Vasko&author=X.+Liang&author=G.+B.+Stroup&author=L.+N.+Casillas&author=R.+W.+Marquis&author=S.+Kumar&title=The+bone-building+effects+of+the+oral+calcium-sensing+receptor+antagonist%2C+ronacaleret%2C+in+ovariectomized+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520bone-building%2520effects%2520of%2520the%2520oral%2520calcium-sensing%2520receptor%2520antagonist%252C%2520ronacaleret%252C%2520in%2520ovariectomized%2520rats%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Fitzpatrick, L. A.; Brennan, E.; Kumar, S.; Matheny, C.; Yi, B.; McLaughlin, M.; Phillips, J.; Skordos, L.; Ethgen, D.</span><span> </span><span class="NLM_article-title">Ronacaleret, a novel calcium-sensing receptor antagonist, demonstrates potential as an oral bone-forming therapy in healthy postmenopausal women</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span>(S) S50, SEP 2008, abstract number 1174, volume 23.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=L.+A.+Fitzpatrick&author=E.+Brennan&author=S.+Kumar&author=C.+Matheny&author=B.+Yi&author=M.+McLaughlin&author=J.+Phillips&author=L.+Skordos&author=D.+Ethgen&title=Ronacaleret%2C+a+novel+calcium-sensing+receptor+antagonist%2C+demonstrates+potential+as+an+oral+bone-forming+therapy+in+healthy+postmenopausal+women"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFitzpatrick%26aufirst%3DL.%2BA.%26atitle%3DRonacaleret%252C%2520a%2520novel%2520calcium-sensing%2520receptor%2520antagonist%252C%2520demonstrates%2520potential%2520as%2520an%2520oral%2520bone-forming%2520therapy%2520in%2520healthy%2520postmenopausal%2520women%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><a href="http://www.gsk.com/" class="extLink">http://www.gsk.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.gsk.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Widler, L.; Gamse, R.; Seuwen, K.; Buhl, T.; Beerli, R.; Breitenstein, W.; Gyaw, S.; Reynolds, C.; Bruin, G.; Belleli, R.; Klickstein, L.; John, M. R.</span><span> </span><span class="NLM_article-title">A novel calcium-sensing receptor antagonist leads to dose-dependent transient release of parathyroid hormone after oral administration to healthy volunteers: an initial proof-of-concept for a potential new class of anabolic osteoporosis therapeutics</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span>(S) S49, SEP 2008, abstract number 1173, volume 23.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=L.+Widler&author=R.+Gamse&author=K.+Seuwen&author=T.+Buhl&author=R.+Beerli&author=W.+Breitenstein&author=S.+Gyaw&author=C.+Reynolds&author=G.+Bruin&author=R.+Belleli&author=L.+Klickstein&author=M.+R.+John&title=A+novel+calcium-sensing+receptor+antagonist+leads+to+dose-dependent+transient+release+of+parathyroid+hormone+after+oral+administration+to+healthy+volunteers%3A+an+initial+proof-of-concept+for+a+potential+new+class+of+anabolic+osteoporosis+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWidler%26aufirst%3DL.%26atitle%3DA%2520novel%2520calcium-sensing%2520receptor%2520antagonist%2520leads%2520to%2520dose-dependent%2520transient%2520release%2520of%2520parathyroid%2520hormone%2520after%2520oral%2520administration%2520to%2520healthy%2520volunteers%253A%2520an%2520initial%2520proof-of-concept%2520for%2520a%2520potential%2520new%2520class%2520of%2520anabolic%2520osteoporosis%2520therapeutics%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matheny, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasko, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroup, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaden, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelMar, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huffman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danoff, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzpatrick, L. A.</span><span> </span><span class="NLM_article-title">An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=534-542&author=S.+Kumarauthor=C.+J.+Mathenyauthor=S.+J.+Hoffmanauthor=R.+W.+Marquisauthor=M.+Schultzauthor=X.+Liangauthor=J.+A.+Vaskoauthor=G.+B.+Stroupauthor=V.+R.+Vadenauthor=H.+Haleyauthor=J.+Foxauthor=E.+G.+DelMarauthor=E.+F.+Nemethauthor=A.+M.+Lagoauthor=J.+F.+Callahanauthor=P.+Bhatnagarauthor=W.+F.+Huffmanauthor=M.+Gowenauthor=B.+Yiauthor=T.+M.+Danoffauthor=L.+A.+Fitzpatrick&title=An+orally+active+calcium-sensing+receptor+antagonist+that+transiently+increases+plasma+concentrations+of+PTH+and+stimulates+bone+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DMatheny%26aufirst%3DC.%2BJ.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DSchultz%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DVasko%26aufirst%3DJ.%2BA.%26aulast%3DStroup%26aufirst%3DG.%2BB.%26aulast%3DVaden%26aufirst%3DV.%2BR.%26aulast%3DHaley%26aufirst%3DH.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DDelMar%26aufirst%3DE.%2BG.%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DLago%26aufirst%3DA.%2BM.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DBhatnagar%26aufirst%3DP.%26aulast%3DHuffman%26aufirst%3DW.%2BF.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DYi%26aufirst%3DB.%26aulast%3DDanoff%26aufirst%3DT.%2BM.%26aulast%3DFitzpatrick%26aufirst%3DL.%2BA.%26atitle%3DAn%2520orally%2520active%2520calcium-sensing%2520receptor%2520antagonist%2520that%2520transiently%2520increases%2520plasma%2520concentrations%2520of%2520PTH%2520and%2520stimulates%2520bone%2520formation%26jtitle%3DBone%26date%3D2010%26volume%3D46%26spage%3D534%26epage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Balan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castrodad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphries, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapinos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khot, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarra, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neagu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span> </span><span class="NLM_article-title">The discovery of novel calcium sensing receptor negative allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3328</span><span class="NLM_x">–</span> <span class="NLM_lpage">3332</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3328-3332&author=G.+Balanauthor=J.+Baumanauthor=S.+Bhattacharyaauthor=M.+Castrodadauthor=D.+R.+Healyauthor=M.+Herrauthor=P.+Humphriesauthor=S.+Jenningsauthor=A.+S.+Kalgutkarauthor=B.+Kapinosauthor=V.+Khotauthor=K.+Lazarraauthor=M.+Liauthor=Y.+Liauthor=C.+Neaguauthor=R.+Oliverauthor=D.+W.+Piotrowskiauthor=D.+Priceauthor=H.+Qiauthor=H.+A.+Simmonsauthor=J.+Southersauthor=L.+Weiauthor=Y.+Zhangauthor=V.+M.+Paralkar&title=The+discovery+of+novel+calcium+sensing+receptor+negative+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBalan%26aufirst%3DG.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DCastrodad%26aufirst%3DM.%26aulast%3DHealy%26aufirst%3DD.%2BR.%26aulast%3DHerr%26aufirst%3DM.%26aulast%3DHumphries%26aufirst%3DP.%26aulast%3DJennings%26aufirst%3DS.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKapinos%26aufirst%3DB.%26aulast%3DKhot%26aufirst%3DV.%26aulast%3DLazarra%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DNeagu%26aufirst%3DC.%26aulast%3DOliver%26aufirst%3DR.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DSimmons%26aufirst%3DH.%2BA.%26aulast%3DSouthers%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26atitle%3DThe%2520discovery%2520of%2520novel%2520calcium%2520sensing%2520receptor%2520negative%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3328%26epage%3D3332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Klaus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span> </span><span class="NLM_article-title">Wnt signalling and its impact on development and cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1038%2Fnrc2389" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18432252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltVGlu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=387-398&author=A.+Klausauthor=W.+Birchmeier&title=Wnt+signalling+and+its+impact+on+development+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt signalling and its impact on development and cancer</span></div><div class="casAuthors">Klaus, Alexandra; Birchmeier, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">387-398</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The Wnt signaling pathway is an ancient system that has been highly conserved during evolution.  It has a crucial role in the embryonic development of all animal species, in the regeneration of tissues in adult organisms and in many other processes.  Mutations or deregulated expression of components of the Wnt pathway can induce disease, most importantly cancer.  The first gene to be identified that encodes a Wnt signaling component, Int1 (integration 1), was molecularly characterized from mouse tumor cells 25 years ago.  In parallel, the homologous gene Wingless in Drosophila melanogaster, which produces developmental defects in embryos, was characterized.  Since then, further components of the Wnt pathway have been identified and their epistatic relationships have been defined.  This article is a Timeline of crucial discoveries about the components and functions of this essential pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXK8cE7Os02LVg90H21EOLACvtfcHk0liQT0N-X953nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltVGlu7c%253D&md5=c76a4450035e4228c4da7a7c12a9c5ea</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1038%2Fnrc2389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2389%26sid%3Dliteratum%253Aachs%26aulast%3DKlaus%26aufirst%3DA.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3DWnt%2520signalling%2520and%2520its%2520impact%2520on%2520development%2520and%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2008%26volume%3D8%26spage%3D387%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Krishnan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDougald, O. A.</span><span> </span><span class="NLM_article-title">Regulation of bone mass by Wnt signaling</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">1202</span><span class="NLM_x">–</span> <span class="NLM_lpage">1209</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2006&pages=1202-1209&author=V.+Krishnanauthor=H.+U.+Bryantauthor=O.+A.+MacDougald&title=Regulation+of+bone+mass+by+Wnt+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnan%26aufirst%3DV.%26aulast%3DBryant%26aufirst%3DH.%2BU.%26aulast%3DMacDougald%26aufirst%3DO.%2BA.%26atitle%3DRegulation%2520of%2520bone%2520mass%2520by%2520Wnt%2520signaling%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2006%26volume%3D116%26spage%3D1202%26epage%3D1209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawadi, G.</span><span> </span><span class="NLM_article-title">Minireview: targeting the Wnt/β-catenin pathway to regulate bone formation in the adult skeleton</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">2635</span><span class="NLM_x">–</span> <span class="NLM_lpage">2643</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2007&pages=2635-2643&author=R.+Baronauthor=G.+Rawadi&title=Minireview%3A+targeting+the+Wnt%2F%CE%B2-catenin+pathway+to+regulate+bone+formation+in+the+adult+skeleton"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DRawadi%26aufirst%3DG.%26atitle%3DMinireview%253A%2520targeting%2520the%2520Wnt%252F%25CE%25B2-catenin%2520pathway%2520to%2520regulate%2520bone%2520formation%2520in%2520the%2520adult%2520skeleton%26jtitle%3DEndocrinology%26date%3D2007%26volume%3D148%26spage%3D2635%26epage%3D2643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlmeier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.-Y.</span><span> </span><span class="NLM_article-title">Wnt signaling and skeletal development</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">999</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.cellsig.2007.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18164181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsF2rtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2008&pages=999-1009&author=F.+Liuauthor=S.+Kohlmeierauthor=C.-Y.+Wang&title=Wnt+signaling+and+skeletal+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt signaling and skeletal development</span></div><div class="casAuthors">Liu, Fei; Kohlmeier, Sean; Wang, Cun-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">999-1009</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Wnt proteins are a family of secreted proteins that regulate many aspects of cellular functions.  The discovery that mutations in low-d. lipoprotein receptor-related protein 5, a putative Wnt coreceptor, could pos. and neg. affect bone mass in humans generated an enormous amt. of interest in the possible role of the Wnt signaling pathway in skeletal biol.  Over the last decade, considerable progress has been made in detg. the role of the canonical Wnt signaling pathway in various aspects of skeletal development.  Furthermore, recent evidence indicates the important role of non-canonical Wnt signaling in skeletal development.  In this review we discuss the current understanding of the role of Wnt signaling in chondrogenesis, osteoblastogenesis, and osteoclastogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGNSx986CCbLVg90H21EOLACvtfcHk0ljFQ5DlwHb9gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsF2rtbY%253D&md5=40c495a0ebdcee11857205fa3a1c49d8</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2007.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2007.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DKohlmeier%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DC.-Y.%26atitle%3DWnt%2520signaling%2520and%2520skeletal%2520development%26jtitle%3DCell.%2520Signalling%26date%3D2008%26volume%3D20%26spage%3D999%26epage%3D1009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Macsai, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xian, C. J.</span><span> </span><span class="NLM_article-title">Roles of Wnt signalling in bone growth, remodelling, skeletal disorders and fracture repair</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">215</span><span class="NLM_x">, </span> <span class="NLM_fpage">578</span><span class="NLM_x">–</span> <span class="NLM_lpage">587</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1002%2Fjcp.21342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18247365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVKgt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2008&pages=578-587&author=C.+E.+Macsaiauthor=B.+K.+Fosterauthor=C.+J.+Xian&title=Roles+of+Wnt+signalling+in+bone+growth%2C+remodelling%2C+skeletal+disorders+and+fracture+repair"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of Wnt signalling in bone growth, remodelling, skeletal disorders and fracture repair</span></div><div class="casAuthors">Macsai, Carmen E.; Foster, Bruce K.; Xian, Cory J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">578-587</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Wnt signalling has an essential role in regulating bone formation and remodelling during embryonic development and throughout postnatal and adult life.  Specifically, Wnt signalling regulates bone formation by controlling embryonic cartilage development and postnatal chondrogenesis, osteoblastogenesis, osteoclastogenesis, endochondral bone formation, and bone remodelling.  Abnormalities in the function of Wnt genes give rise to or contribute to the development of several pathol. bone conditions, including abnormal bone mass, osteosarcomas and bone loss in multiple myeloma.  Furthermore, Wnt signalling is activated during bone fracture repair and plays a crucial role in regulating bone regeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEpVp497Paf7Vg90H21EOLACvtfcHk0ljFQ5DlwHb9gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVKgt70%253D&md5=d08c8707209661dc34628e98adc1773c</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1002%2Fjcp.21342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.21342%26sid%3Dliteratum%253Aachs%26aulast%3DMacsai%26aufirst%3DC.%2BE.%26aulast%3DFoster%26aufirst%3DB.%2BK.%26aulast%3DXian%26aufirst%3DC.%2BJ.%26atitle%3DRoles%2520of%2520Wnt%2520signalling%2520in%2520bone%2520growth%252C%2520remodelling%252C%2520skeletal%2520disorders%2520and%2520fracture%2520repair%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2008%26volume%3D215%26spage%3D578%26epage%3D587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Glass, D. A.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karsenty, G.</span><span> </span><span class="NLM_article-title">Minireview: in vivo analysis of Wnt signaling in bone</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">2630</span><span class="NLM_x">–</span> <span class="NLM_lpage">2634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2007&pages=2630-2634&author=D.+A.+Glassauthor=G.+Karsenty&title=Minireview%3A+in+vivo+analysis+of+Wnt+signaling+in+bone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlass%26aufirst%3DD.%2BA.%26aulast%3DKarsenty%26aufirst%3DG.%26atitle%3DMinireview%253A%2520in%2520vivo%2520analysis%2520of%2520Wnt%2520signaling%2520in%2520bone%26jtitle%3DEndocrinology%26date%3D2007%26volume%3D148%26spage%3D2630%26epage%3D2634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ominsky, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmington, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morony, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalhoub, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haldankar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winters, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, Q.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostenuik, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonet, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacey, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paszty, C.</span><span> </span><span class="NLM_article-title">Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">578</span><span class="NLM_x">–</span> <span class="NLM_lpage">588</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1359%2Fjbmr.081206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19049336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksF2lu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=578-588&author=X.+Liauthor=M.+S.+Ominskyauthor=K.+S.+Warmingtonauthor=S.+Moronyauthor=J.+Gongauthor=J.+Caoauthor=Y.+Gaoauthor=V.+Shalhoubauthor=B.+Tiptonauthor=R.+Haldankarauthor=Q.+Chenauthor=A.+Wintersauthor=T.+Booneauthor=Z.+Gengauthor=Q.-T.+Niuauthor=H.+Z.+Keauthor=P.+J.+Kostenuikauthor=W.+S.+Simonetauthor=D.+L.+Laceyauthor=C.+Paszty&title=Sclerostin+antibody+treatment+increases+bone+formation%2C+bone+mass%2C+and+bone+strength+in+a+rat+model+of+postmenopausal+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis</span></div><div class="casAuthors">Li, Xiaodong; Ominsky, Michael S.; Warmington, Kelly S.; Morony, Sean; Gong, Jianhua; Cao, Jin; Gao, Yongming; Shalhoub, Victoria; Tipton, Barbara; Haldankar, Raj; Chen, Qing; Winters, Aaron; Boone, Tom; Geng, Zhaopo; Niu, Qing-Tian; Ke, Hua Zhu; Kostenuik, Paul J.; Simonet, W. Scott; Lacey, David L.; Paszty, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">578-588</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">The development of bone-rebuilding anabolic agents for potential use in the treatment of bone loss conditions, such as osteoporosis, has been a long-standing goal.  Genetic studies in humans and mice have shown that the secreted protein sclerostin is a key neg. regulator of bone formation, although the magnitude and extent of sclerostin's role in the control of bone formation in the aging skeleton is still unclear.  To study this unexplored area of sclerostin biol. and to assess the pharmacol. effects of sclerostin inhibition, we used a cell culture model of bone formation to identify a sclerostin neutralizing monoclonal antibody (Scl-AbII) for testing in an aged ovariectomized rat model of postmenopausal osteoporosis.  Six-month-old female rats were ovariectomized and left untreated for 1 yr to allow for significant estrogen deficiency-induced bone loss, at which point Scl-AbII was administered for 5 wk.  Scl-AbII treatment in these animals had robust anabolic effects, with marked increases in bone formation on trabecular, periosteal, endocortical, and intracortical surfaces.  This not only resulted in complete reversal, at several skeletal sites, of the 1 yr of estrogen deficiency-induced bone loss, but also further increased bone mass and bone strength to levels greater than those found in non-ovariectomized control rats.  Taken together, these preclin. results establish sclerostin's role as a pivotal neg. regulator of bone formation in the aging skeleton and, furthermore, suggest that antibody-mediated inhibition of sclerostin represents a promising new therapeutic approach for the anabolic treatment of bone-related disorders, such as postmenopausal osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqIMvgmEX9abVg90H21EOLACvtfcHk0ljFQ5DlwHb9gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksF2lu7c%253D&md5=6ba21682e2f0a7aba4e95fede74808b0</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.081206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.081206%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DOminsky%26aufirst%3DM.%2BS.%26aulast%3DWarmington%26aufirst%3DK.%2BS.%26aulast%3DMorony%26aufirst%3DS.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DShalhoub%26aufirst%3DV.%26aulast%3DTipton%26aufirst%3DB.%26aulast%3DHaldankar%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DWinters%26aufirst%3DA.%26aulast%3DBoone%26aufirst%3DT.%26aulast%3DGeng%26aufirst%3DZ.%26aulast%3DNiu%26aufirst%3DQ.-T.%26aulast%3DKe%26aufirst%3DH.%2BZ.%26aulast%3DKostenuik%26aufirst%3DP.%2BJ.%26aulast%3DSimonet%26aufirst%3DW.%2BS.%26aulast%3DLacey%26aufirst%3DD.%2BL.%26aulast%3DPaszty%26aufirst%3DC.%26atitle%3DSclerostin%2520antibody%2520treatment%2520increases%2520bone%2520formation%252C%2520bone%2520mass%252C%2520and%2520bone%2520strength%2520in%2520a%2520rat%2520model%2520of%2520postmenopausal%2520osteoporosis%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2009%26volume%3D24%26spage%3D578%26epage%3D588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Eddleston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marenzana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzylak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, M. K.</span><span> </span><span class="NLM_article-title">A short treatment with an antibody to sclerostin can inhibit bone loss in an ongoing model of colitis</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1662</span><span class="NLM_x">–</span> <span class="NLM_lpage">1671</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1359%2Fjbmr.090403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19419292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGgurfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=1662-1671&author=A.+Eddlestonauthor=M.+Marenzanaauthor=A.+R.+Mooreauthor=P.+Stephensauthor=M.+Muzylakauthor=D.+Marshallauthor=M.+K.+Robinson&title=A+short+treatment+with+an+antibody+to+sclerostin+can+inhibit+bone+loss+in+an+ongoing+model+of+colitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">A short treatment with an antibody to sclerostin can inhibit bone loss in an ongoing model of colitis</span></div><div class="casAuthors">Eddleston, Alison; Marenzana, Massimo; Moore, Adrian R.; Stephens, Paul; Muzylak, Mariusz; Marshall, Diane; Robinson, Martyn K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1662-1671</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">Chronic inflammation leads to bone loss, and increased fracture rates have been reported in a no. of human chronic inflammatory conditions.  The study reported here investigates the skeletal effects of dosing a neutralizing antibody to the bone regulatory protein sclerostin in a mouse model of chronic colitis.  When dosed prophylactically, an antibody to sclerostin (Scl-AbI) did not reduce the wt. loss or histol. changes assocd. with colitis but did prevent inflammation-induced bone loss.  At the end of the expt., Scl-AbI-treated animals had a significantly higher femoral BMD (+27%, p < 0.05) than control antibody (Cntrl-Ab)-treated animals.  In a second expt., treatment with Scl-AbI was delayed until colitis had developed, by which time the mech. properties of femurs in colitic animals were significantly worse than those of healthy age-matched control mice (max. load, -26%, p < 0.05; energy, -37%, p < 0.05; ultimate strength, -33%, p < 0.05; elastic modulus, -17%, p < 0.05).  A short treatment with Scl-AbI halted bone loss and reversed the decline of both intrinsic and extrinsic mech. properties of the femur such that, after 19 days of treatment, the bone mech. properties in the Scl-AbI-treated animals were not significantly different from those of noncolitic age-matched controls.  Serum markers of bone formation and resorption suggested that the antibody to sclerostin stimulated osteoblast activity and inhibited osteoclast-mediated bone resorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorHiblBDi_6bVg90H21EOLACvtfcHk0lg0crq624SPjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlGgurfM&md5=5aa298df22635caa3cffdeb5d9224581</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.090403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.090403%26sid%3Dliteratum%253Aachs%26aulast%3DEddleston%26aufirst%3DA.%26aulast%3DMarenzana%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DA.%2BR.%26aulast%3DStephens%26aufirst%3DP.%26aulast%3DMuzylak%26aufirst%3DM.%26aulast%3DMarshall%26aufirst%3DD.%26aulast%3DRobinson%26aufirst%3DM.%2BK.%26atitle%3DA%2520short%2520treatment%2520with%2520an%2520antibody%2520to%2520sclerostin%2520can%2520inhibit%2520bone%2520loss%2520in%2520an%2520ongoing%2520model%2520of%2520colitis%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2009%26volume%3D24%26spage%3D1662%26epage%3D1671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Padhi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stouch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glise, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posvar, E.</span><span> </span><span class="NLM_article-title">Anti-sclerostin antibody increases markers of bone formation in healthy postmenopausal women</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">S1</span><span class="NLM_x">–</span> <span class="NLM_lpage">S37</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=S1-S37&author=D.+Padhiauthor=B.+Stouchauthor=G.+Jangauthor=L.+Fangauthor=M.+Darlingauthor=H.+Gliseauthor=M.+Robinsonauthor=S.+Harrisauthor=E.+Posvar&title=Anti-sclerostin+antibody+increases+markers+of+bone+formation+in+healthy+postmenopausal+women"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPadhi%26aufirst%3DD.%26aulast%3DStouch%26aufirst%3DB.%26aulast%3DJang%26aufirst%3DG.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DDarling%26aufirst%3DM.%26aulast%3DGlise%26aufirst%3DH.%26aulast%3DRobinson%26aufirst%3DM.%26aulast%3DHarris%26aufirst%3DS.%26aulast%3DPosvar%26aufirst%3DE.%26atitle%3DAnti-sclerostin%2520antibody%2520increases%2520markers%2520of%2520bone%2520formation%2520in%2520healthy%2520postmenopausal%2520women%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2007%26volume%3D22%26spage%3DS1%26epage%3DS37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Grisanti, M.; Niu, Q. T.; Fan, W.; Asuncion, F.; Lee, J.; Steavenson, S.; Chen, Q.; Li, J.; Geng, Z.; Kostenuik, P.; Lacey, D. L.; Simonet, W. S.; Ominsky, M.; Li, X.; Richards, W. G.</span><span> </span><span class="NLM_article-title">Dkk-1 inhibition increases bone mineral density in rodents</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span>(1) S25, SEP 2006, abstract number 1089, volume 21.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Grisanti&author=Q.+T.+Niu&author=W.+Fan&author=F.+Asuncion&author=J.+Lee&author=S.+Steavenson&author=Q.+Chen&author=J.+Li&author=Z.+Geng&author=P.+Kostenuik&author=D.+L.+Lacey&author=W.+S.+Simonet&author=M.+Ominsky&author=X.+Li&author=W.+G.+Richards&title=Dkk-1+inhibition+increases+bone+mineral+density+in+rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrisanti%26aufirst%3DM.%26atitle%3DDkk-1%2520inhibition%2520increases%2520bone%2520mineral%2520density%2520in%2520rodents%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Diarra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polzer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwerina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ominsky, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smolen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheinecker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Heide, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landewe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schett, G.</span><span> </span><span class="NLM_article-title">Dickkopf-1 is a master regulator of joint remodeling</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1038%2Fnm1538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17237793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVyktbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=156-163&author=D.+Diarraauthor=M.+Stolinaauthor=K.+Polzerauthor=J.+Zwerinaauthor=M.+S.+Ominskyauthor=D.+Dwyerauthor=A.+Korbauthor=J.+Smolenauthor=M.+Hoffmannauthor=C.+Scheineckerauthor=D.+van+der+Heideauthor=R.+Landeweauthor=D.+Laceyauthor=W.+G.+Richardsauthor=G.+Schett&title=Dickkopf-1+is+a+master+regulator+of+joint+remodeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Dickkopf-1 is a master regulator of joint remodeling</span></div><div class="casAuthors">Diarra, Danielle; Stolina, Marina; Polzer, Karin; Zwerina, Jochen; Ominsky, Michael S.; Dwyer, Denise; Korb, Adelheid; Smolen, Josef; Hoffmann, Markus; Scheinecker, Clemens; van der Heide, Desiree; Landewe, Robert; Lacey, Dave; Richards, William G.; Schett, Georg</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">156-163</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Degenerative and inflammatory joint diseases lead to a destruction of the joint architecture.  Whereas degenerative osteoarthritis results in the formation of new bone, rheumatoid arthritis leads to bone resorption.  The mol. basis of these different patterns of joint disease is unknown.  By inhibiting Dickkopf-1 (DKK-1), a regulatory mol. of the Wnt pathway, the authors were able to reverse the bone-destructive pattern of a mouse model of rheumatoid arthritis to the bone-forming pattern of osteoarthritis.  In this way, no overall bone erosion resulted, although bony nodules, so-called osteophytes, did form.  The authors identified tumor necrosis factor-α (TNF) as a key inducer of DKK-1 in the mouse inflammatory arthritis model and in human rheumatoid arthritis.  These results suggest that the Wnt pathway is a key regulator of joint remodeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoctqLrJQzr7Vg90H21EOLACvtfcHk0lg0crq624SPjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVyktbY%253D&md5=24e33f09eba01d2f5172b639d45549c4</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fnm1538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1538%26sid%3Dliteratum%253Aachs%26aulast%3DDiarra%26aufirst%3DD.%26aulast%3DStolina%26aufirst%3DM.%26aulast%3DPolzer%26aufirst%3DK.%26aulast%3DZwerina%26aufirst%3DJ.%26aulast%3DOminsky%26aufirst%3DM.%2BS.%26aulast%3DDwyer%26aufirst%3DD.%26aulast%3DKorb%26aufirst%3DA.%26aulast%3DSmolen%26aufirst%3DJ.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DScheinecker%26aufirst%3DC.%26aulast%3Dvan%2Bder%2BHeide%26aufirst%3DD.%26aulast%3DLandewe%26aufirst%3DR.%26aulast%3DLacey%26aufirst%3DD.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DSchett%26aufirst%3DG.%26atitle%3DDickkopf-1%2520is%2520a%2520master%2520regulator%2520of%2520joint%2520remodeling%26jtitle%3DNat.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D156%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Fulciniti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tassone, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanjappa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ettenberg, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, Y.-t.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauhan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsiades, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stover, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, N. C.</span><span> </span><span class="NLM_article-title">Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=371-379&author=M.+Fulcinitiauthor=P.+Tassoneauthor=T.+Hideshimaauthor=S.+Valletauthor=P.+Nanjappaauthor=S.+A.+Ettenbergauthor=Z.+Shenauthor=N.+Patelauthor=Y.-t.+Taiauthor=D.+Chauhanauthor=C.+Mitsiadesauthor=R.+Prabhalaauthor=N.+Rajeauthor=K.+C.+Andersonauthor=D.+R.+Stoverauthor=N.+C.+Munshi&title=Anti-DKK1+mAb+%28BHQ880%29+as+a+potential+therapeutic+agent+for+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFulciniti%26aufirst%3DM.%26aulast%3DTassone%26aufirst%3DP.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DVallet%26aufirst%3DS.%26aulast%3DNanjappa%26aufirst%3DP.%26aulast%3DEttenberg%26aufirst%3DS.%2BA.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DTai%26aufirst%3DY.-t.%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DMitsiades%26aufirst%3DC.%26aulast%3DPrabhala%26aufirst%3DR.%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DStover%26aufirst%3DD.%2BR.%26aulast%3DMunshi%26aufirst%3DN.%2BC.%26atitle%3DAnti-DKK1%2520mAb%2520%2528BHQ880%2529%2520as%2520a%2520potential%2520therapeutic%2520agent%2520for%2520multiple%2520myeloma%26jtitle%3DBlood%26date%3D2009%26volume%3D114%26spage%3D371%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Heath, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chantry, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckle, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaughnessy, J. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snowden, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stover, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderkerken, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croucher, P. I.</span><span> </span><span class="NLM_article-title">Inhibiting dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">436</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1359%2Fjbmr.081104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19016584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjslKru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=425-436&author=D.+J.+Heathauthor=A.+D.+Chantryauthor=C.+H.+Buckleauthor=L.+Coultonauthor=J.+D.+Shaughnessyauthor=H.+R.+Evansauthor=J.+A.+Snowdenauthor=D.+R.+Stoverauthor=K.+Vanderkerkenauthor=P.+I.+Croucher&title=Inhibiting+dickkopf-1+%28Dkk1%29+removes+suppression+of+bone+formation+and+prevents+the+development+of+osteolytic+bone+disease+in+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma</span></div><div class="casAuthors">Heath, Deborah J.; Chantry, Andrew D.; Buckle, Clive H.; Coulton, Les; Shaughnessy, John D., Jr.; Evans, Holly R.; Snowden, John A.; Stover, David R.; Vanderkerken, Karin; Croucher, Peter I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">425-436</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">Multiple myeloma (MM) is assocd. with the development of osteolytic bone disease, mediated by increased osteoclastic bone resorption and impaired osteoblastic bone formation.  Dickkopf-1 (Dkk1), a sol. inhibitor of wingless/int (Wnt) signaling and osteoblastogenesis, is elevated in patients with MM and correlates with osteolytic bone disease.  In this study, we investigated the effect of inhibiting Dkk1 on the development of osteolytic lesions in the 5T2MM murine model of myeloma.  We showed that Dkk1 is expressed by murine 5T2MM myeloma cells.  Injection of 5T2MM cells into C57BL/KaLwRij mice resulted in the development of osteolytic bone lesions (p < 0.05), mediated by increased osteoclast nos. (p < 0.001) and a decrease in osteoblast nos. (p < 0.001) and mineralizing surface (p < 0.05).  Mice bearing 5T2MM cells were treated with an anti-Dkk1 antibody (BHQ880, 10 mg/kg, IV, twice weekly for 4 wk) from time of paraprotein detection.  Anti-Dkk1 treatment prevented 5T2MM-induced suppression of osteoblast nos. (p < 0.001) and surface (p < 0.001).  Treatment increased mineralizing surface by 28% and bone formation rate by 25%; however, there was no change in mineral apposition rate.  Inhibiting Dkk1 had no effect on osteoclast nos.  μCT anal. showed that anti-Dkk1 treatment significantly protected against 5T2MM-induced trabecular bone loss (p < 0.05) and reduced the development of osteolytic bone lesions (p < 0.05).  Treatment had no significant effect on tumor burden.  These data suggest that inhibiting Dkk1 prevents the suppression of bone formation and in doing so is effective in preventing the development of osteolytic bone disease in myeloma, offering an effective therapeutic approach to treating this clin. important aspect of myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSg4wcjmMeRLVg90H21EOLACvtfcHk0lgBkMEc9KzBmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjslKru78%253D&md5=fc15e5571454e63efa18581af393fe0a</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.081104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.081104%26sid%3Dliteratum%253Aachs%26aulast%3DHeath%26aufirst%3DD.%2BJ.%26aulast%3DChantry%26aufirst%3DA.%2BD.%26aulast%3DBuckle%26aufirst%3DC.%2BH.%26aulast%3DCoulton%26aufirst%3DL.%26aulast%3DShaughnessy%26aufirst%3DJ.%2BD.%26aulast%3DEvans%26aufirst%3DH.%2BR.%26aulast%3DSnowden%26aufirst%3DJ.%2BA.%26aulast%3DStover%26aufirst%3DD.%2BR.%26aulast%3DVanderkerken%26aufirst%3DK.%26aulast%3DCroucher%26aufirst%3DP.%2BI.%26atitle%3DInhibiting%2520dickkopf-1%2520%2528Dkk1%2529%2520removes%2520suppression%2520of%2520bone%2520formation%2520and%2520prevents%2520the%2520development%2520of%2520osteolytic%2520bone%2520disease%2520in%2520multiple%2520myeloma%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2009%26volume%3D24%26spage%3D425%26epage%3D436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Pelletier, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundquist, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bex, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleburn, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felix, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauze, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharode, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhead, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matteo, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehlmann, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murrills, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirrello, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unwalla, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vera, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobel, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaworsky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodine, P. V. N.</span><span> </span><span class="NLM_article-title">(1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: a wingless β-catenin agonist that increases bone formation rate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6962</span><span class="NLM_x">–</span> <span class="NLM_lpage">6965</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9014197" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6962-6965&author=J.+C.+Pelletierauthor=J.+T.+Lundquistauthor=A.+M.+Gilbertauthor=N.+Alonauthor=F.+J.+Bexauthor=B.+M.+Bhatauthor=M.+G.+Bursavichauthor=V.+E.+Coleburnauthor=L.+A.+Felixauthor=D.+M.+Greenauthor=P.+Greenauthor=D.+B.+Hauzeauthor=Y.+P.+Kharodeauthor=H.-S.+Lamauthor=S.+R.+Lockheadauthor=R.+L.+Magoldaauthor=J.+J.+Matteoauthor=J.+F.+Mehlmannauthor=C.+Milliganauthor=R.+J.+Murrillsauthor=J.+Pirrelloauthor=S.+Selimauthor=M.+C.+Sharpauthor=R.+J.+Unwallaauthor=M.+D.+Veraauthor=J.+E.+Wrobelauthor=P.+Yaworskyauthor=P.+V.+N.+Bodine&title=%281-%284-%28Naphthalen-2-yl%29pyrimidin-2-yl%29piperidin-4-yl%29methanamine%3A+a+wingless+%CE%B2-catenin+agonist+that+increases+bone+formation+rate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Fjm9014197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9014197%26sid%3Dliteratum%253Aachs%26aulast%3DPelletier%26aufirst%3DJ.%2BC.%26aulast%3DLundquist%26aufirst%3DJ.%2BT.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DAlon%26aufirst%3DN.%26aulast%3DBex%26aufirst%3DF.%2BJ.%26aulast%3DBhat%26aufirst%3DB.%2BM.%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DColeburn%26aufirst%3DV.%2BE.%26aulast%3DFelix%26aufirst%3DL.%2BA.%26aulast%3DGreen%26aufirst%3DD.%2BM.%26aulast%3DGreen%26aufirst%3DP.%26aulast%3DHauze%26aufirst%3DD.%2BB.%26aulast%3DKharode%26aufirst%3DY.%2BP.%26aulast%3DLam%26aufirst%3DH.-S.%26aulast%3DLockhead%26aufirst%3DS.%2BR.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DMatteo%26aufirst%3DJ.%2BJ.%26aulast%3DMehlmann%26aufirst%3DJ.%2BF.%26aulast%3DMilligan%26aufirst%3DC.%26aulast%3DMurrills%26aufirst%3DR.%2BJ.%26aulast%3DPirrello%26aufirst%3DJ.%26aulast%3DSelim%26aufirst%3DS.%26aulast%3DSharp%26aufirst%3DM.%2BC.%26aulast%3DUnwalla%26aufirst%3DR.%2BJ.%26aulast%3DVera%26aufirst%3DM.%2BD.%26aulast%3DWrobel%26aufirst%3DJ.%2BE.%26aulast%3DYaworsky%26aufirst%3DP.%26aulast%3DBodine%26aufirst%3DP.%2BV.%2BN.%26atitle%3D%25281-%25284-%2528Naphthalen-2-yl%2529pyrimidin-2-yl%2529piperidin-4-yl%2529methanamine%253A%2520a%2520wingless%2520%25CE%25B2-catenin%2520agonist%2520that%2520increases%2520bone%2520formation%2520rate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6962%26epage%3D6965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Gilbert, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bex, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleburn, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gironda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauze, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharode, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamurthy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirisits, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matteo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murrills, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unwalla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varadarajan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaworsky, P. J.</span><span> </span><span class="NLM_article-title">Hit to lead studies on (hetero)arylpyrimidines—agonists of the canonical Wnt-β-catenin cellular messaging system</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=366-370&author=A.+M.+Gilbertauthor=M.+G.+Bursavichauthor=N.+Alonauthor=B.+M.+Bhatauthor=F.+J.+Bexauthor=M.+Cainauthor=V.+Coleburnauthor=V.+Girondaauthor=P.+Greenauthor=D.+B.+Hauzeauthor=Y.+Kharodeauthor=G.+Krishnamurthyauthor=M.+Kirisitsauthor=H.-S.+Lamauthor=Y.-B.+Liuauthor=S.+Lombardiauthor=J.+Matteoauthor=R.+Murrillsauthor=J.+A.+Robinsonauthor=S.+Selimauthor=M.+Sharpauthor=R.+Unwallaauthor=U.+Varadarajanauthor=W.+Zhaoauthor=P.+J.+Yaworsky&title=Hit+to+lead+studies+on+%28hetero%29arylpyrimidines%E2%80%94agonists+of+the+canonical+Wnt-%CE%B2-catenin+cellular+messaging+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DAlon%26aufirst%3DN.%26aulast%3DBhat%26aufirst%3DB.%2BM.%26aulast%3DBex%26aufirst%3DF.%2BJ.%26aulast%3DCain%26aufirst%3DM.%26aulast%3DColeburn%26aufirst%3DV.%26aulast%3DGironda%26aufirst%3DV.%26aulast%3DGreen%26aufirst%3DP.%26aulast%3DHauze%26aufirst%3DD.%2BB.%26aulast%3DKharode%26aufirst%3DY.%26aulast%3DKrishnamurthy%26aufirst%3DG.%26aulast%3DKirisits%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DH.-S.%26aulast%3DLiu%26aufirst%3DY.-B.%26aulast%3DLombardi%26aufirst%3DS.%26aulast%3DMatteo%26aufirst%3DJ.%26aulast%3DMurrills%26aufirst%3DR.%26aulast%3DRobinson%26aufirst%3DJ.%2BA.%26aulast%3DSelim%26aufirst%3DS.%26aulast%3DSharp%26aufirst%3DM.%26aulast%3DUnwalla%26aufirst%3DR.%26aulast%3DVaradarajan%26aufirst%3DU.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DYaworsky%26aufirst%3DP.%2BJ.%26atitle%3DHit%2520to%2520lead%2520studies%2520on%2520%2528hetero%2529arylpyrimidines%25E2%2580%2594agonists%2520of%2520the%2520canonical%2520Wnt-%25CE%25B2-catenin%2520cellular%2520messaging%2520system%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D366%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Gopalsamy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billiard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponce-de-Leon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seestaller-Wehr, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamurthy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodine, P.</span><span> </span><span class="NLM_article-title">Identification of diarylsulfone sulfonamides as secreted frizzled related protein-1 (sFRP-1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7670</span><span class="NLM_x">–</span> <span class="NLM_lpage">7672</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801069w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7670-7672&author=A.+Gopalsamyauthor=M.+Shiauthor=B.+Staufferauthor=R.+Bahatauthor=J.+Billiardauthor=H.+Ponce-de-Leonauthor=L.+Seestaller-Wehrauthor=S.+Fukayamaauthor=A.+Mangineauthor=R.+Moranauthor=G.+Krishnamurthyauthor=P.+Bodine&title=Identification+of+diarylsulfone+sulfonamides+as+secreted+frizzled+related+protein-1+%28sFRP-1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1021%2Fjm801069w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801069w%26sid%3Dliteratum%253Aachs%26aulast%3DGopalsamy%26aufirst%3DA.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DStauffer%26aufirst%3DB.%26aulast%3DBahat%26aufirst%3DR.%26aulast%3DBilliard%26aufirst%3DJ.%26aulast%3DPonce-de-Leon%26aufirst%3DH.%26aulast%3DSeestaller-Wehr%26aufirst%3DL.%26aulast%3DFukayama%26aufirst%3DS.%26aulast%3DMangine%26aufirst%3DA.%26aulast%3DMoran%26aufirst%3DR.%26aulast%3DKrishnamurthy%26aufirst%3DG.%26aulast%3DBodine%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520diarylsulfone%2520sulfonamides%2520as%2520secreted%2520frizzled%2520related%2520protein-1%2520%2528sFRP-1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7670%26epage%3D7672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Moore, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Commons, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goljer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamurthy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nogle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trybulski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welmaker, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodine, P. V. N.</span><span> </span><span class="NLM_article-title">Modulation of Wnt signaling through inhibition of secreted frizzled-related protein I (sFRP-1) with N-substituted piperidinyl diphenylsulfonyl sulfonamides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801144h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=105-116&author=W.+J.+Mooreauthor=J.+C.+Kernauthor=R.+Bhatauthor=T.+J.+Commonsauthor=S.+Fukayamaauthor=I.+Goljerauthor=G.+Krishnamurthyauthor=R.+L.+Magoldaauthor=L.+Nogleauthor=K.+Pittsauthor=B.+Staufferauthor=E.+J.+Trybulskiauthor=G.+S.+Welmakerauthor=M.+Wilsonauthor=P.+V.+N.+Bodine&title=Modulation+of+Wnt+signaling+through+inhibition+of+secreted+frizzled-related+protein+I+%28sFRP-1%29+with+N-substituted+piperidinyl+diphenylsulfonyl+sulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fjm801144h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801144h%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DW.%2BJ.%26aulast%3DKern%26aufirst%3DJ.%2BC.%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DCommons%26aufirst%3DT.%2BJ.%26aulast%3DFukayama%26aufirst%3DS.%26aulast%3DGoljer%26aufirst%3DI.%26aulast%3DKrishnamurthy%26aufirst%3DG.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DNogle%26aufirst%3DL.%26aulast%3DPitts%26aufirst%3DK.%26aulast%3DStauffer%26aufirst%3DB.%26aulast%3DTrybulski%26aufirst%3DE.%2BJ.%26aulast%3DWelmaker%26aufirst%3DG.%2BS.%26aulast%3DWilson%26aufirst%3DM.%26aulast%3DBodine%26aufirst%3DP.%2BV.%2BN.%26atitle%3DModulation%2520of%2520Wnt%2520signaling%2520through%2520inhibition%2520of%2520secreted%2520frizzled-related%2520protein%2520I%2520%2528sFRP-1%2529%2520with%2520N-substituted%2520piperidinyl%2520diphenylsulfonyl%2520sulfonamides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D105%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Bodine, P. V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponce-de-Leon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seestaller-Wehr, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billiard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komm, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamurthy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalsamy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Commons, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodworth, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welmaker, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trybulski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, W. J.</span><span> </span><span class="NLM_article-title">A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1063</span><span class="NLM_x">–</span> <span class="NLM_lpage">1068</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=1063-1068&author=P.+V.+N.+Bodineauthor=B.+Staufferauthor=H.+Ponce-de-Leonauthor=R.+A.+Bhatauthor=A.+Mangineauthor=L.+M.+Seestaller-Wehrauthor=R.+A.+Moranauthor=J.+Billiardauthor=S.+Fukayamaauthor=B.+S.+Kommauthor=K.+Pittsauthor=G.+Krishnamurthyauthor=A.+Gopalsamyauthor=M.+Shiauthor=J.+C.+Kernauthor=T.+J.+Commonsauthor=R.+P.+Woodworthauthor=M.+A.+Wilsonauthor=G.+S.+Welmakerauthor=E.+J.+Trybulskiauthor=W.+J.+Moore&title=A+small+molecule+inhibitor+of+the+Wnt+antagonist+secreted+frizzled-related+protein-1+stimulates+bone+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBodine%26aufirst%3DP.%2BV.%2BN.%26aulast%3DStauffer%26aufirst%3DB.%26aulast%3DPonce-de-Leon%26aufirst%3DH.%26aulast%3DBhat%26aufirst%3DR.%2BA.%26aulast%3DMangine%26aufirst%3DA.%26aulast%3DSeestaller-Wehr%26aufirst%3DL.%2BM.%26aulast%3DMoran%26aufirst%3DR.%2BA.%26aulast%3DBilliard%26aufirst%3DJ.%26aulast%3DFukayama%26aufirst%3DS.%26aulast%3DKomm%26aufirst%3DB.%2BS.%26aulast%3DPitts%26aufirst%3DK.%26aulast%3DKrishnamurthy%26aufirst%3DG.%26aulast%3DGopalsamy%26aufirst%3DA.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DKern%26aufirst%3DJ.%2BC.%26aulast%3DCommons%26aufirst%3DT.%2BJ.%26aulast%3DWoodworth%26aufirst%3DR.%2BP.%26aulast%3DWilson%26aufirst%3DM.%2BA.%26aulast%3DWelmaker%26aufirst%3DG.%2BS.%26aulast%3DTrybulski%26aufirst%3DE.%2BJ.%26aulast%3DMoore%26aufirst%3DW.%2BJ.%26atitle%3DA%2520small%2520molecule%2520inhibitor%2520of%2520the%2520Wnt%2520antagonist%2520secreted%2520frizzled-related%2520protein-1%2520stimulates%2520bone%2520formation%26jtitle%3DBone%26date%3D2009%26volume%3D44%26spage%3D1063%26epage%3D1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Shi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billiard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponce-de-Leon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seestaller-Wehr, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamurthy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalsamy, A.</span><span> </span><span class="NLM_article-title">Identification of iminooxothiazolidines as secreted frizzled related protein-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6337</span><span class="NLM_x">–</span> <span class="NLM_lpage">6339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6337-6339&author=M.+Shiauthor=B.+Staufferauthor=R.+Bhatauthor=J.+Billiardauthor=H.+Ponce-de-Leonauthor=L.+Seestaller-Wehrauthor=S.+Fukayamaauthor=A.+Mangineauthor=R.+Moranauthor=G.+Krishnamurthyauthor=P.+Bodineauthor=A.+Gopalsamy&title=Identification+of+iminooxothiazolidines+as+secreted+frizzled+related+protein-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DM.%26aulast%3DStauffer%26aufirst%3DB.%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DBilliard%26aufirst%3DJ.%26aulast%3DPonce-de-Leon%26aufirst%3DH.%26aulast%3DSeestaller-Wehr%26aufirst%3DL.%26aulast%3DFukayama%26aufirst%3DS.%26aulast%3DMangine%26aufirst%3DA.%26aulast%3DMoran%26aufirst%3DR.%26aulast%3DKrishnamurthy%26aufirst%3DG.%26aulast%3DBodine%26aufirst%3DP.%26aulast%3DGopalsamy%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520iminooxothiazolidines%2520as%2520secreted%2520frizzled%2520related%2520protein-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6337%26epage%3D6339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Hernandez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, J.</span><span> </span><span class="NLM_article-title">The role of glycogen synthase kinase 3 in the early stages of Alzheimer's disease</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">582</span><span class="NLM_x">, </span> <span class="NLM_fpage">3848</span><span class="NLM_x">–</span> <span class="NLM_lpage">3854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=582&publication_year=2008&pages=3848-3854&author=F.+Hernandezauthor=J.+Avila&title=The+role+of+glycogen+synthase+kinase+3+in+the+early+stages+of+Alzheimer%27s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez%26aufirst%3DF.%26aulast%3DAvila%26aufirst%3DJ.%26atitle%3DThe%2520role%2520of%2520glycogen%2520synthase%2520kinase%25203%2520in%2520the%2520early%2520stages%2520of%2520Alzheimer%2527s%2520disease%26jtitle%3DFEBS%2520Lett.%26date%3D2008%26volume%3D582%26spage%3D3848%26epage%3D3854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3 and cancer: good cop, bad cop?</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=351-353&author=S.+Patelauthor=J.+Woodgett&title=Glycogen+synthase+kinase-3+and+cancer%3A+good+cop%2C+bad+cop%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWoodgett%26aufirst%3DJ.%26atitle%3DGlycogen%2520synthase%2520kinase-3%2520and%2520cancer%253A%2520good%2520cop%252C%2520bad%2520cop%253F%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D14%26spage%3D351%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">MacAulay, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of type 2 diabetes</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1265</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1517%2F14728222.12.10.1265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18781825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsrnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=1265-1274&author=K.+MacAulayauthor=J.+R.+Woodgett&title=Targeting+glycogen+synthase+kinase-3+%28GSK-3%29+in+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes</span></div><div class="casAuthors">MacAulay, Katrina; Woodgett, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1265-1274</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: In spite of its rather specific name, glycogen synthase kinase-3 (GSK-3) is an eclectic cellular regulator that modulates an array of processes from nuclear transcription, to neurol. functions and metab.  The enzyme is also a focal point for diverse signaling pathways that act to suppress its activity.  Objectives: To review recent evidence supporting the important role GSK-3 plays in glucose homeostasis and discuss the therapeutic potential of inhibiting this enzyme in the treatment of diabetes and insulin resistance.  Results/conclusion: Despite its pleiotropic nature, GSK-3 has significant promise as a target for diabetes due to functional partitioning of the enzyme, tissue-selectivity and acute dosage-dependency of effects of inhibition, suggesting useful therapeutic windows.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGripu8iM9eVobVg90H21EOLACvtfcHk0liEQfoqD0tfQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsrnP&md5=bddd77ada6a8b8ab3ba1b5d5f868cde1</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1517%2F14728222.12.10.1265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.12.10.1265%26sid%3Dliteratum%253Aachs%26aulast%3DMacAulay%26aufirst%3DK.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DTargeting%2520glycogen%2520synthase%2520kinase-3%2520%2528GSK-3%2529%2520in%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2008%26volume%3D12%26spage%3D1265%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Doble, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kockeritz, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">Functional redundancy of GSK-3α and GSK-3β in Wnt/β-catenin signaling shown by using an allelic series of embryonic stem cell lines</span> <span class="citation_source-journal">Dev. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">957</span><span class="NLM_x">–</span> <span class="NLM_lpage">971</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=957-971&author=B.+W.+Dobleauthor=S.+Patelauthor=G.+A.+Woodauthor=L.+K.+Kockeritzauthor=J.+R.+Woodgett&title=Functional+redundancy+of+GSK-3%CE%B1+and+GSK-3%CE%B2+in+Wnt%2F%CE%B2-catenin+signaling+shown+by+using+an+allelic+series+of+embryonic+stem+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoble%26aufirst%3DB.%2BW.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DG.%2BA.%26aulast%3DKockeritz%26aufirst%3DL.%2BK.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DFunctional%2520redundancy%2520of%2520GSK-3%25CE%25B1%2520and%2520GSK-3%25CE%25B2%2520in%2520Wnt%252F%25CE%25B2-catenin%2520signaling%2520shown%2520by%2520using%2520an%2520allelic%2520series%2520of%2520embryonic%2520stem%2520cell%2520lines%26jtitle%3DDev.%2520Cell%26date%3D2007%26volume%3D12%26spage%3D957%26epage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Klein, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melton, D. A.</span><span> </span><span class="NLM_article-title">A molecular mechanism for the effect of lithium on development</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">8455</span><span class="NLM_x">–</span> <span class="NLM_lpage">8459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1073%2Fpnas.93.16.8455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=8710892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADyaK28XkvFyksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=8455-8459&author=P.+S.+Kleinauthor=D.+A.+Melton&title=A+molecular+mechanism+for+the+effect+of+lithium+on+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">A molecular mechanism for the effect of lithium on development</span></div><div class="casAuthors">Klein, Peter S.; Melton, Douglas A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">8455-8459</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Lithium, one of the most effective drugs for the treatment of bipolar (manic-depressive) disorder, also has dramatic effects on morphogenesis in the early development of numerous organisms.  How lithium exerts these diverse effects is unclear, but the favored hypothesis is that lithium acts through inhibition of inositol monophosphatase (IMPase).  We show here that complete inhibition of IMPase has no effect on the morphogenesis of Xenopus embryos and present a different hypothesis to explain the broad action of lithium.  Our results suggest that lithium acts through inhibition of glycogen synthase kinase-3β (GSK-3β), which regulates cell fate detn. in diverse organisms including dictyostelium, Drosophila, and Xenopus.  Lithium potently inhibits GSK-3β activity (Ki = 2 mM), but is not a general inhibitor of other protein kinases.  In support of this hypothesis, lithium treatment phenocopies loss of GSK-3β function of Xenopus and Dictyostelium.  These observations help explain the effect of lithium on cell-fate detn. and could provide insights into the pathogenesis and treatment of bipolar disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwmgF9XN0PabVg90H21EOLACvtfcHk0liVG2n88BDt8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFyksLY%253D&md5=611ae73b9ec411df9ff84da5fdaffcfc</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.16.8455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.16.8455%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DP.%2BS.%26aulast%3DMelton%26aufirst%3DD.%2BA.%26atitle%3DA%2520molecular%2520mechanism%2520for%2520the%2520effect%2520of%2520lithium%2520on%2520development%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D8455%26epage%3D8459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Clement-Lacroix, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morvan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman-Roman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vayssiere, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belleville, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrera, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawadi, G.</span><span> </span><span class="NLM_article-title">Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">17406</span><span class="NLM_x">–</span> <span class="NLM_lpage">17411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=17406-17411&author=P.+Clement-Lacroixauthor=M.+Aiauthor=F.+Morvanauthor=S.+Roman-Romanauthor=B.+Vayssiereauthor=C.+Bellevilleauthor=K.+Estreraauthor=M.+L.+Warmanauthor=R.+Baronauthor=G.+Rawadi&title=Lrp5-independent+activation+of+Wnt+signaling+by+lithium+chloride+increases+bone+formation+and+bone+mass+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClement-Lacroix%26aufirst%3DP.%26aulast%3DAi%26aufirst%3DM.%26aulast%3DMorvan%26aufirst%3DF.%26aulast%3DRoman-Roman%26aufirst%3DS.%26aulast%3DVayssiere%26aufirst%3DB.%26aulast%3DBelleville%26aufirst%3DC.%26aulast%3DEstrera%26aufirst%3DK.%26aulast%3DWarman%26aufirst%3DM.%2BL.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DRawadi%26aufirst%3DG.%26atitle%3DLrp5-independent%2520activation%2520of%2520Wnt%2520signaling%2520by%2520lithium%2520chloride%2520increases%2520bone%2520formation%2520and%2520bone%2520mass%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D17406%26epage%3D17411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Kulkarni, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onyia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolik, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kriauciunas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y. L.</span><span> </span><span class="NLM_article-title">Orally bioavailable GSK-3α/β dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">910</span><span class="NLM_x">–</span> <span class="NLM_lpage">920</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1359%2Fjbmr.060316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16753022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvVamurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=910-920&author=N.+H.+Kulkarniauthor=J.+E.+Onyiaauthor=Q.+Zengauthor=X.+Tianauthor=M.+Liuauthor=D.+L.+Halladayauthor=C.+A.+Frolikauthor=T.+Englerauthor=T.+Weiauthor=A.+Kriauciunasauthor=T.+J.+Martinauthor=M.+Satoauthor=H.+U.+Bryantauthor=Y.+L.+Ma&title=Orally+bioavailable+GSK-3%CE%B1%2F%CE%B2+dual+inhibitor+increases+markers+of+cellular+differentiation+in+vitro+and+bone+mass+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Orally bioavailable GSK-3α/β dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo</span></div><div class="casAuthors">Kulkarni, Nalini H.; Onyia, Jude E.; Zeng, QingQiang; Tian, Xioayan; Liu, Min; Halladay, David L.; Frolik, Charles A.; Engler, Thomas; Wei, Tao; Kriauciunas, Aidas; Martin, T. John; Sato, Masahiko; Bryant, Henry U.; Ma, Yanfei L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">910-920</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">GSK-3, a component of the canonical Wnt signaling pathway, is implicated in regulation of bone mass.  The effect of a small mol. GSK-3 inhibitor was evaluated in pre-osteoblasts and in osteopenic rats.  GSK-3 inhibitor induced osteoblast differentiation in vitro and increased markers of bone formation in vitro and in vivo with concomitant increased bone mass and strength in rats.  Introduction: Inactivation of glycogen synthase kinase-3 (GSK-3) leads to stabilization, accumulation, and translocation of β-catenin into the nucleus to activate downstream Wnt target genes.  To examine whether GSK-3 directly regulates bone formation and mass we evaluated the effect of 603281-31-8, a small mol. GSK-3 α/β dual inhibitor in preosteoblastic cells and in osteopenic rats.  Materials and Methods: Murine mesenchymal C3H10T1/2 cells were treated with GSK-3 inhibitor (603281-31-8) and assayed for β-catenin levels, activity of Wnt-responsive promoter, expression of mRNA for bone formation, and adipogenic markers and alk. phosphatase activity.  In vivo, 6-mo-old rats were ovariectomized (OVX), allowed to lose bone for 1 mo, and treated with GSK-3 inhibitor at 3 mg/kg/day orally for 60 days.  At the end of treatment, BMD was measured by DXA, bone formation rate by histomorphometry, vertebral strength (failure in compression), and the expression levels of osteoblast-related genes by real-time PCR.  Results: Treatment of C3H10T1/2 cells with the GSK-3 inhibitor increased the levels of β-catenin accompanied by activation of Wnt-responsive TBE6-luciferase reporter gene.  This was assocd. with an increased expression of mRNA for bone sialoprotein (1.4-fold), collagen α1 (I) (∼2-fold), osteocalcin (1.2-fold), collagen α1 (V) (1.5-fold), alk. phosphatase (∼160-fold), and runx2 (1.6-fold), markers of the osteoblast phenotype and bone formation activity.  Alk. phosphatase mRNA expression paralleled alk. phosphatase activity.  The mRNA levels of collagens α1 (I), α1 (V), biglycan, osteonectin, and runx-2 increased on treatment with the GSK-3 inhibitor in rat femur compared with the OVX control.  DXA analyses revealed significant increases in BMC and BMD in cancellous and cortical bone of OVX rats treated with GSK-3 inhibitor.  This was assocd. with increased strength (peak load, energy, and stiffness) assessed by lumbar vertebra load to failure in compression.  Histomorphometric analyses showed that 603281-31-8 robustly increased bone formation but did not exclude a small effect on osteoclasts (resorption).  Conclusions: An orally active, small mol. GSK-3 inhibitor induced osteoblast differentiation and increased markers of bone formation in vitro, and increased markers of bone formation, bone mass, and strength in vivo, consistent with a role for the canonical Wnt pathway in osteogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQZCO5qxBPvrVg90H21EOLACvtfcHk0liVG2n88BDt8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvVamurc%253D&md5=54520a35e9ef9b7238275f1780208d88</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.060316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.060316%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DN.%2BH.%26aulast%3DOnyia%26aufirst%3DJ.%2BE.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DHalladay%26aufirst%3DD.%2BL.%26aulast%3DFrolik%26aufirst%3DC.%2BA.%26aulast%3DEngler%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DT.%26aulast%3DKriauciunas%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DT.%2BJ.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DBryant%26aufirst%3DH.%2BU.%26aulast%3DMa%26aufirst%3DY.%2BL.%26atitle%3DOrally%2520bioavailable%2520GSK-3%25CE%25B1%252F%25CE%25B2%2520dual%2520inhibitor%2520increases%2520markers%2520of%2520cellular%2520differentiation%2520in%2520vitro%2520and%2520bone%2520mass%2520in%2520vivo%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2006%26volume%3D21%26spage%3D910%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Engler, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malhotra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furness, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brozinick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkholder, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clay, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diefenbacher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iversen, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquart, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misener, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Toole, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queener, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reel, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brier, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eessalu, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughn, R.</span><span> </span><span class="NLM_article-title">Substituted 3-imidazo[1,2-<i>a</i>]pyridin-3-yl-4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-<i>hi</i>]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3934</span><span class="NLM_x">–</span> <span class="NLM_lpage">3937</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049768a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3934-3937&author=T.+A.+Englerauthor=J.+R.+Henryauthor=S.+Malhotraauthor=B.+Cunninghamauthor=K.+Furnessauthor=J.+Brozinickauthor=T.+P.+Burkholderauthor=M.+P.+Clayauthor=J.+Claytonauthor=C.+Diefenbacherauthor=E.+Hawkinsauthor=P.+W.+Iversenauthor=Y.+Liauthor=T.+D.+Lindstromauthor=A.+L.+Marquartauthor=J.+McLeanauthor=D.+Mendelauthor=E.+Misenerauthor=D.+Briereauthor=J.+C.+O%27Tooleauthor=W.+J.+Porterauthor=S.+Queenerauthor=J.+K.+Reelauthor=R.+A.+Owensauthor=R.+A.+Brierauthor=T.+E.+Eessaluauthor=J.+R.+Wagnerauthor=R.+M.+Campbellauthor=R.+Vaughn&title=Substituted+3-imidazo%5B1%2C2-a%5Dpyridin-3-yl-4-%281%2C2%2C3%2C4-tetrahydro-%5B1%2C4%5Ddiazepino-%5B6%2C7%2C1-hi%5Dindol-7-yl%29pyrrole-2%2C5-diones+as+highly+selective+and+potent+inhibitors+of+glycogen+synthase+kinase-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Fjm049768a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049768a%26sid%3Dliteratum%253Aachs%26aulast%3DEngler%26aufirst%3DT.%2BA.%26aulast%3DHenry%26aufirst%3DJ.%2BR.%26aulast%3DMalhotra%26aufirst%3DS.%26aulast%3DCunningham%26aufirst%3DB.%26aulast%3DFurness%26aufirst%3DK.%26aulast%3DBrozinick%26aufirst%3DJ.%26aulast%3DBurkholder%26aufirst%3DT.%2BP.%26aulast%3DClay%26aufirst%3DM.%2BP.%26aulast%3DClayton%26aufirst%3DJ.%26aulast%3DDiefenbacher%26aufirst%3DC.%26aulast%3DHawkins%26aufirst%3DE.%26aulast%3DIversen%26aufirst%3DP.%2BW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DMarquart%26aufirst%3DA.%2BL.%26aulast%3DMcLean%26aufirst%3DJ.%26aulast%3DMendel%26aufirst%3DD.%26aulast%3DMisener%26aufirst%3DE.%26aulast%3DBriere%26aufirst%3DD.%26aulast%3DO%2527Toole%26aufirst%3DJ.%2BC.%26aulast%3DPorter%26aufirst%3DW.%2BJ.%26aulast%3DQueener%26aufirst%3DS.%26aulast%3DReel%26aufirst%3DJ.%2BK.%26aulast%3DOwens%26aufirst%3DR.%2BA.%26aulast%3DBrier%26aufirst%3DR.%2BA.%26aulast%3DEessalu%26aufirst%3DT.%2BE.%26aulast%3DWagner%26aufirst%3DJ.%2BR.%26aulast%3DCampbell%26aufirst%3DR.%2BM.%26aulast%3DVaughn%26aufirst%3DR.%26atitle%3DSubstituted%25203-imidazo%255B1%252C2-a%255Dpyridin-3-yl-4-%25281%252C2%252C3%252C4-tetrahydro-%255B1%252C4%255Ddiazepino-%255B6%252C7%252C1-hi%255Dindol-7-yl%2529pyrrole-2%252C5-diones%2520as%2520highly%2520selective%2520and%2520potent%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3934%26epage%3D3937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Polakis, P.</span><span> </span><span class="NLM_article-title">The many ways of Wnt in cancer</span> <span class="citation_source-journal">Curr. Opin. Genet. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.gde.2006.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17208432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslOnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=45-51&author=P.+Polakis&title=The+many+ways+of+Wnt+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">The many ways of Wnt in cancer</span></div><div class="casAuthors">Polakis, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Genetics & Development</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-51</span>CODEN:
                <span class="NLM_cas:coden">COGDET</span>;
        ISSN:<span class="NLM_cas:issn">0959-437X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  More than 20 years ago, the oncogenicity of a Wnt ligand was revealed in a series of expts. originating with random proviral integration in mice.  The significance of Wnt signaling in human cancer has since been buttressed by the identification of mutations in genes coding for the Wnt pathway components Axin, APC, and β-catenin.  This review summarizes the reported genetic defects in the Wnt pathway, with an emphasis on their functional contribution to human tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnNmcIi7W_97Vg90H21EOLACvtfcHk0lhM5aweqREBCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslOnsw%253D%253D&md5=5e82fbbbe4c3ae05c4ff96b339c5bbac</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2006.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2006.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DPolakis%26aufirst%3DP.%26atitle%3DThe%2520many%2520ways%2520of%2520Wnt%2520in%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2007%26volume%3D17%26spage%3D45%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Ougolkov, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Zapico, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilim, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyrk, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chari, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billadeau, D. D.</span><span> </span><span class="NLM_article-title">Aberrant nuclear accumulation of glycogen synthase kinase-3β in human pancreatic cancer: association with kinase activity and tumor dedifferentiation</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5074</span><span class="NLM_x">–</span> <span class="NLM_lpage">5081</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1158%2F1078-0432.CCR-06-0196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16951223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28XovF2gsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=5074-5081&author=A.+V.+Ougolkovauthor=M.+E.+Fernandez-Zapicoauthor=V.+N.+Bilimauthor=T.+C.+Smyrkauthor=S.+T.+Chariauthor=D.+D.+Billadeau&title=Aberrant+nuclear+accumulation+of+glycogen+synthase+kinase-3%CE%B2+in+human+pancreatic+cancer%3A+association+with+kinase+activity+and+tumor+dedifferentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant Nuclear Accumulation of Glycogen Synthase Kinase-3{szligbeta} in Human Pancreatic Cancer: Association with Kinase Activity and Tumor Dedifferentiation</span></div><div class="casAuthors">Ougolkov, Andrei V.; Fernandez-Zapico, Martin E.; Bilim, Vladimir N.; Smyrk, Thomas C.; Chari, Suresh T.; Billadeau, Daniel D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5074-5081</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: We have shown recently that glycogen synthase kinase-3 (GSK-3) β regulates nuclear factor-κB (NF-κB)-mediated pancreatic cancer cell survival and proliferation in vitro.  Our objective was to det. the localization of GSK-3β in pancreatic cancer cells and assess the antitumor effect of GSK-3 inhibition in vivo to improve our understanding of the mechanism by which GSK-3β affects NF-κB activity in pancreatic cancer.  Exptl. Design: Immunohistochem. and cytosolic/nuclear fractionation were done to det. the localization of GSK-3β in human pancreatic tumors.  We studied the effect of GSK-3 inhibition on tumor growth, cancer cell proliferation, and survival in established CAPAN2 tumor xenografts using a tumor regrowth delay assay, Western blotting, bromodeoxyuridine incorporation, and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling.  RESULTS: We found nuclear accumulation of GSK-3β in pancreatic cancer cell lines and in 62 of 122 (51%) human pancreatic adenocarcinomas.  GSK-3β nuclear accumulation is significantly correlated with human pancreatic cancer dedifferentiation.  We have found that active GSK-3β can accumulate in the nucleus of pancreatic cancer cells and that inhibition of GSK-3 kinase activity represses its nuclear accumulation via proteasomal degrdn. within the nucleus.  Lastly, we have found that inhibition of GSK-3 arrests pancreatic tumor growth in vivo and decreases NF-κB-mediated pancreatic cancer cell survival and proliferation in established tumor xenografts.  CONCLUSIONS: Our results show the antitumor effect of GSK-3 inhibition in vivo, identify GSK-3β nuclear accumulation as a hallmark of poorly differentiated pancreatic adenocarcinoma, and provide new insight into the mechanism by which GSK-3β regulates NF-κB activity in pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCHtcOR2osCLVg90H21EOLACvtfcHk0liW3zp-zU_TFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovF2gsr4%253D&md5=807ef4e512335f9c988b57e2fb8c1b22</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-0196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-0196%26sid%3Dliteratum%253Aachs%26aulast%3DOugolkov%26aufirst%3DA.%2BV.%26aulast%3DFernandez-Zapico%26aufirst%3DM.%2BE.%26aulast%3DBilim%26aufirst%3DV.%2BN.%26aulast%3DSmyrk%26aufirst%3DT.%2BC.%26aulast%3DChari%26aufirst%3DS.%2BT.%26aulast%3DBilladeau%26aufirst%3DD.%2BD.%26atitle%3DAberrant%2520nuclear%2520accumulation%2520of%2520glycogen%2520synthase%2520kinase-3%25CE%25B2%2520in%2520human%2520pancreatic%2520cancer%253A%2520association%2520with%2520kinase%2520activity%2520and%2520tumor%2520dedifferentiation%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D5074%26epage%3D5081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugs</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">773</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1002%2Fmed.20119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18271054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2qsLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=773-796&author=A.+Martinez&title=Preclinical+efficacy+on+GSK-3+inhibitors%3A+towards+a+future+generation+of+powerful+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugs</span></div><div class="casAuthors">Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">773-796</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The renewed interest in glycogen synthase kinase-3 (GSK-3), involved in the mol. pathogenesis of human severe diseases, is focused on the potential of its inhibitors to treat diseases that have significant limitations in their current treatments.  During the last 5 years, a lot of literature discuss progress in the search and pharmacol. actions of GSK-3 inhibitors, but now, evidence have been accumulated showing preclin. efficacy for these new drugs, in very different models of several distinct pathologies.  These studies have been summarized in the present review offering promising examples for new therapies for diabetes, cancer, inflammation, Alzheimer's disease and other neurol. pathologies, and mood disorders.  Now, clin. human trials are awaiting to confirm the ray of hope that GSK-3 inhibitors are arising for the future treatment of severe unmet diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiNZASfEwzRLVg90H21EOLACvtfcHk0liW3zp-zU_TFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2qsLvJ&md5=96cd9bc1d03273a8448f455c3cceb32c</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1002%2Fmed.20119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20119%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DPreclinical%2520efficacy%2520on%2520GSK-3%2520inhibitors%253A%2520towards%2520a%2520future%2520generation%2520of%2520powerful%2520drugs%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2008%26volume%3D28%26spage%3D773%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">A small molecule with osteogenesis-inducing activity in multipotent mesenchymal progenitor cells</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">14520</span><span class="NLM_x">–</span> <span class="NLM_lpage">14521</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0283908" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=14520-14521&author=X.+Wuauthor=S.+Dingauthor=Q.+Dingauthor=N.+S.+Grayauthor=P.+G.+Schultz&title=A+small+molecule+with+osteogenesis-inducing+activity+in+multipotent+mesenchymal+progenitor+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Fja0283908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0283908%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DA%2520small%2520molecule%2520with%2520osteogenesis-inducing%2520activity%2520in%2520multipotent%2520mesenchymal%2520progenitor%2520cells%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D14520%26epage%3D14521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">Purmorphamine induces osteogenesis by activation of the hedgehog signaling pathway</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1229</span><span class="NLM_x">–</span> <span class="NLM_lpage">1238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.chembiol.2004.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=15380183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslGnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=1229-1238&author=X.+Wuauthor=J.+Walkerauthor=J.+Zhangauthor=S.+Dingauthor=P.+G.+Schultz&title=Purmorphamine+induces+osteogenesis+by+activation+of+the+hedgehog+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Purmorphamine Induces Osteogenesis by Activation of the Hedgehog Signaling Pathway</span></div><div class="casAuthors">Wu, Xu; Walker, John; Zhang, Jie; Ding, Sheng; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1229-1238</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Previously, a small mol., purmorphamine, was identified that selectively induces osteogenesis in multipotent mesenchymal progenitor cells.  In order to gain insights into the mechanism of action of purmorphamine, high-d. oligonucleotide microarrays were used to profile gene expression in multipotent mesenchymal progenitor cells treated with either purmorphamine or bone morphogenetic protein-4 (BMP-4).  In contrast to BMP-4 treatment, purmorphamine activates the Hedgehog (Hh) signaling pathway, resulting in the up- and downregulation of its downstream target genes, including Gli1 and Patched.  Moreover, the known Hh signaling antagonists, cyclopamine and forskolin, completely block the osteogenesis and Glimediated transcription induced by purmorphamine.  These results demonstrate that purmorphamine is a small mol. agonist of Hedgehog signaling, and it may ultimately be useful in the treatment of bone-related disease and neurodegenerative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxYQ_VELcKaLVg90H21EOLACvtfcHk0liF3Tj8D8wVZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslGnu74%253D&md5=22d0d8da147f5c537b99c0ac07093d4f</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWalker%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DS.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DPurmorphamine%2520induces%2520osteogenesis%2520by%2520activation%2520of%2520the%2520hedgehog%2520signaling%2520pathway%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D1229%26epage%3D1238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. K.</span><span> </span><span class="NLM_article-title">Purmorphamine activates the Hedgehog pathway by targeting Smoothened</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1038%2Fnchembio753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16408088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqu7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=29-30&author=S.+Sinhaauthor=J.+K.+Chen&title=Purmorphamine+activates+the+Hedgehog+pathway+by+targeting+Smoothened"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Purmorphamine activates the Hedgehog pathway by targeting Smoothened</span></div><div class="casAuthors">Sinha, Surajit; Chen, James K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-30</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hedgehog (Hh) signaling is an important regulator of embryonic patterning, tissue regeneration, stem cell renewal and cancer growth.  A purine deriv. named purmorphamine was previously found to activate the Hh pathway and affect osteoblast differentiation through an unknown mechanism.  The authors demonstrate here that purmorphamine directly targets Smoothened, a crit. component of the Hh signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3uCrERtgsx7Vg90H21EOLACvtfcHk0liF3Tj8D8wVZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqu7jM&md5=47a8e5bb03eb09c1c355dd3ee8022fda</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1038%2Fnchembio753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio753%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DJ.%2BK.%26atitle%3DPurmorphamine%2520activates%2520the%2520Hedgehog%2520pathway%2520by%2520targeting%2520Smoothened%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D29%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Han, C.-Y. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Jean, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babij, P.</span><span> </span><span class="NLM_article-title">Small molecules with potent osteogenic-inducing activity in osteoblast cells</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1442</span><span class="NLM_x">–</span> <span class="NLM_lpage">1445</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1442-1445&author=C.-Y.+E.+Hanauthor=Y.+Wangauthor=L.+Yuauthor=D.+Powersauthor=X.+Xiongauthor=V.+Yuauthor=Y.+Nguyenauthor=D.+J.+St.+Jeanauthor=P.+Babij&title=Small+molecules+with+potent+osteogenic-inducing+activity+in+osteoblast+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DC.-Y.%2BE.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DXiong%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DNguyen%26aufirst%3DY.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DBabij%26aufirst%3DP.%26atitle%3DSmall%2520molecules%2520with%2520potent%2520osteogenic-inducing%2520activity%2520in%2520osteoblast%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1442%26epage%3D1445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Karsenty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kronenberg, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settembre, C.</span><span> </span><span class="NLM_article-title">Genetic control of bone formation</span> <span class="citation_source-journal">Annu. Rev. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2009&pages=629-648&author=G.+Karsentyauthor=H.+M.+Kronenbergauthor=C.+Settembre&title=Genetic+control+of+bone+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarsenty%26aufirst%3DG.%26aulast%3DKronenberg%26aufirst%3DH.%2BM.%26aulast%3DSettembre%26aufirst%3DC.%26atitle%3DGenetic%2520control%2520of%2520bone%2520formation%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D2009%26volume%3D25%26spage%3D629%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parlato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mundy, G.</span><span> </span><span class="NLM_article-title">CREB induces BMP2 transcription in osteoblasts and CREB knockout reduces bone mass in mice</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">S27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=S27&author=M.+Zhaoauthor=J.+Edwardsauthor=S.+Koauthor=R.+Parlatoauthor=S.+Harrisauthor=G.+Mundy&title=CREB+induces+BMP2+transcription+in+osteoblasts+and+CREB+knockout+reduces+bone+mass+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DKo%26aufirst%3DS.%26aulast%3DParlato%26aufirst%3DR.%26aulast%3DHarris%26aufirst%3DS.%26aulast%3DMundy%26aufirst%3DG.%26atitle%3DCREB%2520induces%2520BMP2%2520transcription%2520in%2520osteoblasts%2520and%2520CREB%2520knockout%2520reduces%2520bone%2520mass%2520in%2520mice%26jtitle%3DBone%26date%3D2009%26volume%3D44%26spage%3DS27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Hojo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtler, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, J.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonezawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, U.-I.</span><span> </span><span class="NLM_article-title">Development of high-throughput screening system for osteogenic drugs using a cell-based sensor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2008&pages=375-379&author=H.+Hojoauthor=K.+Igawaauthor=S.+Ohbaauthor=F.+Yanoauthor=K.+Nakajimaauthor=Y.+Komiyamaauthor=T.+Ikedaauthor=A.+C.+Lichtlerauthor=J.-T.+Wooauthor=T.+Yonezawaauthor=T.+Takatoauthor=U.-I.+Chung&title=Development+of+high-throughput+screening+system+for+osteogenic+drugs+using+a+cell-based+sensor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHojo%26aufirst%3DH.%26aulast%3DIgawa%26aufirst%3DK.%26aulast%3DOhba%26aufirst%3DS.%26aulast%3DYano%26aufirst%3DF.%26aulast%3DNakajima%26aufirst%3DK.%26aulast%3DKomiyama%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DT.%26aulast%3DLichtler%26aufirst%3DA.%2BC.%26aulast%3DWoo%26aufirst%3DJ.-T.%26aulast%3DYonezawa%26aufirst%3DT.%26aulast%3DTakato%26aufirst%3DT.%26aulast%3DChung%26aufirst%3DU.-I.%26atitle%3DDevelopment%2520of%2520high-throughput%2520screening%2520system%2520for%2520osteogenic%2520drugs%2520using%2520a%2520cell-based%2520sensor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D376%26spage%3D375%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Liu, Z.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, X.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Si, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.-R.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 1-(benzo[<i>b</i>]thiophen-2-yl)ethanone analogues as novel anti-osteoporosis agents acting on BMP-2 promotor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4167</span><span class="NLM_x">–</span> <span class="NLM_lpage">4170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4167-4170&author=Z.-Y.+Liuauthor=X.-B.+Heauthor=Z.-Y.+Yangauthor=H.-Y.+Shaoauthor=X.+Liauthor=H.-F.+Guoauthor=Y.-Q.+Zhangauthor=S.-Y.+Siauthor=Z.-R.+Li&title=Synthesis+and+evaluation+of+1-%28benzo%5Bb%5Dthiophen-2-yl%29ethanone+analogues+as+novel+anti-osteoporosis+agents+acting+on+BMP-2+promotor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.-Y.%26aulast%3DHe%26aufirst%3DX.-B.%26aulast%3DYang%26aufirst%3DZ.-Y.%26aulast%3DShao%26aufirst%3DH.-Y.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DH.-F.%26aulast%3DZhang%26aufirst%3DY.-Q.%26aulast%3DSi%26aufirst%3DS.-Y.%26aulast%3DLi%26aufirst%3DZ.-R.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25201-%2528benzo%255Bb%255Dthiophen-2-yl%2529ethanone%2520analogues%2520as%2520novel%2520anti-osteoporosis%2520agents%2520acting%2520on%2520BMP-2%2520promotor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4167%26epage%3D4170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Mundy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, G.</span><span> </span><span class="NLM_article-title">Stimulation of bone formation in vitro and in rodents by statins</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">1946</span><span class="NLM_x">–</span> <span class="NLM_lpage">1949</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1126%2Fscience.286.5446.1946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=10583956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADyaK1MXnvFSiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=1946-1949&author=G.+Mundyauthor=R.+Garrettauthor=S.+Harrisauthor=J.+Chanauthor=D.+Chenauthor=G.+Rossiniauthor=B.+Boyceauthor=M.+Zhaoauthor=G.+Gutierrez&title=Stimulation+of+bone+formation+in+vitro+and+in+rodents+by+statins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of bone formation in vitro and in rodents by statins</span></div><div class="casAuthors">Mundy, G.; Garrett, R.; Harris, S.; Chan, J.; Chen, D.; Rossini, G.; Boyce, B.; Zhao, M.; Gutierrez, G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5446</span>),
    <span class="NLM_cas:pages">1946-1949</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Osteoporosis and other diseases of bone loss are a major public health problem.  Here it is shown that the statins, drugs widely used for lowering serum cholesterol, also enhance new bone formation in vitro and in rodents.  This effect was assocd. with increased expression of the bone morphogenetic protein-2 (BMP-2) gene in bone cells.  Lovastatin and simvastatin increased bone formation when injected s.c. over the calvaria of mice and increased cancelous bone vol. when orally administered to rats.  Thus, in appropriate doses, statins may have therapeutic applications for the treatment of osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGqsu8Ww1_x7Vg90H21EOLACvtfcHk0li7v-pgirbewg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnvFSiu78%253D&md5=6752eecfe7e6058ff4634b07817a7f53</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5446.1946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5446.1946%26sid%3Dliteratum%253Aachs%26aulast%3DMundy%26aufirst%3DG.%26aulast%3DGarrett%26aufirst%3DR.%26aulast%3DHarris%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DRossini%26aufirst%3DG.%26aulast%3DBoyce%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DGutierrez%26aufirst%3DG.%26atitle%3DStimulation%2520of%2520bone%2520formation%2520in%2520vitro%2520and%2520in%2520rodents%2520by%2520statins%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D1946%26epage%3D1949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Shimazaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kameo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiuchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, A.</span><span> </span><span class="NLM_article-title">Synthesis and structure−activity relationships of a new class of selective EP3 receptor agonist, 13,14-didehydro-16-phenoxy analogues of prostaglandin E1</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2000&pages=353-362&author=Y.+Shimazakiauthor=K.+Kameoauthor=T.+Tanamiauthor=H.+Tanakaauthor=N.+Onoauthor=Y.+Kiuchiauthor=S.+Okamotoauthor=F.+Satoauthor=A.+Ichikawa&title=Synthesis+and+structure%E2%88%92activity+relationships+of+a+new+class+of+selective+EP3+receptor+agonist%2C+13%2C14-didehydro-16-phenoxy+analogues+of+prostaglandin+E1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimazaki%26aufirst%3DY.%26aulast%3DKameo%26aufirst%3DK.%26aulast%3DTanami%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DN.%26aulast%3DKiuchi%26aufirst%3DY.%26aulast%3DOkamoto%26aufirst%3DS.%26aulast%3DSato%26aufirst%3DF.%26aulast%3DIchikawa%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%2520a%2520new%2520class%2520of%2520selective%2520EP3%2520receptor%2520agonist%252C%252013%252C14-didehydro-16-phenoxy%2520analogues%2520of%2520prostaglandin%2520E1%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2000%26volume%3D8%26spage%3D353%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. D.</span><span> </span><span class="NLM_article-title">A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2033</span><span class="NLM_x">–</span> <span class="NLM_lpage">2042</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1359%2Fjbmr.2003.18.11.2033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=14606517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptVyiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=2033-2042&author=M.+Liauthor=H.+Z.+Keauthor=H.+Qiauthor=D.+R.+Healyauthor=Y.+Liauthor=D.+T.+Crawfordauthor=V.+M.+Paralkarauthor=T.+A.+Owenauthor=K.+O.+Cameronauthor=B.+A.+Lefkerauthor=T.+A.+Brownauthor=D.+D.+Thompson&title=A+novel%2C+non-prostanoid+EP2+receptor-selective+prostaglandin+E2+agonist+stimulates+local+bone+formation+and+enhances+fracture+healing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing</span></div><div class="casAuthors">Li, Mei; Ke, Hua Zhu; Qi, Hong; Healy, David R.; Li, Yan; Crawford, D. Todd; Paralkar, Vishwas M.; Owen, Thomas A.; Cameron, Kimberly O.; Lefker, Bruce A.; Brown, Thomas A.; Thompson, David D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2033-2042</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">CP-533,536, a newly discovered, non-prostanoid EP2 receptor-selective PGE2 agonist, stimulates local bone formation and enhances fracture healing in rat models.  There is a significant medical need for agents that can stimulate local bone formation and enhance fracture healing.  The authors tested the effects of CP-533,536, a newly discovered, non-prostanoid EP2 receptor-selective PGE2 agonist, in stimulating local bone formation and enhancing fracture healing in rat models.  In the first model, a single injection of CP-533,536 at doses of 0.3, 1, or 3 mg/kg to the proximal tibial metaphysis of 6-wk-old male rats was given on day 1, and the local bone anabolic effect was detd. on day 7.  The authors then tested the effects of this compd. in inducing bone formation on rat periosteum of the femur.  A single dose of 0.3 mg of CP-533,536 incorporated in a poly-(DL-lactide-co-glycolide) (PLGH) matrix was injected onto the periosteum of the femur in 3-wk-old male rats, and local bone formation was detd. on day 14.  Finally, the ability of CP-533,536 in PLGH matrix in enhancing fracture healing was tested using the rat femoral fracture model.  CP-533,536 in PLGH matrix at doses of 0.05, 0.5, or 5 mg was delivered to the local fracture site on the same day of fracture, and its efficacy was evaluated on day 21.  A single injection of CP-533,536 at doses of 0.3, 1, or 3 mg/kg to the proximal tibial metaphysis dose-dependently stimulated local lamellar bone formation on trabecular, endocortical, and periosteal surfaces, and thus increased bone mineral content and bone strength at the injected site.  Similarly, a single injection of 0.3 mg of CP-533,536 incorporated in PLGH matrix onto the periosteum of the femur induced significantly local bone formation.  In the rat femoral fracture model, CP-533,536 in PLGH matrix at doses of 0.05, 0.5, and 5 mg dose-dependently increased callus size, d., and strength compared with PLGH matrix alone.  These results show that CP-533,536 stimulates new bone formation on trabecular, endocortical, and periosteal surfaces and enhances fracture healing.  These data reveal that EP2 receptor-selective agonists provide therapeutic potential for local bone augmentation, bone repair, and bone healing in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-eB8GOoJsErVg90H21EOLACvtfcHk0li7v-pgirbewg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptVyiu7o%253D&md5=96d5d5fca5c87a121edda85af9cdbb9b</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.2003.18.11.2033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.2003.18.11.2033%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DKe%26aufirst%3DH.%2BZ.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DHealy%26aufirst%3DD.%2BR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCrawford%26aufirst%3DD.%2BT.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26aulast%3DOwen%26aufirst%3DT.%2BA.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DBrown%26aufirst%3DT.%2BA.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26atitle%3DA%2520novel%252C%2520non-prostanoid%2520EP2%2520receptor-selective%2520prostaglandin%2520E2%2520agonist%2520stimulates%2520local%2520bone%2520formation%2520and%2520enhances%2520fracture%2520healing%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2003%26volume%3D18%26spage%3D2033%26epage%3D2042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Scutt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeschnigk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertram, P.</span><span> </span><span class="NLM_article-title">PGE2 induces the transition from non-adherent to adherent bone marrow mesenchymal precursor cells via a cAMP/EP2-mediated mechanism</span> <span class="citation_source-journal">Prostaglandins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1995&pages=383-95&author=A.+Scuttauthor=M.+Zeschnigkauthor=P.+Bertram&title=PGE2+induces+the+transition+from+non-adherent+to+adherent+bone+marrow+mesenchymal+precursor+cells+via+a+cAMP%2FEP2-mediated+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScutt%26aufirst%3DA.%26aulast%3DZeschnigk%26aufirst%3DM.%26aulast%3DBertram%26aufirst%3DP.%26atitle%3DPGE2%2520induces%2520the%2520transition%2520from%2520non-adherent%2520to%2520adherent%2520bone%2520marrow%2520mesenchymal%2520precursor%2520cells%2520via%2520a%2520cAMP%252FEP2-mediated%2520mechanism%26jtitle%3DProstaglandins%26date%3D1995%26volume%3D49%26spage%3D383%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Woodiel, F. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fall, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raisz, L. G.</span><span> </span><span class="NLM_article-title">Anabolic effects of prostaglandins in cultured fetal rat calvariae: structure−activity relations and signal transduction pathway</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1249</span><span class="NLM_x">–</span> <span class="NLM_lpage">1255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1002%2Fjbmr.5650110909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=8864899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADyaK28Xls1ChtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1996&pages=1249-1255&author=F.+N.+Woodielauthor=P.+M.+Fallauthor=L.+G.+Raisz&title=Anabolic+effects+of+prostaglandins+in+cultured+fetal+rat+calvariae%3A+structure%E2%88%92activity+relations+and+signal+transduction+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Anabolic effects of prostaglandins in cultured fetal rat calvariae: Structure-activity relations and signal transduction pathway</span></div><div class="casAuthors">Woodiel, Florence N.; Fall, Pamela M.; Raisz, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1249-1255</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">Blackwell</span>)
        </div><div class="casAbstract">The structure-activity relations and signal transduction pathways for the anabolic effects of prostaglandins were examd. in cultured fetal rat calvariae.  In the presence of cortisol prostaglandins of the E and F series (10-9 to 10-5 M) produced a dose-related increase in [3H]thymidine incorporation up to 4-fold at 24 h.  Prostaglandin E2 (PGE2) was also effective in the absence of cortisol.  Butaprost (10-6 M), a selective EP-2 receptor agonist, produced partial stimulation.  Prostaglandin D2, prostacyclin, sulprostone, an EP-1 and EP-3 receptor agonist, and fluprostenol, an FP receptor agonist, were ineffective.  Forskolin (10-4 M) increased [3H]thymidine incorporation 3-fold, while phorbol myristate acetate (PMA) (10-6 M) produced a 1.8-fold increase.  Isobutylmethylxanthine (IBMX) increased [3H]thymidine incorporation in control cultures, in the absence of cortisol, and increased the response to PGE2 in control and cortisol-treated cultures.  [3H]proline incorporation into collagen and noncollagen protein was measured in the continuous presence of prostaglandins and cortisol for 72-96 h (continuous model) or when prostaglandins and cortisol were applied for 24 h, followed by culture for 48 h in control medium (on/off model).  The effects on collagen were greater than on noncollagen proteins, so that the percent of collagen synthesis increased.  The effects of prostaglandins and forskolin paralleled their mitogenic effects.  PMA increased only noncollagen protein.  Indomethacin did not diminish the anabolic response, while aphidicolin produced only partial inhibition.  We conclude that the anabolic effects of prostaglandins on replication and differentiation of osteoblasts are likely to be mediated by an EP-2 receptor that stimulates adenylate cyclase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTNtgUF7Itx7Vg90H21EOLACvtfcHk0liBKr9ylABnlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xls1ChtL0%253D&md5=772191cf873da2b4fba93727622f2be1</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1002%2Fjbmr.5650110909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbmr.5650110909%26sid%3Dliteratum%253Aachs%26aulast%3DWoodiel%26aufirst%3DF.%2BN.%26aulast%3DFall%26aufirst%3DP.%2BM.%26aulast%3DRaisz%26aufirst%3DL.%2BG.%26atitle%3DAnabolic%2520effects%2520of%2520prostaglandins%2520in%2520cultured%2520fetal%2520rat%2520calvariae%253A%2520structure%25E2%2588%2592activity%2520relations%2520and%2520signal%2520transduction%2520pathway%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D1996%26volume%3D11%26spage%3D1249%26epage%3D1255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Yoshida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ushikubi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohuchida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span> </span><span class="NLM_article-title">Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">4580</span><span class="NLM_x">–</span> <span class="NLM_lpage">4585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=4580-4585&author=K.+Yoshidaauthor=H.+Oidaauthor=T.+Kobayashiauthor=T.+Maruyamaauthor=M.+Tanakaauthor=T.+Katayamaauthor=K.+Yamaguchiauthor=E.+Segiauthor=T.+Tsuboyamaauthor=M.+Matsushitaauthor=K.+Itoauthor=Y.+Itoauthor=Y.+Sugimotoauthor=F.+Ushikubiauthor=S.+Ohuchidaauthor=K.+Kondoauthor=T.+Nakamuraauthor=S.+Narumiya&title=Stimulation+of+bone+formation+and+prevention+of+bone+loss+by+prostaglandin+E+EP4+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DK.%26aulast%3DOida%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DKatayama%26aufirst%3DT.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DSegi%26aufirst%3DE.%26aulast%3DTsuboyama%26aufirst%3DT.%26aulast%3DMatsushita%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DUshikubi%26aufirst%3DF.%26aulast%3DOhuchida%26aufirst%3DS.%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DNarumiya%26aufirst%3DS.%26atitle%3DStimulation%2520of%2520bone%2520formation%2520and%2520prevention%2520of%2520bone%2520loss%2520by%2520prostaglandin%2520E%2520EP4%2520receptor%2520activation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D4580%26epage%3D4585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Graham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polyzois, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narvani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzafetta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsiridis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heliotis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantalaris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsiridis, E.</span><span> </span><span class="NLM_article-title">Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing: in vivo and in vitro evidence</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">766</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=749-766&author=S.+Grahamauthor=Z.+Gamieauthor=I.+Polyzoisauthor=A.+A.+Narvaniauthor=K.+Tzafettaauthor=E.+Tsiridisauthor=M.+Heliotisauthor=A.+Mantalarisauthor=E.+Tsiridis&title=Prostaglandin+EP2+and+EP4+receptor+agonists+in+bone+formation+and+bone+healing%3A+in+vivo+and+in+vitro+evidence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGraham%26aufirst%3DS.%26aulast%3DGamie%26aufirst%3DZ.%26aulast%3DPolyzois%26aufirst%3DI.%26aulast%3DNarvani%26aufirst%3DA.%2BA.%26aulast%3DTzafetta%26aufirst%3DK.%26aulast%3DTsiridis%26aufirst%3DE.%26aulast%3DHeliotis%26aufirst%3DM.%26aulast%3DMantalaris%26aufirst%3DA.%26aulast%3DTsiridis%26aufirst%3DE.%26atitle%3DProstaglandin%2520EP2%2520and%2520EP4%2520receptor%2520agonists%2520in%2520bone%2520formation%2520and%2520bone%2520healing%253A%2520in%2520vivo%2520and%2520in%2520vitro%2520evidence%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D749%26epage%3D766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Cameron, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu-Moyer, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jardine, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeNinno, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasser, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjoa, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawistoski, M. P.</span><span> </span><span class="NLM_article-title">Discovery of highly selective EP4 receptor agonists that stimulate new bone formation and restore bone mass in ovariectomized rats</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1799</span><span class="NLM_x">–</span> <span class="NLM_lpage">1802</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1799-1802&author=K.+O.+Cameronauthor=B.+A.+Lefkerauthor=M.+Y.+Chu-Moyerauthor=D.+T.+Crawfordauthor=P.+D.+Jardineauthor=S.+L.+DeNinnoauthor=S.+Gilbertauthor=W.+A.+Grasserauthor=H.+Keauthor=B.+Luauthor=T.+A.+Owenauthor=V.+M.+Paralkarauthor=H.+Qiauthor=D.+O.+Scottauthor=D.+D.+Thompsonauthor=C.+M.+Tjoaauthor=M.+P.+Zawistoski&title=Discovery+of+highly+selective+EP4+receptor+agonists+that+stimulate+new+bone+formation+and+restore+bone+mass+in+ovariectomized+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DChu-Moyer%26aufirst%3DM.%2BY.%26aulast%3DCrawford%26aufirst%3DD.%2BT.%26aulast%3DJardine%26aufirst%3DP.%2BD.%26aulast%3DDeNinno%26aufirst%3DS.%2BL.%26aulast%3DGilbert%26aufirst%3DS.%26aulast%3DGrasser%26aufirst%3DW.%2BA.%26aulast%3DKe%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DOwen%26aufirst%3DT.%2BA.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26aulast%3DTjoa%26aufirst%3DC.%2BM.%26aulast%3DZawistoski%26aufirst%3DM.%2BP.%26atitle%3DDiscovery%2520of%2520highly%2520selective%2520EP4%2520receptor%2520agonists%2520that%2520stimulate%2520new%2520bone%2520formation%2520and%2520restore%2520bone%2520mass%2520in%2520ovariectomized%2520rats%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1799%26epage%3D1802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Ke, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasser, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaSilva-Jardine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jee, W. S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. D.</span><span> </span><span class="NLM_article-title">A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">575</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1359%2Fjbmr.051110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16598377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1Kqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=565-575&author=H.+Z.+Keauthor=D.+T.+Crawfordauthor=H.+Qiauthor=H.+A.+Simmonsauthor=T.+A.+Owenauthor=V.+M.+Paralkarauthor=M.+Liauthor=B.+Luauthor=W.+A.+Grasserauthor=K.+O.+Cameronauthor=B.+A.+Lefkerauthor=P.+DaSilva-Jardineauthor=D.+O.+Scottauthor=Q.+Zhangauthor=X.+Y.+Tianauthor=W.+S.+S.+Jeeauthor=T.+A.+Brownauthor=D.+D.+Thompson&title=A+nonprostanoid+EP4+receptor+selective+prostaglandin+E2+agonist+restores+bone+mass+and+strength+in+aged%2C+ovariectomized+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats</span></div><div class="casAuthors">Ke, Hua Zhu; Crawford, D. Todd; Qi, Hong; Simmons, Hollis A.; Owen, Thomas A.; Paralkar, Vishwas M.; Li, Mei; Lu, Bihong; Grasser, William A.; Cameron, Kimberly O.; Lefker, Bruce A.; DaSilva-Jardine, Paul; Scott, Dennis O.; Zhang, Qing; Tian, Xiao Yan; Jee, Webster S. S.; Brown, Thomas A.; Thompson, David D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">565-575</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">CP432 is a newly discovered, nonprostanoid EP4 receptor selective prostaglandin E2 agonist.  CP432 stimulates trabecular and cortical bone formation and restores bone mass and bone strength in aged ovariectomized rats with established osteopenia.  Introduction: The purpose of this study was to det. whether a newly discovered, nonprostanoid EP4 receptor selective prostaglandin E2 (PGE2) agonist, CP432, could produce bone anabolic effects in aged, ovariectomized (OVX) rats with established osteopenia.  Materials and Methods: CP432 at 0.3, 1, or 3 mg/kg/day was given for 6 wk by s.c. injection to 12-mo-old rats that had been OVX for 8.5 mo.  The effects on bone mass, bone formation, bone resorption, and bone strength were detd.  Results: Total femoral BMD increased significantly in OVX rats treated with CP432 at all doses.  CP432 completely restored trabecular bone vol. of the third lumbar vertebral body accompanied with a dose-dependent decrease in osteoclast no. and osteoclast surface and a dose-dependent increase in mineralizing surface, mineral apposition rate, and bone formation rate-tissue ref. in OVX rats.  CP432 at 1 and 3 mg/kg/day significantly increased total tissue area, cortical bone area, and periosteal and endocortical bone formation in the tibial shafts compared with both sham and OVX controls.  CP432 at all doses significantly and dose-dependently increased ultimate strength in the fifth lumbar vertebral body compared with both sham and OVX controls.  At 1 and 3 mg/kg/day, CP432 significantly increased maximal load in a three-point bending test of femoral shaft compared with both sham and OVX controls.  Conclusions: CP432 completely restored trabecular and cortical bone mass and strength in established osteopenic, aged OVX rats by stimulating bone formation and inhibiting bone resorption on trabecular and cortical surfaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSEcjkrLziTbVg90H21EOLACvtfcHk0lhUa2CJfQiAZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1Kqs78%253D&md5=de11185b404b72c5063482ff4e5e388b</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.051110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.051110%26sid%3Dliteratum%253Aachs%26aulast%3DKe%26aufirst%3DH.%2BZ.%26aulast%3DCrawford%26aufirst%3DD.%2BT.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DSimmons%26aufirst%3DH.%2BA.%26aulast%3DOwen%26aufirst%3DT.%2BA.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DGrasser%26aufirst%3DW.%2BA.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DDaSilva-Jardine%26aufirst%3DP.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTian%26aufirst%3DX.%2BY.%26aulast%3DJee%26aufirst%3DW.%2BS.%2BS.%26aulast%3DBrown%26aufirst%3DT.%2BA.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26atitle%3DA%2520nonprostanoid%2520EP4%2520receptor%2520selective%2520prostaglandin%2520E2%2520agonist%2520restores%2520bone%2520mass%2520and%2520strength%2520in%2520aged%252C%2520ovariectomized%2520rats%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2006%26volume%3D21%26spage%3D565%26epage%3D575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Cameron, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawistoski, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjoa, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeNinno, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. D.</span><span> </span><span class="NLM_article-title">Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2075</span><span class="NLM_x">–</span> <span class="NLM_lpage">2078</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2075-2078&author=K.+O.+Cameronauthor=B.+A.+Lefkerauthor=H.+Z.+Keauthor=M.+Liauthor=M.+P.+Zawistoskiauthor=C.+M.+Tjoaauthor=A.+S.+Wrightauthor=S.+L.+DeNinnoauthor=V.+M.+Paralkarauthor=T.+A.+Owenauthor=L.+Yuauthor=D.+D.+Thompson&title=Discovery+of+CP-533536%3A+an+EP2+receptor+selective+prostaglandin+E2+%28PGE2%29+agonist+that+induces+local+bone+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DKe%26aufirst%3DH.%2BZ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DZawistoski%26aufirst%3DM.%2BP.%26aulast%3DTjoa%26aufirst%3DC.%2BM.%26aulast%3DWright%26aufirst%3DA.%2BS.%26aulast%3DDeNinno%26aufirst%3DS.%2BL.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26aulast%3DOwen%26aufirst%3DT.%2BA.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26atitle%3DDiscovery%2520of%2520CP-533536%253A%2520an%2520EP2%2520receptor%2520selective%2520prostaglandin%2520E2%2520%2528PGE2%2529%2520agonist%2520that%2520induces%2520local%2520bone%2520formation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2075%26epage%3D2078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span>ClinicalTrials.gov. Identifier: NCT00533377. <a href="http://clinicaltrials.gov/ct2/show/NCT00533377" class="extLink">http://clinicaltrials.gov/ct2/show/NCT00533377</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Identifier%3A+NCT00533377.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00533377."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinagawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohuchida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of a highly selective EP4-receptor agonist. Part 2. 5-Thia and 9β-halo-PG derivatives with improved stability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2033</span><span class="NLM_x">–</span> <span class="NLM_lpage">2035</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=2033-2035&author=T.+Maruyamaauthor=M.+Asadaauthor=T.+Shiraishiauthor=K.+Sakataauthor=A.+Sekiauthor=H.+Yoshidaauthor=Y.+Shinagawaauthor=T.+Maruyamaauthor=S.+Ohuchidaauthor=H.+Nakaiauthor=K.+Kondoauthor=M.+Toda&title=Design+and+synthesis+of+a+highly+selective+EP4-receptor+agonist.+Part+2.+5-Thia+and+9%CE%B2-halo-PG+derivatives+with+improved+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DAsada%26aufirst%3DM.%26aulast%3DShiraishi%26aufirst%3DT.%26aulast%3DSakata%26aufirst%3DK.%26aulast%3DSeki%26aufirst%3DA.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DShinagawa%26aufirst%3DY.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DOhuchida%26aufirst%3DS.%26aulast%3DNakai%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DToda%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520highly%2520selective%2520EP4-receptor%2520agonist.%2520Part%25202.%25205-Thia%2520and%25209%25CE%25B2-halo-PG%2520derivatives%2520with%2520improved%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D2033%26epage%3D2035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwabe, S.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinagawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohuchida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of a selective EP4-receptor agonist. Part 4: Practical synthesis and biological evaluation of a novel highly selective EP4-receptor agonist</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2103</span><span class="NLM_x">–</span> <span class="NLM_lpage">2110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=2103-2110&author=T.+Maruyamaauthor=S.-I.+Kuwabeauthor=Y.+Kawanakaauthor=T.+Shiraishiauthor=Y.+Shinagawaauthor=K.+Sakataauthor=A.+Sekiauthor=Y.+Kishidaauthor=H.+Yoshidaauthor=T.+Maruyamaauthor=S.+Ohuchidaauthor=H.+Nakaiauthor=S.+Hashimotoauthor=M.+Kawamuraauthor=K.+Kondoauthor=M.+Toda&title=Design+and+synthesis+of+a+selective+EP4-receptor+agonist.+Part+4%3A+Practical+synthesis+and+biological+evaluation+of+a+novel+highly+selective+EP4-receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DKuwabe%26aufirst%3DS.-I.%26aulast%3DKawanaka%26aufirst%3DY.%26aulast%3DShiraishi%26aufirst%3DT.%26aulast%3DShinagawa%26aufirst%3DY.%26aulast%3DSakata%26aufirst%3DK.%26aulast%3DSeki%26aufirst%3DA.%26aulast%3DKishida%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DOhuchida%26aufirst%3DS.%26aulast%3DNakai%26aufirst%3DH.%26aulast%3DHashimoto%26aufirst%3DS.%26aulast%3DKawamura%26aufirst%3DM.%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DToda%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520selective%2520EP4-receptor%2520agonist.%2520Part%25204%253A%2520Practical%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520novel%2520highly%2520selective%2520EP4-receptor%2520agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D2103%26epage%3D2110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Nakagawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaoka, K.</span><span> </span><span class="NLM_article-title">Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2007&pages=543-548&author=K.+Nakagawaauthor=Y.+Imaiauthor=Y.+Ohtaauthor=K.+Takaoka&title=Prostaglandin+E2+EP4+agonist+%28ONO-4819%29+accelerates+BMP-induced+osteoblastic+differentiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DOhta%26aufirst%3DY.%26aulast%3DTakaoka%26aufirst%3DK.%26atitle%3DProstaglandin%2520E2%2520EP4%2520agonist%2520%2528ONO-4819%2529%2520accelerates%2520BMP-induced%2520osteoblastic%2520differentiation%26jtitle%3DBone%26date%3D2007%26volume%3D41%26spage%3D543%26epage%3D548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Toyoda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaoka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaoka, K.</span><span> </span><span class="NLM_article-title">Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2005&pages=555-562&author=H.+Toyodaauthor=H.+Teraiauthor=R.+Sasaokaauthor=K.+Odaauthor=K.+Takaoka&title=Augmentation+of+bone+morphogenetic+protein-induced+bone+mass+by+local+delivery+of+a+prostaglandin+E+EP4+receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToyoda%26aufirst%3DH.%26aulast%3DTerai%26aufirst%3DH.%26aulast%3DSasaoka%26aufirst%3DR.%26aulast%3DOda%26aufirst%3DK.%26aulast%3DTakaoka%26aufirst%3DK.%26atitle%3DAugmentation%2520of%2520bone%2520morphogenetic%2520protein-induced%2520bone%2520mass%2520by%2520local%2520delivery%2520of%2520a%2520prostaglandin%2520E%2520EP4%2520receptor%2520agonist%26jtitle%3DBone%26date%3D2005%26volume%3D37%26spage%3D555%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Ito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span> </span><span class="NLM_article-title">Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2006&pages=453-459&author=M.+Itoauthor=K.+Nakayamaauthor=A.+Konakaauthor=K.+Sakataauthor=K.+Ikedaauthor=T.+Maruyama&title=Effects+of+a+prostaglandin+EP4+agonist%2C+ONO-4819%2C+and+risedronate+on+trabecular+microstructure+and+bone+strength+in+mature+ovariectomized+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DM.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DKonaka%26aufirst%3DA.%26aulast%3DSakata%26aufirst%3DK.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DMaruyama%26aufirst%3DT.%26atitle%3DEffects%2520of%2520a%2520prostaglandin%2520EP4%2520agonist%252C%2520ONO-4819%252C%2520and%2520risedronate%2520on%2520trabecular%2520microstructure%2520and%2520bone%2520strength%2520in%2520mature%2520ovariectomized%2520rats%26jtitle%3DBone%26date%3D2006%26volume%3D39%26spage%3D453%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Ofek, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karsak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leclerc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frenkel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attar-Namdar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kram, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shohami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bab, I.</span><span> </span><span class="NLM_article-title">Peripheral cannabinoid receptor, CB2, regulates bone mass</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">696</span><span class="NLM_x">–</span> <span class="NLM_lpage">701</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1073%2Fpnas.0504187103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16407142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=696-701&author=O.+Ofekauthor=M.+Karsakauthor=N.+Leclercauthor=M.+Fogelauthor=B.+Frenkelauthor=K.+Wrightauthor=J.+Tamauthor=M.+Attar-Namdarauthor=V.+Kramauthor=E.+Shohamiauthor=R.+Mechoulamauthor=A.+Zimmerauthor=I.+Bab&title=Peripheral+cannabinoid+receptor%2C+CB2%2C+regulates+bone+mass"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral cannabinoid receptor, CB2, regulates bone mass</span></div><div class="casAuthors">Ofek, Orr; Karsak, Meliha; Leclerc, Nathalie; Fogel, Meirav; Frenkel, Baruch; Wright, Karen; Tam, Joseph; Attar-Namdar, Malka; Kram, Vardit; Shohami, Esther; Mechoulam, Raphael; Zimmer, Andreas; Bab, Itai</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">696-701</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The endogenous cannabinoids bind to and activate two G protein-coupled receptors, the predominantly central cannabinoid receptor type 1 (CB1) and peripheral cannabinoid receptor type 2 (CB2).  Whereas CB1 mediates the cannabinoid psychotropic, analgesic, and orectic effects, CB2 has been implicated recently in the regulation of liver fibrosis and atherosclerosis.  Here we show that CB2-deficient mice have a markedly accelerated age-related trabecular bone loss and cortical expansion, although cortical thickness remains unaltered.  These changes are reminiscent of human osteoporosis and may result from differential regulation of trabecular and cortical bone remodeling.  The CB2-/- phenotype is also characterized by increased activity of trabecular osteoblasts (bone-forming cells), increased osteoclast (the bone-resorbing cell) no., and a markedly decreased no. of diaphyseal osteoblast precursors.  CB2 is expressed in osteoblasts, osteocytes, and osteoclasts.  A CB2-specific agonist that does not have any psychotropic effects enhances endocortical osteoblast no. and activity and restrains trabecular osteoclastogenesis, apparently by inhibiting proliferation of osteoclast precursors and receptor activator of NF-κB ligand expression in bone marrow-derived osteoblasts/stromal cells.  The same agonist attenuates ovariectomy-induced bone loss and markedly stimulates cortical thickness through the resp. suppression of osteoclast no. and stimulation of endocortical bone formation.  These results demonstrate that the endocannabinoid system is essential for the maintenance of normal bone mass by osteoblastic and osteoclastic CB2 signaling.  Hence, CB2 offers a mol. target for the diagnosis and treatment of osteoporosis, the most prevalent degenerative disease in developed countries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUeW3SSIrXSbVg90H21EOLACvtfcHk0ljN41Z74STzXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhsr4%253D&md5=222e7dfb53af21baf8c0bc4d7bb71eac</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0504187103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0504187103%26sid%3Dliteratum%253Aachs%26aulast%3DOfek%26aufirst%3DO.%26aulast%3DKarsak%26aufirst%3DM.%26aulast%3DLeclerc%26aufirst%3DN.%26aulast%3DFogel%26aufirst%3DM.%26aulast%3DFrenkel%26aufirst%3DB.%26aulast%3DWright%26aufirst%3DK.%26aulast%3DTam%26aufirst%3DJ.%26aulast%3DAttar-Namdar%26aufirst%3DM.%26aulast%3DKram%26aufirst%3DV.%26aulast%3DShohami%26aufirst%3DE.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DZimmer%26aufirst%3DA.%26aulast%3DBab%26aufirst%3DI.%26atitle%3DPeripheral%2520cannabinoid%2520receptor%252C%2520CB2%252C%2520regulates%2520bone%2520mass%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D696%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Bab, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, A.</span><span> </span><span class="NLM_article-title">Cannabinoid receptors and the regulation of bone mass</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1038%2Fsj.bjp.0707593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18071301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFClsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=182-188&author=I.+Babauthor=A.+Zimmer&title=Cannabinoid+receptors+and+the+regulation+of+bone+mass"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid receptors and the regulation of bone mass</span></div><div class="casAuthors">Bab, I.; Zimmer, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-188</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A functional endocannabinoid system is present in several mammalian organs and tissues.  Recently, endocannabinoids and their receptors have been reported in the skeleton.  Osteoblasts, the bone forming cells, and osteoclasts, the bone resorbing cells, produce the endocannabinoids anandamide and 2-arachidonoylglycerol and express CB2 cannabinoid receptors.  Although CB2 has been implicated in pathol. processes in the central nervous system and peripheral tissues, the skeleton appears as the main system physiol. regulated by CB2.  CB2-deficient mice show a markedly accelerated age-related bone loss and the CNR2 gene (encoding CB2) in women is assocd. with low bone mineral d.  The activation of CB2 attenuates ovariectomy-induced bone loss in mice by restraining bone resorption and enhancing bone formation.  Hence synthetic CB2 ligands, which are stable and orally available, provide a basis for developing novel anti-osteoporotic therapies.  Activation of CB1 in sympathetic nerve terminals in bone inhibits norepinephrine release, thus balancing the tonic sympathetic restrain of bone formation.  Low levels of CB1 were also reported in osteoclasts.  CB1-null mice display a skeletal phenotype that is dependent on the mouse strain, gender and specific mutation of the CB1 encoding gene, CNR1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe0y7uhkrEE7Vg90H21EOLACvtfcHk0lioe2y26xDy6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFClsA%253D%253D&md5=c461a34365f7c258bbb9b422f8e0bd48</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707593%26sid%3Dliteratum%253Aachs%26aulast%3DBab%26aufirst%3DI.%26aulast%3DZimmer%26aufirst%3DA.%26atitle%3DCannabinoid%2520receptors%2520and%2520the%2520regulation%2520of%2520bone%2520mass%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D182%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Idris, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sophocleous, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landao-Bassonga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van't Hof, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralston, S. H.</span><span> </span><span class="NLM_article-title">Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">5619</span><span class="NLM_x">–</span> <span class="NLM_lpage">5626</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2008&pages=5619-5626&author=A.+I.+Idrisauthor=A.+Sophocleousauthor=E.+Landao-Bassongaauthor=R.+J.+van%27t+Hofauthor=S.+H.+Ralston&title=Regulation+of+bone+mass%2C+osteoclast+function%2C+and+ovariectomy-induced+bone+loss+by+the+type+2+cannabinoid+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIdris%26aufirst%3DA.%2BI.%26aulast%3DSophocleous%26aufirst%3DA.%26aulast%3DLandao-Bassonga%26aufirst%3DE.%26aulast%3Dvan%2527t%2BHof%26aufirst%3DR.%2BJ.%26aulast%3DRalston%26aufirst%3DS.%2BH.%26atitle%3DRegulation%2520of%2520bone%2520mass%252C%2520osteoclast%2520function%252C%2520and%2520ovariectomy-induced%2520bone%2520loss%2520by%2520the%2520type%25202%2520cannabinoid%2520receptor%26jtitle%3DEndocrinology%26date%3D2008%26volume%3D149%26spage%3D5619%26epage%3D5626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Tam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trembovler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrosino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandrovich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casap, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shteyer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karsak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yirmiya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shohami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bab, I.</span><span> </span><span class="NLM_article-title">The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1096%2Ffj.06-7957com" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17704191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=285-294&author=J.+Tamauthor=V.+Trembovlerauthor=V.+Di+Marzoauthor=S.+Petrosinoauthor=G.+Leoauthor=A.+Alexandrovichauthor=E.+Regevauthor=N.+Casapauthor=A.+Shteyerauthor=C.+Ledentauthor=M.+Karsakauthor=A.+Zimmerauthor=R.+Mechoulamauthor=R.+Yirmiyaauthor=E.+Shohamiauthor=I.+Bab&title=The+cannabinoid+CB1+receptor+regulates+bone+formation+by+modulating+adrenergic+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling</span></div><div class="casAuthors">Tam, Joseph; Trembovler, Victoria; Di Marzo, Vincenzo; Petrosino, Stefania; Leo, Gabriella; Alexandrovich, Alex; Regev, Eran; Casap, Nardy; Shteyer, Arie; Ledent, Catherine; Karsak, Meliha; Zimmer, Andreas; Mechoulam, Raphael; Yirmiya, Raz; Shohami, Esther; Bab, Itai</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">285-294, 10.1096/fj.06-7957com</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">We have recently reported that in bone the cannabinoid CB1 receptor is present in sympathetic terminals.  Here we show that traumatic brain injury (TBI), which in humans enhances peripheral osteogenesis and fracture healing, acutely stimulates bone formation in a distant skeletal site.  At this site we demonstrate (i) a high level of the main endocannabinoid, 2-arachidonoylglycerol (2-AG), and expression of diacylglycerol lipases, enzymes essential for 2-AG synthesis; (ii) that the TBI-induced increase in bone formation is preceded by elevation of the 2-AG and a decrease in norepinephrine (NE) levels.  The TBI stimulation of bone formation was absent in CB1-null mice.  In wild-type animals it could be mimicked, including the suppression of NE levels, by 2-AG administration.  The TBI- and 2-AG-induced stimulation of osteogenesis was restrained by the β-adrenergic receptor agonist isoproterenol.  NE from sympathetic terminals is known to tonically inhibit bone formation by activating osteoblastic β2-adrenergic receptors.  The present findings further demonstrate that the sympathetic control of bone formation is regulated through 2-AG activation of prejunctional CB1.  Elevation of bone 2-AG apparently suppresses NE release from bone sympathetic terminals, thus alleviating the inhibition of bone formation.  The involvement of osteoblastic CB2 signaling in this process is minimal, if any.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHBWEs2cC3IrVg90H21EOLACvtfcHk0lioe2y26xDy6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslWmsw%253D%253D&md5=18848f3beebb92be4b7a354ba8d4ea4f</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1096%2Ffj.06-7957com&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.06-7957com%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DJ.%26aulast%3DTrembovler%26aufirst%3DV.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DLeo%26aufirst%3DG.%26aulast%3DAlexandrovich%26aufirst%3DA.%26aulast%3DRegev%26aufirst%3DE.%26aulast%3DCasap%26aufirst%3DN.%26aulast%3DShteyer%26aufirst%3DA.%26aulast%3DLedent%26aufirst%3DC.%26aulast%3DKarsak%26aufirst%3DM.%26aulast%3DZimmer%26aufirst%3DA.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DYirmiya%26aufirst%3DR.%26aulast%3DShohami%26aufirst%3DE.%26aulast%3DBab%26aufirst%3DI.%26atitle%3DThe%2520cannabinoid%2520CB1%2520receptor%2520regulates%2520bone%2520formation%2520by%2520modulating%2520adrenergic%2520signaling%26jtitle%3DFASEB%2520J.%26date%3D2008%26volume%3D22%26spage%3D285%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group">Idris, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sophocleous, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landao-Bassonga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van't Hof, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralston, S. H.</span><span> </span><span class="NLM_article-title">Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.cmet.2009.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19656492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVChsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=139-47&author=A.+I.+Idrisauthor=A.+Sophocleousauthor=E.+Landao-Bassongaauthor=M.+Canalsauthor=G.+Milliganauthor=D.+Bakerauthor=R.+J.+van%27t+Hofauthor=S.+H.+Ralston&title=Cannabinoid+receptor+type+1+protects+against+age-related+osteoporosis+by+regulating+osteoblast+and+adipocyte+differentiation+in+marrow+stromal+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells</span></div><div class="casAuthors">Idris, Aymen I.; Sophocleous, Antonia; Landao-Bassonga, Euphemie; Canals, Meritxell; Milligan, Graeme; Baker, David; van't Hof, Robert J.; Ralston, Stuart H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Age-related osteoporosis is characterized by reduced bone formation and accumulation of fat in the bone marrow compartment.  Here, we report that the type 1 cannabinoid receptor (CB1) regulates this process.  Mice with CB1 deficiency (CB1-/-) had increased peak bone mass due to reduced bone resorption, but developed age-related osteoporosis with reduced bone formation and accumulation of adipocytes in the bone marrow space.  Marrow stromal cells from CB1-/- mice had an enhanced capacity for adipocyte differentiation, a reduced capacity for osteoblast differentiation, and increased expression of phosphorylated CREB (pCREB) and PPARγ.  Pharmacol. blockade of CB1 receptors stimulated adipocyte differentiation, inhibited osteoblast differentiation, and increased cAMP and pCREB in osteoblast and adipocyte precursors.  The CB1 receptor is therefore unique in that it regulates peak bone mass through an effect on osteoclast activity, but protects against age-related bone loss by regulating adipocyte and osteoblast differentiation of bone marrow stromal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNvLw59pncD7Vg90H21EOLACvtfcHk0lioe2y26xDy6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVChsLrE&md5=feb740ebad00e3db6a076cf2f245d2d0</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2009.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2009.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DIdris%26aufirst%3DA.%2BI.%26aulast%3DSophocleous%26aufirst%3DA.%26aulast%3DLandao-Bassonga%26aufirst%3DE.%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3Dvan%2527t%2BHof%26aufirst%3DR.%2BJ.%26aulast%3DRalston%26aufirst%3DS.%2BH.%26atitle%3DCannabinoid%2520receptor%2520type%25201%2520protects%2520against%2520age-related%2520osteoporosis%2520by%2520regulating%2520osteoblast%2520and%2520adipocyte%2520differentiation%2520in%2520marrow%2520stromal%2520cells%26jtitle%3DCell%2520Metab.%26date%3D2009%26volume%3D10%26spage%3D139%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Rinaldi-Carmona, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pialot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brelière, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soubrié, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Fur, G.</span><span> </span><span class="NLM_article-title">Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1239</span><span class="NLM_x">–</span> <span class="NLM_lpage">1247</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1996&pages=1239-1247&author=M.+Rinaldi-Carmonaauthor=F.+Pialotauthor=C.+Congyauthor=E.+Redonauthor=F.+Barthauthor=A.+Bachyauthor=J.+C.+Breli%C3%A8reauthor=P.+Soubri%C3%A9author=G.+Le+Fur&title=Characterization+and+distribution+of+binding+sites+for+%5B3H%5D-SR+141716A%2C+a+selective+brain+%28CB1%29+cannabinoid+receptor+antagonist%2C+in+rodent+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRinaldi-Carmona%26aufirst%3DM.%26aulast%3DPialot%26aufirst%3DF.%26aulast%3DCongy%26aufirst%3DC.%26aulast%3DRedon%26aufirst%3DE.%26aulast%3DBarth%26aufirst%3DF.%26aulast%3DBachy%26aufirst%3DA.%26aulast%3DBreli%25C3%25A8re%26aufirst%3DJ.%2BC.%26aulast%3DSoubri%25C3%25A9%26aufirst%3DP.%26aulast%3DLe%2BFur%26aufirst%3DG.%26atitle%3DCharacterization%2520and%2520distribution%2520of%2520binding%2520sites%2520for%2520%255B3H%255D-SR%2520141716A%252C%2520a%2520selective%2520brain%2520%2528CB1%2529%2520cannabinoid%2520receptor%2520antagonist%252C%2520in%2520rodent%2520brain%26jtitle%3DLife%2520Sci.%26date%3D1996%26volume%3D58%26spage%3D1239%26epage%3D1247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group">Lan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernando, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCallion, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span> </span><span class="NLM_article-title">Structure−activity relationships of pyrazole derivatives as cannabinoid receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980363y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=769-776&author=R.+Lanauthor=Q.+Liuauthor=P.+Fanauthor=S.+Linauthor=S.+R.+Fernandoauthor=D.+McCallionauthor=R.+Pertweeauthor=A.+Makriyannis&title=Structure%E2%88%92activity+relationships+of+pyrazole+derivatives+as+cannabinoid+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1021%2Fjm980363y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980363y%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DFan%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DFernando%26aufirst%3DS.%2BR.%26aulast%3DMcCallion%26aufirst%3DD.%26aulast%3DPertwee%26aufirst%3DR.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520of%2520pyrazole%2520derivatives%2520as%2520cannabinoid%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D769%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Huffman, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liddle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aung, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abood, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">3-(1′,1′-Dimethylbutyl)-1-deoxy-Δ8-THC and related compounds: synthesis of selective ligands for the CB2 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2905</span><span class="NLM_x">–</span> <span class="NLM_lpage">2914</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=2905-2914&author=J.+W.+Huffmanauthor=J.+Liddleauthor=S.+Yuauthor=M.+M.+Aungauthor=M.+E.+Aboodauthor=J.+L.+Wileyauthor=B.+R.+Martin&title=3-%281%E2%80%B2%2C1%E2%80%B2-Dimethylbutyl%29-1-deoxy-%CE%948-THC+and+related+compounds%3A+synthesis+of+selective+ligands+for+the+CB2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuffman%26aufirst%3DJ.%2BW.%26aulast%3DLiddle%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DAung%26aufirst%3DM.%2BM.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3D3-%25281%25E2%2580%25B2%252C1%25E2%2580%25B2-Dimethylbutyl%2529-1-deoxy-%25CE%25948-THC%2520and%2520related%2520compounds%253A%2520synthesis%2520of%2520selective%2520ligands%2520for%2520the%2520CB2%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1999%26volume%3D7%26spage%3D2905%26epage%3D2914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Sophocleous, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landao-Bassonga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van't Hof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralston, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idris, A. I.</span><span> </span><span class="NLM_article-title">The type 2 cannabinoid receptor (CB2) protects against age-related osteoporosis by affecting bone formation and CB2 agonists exhibit anabolic activity in vivo</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">S219</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=S219&author=A.+Sophocleousauthor=E.+Landao-Bassongaauthor=R.+van%27t+Hofauthor=S.+H.+Ralstonauthor=A.+I.+Idris&title=The+type+2+cannabinoid+receptor+%28CB2%29+protects+against+age-related+osteoporosis+by+affecting+bone+formation+and+CB2+agonists+exhibit+anabolic+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSophocleous%26aufirst%3DA.%26aulast%3DLandao-Bassonga%26aufirst%3DE.%26aulast%3Dvan%2527t%2BHof%26aufirst%3DR.%26aulast%3DRalston%26aufirst%3DS.%2BH.%26aulast%3DIdris%26aufirst%3DA.%2BI.%26atitle%3DThe%2520type%25202%2520cannabinoid%2520receptor%2520%2528CB2%2529%2520protects%2520against%2520age-related%2520osteoporosis%2520by%2520affecting%2520bone%2520formation%2520and%2520CB2%2520agonists%2520exhibit%2520anabolic%2520activity%2520in%2520vivo%26jtitle%3DBone%26date%3D2009%26volume%3D44%26spage%3DS219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Marriott, K.-S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huffman, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacology of 11-nor-1-methoxy-9-hydroxyhexahydrocannabinols and 11-nor-1-deoxy-9-hydroxyhexahydrocannabinols: new selective ligands for the cannabinoid CB2 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2386</span><span class="NLM_x">–</span> <span class="NLM_lpage">2397</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=2386-2397&author=K.-S.+C.+Marriottauthor=J.+W.+Huffmanauthor=J.+L.+Wileyauthor=B.+R.+Martin&title=Synthesis+and+pharmacology+of+11-nor-1-methoxy-9-hydroxyhexahydrocannabinols+and+11-nor-1-deoxy-9-hydroxyhexahydrocannabinols%3A+new+selective+ligands+for+the+cannabinoid+CB2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarriott%26aufirst%3DK.-S.%2BC.%26aulast%3DHuffman%26aufirst%3DJ.%2BW.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%2520and%2520pharmacology%2520of%252011-nor-1-methoxy-9-hydroxyhexahydrocannabinols%2520and%252011-nor-1-deoxy-9-hydroxyhexahydrocannabinols%253A%2520new%2520selective%2520ligands%2520for%2520the%2520cannabinoid%2520CB2%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D2386%26epage%3D2397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Hanus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breuer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchilibon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiloah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horowitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fride, E.</span><span> </span><span class="NLM_article-title">HU-308: a specific agonist for CB2, a peripheral cannabinoid receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">14228</span><span class="NLM_x">–</span> <span class="NLM_lpage">14233</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=14228-14233&author=L.+Hanusauthor=A.+Breuerauthor=S.+Tchilibonauthor=S.+Shiloahauthor=D.+Goldenbergauthor=M.+Horowitzauthor=R.+G.+Pertweeauthor=R.+A.+Rossauthor=R.+Mechoulamauthor=E.+Fride&title=HU-308%3A+a+specific+agonist+for+CB2%2C+a+peripheral+cannabinoid+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanus%26aufirst%3DL.%26aulast%3DBreuer%26aufirst%3DA.%26aulast%3DTchilibon%26aufirst%3DS.%26aulast%3DShiloah%26aufirst%3DS.%26aulast%3DGoldenberg%26aufirst%3DD.%26aulast%3DHorowitz%26aufirst%3DM.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DRoss%26aufirst%3DR.%2BA.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DFride%26aufirst%3DE.%26atitle%3DHU-308%253A%2520a%2520specific%2520agonist%2520for%2520CB2%252C%2520a%2520peripheral%2520cannabinoid%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D14228%26epage%3D14233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Page, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balaux, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boisvert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszewski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walpole, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodzic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Onge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godbout, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salois, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payza, K.</span><span> </span><span class="NLM_article-title">Novel benzimidazole derivatives as selective CB2 agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3695</span><span class="NLM_x">–</span> <span class="NLM_lpage">3700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.bmcl.2008.05.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18522867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1Ohurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3695-3700&author=D.+Pageauthor=E.+Balauxauthor=L.+Boisvertauthor=Z.+Liuauthor=C.+Milburnauthor=M.+Tremblayauthor=Z.+Weiauthor=S.+Wooauthor=X.+Luoauthor=Y.-X.+Chengauthor=H.+Yangauthor=S.+Srivastavaauthor=F.+Zhouauthor=W.+Brownauthor=M.+Tomaszewskiauthor=C.+Walpoleauthor=L.+Hodzicauthor=S.+St-Ongeauthor=C.+Godboutauthor=D.+Saloisauthor=K.+Payza&title=Novel+benzimidazole+derivatives+as+selective+CB2+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Novel benzimidazole derivatives as selective CB2 agonists</span></div><div class="casAuthors">Page, Daniel; Balaux, Elise; Boisvert, Luc; Liu, Ziping; Milburn, Claire; Tremblay, Maxime; Wei, Zhongyong; Woo, Simon; Luo, Xuehong; Cheng, Yun-Xing; Yang, Hua; Srivastava, Sanjay; Zhou, Fei; Brown, William; Tomaszewski, Miroslaw; Walpole, Christopher; Hodzic, Leila; St-Onge, Stephane; Godbout, Claude; Salois, Dominic; Payza, Keymal</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3695-3700</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The prepn. and evaluation of a novel class of CB2 agonists based on a benzimidazole moiety, e.g., I, are reported.  They showed binding affinities up to 1 nM towards the CB2 receptor with partial to full agonist potencies.  They also demonstrated good to excellent selectivity (>1000-fold) over the CB1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbeiXe1I0Yg7Vg90H21EOLACvtfcHk0lj_DnClNugInw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1Ohurs%253D&md5=fa9e0921054b0d9f26044a1feb82a604</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.05.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.05.073%26sid%3Dliteratum%253Aachs%26aulast%3DPage%26aufirst%3DD.%26aulast%3DBalaux%26aufirst%3DE.%26aulast%3DBoisvert%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMilburn%26aufirst%3DC.%26aulast%3DTremblay%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DZ.%26aulast%3DWoo%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DY.-X.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DBrown%26aufirst%3DW.%26aulast%3DTomaszewski%26aufirst%3DM.%26aulast%3DWalpole%26aufirst%3DC.%26aulast%3DHodzic%26aufirst%3DL.%26aulast%3DSt-Onge%26aufirst%3DS.%26aulast%3DGodbout%26aufirst%3DC.%26aulast%3DSalois%26aufirst%3DD.%26aulast%3DPayza%26aufirst%3DK.%26atitle%3DNovel%2520benzimidazole%2520derivatives%2520as%2520selective%2520CB2%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3695%26epage%3D3700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Markt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollinger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raduner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuster, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchmair, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Distinto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spitzer, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolber, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laggner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmann, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gertsch, J.</span><span> </span><span class="NLM_article-title">Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflow</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801044g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=369-378&author=P.+Marktauthor=C.+Feldmannauthor=J.+M.+Rollingerauthor=S.+Radunerauthor=D.+Schusterauthor=J.+Kirchmairauthor=S.+Distintoauthor=G.+M.+Spitzerauthor=G.+Wolberauthor=C.+Laggnerauthor=K.-H.+Altmannauthor=T.+Langerauthor=J.+Gertsch&title=Discovery+of+novel+CB2+receptor+ligands+by+a+pharmacophore-based+virtual+screening+workflow"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Fjm801044g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801044g%26sid%3Dliteratum%253Aachs%26aulast%3DMarkt%26aufirst%3DP.%26aulast%3DFeldmann%26aufirst%3DC.%26aulast%3DRollinger%26aufirst%3DJ.%2BM.%26aulast%3DRaduner%26aufirst%3DS.%26aulast%3DSchuster%26aufirst%3DD.%26aulast%3DKirchmair%26aufirst%3DJ.%26aulast%3DDistinto%26aufirst%3DS.%26aulast%3DSpitzer%26aufirst%3DG.%2BM.%26aulast%3DWolber%26aufirst%3DG.%26aulast%3DLaggner%26aufirst%3DC.%26aulast%3DAltmann%26aufirst%3DK.-H.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DGertsch%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520novel%2520CB2%2520receptor%2520ligands%2520by%2520a%2520pharmacophore-based%2520virtual%2520screening%2520workflow%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D369%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group">Huffman, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padgett, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isherwood, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5432</span><span class="NLM_x">–</span> <span class="NLM_lpage">5435</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5432-5435&author=J.+W.+Huffmanauthor=L.+W.+Padgettauthor=M.+L.+Isherwoodauthor=J.+L.+Wileyauthor=B.+R.+Martin&title=1-Alkyl-2-aryl-4-%281-naphthoyl%29pyrroles%3A+new+high+affinity+ligands+for+the+cannabinoid+CB1+and+CB2+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuffman%26aufirst%3DJ.%2BW.%26aulast%3DPadgett%26aufirst%3DL.%2BW.%26aulast%3DIsherwood%26aufirst%3DM.%2BL.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3D1-Alkyl-2-aryl-4-%25281-naphthoyl%2529pyrroles%253A%2520new%2520high%2520affinity%2520ligands%2520for%2520the%2520cannabinoid%2520CB1%2520and%2520CB2%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5432%26epage%3D5435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Whyte, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridge, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greasley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, M. J.</span><span> </span><span class="NLM_article-title">The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">16511</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=16511-16516&author=L.+S.+Whyteauthor=E.+Rybergauthor=N.+A.+Simsauthor=S.+A.+Ridgeauthor=K.+Mackieauthor=P.+J.+Greasleyauthor=R.+A.+Rossauthor=M.+J.+Rogers&title=The+putative+cannabinoid+receptor+GPR55+affects+osteoclast+function+in+vitro+and+bone+mass+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhyte%26aufirst%3DL.%2BS.%26aulast%3DRyberg%26aufirst%3DE.%26aulast%3DSims%26aufirst%3DN.%2BA.%26aulast%3DRidge%26aufirst%3DS.%2BA.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DGreasley%26aufirst%3DP.%2BJ.%26aulast%3DRoss%26aufirst%3DR.%2BA.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520putative%2520cannabinoid%2520receptor%2520GPR55%2520affects%2520osteoclast%2520function%2520in%2520vitro%2520and%2520bone%2520mass%2520in%2520vivo%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D16511%26epage%3D16516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Pertwee, R. G.</span><span> </span><span class="NLM_article-title">The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta 9-tetrahydrocannabinol, cannabidiol and delta 9-tetrahydrocannabivarin</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1038%2Fsj.bjp.0707442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17828291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFCkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=199-215&author=R.+G.+Pertwee&title=The+diverse+CB1+and+CB2+receptor+pharmacology+of+three+plant+cannabinoids%3A+delta+9-tetrahydrocannabinol%2C+cannabidiol+and+delta+9-tetrahydrocannabivarin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin</span></div><div class="casAuthors">Pertwee, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-215</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cannabis sativa is the source of a unique set of compds. known collectively as plant cannabinoids or phytocannabinoids.  This review focuses on the manner with which three of these compds., (-)-trans-Δ9-tetrahydrocannabinol (Δ9-THC), (-)-cannabidiol (CBD) and (-)-trans-Δ9-tetrahydrocannabivarin (Δ9-THCV), interact with cannabinoid CB1 and CB2 receptors. Δ9-THC, the main psychotropic constituent of cannabis, is a CB1 and CB2 receptor partial agonist and in line with classical pharmacol., the responses it elicits appear to be strongly influenced both by the expression level and signalling efficiency of cannabinoid receptors and by ongoing endogenous cannabinoid release.  CBD displays unexpectedly high potency as an antagonist of CB1/CB2 receptor agonists in CB1- and CB2-expressing cells or tissues, the manner with which it interacts with CB2 receptors providing a possible explanation for its ability to inhibit evoked immune cell migration. Δ9-THCV behaves as a potent CB2 receptor partial agonist in vitro.  In contrast, it antagonizes cannabinoid receptor agonists in CB1-expressing tissues.  This it does with relatively high potency and in a manner that is both tissue and ligand dependent. Δ9-THCV also interacts with CB1 receptors when administered in vivo, behaving either as a CB1 antagonist or, at higher doses, as a CB1 receptor agonist.  Brief mention is also made in this review, first of the prodn. by Δ9-THC of pharmacodynamic tolerance, second of current knowledge about the extent to which Δ9-THC, CBD and Δ9-THCV interact with pharmacol. targets other than CB1 or CB2 receptors, and third of actual and potential therapeutic applications for each of these cannabinoids.  British Journal of Pharmacol. (2008) 153, 199-215; doi:10.1038/sj.bjp.0707442; published online 10 Sept. 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdNia0Z97Wz7Vg90H21EOLACvtfcHk0ljAdLb04Px5KQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFCkuw%253D%253D&md5=53187d5a54c048cbbd0d0b0143feb206</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707442%26sid%3Dliteratum%253Aachs%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26atitle%3DThe%2520diverse%2520CB1%2520and%2520CB2%2520receptor%2520pharmacology%2520of%2520three%2520plant%2520cannabinoids%253A%2520delta%25209-tetrahydrocannabinol%252C%2520cannabidiol%2520and%2520delta%25209-tetrahydrocannabivarin%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D199%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Soriano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geske, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, A.</span><span> </span><span class="NLM_article-title">Targeted disruption of the c-Src proto-oncogene leads to osteopetrosis in mice</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">702</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1991&pages=693-702&author=P.+Sorianoauthor=C.+Montgomeryauthor=R.+Geskeauthor=A.+Bradley&title=Targeted+disruption+of+the+c-Src+proto-oncogene+leads+to+osteopetrosis+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoriano%26aufirst%3DP.%26aulast%3DMontgomery%26aufirst%3DC.%26aulast%3DGeske%26aufirst%3DR.%26aulast%3DBradley%26aufirst%3DA.%26atitle%3DTargeted%2520disruption%2520of%2520the%2520c-Src%2520proto-oncogene%2520leads%2520to%2520osteopetrosis%2520in%2520mice%26jtitle%3DCell%26date%3D1991%26volume%3D64%26spage%3D693%26epage%3D702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Boyce, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoneda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mundy, G. R.</span><span> </span><span class="NLM_article-title">Requirement of pp60c-Src expression for osteoclasts to form ruffled borders and resorb bone in mice</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">1622</span><span class="NLM_x">–</span> <span class="NLM_lpage">1627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1992&pages=1622-1627&author=B.+F.+Boyceauthor=T.+Yonedaauthor=C.+Loweauthor=P.+Sorianoauthor=G.+R.+Mundy&title=Requirement+of+pp60c-Src+expression+for+osteoclasts+to+form+ruffled+borders+and+resorb+bone+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyce%26aufirst%3DB.%2BF.%26aulast%3DYoneda%26aufirst%3DT.%26aulast%3DLowe%26aufirst%3DC.%26aulast%3DSoriano%26aufirst%3DP.%26aulast%3DMundy%26aufirst%3DG.%2BR.%26atitle%3DRequirement%2520of%2520pp60c-Src%2520expression%2520for%2520osteoclasts%2520to%2520form%2520ruffled%2520borders%2520and%2520resorb%2520bone%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1992%26volume%3D90%26spage%3D1622%26epage%3D1627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Marzia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taranta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraggiana, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoneda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mundy, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teti, A.</span><span> </span><span class="NLM_article-title">Decreased c-Src expression enhances osteoblast differentiation and bone formation</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2000&pages=311-320&author=M.+Marziaauthor=N.+A.+Simsauthor=S.+Voitauthor=S.+Migliaccioauthor=A.+Tarantaauthor=S.+Bernardiniauthor=T.+Faraggianaauthor=T.+Yonedaauthor=G.+R.+Mundyauthor=B.+F.+Boyceauthor=R.+Baronauthor=A.+Teti&title=Decreased+c-Src+expression+enhances+osteoblast+differentiation+and+bone+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarzia%26aufirst%3DM.%26aulast%3DSims%26aufirst%3DN.%2BA.%26aulast%3DVoit%26aufirst%3DS.%26aulast%3DMigliaccio%26aufirst%3DS.%26aulast%3DTaranta%26aufirst%3DA.%26aulast%3DBernardini%26aufirst%3DS.%26aulast%3DFaraggiana%26aufirst%3DT.%26aulast%3DYoneda%26aufirst%3DT.%26aulast%3DMundy%26aufirst%3DG.%2BR.%26aulast%3DBoyce%26aufirst%3DB.%2BF.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DTeti%26aufirst%3DA.%26atitle%3DDecreased%2520c-Src%2520expression%2520enhances%2520osteoblast%2520differentiation%2520and%2520bone%2520formation%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2000%26volume%3D151%26spage%3D311%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Hennequin, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curwen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fennell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert van der Brempt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgentin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otterbein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costello, G.</span><span> </span><span class="NLM_article-title"><i>N</i>-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2<i>H</i>-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6465</span><span class="NLM_x">–</span> <span class="NLM_lpage">6488</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060434q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6465-6488&author=L.+F.+Hennequinauthor=J.+Allenauthor=J.+Breedauthor=J.+Curwenauthor=M.+Fennellauthor=T.+P.+Greenauthor=C.+Lambert+van+der+Bremptauthor=R.+Morgentinauthor=R.+A.+Normanauthor=A.+Olivierauthor=L.+Otterbeinauthor=P.+A.+Pleauthor=N.+Warinauthor=G.+Costello&title=N-%285-Chloro-1%2C3-benzodioxol-4-yl%29-7-%5B2-%284-methylpiperazin-1-yl%29ethoxy%5D-5-%28tetrahydro-2H-pyran-4-yloxy%29quinazolin-4-amine%2C+a+novel%2C+highly+selective%2C+orally+available%2C+dual-specific+c-Src%2FAbl+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1021%2Fjm060434q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060434q%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DBreed%26aufirst%3DJ.%26aulast%3DCurwen%26aufirst%3DJ.%26aulast%3DFennell%26aufirst%3DM.%26aulast%3DGreen%26aufirst%3DT.%2BP.%26aulast%3DLambert%2Bvan%2Bder%2BBrempt%26aufirst%3DC.%26aulast%3DMorgentin%26aufirst%3DR.%26aulast%3DNorman%26aufirst%3DR.%2BA.%26aulast%3DOlivier%26aufirst%3DA.%26aulast%3DOtterbein%26aufirst%3DL.%26aulast%3DPle%26aufirst%3DP.%2BA.%26aulast%3DWarin%26aufirst%3DN.%26aulast%3DCostello%26aufirst%3DG.%26atitle%3DN-%25285-Chloro-1%252C3-benzodioxol-4-yl%2529-7-%255B2-%25284-methylpiperazin-1-yl%2529ethoxy%255D-5-%2528tetrahydro-2H-pyran-4-yloxy%2529quinazolin-4-amine%252C%2520a%2520novel%252C%2520highly%2520selective%252C%2520orally%2520available%252C%2520dual-specific%2520c-Src%252FAbl%2520kinase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6465%26epage%3D6488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group">de Vries, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullender, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Duin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semeins, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everts, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein-Nulend, J.</span><span> </span><span class="NLM_article-title">The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">476</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1158%2F1541-7786.MCR-08-0219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19372577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1antb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=476-488&author=T.+J.+de+Vriesauthor=M.+G.+Mullenderauthor=M.+A.+van+Duinauthor=C.+M.+Semeinsauthor=N.+Jamesauthor=T.+P.+Greenauthor=V.+Evertsauthor=J.+Klein-Nulend&title=The+Src+inhibitor+AZD0530+reversibly+inhibits+the+formation+and+activity+of+human+osteoclasts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">The Src Inhibitor AZD0530 Reversibly Inhibits the Formation and Activity of Human Osteoclasts</span></div><div class="casAuthors">de Vries, Teun J.; Mullender, Margriet G.; van Duin, Marion A.; Semeins, Cornelis M.; James, Neil; Green, Tim P.; Everts, Vincent; Klein-Nulend, Jenneke</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">476-488</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Tumor cells in the bone microenvironment are able to initiate a vicious cycle of bone degrdn. by mobilizing osteoclasts, multinucleated cells specialized in bone degrdn.  C-Src is highly expressed both in tumors and in osteoclasts.  Therefore, drugs like AZD0530, designed to inhibit Src activity, could selectively interfere with both tumor and osteoclast activity.  Here we explored the effects of AZD0530 on human osteoclast differentiation and activity.  The effect on osteoclasts formed in vivo was assessed in mouse fetal calvarial explants and in isolated rabbit osteoclasts, where it dose-dependently inhibited osteoclast activity.  Its effect on formation and activity of human osteoclasts in vitro was detd. in cocultures of human osteoblasts and peripheral blood mononuclear cells.  AZD0530 was most effective in inhibiting osteoclast-like cell formation when present at the onset of osteoclastogenesis, suggesting that Src activity is important during the initial phase of osteoclast formation.  Formation of active phosphorylated c-Src, which was highly present in osteoclast-like cells in cocultures and in peripheral blood mononuclear cell monocultures, was significantly reduced by AZD0530.  Furthermore, it reversibly prevented osteoclast precursor migration from the osteoblast layer to the bone surface and subsequent formation of actin rings and resorption pits.  These data suggest that Src is pivotal for the formation and activity of human osteoclasts, probably through its effect on the distribution of the actin microfilament system.  The reversible effect of AZD0530 on osteoclast formation and activity makes it a promising candidate to temper osteoclastic bone degrdn. in bone diseases with enhanced osteoclast activity such as osteolytic metastatic bone disease. (Mol Cancer Res 2009;7(4):476-88).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXu-fotK4VKrVg90H21EOLACvtfcHk0lgsXVpi_TF2Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1antb4%253D&md5=80c72d6afedef2ecf63cfcc4dfa05c5e</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-08-0219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-08-0219%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVries%26aufirst%3DT.%2BJ.%26aulast%3DMullender%26aufirst%3DM.%2BG.%26aulast%3Dvan%2BDuin%26aufirst%3DM.%2BA.%26aulast%3DSemeins%26aufirst%3DC.%2BM.%26aulast%3DJames%26aufirst%3DN.%26aulast%3DGreen%26aufirst%3DT.%2BP.%26aulast%3DEverts%26aufirst%3DV.%26aulast%3DKlein-Nulend%26aufirst%3DJ.%26atitle%3DThe%2520Src%2520inhibitor%2520AZD0530%2520reversibly%2520inhibits%2520the%2520formation%2520and%2520activity%2520of%2520human%2520osteoclasts%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2009%26volume%3D7%26spage%3D476%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group">Eastell, R.; Hannon, R. A.; Gallagher, N.; Clack, G.; Macpherson, M.; Marshall, A.</span><span> </span><span class="NLM_article-title">The effect of AZD0530, a highly selective, orally available Src/Abl kinase inhibitor, on biomarkers of bone resorption in healthy males</span>.  <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span>, Abstract 3041.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&author=R.+Eastell&author=R.+A.+Hannon&author=N.+Gallagher&author=G.+Clack&author=M.+Macpherson&author=A.+Marshall&title=The+effect+of+AZD0530%2C+a+highly+selective%2C+orally+available+Src%2FAbl+kinase+inhibitor%2C+on+biomarkers+of+bone+resorption+in+healthy+males"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEastell%26aufirst%3DR.%26atitle%3DThe%2520effect%2520of%2520AZD0530%252C%2520a%2520highly%2520selective%252C%2520orally%2520available%2520Src%252FAbl%2520kinase%2520inhibitor%252C%2520on%2520biomarkers%2520of%2520bone%2520resorption%2520in%2520healthy%2520males%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group">Chang, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosania, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarohia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leost, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2FS1074-5521%2899%2980048-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=10375538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFOgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=361-375&author=Y.-T.+Changauthor=N.+S.+Grayauthor=G.+R.+Rosaniaauthor=D.+P.+Sutherlinauthor=S.+Kwonauthor=T.+C.+Normanauthor=R.+Sarohiaauthor=M.+Leostauthor=L.+Meijerauthor=P.+G.+Schultz&title=Synthesis+and+application+of+functionally+diverse+2%2C6%2C9-trisubstituted+purine+libraries+as+CDK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors</span></div><div class="casAuthors">Chang, Young-Tae; Gray, Nathanael S.; Rosania, Gustavo R.; Sutherlin, Daniel P.; Kwon, Soojin; Norman, Thea C.; Sarohia, Radhika; Leost, Maryse; Meijer, Laurent; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">361-375</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Purines constitute a structural class of protein ligands involved in mediating an astonishing array of metabolic processes and signal pathways in all living organisms.  Synthesis of purine derivs. targeting specific purine-binding proteins in vivo could lead to versatile lead compds. for use as biol. probes or drug candidates.  We synthesized several libraries of 2,6,9-trisubstituted purines using both soln.- and solid-phase chem., and screened the compds. for inhibition of cyclin-dependent kinase (CDK) activity and human leukemic cell growth.  Lead compds. were optimized by iterative synthesis based on structure-activity relationships (SARs), as well as anal. of several CDK-inhibitor cocrystal structures, to afford several interesting compds. including one of the most potent CDK inhibitors known to date.  Unexpectedly, some compds. with similar CDK inhibitory activity arrested cellular proliferation at distinctly different phases of the cell cycle, and another inhibitor directly induced apoptosis, bypassing cell-cycle arrest.  Some of these compds. selectively inhibited growth of cells derived from specific tumors.  2,6,9-Trisubstituted purines have various and potent biol. activities, despite high concns. of competing endogenous purine ligands in living cells.  Purine libraries constitute a versatile source of small mols. that affect distinct biochem. pathways mediating different cellular functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGromOmpUr_CvbVg90H21EOLACvtfcHk0lha4qN4Yxm7fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFOgtLo%253D&md5=67311217da8fecdddf96b9908a20c906</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2899%2980048-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252899%252980048-9%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DY.-T.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DRosania%26aufirst%3DG.%2BR.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DKwon%26aufirst%3DS.%26aulast%3DNorman%26aufirst%3DT.%2BC.%26aulast%3DSarohia%26aufirst%3DR.%26aulast%3DLeost%26aufirst%3DM.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DSynthesis%2520and%2520application%2520of%2520functionally%2520diverse%25202%252C6%252C9-trisubstituted%2520purine%2520libraries%2520as%2520CDK%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D361%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group">Dalgarno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stehle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schelling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Schravendijk, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keats, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNeil, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, C.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohacek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigele, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T.</span><span> </span><span class="NLM_article-title">Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1111%2Fj.1747-0285.2005.00316.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16492148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=46-57&author=D.+Dalgarnoauthor=T.+Stehleauthor=S.+Narulaauthor=P.+Schellingauthor=M.+R.+van+Schravendijkauthor=S.+Adamsauthor=L.+Andradeauthor=J.+Keatsauthor=M.+Ramauthor=L.+Jinauthor=T.+Grossmanauthor=I.+MacNeilauthor=C.+Metcalfauthor=W.+Shakespeareauthor=Y.+Wangauthor=T.+Keenanauthor=R.+Sundaramoorthiauthor=R.+Bohacekauthor=M.+Weigeleauthor=T.+Sawyer&title=Structural+basis+of+Src+tyrosine+kinase+inhibition+with+a+new+class+of+potent+and+selective+trisubstituted+purine-based+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds</span></div><div class="casAuthors">Dalgarno, David; Stehle, Thilo; Narula, Surinder; Schelling, Pierre; van Schravendijk, Marie Rose; Adams, Susan; Andrade, Lawrence; Keats, Jeff; Ram, Mary; Jin, Lei; Grossman, Trudy; MacNeil, Ian; Metcalf, Chester, III; Shakespeare, William; Wang, Yihan; Keenan, Terry; Sundaramoorthi, Raji; Bohacek, Regine; Weigele, Manfred; Sawyer, Tomi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-57</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The tyrosine kinase pp60src (Src) is the prototypical member of a family of proteins that participate in a broad array of cellular signal transduction processes, including cell growth, differentiation, survival, adhesion, and migration.  Abnormal Src family kinase (SFK) signaling has been linked to several disease states, including osteoporosis and cancer metastases.  Src has thus emerged as a mol. target for the discovery of small-mol. inhibitors that regulate Src kinase activity by binding to the ATP pocket within the catalytic domain.  Here, we present crystal structures of the kinase domain of Src in complex with two purine-based inhibitors: AP23451, a small-mol. inhibitor designed to inhibit Src-dependent bone resorption, and AP23464, a small-mol. inhibitor designed to inhibit the Src-dependent metastatic spread of cancer.  In each case, a trisubstituted purine template core was elaborated using structure-based drug design to yield a potent Src kinase inhibitor.  These structures represent early examples of high affinity purine-based Src family kinase-inhibitor complexes, and they provide a detailed view of the specific protein-ligand interactions that lead to potent inhibition of Src.  In particular, the 3-hydroxyphenethyl N9 substituent of AP23464 forms unique interactions with the protein that are crit. to the picomolar affinity of this compd. for Src.  The comparison of these new structures with two relevant kinase-inhibitor complexes provides a structural basis for the obsd. kinase inhibitory selectivity.  Further comparisons reveal a concerted induced-fit movement between the N- and C-terminal lobes of the kinase that correlates with the affinity of the ligand.  Binding of the most potent inhibitor, AP23464, results in the largest induced-fit movement, which can be directly linked to interactions of the hydrophenethyl N9 substituent with a region at the interface between the two lobes.  A less pronounced induced-fit movement is also obsd. in the Src-AP23451 complex.  These new structures illustrate how the combination of structural, computational, and medicinal chem. can be used to rationalize the process of developing high affinity, selective tyrosine kinase inhibitors as potential therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqAcWZyLy8JrVg90H21EOLACvtfcHk0lha4qN4Yxm7fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7Y%253D&md5=5a89de976e29e65aec0553c84e2e0b92</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2005.00316.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2005.00316.x%26sid%3Dliteratum%253Aachs%26aulast%3DDalgarno%26aufirst%3DD.%26aulast%3DStehle%26aufirst%3DT.%26aulast%3DNarula%26aufirst%3DS.%26aulast%3DSchelling%26aufirst%3DP.%26aulast%3Dvan%2BSchravendijk%26aufirst%3DM.%2BR.%26aulast%3DAdams%26aufirst%3DS.%26aulast%3DAndrade%26aufirst%3DL.%26aulast%3DKeats%26aufirst%3DJ.%26aulast%3DRam%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DGrossman%26aufirst%3DT.%26aulast%3DMacNeil%26aufirst%3DI.%26aulast%3DMetcalf%26aufirst%3DC.%26aulast%3DShakespeare%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKeenan%26aufirst%3DT.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DBohacek%26aufirst%3DR.%26aulast%3DWeigele%26aufirst%3DM.%26aulast%3DSawyer%26aufirst%3DT.%26atitle%3DStructural%2520basis%2520of%2520Src%2520tyrosine%2520kinase%2520inhibition%2520with%2520a%2520new%2520class%2520of%2520potent%2520and%2520selective%2520trisubstituted%2520purine-based%2520compounds%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D46%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group">Shakespeare, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohacek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, C.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dilauro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roeloffzen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltmarsh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paramanathan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgarno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradeepan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Schravendijk, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keats, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iuliucci, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigele, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T. K.</span><span> </span><span class="NLM_article-title">SAR of carbon-linked, 2-substituted purines: synthesis and characterization of AP23451 as a novel bone-targeted inhibitor of Src tyrosine kinase with in vivo anti-resorptive activity</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1111%2Fj.1747-0285.2007.00615.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18179464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFSntbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=97-105&author=W.+C.+Shakespeareauthor=Y.+Wangauthor=R.+Bohacekauthor=T.+Keenanauthor=R.+Sundaramoorthiauthor=C.+Metcalfauthor=A.+Dilauroauthor=S.+Roeloffzenauthor=S.+Liuauthor=J.+Saltmarshauthor=G.+Paramanathanauthor=D.+Dalgarnoauthor=S.+Narulaauthor=S.+Pradeepanauthor=M.+R.+van+Schravendijkauthor=J.+Keatsauthor=M.+Ramauthor=S.+Liouauthor=S.+Adamsauthor=S.+Wardwellauthor=J.+Bogusauthor=J.+Iuliucciauthor=M.+Weigeleauthor=L.+Xingauthor=B.+Boyceauthor=T.+K.+Sawyer&title=SAR+of+carbon-linked%2C+2-substituted+purines%3A+synthesis+and+characterization+of+AP23451+as+a+novel+bone-targeted+inhibitor+of+Src+tyrosine+kinase+with+in+vivo+anti-resorptive+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">SAR of carbon-linked, 2-substituted purines: synthesis and characterization of AP23451 as a novel bone-targeted inhibitor of Src tyrosine kinase with in vivo anti-resorptive activity</span></div><div class="casAuthors">Shakespeare, William C.; Wang, Yihan; Bohacek, Regine; Keenan, Terry; Sundaramoorthi, Raji; Metcalf, Chet, III; Dilauro, Anne; Roeloffzen, Sonya; Liu, Shuangying; Saltmarsh, Jennifer; Paramanathan, Guru; Dalgarno, David; Narula, Surinder; Pradeepan, Selvi; van Schravendijk, Marie Rose; Keats, Jeff; Ram, Mary; Liou, Shuenn; Adams, Susan; Wardwell, Scott; Bogus, Julie; Iuliucci, John; Weigele, Manfred; Xing, Lianping; Boyce, Brendan; Sawyer, Tomi K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-105</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Targeted disruption of the pp60src (Src) gene has implicated this tyrosine kinase in osteoclast-mediated bone resorption and as a therapeutic target for the treatment of osteoporosis and other bone-related diseases.  Here, we describe structure activity relationships of a novel series of carbon-linked, 2-substituted purines that led to the identification of AP23451 as a potent inhibitor of Src tyrosine kinase with antiresorptive activity in vivo.  AP23451 features the use of an arylphosphinylmethylphosphinic acid moiety which confers bone-targeting properties to the mol., thereby increasing local concns. of the inhibitor to actively resorbing osteoclasts at the bone interface.  AP23451 exhibited an IC50 = 68 nM against Src kinase; an x-ray crystal structure of the mol. complexed with Src detailed the mol. interactions responsible for its Src inhibition.  In vivo, AP23451 demonstrated a dose-dependent decrease in PTH-induced hypercalcemia.  Moreover, AP23517, a structurally and biochem. similar mol. with comparable activity (IC50 = 73 nM) except devoid of the bone-targeting element, demonstrated significantly reduced in vivo efficacy, suggesting that Src activity was necessary but not sufficient for in vivo activity in this series of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMOkUhcT4xFrVg90H21EOLACvtfcHk0ljIPvapdvzvSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFSntbs%253D&md5=256b265a9c89d3702881efdd357c31f9</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2007.00615.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2007.00615.x%26sid%3Dliteratum%253Aachs%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBohacek%26aufirst%3DR.%26aulast%3DKeenan%26aufirst%3DT.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DMetcalf%26aufirst%3DC.%26aulast%3DDilauro%26aufirst%3DA.%26aulast%3DRoeloffzen%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DSaltmarsh%26aufirst%3DJ.%26aulast%3DParamanathan%26aufirst%3DG.%26aulast%3DDalgarno%26aufirst%3DD.%26aulast%3DNarula%26aufirst%3DS.%26aulast%3DPradeepan%26aufirst%3DS.%26aulast%3Dvan%2BSchravendijk%26aufirst%3DM.%2BR.%26aulast%3DKeats%26aufirst%3DJ.%26aulast%3DRam%26aufirst%3DM.%26aulast%3DLiou%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DS.%26aulast%3DWardwell%26aufirst%3DS.%26aulast%3DBogus%26aufirst%3DJ.%26aulast%3DIuliucci%26aufirst%3DJ.%26aulast%3DWeigele%26aufirst%3DM.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DBoyce%26aufirst%3DB.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26atitle%3DSAR%2520of%2520carbon-linked%252C%25202-substituted%2520purines%253A%2520synthesis%2520and%2520characterization%2520of%2520AP23451%2520as%2520a%2520novel%2520bone-targeted%2520inhibitor%2520of%2520Src%2520tyrosine%2520kinase%2520with%2520in%2520vivo%2520anti-resorptive%2520activity%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2008%26volume%3D71%26spage%3D97%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group">Kingsley, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirgwin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guise, T. A.</span><span> </span><span class="NLM_article-title">Breaking new ground to build bone</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">10753</span><span class="NLM_x">–</span> <span class="NLM_lpage">10754</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=10753-10754&author=L.+A.+Kingsleyauthor=J.+M.+Chirgwinauthor=T.+A.+Guise&title=Breaking+new+ground+to+build+bone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKingsley%26aufirst%3DL.%2BA.%26aulast%3DChirgwin%26aufirst%3DJ.%2BM.%26aulast%3DGuise%26aufirst%3DT.%2BA.%26atitle%3DBreaking%2520new%2520ground%2520to%2520build%2520bone%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D10753%26epage%3D10754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group">Gil-Henn, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Destaing, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alles, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neff, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanjay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzaniti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Camilli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span> </span><span class="NLM_article-title">Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2−/− mice</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">1053</span><span class="NLM_x">–</span> <span class="NLM_lpage">1064</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2007&pages=1053-1064&author=H.+Gil-Hennauthor=O.+Destaingauthor=N.+A.+Simsauthor=K.+Aokiauthor=N.+Allesauthor=L.+Neffauthor=A.+Sanjayauthor=A.+Bruzzanitiauthor=P.+De+Camilliauthor=R.+Baronauthor=J.+Schlessinger&title=Defective+microtubule-dependent+podosome+organization+in+osteoclasts+leads+to+increased+bone+density+in+Pyk2%E2%88%92%2F%E2%88%92+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGil-Henn%26aufirst%3DH.%26aulast%3DDestaing%26aufirst%3DO.%26aulast%3DSims%26aufirst%3DN.%2BA.%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DAlles%26aufirst%3DN.%26aulast%3DNeff%26aufirst%3DL.%26aulast%3DSanjay%26aufirst%3DA.%26aulast%3DBruzzaniti%26aufirst%3DA.%26aulast%3DDe%2BCamilli%26aufirst%3DP.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DSchlessinger%26aufirst%3DJ.%26atitle%3DDefective%2520microtubule-dependent%2520podosome%2520organization%2520in%2520osteoclasts%2520leads%2520to%2520increased%2520bone%2520density%2520in%2520Pyk2%25E2%2588%2592%252F%25E2%2588%2592%2520mice%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2007%26volume%3D178%26spage%3D1053%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group">Buckbinder, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnette, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hambor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasser, W. A.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzzio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulford, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebhard, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smock, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman-Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span> </span><span class="NLM_article-title">Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">10619</span><span class="NLM_x">–</span> <span class="NLM_lpage">10624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1073%2Fpnas.0701421104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17537919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnt1Ohtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=10619-10624&author=L.+Buckbinderauthor=D.+T.+Crawfordauthor=H.+Qiauthor=H.+Z.+Keauthor=L.+M.+Olsonauthor=K.+R.+Longauthor=P.+C.+Bonnetteauthor=A.+P.+Baumannauthor=J.+E.+Hamborauthor=W.+A.+Grasserauthor=L.+C.+Panauthor=T.+A.+Owenauthor=M.+J.+Luzzioauthor=C.+A.+Hulfordauthor=D.+F.+Gebhardauthor=V.+M.+Paralkarauthor=H.+A.+Simmonsauthor=J.+C.+Kathauthor=W.+G.+Robertsauthor=S.+L.+Smockauthor=A.+Guzman-Perezauthor=T.+A.+Brownauthor=M.+Li&title=Proline-rich+tyrosine+kinase+2+regulates+osteoprogenitor+cells+and+bone+formation%2C+and+offers+an+anabolic+treatment+approach+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis</span></div><div class="casAuthors">Buckbinder, Leonard; Crawford, David T.; Qi, Hong; Ke, Hua Zhu; Olson, Lisa M.; Long, Kelly R.; Bonnette, Peter C.; Baumann, Amy P.; Hambor, John E.; Grasser, William A., III; Pan, Lydia C.; Owen, Thomas A.; Luzzio, Michael J.; Hulford, Catherine A.; Gebhard, David F.; Paralkar, Vishwas M.; Simmons, Hollis A.; Kath, John C.; Roberts, W. Gregory; Smock, Steven L.; Guzman-Perez, Angel; Brown, Thomas A.; Li, Mei</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">10619-10624</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Bone is accrued and maintained primarily through the coupled actions of bone-forming osteoblasts and bone-resorbing osteoclasts.  Cumulative in vitro studies indicated that proline-rich tyrosine kinase 2 (PYK2) is a pos. mediator of osteoclast function and activity.  However, our investigation of PYK2-/- mice did not reveal evidence supporting an essential function for PYK2 in osteoclasts either in vivo or in culture.  We find that PYK2-/- mice have high bone mass resulting from an unexpected increase in bone formation.  Consistent with the in vivo findings, mouse bone marrow cultures show that PYK2 deficiency enhances differentiation and activity of osteoprogenitor cells, as does expressing a PYK2-specific short hairpin RNA or dominantly interfering proteins in human mesenchymal stem cells.  Furthermore, the daily administration of a small-mol. PYK2 inhibitor increases bone formation and protects against bone loss in ovariectomized rats, an established preclin. model of postmenopausal osteoporosis.  In summary, we find that PYK2 regulates the differentiation of early osteoprogenitor cells across species and that inhibitors of the PYK2 have potential as a bone anabolic approach for the treatment of osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpENpFzA2DSTrVg90H21EOLACvtfcHk0lgFSTB9CgPtXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnt1Ohtro%253D&md5=6327da043a470ce6c932d1f09c23fee8</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0701421104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0701421104%26sid%3Dliteratum%253Aachs%26aulast%3DBuckbinder%26aufirst%3DL.%26aulast%3DCrawford%26aufirst%3DD.%2BT.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DKe%26aufirst%3DH.%2BZ.%26aulast%3DOlson%26aufirst%3DL.%2BM.%26aulast%3DLong%26aufirst%3DK.%2BR.%26aulast%3DBonnette%26aufirst%3DP.%2BC.%26aulast%3DBaumann%26aufirst%3DA.%2BP.%26aulast%3DHambor%26aufirst%3DJ.%2BE.%26aulast%3DGrasser%26aufirst%3DW.%2BA.%26aulast%3DPan%26aufirst%3DL.%2BC.%26aulast%3DOwen%26aufirst%3DT.%2BA.%26aulast%3DLuzzio%26aufirst%3DM.%2BJ.%26aulast%3DHulford%26aufirst%3DC.%2BA.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26aulast%3DSimmons%26aufirst%3DH.%2BA.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26aulast%3DSmock%26aufirst%3DS.%2BL.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DT.%2BA.%26aulast%3DLi%26aufirst%3DM.%26atitle%3DProline-rich%2520tyrosine%2520kinase%25202%2520regulates%2520osteoprogenitor%2520cells%2520and%2520bone%2520formation%252C%2520and%2520offers%2520an%2520anabolic%2520treatment%2520approach%2520for%2520osteoporosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D10619%26epage%3D10624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group">Siu, L. L.; Burris, H. A.; Mileshkin, L.; Camidge, D. R.; Rischin, D.; Chen, E. X.; Jones, S.; Yin, D.; Fingert, H.</span><span> </span><span class="NLM_article-title">Phase 1 study of a focal adhesion kinase (FAK) inhibitor PF-00562271 in patients (pts) with advanced solid tumors</span>.  <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span>, Abstract 3527.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&author=L.+L.+Siu&author=H.+A.+Burris&author=L.+Mileshkin&author=D.+R.+Camidge&author=D.+Rischin&author=E.+X.+Chen&author=S.+Jones&author=D.+Yin&author=H.+Fingert&title=Phase+1+study+of+a+focal+adhesion+kinase+%28FAK%29+inhibitor+PF-00562271+in+patients+%28pts%29+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DL.%2BL.%26atitle%3DPhase%25201%2520study%2520of%2520a%2520focal%2520adhesion%2520kinase%2520%2528FAK%2529%2520inhibitor%2520PF-00562271%2520in%2520patients%2520%2528pts%2529%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnette, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrunyk, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aspnes, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brosius, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckbinder, L.</span><span> </span><span class="NLM_article-title">Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique (DFG-out) conformation and enables inhibitor design</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">13193</span><span class="NLM_x">–</span> <span class="NLM_lpage">13201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1074%2Fjbc.M809038200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19244237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltlemtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=13193-13201&author=S.+Hanauthor=A.+Mistryauthor=J.+S.+Changauthor=D.+Cunninghamauthor=M.+Grifforauthor=P.+C.+Bonnetteauthor=H.+Wangauthor=B.+A.+Chrunykauthor=G.+E.+Aspnesauthor=D.+P.+Walkerauthor=A.+D.+Brosiusauthor=L.+Buckbinder&title=Structural+characterization+of+proline-rich+tyrosine+kinase+2+%28PYK2%29+reveals+a+unique+%28DFG-out%29+conformation+and+enables+inhibitor+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Characterization of Proline-rich Tyrosine Kinase 2 (PYK2) Reveals a Unique (DFG-out) Conformation and Enables Inhibitor Design</span></div><div class="casAuthors">Han, Seungil; Mistry, Anil; Chang, Jeanne S.; Cunningham, David; Griffor, Matt; Bonnette, Peter C.; Wang, Hong; Chrunyk, Boris A.; Aspnes, Gary E.; Walker, Daniel P.; Brosius, Arthur D.; Buckbinder, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">13193-13201</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Proline-rich tyrosine kinase 2 (PYK2) is a cytoplasmic, non-receptor tyrosine kinase implicated in multiple signaling pathways.  It is a neg. regulator of osteogenesis and considered a viable drug target for osteoporosis treatment.  The high-resoln. structures of the human PYK2 kinase domain with different inhibitor complexes establish the conventional bilobal kinase architecture and show the conformational variability of the DFG loop.  The basis for the lack of selectivity for the classical kinase inhibitor, PF-431396, within the FAK family is explained by our structural analyses.  Importantly, the novel DFG-out conformation with two diarylurea inhibitors (BIRB796, PF-4618433) reveals a distinct subclass of non-receptor tyrosine kinases identifiable by the gatekeeper Met-502 and the unique hinge loop conformation of Leu-504.  This is the first example of a leucine residue in the hinge loop that blocks the ATP binding site in the DFG-out conformation.  Our structural, biophys., and pharmacol. studies suggest that the unique features of the DFG motif, including Leu-504 hinge-loop variability, can be exploited for the development of selective protein kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRnQx5xeYf37Vg90H21EOLACvtfcHk0lgFSTB9CgPtXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltlemtr4%253D&md5=3fc4091566d670f2293f8424dd72243c</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M809038200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M809038200%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DMistry%26aufirst%3DA.%26aulast%3DChang%26aufirst%3DJ.%2BS.%26aulast%3DCunningham%26aufirst%3DD.%26aulast%3DGriffor%26aufirst%3DM.%26aulast%3DBonnette%26aufirst%3DP.%2BC.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DChrunyk%26aufirst%3DB.%2BA.%26aulast%3DAspnes%26aufirst%3DG.%2BE.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBrosius%26aufirst%3DA.%2BD.%26aulast%3DBuckbinder%26aufirst%3DL.%26atitle%3DStructural%2520characterization%2520of%2520proline-rich%2520tyrosine%2520kinase%25202%2520%2528PYK2%2529%2520reveals%2520a%2520unique%2520%2528DFG-out%2529%2520conformation%2520and%2520enables%2520inhibitor%2520design%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D13193%26epage%3D13201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group">Allen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, C.-Y. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Connor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roveto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babij, P.</span><span> </span><span class="NLM_article-title">Identification of small molecule inhibitors of proline-rich tyrosine kinase 2 (Pyk2) with osteogenic activity in osteoblast cells</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4924</span><span class="NLM_x">–</span> <span class="NLM_lpage">4928</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4924-4928&author=J.+G.+Allenauthor=M.+R.+Leeauthor=C.-Y.+E.+Hanauthor=J.+Scherrerauthor=S.+Flynnauthor=C.+Boucherauthor=H.+Zhaoauthor=A.+B.+O%27Connorauthor=P.+Rovetoauthor=D.+Bauerauthor=R.+Graceffaauthor=W.+G.+Richardsauthor=P.+Babij&title=Identification+of+small+molecule+inhibitors+of+proline-rich+tyrosine+kinase+2+%28Pyk2%29+with+osteogenic+activity+in+osteoblast+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BG.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DHan%26aufirst%3DC.-Y.%2BE.%26aulast%3DScherrer%26aufirst%3DJ.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DO%2527Connor%26aufirst%3DA.%2BB.%26aulast%3DRoveto%26aufirst%3DP.%26aulast%3DBauer%26aufirst%3DD.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DBabij%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520small%2520molecule%2520inhibitors%2520of%2520proline-rich%2520tyrosine%2520kinase%25202%2520%2528Pyk2%2529%2520with%2520osteogenic%2520activity%2520in%2520osteoblast%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4924%26epage%3D4928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group">Liao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiipakka, R. A.</span><span> </span><span class="NLM_article-title">Green tea: biochemical and biological basis for health benefits</span> <span class="citation_source-journal">Vitam. Horm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2FS0083-6729%2801%2962001-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=11345896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlenu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2001&pages=1-94&author=S.+Liaoauthor=Y.-H.+Kaoauthor=R.+A.+Hiipakka&title=Green+tea%3A+biochemical+and+biological+basis+for+health+benefits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Green tea: biochemical and biological basis for health benefits</span></div><div class="casAuthors">Liao, Shutsung; Kao, Yung-Hsi; Hiipakka, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Vitamins and Hormones (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-94</span>CODEN:
                <span class="NLM_cas:coden">VIHOAQ</span>;
        ISSN:<span class="NLM_cas:issn">0083-6729</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review, with many refs., on the medical efficacy of green tea in the prevention and treatment of various diseases.  Pure green tea catechins have been used in a no. of studies examg. catechin effects on isolated enzyme systems and cells in cultures to det. the mol. mechanisms for the putative health benefits of green tea.  Topics discussed include: catechins and other constituents of green tea; structure, pharmacol., and metab. of catechins; chem. and biochem. properties of catechins; biol. activity of green tea catechins; and mol. and cellular bases for biol. effects of catechins.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBmXgIKSCIVLVg90H21EOLACvtfcHk0ljAN4vyyCYmtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktlenu7w%253D&md5=0ce9de01347e83b13ebf20460d37ee8f</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1016%2FS0083-6729%2801%2962001-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0083-6729%252801%252962001-6%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DS.%26aulast%3DKao%26aufirst%3DY.-H.%26aulast%3DHiipakka%26aufirst%3DR.%2BA.%26atitle%3DGreen%2520tea%253A%2520biochemical%2520and%2520biological%2520basis%2520for%2520health%2520benefits%26jtitle%3DVitam.%2520Horm.%26date%3D2001%26volume%3D62%26spage%3D1%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group">Delaisse, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eeckhout, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaes, G.</span><span> </span><span class="NLM_article-title">Inhibition of bone resorption in culture by (+)-catechin</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">3091</span><span class="NLM_x">–</span> <span class="NLM_lpage">3094</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1986&pages=3091-3094&author=J.+M.+Delaisseauthor=Y.+Eeckhoutauthor=G.+Vaes&title=Inhibition+of+bone+resorption+in+culture+by+%28%2B%29-catechin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelaisse%26aufirst%3DJ.%2BM.%26aulast%3DEeckhout%26aufirst%3DY.%26aulast%3DVaes%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520bone%2520resorption%2520in%2520culture%2520by%2520%2528%252B%2529-catechin%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1986%26volume%3D35%26spage%3D3091%26epage%3D3094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group">Lin, R.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.-J.</span><span> </span><span class="NLM_article-title">(−)-Epigallocatechin gallate inhibition of osteoclastic differentiation via NF-kB</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">379</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2009&pages=1033-1037&author=R.-W.+Linauthor=C.-H.+Chenauthor=Y.-H.+Wangauthor=M.-L.+Hoauthor=S.-H.+Hungauthor=I.-S.+Chenauthor=G.-J.+Wang&title=%28%E2%88%92%29-Epigallocatechin+gallate+inhibition+of+osteoclastic+differentiation+via+NF-kB"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DR.-W.%26aulast%3DChen%26aufirst%3DC.-H.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DHo%26aufirst%3DM.-L.%26aulast%3DHung%26aufirst%3DS.-H.%26aulast%3DChen%26aufirst%3DI.-S.%26aulast%3DWang%26aufirst%3DG.-J.%26atitle%3D%2528%25E2%2588%2592%2529-Epigallocatechin%2520gallate%2520inhibition%2520of%2520osteoclastic%2520differentiation%2520via%2520NF-kB%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D379%26spage%3D1033%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group">Chang, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. W.</span><span> </span><span class="NLM_article-title">Proliferative effects of flavan-3-ols and propelargonidins from rhizomes of <i>Drynaria fortunei</i> on MCF-7 and osteoblastic cells</span> <span class="citation_source-journal">Arch. Pharmacal Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">620</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1007%2FBF02976711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=12967197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Wgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2003&pages=620-630&author=E.+J.+Changauthor=W.+J.+Leeauthor=S.+H.+Choauthor=S.+W.+Choi&title=Proliferative+effects+of+flavan-3-ols+and+propelargonidins+from+rhizomes+of+Drynaria+fortunei+on+MCF-7+and+osteoblastic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Proliferative effects of flavan-3-ols and propelargonidins from rhizomes of Drynaria fortunei on MCF-7 and osteoblastic cells</span></div><div class="casAuthors">Chang, Eun Ju; Lee, Won Jung; Cho, Sung Hee; Choi, Sang Won</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">620-630</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">The proliferative effects of thirty Oriental medicinal herbs on MCF-7 (estrogen-sensitive breast cancer cell line) and ROS 17/2.8 osteoblast-like cells were detd. using the MTT assay.  Methanol exts. from several herbs was found to show proliferative activity on the above two cell lines in the range of 5 to 100 μg/mL.  Among these active herbs, the methanol ext. from the rhizomes of Drynaria fortunei showed the most potent proliferative activity, and the cell proliferations were significantly increase by 136 and 158% in the MCF-7 and ROS 17/2.8 cells, resp., when treated with 100 μg/mL.  Through a bioassay-guided sepn., eight flavonoids, including four new flavan-3-ols and two propelargonidins, together with the known (-)-epiafzelechin and naringin, were isolated.  Their chem. structures were characterized as (-)-epiafzelechin (1), (-)-epiafzelechin-3-O-β-D-allopyranoside (2), (-)-epiafzelechin-3-O-(6''-O-acetyl)-β-D-allopyranoside (3), 4β-carboxymethyl-(-)-epiafzelechin Me ester (4), 4β-carboxymethyl-(-)-epiafzelechin sodium salt (5), naringin (6), (-)-epiafzelechin-(4β→8)-4β-carboxymethylepiafzelechin Me ester (7) and (-)-epiafzelechin-(4β→8, 2β→O→7)-epiafzelechin-(4β→8)-epiafzelechin (8) by extensive 1D and 2D NMR spectroscopy.  Most of these flavonoids, in the range of 10-15∼10-6 M, accelerated the proliferation of MCF-7 cell, with compds. 7 and 8, in the range of 10-15∼10-12 M, showing esp. potent proliferation effects.  Meanwhile, seven flavonoids, with the exception of compd. 4, stimulated the proliferation of ROS 17/2.8 cells in the range of 10-15∼10-6 M, with compds. 5-8 esp. accelerating the proliferation, in dose-dependent manners (10-15∼10-9 M), and their proliferative effect was much stronger than that of E2 and genistein.  These results suggest that propelargonidin dimers and trimers isolated from the rhizomes of Drynaria fortunei may be useful as potential phytoestrogens, which play important physiol. roles in the prevention of postmenopausal osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU4_vU_xYRybVg90H21EOLACvtfcHk0ljMngBnr55QBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Wgtro%253D&md5=870accea2a6555d556ff86d7d4cf77ac</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1007%2FBF02976711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02976711%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DE.%2BJ.%26aulast%3DLee%26aufirst%3DW.%2BJ.%26aulast%3DCho%26aufirst%3DS.%2BH.%26aulast%3DChoi%26aufirst%3DS.%2BW.%26atitle%3DProliferative%2520effects%2520of%2520flavan-3-ols%2520and%2520propelargonidins%2520from%2520rhizomes%2520of%2520Drynaria%2520fortunei%2520on%2520MCF-7%2520and%2520osteoblastic%2520cells%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2003%26volume%3D26%26spage%3D620%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group">Wang, X.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, W.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, X.-S.</span><span> </span><span class="NLM_article-title">Effects of eleven flavonoids from the osteoprotective fraction of <i>Drynaria fortunei</i> (Kunze) J. SM. on osteoblastic proliferation using an osteoblast-like cell line</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2008&pages=46-51&author=X.-L.+Wangauthor=N.-L.+Wangauthor=Y.+Zhangauthor=H.+Gaoauthor=W.-Y.+Pangauthor=M.-S.+Wongauthor=G.+Zhangauthor=L.+Qinauthor=X.-S.+Yao&title=Effects+of+eleven+flavonoids+from+the+osteoprotective+fraction+of+Drynaria+fortunei+%28Kunze%29+J.+SM.+on+osteoblastic+proliferation+using+an+osteoblast-like+cell+line"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.-L.%26aulast%3DWang%26aufirst%3DN.-L.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DPang%26aufirst%3DW.-Y.%26aulast%3DWong%26aufirst%3DM.-S.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DQin%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DX.-S.%26atitle%3DEffects%2520of%2520eleven%2520flavonoids%2520from%2520the%2520osteoprotective%2520fraction%2520of%2520Drynaria%2520fortunei%2520%2528Kunze%2529%2520J.%2520SM.%2520on%2520osteoblastic%2520proliferation%2520using%2520an%2520osteoblast-like%2520cell%2520line%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2008%26volume%3D56%26spage%3D46%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group">Lee, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span> </span><span class="NLM_article-title">Osteoblast differentiation stimulating activity of biflavonoids from <i>Cephalotaxus koreana</i></span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2850</span><span class="NLM_x">–</span> <span class="NLM_lpage">2854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2850-2854&author=M.+K.+Leeauthor=S.+W.+Limauthor=H.+Yangauthor=S.+H.+Sungauthor=H.-S.+Leeauthor=M.+J.+Parkauthor=Y.+C.+Kim&title=Osteoblast+differentiation+stimulating+activity+of+biflavonoids+from+Cephalotaxus+koreana"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3DLim%26aufirst%3DS.%2BW.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSung%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DH.-S.%26aulast%3DPark%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BC.%26atitle%3DOsteoblast%2520differentiation%2520stimulating%2520activity%2520of%2520biflavonoids%2520from%2520Cephalotaxus%2520koreana%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2850%26epage%3D2854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group">Tung, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiem, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minh, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. H.</span><span> </span><span class="NLM_article-title">New anthracene glycosides from Rhodomyrtus tomentosa stimulate osteoblastic differentiation of MC3T3-E1 cells</span> <span class="citation_source-journal">Arch. Pharmacal Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1007%2Fs12272-009-1406-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19407968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Kjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=515-520&author=N.+H.+Tungauthor=Y.+Dingauthor=E.+M.+Choiauthor=P.+V.+Kiemauthor=C.+V.+Minhauthor=Y.+H.+Kim&title=New+anthracene+glycosides+from+Rhodomyrtus+tomentosa+stimulate+osteoblastic+differentiation+of+MC3T3-E1+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">New anthracene glycosides from Rhodomyrtus tomentosa stimulate osteoblastic differentiation of MC3T3-E1 cells</span></div><div class="casAuthors">Tung, Nguyen Huu; Ding, Yan; Choi, Eun Mi; Kiem, Phan Van; Minh, Chau Van; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">515-520</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">Two new anthracene glycosides (1-2) were isolated from aerial parts of Rhodomyrtus tomentosa, along with three known compds. (3-5).  The structures of two new compds. were established to be 4,8,9,10-tetrahydroxy-2,3,7-trimethoxyanthracene-6-O-β-D-glucopyranoside (1)and 2,4,7,8,9,10-hexahydroxy-3-methoxyanthracene-6-O-α-L-rhamnopyranoside (2) based on spectroscopic and chem. methods.  Among them, compd. 1, 2, and 5 significantly (P<0.05) increased the alk. phosphatase activity, collagen synthesis, and mineralization of the nodules of MC3T3-E1 osteoblastic cells compared to those of the control, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMcL5xMG8zu7Vg90H21EOLACvtfcHk0lhKdv2XNztaag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Kjs7g%253D&md5=b595a4670223d315c016a144d5bf92a7</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1007%2Fs12272-009-1406-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-009-1406-8%26sid%3Dliteratum%253Aachs%26aulast%3DTung%26aufirst%3DN.%2BH.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DChoi%26aufirst%3DE.%2BM.%26aulast%3DKiem%26aufirst%3DP.%2BV.%26aulast%3DMinh%26aufirst%3DC.%2BV.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DNew%2520anthracene%2520glycosides%2520from%2520Rhodomyrtus%2520tomentosa%2520stimulate%2520osteoblastic%2520differentiation%2520of%2520MC3T3-E1%2520cells%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2009%26volume%3D32%26spage%3D515%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group">Kiem, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tri, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuong, L. V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quang, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minh, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. H.</span><span> </span><span class="NLM_article-title">Chemical constituents from the leaves of <i>Manglietia phuthoensis</i> and their effects on osteoblastic MC3T3-E1 cells</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1270</span><span class="NLM_x">–</span> <span class="NLM_lpage">1275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2008&pages=1270-1275&author=P.+V.+Kiemauthor=M.+D.+Triauthor=L.+V.+D.+Tuongauthor=H.+T.+Nguyenauthor=N.+H.+Nguyenauthor=T.+H.+Quangauthor=X.+C.+Nguyenauthor=C.+V.+Minhauthor=E.-M.+Choiauthor=Y.+H.+Kim&title=Chemical+constituents+from+the+leaves+of+Manglietia+phuthoensis+and+their+effects+on+osteoblastic+MC3T3-E1+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiem%26aufirst%3DP.%2BV.%26aulast%3DTri%26aufirst%3DM.%2BD.%26aulast%3DTuong%26aufirst%3DL.%2BV.%2BD.%26aulast%3DNguyen%26aufirst%3DH.%2BT.%26aulast%3DNguyen%26aufirst%3DN.%2BH.%26aulast%3DQuang%26aufirst%3DT.%2BH.%26aulast%3DNguyen%26aufirst%3DX.%2BC.%26aulast%3DMinh%26aufirst%3DC.%2BV.%26aulast%3DChoi%26aufirst%3DE.-M.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DChemical%2520constituents%2520from%2520the%2520leaves%2520of%2520Manglietia%2520phuthoensis%2520and%2520their%2520effects%2520on%2520osteoblastic%2520MC3T3-E1%2520cells%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2008%26volume%3D56%26spage%3D1270%26epage%3D1275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group">Cuong, N. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuan, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiem, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minh, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. H.</span><span> </span><span class="NLM_article-title">New cembranoid diterpenes from the Vietnamese soft coral <i>Sarcophyton mililatensis</i> stimulate osteoblastic differentiation in MC3T3-E1 cells</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">–</span> <span class="NLM_lpage">992</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2008&pages=988-992&author=N.+X.+Cuongauthor=T.+A.+Tuanauthor=P.+V.+Kiemauthor=C.+V.+Minhauthor=E.+M.+Choiauthor=Y.+H.+Kim&title=New+cembranoid+diterpenes+from+the+Vietnamese+soft+coral+Sarcophyton+mililatensis+stimulate+osteoblastic+differentiation+in+MC3T3-E1+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuong%26aufirst%3DN.%2BX.%26aulast%3DTuan%26aufirst%3DT.%2BA.%26aulast%3DKiem%26aufirst%3DP.%2BV.%26aulast%3DMinh%26aufirst%3DC.%2BV.%26aulast%3DChoi%26aufirst%3DE.%2BM.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DNew%2520cembranoid%2520diterpenes%2520from%2520the%2520Vietnamese%2520soft%2520coral%2520Sarcophyton%2520mililatensis%2520stimulate%2520osteoblastic%2520differentiation%2520in%2520MC3T3-E1%2520cells%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2008%26volume%3D56%26spage%3D988%26epage%3D992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S. X.</span><span> </span><span class="NLM_article-title">Skeleton-rearranged pentacyclic diterpenoids possessing a cyclobutane ring from Euphorbia wallichii</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2775</span><span class="NLM_x">–</span> <span class="NLM_lpage">2778</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0608552" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVCgsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=2775-2778&author=L.+Panauthor=P.+Zhouauthor=X.+Zhangauthor=S.+Pengauthor=L.+Dingauthor=S.+X.+Qiu&title=Skeleton-rearranged+pentacyclic+diterpenoids+possessing+a+cyclobutane+ring+from+Euphorbia+wallichii"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Skeleton-Rearranged Pentacyclic Diterpenoids Possessing a Cyclobutane Ring om Euphorbia wallichii</span></div><div class="casAuthors">Pan, Li; Zhou, Ping; Zhang, Xiaofeng; Peng, Shulin; Ding, Lisheng; Qiu, Samuel X.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2775-2778</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two novel rearranged trachylobane diterpenoids, designated as wallichanol A (I) and wallichanol B, consisting of an unprecedented pentacyclic skeleton named wallichane with a cyclobutane ring, and a new ent-trachylobane diterpenoid, 3-oxo-ent-trachyloban-17-oic acid, were isolated om the roots of Euphorbia wallichii.  Their structures were elucidated by comprehensive anal. of 2D-NMR spectroscopic data, with the stereochem. of 1 confirmed by X-ray crystallog. study.  All of these compds. potently block osteoclastogenesis in vitro, suggesting a potential therapeutic application in prevention of osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRe_vVsVZyl7Vg90H21EOLACvtfcHk0lhKdv2XNztaag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVCgsbc%253D&md5=40f5339cfe213dc4f509d5a2faa5ddfb</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1021%2Fol0608552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0608552%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DS.%2BX.%26atitle%3DSkeleton-rearranged%2520pentacyclic%2520diterpenoids%2520possessing%2520a%2520cyclobutane%2520ring%2520from%2520Euphorbia%2520wallichii%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D2775%26epage%3D2778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group">Qiu, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, L.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farnsworth, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span> </span><span class="NLM_article-title">A triterpene glycoside from black cohosh that inhibits osteoclastogenesis by modulating RANKL and TNFα signaling pathways</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">860</span><span class="NLM_x">–</span> <span class="NLM_lpage">869</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.chembiol.2007.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17656322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlSnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=860-869&author=S.+X.+Qiuauthor=C.+Danauthor=L.-S.+Dingauthor=S.+Pengauthor=S.-N.+Chenauthor=N.+R.+Farnsworthauthor=J.+Noltaauthor=M.+L.+Grossauthor=P.+Zhou&title=A+triterpene+glycoside+from+black+cohosh+that+inhibits+osteoclastogenesis+by+modulating+RANKL+and+TNF%CE%B1+signaling+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">A Triterpene Glycoside from Black Cohosh that Inhibits Osteoclastogenesis by Modulating RANKL and TNFα Signaling Pathways</span></div><div class="casAuthors">Qiu, Samuel X.; Dan, Chun; Ding, Li-Sheng; Peng, Shulin; Chen, Shao-Nong; Farnsworth, Norman R.; Nolta, Jan; Gross, Michael L.; Zhou, Ping</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">860-869</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Osteoporosis is a major age-related source of morbidity and mortality.  Increased bone resorption mediated by osteoclasts is central to its pathogenesis.  Cytokines, particularly RANKL and TNFα, are often increased under pathol. conditions, leading to enhanced osteoclastogenesis.  Black cohosh (Actaea/Cimicifuga racemosa L), a popular herbal supplement for the treatment of menopausal symptoms, was recently shown to have the beneficial effect of preventing bone loss.  Here, the authors demonstrate that 25-acetylcimigenol xylopyranoside (ACCX), a triterpenoid glycoside isolated from black cohosh, potently blocks in vitro osteoclastogenesis induced by either RANKL or TNFα.  This blockage of osteoclastogenesis elicited by ACCX results from abrogation of the NF-κB and ERK pathways induced by either RANKL or TNFα, resp.  Importantly, this compd. attenuates TNFα-induced bone loss in vivo.  Therefore, ACCX represents a potential lead for the development of a new class of antiosteoporosis agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUxbJizDoiZrVg90H21EOLACvtfcHk0lhKdv2XNztaag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlSnu7k%253D&md5=90148213836966465d286426ed907702</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2007.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2007.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DS.%2BX.%26aulast%3DDan%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DL.-S.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DS.-N.%26aulast%3DFarnsworth%26aufirst%3DN.%2BR.%26aulast%3DNolta%26aufirst%3DJ.%26aulast%3DGross%26aufirst%3DM.%2BL.%26aulast%3DZhou%26aufirst%3DP.%26atitle%3DA%2520triterpene%2520glycoside%2520from%2520black%2520cohosh%2520that%2520inhibits%2520osteoclastogenesis%2520by%2520modulating%2520RANKL%2520and%2520TNF%25CE%25B1%2520signaling%2520pathways%26jtitle%3DChem.%2520Biol.%26date%3D2007%26volume%3D14%26spage%3D860%26epage%3D869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group">Khosla, S.</span><span> </span><span class="NLM_article-title">Increasing options for the treatment of osteoporosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">818</span><span class="NLM_x">–</span> <span class="NLM_lpage">820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1056%2FNEJMe0905480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19671654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWltrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=818-820&author=S.+Khosla&title=Increasing+options+for+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Increasing options for the treatment of osteoporosis</span></div><div class="casAuthors">Khosla, Sundeep</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">818-820</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbUHU7TMyG9rVg90H21EOLACvtfcHk0lgH-A3uMY4Pqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWltrnL&md5=ef4cce192b0a1788053a59c765a81911</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1056%2FNEJMe0905480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMe0905480%26sid%3Dliteratum%253Aachs%26aulast%3DKhosla%26aufirst%3DS.%26atitle%3DIncreasing%2520options%2520for%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D818%26epage%3D820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group">Canalis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giustina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span> </span><span class="NLM_article-title">Mechanisms of anabolic therapies for osteoporosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1056%2FNEJMra067395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17761594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvVylurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2007&pages=905-916&author=E.+Canalisauthor=A.+Giustinaauthor=J.+P.+Bilezikian&title=Mechanisms+of+anabolic+therapies+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of anabolic therapies for osteoporosis</span></div><div class="casAuthors">Canalis, Ernesto; Giustina, Andrea; Bilezikian, John P.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">905-916</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review on mechanisms of anabolic therapies for osteoporosis.  The subtitles include: (1) bone remodeling and modeling; (2) signals that regulate bone formation; (3) clinic relevance of anabolic signaling mols.; (4) other candidate mols. for anabolic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryIE9xAuRdirVg90H21EOLACvtfcHk0lgH-A3uMY4Pqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvVylurk%253D&md5=97d892443d8a7a2d581ee3990e892e7e</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1056%2FNEJMra067395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra067395%26sid%3Dliteratum%253Aachs%26aulast%3DCanalis%26aufirst%3DE.%26aulast%3DGiustina%26aufirst%3DA.%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26atitle%3DMechanisms%2520of%2520anabolic%2520therapies%2520for%2520osteoporosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2007%26volume%3D357%26spage%3D905%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group">Yadav, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingrich, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glorieux, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajac, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insogna, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karsenty, G.</span><span> </span><span class="NLM_article-title">Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2008&pages=825-837&author=V.+K.+Yadavauthor=J.-H.+Ryuauthor=N.+Sudaauthor=K.+F.+Tanakaauthor=J.+A.+Gingrichauthor=G.+Schutzauthor=F.+H.+Glorieuxauthor=C.+Y.+Chiangauthor=J.+D.+Zajacauthor=K.+L.+Insognaauthor=J.+J.+Mannauthor=R.+Henauthor=P.+Ducyauthor=G.+Karsenty&title=Lrp5+controls+bone+formation+by+inhibiting+serotonin+synthesis+in+the+duodenum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DV.%2BK.%26aulast%3DRyu%26aufirst%3DJ.-H.%26aulast%3DSuda%26aufirst%3DN.%26aulast%3DTanaka%26aufirst%3DK.%2BF.%26aulast%3DGingrich%26aufirst%3DJ.%2BA.%26aulast%3DSchutz%26aufirst%3DG.%26aulast%3DGlorieux%26aufirst%3DF.%2BH.%26aulast%3DChiang%26aufirst%3DC.%2BY.%26aulast%3DZajac%26aufirst%3DJ.%2BD.%26aulast%3DInsogna%26aufirst%3DK.%2BL.%26aulast%3DMann%26aufirst%3DJ.%2BJ.%26aulast%3DHen%26aufirst%3DR.%26aulast%3DDucy%26aufirst%3DP.%26aulast%3DKarsenty%26aufirst%3DG.%26atitle%3DLrp5%2520controls%2520bone%2520formation%2520by%2520inhibiting%2520serotonin%2520synthesis%2520in%2520the%2520duodenum%26jtitle%3DCell%26date%3D2008%26volume%3D135%26spage%3D825%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group">Yadav, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oury, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Confavreux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klemenhagen, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingrich, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, X. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tecott, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karsenty, G.</span><span> </span><span class="NLM_article-title">A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">976</span><span class="NLM_x">–</span> <span class="NLM_lpage">989</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2009&pages=976-989&author=V.+K.+Yadavauthor=F.+Ouryauthor=N.+Sudaauthor=Z.-W.+Liuauthor=X.-B.+Gaoauthor=C.+Confavreuxauthor=K.+C.+Klemenhagenauthor=K.+F.+Tanakaauthor=J.+A.+Gingrichauthor=X.+E.+Guoauthor=L.+H.+Tecottauthor=J.+J.+Mannauthor=R.+Henauthor=T.+L.+Horvathauthor=G.+Karsenty&title=A+serotonin-dependent+mechanism+explains+the+leptin+regulation+of+bone+mass%2C+appetite%2C+and+energy+expenditure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DV.%2BK.%26aulast%3DOury%26aufirst%3DF.%26aulast%3DSuda%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DZ.-W.%26aulast%3DGao%26aufirst%3DX.-B.%26aulast%3DConfavreux%26aufirst%3DC.%26aulast%3DKlemenhagen%26aufirst%3DK.%2BC.%26aulast%3DTanaka%26aufirst%3DK.%2BF.%26aulast%3DGingrich%26aufirst%3DJ.%2BA.%26aulast%3DGuo%26aufirst%3DX.%2BE.%26aulast%3DTecott%26aufirst%3DL.%2BH.%26aulast%3DMann%26aufirst%3DJ.%2BJ.%26aulast%3DHen%26aufirst%3DR.%26aulast%3DHorvath%26aufirst%3DT.%2BL.%26aulast%3DKarsenty%26aufirst%3DG.%26atitle%3DA%2520serotonin-dependent%2520mechanism%2520explains%2520the%2520leptin%2520regulation%2520of%2520bone%2520mass%252C%2520appetite%252C%2520and%2520energy%2520expenditure%26jtitle%3DCell%26date%3D2009%26volume%3D138%26spage%3D976%26epage%3D989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group">Schwan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, P.</span><span> </span><span class="NLM_article-title">SSRIs, bone mineral density, and risk of fractures—a review</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.euroneuro.2009.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19541458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVKrsbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=683-692&author=S.+Schwanauthor=P.+Hallberg&title=SSRIs%2C+bone+mineral+density%2C+and+risk+of+fractures%E2%80%94a+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">SSRIs, bone mineral density, and risk of fractures - a review</span></div><div class="casAuthors">Schwan, Sofie; Hallberg, Paer</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">683-692</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A possibility for selective serotonin reuptake inhibitors (SSRIs) to increase the risk of bone fracture has been debated during recent years.  Proposed causes include an ability for the drugs to reduce bone mineral d. (BMD).  Exptl. data have identified a functional 5-HT system in bone, although its role is unclear.  Results from numerous epidemiol. studies are heterogeneous and several different assocns. have been suggested; between depression and low BMD, SSRIs and low BMD, depression and falls, SSRIs and falls, depression and fractures, and SSRIs and fractures.  In this paper, we review the available data and discuss the various study results.  Based on the current available data, we conclude that it is not possible to det. whether SSRIs may neg. influence bone regulation or are innocent bystanders.  It is likely that only a large, prospective, long-term study designed to investigate changes in BMD will be able to answer the question.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH8YDkzKzvgrVg90H21EOLACvtfcHk0ljtCu0nE4RYZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVKrsbzE&md5=7617662d8e7583c7888a1f487e576c14</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2009.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2009.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DSchwan%26aufirst%3DS.%26aulast%3DHallberg%26aufirst%3DP.%26atitle%3DSSRIs%252C%2520bone%2520mineral%2520density%252C%2520and%2520risk%2520of%2520fractures%25E2%2580%2594a%2520review%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2009%26volume%3D19%26spage%3D683%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group">Jones, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oukka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofstaetter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glimcher, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glimcher, L. H.</span><span> </span><span class="NLM_article-title">Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">1223</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2006&pages=1223-1227&author=D.+C.+Jonesauthor=M.+N.+Weinauthor=M.+Oukkaauthor=J.+G.+Hofstaetterauthor=M.+J.+Glimcherauthor=L.+H.+Glimcher&title=Regulation+of+adult+bone+mass+by+the+zinc+finger+adapter+protein+Schnurri-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DD.%2BC.%26aulast%3DWein%26aufirst%3DM.%2BN.%26aulast%3DOukka%26aufirst%3DM.%26aulast%3DHofstaetter%26aufirst%3DJ.%2BG.%26aulast%3DGlimcher%26aufirst%3DM.%2BJ.%26aulast%3DGlimcher%26aufirst%3DL.%2BH.%26atitle%3DRegulation%2520of%2520adult%2520bone%2520mass%2520by%2520the%2520zinc%2520finger%2520adapter%2520protein%2520Schnurri-3%26jtitle%3DScience%26date%3D2006%26volume%3D312%26spage%3D1223%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group">Yamashita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, S.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, C.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. E.</span><span> </span><span class="NLM_article-title">Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2005&pages=101-113&author=M.+Yamashitaauthor=S.-X.+Yingauthor=G.-M.+Zhangauthor=C.+Liauthor=S.+Y.+Chengauthor=C.-X.+Dengauthor=Y.+E.+Zhang&title=Ubiquitin+ligase+Smurf1+controls+osteoblast+activity+and+bone+homeostasis+by+targeting+MEKK2+for+degradation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamashita%26aufirst%3DM.%26aulast%3DYing%26aufirst%3DS.-X.%26aulast%3DZhang%26aufirst%3DG.-M.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DS.%2BY.%26aulast%3DDeng%26aufirst%3DC.-X.%26aulast%3DZhang%26aufirst%3DY.%2BE.%26atitle%3DUbiquitin%2520ligase%2520Smurf1%2520controls%2520osteoblast%2520activity%2520and%2520bone%2520homeostasis%2520by%2520targeting%2520MEKK2%2520for%2520degradation%26jtitle%3DCell%26date%3D2005%26volume%3D121%26spage%3D101%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyajobi, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mundy, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span> </span><span class="NLM_article-title">Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">12854</span><span class="NLM_x">–</span> <span class="NLM_lpage">12859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=12854-12859&author=M.+Zhaoauthor=M.+Qiaoauthor=S.+E.+Harrisauthor=B.+O.+Oyajobiauthor=G.+R.+Mundyauthor=D.+Chen&title=Smurf1+inhibits+osteoblast+differentiation+and+bone+formation+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DQiao%26aufirst%3DM.%26aulast%3DHarris%26aufirst%3DS.%2BE.%26aulast%3DOyajobi%26aufirst%3DB.%2BO.%26aulast%3DMundy%26aufirst%3DG.%2BR.%26aulast%3DChen%26aufirst%3DD.%26atitle%3DSmurf1%2520inhibits%2520osteoblast%2520differentiation%2520and%2520bone%2520formation%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D12854%26epage%3D12859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group">Pearsall, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canalis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornwall-Brady, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underwood, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ucran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pobre, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glatt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadmeyer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seehra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouxsein, M. L.</span><span> </span><span class="NLM_article-title">A soluble activin type IIA receptor induces bone formation and improves skeletal integrity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">7082</span><span class="NLM_x">–</span> <span class="NLM_lpage">7087</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=7082-7087&author=R.+S.+Pearsallauthor=E.+Canalisauthor=M.+Cornwall-Bradyauthor=K.+W.+Underwoodauthor=B.+Haigisauthor=J.+Ucranauthor=R.+Kumarauthor=E.+Pobreauthor=A.+Grinbergauthor=E.+D.+Wernerauthor=V.+Glattauthor=L.+Stadmeyerauthor=D.+Smithauthor=J.+Seehraauthor=M.+L.+Bouxsein&title=A+soluble+activin+type+IIA+receptor+induces+bone+formation+and+improves+skeletal+integrity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPearsall%26aufirst%3DR.%2BS.%26aulast%3DCanalis%26aufirst%3DE.%26aulast%3DCornwall-Brady%26aufirst%3DM.%26aulast%3DUnderwood%26aufirst%3DK.%2BW.%26aulast%3DHaigis%26aufirst%3DB.%26aulast%3DUcran%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DPobre%26aufirst%3DE.%26aulast%3DGrinberg%26aufirst%3DA.%26aulast%3DWerner%26aufirst%3DE.%2BD.%26aulast%3DGlatt%26aufirst%3DV.%26aulast%3DStadmeyer%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DSeehra%26aufirst%3DJ.%26aulast%3DBouxsein%26aufirst%3DM.%2BL.%26atitle%3DA%2520soluble%2520activin%2520type%2520IIA%2520receptor%2520induces%2520bone%2520formation%2520and%2520improves%2520skeletal%2520integrity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D7082%26epage%3D7087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group">Ruckle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearsall, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underwood, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seehra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, M. L.</span><span> </span><span class="NLM_article-title">Single-dose, randomized, double-blind, placebo-controlled study of ACE-011 (ActRIIA-IgG1) in postmenopausal women</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">744</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1359%2Fjbmr.081208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19049340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksF2ksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=744-752&author=J.+Ruckleauthor=M.+Jacobsauthor=W.+Kramerauthor=A.+E.+Pearsallauthor=R.+Kumarauthor=K.+W.+Underwoodauthor=J.+Seehraauthor=Y.+Yangauthor=C.+H.+Condonauthor=M.+L.+Sherman&title=Single-dose%2C+randomized%2C+double-blind%2C+placebo-controlled+study+of+ACE-011+%28ActRIIA-IgG1%29+in+postmenopausal+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Single-dose, randomized, double-blind, placebo-controlled study of ACE-011 (ActRIIA-IgG1) in postmenopausal women</span></div><div class="casAuthors">Ruckle, Jon; Jacobs, Mark; Kramer, William; Pearsall, Amelia E.; Kumar, Ravindra; Underwood, Kathryn W.; Seehra, Jasbir; Yang, Yijun; Condon, Carolyn H.; Sherman, Matthew L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">744-752</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">The effects of ACE-011 on safety, pharmacokinetics, and bone biomarkers were evaluated in healthy, postmenopausal women.  Our data indicate that ACE-011 results in a sustained increase in biomarkers of bone formation and redn. in markers of bone resorption.  The activin type IIA receptor (ActRIIA) is the high-affinity receptor for activin.  ACE-011 is a dimeric fusion protein consisting of the extracellular domain of the human ActRIIA linked to the Fc portion of human IgG1.  ACE-011 binds to activin, preventing activin from binding endogenous receptors.  A randomized, double-blind, placebo-controlled study was conducted to evaluate the safety and tolerability of ACE-011.  Forty-eight healthy, postmenopausal women were randomized to receive either a single dose of ACE-011 or placebo and were followed for 4 mo.  Dose levels ranged from 0.01 to 3.0 mg/kg i.v. and from 0.03 to 0.1 mg/kg s.c.  Safety and pharmacokinetic (PK) analyses and the biol. activity of ACE-011, as assessed by markers of bone turnover, and FSH levels were measured.  No serious adverse events (AEs) were reported.  AEs were generally mild and transient.  The PK of ACE-011 was linear over the dose range studied, with a mean half-life of 24-32 days.  The absorption after s.c. dosing was essentially complete.  ACE-011 caused a rapid and sustained dose-dependent increase in serum levels of bone-specific alk. phosphatase (BSALP) and a dose-dependent decrease in C-terminal type 1 collagen telopeptide (CTX) and TRACP-5b levels.  There was also a dose-dependent decrease in serum FSH levels consistent with inhibition of activin.  ACE-011 is a novel agent with biol. evidence of both an increase in bone formation and a decrease in bone resorption.  ACE-011 may be an effective therapy in a variety of diseases involving bone loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn_t2QS_ybO7Vg90H21EOLACvtfcHk0lhChLFugWf8Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksF2ksLg%253D&md5=e8df87da08ce88ccc103f36b8387a6b6</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.081208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.081208%26sid%3Dliteratum%253Aachs%26aulast%3DRuckle%26aufirst%3DJ.%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DKramer%26aufirst%3DW.%26aulast%3DPearsall%26aufirst%3DA.%2BE.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DUnderwood%26aufirst%3DK.%2BW.%26aulast%3DSeehra%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DCondon%26aufirst%3DC.%2BH.%26aulast%3DSherman%26aufirst%3DM.%2BL.%26atitle%3DSingle-dose%252C%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520study%2520of%2520ACE-011%2520%2528ActRIIA-IgG1%2529%2520in%2520postmenopausal%2520women%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2009%26volume%3D24%26spage%3D744%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, S.</span><span> </span><span class="NLM_article-title">A chemical approach to stem-cell biology and regenerative medicine</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">453</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=453&publication_year=2008&pages=338-344&author=Y.+Xuauthor=Y.+Shiauthor=S.+Ding&title=A+chemical+approach+to+stem-cell+biology+and+regenerative+medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DS.%26atitle%3DA%2520chemical%2520approach%2520to%2520stem-cell%2520biology%2520and%2520regenerative%2520medicine%26jtitle%3DNature%26date%3D2008%26volume%3D453%26spage%3D338%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takanashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">Reversine increases the plasticity of lineage-committed mammalian cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">10482</span><span class="NLM_x">–</span> <span class="NLM_lpage">10487</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=10482-10487&author=S.+Chenauthor=S.+Takanashiauthor=Q.+Zhangauthor=W.+Xiongauthor=S.+Zhuauthor=E.+C.+Petersauthor=S.+Dingauthor=P.+G.+Schultz&title=Reversine+increases+the+plasticity+of+lineage-committed+mammalian+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DTakanashi%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DXiong%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DPeters%26aufirst%3DE.%2BC.%26aulast%3DDing%26aufirst%3DS.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DReversine%2520increases%2520the%2520plasticity%2520of%2520lineage-committed%2520mammalian%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D10482%26epage%3D10487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group">Mukherjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoonmaker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouxsein, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chhetri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aronson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulciniti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purton, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glimcher, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lian, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scadden, D. T.</span><span> </span><span class="NLM_article-title">Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=491-504&author=S.+Mukherjeeauthor=N.+Rajeauthor=J.+A.+Schoonmakerauthor=J.+C.+Liuauthor=T.+Hideshimaauthor=M.+N.+Weinauthor=D.+C.+Jonesauthor=S.+Valletauthor=M.+L.+Bouxseinauthor=S.+Pozziauthor=S.+Chhetriauthor=Y.+D.+Seoauthor=J.+P.+Aronsonauthor=C.+Patelauthor=M.+Fulcinitiauthor=L.+E.+Purtonauthor=L.+H.+Glimcherauthor=J.+B.+Lianauthor=G.+Steinauthor=K.+C.+Andersonauthor=D.+T.+Scadden&title=Pharmacologic+targeting+of+a+stem%2Fprogenitor+population+in+vivo+is+associated+with+enhanced+bone+regeneration+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DS.%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DSchoonmaker%26aufirst%3DJ.%2BA.%26aulast%3DLiu%26aufirst%3DJ.%2BC.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DWein%26aufirst%3DM.%2BN.%26aulast%3DJones%26aufirst%3DD.%2BC.%26aulast%3DVallet%26aufirst%3DS.%26aulast%3DBouxsein%26aufirst%3DM.%2BL.%26aulast%3DPozzi%26aufirst%3DS.%26aulast%3DChhetri%26aufirst%3DS.%26aulast%3DSeo%26aufirst%3DY.%2BD.%26aulast%3DAronson%26aufirst%3DJ.%2BP.%26aulast%3DPatel%26aufirst%3DC.%26aulast%3DFulciniti%26aufirst%3DM.%26aulast%3DPurton%26aufirst%3DL.%2BE.%26aulast%3DGlimcher%26aufirst%3DL.%2BH.%26aulast%3DLian%26aufirst%3DJ.%2BB.%26aulast%3DStein%26aufirst%3DG.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DScadden%26aufirst%3DD.%2BT.%26atitle%3DPharmacologic%2520targeting%2520of%2520a%2520stem%252Fprogenitor%2520population%2520in%2520vivo%2520is%2520associated%2520with%2520enhanced%2520bone%2520regeneration%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D491%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group">Calvi, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weibrecht, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schipani, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Divieti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bringhurst, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milner, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kronenberg, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scadden, D. T.</span><span> </span><span class="NLM_article-title">Osteoblastic cells regulate the hematopoietic stem cell niche</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">425</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=841-846&author=L.+M.+Calviauthor=G.+B.+Adamsauthor=K.+W.+Weibrechtauthor=J.+M.+Weberauthor=D.+P.+Olsonauthor=M.+C.+Knightauthor=R.+P.+Martinauthor=E.+Schipaniauthor=P.+Divietiauthor=F.+R.+Bringhurstauthor=L.+A.+Milnerauthor=H.+M.+Kronenbergauthor=D.+T.+Scadden&title=Osteoblastic+cells+regulate+the+hematopoietic+stem+cell+niche"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCalvi%26aufirst%3DL.%2BM.%26aulast%3DAdams%26aufirst%3DG.%2BB.%26aulast%3DWeibrecht%26aufirst%3DK.%2BW.%26aulast%3DWeber%26aufirst%3DJ.%2BM.%26aulast%3DOlson%26aufirst%3DD.%2BP.%26aulast%3DKnight%26aufirst%3DM.%2BC.%26aulast%3DMartin%26aufirst%3DR.%2BP.%26aulast%3DSchipani%26aufirst%3DE.%26aulast%3DDivieti%26aufirst%3DP.%26aulast%3DBringhurst%26aufirst%3DF.%2BR.%26aulast%3DMilner%26aufirst%3DL.%2BA.%26aulast%3DKronenberg%26aufirst%3DH.%2BM.%26aulast%3DScadden%26aufirst%3DD.%2BT.%26atitle%3DOsteoblastic%2520cells%2520regulate%2520the%2520hematopoietic%2520stem%2520cell%2520niche%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D841%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group">Adams, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alley, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabner, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvi, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kronenberg, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scadden, D. T.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of a stem cell niche</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=238-243&author=G.+B.+Adamsauthor=R.+P.+Martinauthor=I.+R.+Alleyauthor=K.+T.+Chabnerauthor=K.+S.+Cohenauthor=L.+M.+Calviauthor=H.+M.+Kronenbergauthor=D.+T.+Scadden&title=Therapeutic+targeting+of+a+stem+cell+niche"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DG.%2BB.%26aulast%3DMartin%26aufirst%3DR.%2BP.%26aulast%3DAlley%26aufirst%3DI.%2BR.%26aulast%3DChabner%26aufirst%3DK.%2BT.%26aulast%3DCohen%26aufirst%3DK.%2BS.%26aulast%3DCalvi%26aufirst%3DL.%2BM.%26aulast%3DKronenberg%26aufirst%3DH.%2BM.%26aulast%3DScadden%26aufirst%3DD.%2BT.%26atitle%3DTherapeutic%2520targeting%2520of%2520a%2520stem%2520cell%2520niche%26jtitle%3DNat.%2520Biotechnol.%26date%3D2007%26volume%3D25%26spage%3D238%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 24 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Chao Zhao, Dane Huang, Ruyue Li, Yida Xu, Shimin Su, Qiong Gu, <span class="NLM_string-name hlFld-ContribAuthor">Jun Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Identifying Novel Anti-Osteoporosis Leads with a Chemotype-Assembly Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (12)
                                     , 5885-5900. <a href="https://doi.org/10.1021/acs.jmedchem.9b00517" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00517</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00517%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentifying%252BNovel%252BAnti-Osteoporosis%252BLeads%252Bwith%252Ba%252BChemotype-Assembly%252BApproach%26aulast%3DZhao%26aufirst%3DChao%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24032019%26date%3D07062019%26date%3D24052019%26volume%3D62%26issue%3D12%26spage%3D5885%26epage%3D5900" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Radu M. Suciu, Armand B. Cognetta, III, Zachary E. Potter, <span class="NLM_string-name hlFld-ContribAuthor">Benjamin F. Cravatt</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Irreversible Inhibitors of the Wnt-Deacylating Enzyme NOTUM Developed by Activity-Based Protein Profiling. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (6)
                                     , 563-568. <a href="https://doi.org/10.1021/acsmedchemlett.8b00191" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00191%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSelective%252BIrreversible%252BInhibitors%252Bof%252Bthe%252BWnt-Deacylating%252BEnzyme%252BNOTUM%252BDeveloped%252Bby%252BActivity-Based%252BProtein%252BProfiling%26aulast%3DSuciu%26aufirst%3DRadu%2BM.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D25042018%26date%3D17052018%26date%3D26052018%26volume%3D9%26issue%3D6%26spage%3D563%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Carlino</span> and <span class="hlFld-ContribAuthor ">Giulio  Rastelli</span>  . </span><span class="cited-content_cbyCitation_article-title">Dual Kinase-Bromodomain Inhibitors in Anticancer Drug Discovery: A Structural and Pharmacological Perspective. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (20)
                                     , 9305-9320. <a href="https://doi.org/10.1021/acs.jmedchem.6b00438" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00438</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00438%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual%252BKinase-Bromodomain%252BInhibitors%252Bin%252BAnticancer%252BDrug%252BDiscovery%25253A%252BA%252BStructural%252Band%252BPharmacological%252BPerspective%26aulast%3DCarlino%26aufirst%3DLuca%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D24032016%26date%3D07092016%26date%3D27102016%26date%3D25082016%26volume%3D59%26issue%3D20%26spage%3D9305%26epage%3D9320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serena  Pasquini</span>, <span class="hlFld-ContribAuthor ">Claudia  Mugnaini</span>, <span class="hlFld-ContribAuthor ">Alessia  Ligresti</span>, <span class="hlFld-ContribAuthor ">Andrea  Tafi</span>, <span class="hlFld-ContribAuthor ">Simone  Brogi</span>, <span class="hlFld-ContribAuthor ">Chiara  Falciani</span>, <span class="hlFld-ContribAuthor ">Valentina  Pedani</span>, <span class="hlFld-ContribAuthor ">Nicolò  Pesco</span>, <span class="hlFld-ContribAuthor ">Francesca  Guida</span>, <span class="hlFld-ContribAuthor ">Livio  Luongo</span>, <span class="hlFld-ContribAuthor ">Katia  Varani</span>, <span class="hlFld-ContribAuthor ">Pier Andrea  Borea</span>, <span class="hlFld-ContribAuthor ">Sabatino  Maione</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Di Marzo</span>, and <span class="hlFld-ContribAuthor ">Federico  Corelli</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Pharmacological Characterization of Indol-3-ylacetamides, Indol-3-yloxoacetamides, and Indol-3-ylcarboxamides: Potent and Selective CB2 Cannabinoid Receptor Inverse Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (11)
                                     , 5391-5402. <a href="https://doi.org/10.1021/jm3003334" title="DOI URL">https://doi.org/10.1021/jm3003334</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3003334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3003334%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPharmacological%252BCharacterization%252Bof%252BIndol-3-ylacetamides%25252C%252BIndol-3-yloxoacetamides%25252C%252Band%252BIndol-3-ylcarboxamides%25253A%252BPotent%252Band%252BSelective%252BCB2%252BCannabinoid%252BReceptor%252BInverse%252BAgonists%26aulast%3DPasquini%26aufirst%3DSerena%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D09032012%26date%3D16052012%26date%3D14062012%26date%3D02052012%26volume%3D55%26issue%3D11%26spage%3D5391%26epage%3D5402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Serena  Pasquini</span>, <span class="hlFld-ContribAuthor ">Maria  De Rosa</span>, <span class="hlFld-ContribAuthor ">Valentina  Pedani</span>, <span class="hlFld-ContribAuthor ">Claudia  Mugnaini</span>, <span class="hlFld-ContribAuthor ">Francesca  Guida</span>, <span class="hlFld-ContribAuthor ">Livio  Luongo</span>, <span class="hlFld-ContribAuthor ">Maria  De Chiaro</span>, <span class="hlFld-ContribAuthor ">Sabatino  Maione</span>, <span class="hlFld-ContribAuthor ">Stefania  Dragoni</span>, <span class="hlFld-ContribAuthor ">Maria  Frosini</span>, <span class="hlFld-ContribAuthor ">Alessia  Ligresti</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Di Marzo</span>, and <span class="hlFld-ContribAuthor ">Federico  Corelli</span>  . </span><span class="cited-content_cbyCitation_article-title">Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 4. Identification of New Potent and Selective Ligands for the Cannabinoid Type 2 Receptor with Diverse Substitution Patterns and Antihyperalgesic Effects in Mice. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (15)
                                     , 5444-5453. <a href="https://doi.org/10.1021/jm200476p" title="DOI URL">https://doi.org/10.1021/jm200476p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm200476p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm200476p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInvestigations%252Bon%252Bthe%252B4-Quinolone-3-carboxylic%252BAcid%252BMotif.%252B4.%252BIdentification%252Bof%252BNew%252BPotent%252Band%252BSelective%252BLigands%252Bfor%252Bthe%252BCannabinoid%252BType%252B2%252BReceptor%252Bwith%252BDiverse%252BSubstitution%252BPatterns%252Band%252BAntihyperalgesic%252BEffects%252Bin%252BMice%26aulast%3DPasquini%26aufirst%3DSerena%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D20042011%26date%3D06072011%26date%3D11082011%26date%3D27062011%26volume%3D54%26issue%3D15%26spage%3D5444%26epage%3D5453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jung-Rae  Rho</span>, <span class="hlFld-ContribAuthor ">Buyng Su  Hwang</span>, <span class="hlFld-ContribAuthor ">Seewon  Joung</span>, <span class="hlFld-ContribAuthor ">Mi Ran  Byun</span>, <span class="hlFld-ContribAuthor ">Jeong-Ho  Hong</span>, and <span class="hlFld-ContribAuthor ">Hee-Yoon  Lee</span>  . </span><span class="cited-content_cbyCitation_article-title">Phorbasones A and B, Sesterterpenoids Isolated from the Marine Sponge Phorbas sp. and Induction of Osteoblast Differentiation. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2011,</strong> <em>13 </em>
                                    (5)
                                     , 884-887. <a href="https://doi.org/10.1021/ol1029386" title="DOI URL">https://doi.org/10.1021/ol1029386</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol1029386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol1029386%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPhorbasones%252BA%252Band%252BB%25252C%252BSesterterpenoids%252BIsolated%252Bfrom%252Bthe%252BMarine%252BSponge%252BPhorbas%252Bsp.%252Band%252BInduction%252Bof%252BOsteoblast%252BDifferentiation%26aulast%3DRho%26aufirst%3DJung-Rae%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D05122010%26date%3D27012011%26date%3D04032011%26volume%3D13%26issue%3D5%26spage%3D884%26epage%3D887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shiyang  Zhou</span>, <span class="hlFld-ContribAuthor ">Gangliang  Huang</span>, <span class="hlFld-ContribAuthor ">Guangying  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological activities of drugs for the treatment of osteoporosis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>197 </em>, 112313. <a href="https://doi.org/10.1016/j.ejmech.2020.112313" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112313%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bactivities%252Bof%252Bdrugs%252Bfor%252Bthe%252Btreatment%252Bof%252Bosteoporosis%26aulast%3DZhou%26aufirst%3DShiyang%26date%3D2020%26volume%3D197%26spage%3D112313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ioannis  Fotopoulos</span>, <span class="hlFld-ContribAuthor ">Dimitra  Hadjipavlou-Litina</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrids of Coumarin Derivatives as Potent and Multifunctional Bioactive Agents: A Review. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry</span><span> <strong>2020,</strong> <em>16 </em>
                                    (3)
                                     , 272-306. <a href="https://doi.org/10.2174/1573406415666190416121448" title="DOI URL">https://doi.org/10.2174/1573406415666190416121448</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1573406415666190416121448&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1573406415666190416121448%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%26atitle%3DHybrids%252Bof%252BCoumarin%252BDerivatives%252Bas%252BPotent%252Band%252BMultifunctional%252BBioactive%252BAgents%25253A%252BA%252BReview%26aulast%3DFotopoulos%26aufirst%3DIoannis%26date%3D2020%26volume%3D16%26issue%3D3%26spage%3D272%26epage%3D306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Zhao</span>, <span class="hlFld-ContribAuthor ">Dane  Huang</span>, <span class="hlFld-ContribAuthor ">Ruyue  Li</span>, <span class="hlFld-ContribAuthor ">Jiake  Xu</span>, <span class="hlFld-ContribAuthor ">Qiong  Gu</span>, <span class="hlFld-ContribAuthor ">Jun  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new inhibitors against both NF-κB and osteoclastogenesis from in-house library with α, β-unsaturated-enone fragment. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>87 </em>, 638-646. <a href="https://doi.org/10.1016/j.bioorg.2019.03.066" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.03.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.03.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.03.066%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnew%252Binhibitors%252Bagainst%252Bboth%252BNF-%2525CE%2525BAB%252Band%252Bosteoclastogenesis%252Bfrom%252Bin-house%252Blibrary%252Bwith%252B%2525CE%2525B1%25252C%252B%2525CE%2525B2-unsaturated-enone%252Bfragment%26aulast%3DZhao%26aufirst%3DChao%26date%3D2019%26volume%3D87%26spage%3D638%26epage%3D646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Brommage</span>. </span><span class="cited-content_cbyCitation_article-title">New Targets and Emergent Therapies for Osteoporosis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 451-473. <a href="https://doi.org/10.1007/164_2019_329" title="DOI URL">https://doi.org/10.1007/164_2019_329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/164_2019_329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F164_2019_329%26sid%3Dliteratum%253Aachs%26atitle%3DNew%252BTargets%252Band%252BEmergent%252BTherapies%252Bfor%252BOsteoporosis%26aulast%3DBrommage%26aufirst%3DRobert%26date%3D2019%26date%3D2019%26spage%3D451%26epage%3D473%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DBone%252BRegulators%252Band%252BOsteoporosis%252BTherapy%26aulast%3DStern%26aufirst%3DPaula%2BH.%26date%3D2020%26volume%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chenhui  Zhu</span>, <span class="hlFld-ContribAuthor ">Huan  Lei</span>, <span class="hlFld-ContribAuthor ">Shangshang  Wang</span>, <span class="hlFld-ContribAuthor ">Zhiguang  Duan</span>, <span class="hlFld-ContribAuthor ">Rongzhan  Fu</span>, <span class="hlFld-ContribAuthor ">Jianjun  Deng</span>, <span class="hlFld-ContribAuthor ">Daidi  Fan</span>, <span class="hlFld-ContribAuthor ">Xingqiang  Lv</span>. </span><span class="cited-content_cbyCitation_article-title">The effect of human-like collagen calcium complex on osteoporosis mice. </span><span class="cited-content_cbyCitation_journal-name">Materials Science and Engineering: C</span><span> <strong>2018,</strong> <em>93 </em>, 630-639. <a href="https://doi.org/10.1016/j.msec.2018.08.011" title="DOI URL">https://doi.org/10.1016/j.msec.2018.08.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.msec.2018.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.msec.2018.08.011%26sid%3Dliteratum%253Aachs%26jtitle%3DMaterials%2520Science%2520and%2520Engineering%253A%2520C%26atitle%3DThe%252Beffect%252Bof%252Bhuman-like%252Bcollagen%252Bcalcium%252Bcomplex%252Bon%252Bosteoporosis%252Bmice%26aulast%3DZhu%26aufirst%3DChenhui%26date%3D2018%26volume%3D93%26spage%3D630%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harshika  Awasthi</span>, <span class="hlFld-ContribAuthor ">Dayanandan  Mani</span>, <span class="hlFld-ContribAuthor ">Divya  Singh</span>, <span class="hlFld-ContribAuthor ">Atul  Gupta</span>. </span><span class="cited-content_cbyCitation_article-title">The underlying pathophysiology and therapeutic approaches for osteoporosis. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2018,</strong> <em>38 </em>
                                    (6)
                                     , 2024-2057. <a href="https://doi.org/10.1002/med.21504" title="DOI URL">https://doi.org/10.1002/med.21504</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21504%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DThe%252Bunderlying%252Bpathophysiology%252Band%252Btherapeutic%252Bapproaches%252Bfor%252Bosteoporosis%26aulast%3DAwasthi%26aufirst%3DHarshika%26date%3D2018%26date%3D2018%26volume%3D38%26issue%3D6%26spage%3D2024%26epage%3D2057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Lu</span>, <span class="hlFld-ContribAuthor ">Maolin  Wang</span>, <span class="hlFld-ContribAuthor ">Ziyue  Wang</span>, <span class="hlFld-ContribAuthor ">Zhongqi  Fu</span>, <span class="hlFld-ContribAuthor ">Aiping  Lu</span>, <span class="hlFld-ContribAuthor ">Ge  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the discovery of cathepsin K inhibitors on bone resorption. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 890-904. <a href="https://doi.org/10.1080/14756366.2018.1465417" title="DOI URL">https://doi.org/10.1080/14756366.2018.1465417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1465417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1465417%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DAdvances%252Bin%252Bthe%252Bdiscovery%252Bof%252Bcathepsin%252BK%252Binhibitors%252Bon%252Bbone%252Bresorption%26aulast%3DLu%26aufirst%3DJun%26date%3D2018%26date%3D2018%26volume%3D33%26issue%3D1%26spage%3D890%26epage%3D904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Padam  Kumar</span>, <span class="hlFld-ContribAuthor ">Priyanka  Kushwaha</span>, <span class="hlFld-ContribAuthor ">Naseer  Ahmad</span>, <span class="hlFld-ContribAuthor ">Saransh Wales  Maurya</span>, <span class="hlFld-ContribAuthor ">Kapil  Dev</span>, <span class="hlFld-ContribAuthor ">Vikram  Khedgikar</span>, <span class="hlFld-ContribAuthor ">Ibadur Rahman  Siddiqui</span>, <span class="hlFld-ContribAuthor ">Ritu  Trivedi</span>, <span class="hlFld-ContribAuthor ">Rakesh  Maurya</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of dalbergin analogues and evaluation of anti-osteoporotic activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (8)
                                     , 1765-1775. <a href="https://doi.org/10.1016/j.bmcl.2017.02.062" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.02.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.02.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.02.062%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bdalbergin%252Banalogues%252Band%252Bevaluation%252Bof%252Banti-osteoporotic%252Bactivity%26aulast%3DKumar%26aufirst%3DPadam%26date%3D2017%26volume%3D27%26issue%3D8%26spage%3D1765%26epage%3D1775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James E.  Tarver</span>, <span class="hlFld-ContribAuthor ">Praveen K.  Pabba</span>, <span class="hlFld-ContribAuthor ">Joseph  Barbosa</span>, <span class="hlFld-ContribAuthor ">Qiang  Han</span>, <span class="hlFld-ContribAuthor ">Michael W.  Gardyan</span>, <span class="hlFld-ContribAuthor ">Robert  Brommage</span>, <span class="hlFld-ContribAuthor ">Andrea Y.  Thompson</span>, <span class="hlFld-ContribAuthor ">James M.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Alan G.E.  Wilson</span>, <span class="hlFld-ContribAuthor ">Wei  He</span>, <span class="hlFld-ContribAuthor ">Victoria K.  Lombardo</span>, <span class="hlFld-ContribAuthor ">Kenneth G.  Carson</span>. </span><span class="cited-content_cbyCitation_article-title">Stimulation of cortical bone formation with thienopyrimidine based inhibitors of Notum Pectinacetylesterase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (6)
                                     , 1525-1528. <a href="https://doi.org/10.1016/j.bmcl.2016.02.021" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.02.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.02.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.02.021%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStimulation%252Bof%252Bcortical%252Bbone%252Bformation%252Bwith%252Bthienopyrimidine%252Bbased%252Binhibitors%252Bof%252BNotum%252BPectinacetylesterase%26aulast%3DTarver%26aufirst%3DJames%2BE.%26date%3D2016%26volume%3D26%26issue%3D6%26spage%3D1525%26epage%3D1528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiang  Han</span>, <span class="hlFld-ContribAuthor ">Praveen K.  Pabba</span>, <span class="hlFld-ContribAuthor ">Joseph  Barbosa</span>, <span class="hlFld-ContribAuthor ">Ross  Mabon</span>, <span class="hlFld-ContribAuthor ">Jason P.  Healy</span>, <span class="hlFld-ContribAuthor ">Michael W.  Gardyan</span>, <span class="hlFld-ContribAuthor ">Kristen M.  Terranova</span>, <span class="hlFld-ContribAuthor ">Robert  Brommage</span>, <span class="hlFld-ContribAuthor ">Andrea Y.  Thompson</span>, <span class="hlFld-ContribAuthor ">James M.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Alan G.E.  Wilson</span>, <span class="hlFld-ContribAuthor ">Xiaolian  Xu</span>, <span class="hlFld-ContribAuthor ">James E.  Tarver</span>, <span class="hlFld-ContribAuthor ">Kenneth G.  Carson</span>. </span><span class="cited-content_cbyCitation_article-title">4H-Thieno[3,2-c]chromene based inhibitors of Notum Pectinacetylesterase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (4)
                                     , 1184-1187. <a href="https://doi.org/10.1016/j.bmcl.2016.01.038" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.01.038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.01.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.01.038%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D4H-Thieno%25255B3%25252C2-c%25255Dchromene%252Bbased%252Binhibitors%252Bof%252BNotum%252BPectinacetylesterase%26aulast%3DHan%26aufirst%3DQiang%26date%3D2016%26volume%3D26%26issue%3D4%26spage%3D1184%26epage%3D1187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atul  Goel</span>, <span class="hlFld-ContribAuthor ">Ashutosh  Raghuvanshi</span>, <span class="hlFld-ContribAuthor ">Amit  Kumar</span>, <span class="hlFld-ContribAuthor ">Abnish  Gautam</span>, <span class="hlFld-ContribAuthor ">Kamini  Srivastava</span>, <span class="hlFld-ContribAuthor ">Jyoti  Kureel</span>, <span class="hlFld-ContribAuthor ">Divya  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">9-Demethoxy-medicarpin promotes peak bone mass achievement and has bone conserving effect in ovariectomized mice: Positively regulates osteoblast functions and suppresses osteoclastogenesis. </span><span class="cited-content_cbyCitation_journal-name">Molecular and Cellular Endocrinology</span><span> <strong>2015,</strong> <em>411 </em>, 155-166. <a href="https://doi.org/10.1016/j.mce.2015.04.023" title="DOI URL">https://doi.org/10.1016/j.mce.2015.04.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mce.2015.04.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mce.2015.04.023%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520and%2520Cellular%2520Endocrinology%26atitle%3D9-Demethoxy-medicarpin%252Bpromotes%252Bpeak%252Bbone%252Bmass%252Bachievement%252Band%252Bhas%252Bbone%252Bconserving%252Beffect%252Bin%252Bovariectomized%252Bmice%25253A%252BPositively%252Bregulates%252Bosteoblast%252Bfunctions%252Band%252Bsuppresses%252Bosteoclastogenesis%26aulast%3DGoel%26aufirst%3DAtul%26date%3D2015%26volume%3D411%26spage%3D155%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan D.  Mills</span>, <span class="hlFld-ContribAuthor ">Mitsuo  Mita</span>, <span class="hlFld-ContribAuthor ">Jun-ichi  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Masaru  Shoji</span>, <span class="hlFld-ContribAuthor ">Cindy  Sutherland</span>, <span class="hlFld-ContribAuthor ">Michael P.  Walsh</span>. </span><span class="cited-content_cbyCitation_article-title">A Role for the Tyrosine Kinase Pyk2 in Depolarization-induced Contraction of Vascular Smooth Muscle. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2015,</strong> <em>290 </em>
                                    (14)
                                     , 8677-8692. <a href="https://doi.org/10.1074/jbc.M114.633107" title="DOI URL">https://doi.org/10.1074/jbc.M114.633107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M114.633107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M114.633107%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DA%252BRole%252Bfor%252Bthe%252BTyrosine%252BKinase%252BPyk2%252Bin%252BDepolarization-induced%252BContraction%252Bof%252BVascular%252BSmooth%252BMuscle%26aulast%3DMills%26aufirst%3DRyan%2BD.%26date%3D2015%26volume%3D290%26issue%3D14%26spage%3D8677%26epage%3D8692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad Faheem  Khan</span>, <span class="hlFld-ContribAuthor ">Kapil  Dev</span>, <span class="hlFld-ContribAuthor ">Shibani  Lahiri</span>, <span class="hlFld-ContribAuthor ">Manisha  Dixit</span>, <span class="hlFld-ContribAuthor ">Ritu  Trivedi</span>, <span class="hlFld-ContribAuthor ">Divya  Singh</span>, <span class="hlFld-ContribAuthor ">Rakesh  Maurya</span>. </span><span class="cited-content_cbyCitation_article-title">Osteogenic activity of natural diterpenoids isolated from Cupressus sempervirens fruits in calvarial derived osteoblast cells via differentiation and mineralization. </span><span class="cited-content_cbyCitation_journal-name">Phytomedicine</span><span> <strong>2014,</strong> <em>21 </em>
                                    (14)
                                     , 1794-1800. <a href="https://doi.org/10.1016/j.phymed.2014.09.004" title="DOI URL">https://doi.org/10.1016/j.phymed.2014.09.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phymed.2014.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phymed.2014.09.004%26sid%3Dliteratum%253Aachs%26jtitle%3DPhytomedicine%26atitle%3DOsteogenic%252Bactivity%252Bof%252Bnatural%252Bditerpenoids%252Bisolated%252Bfrom%252BCupressus%252Bsempervirens%252Bfruits%252Bin%252Bcalvarial%252Bderived%252Bosteoblast%252Bcells%252Bvia%252Bdifferentiation%252Band%252Bmineralization%26aulast%3DKhan%26aufirst%3DMohammad%2BFaheem%26date%3D2014%26volume%3D21%26issue%3D14%26spage%3D1794%26epage%3D1800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minglei  Chen</span>, <span class="hlFld-ContribAuthor ">Hongzhi  Qiao</span>, <span class="hlFld-ContribAuthor ">Zhigui  Su</span>, <span class="hlFld-ContribAuthor ">Huipeng  Li</span>, <span class="hlFld-ContribAuthor ">Qineng  Ping</span>, <span class="hlFld-ContribAuthor ">Li  Zong</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging therapeutic targets for osteoporosis treatment. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Targets</span><span> <strong>2014,</strong> <em>18 </em>
                                    (7)
                                     , 817-831. <a href="https://doi.org/10.1517/14728222.2014.912632" title="DOI URL">https://doi.org/10.1517/14728222.2014.912632</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/14728222.2014.912632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F14728222.2014.912632%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Targets%26atitle%3DEmerging%252Btherapeutic%252Btargets%252Bfor%252Bosteoporosis%252Btreatment%26aulast%3DChen%26aufirst%3DMinglei%26date%3D2014%26date%3D2014%26volume%3D18%26issue%3D7%26spage%3D817%26epage%3D831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Koneni V.  Sashidhara</span>, <span class="hlFld-ContribAuthor ">Ram K.  Modukuri</span>, <span class="hlFld-ContribAuthor ">Dharmendra  Choudhary</span>, <span class="hlFld-ContribAuthor ">K.  Bhaskara Rao</span>, <span class="hlFld-ContribAuthor ">Manoj  Kumar</span>, <span class="hlFld-ContribAuthor ">Vikram  Khedgikar</span>, <span class="hlFld-ContribAuthor ">Ritu  Trivedi</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of new coumarin–pyridine hybrids with promising anti-osteoporotic activities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>70 </em>, 802-810. <a href="https://doi.org/10.1016/j.ejmech.2013.10.060" title="DOI URL">https://doi.org/10.1016/j.ejmech.2013.10.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2013.10.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2013.10.060%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnew%252Bcoumarin%2525E2%252580%252593pyridine%252Bhybrids%252Bwith%252Bpromising%252Banti-osteoporotic%252Bactivities%26aulast%3DSashidhara%26aufirst%3DKoneni%2BV.%26date%3D2013%26volume%3D70%26spage%3D802%26epage%3D810" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samit K.  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Gary E.  Aspnes</span>, <span class="hlFld-ContribAuthor ">Scott W.  Bagley</span>, <span class="hlFld-ContribAuthor ">Markus  Boehm</span>, <span class="hlFld-ContribAuthor ">Arthur D.  Brosius</span>, <span class="hlFld-ContribAuthor ">Leonard  Buckbinder</span>, <span class="hlFld-ContribAuthor ">Jeanne S.  Chang</span>, <span class="hlFld-ContribAuthor ">Joseph  Dibrino</span>, <span class="hlFld-ContribAuthor ">Heather  Eng</span>, <span class="hlFld-ContribAuthor ">Kosea S.  Frederick</span>, <span class="hlFld-ContribAuthor ">David A.  Griffith</span>, <span class="hlFld-ContribAuthor ">Matthew C.  Griffor</span>, <span class="hlFld-ContribAuthor ">Cristiano R.W.  Guimarães</span>, <span class="hlFld-ContribAuthor ">Angel  Guzman-Perez</span>, <span class="hlFld-ContribAuthor ">Seungil  Han</span>, <span class="hlFld-ContribAuthor ">Amit S.  Kalgutkar</span>, <span class="hlFld-ContribAuthor ">Jacquelyn  Klug-McLeod</span>, <span class="hlFld-ContribAuthor ">Carmen  Garcia-Irizarry</span>, <span class="hlFld-ContribAuthor ">Jianke  Li</span>, <span class="hlFld-ContribAuthor ">Blaise  Lippa</span>, <span class="hlFld-ContribAuthor ">David A.  Price</span>, <span class="hlFld-ContribAuthor ">James A.  Southers</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Walker</span>, <span class="hlFld-ContribAuthor ">Liuqing  Wei</span>, <span class="hlFld-ContribAuthor ">Jun  Xiao</span>, <span class="hlFld-ContribAuthor ">Michael P.  Zawistoski</span>, <span class="hlFld-ContribAuthor ">Xumiao  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel series of pyrazole and indole-urea based DFG-out PYK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (24)
                                     , 7523-7529. <a href="https://doi.org/10.1016/j.bmcl.2012.10.039" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.10.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.10.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.10.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Bnovel%252Bseries%252Bof%252Bpyrazole%252Band%252Bindole-urea%252Bbased%252BDFG-out%252BPYK2%252Binhibitors%26aulast%3DBhattacharya%26aufirst%3DSamit%2BK.%26date%3D2012%26volume%3D22%26issue%3D24%26spage%3D7523%26epage%3D7529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junji  Miyata</span>, <span class="hlFld-ContribAuthor ">Chiyoshi  Kasahara</span>, <span class="hlFld-ContribAuthor ">Toru  Asano</span>, <span class="hlFld-ContribAuthor ">Shinji  Ito</span>, <span class="hlFld-ContribAuthor ">Norio  Seki</span>, <span class="hlFld-ContribAuthor ">Yasuko  Kato</span>, <span class="hlFld-ContribAuthor ">Noriyuki  Morikawa</span>, <span class="hlFld-ContribAuthor ">Kazuyoshi  Nozaki</span>, <span class="hlFld-ContribAuthor ">Kouji  Nishimura</span>, <span class="hlFld-ContribAuthor ">Hisashi  Akamatsu</span>, <span class="hlFld-ContribAuthor ">Yusuke  Taguchi</span>, <span class="hlFld-ContribAuthor ">Tomonori  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Yoshito  Abe</span>, <span class="hlFld-ContribAuthor ">Mitsuru  Ohkubo</span>, <span class="hlFld-ContribAuthor ">Toshihiro  Watanabe</span>, <span class="hlFld-ContribAuthor ">Mitsuaki  Ohta</span>, <span class="hlFld-ContribAuthor ">Makoto  Takeuchi</span>. </span><span class="cited-content_cbyCitation_article-title">Orally available pyridinylpyrimidine derivatives as novel RANKL-induced osteoclastogenesis inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (17)
                                     , 5681-5684. <a href="https://doi.org/10.1016/j.bmcl.2012.06.087" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.06.087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.06.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.06.087%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOrally%252Bavailable%252Bpyridinylpyrimidine%252Bderivatives%252Bas%252Bnovel%252BRANKL-induced%252Bosteoclastogenesis%252Binhibitors%26aulast%3DMiyata%26aufirst%3DJunji%26date%3D2012%26volume%3D22%26issue%3D17%26spage%3D5681%26epage%3D5684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leo  Widler</span>. </span><span class="cited-content_cbyCitation_article-title">Calcilytics: antagonists of the calcium-sensing receptor for the treatment of osteoporosis. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2011,</strong> <em>3 </em>
                                    (5)
                                     , 535-547. <a href="https://doi.org/10.4155/fmc.11.17" title="DOI URL">https://doi.org/10.4155/fmc.11.17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.11.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.11.17%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DCalcilytics%25253A%252Bantagonists%252Bof%252Bthe%252Bcalcium-sensing%252Breceptor%252Bfor%252Bthe%252Btreatment%252Bof%252Bosteoporosis%26aulast%3DWidler%26aufirst%3DLeo%26date%3D2011%26volume%3D3%26issue%3D5%26spage%3D535%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="fig1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Role of OPG/RANKL and emerging new targets in bone remodeling. OPG and RANKL are expressed in many tissues and cell types including osteoblasts. Cellular locations of emerging antiresorptive, anabolic, and potential dual-acting agents are shown and described in the text. Abbreviations are as follows: BLC, bone lining cell; OY, osteocyte; OC, osteoclast; OB, osteoblast.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cathepsin K inhibitors in various stages of development.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Schematic representation of the cathepsin K active site.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Examples of integrin α<sub>v</sub>β<sub>3</sub> inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0014.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Parathyroid hormone mimetics.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Calcium sensing receptor antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. WNT pathway inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Eli Lilly GSK inhibitor <b>43</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Osteogenic compounds identified through whole cell screening.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Prostaglandin E2 receptor EP2 and EP4 agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0006.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Cannabinoid CB1 and CB2 binders and GPR55 antagonist <b>59</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0007.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. SRC tyrosine kinase inhbitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0008.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. PYK2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/medium/jm-2009-018756_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0009.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Natural products that modify bone metabolism.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-11/jm9018756/production/images/large/jm-2009-018756_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9018756&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31077" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31077" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 216 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Riggs, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parfitt, A. M.</span><span> </span><span class="NLM_article-title">Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">177</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1359%2FJBMR.041114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=15647810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFarsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&pages=177-184&author=B.+L.+Riggsauthor=A.+M.+Parfitt&title=Drugs+used+to+treat+osteoporosis%3A+the+critical+need+for+a+uniform+nomenclature+based+on+their+action+on+bone+remodeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling</span></div><div class="casAuthors">Riggs, B. Lawrence; Parfitt, A. Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">177-184</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">A review.  There continues to be uncertainty about the classification of available drugs for treating osteoporosis.  We find that grouping them into anti-catabolic and anabolic classes based on the mechanisms of their action on bone remodeling and fracture redn. removes ambiguities and provides a relatively straightforward classification.  The recent introduction of teriparatide into clin. practice initiated the era of anabolic therapy for osteoporosis, but it is still unclear how to define an anabolic drug.  All drugs that increase bone mass do so by affecting bone remodeling.  When their mechanisms of action on bone remodeling and on fracture redn. are considered, we find that anti-osteoporotic drugs fall naturally into either anti-catabolic or anabolic classes.  Anti-catabolic drugs increase bone strength and reduce fractures mainly by decreasing the no. of bone multicellular units (BMUs).  This reduces perforative resorption and preserves skeletal microarchitecture (by preventing further structural damage to trabecular bone and increased porosity in cortical bone induced by high bone remodeling).  Redn. in bone remodeling by anti-catabolic drugs may increase bone mass moderately during the interval in which previously initiated BMUs are completing mineralization.  Some anti-catabolic drugs may also enhance the formation phase of the remodeling cycle, but their major action is to reduce overall bone turnover (i.e., the no. of BMUs in bone).  In contrast, anabolic drugs increase bone strength and reduce fractures by substantially increasing bone mass as a result of an overall increase in the no. of BMUs combined with a pos. BMU balance (the magnitude of the formation phase is greater than that of the resorption phase).  Some anabolic drugs also induce renewed modeling, increase periosteal apposition and repair of trabecular microstructure.  We hope that this classification will serve as a starting point for continued discussion on the important issue of nomenclature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplvXiQnmgRwbVg90H21EOLACvtfcHk0lhoBOxih7MXvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFarsr8%253D&md5=68dbfe2d250d2632369191d4ef6a9804</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1359%2FJBMR.041114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252FJBMR.041114%26sid%3Dliteratum%253Aachs%26aulast%3DRiggs%26aufirst%3DB.%2BL.%26aulast%3DParfitt%26aufirst%3DA.%2BM.%26atitle%3DDrugs%2520used%2520to%2520treat%2520osteoporosis%253A%2520the%2520critical%2520need%2520for%2520a%2520uniform%2520nomenclature%2520based%2520on%2520their%2520action%2520on%2520bone%2520remodeling%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2005%26volume%3D20%26spage%3D177%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellido, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khosla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recker, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaney, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papapoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldring, S. R.</span><span> </span><span class="NLM_article-title">Targeting bone remodeling for the treatment of osteoporosis: summary of the proceedings of an ASBMR workshop</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">373</span><span class="NLM_x">–</span> <span class="NLM_lpage">385</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1359%2Fjbmr.090105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19260805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A280%3ADC%252BD1M7osF2qtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=373-385&author=J.+P.+Bilezikianauthor=T.+Matsumotoauthor=T.+Bellidoauthor=S.+Khoslaauthor=J.+Martinauthor=R.+R.+Reckerauthor=R.+Heaneyauthor=E.+Seemanauthor=S.+Papapoulosauthor=S.+R.+Goldring&title=Targeting+bone+remodeling+for+the+treatment+of+osteoporosis%3A+summary+of+the+proceedings+of+an+ASBMR+workshop"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting bone remodeling for the treatment of osteoporosis: summary of the proceedings of an ASBMR workshop</span></div><div class="casAuthors">Bilezikian John P; Matsumoto Toshio; Bellido Teresita; Khosla Sundeep; Martin Jack; Recker Robert R; Heaney Robert; Seeman Ego; Papapoulos Socrates; Goldring Steven R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">373-85</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSq7pzmphErRhJ5E29YNGvQfW6udTcc2eabr-8cu8wEPrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7osF2qtQ%253D%253D&md5=20a66f1cf0c30690c059ea2a7238176e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.090105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.090105%26sid%3Dliteratum%253Aachs%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26aulast%3DMatsumoto%26aufirst%3DT.%26aulast%3DBellido%26aufirst%3DT.%26aulast%3DKhosla%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DJ.%26aulast%3DRecker%26aufirst%3DR.%2BR.%26aulast%3DHeaney%26aufirst%3DR.%26aulast%3DSeeman%26aufirst%3DE.%26aulast%3DPapapoulos%26aufirst%3DS.%26aulast%3DGoldring%26aufirst%3DS.%2BR.%26atitle%3DTargeting%2520bone%2520remodeling%2520for%2520the%2520treatment%2520of%2520osteoporosis%253A%2520summary%2520of%2520the%2520proceedings%2520of%2520an%2520ASBMR%2520workshop%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2009%26volume%3D24%26spage%3D373%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Eastell, R.</span><span> </span><span class="NLM_article-title">Treatment of postmenopausal osteoporosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">338</span><span class="NLM_x">, </span> <span class="NLM_fpage">736</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1056%2FNEJM199803123381107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=9494151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADyaK1cXitFars70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=338&publication_year=1998&pages=736-746&author=R.+Eastell&title=Treatment+of+postmenopausal+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of postmenopausal osteoporosis</span></div><div class="casAuthors">Eastell, Richard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">338</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">736-746</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review with 95 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNnI99Uw6Lv7Vg90H21EOLACvtfcHk0ljFL-cVaPWavA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitFars70%253D&md5=01c6d630a7e327295829b5cb1129e233</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1056%2FNEJM199803123381107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199803123381107%26sid%3Dliteratum%253Aachs%26aulast%3DEastell%26aufirst%3DR.%26atitle%3DTreatment%2520of%2520postmenopausal%2520osteoporosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1998%26volume%3D338%26spage%3D736%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Seeman, E.</span><span> </span><span class="NLM_article-title">Invited review: pathogenesis of osteoporosis</span> <span class="citation_source-journal">J. Appl. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">2142</span><span class="NLM_x">–</span> <span class="NLM_lpage">2151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2003&pages=2142-2151&author=E.+Seeman&title=Invited+review%3A+pathogenesis+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeeman%26aufirst%3DE.%26atitle%3DInvited%2520review%253A%2520pathogenesis%2520of%2520osteoporosis%26jtitle%3DJ.%2520Appl.%2520Physiol.%26date%3D2003%26volume%3D95%26spage%3D2142%26epage%3D2151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Ralston, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Crombrugghe, B.</span><span> </span><span class="NLM_article-title">Genetic regulation of bone mass and susceptibility to osteoporosis</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2492</span><span class="NLM_x">–</span> <span class="NLM_lpage">2506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=2492-2506&author=S.+H.+Ralstonauthor=B.+de+Crombrugghe&title=Genetic+regulation+of+bone+mass+and+susceptibility+to+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRalston%26aufirst%3DS.%2BH.%26aulast%3Dde%2BCrombrugghe%26aufirst%3DB.%26atitle%3DGenetic%2520regulation%2520of%2520bone%2520mass%2520and%2520susceptibility%2520to%2520osteoporosis%26jtitle%3DGenes%2520Dev.%26date%3D2006%26volume%3D20%26spage%3D2492%26epage%3D2506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Lewiecki, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeBoff, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P. D.</span><span> </span><span class="NLM_article-title">2008 Santa Fe Bone Symposium: update on osteoporosis</span> <span class="citation_source-journal">J. Clin. Densitom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.jocd.2009.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19426925" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A280%3ADC%252BD1MzjtlSjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2009&pages=135-157&author=E.+M.+Lewieckiauthor=S.+Baimauthor=J.+P.+Bilezikianauthor=R.+Eastellauthor=M.+S.+LeBoffauthor=P.+D.+Miller&title=2008+Santa+Fe+Bone+Symposium%3A+update+on+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">2008 Santa Fe Bone Symposium: update on osteoporosis</span></div><div class="casAuthors">Lewiecki E Michael; Baim Sanford; Bilezikian John P; Eastell Richard; LeBoff Meryl S; Miller Paul D</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">135-57</span>
        ISSN:<span class="NLM_cas:issn">1094-6950</span>.
    </div><div class="casAbstract">The Ninth Annual Santa Fe Bone Symposium was held on August 1-2, 2008, in Santa Fe, New Mexico, USA.  The symposium faculty presented the current best evidence on selected topics of clinical relevance in the fields of osteoporosis, metabolic bone disease, and assessment of skeletal health.  The educational venues were in the form of didactic presentations, panel discussions, challenging cases, and numerous interactive discussions.  Knowledge of basic science and clinical trials was applied to real-world patient scenarios that were discussed by faculty experts and clinician participants.  Topics included an update on the rationale and development of new agents for the treatment of osteoporosis, the use of bone turnover markers in clinical practice, hospital-based pathways for the management of hip fracture patients, injectable bisphosphonates for the treatment of osteoporosis, combination therapy with anabolic and antiresorptive agents, and assessment of skeletal health with devices other than central dual-energy X-ray absorptiometry.  This is a collection of scientific essays based on presentations and discussions at the 2008 Santa Fe Bone Symposium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxgtfX2XicQUNoizSOkG_FfW6udTcc2ea6bMwvmXc7Vbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MzjtlSjtg%253D%253D&md5=e19e58bcedb43def6a2973b693fc93c9</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.jocd.2009.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jocd.2009.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DLewiecki%26aufirst%3DE.%2BM.%26aulast%3DBaim%26aufirst%3DS.%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26aulast%3DEastell%26aufirst%3DR.%26aulast%3DLeBoff%26aufirst%3DM.%2BS.%26aulast%3DMiller%26aufirst%3DP.%2BD.%26atitle%3D2008%2520Santa%2520Fe%2520Bone%2520Symposium%253A%2520update%2520on%2520osteoporosis%26jtitle%3DJ.%2520Clin.%2520Densitom.%26date%3D2009%26volume%3D12%26spage%3D135%26epage%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Boyle, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonet, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacey, D. L.</span><span> </span><span class="NLM_article-title">Osteoclast differentiation and activation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">423</span><span class="NLM_x">, </span> <span class="NLM_fpage">337</span><span class="NLM_x">–</span> <span class="NLM_lpage">342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1038%2Fnature01658" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=12748652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjs1ynu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=423&publication_year=2003&pages=337-342&author=W.+J.+Boyleauthor=W.+S.+Simonetauthor=D.+L.+Lacey&title=Osteoclast+differentiation+and+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Osteoclast differentiation and activation</span></div><div class="casAuthors">Boyle, William J.; Simonet, W. Scott; Lacey, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">423</span>
        (<span class="NLM_cas:issue">6937</span>),
    <span class="NLM_cas:pages">337-342</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Osteoclasts are specialized cells derived from the monocyte/macrophage hematopoietic lineage that develop and adhere to bone matrix, then secrete acid and lytic enzymes that degrade it in a specialized, extracellular compartment.  Discovery of the RANK signaling pathway in the osteoclast has provided insight into the mechanisms of osteoclastogenesis and activation of bone resorption, and how hormonal signals impact bone structure and mass.  Further study of this pathway is providing the mol. basis for developing therapeutics to treat osteoporosis and other diseases of bone loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9r8QN5mP3a7Vg90H21EOLACvtfcHk0ljFL-cVaPWavA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjs1ynu7g%253D&md5=0d6ef73c5aa7c17f6abeb533fe31f39a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnature01658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01658%26sid%3Dliteratum%253Aachs%26aulast%3DBoyle%26aufirst%3DW.%2BJ.%26aulast%3DSimonet%26aufirst%3DW.%2BS.%26aulast%3DLacey%26aufirst%3DD.%2BL.%26atitle%3DOsteoclast%2520differentiation%2520and%2520activation%26jtitle%3DNature%26date%3D2003%26volume%3D423%26spage%3D337%26epage%3D342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kearns, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khosla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostenuik, P. J.</span><span> </span><span class="NLM_article-title">Receptor activator of nuclear factor kB ligand and osteoprotegerin regulation of bone remodeling in health and disease</span> <span class="citation_source-journal">Endocr. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">155</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1210%2Fer.2007-0014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18057140" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlOhsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=155-192&author=A.+E.+Kearnsauthor=S.+Khoslaauthor=P.+J.+Kostenuik&title=Receptor+activator+of+nuclear+factor+kB+ligand+and+osteoprotegerin+regulation+of+bone+remodeling+in+health+and+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Receptor activator of nuclear factor κB ligand and osteoprotegerin regulation of bone remodeling in health and disease</span></div><div class="casAuthors">Kearns, Ann E.; Khosla, Sundeep; Kostenuik, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Endocrine Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-192</span>CODEN:
                <span class="NLM_cas:coden">ERVIDP</span>;
        ISSN:<span class="NLM_cas:issn">0163-769X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">A review.  Osteoclasts and osteoblasts dictate skeletal mass, structure, and strength via their resp. roles in resorbing and forming bone.  Bone remodeling is a spatially coordinated lifelong process whereby old bone is removed by osteoclasts and replaced by bone-forming osteoblasts.  The refilling of resorption cavities is incomplete in many pathol. states, which leads to a net loss of bone mass with each remodeling cycle.  Postmenopausal osteoporosis and other conditions are assocd. with an increased rate of bone remodeling, which leads to accelerated bone loss and increased risk of fracture.  Bone resorption is dependent on a cytokine known as RANKL (receptor activator of nuclear factor κB ligand), a TNF family member that is essential for osteoclast formation, activity, and survival in normal and pathol. states of bone remodeling.  The catabolic effects of RANKL are prevented by osteoprotegerin (OPG), a TNF receptor family member that binds RANKL and thereby prevents activation of its single cognate receptor called RANK.  Osteoclast activity is likely to depend, at least in part, on the relative balance of RANKL and OPG.  Studies in numerous animal models of bone disease show that RANKL inhibition leads to marked suppression of bone resorption and increases in cortical and cancelous bone vol., d., and strength.  RANKL inhibitors also prevent focal bone loss that occurs in animal models of rheumatoid arthritis and bone metastasis.  Clin. trials are exploring the effects of denosumab, a fully human anti-RANKL antibody, on bone loss in patients with osteoporosis, bone metastasis, myeloma, and rheumatoid arthritis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG6-aul71sSLVg90H21EOLACvtfcHk0lgaMZiMqb_Erg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlOhsr0%253D&md5=0d30b55f492ce4f438654f1fa8418495</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1210%2Fer.2007-0014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fer.2007-0014%26sid%3Dliteratum%253Aachs%26aulast%3DKearns%26aufirst%3DA.%2BE.%26aulast%3DKhosla%26aufirst%3DS.%26aulast%3DKostenuik%26aufirst%3DP.%2BJ.%26atitle%3DReceptor%2520activator%2520of%2520nuclear%2520factor%2520kB%2520ligand%2520and%2520osteoprotegerin%2520regulation%2520of%2520bone%2520remodeling%2520in%2520health%2520and%2520disease%26jtitle%3DEndocr.%2520Rev.%26date%3D2008%26volume%3D29%26spage%3D155%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Smith, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egerdie, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toriz, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tammela, T. L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saad, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heracek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szwedowski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kupic, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leder, B. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goessl, C.</span><span> </span><span class="NLM_article-title">Denosumab in men receiving androgen-deprivation therapy for prostate cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">755</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1056%2FNEJMoa0809003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19671656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWls7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=745-755&author=M.+R.+Smithauthor=B.+Egerdieauthor=N.+H.+Torizauthor=R.+Feldmanauthor=T.+L.+J.+Tammelaauthor=F.+Saadauthor=J.+Heracekauthor=M.+Szwedowskiauthor=C.+Keauthor=A.+Kupicauthor=B.+Z.+Lederauthor=C.+Goessl&title=Denosumab+in+men+receiving+androgen-deprivation+therapy+for+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Denosumab in men receiving androgen-deprivation therapy for prostate cancer</span></div><div class="casAuthors">Smith, Matthew R.; Egerdie, Blair; Toriz, Narciso Hernandez; Feldman, Robert; Tammela, Teuvo L. J.; Saad, Fred; Heracek, Jiri; Szwedowski, Maciej; Ke, Chunlei; Kupic, Amy; Leder, Benjamin Z.; Goessl, Carsten</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">745-755</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Androgen-deprivation therapy is well-established for treating prostate cancer but is assocd. with bone loss and an increased risk of fracture.  We investigated the effects of Denosumab, a fully human monoclonal antibody against receptor activator of nuclear factor-κB ligand, on bone mineral d. and fractures in men receiving androgen-deprivation therapy for nonmetastatic prostate cancer.  In this double-blind, multicenter study, we randomly assigned patients to receive Denosumab at a dose of 60 mg s.c. every 6 mo or placebo (734 patients in each group).  The primary end point was percent change in bone mineral d. at the lumbar spine at 24 mo.  Key secondary end points included percent change in bone mineral densities at the femoral neck and total hip at 24 mo and at all three sites at 36 mo, as well as incidence of new vertebral fractures.  At 24 mo, bone mineral d. of the lumbar spine had increased by 5.60% in the Denosumab group as compared with a loss of 1.0% in the placebo group (P < 0.001); significant differences between the two groups were seen at as early as 1 mo and sustained through 36 mo.  Denosumab therapy was also assocd. with significant increases in bone mineral d. at the total hip, femoral neck, and distal third of the radius at all time points.  Patients who received Denosumab had a decreased incidence of new vertebral fractures at 36 mo (1.5%, vs. 3.9% with placebo) (relative risk, 0.38; 95% confidence interval, 0.19 to 0.78; P = 0.006).  Rates of adverse events were similar between the two groups.  Denosumab was assocd. with increased bone mineral d. at all sites and a redn. in the incidence of new vertebral fractures among men receiving androgen-deprivation therapy for nonmetastatic prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoorugOPElZobVg90H21EOLACvtfcHk0lgaMZiMqb_Erg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWls7rF&md5=b96aa8f8eefa61f0d8d01763630dfe09</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0809003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0809003%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DM.%2BR.%26aulast%3DEgerdie%26aufirst%3DB.%26aulast%3DToriz%26aufirst%3DN.%2BH.%26aulast%3DFeldman%26aufirst%3DR.%26aulast%3DTammela%26aufirst%3DT.%2BL.%2BJ.%26aulast%3DSaad%26aufirst%3DF.%26aulast%3DHeracek%26aufirst%3DJ.%26aulast%3DSzwedowski%26aufirst%3DM.%26aulast%3DKe%26aufirst%3DC.%26aulast%3DKupic%26aufirst%3DA.%26aulast%3DLeder%26aufirst%3DB.%2BZ.%26aulast%3DGoessl%26aufirst%3DC.%26atitle%3DDenosumab%2520in%2520men%2520receiving%2520androgen-deprivation%2520therapy%2520for%2520prostate%2520cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D745%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Cummings, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Martin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClung, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siris, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eastell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reid, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmas, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoog, H. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kutilek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanchetta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libanati, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddhanti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christiansen, C.</span><span> </span><span class="NLM_article-title">Denosumab for prevention of fractures in postmenopausal women with osteoporosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">756</span><span class="NLM_x">–</span> <span class="NLM_lpage">765</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1056%2FNEJMoa0809493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19671655" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWls7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=756-765&author=S.+R.+Cummingsauthor=J.+San+Martinauthor=M.+R.+McClungauthor=E.+S.+Sirisauthor=R.+Eastellauthor=I.+R.+Reidauthor=P.+Delmasauthor=H.+B.+Zoogauthor=M.+Austinauthor=A.+Wangauthor=S.+Kutilekauthor=S.+Adamiauthor=J.+Zanchettaauthor=C.+Libanatiauthor=S.+Siddhantiauthor=C.+Christiansen&title=Denosumab+for+prevention+of+fractures+in+postmenopausal+women+with+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Denosumab for prevention of fractures in postmenopausal women with osteoporosis</span></div><div class="casAuthors">Cummings, Steven R.; San Martin, Javier; McClung, Michael R.; Siris, Ethel S.; Eastell, Richard; Reid, Ian R.; Delmas, Pierre; Zoog, Holly B.; Austin, Matt; Wang, Andrea; Kutilek, Stepan; Adami, Silvano; Zanchetta, Jose; Libanati, Cesar; Siddhanti, Suresh; Christiansen, Claus</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">756-765</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Denosumab is a fully human monoclonal antibody to the receptor activator of nuclear factor-κB ligand (RANKL) that blocks its binding to RANK, inhibiting the development and activity of osteoclasts, decreasing bone resorption, and increasing bone d.  Given its unique actions, Denosumab may be useful in the treatment of osteoporosis.  The authors enrolled 7868 women between the ages of 60 and 90 years who had a bone mineral d. T score of less than -2.5 but not less than -4.0 at the lumbar spine or total hip.  Subjects were randomly assigned to receive either 60 mg of Denosumab or placebo s.c. every 6 mo for 36 mo.  The primary end point was new vertebral fracture.  Secondary end points included nonvertebral and hip fractures.  As compared with placebo, Denosumab reduced the risk of new radiog. vertebral fracture, with a cumulative incidence of 2.3% in the Denosumab group, vs. 7.2% in the placebo group (risk ratio, 0.32; 95% confidence interval [CI], 0.26 to 0.41; P < 0.001) - a relative decrease of 68%.  Denosumab reduced the risk of hip fracture, with a cumulative incidence of 0.7% in the Denosumab group, vs. 1.2% in the placebo group (hazard ratio, 0.60; 95% CI, 0.37 to 0.97; P = 0.04) - a relative decrease of 40%.  Denosumab also reduced the risk of nonvertebral fracture, with a cumulative incidence of 6.5% in the Denosumab group, vs. 8.0% in the placebo group (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P = 0.01) - a relative decrease of 20%.  There was no increase in the risk of cancer, infection, cardiovascular disease, delayed fracture healing, or hypocalcemia, and there were no cases of osteonecrosis of the jaw and no adverse reactions to the injection of Denosumab.  Denosumab given s.c. twice yearly for 36 mo was assocd. with a redn. in the risk of vertebral, nonvertebral, and hip fractures in women with osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNRIIi_v86Q7Vg90H21EOLACvtfcHk0lgaMZiMqb_Erg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWls7nF&md5=cb12769a605cf79727596902520bd865</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0809493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0809493%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DS.%2BR.%26aulast%3DSan%2BMartin%26aufirst%3DJ.%26aulast%3DMcClung%26aufirst%3DM.%2BR.%26aulast%3DSiris%26aufirst%3DE.%2BS.%26aulast%3DEastell%26aufirst%3DR.%26aulast%3DReid%26aufirst%3DI.%2BR.%26aulast%3DDelmas%26aufirst%3DP.%26aulast%3DZoog%26aufirst%3DH.%2BB.%26aulast%3DAustin%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DKutilek%26aufirst%3DS.%26aulast%3DAdami%26aufirst%3DS.%26aulast%3DZanchetta%26aufirst%3DJ.%26aulast%3DLibanati%26aufirst%3DC.%26aulast%3DSiddhanti%26aufirst%3DS.%26aulast%3DChristiansen%26aufirst%3DC.%26atitle%3DDenosumab%2520for%2520prevention%2520of%2520fractures%2520in%2520postmenopausal%2520women%2520with%2520osteoporosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D756%26epage%3D765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Chapurlat, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmas, P. D.</span><span> </span><span class="NLM_article-title">Drug insight: bisphosphonates for postmenopausal osteoporosis</span> <span class="citation_source-journal">Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFSrtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=211-219&author=R.+D.+Chapurlatauthor=P.+D.+Delmas&title=Drug+insight%3A+bisphosphonates+for+postmenopausal+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Drug insight: bisphosphonates for postmenopausal osteoporosis</span></div><div class="casAuthors">Chapurlat, Roland D.; Delmas, Pierre D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Clinical Practice Endocrinology & Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">211-219</span>CODEN:
                <span class="NLM_cas:coden">NCPEDB</span>;
        ISSN:<span class="NLM_cas:issn">1745-8366</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Bisphosphonates are potent antiresorptive agents, which have largely been used for the treatment of postmenopausal osteoporosis during the past 10 years.  When embedded in bone matrix, bisphosphonates are taken up by osteoclasts engaged in bone resorption, leading-mainly by inhibition of farnesyl diphosphate synthase, a key enzyme of the mevalonate pathway-to osteoclast apoptosis.  Bone resorption decreases, with consequent improvement in the mech. properties of bone and a reduced risk of fracture.  Alendronate and risedronate are oral nitrogen-contg. bisphosphonates.  Several randomized, placebo-controlled trials have shown the ability of these bisphosphonates to halve the risk of vertebral fracture when taken daily for 3 years.  Nonvertebral fracture risk, including that at the hip, was also significantly decreased.  Weekly regimens have simplified the administration of bisphosphonates and, probably, improved adherence to treatment.  A significant redn. in the risk of vertebral fracture has also been demonstrated with an intermittent regimen of ibandronate, which is a new, potent, nitrogen-contg. bisphosphonate.  Ibandronate was recently marketed for use in an oral, once-monthly dose of 150 mg, with the goal of improving compliance.  Bisphosphonates are usually well tolerated in the long term.  I.v. administration of bisphosphonates in women with osteoporosis, which is currently under investigation, might be an interesting future option for women who cannot tolerate oral regimens, and for enhancing compliance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO6jSyazonebVg90H21EOLACvtfcHk0ljgOCM6dn9DHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFSrtLY%253D&md5=f47925a8a7424f026776f5c8ddd4a67b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChapurlat%26aufirst%3DR.%2BD.%26aulast%3DDelmas%26aufirst%3DP.%2BD.%26atitle%3DDrug%2520insight%253A%2520bisphosphonates%2520for%2520postmenopausal%2520osteoporosis%26jtitle%3DEndocrinol.%2520Metab.%26date%3D2006%26volume%3D2%26spage%3D211%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Yasothan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kar, S.</span><span> </span><span class="NLM_article-title">Osteoporosis: overview and pipeline</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=725-726&author=U.+Yasothanauthor=S.+Kar&title=Osteoporosis%3A+overview+and+pipeline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYasothan%26aufirst%3DU.%26aulast%3DKar%26aufirst%3DS.%26atitle%3DOsteoporosis%253A%2520overview%2520and%2520pipeline%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D725%26epage%3D726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Raisz, L. G.</span><span> </span><span class="NLM_article-title">Pathogenesis of osteoporosis: concepts, conflicts, and prospects</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">3318</span><span class="NLM_x">–</span> <span class="NLM_lpage">3325</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1172%2FJCI27071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16322775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2005&pages=3318-3325&author=L.+G.+Raisz&title=Pathogenesis+of+osteoporosis%3A+concepts%2C+conflicts%2C+and+prospects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Pathogenesis of osteoporosis: Concepts, conflicts, and prospects</span></div><div class="casAuthors">Raisz, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3318-3325</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">A review.  Osteoporosis is a disorder in which loss of bone strength leads to fragility fractures.  This review examines the fundamental pathogenetic mechanisms underlying this disorder, which include: (a) failure to achieve a skeleton of optimal strength during growth and development; (b) excessive bone resorption resulting in loss of bone mass and disruption of architecture; and (c) failure to replace lost bone due to defects in bone formation.  Estrogen deficiency is known to play a crit. role in the development of osteoporosis, while calcium and vitamin D deficiencies and secondary hyperparathyroidism also contribute.  There are multiple mechanisms underlying the regulation of bone remodeling, and these involve not only the osteoblastic and osteoclastic cell lineages but also other marrow cells, in addn. to the interaction of systemic hormones, local cytokines, growth factors, and transcription factors.  Polymorphisms of a large no. of genes have been assocd. with differences in bone mass and fragility.  It is now possible to diagnose osteoporosis, assess fracture risk, and reduce that risk with antiresorptive or other available therapies.  However, new and more effective approaches are likely to emerge from a better understanding of the regulators of bone cell function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr4gmjg9pMWrVg90H21EOLACvtfcHk0ljgOCM6dn9DHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqtLzJ&md5=77de4d8a09119f8178d1277e441e1bff</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1172%2FJCI27071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI27071%26sid%3Dliteratum%253Aachs%26aulast%3DRaisz%26aufirst%3DL.%2BG.%26atitle%3DPathogenesis%2520of%2520osteoporosis%253A%2520concepts%252C%2520conflicts%252C%2520and%2520prospects%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2005%26volume%3D115%26spage%3D3318%26epage%3D3325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Mohler, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohl, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coss, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span> </span><span class="NLM_article-title">Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3597</span><span class="NLM_x">–</span> <span class="NLM_lpage">3617</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900280m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3597-3617&author=M.+L.+Mohlerauthor=C.+E.+Bohlauthor=A.+Jonesauthor=C.+C.+Cossauthor=R.+Narayananauthor=Y.+Heauthor=D.+J.+Hwangauthor=J.+T.+Daltonauthor=D.+D.+Miller&title=Nonsteroidal+selective+androgen+receptor+modulators+%28SARMs%29%3A+dissociating+the+anabolic+and+androgenic+activities+of+the+androgen+receptor+for+therapeutic+benefit"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm900280m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900280m%26sid%3Dliteratum%253Aachs%26aulast%3DMohler%26aufirst%3DM.%2BL.%26aulast%3DBohl%26aufirst%3DC.%2BE.%26aulast%3DJones%26aufirst%3DA.%26aulast%3DCoss%26aufirst%3DC.%2BC.%26aulast%3DNarayanan%26aufirst%3DR.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DHwang%26aufirst%3DD.%2BJ.%26aulast%3DDalton%26aufirst%3DJ.%2BT.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3DNonsteroidal%2520selective%2520androgen%2520receptor%2520modulators%2520%2528SARMs%2529%253A%2520dissociating%2520the%2520anabolic%2520and%2520androgenic%2520activities%2520of%2520the%2520androgen%2520receptor%2520for%2520therapeutic%2520benefit%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3597%26epage%3D3617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Mathoo, J. M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumbhare, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adachi, J. D.</span><span> </span><span class="NLM_article-title">Therapeutic advances in the treatment of osteoporosis</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">277</span><span class="NLM_x">–</span> <span class="NLM_lpage">285</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1517%2F13543776.17.3.277" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFSjtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=277-285&author=J.+M.+R.+Mathooauthor=L.+Beckerauthor=D.+Kumbhareauthor=J.+D.+Adachi&title=Therapeutic+advances+in+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic advances in the treatment of osteoporosis</span></div><div class="casAuthors">Mathoo, Julian M. R.; Becker, Lisa; Kumbhare, Dinesh; Adachi, Jonathan D.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-285</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Until recently, pharmacol. options for the treatment of osteoporosis have been limited to antiresorptive agents, including the oral bisphosphonates.  Evidence from randomized controlled trials and meta-analyses support the efficacy and safety of oral bisphosphonates as first-line pharmacol. agents in the prevention and treatment of osteoporosis.  However, advances in parenteral bisphosphonate therapy, the development of antireceptor activator of NF-κB ligand (anti-RANKL) therapy, the development of anabolic agents, namely parathyroid hormone and related peptides, as well as the emergence of strontium ranelate as a novel therapeutic agent with both anabolic and antiresporptive properties, have dramatically expanded our pharmacol. armamentarium of antiosteoporosis treatments.  Effective treatment options now exist for patients in whom older agents were either contraindicated or not tolerated.  This review will focus on recent developments in osteoporosis treatments in advanced phases of development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq0C-Hht7lx7Vg90H21EOLACvtfcHk0ljgOCM6dn9DHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFSjtbc%253D&md5=0e5b0fba3831d4891d2693f40eb18608</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F13543776.17.3.277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.17.3.277%26sid%3Dliteratum%253Aachs%26aulast%3DMathoo%26aufirst%3DJ.%2BM.%2BR.%26aulast%3DBecker%26aufirst%3DL.%26aulast%3DKumbhare%26aufirst%3DD.%26aulast%3DAdachi%26aufirst%3DJ.%2BD.%26atitle%3DTherapeutic%2520advances%2520in%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2007%26volume%3D17%26spage%3D277%26epage%3D285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Grey, A.</span><span> </span><span class="NLM_article-title">Emerging pharmacologic therapies for osteoporosis</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">508</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1517%2F14728214.12.3.493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17874975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCit77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=493-508&author=A.+Grey&title=Emerging+pharmacologic+therapies+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging pharmacologic therapies for osteoporosis</span></div><div class="casAuthors">Grey, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">493-508</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>;
        ISSN:<span class="NLM_cas:issn">1472-8214</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Osteoporotic fractures are an important public health problem, contributing substantially to morbidity and mortality in an ageing world population and consuming considerable health resources.  Presently available pharmacol. therapies for prevention of fragility fractures are limited in scope, efficacy and acceptability to patients.  Considerable efforts are being made to develop new, more effective treatments for osteoporosis, and to refine/optimize existing therapies.  These novel treatments include an expanding array of drugs that primarily inhibit osteoclastic bone resorption: estrogenic compds., bisphosphonates, inhibitors of receptor activator of NF-κB ligand signaling, cathepsin K inhibitors, c-src kinase inhibitors, integrin inhibitors and chloride channel inhibitors.  The advent of intermittent parathyroid hormone (PTH) therapy has provided proof-of-principle that osteoblast-targeted (anabolic) agents can effectively prevent osteoporotic fractures, and is likely to be followed by the introduction of other therapies based on PTH (orally active PTH analogs, antagonists of the calcium sensing receptor, PTH-related peptide analogs) and/or agents that induce osteoblast anabolism by means of pathways involving key, recently identified, mol. targets (wnt-low-d. lipoprotein receptor-related protein 5 signaling, sclerostin and matrix extracellular phosphoglycoprotein).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1sq6IuCjXrbVg90H21EOLACvtfcHk0lj_u9FClxJOrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCit77K&md5=f6e04bffc4c2167b74eb914811256f76</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1517%2F14728214.12.3.493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.12.3.493%26sid%3Dliteratum%253Aachs%26aulast%3DGrey%26aufirst%3DA.%26atitle%3DEmerging%2520pharmacologic%2520therapies%2520for%2520osteoporosis%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2007%26volume%3D12%26spage%3D493%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Sun, S.</span><span> </span><span class="NLM_article-title">Bone disease drug discovery: examining the interactions between osteoblast and osteoclast</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1517%2F14728222.12.2.239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18208371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFCqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=239-251&author=S.+Sun&title=Bone+disease+drug+discovery%3A+examining+the+interactions+between+osteoblast+and+osteoclast"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Bone disease drug discovery: examining the interactions between osteoblast and osteoclast</span></div><div class="casAuthors">Sun, Sengen</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">239-251</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Existing drugs, including bisphosphonates and calcitonin, cannot meet the strong demand for a possible cure of bone diseases, the prevailing cause of human disabilities.  To understand on-going drug discovery activities, new trends and different opinions in the treatment of bone diseases, the recent literature up to August 2007 related to osteoporosis and joint diseases was searched, summarized, and analyzed.  The drug discovery based on the mol. mechanism of bone remodeling has made some progress, but there are challenges, difficulties and different opinions.  Bone resorption by osteoclasts is directly regulated by osteoblasts via the receptor activator of NF-κB/receptor activator of NF-κB ligand/osteoprotegerin signaling pathway, whereas the regulation of bone formation is poorly understood.  Several aspects, including the present state and future trends, are commented on as the expert opinions in this paper.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSx8IbypuL7rVg90H21EOLACvtfcHk0lj_u9FClxJOrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFCqtA%253D%253D&md5=1ee153044909a68690ec5b5abbc93264</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F14728222.12.2.239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.12.2.239%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%26atitle%3DBone%2520disease%2520drug%2520discovery%253A%2520examining%2520the%2520interactions%2520between%2520osteoblast%2520and%2520osteoclast%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2008%26volume%3D12%26spage%3D239%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Gelb, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, G.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desnick, R. J.</span><span> </span><span class="NLM_article-title">Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">1236</span><span class="NLM_x">–</span> <span class="NLM_lpage">1238</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1996&pages=1236-1238&author=B.+D.+Gelbauthor=G.-P.+Shiauthor=H.+A.+Chapmanauthor=R.+J.+Desnick&title=Pycnodysostosis%2C+a+lysosomal+disease+caused+by+cathepsin+K+deficiency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGelb%26aufirst%3DB.%2BD.%26aulast%3DShi%26aufirst%3DG.-P.%26aulast%3DChapman%26aufirst%3DH.%2BA.%26aulast%3DDesnick%26aufirst%3DR.%2BJ.%26atitle%3DPycnodysostosis%252C%2520a%2520lysosomal%2520disease%2520caused%2520by%2520cathepsin%2520K%2520deficiency%26jtitle%3DScience%26date%3D1996%26volume%3D273%26spage%3D1236%26epage%3D1238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunziker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wehmeyer, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rommerskirch, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moritz, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von Figura, K.</span><span> </span><span class="NLM_article-title">Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">13453</span><span class="NLM_x">–</span> <span class="NLM_lpage">13458</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=13453-13458&author=P.+Saftigauthor=E.+Hunzikerauthor=O.+Wehmeyerauthor=S.+Jonesauthor=A.+Boydeauthor=W.+Rommerskirchauthor=J.+D.+Moritzauthor=P.+Schuauthor=K.+Von+Figura&title=Impaired+osteoclastic+bone+resorption+leads+to+osteopetrosis+in+cathepsin-K-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DHunziker%26aufirst%3DE.%26aulast%3DWehmeyer%26aufirst%3DO.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DBoyde%26aufirst%3DA.%26aulast%3DRommerskirch%26aufirst%3DW.%26aulast%3DMoritz%26aufirst%3DJ.%2BD.%26aulast%3DSchu%26aufirst%3DP.%26aulast%3DVon%2BFigura%26aufirst%3DK.%26atitle%3DImpaired%2520osteoclastic%2520bone%2520resorption%2520leads%2520to%2520osteopetrosis%2520in%2520cathepsin-K-deficient%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D13453%26epage%3D13458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Kim, T.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasker, A. S.</span><span> </span><span class="NLM_article-title">Non-covalent cathepsin K inhibitors for the treatment of osteoporosis</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.2174%2F156802606776287036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16611147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtVahsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=355-360&author=T.-S.+Kimauthor=A.+S.+Tasker&title=Non-covalent+cathepsin+K+inhibitors+for+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Non-covalent cathepsin K inhibitors for the treatment of osteoporosis</span></div><div class="casAuthors">Kim, Tae-Seong; Tasker, Andrew S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-360</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cathepsin K is a cysteine protease that plays an important role in the pathol. process of bone resorption.  Selective cathepsin K inhibitors may thus provide great potential in the treatment of osteoporosis.  Pharmaceutical interest in this area is highlighted by the rising no. of publications and patent applications.  Most recently, the interim results of 3 clin. trials conducted by Novartis, GlaxoSmithKline, and Merck have strengthened the validation of the target for the therapeutic intervention of osteoporosis.  Here we report a series of Cbz-leucyl-(4-piperidinylphenyl)aminoethyl amides based on dipeptidyl anilines for cathepsin K inhibition.  These new non-covalent inhibitors exhibit single digit nM inhibition of the cathepsin family.  Mol. modeling studies on the interactions responsible for the potency of these inhibitors for cathepsin K will be also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQqiDzuZl3EbVg90H21EOLACvtfcHk0lhgqp1Y3-eAHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtVahsbw%253D&md5=05adceb5089c3f01187638ed00aab36e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.2174%2F156802606776287036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802606776287036%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DT.-S.%26aulast%3DTasker%26aufirst%3DA.%2BS.%26atitle%3DNon-covalent%2520cathepsin%2520K%2520inhibitors%2520for%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D355%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Bromme, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecaille, F.</span><span> </span><span class="NLM_article-title">Cathepsin K inhibitors for osteoporosis and potential off-target effects</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">585</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=585-600&author=D.+Brommeauthor=F.+Lecaille&title=Cathepsin+K+inhibitors+for+osteoporosis+and+potential+off-target+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBromme%26aufirst%3DD.%26aulast%3DLecaille%26aufirst%3DF.%26atitle%3DCathepsin%2520K%2520inhibitors%2520for%2520osteoporosis%2520and%2520potential%2520off-target%2520effects%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D585%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Vasiljeva, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinheckel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turk, B.</span><span> </span><span class="NLM_article-title">Emerging roles of cysteine cathepsins in disease and their potential as drug targets</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.2174%2F138161207780162962" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17311556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvVyltrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=387-403&author=O.+Vasiljevaauthor=T.+Reinheckelauthor=C.+Petersauthor=D.+Turkauthor=V.+Turkauthor=B.+Turk&title=Emerging+roles+of+cysteine+cathepsins+in+disease+and+their+potential+as+drug+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging roles of cysteine cathepsins in disease and their potential as drug targets</span></div><div class="casAuthors">Vasiljeva, Olga; Reinheckel, Thomas; Peters, Christoph; Turk, Dusan; Turk, Vito; Turk, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">387-403</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The general view on Cys cathepsins, which were long believed to be primarily involved in intracellular protein turnover, has dramatically changed in last 10 to 15 years.  The discovery of new cathepsins, such as cathepsins K, V, X, F and O, and their tissue distribution suggested that at least some of them are involved in very specific cellular processes.  Moreover, gene ablation expts. revealed that cathepsins play a vital role in numerous physiol. processes, such as antigen processing and presentation, bone remodeling, prohormone processing and wound healing.  Their involvement in several pathologies, including osteoporosis, rheumatoid arthritis, osteoarthritis, bronchial asthma and cancer were also confirmed and today several of them were validated as relevant targets for therapies.  Compds. targeting cathepsins S and K are already in clin. evaluation, whereas others are in exptl. phases.  The cathepsin K inhibitor AAE-581 (balicatib) as the most advanced of them passed Phase II clin. trials in 2005.  In this review, we discuss the current view on cathepsins as an emerging group of targets for several diseases and the development of cathepsin K and S inhibitors for treatment of osteoporosis and various immune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpl43svUGSDrVg90H21EOLACvtfcHk0lhgqp1Y3-eAHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvVyltrg%253D&md5=50a14bd3146b8c29e745f4bb3af85af7</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.2174%2F138161207780162962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161207780162962%26sid%3Dliteratum%253Aachs%26aulast%3DVasiljeva%26aufirst%3DO.%26aulast%3DReinheckel%26aufirst%3DT.%26aulast%3DPeters%26aufirst%3DC.%26aulast%3DTurk%26aufirst%3DD.%26aulast%3DTurk%26aufirst%3DV.%26aulast%3DTurk%26aufirst%3DB.%26atitle%3DEmerging%2520roles%2520of%2520cysteine%2520cathepsins%2520in%2520disease%2520and%2520their%2520potential%2520as%2520drug%2520targets%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2007%26volume%3D13%26spage%3D387%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">McGrath, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bromme, D.</span><span> </span><span class="NLM_article-title">Crystal structure of human cathepsin K complexed with a potent inhibitor</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">109</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1997&pages=105-109&author=M.+E.+McGrathauthor=J.+L.+Klausauthor=M.+G.+Barnesauthor=D.+Bromme&title=Crystal+structure+of+human+cathepsin+K+complexed+with+a+potent+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DKlaus%26aufirst%3DJ.%2BL.%26aulast%3DBarnes%26aufirst%3DM.%2BG.%26aulast%3DBromme%26aufirst%3DD.%26atitle%3DCrystal%2520structure%2520of%2520human%2520cathepsin%2520K%2520complexed%2520with%2520a%2520potent%2520inhibitor%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D1997%26volume%3D4%26spage%3D105%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Asagiri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunigami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gober, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishikawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golenbock, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morishita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazono, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takayanagi, H.</span><span> </span><span class="NLM_article-title">Cathepsin K-dependent toll-like receptor 9 signaling revealed in experimental arthritis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2008&pages=624-627&author=M.+Asagiriauthor=T.+Hiraiauthor=T.+Kunigamiauthor=S.+Kamanoauthor=H.-J.+Goberauthor=K.+Okamotoauthor=K.+Nishikawaauthor=E.+Latzauthor=D.+T.+Golenbockauthor=K.+Aokiauthor=K.+Ohyaauthor=Y.+Imaiauthor=Y.+Morishitaauthor=K.+Miyazonoauthor=S.+Katoauthor=P.+Saftigauthor=H.+Takayanagi&title=Cathepsin+K-dependent+toll-like+receptor+9+signaling+revealed+in+experimental+arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAsagiri%26aufirst%3DM.%26aulast%3DHirai%26aufirst%3DT.%26aulast%3DKunigami%26aufirst%3DT.%26aulast%3DKamano%26aufirst%3DS.%26aulast%3DGober%26aufirst%3DH.-J.%26aulast%3DOkamoto%26aufirst%3DK.%26aulast%3DNishikawa%26aufirst%3DK.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DGolenbock%26aufirst%3DD.%2BT.%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DOhya%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DMorishita%26aufirst%3DY.%26aulast%3DMiyazono%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DS.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DTakayanagi%26aufirst%3DH.%26atitle%3DCathepsin%2520K-dependent%2520toll-like%2520receptor%25209%2520signaling%2520revealed%2520in%2520experimental%2520arthritis%26jtitle%3DScience%26date%3D2008%26volume%3D319%26spage%3D624%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Westover, A. J.; Chagnovich, D.; Long, M. W.</span><span> </span><span class="NLM_article-title">Dual-action cathepsin K inhibitors: modulation of human osteoclast function</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span>), Abstract M389.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&issue=Suppl.+1&author=A.+J.+Westover&author=D.+Chagnovich&author=M.+W.+Long&title=Dual-action+cathepsin+K+inhibitors%3A+modulation+of+human+osteoclast+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWestover%26aufirst%3DA.%2BJ.%26atitle%3DDual-action%2520cathepsin%2520K%2520inhibitors%253A%2520modulation%2520of%2520human%2520osteoclast%2520function%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2007%26volume%3D22%26issue%3DSuppl.%25201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Twomey, T.; Chagnovich, D.; Zielenski, J.; Long, M. W.</span><span> </span><span class="NLM_article-title">Dual-action cathepsin K inhibitors: regulation of human mesenchymal stem cell (MSC) lineage commitment</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span>), Abstract W315.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&issue=Suppl.+1&author=T.+Twomey&author=D.+Chagnovich&author=J.+Zielenski&author=M.+W.+Long&title=Dual-action+cathepsin+K+inhibitors%3A+regulation+of+human+mesenchymal+stem+cell+%28MSC%29+lineage+commitment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTwomey%26aufirst%3DT.%26atitle%3DDual-action%2520cathepsin%2520K%2520inhibitors%253A%2520regulation%2520of%2520human%2520mesenchymal%2520stem%2520cell%2520%2528MSC%2529%2520lineage%2520commitment%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2007%26volume%3D22%26issue%3DSuppl.%25201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Chagnovich, D.; Fellows, J.; Dyer, R. D.; Long, M. W.</span><span> </span><span class="NLM_article-title">A role for cathepsin K inhibitors in rheumatoid arthritis: VEL-0230 phase I clinical trial results</span>.  <span class="citation_source-journal">Inflammation Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 2</span>), Abstract A108.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2008&issue=Suppl.+2&author=D.+Chagnovich&author=J.+Fellows&author=R.+D.+Dyer&author=M.+W.+Long&title=A+role+for+cathepsin+K+inhibitors+in+rheumatoid+arthritis%3A+VEL-0230+phase+I+clinical+trial+results"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChagnovich%26aufirst%3DD.%26atitle%3DA%2520role%2520for%2520cathepsin%2520K%2520inhibitors%2520in%2520rheumatoid%2520arthritis%253A%2520VEL-0230%2520phase%2520I%2520clinical%2520trial%2520results%26jtitle%3DInflammation%2520Res.%26date%3D2008%26volume%3D57%26issue%3DSuppl.%25202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span>Velcura Therapeutics. <a href="http://www.velcura.com/" class="extLink">http://www.velcura.com/</a> (accessed May 8,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Velcura+Therapeutics.+http%3A%2F%2Fwww.velcura.com%2F+%28accessed+May+8%2C+2008%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Setti, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J.</span><span> </span><span class="NLM_article-title">3,4-Disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P2 elements for selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2051</span><span class="NLM_x">–</span> <span class="NLM_lpage">2053</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2051-2053&author=E.+L.+Settiauthor=D.+Davisauthor=T.+Chungauthor=J.+McCarter&title=3%2C4-Disubstituted+azetidinones+as+selective+inhibitors+of+the+cysteine+protease+cathepsin+K.+Exploring+P2+elements+for+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSetti%26aufirst%3DE.%2BL.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DChung%26aufirst%3DT.%26aulast%3DMcCarter%26aufirst%3DJ.%26atitle%3D3%252C4-Disubstituted%2520azetidinones%2520as%2520selective%2520inhibitors%2520of%2520the%2520cysteine%2520protease%2520cathepsin%2520K.%2520Exploring%2520P2%2520elements%2520for%2520selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2051%26epage%3D2053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Setti, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janc, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffery, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span> </span><span class="NLM_article-title">3,4-Disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P3 elements for potency and selectivity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1529</span><span class="NLM_x">–</span> <span class="NLM_lpage">1534</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1529-1534&author=E.+L.+Settiauthor=D.+Davisauthor=J.+W.+Jancauthor=D.+A.+Jefferyauthor=H.+Cheungauthor=W.+Yu&title=3%2C4-Disubstituted+azetidinones+as+selective+inhibitors+of+the+cysteine+protease+cathepsin+K.+Exploring+P3+elements+for+potency+and+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSetti%26aufirst%3DE.%2BL.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DJanc%26aufirst%3DJ.%2BW.%26aulast%3DJeffery%26aufirst%3DD.%2BA.%26aulast%3DCheung%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DW.%26atitle%3D3%252C4-Disubstituted%2520azetidinones%2520as%2520selective%2520inhibitors%2520of%2520the%2520cysteine%2520protease%2520cathepsin%2520K.%2520Exploring%2520P3%2520elements%2520for%2520potency%2520and%2520selectivity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1529%26epage%3D1534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khougaz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toulmond, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span> </span><span class="NLM_article-title">Lysosomotropism of basic cathepsin K inhibitors contributes to increased cellular potencies against off-target cathepsins and reduced functional selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7535</span><span class="NLM_x">–</span> <span class="NLM_lpage">7543</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0504961" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7535-7543&author=J.-P.+Falgueyretauthor=S.+Desmaraisauthor=R.+Oballaauthor=W.+C.+Blackauthor=W.+Cromlishauthor=K.+Khougazauthor=S.+Lamontagneauthor=F.+Masseauthor=D.+Riendeauauthor=S.+Toulmondauthor=M.+D.+Percival&title=Lysosomotropism+of+basic+cathepsin+K+inhibitors+contributes+to+increased+cellular+potencies+against+off-target+cathepsins+and+reduced+functional+selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomotropism of Basic Cathepsin K Inhibitors Contributes to Increased Cellular Potencies against Off-Target Cathepsins and Reduced Functional Selectivity</span></div><div class="casAuthors">Falgueyret, Jean-Pierre; Desmarais, Sylvie; Oballa, Renata; Black, W. Cameron; Cromlish, Wanda; Khougaz, Karine; Lamontagne, Sonia; Masse, Frederic; Riendeau, Denis; Toulmond, Sylvie; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7535-7543</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lysosomal cysteine protease cathepsin K is a target for osteoporosis therapy.  The aryl-piperazine-contg. cathepsin K inhibitor CRA-013783/L-006235 (1) displays greater than 4000-fold selectivity against the lysosomal/endosomal antitargets cathepsin B, L, and S.  However, 1 and other aryl-piperazine-contg. analogs, including balicatib (10), are ∼10-100-fold more potent in cell-based enzyme occupancy assays than against each purified enzyme.  This phenomenon arises from their basic, lipophilic nature, which results in lysosomal trapping.  Consistent with its lysosomotropic nature, 1 accumulates in cells and in rat tissues of high lysosome content.  In contrast, nonbasic aryl-morpholino-contg. analogs do not exhibit lysosomotropic properties.  Increased off-target activities of basic cathepsin K inhibitors were obsd. in a cell-based cathepsin S antigen presentation assay.  No potency increases of basic inhibitors in a functional cathepsin K bone resorption whole cell assay were detected.  Therefore, basic cathepsin K inhibitors, such as 1, suffer from reduced functional selectivities compared to those predicted using purified enzyme assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1NUHyZtwrwLVg90H21EOLACvtfcHk0lj5Cmih6XfBxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKgsLbE&md5=9522026bb34984bc66b462b2e95fcbb0</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm0504961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0504961%26sid%3Dliteratum%253Aachs%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DKhougaz%26aufirst%3DK.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DToulmond%26aufirst%3DS.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DLysosomotropism%2520of%2520basic%2520cathepsin%2520K%2520inhibitors%2520contributes%2520to%2520increased%2520cellular%2520potencies%2520against%2520off-target%2520cathepsins%2520and%2520reduced%2520functional%2520selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7535%26epage%3D7543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Adami, S.; Supronik, J.; Hala, T.; Brown, J. P.; Garnero, P.; Haemmerle, S.; Ortmann, C. E.; Bouisset, F.; Trechsel, U.</span><span> </span><span class="NLM_article-title">Effect of one year treatment with the cathepsin-K inhibitor, balicatib, on bone mineral density (BMD) in postmenopausal women with osteopenia/osteoporosis</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span>, Abstract 1085.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&author=S.+Adami&author=J.+Supronik&author=T.+Hala&author=J.+P.+Brown&author=P.+Garnero&author=S.+Haemmerle&author=C.+E.+Ortmann&author=F.+Bouisset&author=U.+Trechsel&title=Effect+of+one+year+treatment+with+the+cathepsin-K+inhibitor%2C+balicatib%2C+on+bone+mineral+density+%28BMD%29+in+postmenopausal+women+with+osteopenia%2Fosteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdami%26aufirst%3DS.%26atitle%3DEffect%2520of%2520one%2520year%2520treatment%2520with%2520the%2520cathepsin-K%2520inhibitor%252C%2520balicatib%252C%2520on%2520bone%2520mineral%2520density%2520%2528BMD%2529%2520in%2520postmenopausal%2520women%2520with%2520osteopenia%252Fosteoporosis%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2006%26volume%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tawa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickarski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span> </span><span class="NLM_article-title">Effect of cathepsin K inhibitor basicity on in vivo off-target activities</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">147</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1124%2Fmol.107.039511" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17940194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslCqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=147-156&author=S.+Desmaraisauthor=W.+C.+Blackauthor=R.+Oballaauthor=S.+Lamontagneauthor=D.+Riendeauauthor=P.+Tawaauthor=L.+T.+Duongauthor=M.+Pickarskiauthor=M.+D.+Percival&title=Effect+of+cathepsin+K+inhibitor+basicity+on+in+vivo+off-target+activities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of cathepsin K inhibitor basicity on in vivo off-target activities</span></div><div class="casAuthors">Desmarais, Sylvie; Black, W. Cameron; Oballa, Renata; Lamontagne, Sonia; Riendeau, Denis; Tawa, Paul; Duong, Le Thi; Pickarski, Maureen; Percival, M. David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">147-156</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cathepsin K is a lysosomal cysteine protease that is a pharmacol. target for the treatment of osteoporosis.  Previous studies showed that basic, lipophilic cathepsin K inhibitors are lysosomotropic and have greater activities in cell-based assays against cathepsin K, as well as the physiol. important lysosomal cysteine cathepsins B, L, and S, than expected based on their potencies against these isolated enzymes.  Long-term administration of the basic cathepsin K inhibitors N-(1-(((cyanomethyl)amino)carbonyl)cyclohexyl)-4-(2-(4-methylpiperazin-1-yl)-1,3-thiazol-4-yl)benzamide (L-006235) and balicatib to rats at a supratherapeutic dose of 500 mg/kg/day for 4 wk resulted in increased tissue protein levels of cathepsin B and L but had no effect on cathepsin B and L message.  This is attributed to the inhibitor engagement of these off-target enzymes and their stabilization to proteolytic degrdn.  No such increase in these tissue cathepsins was detected at the same dose of L-873724, a potent nonbasic cathepsin K inhibitor with a similar off-target profile, although all three inhibitors provided similar plasma exposures.  Using an activity-based probe, 125I-BIL-DMK, in vivo inhibition of cathepsins B, L, and S was detected in tissues of mice given a single oral dose of L-006235 and balicatib, but not in mice given L-873724.  In each case, similar tissue levels were achieved by all three compds., thereby demonstrating the in vivo cathepsin selectivity of L-873724.  In conclusion, basic cathepsin K inhibitors demonstrate increased off-target cysteine cathepsin activities than their nonbasic analogs and potentially have a greater risk of adverse effects assocd. with inhibition of these cathepsins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrE1Ff2aKlZ57Vg90H21EOLACvtfcHk0lhUb6UEyPrZnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslCqtg%253D%253D&md5=53c20d61bd9b84db2d0cc4fe071040f4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fmol.107.039511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.107.039511%26sid%3Dliteratum%253Aachs%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DTawa%26aufirst%3DP.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DPickarski%26aufirst%3DM.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26atitle%3DEffect%2520of%2520cathepsin%2520K%2520inhibitor%2520basicity%2520on%2520in%2520vivo%2520off-target%2520activities%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D73%26spage%3D147%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Peroni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braga, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colato, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girolomoni, G.</span><span> </span><span class="NLM_article-title">Drug-induced morphea: report of a case induced by balicatib and review of the literature</span> <span class="citation_source-journal">J. Am. Acad. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.jaad.2008.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18410981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A280%3ADC%252BD1czpvVGjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2008&pages=125-129&author=A.+Peroniauthor=A.+Ziniauthor=V.+Bragaauthor=C.+Colatoauthor=S.+Adamiauthor=G.+Girolomoni&title=Drug-induced+morphea%3A+report+of+a+case+induced+by+balicatib+and+review+of+the+literature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-induced morphea: report of a case induced by balicatib and review of the literature</span></div><div class="casAuthors">Peroni Anna; Zini Antonio; Braga Vania; Colato Chiara; Adami Silvano; Girolomoni Giampiero</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Academy of Dermatology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Drug-induced scleroderma has been rarely reported, mostly with the features of diffuse scleroderma or acrosclerosis, and exceptionally with the characteristics of morphea.  We report the case of an adult white woman, enrolled in a double-blind, placebo-controlled, multicentric trial evaluating the efficacy and safety of the cathepsin K inhibitor balicatib for osteoporosis.  Typical morphea lesions developed on the patient's trunk 9 months after the beginning of therapy.  Lesions completely resolved after drug withdrawal and a single brief course of systemic steroids.  No recurrence occurred in a 2-year follow-up.  Fifteen cases of drug-induced morphea could be retrieved from the literature.  Drug withdrawal determined complete remission in only a few patients.  Different drug classes have been implicated.  Some of these, including balicatib, alter directly connective tissue metabolism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7h78HCX_qQIUSrryheKE6fW6udTcc2eZBCElYKYLUVrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1czpvVGjsA%253D%253D&md5=61fd8e59d3f450f6263ae45f59767616</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.jaad.2008.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jaad.2008.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DPeroni%26aufirst%3DA.%26aulast%3DZini%26aufirst%3DA.%26aulast%3DBraga%26aufirst%3DV.%26aulast%3DColato%26aufirst%3DC.%26aulast%3DAdami%26aufirst%3DS.%26aulast%3DGirolomoni%26aufirst%3DG.%26atitle%3DDrug-induced%2520morphea%253A%2520report%2520of%2520a%2520case%2520induced%2520by%2520balicatib%2520and%2520review%2520of%2520the%2520literature%26jtitle%3DJ.%2520Am.%2520Acad.%2520Dermatol.%26date%3D2008%26volume%3D59%26spage%3D125%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Altmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aichholz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betschart, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irie, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tintelnot-Blomley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Missbach, M.</span><span> </span><span class="NLM_article-title">2-Cyano-pyrimidines: a new chemotype for inhibitors of the cysteine protease cathepsin K</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">594</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0613525" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=591-594&author=E.+Altmannauthor=R.+Aichholzauthor=C.+Betschartauthor=T.+Buhlauthor=J.+Greenauthor=O.+Irieauthor=N.+Tenoauthor=R.+Lattmannauthor=M.+Tintelnot-Blomleyauthor=M.+Missbach&title=2-Cyano-pyrimidines%3A+a+new+chemotype+for+inhibitors+of+the+cysteine+protease+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm0613525&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0613525%26sid%3Dliteratum%253Aachs%26aulast%3DAltmann%26aufirst%3DE.%26aulast%3DAichholz%26aufirst%3DR.%26aulast%3DBetschart%26aufirst%3DC.%26aulast%3DBuhl%26aufirst%3DT.%26aulast%3DGreen%26aufirst%3DJ.%26aulast%3DIrie%26aufirst%3DO.%26aulast%3DTeno%26aufirst%3DN.%26aulast%3DLattmann%26aufirst%3DR.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DMissbach%26aufirst%3DM.%26atitle%3D2-Cyano-pyrimidines%253A%2520a%2520new%2520chemotype%2520for%2520inhibitors%2520of%2520the%2520cysteine%2520protease%2520cathepsin%2520K%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D591%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Teno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irie, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmori, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunji, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitomi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gohda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umemura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kometani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasaki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan-Jacob, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Missbach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betschart, C.</span><span> </span><span class="NLM_article-title">Novel scaffold for cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6096</span><span class="NLM_x">–</span> <span class="NLM_lpage">6100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.bmcl.2007.09.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17911019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFOjt77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=6096-6100&author=N.+Tenoauthor=T.+Miyakeauthor=T.+Eharaauthor=O.+Irieauthor=J.+Sakakiauthor=O.+Ohmoriauthor=H.+Gunjiauthor=N.+Matsuuraauthor=K.+Masuyaauthor=Y.+Hitomiauthor=K.+Nonomuraauthor=M.+Horiuchiauthor=K.+Gohdaauthor=A.+Iwasakiauthor=I.+Umemuraauthor=S.+Tadaauthor=M.+Kometaniauthor=G.+Iwasakiauthor=S.+W.+Cowan-Jacobauthor=M.+Missbachauthor=R.+Lattmannauthor=C.+Betschart&title=Novel+scaffold+for+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Novel scaffold for cathepsin K inhibitors</span></div><div class="casAuthors">Teno, Naoki; Miyake, Takahiro; Ehara, Takeru; Irie, Osamu; Sakaki, Junichi; Ohmori, Osamu; Gunji, Hiroki; Matsuura, Naoko; Masuya, Keiichi; Hitomi, Yuko; Nonomura, Kazuhiko; Horiuchi, Miyuki; Gohda, Keigo; Iwasaki, Atsuko; Umemura, Ichiro; Tada, Sachiyo; Kometani, Motohiko; Iwasaki, Genji; Cowan-Jacob, Sandra W.; Missbach, Martin; Lattmann, Rene; Betschart, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6096-6100</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pyrrolopyrimidine, a novel scaffold, allows to adjust interactions within the S3 subsite of cathepsin K.  The core intermediate 10 (I) facilitated the P3 optimization and identified highly potent and selective cathepsin K inhibitors 11-20.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovAekeL5ajUrVg90H21EOLACvtfcHk0lhHF7goXOXz0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFOjt77N&md5=9320305ef6bd02c637ffb0dd1afd367d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.09.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.09.047%26sid%3Dliteratum%253Aachs%26aulast%3DTeno%26aufirst%3DN.%26aulast%3DMiyake%26aufirst%3DT.%26aulast%3DEhara%26aufirst%3DT.%26aulast%3DIrie%26aufirst%3DO.%26aulast%3DSakaki%26aufirst%3DJ.%26aulast%3DOhmori%26aufirst%3DO.%26aulast%3DGunji%26aufirst%3DH.%26aulast%3DMatsuura%26aufirst%3DN.%26aulast%3DMasuya%26aufirst%3DK.%26aulast%3DHitomi%26aufirst%3DY.%26aulast%3DNonomura%26aufirst%3DK.%26aulast%3DHoriuchi%26aufirst%3DM.%26aulast%3DGohda%26aufirst%3DK.%26aulast%3DIwasaki%26aufirst%3DA.%26aulast%3DUmemura%26aufirst%3DI.%26aulast%3DTada%26aufirst%3DS.%26aulast%3DKometani%26aufirst%3DM.%26aulast%3DIwasaki%26aufirst%3DG.%26aulast%3DCowan-Jacob%26aufirst%3DS.%2BW.%26aulast%3DMissbach%26aufirst%3DM.%26aulast%3DLattmann%26aufirst%3DR.%26aulast%3DBetschart%26aufirst%3DC.%26atitle%3DNovel%2520scaffold%2520for%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D6096%26epage%3D6100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Teno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irie, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gohda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horiuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kometani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasaki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betschart, C.</span><span> </span><span class="NLM_article-title">New chemotypes for cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2599</span><span class="NLM_x">–</span> <span class="NLM_lpage">2603</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.bmcl.2008.03.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18375120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXks1akt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2599-2603&author=N.+Tenoauthor=O.+Irieauthor=T.+Miyakeauthor=K.+Gohdaauthor=M.+Horiuchiauthor=S.+Tadaauthor=K.+Nonomuraauthor=M.+Kometaniauthor=G.+Iwasakiauthor=C.+Betschart&title=New+chemotypes+for+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">New chemotypes for cathepsin K inhibitors</span></div><div class="casAuthors">Teno, Naoki; Irie, Osamu; Miyake, Takahiro; Gohda, Keigo; Horiuchi, Miyuki; Tada, Sachiyo; Nonomura, Kazuhiko; Kometani, Motohiko; Iwasaki, Genji; Betschart, Claudia</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2599-2603</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Alkynyl- and tert-aminopyrimidinecarbonitriles were prepd. and tested for inhibitory activities against cathepsin K and the highly homologous cathepsins L and S.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoS5QY0yeimmrVg90H21EOLACvtfcHk0lhHF7goXOXz0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXks1akt74%253D&md5=88877c6dea5e08af2b0fafead6998e68</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.03.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.03.036%26sid%3Dliteratum%253Aachs%26aulast%3DTeno%26aufirst%3DN.%26aulast%3DIrie%26aufirst%3DO.%26aulast%3DMiyake%26aufirst%3DT.%26aulast%3DGohda%26aufirst%3DK.%26aulast%3DHoriuchi%26aufirst%3DM.%26aulast%3DTada%26aufirst%3DS.%26aulast%3DNonomura%26aufirst%3DK.%26aulast%3DKometani%26aufirst%3DM.%26aulast%3DIwasaki%26aufirst%3DG.%26aulast%3DBetschart%26aufirst%3DC.%26atitle%3DNew%2520chemotypes%2520for%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2599%26epage%3D2603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Teno, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyake, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irie, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitomi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umemura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwasaki, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukaya, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toriyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchiyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonomura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kometani, M.</span><span> </span><span class="NLM_article-title">Effect of cathepsin K inhibitors on bone resorption</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5459</span><span class="NLM_x">–</span> <span class="NLM_lpage">5462</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800626a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5459-5462&author=N.+Tenoauthor=K.+Masuyaauthor=T.+Eharaauthor=T.+Kosakaauthor=T.+Miyakeauthor=O.+Irieauthor=Y.+Hitomiauthor=N.+Matsuuraauthor=I.+Umemuraauthor=G.+Iwasakiauthor=H.+Fukayaauthor=K.+Toriyamaauthor=N.+Uchiyamaauthor=K.+Nonomuraauthor=I.+Sugiyamaauthor=M.+Kometani&title=Effect+of+cathepsin+K+inhibitors+on+bone+resorption"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Cathepsin K Inhibitors on Bone Resorption</span></div><div class="casAuthors">Teno, Naoki; Masuya, Keiichi; Ehara, Takeru; Kosaka, Takatoshi; Miyake, Takahiro; Irie, Osamu; Hitomi, Yuko; Matsuura, Naoko; Umemura, Ichiro; Iwasaki, Genji; Fukaya, Hiroaki; Toriyama, Kazuhiro; Uchiyama, Noriko; Nonomura, Kazuhiko; Sugiyama, Ikuo; Kometani, Motohiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5459-5462</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of the pyrrolopyrimidine core structure that was previously discovered, cathepsin K inhibitors having a spiro amine at the P3 have been explored to enhance the target, bone marrow, tissue distribution.  Several spiro structures were identified with improved distribution toward bone marrow.  The representative inhibitor 7 of this series revealed in vivo redn. in C-terminal telopeptide of type I collagen in rats and monkeys.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUGSZEmNpl4rVg90H21EOLACvtfcHk0lhHF7goXOXz0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurbE&md5=ff9f7cce2fc32fa0cb8fe692f6bb5bac</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm800626a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800626a%26sid%3Dliteratum%253Aachs%26aulast%3DTeno%26aufirst%3DN.%26aulast%3DMasuya%26aufirst%3DK.%26aulast%3DEhara%26aufirst%3DT.%26aulast%3DKosaka%26aufirst%3DT.%26aulast%3DMiyake%26aufirst%3DT.%26aulast%3DIrie%26aufirst%3DO.%26aulast%3DHitomi%26aufirst%3DY.%26aulast%3DMatsuura%26aufirst%3DN.%26aulast%3DUmemura%26aufirst%3DI.%26aulast%3DIwasaki%26aufirst%3DG.%26aulast%3DFukaya%26aufirst%3DH.%26aulast%3DToriyama%26aufirst%3DK.%26aulast%3DUchiyama%26aufirst%3DN.%26aulast%3DNonomura%26aufirst%3DK.%26aulast%3DSugiyama%26aufirst%3DI.%26aulast%3DKometani%26aufirst%3DM.%26atitle%3DEffect%2520of%2520cathepsin%2520K%2520inhibitors%2520on%2520bone%2520resorption%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5459%26epage%3D5462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Böttiger, D.; Darpö, B.; Grabowska, U.; Shiroo, M.; Chambers, T. J.; Samuelsson, B.</span><span> </span><span class="NLM_article-title">Cathepsin K inhibitor, MIV-701, suppresses bone resorption markers in healthy PMW: results of a phase I clinical trial</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span>), Abstract F433.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&issue=Suppl.+1&author=D.+B%C3%B6ttiger&author=B.+Darp%C3%B6&author=U.+Grabowska&author=M.+Shiroo&author=T.+J.+Chambers&author=B.+Samuelsson&title=Cathepsin+K+inhibitor%2C+MIV-701%2C+suppresses+bone+resorption+markers+in+healthy+PMW%3A+results+of+a+phase+I+clinical+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25B6ttiger%26aufirst%3DD.%26atitle%3DCathepsin%2520K%2520inhibitor%252C%2520MIV-701%252C%2520suppresses%2520bone%2520resorption%2520markers%2520in%2520healthy%2520PMW%253A%2520results%2520of%2520a%2520phase%2520I%2520clinical%2520trial%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2008%26volume%3D23%26issue%3DSuppl.%25201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Fuller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grabowska, U. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiroo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, T. J.</span><span> </span><span class="NLM_article-title">Cathepsin K inhibitors prevent matrix-derived growth factor degradation by human osteoclasts</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">200</span><span class="NLM_x">–</span> <span class="NLM_lpage">211</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2008&pages=200-211&author=K.+Fullerauthor=K.+M.+Lawrenceauthor=J.+L.+Rossauthor=U.+B.+Grabowskaauthor=M.+Shirooauthor=B.+Samuelssonauthor=T.+J.+Chambers&title=Cathepsin+K+inhibitors+prevent+matrix-derived+growth+factor+degradation+by+human+osteoclasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFuller%26aufirst%3DK.%26aulast%3DLawrence%26aufirst%3DK.%2BM.%26aulast%3DRoss%26aufirst%3DJ.%2BL.%26aulast%3DGrabowska%26aufirst%3DU.%2BB.%26aulast%3DShiroo%26aufirst%3DM.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DChambers%26aufirst%3DT.%2BJ.%26atitle%3DCathepsin%2520K%2520inhibitors%2520prevent%2520matrix-derived%2520growth%2520factor%2520degradation%2520by%2520human%2520osteoclasts%26jtitle%3DBone%26date%3D2008%26volume%3D42%26spage%3D200%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Marquis, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ru, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LoCastro, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erhard, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszek, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tew, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salyers, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proksch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haltiwanger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trescher, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemling, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQueney, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D'Alessio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marzulli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodds, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blake, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, S.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gress, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lark, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span> </span><span class="NLM_article-title">Azepanone-based inhibitors of human and rat cathepsin K</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1380</span><span class="NLM_x">–</span> <span class="NLM_lpage">1395</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000481x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=1380-1395&author=R.+W.+Marquisauthor=Y.+Ruauthor=S.+M.+LoCastroauthor=J.+Zengauthor=D.+S.+Yamashitaauthor=H.-J.+Ohauthor=K.+F.+Erhardauthor=L.+D.+Davisauthor=T.+A.+Tomaszekauthor=D.+Tewauthor=K.+Salyersauthor=J.+Prokschauthor=K.+Wardauthor=B.+Smithauthor=M.+Levyauthor=M.+D.+Cummingsauthor=R.+C.+Haltiwangerauthor=G.+Trescherauthor=B.+Wangauthor=M.+E.+Hemlingauthor=C.+J.+Quinnauthor=H.+Y.+Chengauthor=F.+Linauthor=W.+W.+Smithauthor=C.+A.+Jansonauthor=B.+Zhaoauthor=M.+S.+McQueneyauthor=K.+D%27Alessioauthor=C.-P.+Leeauthor=A.+Marzulliauthor=R.+A.+Doddsauthor=S.+Blakeauthor=S.-M.+Hwangauthor=I.+E.+Jamesauthor=C.+J.+Gressauthor=B.+R.+Bradleyauthor=M.+W.+Larkauthor=M.+Gowenauthor=D.+F.+Veber&title=Azepanone-based+inhibitors+of+human+and+rat+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm000481x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000481x%26sid%3Dliteratum%253Aachs%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DRu%26aufirst%3DY.%26aulast%3DLoCastro%26aufirst%3DS.%2BM.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DYamashita%26aufirst%3DD.%2BS.%26aulast%3DOh%26aufirst%3DH.-J.%26aulast%3DErhard%26aufirst%3DK.%2BF.%26aulast%3DDavis%26aufirst%3DL.%2BD.%26aulast%3DTomaszek%26aufirst%3DT.%2BA.%26aulast%3DTew%26aufirst%3DD.%26aulast%3DSalyers%26aufirst%3DK.%26aulast%3DProksch%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DLevy%26aufirst%3DM.%26aulast%3DCummings%26aufirst%3DM.%2BD.%26aulast%3DHaltiwanger%26aufirst%3DR.%2BC.%26aulast%3DTrescher%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DHemling%26aufirst%3DM.%2BE.%26aulast%3DQuinn%26aufirst%3DC.%2BJ.%26aulast%3DCheng%26aufirst%3DH.%2BY.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DMcQueney%26aufirst%3DM.%2BS.%26aulast%3DD%2527Alessio%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DC.-P.%26aulast%3DMarzulli%26aufirst%3DA.%26aulast%3DDodds%26aufirst%3DR.%2BA.%26aulast%3DBlake%26aufirst%3DS.%26aulast%3DHwang%26aufirst%3DS.-M.%26aulast%3DJames%26aufirst%3DI.%2BE.%26aulast%3DGress%26aufirst%3DC.%2BJ.%26aulast%3DBradley%26aufirst%3DB.%2BR.%26aulast%3DLark%26aufirst%3DM.%2BW.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26atitle%3DAzepanone-based%2520inhibitors%2520of%2520human%2520and%2520rat%2520cathepsin%2520K%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D1380%26epage%3D1395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Yamashita, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nidamarthy, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, J. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erhard, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roethke, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevins, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haltiwanger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narducci Sarjeant, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liable-Sands, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McQueney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gress, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zembryki, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lark, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veber, D. F.</span><span> </span><span class="NLM_article-title">Structure activity relationships of 5-, 6-, and 7-methyl-substituted azepan-3-one cathepsin K inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1597</span><span class="NLM_x">–</span> <span class="NLM_lpage">1612</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050915u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1597-1612&author=D.+S.+Yamashitaauthor=R.+W.+Marquisauthor=R.+Xieauthor=S.+D.+Nidamarthyauthor=H.-J.+Ohauthor=J.+U.+Jeongauthor=K.+F.+Erhardauthor=K.+W.+Wardauthor=T.+J.+Roethkeauthor=B.+R.+Smithauthor=H.-Y.+Chengauthor=X.+Gengauthor=F.+Linauthor=P.+H.+Offenauthor=B.+Wangauthor=N.+Nevinsauthor=M.+S.+Headauthor=R.+C.+Haltiwangerauthor=A.+A.+Narducci+Sarjeantauthor=L.+M.+Liable-Sandsauthor=B.+Zhaoauthor=W.+W.+Smithauthor=C.+A.+Jansonauthor=E.+Gaoauthor=T.+Tomaszekauthor=M.+McQueneyauthor=I.+E.+Jamesauthor=C.+J.+Gressauthor=D.+L.+Zembrykiauthor=M.+W.+Larkauthor=D.+F.+Veber&title=Structure+activity+relationships+of+5-%2C+6-%2C+and+7-methyl-substituted+azepan-3-one+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm050915u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050915u%26sid%3Dliteratum%253Aachs%26aulast%3DYamashita%26aufirst%3DD.%2BS.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DXie%26aufirst%3DR.%26aulast%3DNidamarthy%26aufirst%3DS.%2BD.%26aulast%3DOh%26aufirst%3DH.-J.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DErhard%26aufirst%3DK.%2BF.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DRoethke%26aufirst%3DT.%2BJ.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DCheng%26aufirst%3DH.-Y.%26aulast%3DGeng%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DF.%26aulast%3DOffen%26aufirst%3DP.%2BH.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DNevins%26aufirst%3DN.%26aulast%3DHead%26aufirst%3DM.%2BS.%26aulast%3DHaltiwanger%26aufirst%3DR.%2BC.%26aulast%3DNarducci%2BSarjeant%26aufirst%3DA.%2BA.%26aulast%3DLiable-Sands%26aufirst%3DL.%2BM.%26aulast%3DZhao%26aufirst%3DB.%26aulast%3DSmith%26aufirst%3DW.%2BW.%26aulast%3DJanson%26aufirst%3DC.%2BA.%26aulast%3DGao%26aufirst%3DE.%26aulast%3DTomaszek%26aufirst%3DT.%26aulast%3DMcQueney%26aufirst%3DM.%26aulast%3DJames%26aufirst%3DI.%2BE.%26aulast%3DGress%26aufirst%3DC.%2BJ.%26aulast%3DZembryki%26aufirst%3DD.%2BL.%26aulast%3DLark%26aufirst%3DM.%2BW.%26aulast%3DVeber%26aufirst%3DD.%2BF.%26atitle%3DStructure%2520activity%2520relationships%2520of%25205-%252C%25206-%252C%2520and%25207-methyl-substituted%2520azepan-3-one%2520cathepsin%2520K%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1597%26epage%3D1612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Barrett, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catalano, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deaton, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFadyen, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samano, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells-Knecht, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.-Q. Q.</span><span> </span><span class="NLM_article-title">Acyclic, orally bioavailable ketone-based cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">22</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=22-27&author=D.+G.+Barrettauthor=J.+G.+Catalanoauthor=D.+N.+Deatonauthor=S.+T.+Longauthor=R.+B.+McFadyenauthor=A.+B.+Millerauthor=L.+R.+Millerauthor=V.+Samanoauthor=F.+X.+Tavaresauthor=K.+J.+Wells-Knechtauthor=L.+L.+Wrightauthor=H.-Q.+Q.+Zhou&title=Acyclic%2C+orally+bioavailable+ketone-based+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DD.%2BG.%26aulast%3DCatalano%26aufirst%3DJ.%2BG.%26aulast%3DDeaton%26aufirst%3DD.%2BN.%26aulast%3DLong%26aufirst%3DS.%2BT.%26aulast%3DMcFadyen%26aufirst%3DR.%2BB.%26aulast%3DMiller%26aufirst%3DA.%2BB.%26aulast%3DMiller%26aufirst%3DL.%2BR.%26aulast%3DSamano%26aufirst%3DV.%26aulast%3DTavares%26aufirst%3DF.%2BX.%26aulast%3DWells-Knecht%26aufirst%3DK.%2BJ.%26aulast%3DWright%26aufirst%3DL.%2BL.%26aulast%3DZhou%26aufirst%3DH.-Q.%2BQ.%26atitle%3DAcyclic%252C%2520orally%2520bioavailable%2520ketone-based%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D22%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Kumar, S.; Rehm, S.; Boyce, R.; Birmingham, J.; Stroup, G.; Jerome, C.; Weir, P.</span><span> </span><span class="NLM_article-title">Treatment of young male monkeys for 12 months with a highly potent inhibitor of cathepsin K inhibits bone resorption, and increases bone mineral density and strength</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span>), Abstract F232.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2005&issue=Suppl.+1&author=S.+Kumar&author=S.+Rehm&author=R.+Boyce&author=J.+Birmingham&author=G.+Stroup&author=C.+Jerome&author=P.+Weir&title=Treatment+of+young+male+monkeys+for+12+months+with+a+highly+potent+inhibitor+of+cathepsin+K+inhibits+bone+resorption%2C+and+increases+bone+mineral+density+and+strength"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26atitle%3DTreatment%2520of%2520young%2520male%2520monkeys%2520for%252012%2520months%2520with%2520a%2520highly%2520potent%2520inhibitor%2520of%2520cathepsin%2520K%2520inhibits%2520bone%2520resorption%252C%2520and%2520increases%2520bone%2520mineral%2520density%2520and%2520strength%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2005%26volume%3D20%26issue%3DSuppl.%25201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Adkison, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deaton, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gampe, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassell, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFadyen, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shewchuk, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells-Knecht, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willard, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, L. L.</span><span> </span><span class="NLM_article-title">Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">978</span><span class="NLM_x">–</span> <span class="NLM_lpage">983</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=978-983&author=K.+K.+Adkisonauthor=D.+G.+Barrettauthor=D.+N.+Deatonauthor=R.+T.+Gampeauthor=A.+M.+Hassellauthor=S.+T.+Longauthor=R.+B.+McFadyenauthor=A.+B.+Millerauthor=L.+R.+Millerauthor=J.+A.+Payneauthor=L.+M.+Shewchukauthor=K.+J.+Wells-Knechtauthor=D.+H.+Willardauthor=L.+L.+Wright&title=Semicarbazone-based+inhibitors+of+cathepsin+K%2C+are+they+prodrugs+for+aldehyde+inhibitors%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdkison%26aufirst%3DK.%2BK.%26aulast%3DBarrett%26aufirst%3DD.%2BG.%26aulast%3DDeaton%26aufirst%3DD.%2BN.%26aulast%3DGampe%26aufirst%3DR.%2BT.%26aulast%3DHassell%26aufirst%3DA.%2BM.%26aulast%3DLong%26aufirst%3DS.%2BT.%26aulast%3DMcFadyen%26aufirst%3DR.%2BB.%26aulast%3DMiller%26aufirst%3DA.%2BB.%26aulast%3DMiller%26aufirst%3DL.%2BR.%26aulast%3DPayne%26aufirst%3DJ.%2BA.%26aulast%3DShewchuk%26aufirst%3DL.%2BM.%26aulast%3DWells-Knecht%26aufirst%3DK.%2BJ.%26aulast%3DWillard%26aufirst%3DD.%2BH.%26aulast%3DWright%26aufirst%3DL.%2BL.%26atitle%3DSemicarbazone-based%2520inhibitors%2520of%2520cathepsin%2520K%252C%2520are%2520they%2520prodrugs%2520for%2520aldehyde%2520inhibitors%253F%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D978%26epage%3D983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeRiche, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, V.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venuti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span> </span><span class="NLM_article-title">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">928</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.bmcl.2007.12.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18226527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=923-928&author=J.+Y.+Gauthierauthor=N.+Chauretauthor=W.+Cromlishauthor=S.+Desmaraisauthor=L.+T.+Duongauthor=J.-P.+Falgueyretauthor=D.+B.+Kimmelauthor=S.+Lamontagneauthor=S.+Legerauthor=T.+LeRicheauthor=C.+S.+Liauthor=F.+Masseauthor=D.+J.+McKayauthor=D.+A.+Nicoll-Griffithauthor=R.+M.+Oballaauthor=J.+T.+Palmerauthor=M.+D.+Percivalauthor=D.+Riendeauauthor=J.+Robichaudauthor=G.+A.+Rodanauthor=S.+B.+Rodanauthor=C.+Setoauthor=M.+Therienauthor=V.-L.+Truongauthor=M.+C.+Venutiauthor=G.+Wesolowskiauthor=R.+N.+Youngauthor=R.+Zamboniauthor=W.+C.+Black&title=The+discovery+of+odanacatib+%28MK-0822%29%2C+a+selective+inhibitor+of+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span></div><div class="casAuthors">Gauthier, Jacques Yves; Chauret, Nathalie; Cromlish, Wanda; Desmarais, Sylvie; Duong, Le T.; Falgueyret, Jean-Pierre; Kimmel, Donald B.; Lamontagne, Sonia; Leger, Serge; LeRiche, Tammy; Li, Chun Sing; Masse, Frederic; McKay, Daniel J.; Nicoll-Griffith, Deborah A.; Oballa, Renata M.; Palmer, James T.; Percival, M. David; Riendeau, Denis; Robichaud, Joel; Rodan, Gideon A.; Rodan, Sevgi B.; Seto, Carmai; Therien, Michel; Truong, Vouy-Linh; Venuti, Michael C.; Wesolowski, Gregg; Young, Robert N.; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">923-928</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Odanacatib is a potent, selective, and neutral cathepsin K inhibitor which was developed to address the metabolic liabilities of the Cat K inhibitor L-873724.  Substituting P1 and modifying the P2 side chain led to a metabolically robust inhibitor with a long half-life in preclin. species.  Odanacatib was more selective in whole cell assays than the published Cat K inhibitors balicatib and relacatib.  Evaluation in dermal fibroblast culture showed minimal intracellular collagen accumulation relative to less selective Cat K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7ytNI-SBgarVg90H21EOLACvtfcHk0libjWi0Fpy7LQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D&md5=e432a420a3ec99c784117750b9bbeda8</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.047%26sid%3Dliteratum%253Aachs%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DLeRiche%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DSeto%26aufirst%3DC.%26aulast%3DTherien%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.-L.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DThe%2520discovery%2520of%2520odanacatib%2520%2528MK-0822%2529%252C%2520a%2520selective%2520inhibitor%2520of%2520cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D923%26epage%3D928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span> </span><span class="NLM_article-title">Cathepsin K: a new molecular target for osteoporosis</span> <span class="citation_source-journal">IBMS BoneKEy</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2008&pages=16-24&author=S.+B.+Rodanauthor=L.+T.+Duong&title=Cathepsin+K%3A+a+new+molecular+target+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26atitle%3DCathepsin%2520K%253A%2520a%2520new%2520molecular%2520target%2520for%2520osteoporosis%26jtitle%3DIBMS%2520BoneKEy%26date%3D2008%26volume%3D5%26spage%3D16%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Setti, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of tetracyclic nonpeptidic biaryl nitrile inhibitors of cathepsin K</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">4296</span><span class="NLM_x">–</span> <span class="NLM_lpage">4299</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=4296-4299&author=E.+L.+Settiauthor=S.+Venkatramanauthor=J.+T.+Palmerauthor=X.+Xieauthor=H.+Cheungauthor=W.+Yuauthor=G.+Wesolowskiauthor=J.+Robichaud&title=Design+and+synthesis+of+tetracyclic+nonpeptidic+biaryl+nitrile+inhibitors+of+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSetti%26aufirst%3DE.%2BL.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DXie%26aufirst%3DX.%26aulast%3DCheung%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DRobichaud%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520tetracyclic%2520nonpeptidic%2520biaryl%2520nitrile%2520inhibitors%2520of%2520cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D4296%26epage%3D4299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span> </span><span class="NLM_article-title">A novel class of nonpeptidic biaryl inhibitors of human cathepsin K</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3709</span><span class="NLM_x">–</span> <span class="NLM_lpage">3727</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0301078" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3709-3727&author=J.+Robichaudauthor=R.+Oballaauthor=P.+Prasitauthor=J.-P.+Falgueyretauthor=M.+D.+Percivalauthor=G.+Wesolowskiauthor=S.+B.+Rodanauthor=D.+Kimmelauthor=C.+Johnsonauthor=C.+Bryantauthor=S.+Venkatramanauthor=E.+Settiauthor=R.+Mendoncaauthor=J.+T.+Palmer&title=A+novel+class+of+nonpeptidic+biaryl+inhibitors+of+human+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fjm0301078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0301078%26sid%3Dliteratum%253Aachs%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DKimmel%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DC.%26aulast%3DBryant%26aufirst%3DC.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DSetti%26aufirst%3DE.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26atitle%3DA%2520novel%2520class%2520of%2520nonpeptidic%2520biaryl%2520inhibitors%2520of%2520human%2520cathepsin%2520K%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3709%26epage%3D3727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setti, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rydzewski, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, Z.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrill, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janc, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somoza, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enriquez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickley, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venuti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G.</span><span> </span><span class="NLM_article-title">Design and synthesis of tri-ring P3 benzamide-containing aminonitriles as potent, selective, orally effective inhibitors of cathepsin K</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">7520</span><span class="NLM_x">–</span> <span class="NLM_lpage">7534</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058198r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7520-7534&author=J.+T.+Palmerauthor=C.+Bryantauthor=D.-X.+Wangauthor=D.+E.+Davisauthor=E.+L.+Settiauthor=R.+M.+Rydzewskiauthor=S.+Venkatramanauthor=Z.-Q.+Tianauthor=L.+C.+Burrillauthor=R.+V.+Mendoncaauthor=E.+Springmanauthor=J.+McCarterauthor=T.+Chungauthor=H.+Cheungauthor=J.+W.+Jancauthor=M.+McGrathauthor=J.+R.+Somozaauthor=P.+Enriquezauthor=Z.+W.+Yuauthor=R.+M.+Strickleyauthor=L.+Liuauthor=M.+C.+Venutiauthor=M.+D.+Percivalauthor=J.-P.+Falgueyretauthor=P.+Prasitauthor=R.+Oballaauthor=D.+Riendeauauthor=R.+N.+Youngauthor=G.+Wesolowskiauthor=S.+B.+Rodanauthor=C.+Johnsonauthor=D.+B.+Kimmelauthor=G.+Rodan&title=Design+and+synthesis+of+tri-ring+P3+benzamide-containing+aminonitriles+as+potent%2C+selective%2C+orally+effective+inhibitors+of+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjm058198r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058198r%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DBryant%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DD.-X.%26aulast%3DDavis%26aufirst%3DD.%2BE.%26aulast%3DSetti%26aufirst%3DE.%2BL.%26aulast%3DRydzewski%26aufirst%3DR.%2BM.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DZ.-Q.%26aulast%3DBurrill%26aufirst%3DL.%2BC.%26aulast%3DMendonca%26aufirst%3DR.%2BV.%26aulast%3DSpringman%26aufirst%3DE.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DChung%26aufirst%3DT.%26aulast%3DCheung%26aufirst%3DH.%26aulast%3DJanc%26aufirst%3DJ.%2BW.%26aulast%3DMcGrath%26aufirst%3DM.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DEnriquez%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DZ.%2BW.%26aulast%3DStrickley%26aufirst%3DR.%2BM.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DOballa%26aufirst%3DR.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DJohnson%26aufirst%3DC.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DRodan%26aufirst%3DG.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520tri-ring%2520P3%2520benzamide-containing%2520aminonitriles%2520as%2520potent%252C%2520selective%252C%2520orally%2520effective%2520inhibitors%2520of%2520cathepsin%2520K%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7520%26epage%3D7534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Li, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deschenes, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrath, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, V.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span> </span><span class="NLM_article-title">Identification of a potent and selective non-basic cathepsin K inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1985</span><span class="NLM_x">–</span> <span class="NLM_lpage">1989</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.bmcl.2005.12.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16413777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvVyqs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1985-1989&author=C.+S.+Liauthor=D.+Deschenesauthor=S.+Desmaraisauthor=J.-P.+Falgueyretauthor=J.+Y.+Gauthierauthor=D.+B.+Kimmelauthor=S.+Legerauthor=F.+Masseauthor=M.+E.+McGrathauthor=D.+J.+McKayauthor=M.+D.+Percivalauthor=D.+Riendeauauthor=S.+B.+Rodanauthor=M.+Therienauthor=V.-L.+Truongauthor=G.+Wesolowskiauthor=R.+Zamboniauthor=W.+C.+Black&title=Identification+of+a+potent+and+selective+non-basic+cathepsin+K+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a potent and selective non-basic cathepsin K inhibitor</span></div><div class="casAuthors">Li, Chun Sing; Deschenes, Denis; Desmarais, Sylvie; Falgueyret, Jean-Pierre; Gauthier, Jacques Yves; Kimmel, Donald. B.; Leger, Serge; Masse, Frederic; McGrath, Mary E.; McKay, Daniel J.; Percival, M. David; Riendeau, Denis; Rodan, Sevgi B.; Therien, Michel; Truong, Vouy-Linh; Wesolowski, Gregg; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1985-1989</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Based on our previous study with trifluoroethylamine as a P2-P3 amide isostere of cathepsin K inhibitor, further optimization led to identification of L-873724 (I) as a potent and selective non-basic cathepsin K inhibitor.  This compd. showed excellent pharmacokinetics and efficacy in an ovariectomized (OVX) rhesus monkey model.  The vols. of distribution close to unity were consistent with this compd. not being lysosomotropic, which is a characteristic of basic cathepsin K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbVLlTt9kYhrVg90H21EOLACvtfcHk0lgAWnhaq38cgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvVyqs74%253D&md5=e63e471204893774e5a617993ed9be18</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.12.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.12.071%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DDeschenes%26aufirst%3DD.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcGrath%26aufirst%3DM.%2BE.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DTherien%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.-L.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DIdentification%2520of%2520a%2520potent%2520and%2520selective%2520non-basic%2520cathepsin%2520K%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1985%26epage%3D1989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span> </span><span class="NLM_article-title">Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4741</span><span class="NLM_x">–</span> <span class="NLM_lpage">4744</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.bmcl.2005.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16154747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVanu7%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4741-4744&author=W.+C.+Blackauthor=C.+I.+Baylyauthor=D.+E.+Davisauthor=S.+Desmaraisauthor=J.-P.+Falgueyretauthor=S.+Legerauthor=C.+S.+Liauthor=F.+Masseauthor=D.+J.+McKayauthor=J.+T.+Palmerauthor=M.+D.+Percivalauthor=J.+Robichaudauthor=N.+Tsouauthor=R.+Zamboni&title=Trifluoroethylamines+as+amide+isosteres+in+inhibitors+of+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K</span></div><div class="casAuthors">Black, W. Cameron; Bayly, Christopher I.; Davis, Dana E.; Desmarais, Sylvie; Falgueyret, Jean-Pierre; Leger, Serge; Li, Chun Sing; Masse, Frederic; McKay, Daniel J.; Palmer, James T.; Percival, M. David; Robichaud, Joel; Tsou, Nancy; Zamboni, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4741-4744</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The P2-P3 amide of dipeptide cathepsin K inhibitors can be replaced by the metabolically stable trifluoroethylamine group.  The nonbasic nature of the nitrogen allows the important hydrogen bond to Gly66 to be made.  The resulting compds. are 10- to 20-fold more potent than the corresponding amide derivs.  Compd. (I) is a 5 pM inhibitor of human cathepsin K with >10,000-fold selectivity over other cathepsins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKJDCfyMa_crVg90H21EOLACvtfcHk0lgAWnhaq38cgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVanu7%252FE&md5=c2ffc9bde9fbee7bb432d3c2485cfc62</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2005.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2005.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DDavis%26aufirst%3DD.%2BE.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DTsou%26aufirst%3DN.%26aulast%3DZamboni%26aufirst%3DR.%26atitle%3DTrifluoroethylamines%2520as%2520amide%2520isosteres%2520in%2520inhibitors%2520of%2520cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4741%26epage%3D4744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">McClung, M.; Bone, H.; Cosman, F.; Roux, C.; Verbruggen, N.; Hustad, C.; DaSilva, C.; Santora, A.; Ince, A.</span><span> </span><span class="NLM_article-title">A randomized, double-blind, placebo-controlled study of odanacatib (MK-822) in the treatment of postmenopausal women with low bone mineral density: 24-month results</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span>), Abstract 1291.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2008&issue=Suppl.+1&author=M.+McClung&author=H.+Bone&author=F.+Cosman&author=C.+Roux&author=N.+Verbruggen&author=C.+Hustad&author=C.+DaSilva&author=A.+Santora&author=A.+Ince&title=A+randomized%2C+double-blind%2C+placebo-controlled+study+of+odanacatib+%28MK-822%29+in+the+treatment+of+postmenopausal+women+with+low+bone+mineral+density%3A+24-month+results"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcClung%26aufirst%3DM.%26atitle%3DA%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520study%2520of%2520odanacatib%2520%2528MK-822%2529%2520in%2520the%2520treatment%2520of%2520postmenopausal%2520women%2520with%2520low%2520bone%2520mineral%2520density%253A%252024-month%2520results%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2008%26volume%3D23%26issue%3DSuppl.%25201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truchon, J.-F.</span><span> </span><span class="NLM_article-title">Primary amides as selective inhibitors of cathepsin K</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4328</span><span class="NLM_x">–</span> <span class="NLM_lpage">4332</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4328-4332&author=S.+Legerauthor=C.+I.+Baylyauthor=W.+C.+Blackauthor=S.+Desmaraisauthor=J.-P.+Falgueyretauthor=F.+Masseauthor=M.+D.+Percivalauthor=J.-F.+Truchon&title=Primary+amides+as+selective+inhibitors+of+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DTruchon%26aufirst%3DJ.-F.%26atitle%3DPrimary%2520amides%2520as%2520selective%2520inhibitors%2520of%2520cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4328%26epage%3D4332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Boyd, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheigetz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span> </span><span class="NLM_article-title">Investigation of ketone warheads as alternatives to the nitrile for preparation of potent and selective cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">675</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=675-679&author=M.+J.+Boydauthor=S.+N.+Craneauthor=J.+Robichaudauthor=J.+Scheigetzauthor=W.+C.+Blackauthor=N.+Chauretauthor=Q.+Wangauthor=F.+Masseauthor=R.+M.+Oballa&title=Investigation+of+ketone+warheads+as+alternatives+to+the+nitrile+for+preparation+of+potent+and+selective+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyd%26aufirst%3DM.%2BJ.%26aulast%3DCrane%26aufirst%3DS.%2BN.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DScheigetz%26aufirst%3DJ.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26atitle%3DInvestigation%2520of%2520ketone%2520warheads%2520as%2520alternatives%2520to%2520the%2520nitrile%2520for%2520preparation%2520of%2520potent%2520and%2520selective%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D675%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirschbein, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janc, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span> </span><span class="NLM_article-title">Keto-1,3,4-oxadiazoles as cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2909</span><span class="NLM_x">–</span> <span class="NLM_lpage">2914</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2909-2914&author=J.+T.+Palmerauthor=B.+L.+Hirschbeinauthor=H.+Cheungauthor=J.+McCarterauthor=J.+W.+Jancauthor=Z.+W.+Yuauthor=G.+Wesolowski&title=Keto-1%2C3%2C4-oxadiazoles+as+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DHirschbein%26aufirst%3DB.%2BL.%26aulast%3DCheung%26aufirst%3DH.%26aulast%3DMcCarter%26aufirst%3DJ.%26aulast%3DJanc%26aufirst%3DJ.%2BW.%26aulast%3DYu%26aufirst%3DZ.%2BW.%26aulast%3DWesolowski%26aufirst%3DG.%26atitle%3DKeto-1%252C3%252C4-oxadiazoles%2520as%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2909%26epage%3D2914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Crane, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Setti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Somoza, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheigetz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ouellet, M.</span><span> </span><span class="NLM_article-title">β-Substituted cyclohexanecarboxamide: a nonpeptidic framework for the design of potent inhibitors of cathepsin K</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1066</span><span class="NLM_x">–</span> <span class="NLM_lpage">1079</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051059p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1066-1079&author=S.+N.+Craneauthor=W.+C.+Blackauthor=J.+T.+Palmerauthor=D.+E.+Davisauthor=E.+Settiauthor=J.+Robichaudauthor=J.+Paquetauthor=R.+M.+Oballaauthor=C.+I.+Baylyauthor=D.+J.+McKayauthor=J.+R.+Somozaauthor=N.+Chauretauthor=C.+Setoauthor=J.+Scheigetzauthor=G.+Wesolowskiauthor=F.+Masseauthor=S.+Desmaraisauthor=M.+Ouellet&title=%CE%B2-Substituted+cyclohexanecarboxamide%3A+a+nonpeptidic+framework+for+the+design+of+potent+inhibitors+of+cathepsin+K"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm051059p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051059p%26sid%3Dliteratum%253Aachs%26aulast%3DCrane%26aufirst%3DS.%2BN.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DDavis%26aufirst%3DD.%2BE.%26aulast%3DSetti%26aufirst%3DE.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DPaquet%26aufirst%3DJ.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DSeto%26aufirst%3DC.%26aulast%3DScheigetz%26aufirst%3DJ.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DOuellet%26aufirst%3DM.%26atitle%3D%25CE%25B2-Substituted%2520cyclohexanecarboxamide%253A%2520a%2520nonpeptidic%2520framework%2520for%2520the%2520design%2520of%2520potent%2520inhibitors%2520of%2520cathepsin%2520K%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1066%26epage%3D1079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truchon, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, S. N.</span><span> </span><span class="NLM_article-title">β-Substituted cyclohexanecarboxamide cathepsin K inhibitors: modification of the 1,2-disubstituted aromatic core</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">3146</span><span class="NLM_x">–</span> <span class="NLM_lpage">3151</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3146-3151&author=J.+Robichaudauthor=C.+I.+Baylyauthor=W.+C.+Blackauthor=S.+Desmaraisauthor=S.+Legerauthor=F.+Masseauthor=D.+J.+McKayauthor=R.+M.+Oballaauthor=J.+Paquetauthor=M.+D.+Percivalauthor=J.-F.+Truchonauthor=G.+Wesolowskiauthor=S.+N.+Crane&title=%CE%B2-Substituted+cyclohexanecarboxamide+cathepsin+K+inhibitors%3A+modification+of+the+1%2C2-disubstituted+aromatic+core"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DPaquet%26aufirst%3DJ.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DTruchon%26aufirst%3DJ.-F.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DCrane%26aufirst%3DS.%2BN.%26atitle%3D%25CE%25B2-Substituted%2520cyclohexanecarboxamide%2520cathepsin%2520K%2520inhibitors%253A%2520modification%2520of%2520the%25201%252C2-disubstituted%2520aromatic%2520core%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D3146%26epage%3D3151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayly, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isabel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellon, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crane, S. N.</span><span> </span><span class="NLM_article-title">Identification of a nonbasic, nitrile-containing cathepsin K inhibitor (MK-1256) that is efficacious in a monkey model of osteoporosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6410</span><span class="NLM_x">–</span> <span class="NLM_lpage">6420</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800610j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6410-6420&author=J.+Robichaudauthor=W.+C.+Blackauthor=M.+Therienauthor=J.+Paquetauthor=R.+M.+Oballaauthor=C.+I.+Baylyauthor=D.+J.+McKayauthor=Q.+Wangauthor=E.+Isabelauthor=S.+Legerauthor=C.+Mellonauthor=D.+B.+Kimmelauthor=G.+Wesolowskiauthor=M.+D.+Percivalauthor=F.+Masseauthor=S.+Desmaraisauthor=J.-P.+Falgueyretauthor=S.+N.+Crane&title=Identification+of+a+nonbasic%2C+nitrile-containing+cathepsin+K+inhibitor+%28MK-1256%29+that+is+efficacious+in+a+monkey+model+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Fjm800610j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800610j%26sid%3Dliteratum%253Aachs%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26aulast%3DTherien%26aufirst%3DM.%26aulast%3DPaquet%26aufirst%3DJ.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DBayly%26aufirst%3DC.%2BI.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DIsabel%26aufirst%3DE.%26aulast%3DLeger%26aufirst%3DS.%26aulast%3DMellon%26aufirst%3DC.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DMasse%26aufirst%3DF.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DCrane%26aufirst%3DS.%2BN.%26atitle%3DIdentification%2520of%2520a%2520nonbasic%252C%2520nitrile-containing%2520cathepsin%2520K%2520inhibitor%2520%2528MK-1256%2529%2520that%2520is%2520efficacious%2520in%2520a%2520monkey%2520model%2520of%2520osteoporosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6410%26epage%3D6420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Quibell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flinn, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramjee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, J.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of <i>cis</i>-hexahydropyrrolo[3,2-<i>b</i>]pyrrol-3-one peptidomimetic inhibitors of CAC1 cysteinyl proteinases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">625</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2005&pages=609-625&author=M.+Quibellauthor=A.+Bennauthor=N.+Flinnauthor=T.+Monkauthor=M.+Ramjeeauthor=P.+Rayauthor=Y.+Wangauthor=J.+Watts&title=Synthesis+and+evaluation+of+cis-hexahydropyrrolo%5B3%2C2-b%5Dpyrrol-3-one+peptidomimetic+inhibitors+of+CAC1+cysteinyl+proteinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuibell%26aufirst%3DM.%26aulast%3DBenn%26aufirst%3DA.%26aulast%3DFlinn%26aufirst%3DN.%26aulast%3DMonk%26aufirst%3DT.%26aulast%3DRamjee%26aufirst%3DM.%26aulast%3DRay%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWatts%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520cis-hexahydropyrrolo%255B3%252C2-b%255Dpyrrol-3-one%2520peptidomimetic%2520inhibitors%2520of%2520CAC1%2520cysteinyl%2520proteinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2005%26volume%3D13%26spage%3D609%26epage%3D625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Morley, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heald, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacFaul, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porres, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilkinson, T. J.</span><span> </span><span class="NLM_article-title">5-Aminopyrimidin-2-ylnitriles as cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1658</span><span class="NLM_x">–</span> <span class="NLM_lpage">1661</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1658-1661&author=A.+D.+Morleyauthor=P.+W.+Kennyauthor=B.+Burtonauthor=R.+A.+Healdauthor=P.+A.+MacFaulauthor=J.+Mullettauthor=K.+Pageauthor=S.+S.+Porresauthor=L.+R.+Ribeiroauthor=P.+Smithauthor=S.+Wardauthor=T.+J.+Wilkinson&title=5-Aminopyrimidin-2-ylnitriles+as+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorley%26aufirst%3DA.%2BD.%26aulast%3DKenny%26aufirst%3DP.%2BW.%26aulast%3DBurton%26aufirst%3DB.%26aulast%3DHeald%26aufirst%3DR.%2BA.%26aulast%3DMacFaul%26aufirst%3DP.%2BA.%26aulast%3DMullett%26aufirst%3DJ.%26aulast%3DPage%26aufirst%3DK.%26aulast%3DPorres%26aufirst%3DS.%2BS.%26aulast%3DRibeiro%26aufirst%3DL.%2BR.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DWard%26aufirst%3DS.%26aulast%3DWilkinson%26aufirst%3DT.%2BJ.%26atitle%3D5-Aminopyrimidin-2-ylnitriles%2520as%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1658%26epage%3D1661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Shinozuka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamane, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuka, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mochizuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohhata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naito, S.</span><span> </span><span class="NLM_article-title">Potent and selective cathepsin K inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6789</span><span class="NLM_x">–</span> <span class="NLM_lpage">6806</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=6789-6806&author=T.+Shinozukaauthor=K.+Shimadaauthor=S.+Matsuiauthor=T.+Yamaneauthor=M.+Amaauthor=T.+Fukudaauthor=M.+Takiauthor=Y.+Takedaauthor=E.+Otsukaauthor=M.+Yamatoauthor=S.+Mochizukiauthor=K.+Ohhataauthor=S.+Naito&title=Potent+and+selective+cathepsin+K+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShinozuka%26aufirst%3DT.%26aulast%3DShimada%26aufirst%3DK.%26aulast%3DMatsui%26aufirst%3DS.%26aulast%3DYamane%26aufirst%3DT.%26aulast%3DAma%26aufirst%3DM.%26aulast%3DFukuda%26aufirst%3DT.%26aulast%3DTaki%26aufirst%3DM.%26aulast%3DTakeda%26aufirst%3DY.%26aulast%3DOtsuka%26aufirst%3DE.%26aulast%3DYamato%26aufirst%3DM.%26aulast%3DMochizuki%26aufirst%3DS.%26aulast%3DOhhata%26aufirst%3DK.%26aulast%3DNaito%26aufirst%3DS.%26atitle%3DPotent%2520and%2520selective%2520cathepsin%2520K%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D6789%26epage%3D6806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span>ClinicalTrials.Gov Identifier NCT00532337. http://clinicaltrials.gov/ct2/show/NCT00532337 (updated June 15,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.Gov+Identifier+NCT00532337.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00532337+%28updated+June+15%2C+2009%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Reinholt, F. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hultenby, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinegaard, D.</span><span> </span><span class="NLM_article-title">Osteopontin, a possible anchor of osteoclasts to bone</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x">, </span> <span class="NLM_fpage">4473</span><span class="NLM_x">–</span> <span class="NLM_lpage">4475</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=1990&pages=4473-4475&author=F.+P.+Reinholtauthor=K.+Hultenbyauthor=A.+Oldbergauthor=D.+Heinegaard&title=Osteopontin%2C+a+possible+anchor+of+osteoclasts+to+bone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReinholt%26aufirst%3DF.%2BP.%26aulast%3DHultenby%26aufirst%3DK.%26aulast%3DOldberg%26aufirst%3DA.%26aulast%3DHeinegaard%26aufirst%3DD.%26atitle%3DOsteopontin%252C%2520a%2520possible%2520anchor%2520of%2520osteoclasts%2520to%2520bone%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1990%26volume%3D87%26spage%3D4473%26epage%3D4475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Dechantsreiter, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathae, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohof, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelzemann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonczyk, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, H.</span><span> </span><span class="NLM_article-title">N-Methylated cyclic RGDpeptides as highly active and selective αVβ3 integrin antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3033</span><span class="NLM_x">–</span> <span class="NLM_lpage">3040</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970832g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=3033-3040&author=M.+A.+Dechantsreiterauthor=E.+Plankerauthor=B.+Mathaeauthor=E.+Lohofauthor=G.+Hoelzemannauthor=A.+Jonczykauthor=S.+L.+Goodmanauthor=H.+Kessler&title=N-Methylated+cyclic+RGDpeptides+as+highly+active+and+selective+%CE%B1V%CE%B23+integrin+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Fjm970832g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970832g%26sid%3Dliteratum%253Aachs%26aulast%3DDechantsreiter%26aufirst%3DM.%2BA.%26aulast%3DPlanker%26aufirst%3DE.%26aulast%3DMathae%26aufirst%3DB.%26aulast%3DLohof%26aufirst%3DE.%26aulast%3DHoelzemann%26aufirst%3DG.%26aulast%3DJonczyk%26aufirst%3DA.%26aulast%3DGoodman%26aufirst%3DS.%2BL.%26aulast%3DKessler%26aufirst%3DH.%26atitle%3DN-Methylated%2520cyclic%2520RGDpeptides%2520as%2520highly%2520active%2520and%2520selective%2520%25CE%25B1V%25CE%25B23%2520integrin%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D3033%26epage%3D3040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seedor, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leu, C.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span> </span><span class="NLM_article-title">The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x">, </span> <span class="NLM_fpage">1411</span><span class="NLM_x">–</span> <span class="NLM_lpage">1419</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=1998&pages=1411-1419&author=M.+Yamamotoauthor=J.+E.+Fisherauthor=M.+Gentileauthor=J.+G.+Seedorauthor=C.-T.+Leuauthor=S.+B.+Rodanauthor=G.+A.+Rodan&title=The+integrin+ligand+echistatin+prevents+bone+loss+in+ovariectomized+mice+and+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DFisher%26aufirst%3DJ.%2BE.%26aulast%3DGentile%26aufirst%3DM.%26aulast%3DSeedor%26aufirst%3DJ.%2BG.%26aulast%3DLeu%26aufirst%3DC.-T.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26atitle%3DThe%2520integrin%2520ligand%2520echistatin%2520prevents%2520bone%2520loss%2520in%2520ovariectomized%2520mice%2520and%2520rats%26jtitle%3DEndocrinology%26date%3D1998%26volume%3D139%26spage%3D1411%26epage%3D1419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Meyer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Auernheimer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modlinger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, H.</span><span> </span><span class="NLM_article-title">Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging and targeting</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2723</span><span class="NLM_x">–</span> <span class="NLM_lpage">2747</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.2174%2F138161206777947740" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16918408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28Xotlalsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=2723-2747&author=A.+Meyerauthor=J.+Auernheimerauthor=A.+Modlingerauthor=H.+Kessler&title=Targeting+RGD+recognizing+integrins%3A+drug+development%2C+biomaterial+research%2C+tumor+imaging+and+targeting"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging and targeting</span></div><div class="casAuthors">Meyer, A.; Auernheimer, J.; Modlinger, A.; Kessler, H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2723-2747</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Integrins constitute an important class of cell adhesion receptors responsible not only for cell-matrix adhesion but also for signaling bidirectionally across the membrane.  Integrins are involved in many biol. processes such as angiogenesis, thrombosis, inflammation, osteoporosis and cancer.  Integrins thus play a key role in many severe human diseases.  In this review the authors will describe recent research and development of RGD-contg. integrin ligands for medical applications including drug design, radiolabeling, drug targeting, as well as biomaterial research.  Many ligands were developed for targeting the αvβ3 integrin to block angiogenesis or osteoporosis, but there are also other integrins like αvβ5 and α5β1 which become more and more interesting for similar purposes.  αIIbβ3 constitutes a potent target in thrombosis therapy; but the search for suitable ligands is still ongoing.  The authors will reconstruct the drug development process for these integrin subtypes considering selected examples with focus on structure based design.  Different structural requirements are pointed out concerning integrin activity and particularly the selectivity towards the distinct integrin types.  Furthermore, the authors will show recent progress in tumor and thrombosis imaging based on radiolabeled RGD-contg. ligands binding αvβ3 or αIIβ3, resp.  Addnl. further advances in biomaterial research are presented.  The authors describe the coating of different implant materials with various αvβ3 recognizing ligands for the purpose of increasing cell attachment and biocompatibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZglS_7z7bJrVg90H21EOLACvtfcHk0lhUfm-5HxpOfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xotlalsbk%253D&md5=9d0a773a6565c32ea6a23c8a28af8df0</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.2174%2F138161206777947740&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206777947740%26sid%3Dliteratum%253Aachs%26aulast%3DMeyer%26aufirst%3DA.%26aulast%3DAuernheimer%26aufirst%3DJ.%26aulast%3DModlinger%26aufirst%3DA.%26aulast%3DKessler%26aufirst%3DH.%26atitle%3DTargeting%2520RGD%2520recognizing%2520integrins%253A%2520drug%2520development%252C%2520biomaterial%2520research%252C%2520tumor%2520imaging%2520and%2520targeting%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D2723%26epage%3D2747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Gramoun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shorey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bashutski, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heersche, J. N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manolson, M. F.</span><span> </span><span class="NLM_article-title">Effects of Vitaxin, a novel therapeutic in trial for metastatic bone tumors, on osteoclast functions in vitro</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">352</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2007&pages=341-352&author=A.+Gramounauthor=S.+Shoreyauthor=J.+D.+Bashutskiauthor=S.+J.+Dixonauthor=S.+M.+Simsauthor=J.+N.+M.+Heerscheauthor=M.+F.+Manolson&title=Effects+of+Vitaxin%2C+a+novel+therapeutic+in+trial+for+metastatic+bone+tumors%2C+on+osteoclast+functions+in+vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGramoun%26aufirst%3DA.%26aulast%3DShorey%26aufirst%3DS.%26aulast%3DBashutski%26aufirst%3DJ.%2BD.%26aulast%3DDixon%26aufirst%3DS.%2BJ.%26aulast%3DSims%26aufirst%3DS.%2BM.%26aulast%3DHeersche%26aufirst%3DJ.%2BN.%2BM.%26aulast%3DManolson%26aufirst%3DM.%2BF.%26atitle%3DEffects%2520of%2520Vitaxin%252C%2520a%2520novel%2520therapeutic%2520in%2520trial%2520for%2520metastatic%2520bone%2520tumors%252C%2520on%2520osteoclast%2520functions%2520in%2520vitro%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2007%26volume%3D102%26spage%3D341%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Wilder, R. L.</span><span> </span><span class="NLM_article-title">Integrin αvβ3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">ii96</span><span class="NLM_x">–</span> <span class="NLM_lpage">ii99</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=12379637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD38XovFagtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2002&pages=ii96-ii99&author=R.+L.+Wilder&title=Integrin+%CE%B1v%CE%B23+as+a+target+for+treatment+of+rheumatoid+arthritis+and+related+rheumatic+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases</span></div><div class="casAuthors">Wilder, R. L.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">ii96-ii99</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">A review.  A substantial and persuasive body of data now exists that supports the view that integrin alpha V beta 3 plays a crit. part in activated macrophage dependent inflammation, osteoclast development, migration, and bone resorption, and inflammatory angiogenesis.  All of these processes play an important part in the pathogenesis of rheumatoid arthritis (RA) and related athropathies.  Animal arthritis model data further support these concepts and also suggest that therapeutic antagonism of integrin alpha V beta 3 is worthy of further investigation in RA and related arthropathies.  To this end, Vitaxin, also known as MEDI-522, has been developed.  Vitaxin is a humanized monoclonal IgG1 antibody that specifically binds a conformational epitope formed by both the integrin alpha V and beta 3 subunits.  It blocks the interaction of alpha V beta 3 with various ligands such as osteopontin and vitronectin.  Clin. trials with Vitaxin in patients with RA are in progress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTbIIw2DS4vrVg90H21EOLACvtfcHk0lhUfm-5HxpOfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovFagtbY%253D&md5=6dca01ff730ae3125afce124a15bd05e</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilder%26aufirst%3DR.%2BL.%26atitle%3DIntegrin%2520%25CE%25B1v%25CE%25B23%2520as%2520a%2520target%2520for%2520treatment%2520of%2520rheumatoid%2520arthritis%2520and%2520related%2520rheumatic%2520diseases%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2002%26volume%3D61%26spage%3Dii96%26epage%3Dii99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Xiong, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stehle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diefenbach, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnaout, M. A.</span><span> </span><span class="NLM_article-title">Crystal structure of the extracellular segment of integrin αvβ3</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">294</span><span class="NLM_x">, </span> <span class="NLM_fpage">339</span><span class="NLM_x">–</span> <span class="NLM_lpage">345</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1126%2Fscience.1064535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=11546839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnsFGqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2001&pages=339-345&author=J.+P.+Xiongauthor=T.+Stehleauthor=B.+Diefenbachauthor=R.+Zhangauthor=R.+Dunkerauthor=D.+L.+Scottauthor=A.+Joachimiakauthor=S.+L.+Goodmanauthor=M.+A.+Arnaout&title=Crystal+structure+of+the+extracellular+segment+of+integrin+%CE%B1v%CE%B23"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the extracellular segment of integrin αVβ3</span></div><div class="casAuthors">Xiong, Jian-Ping; Stehle, Thilo; Diefenbach, Beate; Zhang, Rongguang; Dunker, Reinhardt; Scott, David L.; Joachimiak, Andrzej; Goodman, Simon L.; Arnaout, M. Amin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">5541</span>),
    <span class="NLM_cas:pages">339-345</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Integrins are αβ heterodimeric receptors that mediate divalent cation-dependent cell-cell and cell-matrix adhesion through tightly regulated interactions with ligands.  We have solved the crystal structure of the extracellular portion of integrin αVβ3 at 3.1 Å resoln.  Its 12 domains assemble into an ovoid "head" and two "tails.".  In the crystal, αVβ3 is severely bent at a defined region in its tails, reflecting an unusual flexibility that may be linked to integrin regulation.  The main intersubunit interface lies within the head, between a seven-bladed β-propeller from αV and an A domain from β3, and bears a striking resemblance to the Gα/Gβ interface in G proteins.  A metal ion-dependent adhesion site (MIDAS) in the βA domain is positioned to participate in a ligand-binding interface formed of loops from the propeller and βA domains.  MIDAS lies adjacent to a calcium-binding site with a potential regulatory function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryjkcgYhppB7Vg90H21EOLACvtfcHk0lhUfm-5HxpOfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnsFGqsb4%253D&md5=cae2f78e7d2db79bb4c5c77c488a552d</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1126%2Fscience.1064535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1064535%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DJ.%2BP.%26aulast%3DStehle%26aufirst%3DT.%26aulast%3DDiefenbach%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DDunker%26aufirst%3DR.%26aulast%3DScott%26aufirst%3DD.%2BL.%26aulast%3DJoachimiak%26aufirst%3DA.%26aulast%3DGoodman%26aufirst%3DS.%2BL.%26aulast%3DArnaout%26aufirst%3DM.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520the%2520extracellular%2520segment%2520of%2520integrin%2520%25CE%25B1v%25CE%25B23%26jtitle%3DScience%26date%3D2001%26volume%3D294%26spage%3D339%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Xiong, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stehle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joachimiak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frech, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnaout, M. A.</span><span> </span><span class="NLM_article-title">Crystal structure of the extracellular segment of integrin αvβ3 in complex with an Arg-Gly-Asp ligand</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">296</span><span class="NLM_x">, </span> <span class="NLM_fpage">151</span><span class="NLM_x">–</span> <span class="NLM_lpage">155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1126%2Fscience.1069040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=11884718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD38XivVWjsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=296&publication_year=2002&pages=151-155&author=J.-P.+Xiongauthor=T.+Stehleauthor=R.+Zhangauthor=A.+Joachimiakauthor=M.+Frechauthor=S.+L.+Goodmanauthor=M.+A.+Arnaout&title=Crystal+structure+of+the+extracellular+segment+of+integrin+%CE%B1v%CE%B23+in+complex+with+an+Arg-Gly-Asp+ligand"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the extracellular segment of integrin αvβ3 in complex with an Arg-Gly-Asp ligand</span></div><div class="casAuthors">Xiong, Jian-Ping; Stehle, Thilo; Zhang, Rongguang; Joachimiak, Andrzej; Frech, Matthias; Goodman, Simon L.; Arnaout, M. Amin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">296</span>
        (<span class="NLM_cas:issue">5565</span>),
    <span class="NLM_cas:pages">151-155</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The structural basis for the divalent cation-dependent binding of heterodimeric αβ integrins to their Ligands, which contain the prototypical Arg-Gly-Asp sequence, is unknown.  Interaction with ligands triggers tertiary and quaternary structural rearrangements in integrins that are needed for cell signaling.  Here we report the crystal structure of the extracellular segment of integrin αVβ3 in complex with a cyclic peptide presenting the Arg-Gly-Asp sequence.  The ligand binds at the major interface between the αV and β3 subunits and makes extensive contacts with both.  Both tertiary and quaternary changes are obsd. in the presence of ligand.  The tertiary rearrangements take place in βA, the ligand-binding domain of β3; in the complex, βA acquires two cations, one of which contacts the ligand Asp directly and the other stabilizes the ligand-binding surface.  Ligand binding induces small changes in the orientation of αV relative to β3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo22hT2wzRg0bVg90H21EOLACvtfcHk0ljgWjhwsNZf4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XivVWjsLo%253D&md5=9f7d93de3bbe8dbeb0d860c12213de81</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1126%2Fscience.1069040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1069040%26sid%3Dliteratum%253Aachs%26aulast%3DXiong%26aufirst%3DJ.-P.%26aulast%3DStehle%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DJoachimiak%26aufirst%3DA.%26aulast%3DFrech%26aufirst%3DM.%26aulast%3DGoodman%26aufirst%3DS.%2BL.%26aulast%3DArnaout%26aufirst%3DM.%2BA.%26atitle%3DCrystal%2520structure%2520of%2520the%2520extracellular%2520segment%2520of%2520integrin%2520%25CE%25B1v%25CE%25B23%2520in%2520complex%2520with%2520an%2520Arg-Gly-Asp%2520ligand%26jtitle%3DScience%26date%3D2002%26volume%3D296%26spage%3D151%26epage%3D155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Meissner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihle, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leu, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagy, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor-Olsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitman, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span> </span><span class="NLM_article-title">Nonpeptide αvβ3 antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=25-29&author=R.+S.+Meissnerauthor=J.+J.+Perkinsauthor=L.+T.+Duongauthor=G.+D.+Hartmanauthor=W.+F.+Hoffmanauthor=J.+R.+Huffauthor=N.+C.+Ihleauthor=C.+T.+Leuauthor=R.+M.+Nagyauthor=A.+Naylor-Olsenauthor=G.+A.+Rodanauthor=S.+B.+Rodanauthor=D.+B.+Whitmanauthor=G.+A.+Wesolowskiauthor=M.+E.+Duggan&title=Nonpeptide+%CE%B1v%CE%B23+antagonists.+Part+2%3A+constrained+glycyl+amides+derived+from+the+RGD+tripeptide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeissner%26aufirst%3DR.%2BS.%26aulast%3DPerkins%26aufirst%3DJ.%2BJ.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHoffman%26aufirst%3DW.%2BF.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DIhle%26aufirst%3DN.%2BC.%26aulast%3DLeu%26aufirst%3DC.%2BT.%26aulast%3DNagy%26aufirst%3DR.%2BM.%26aulast%3DNaylor-Olsen%26aufirst%3DA.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DWhitman%26aufirst%3DD.%2BB.%26aulast%3DWesolowski%26aufirst%3DG.%2BA.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26atitle%3DNonpeptide%2520%25CE%25B1v%25CE%25B23%2520antagonists.%2520Part%25202%253A%2520constrained%2520glycyl%2520amides%2520derived%2520from%2520the%2520RGD%2520tripeptide%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D25%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Askew, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitman, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leu, C.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Metzler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merkle, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span> </span><span class="NLM_article-title">Non-peptide αvβ3 antagonists. Part 4: Potent and orally bioavailable chain-shortened RGD mimetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2463</span><span class="NLM_x">–</span> <span class="NLM_lpage">2465</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2463-2465&author=P.+J.+Colemanauthor=B.+C.+Askewauthor=J.+H.+Hutchinsonauthor=D.+B.+Whitmanauthor=J.+J.+Perkinsauthor=G.+D.+Hartmanauthor=G.+A.+Rodanauthor=C.-T.+Leuauthor=T.+Prueksaritanontauthor=C.+Fernandez-Metzlerauthor=K.+M.+Merkleauthor=R.+Lynchauthor=J.+J.+Lynchauthor=S.+B.+Rodanauthor=M.+E.+Duggan&title=Non-peptide+%CE%B1v%CE%B23+antagonists.+Part+4%3A+Potent+and+orally+bioavailable+chain-shortened+RGD+mimetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DAskew%26aufirst%3DB.%2BC.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DWhitman%26aufirst%3DD.%2BB.%26aulast%3DPerkins%26aufirst%3DJ.%2BJ.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DLeu%26aufirst%3DC.-T.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DFernandez-Metzler%26aufirst%3DC.%26aulast%3DMerkle%26aufirst%3DK.%2BM.%26aulast%3DLynch%26aufirst%3DR.%26aulast%3DLynch%26aufirst%3DJ.%2BJ.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26atitle%3DNon-peptide%2520%25CE%25B1v%25CE%25B23%2520antagonists.%2520Part%25204%253A%2520Potent%2520and%2520orally%2520bioavailable%2520chain-shortened%2520RGD%2520mimetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2463%26epage%3D2465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halczenko, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brashear, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Metzler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huff, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leu, C.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meissner, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merkle, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennypacker, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perkins, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varga, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zartman, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span> </span><span class="NLM_article-title">Nonpeptide αvβ3 antagonists. 8. In vitro and in vivo evaluation of a potent αvβ3 antagonist for the prevention and treatment of osteoporosis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">4790</span><span class="NLM_x">–</span> <span class="NLM_lpage">4798</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030306r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4790-4798&author=J.+H.+Hutchinsonauthor=W.+Halczenkoauthor=K.+M.+Brashearauthor=M.+J.+Breslinauthor=P.+J.+Colemanauthor=L.+T.+Duongauthor=C.+Fernandez-Metzlerauthor=M.+A.+Gentileauthor=J.+E.+Fisherauthor=G.+D.+Hartmanauthor=J.+R.+Huffauthor=D.+B.+Kimmelauthor=C.-T.+Leuauthor=R.+S.+Meissnerauthor=K.+Merkleauthor=R.+Nagyauthor=B.+Pennypackerauthor=J.+J.+Perkinsauthor=T.+Prueksaritanontauthor=G.+A.+Rodanauthor=S.+L.+Vargaauthor=G.+A.+Wesolowskiauthor=A.+E.+Zartmanauthor=S.+B.+Rodanauthor=M.+E.+Duggan&title=Nonpeptide+%CE%B1v%CE%B23+antagonists.+8.+In+vitro+and+in+vivo+evaluation+of+a+potent+%CE%B1v%CE%B23+antagonist+for+the+prevention+and+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fjm030306r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030306r%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DHalczenko%26aufirst%3DW.%26aulast%3DBrashear%26aufirst%3DK.%2BM.%26aulast%3DBreslin%26aufirst%3DM.%2BJ.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DFernandez-Metzler%26aufirst%3DC.%26aulast%3DGentile%26aufirst%3DM.%2BA.%26aulast%3DFisher%26aufirst%3DJ.%2BE.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DHuff%26aufirst%3DJ.%2BR.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLeu%26aufirst%3DC.-T.%26aulast%3DMeissner%26aufirst%3DR.%2BS.%26aulast%3DMerkle%26aufirst%3DK.%26aulast%3DNagy%26aufirst%3DR.%26aulast%3DPennypacker%26aufirst%3DB.%26aulast%3DPerkins%26aufirst%3DJ.%2BJ.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DVarga%26aufirst%3DS.%2BL.%26aulast%3DWesolowski%26aufirst%3DG.%2BA.%26aulast%3DZartman%26aufirst%3DA.%2BE.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26atitle%3DNonpeptide%2520%25CE%25B1v%25CE%25B23%2520antagonists.%25208.%2520In%2520vitro%2520and%2520in%2520vivo%2520evaluation%2520of%2520a%2520potent%2520%25CE%25B1v%25CE%25B23%2520antagonist%2520for%2520the%2520prevention%2520and%2520treatment%2520of%2520osteoporosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4790%26epage%3D4798" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Murphy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerchio, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoch, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gottesdiener, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Recker, R.</span><span> </span><span class="NLM_article-title">Effect of L-000845704, an αvβ3 integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women</span> <span class="citation_source-journal">J. Clin. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">2022</span><span class="NLM_x">–</span> <span class="NLM_lpage">2028</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1210%2Fjc.2004-2126" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=15687321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsFWjt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2005&pages=2022-2028&author=M.+G.+Murphyauthor=K.+Cerchioauthor=S.+A.+Stochauthor=K.+Gottesdienerauthor=M.+Wuauthor=R.+Recker&title=Effect+of+L-000845704%2C+an+%CE%B1v%CE%B23+integrin+antagonist%2C+on+markers+of+bone+turnover+and+bone+mineral+density+in+postmenopausal+osteoporotic+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of L-000845704, an αvβ3 integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women</span></div><div class="casAuthors">Murphy, M. G.; Cerchio, K.; Stoch, S. A.; Gottesdiener, K.; Wu, M.; Recker, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Endocrinology and Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2022-2028</span>CODEN:
                <span class="NLM_cas:coden">JCEMAZ</span>;
        ISSN:<span class="NLM_cas:issn">0021-972X</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">The αvβ3 integrin (vitronectin receptor) plays a pivotal role in bone resorption.  We hypothesized that L-000845704, an αvβ3 integrin antagonist, would potently inhibit bone resorption, thereby increasing bone mass as assessed by bone mineral d. (BMD) in women with postmenopausal osteoporosis.  In a multicenter, randomized, double-blind, placebo-controlled, 12-mo study, 227 women (av. 63 yr) with low lumbar spine or femoral neck BMD were randomly assigned to receive 100 or 400 mg L-000845704 once daily (qd), 200 mg L-000845704 twice daily (bid), or placebo.  L-000845704 increased lumbar spine BMD (2.1, 3.1, and 3.5% for the 100-mg-qd, 400-mg-qd, and 200-mg-bid treatment groups, resp., vs. -0.1% for placebo; P < 0.01 all treatments vs. placebo).  Only 200 mg L-000845704 bid significantly increased BMD at the hip (1.7 vs. 0.3% for placebo; P < 0.03) and femoral neck (2.4 vs. 0.7% for placebo; P < 0.05).  No L-000845704 group increased total body BMD.  All doses of L-000845704 resulted in a similar approx. 42% decrease from baseline of N-telopeptide cross-links (P < 0.001 vs. placebo).  L-000845704 was generally well tolerated; adverse events resulting in discontinuation from the study were relatively infrequent.  In conclusion, the antiresorptive effect of the αvβ3 integrin antagonist L-000845704 translated into significant increases in lumbar spine BMD.  Furthermore, 200 mg L-000845704 bid provided efficacy at the hip sites.  These data suggest that the αvβ3 integrin antagonist L-000845704 could be developed as an effective therapeutic agent for osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCPinJOVULILVg90H21EOLACvtfcHk0ljDqqaE4MuEsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsFWjt7o%253D&md5=5849438d1122ca31d921cf67d907a001</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1210%2Fjc.2004-2126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fjc.2004-2126%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DM.%2BG.%26aulast%3DCerchio%26aufirst%3DK.%26aulast%3DStoch%26aufirst%3DS.%2BA.%26aulast%3DGottesdiener%26aufirst%3DK.%26aulast%3DWu%26aufirst%3DM.%26aulast%3DRecker%26aufirst%3DR.%26atitle%3DEffect%2520of%2520L-000845704%252C%2520an%2520%25CE%25B1v%25CE%25B23%2520integrin%2520antagonist%252C%2520on%2520markers%2520of%2520bone%2520turnover%2520and%2520bone%2520mineral%2520density%2520in%2520postmenopausal%2520osteoporotic%2520women%26jtitle%3DJ.%2520Clin.%2520Endocrinol.%2520Metab.%26date%3D2005%26volume%3D90%26spage%3D2022%26epage%3D2028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Zartman, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Metzler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leu, C.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prueksaritanont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duggan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meissner, R. S.</span><span> </span><span class="NLM_article-title">Nonpeptide αvβ3 antagonists: identification of potent, chain-shortened 7-oxo RGD mimetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1647</span><span class="NLM_x">–</span> <span class="NLM_lpage">1650</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1647-1650&author=A.+E.+Zartmanauthor=L.+T.+Duongauthor=C.+Fernandez-Metzlerauthor=G.+D.+Hartmanauthor=C.-T.+Leuauthor=T.+Prueksaritanontauthor=G.+A.+Rodanauthor=S.+B.+Rodanauthor=M.+E.+Dugganauthor=R.+S.+Meissner&title=Nonpeptide+%CE%B1v%CE%B23+antagonists%3A+identification+of+potent%2C+chain-shortened+7-oxo+RGD+mimetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZartman%26aufirst%3DA.%2BE.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DFernandez-Metzler%26aufirst%3DC.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DLeu%26aufirst%3DC.-T.%26aulast%3DPrueksaritanont%26aufirst%3DT.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DDuggan%26aufirst%3DM.%2BE.%26aulast%3DMeissner%26aufirst%3DR.%2BS.%26atitle%3DNonpeptide%2520%25CE%25B1v%25CE%25B23%2520antagonists%253A%2520identification%2520of%2520potent%252C%2520chain-shortened%25207-oxo%2520RGD%2520mimetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1647%26epage%3D1650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DesJarlais, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattanze, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaikin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manthey, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomczuk, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marugan, J. J.</span><span> </span><span class="NLM_article-title">Identification of novel short chain 4-substituted indoles as potent αvβ3 antagonist using structure-based drug design</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">343</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=334-343&author=P.+Raboissonauthor=R.+L.+DesJarlaisauthor=R.+Reedauthor=J.+Lattanzeauthor=M.+Chaikinauthor=C.+L.+Mantheyauthor=B.+E.+Tomczukauthor=J.+J.+Marugan&title=Identification+of+novel+short+chain+4-substituted+indoles+as+potent+%CE%B1v%CE%B23+antagonist+using+structure-based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DDesJarlais%26aufirst%3DR.%2BL.%26aulast%3DReed%26aufirst%3DR.%26aulast%3DLattanze%26aufirst%3DJ.%26aulast%3DChaikin%26aufirst%3DM.%26aulast%3DManthey%26aufirst%3DC.%2BL.%26aulast%3DTomczuk%26aufirst%3DB.%2BE.%26aulast%3DMarugan%26aufirst%3DJ.%2BJ.%26atitle%3DIdentification%2520of%2520novel%2520short%2520chain%25204-substituted%2520indoles%2520as%2520potent%2520%25CE%25B1v%25CE%25B23%2520antagonist%2520using%2520structure-based%2520drug%2520design%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2007%26volume%3D42%26spage%3D334%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Boys, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schretzman, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrakumar, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tollefson, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohler, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penning, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenmark, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spangler, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clare, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desai, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engleman, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanneke, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keene, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klover, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickols, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickols, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steininger, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlin, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Y. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalton, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norring, S. A.</span><span> </span><span class="NLM_article-title">Convergent, parallel synthesis of a series of β-substituted 1,2,4-oxadiazole butanoic acids as potent and selective αvβ3 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">839</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=839-844&author=M.+L.+Boysauthor=L.+A.+Schretzmanauthor=N.+S.+Chandrakumarauthor=M.+B.+Tollefsonauthor=S.+B.+Mohlerauthor=V.+L.+Downsauthor=T.+D.+Penningauthor=M.+A.+Russellauthor=J.+A.+Wendtauthor=B.+B.+Chenauthor=H.+G.+Stenmarkauthor=H.+Wuauthor=D.+P.+Spanglerauthor=M.+Clareauthor=B.+N.+Desaiauthor=I.+K.+Khannaauthor=M.+N.+Nguyenauthor=T.+Duffinauthor=V.+W.+Englemanauthor=M.+B.+Finnauthor=S.+K.+Freemanauthor=M.+L.+Hannekeauthor=J.+L.+Keeneauthor=J.+A.+Kloverauthor=G.+A.+Nickolsauthor=M.+A.+Nickolsauthor=C.+N.+Steiningerauthor=M.+Westlinauthor=W.+Westlinauthor=Y.+X.+Yuauthor=Y.+Wangauthor=C.+R.+Daltonauthor=S.+A.+Norring&title=Convergent%2C+parallel+synthesis+of+a+series+of+%CE%B2-substituted+1%2C2%2C4-oxadiazole+butanoic+acids+as+potent+and+selective+%CE%B1v%CE%B23+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoys%26aufirst%3DM.%2BL.%26aulast%3DSchretzman%26aufirst%3DL.%2BA.%26aulast%3DChandrakumar%26aufirst%3DN.%2BS.%26aulast%3DTollefson%26aufirst%3DM.%2BB.%26aulast%3DMohler%26aufirst%3DS.%2BB.%26aulast%3DDowns%26aufirst%3DV.%2BL.%26aulast%3DPenning%26aufirst%3DT.%2BD.%26aulast%3DRussell%26aufirst%3DM.%2BA.%26aulast%3DWendt%26aufirst%3DJ.%2BA.%26aulast%3DChen%26aufirst%3DB.%2BB.%26aulast%3DStenmark%26aufirst%3DH.%2BG.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DSpangler%26aufirst%3DD.%2BP.%26aulast%3DClare%26aufirst%3DM.%26aulast%3DDesai%26aufirst%3DB.%2BN.%26aulast%3DKhanna%26aufirst%3DI.%2BK.%26aulast%3DNguyen%26aufirst%3DM.%2BN.%26aulast%3DDuffin%26aufirst%3DT.%26aulast%3DEngleman%26aufirst%3DV.%2BW.%26aulast%3DFinn%26aufirst%3DM.%2BB.%26aulast%3DFreeman%26aufirst%3DS.%2BK.%26aulast%3DHanneke%26aufirst%3DM.%2BL.%26aulast%3DKeene%26aufirst%3DJ.%2BL.%26aulast%3DKlover%26aufirst%3DJ.%2BA.%26aulast%3DNickols%26aufirst%3DG.%2BA.%26aulast%3DNickols%26aufirst%3DM.%2BA.%26aulast%3DSteininger%26aufirst%3DC.%2BN.%26aulast%3DWestlin%26aufirst%3DM.%26aulast%3DWestlin%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DY.%2BX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDalton%26aufirst%3DC.%2BR.%26aulast%3DNorring%26aufirst%3DS.%2BA.%26atitle%3DConvergent%252C%2520parallel%2520synthesis%2520of%2520a%2520series%2520of%2520%25CE%25B2-substituted%25201%252C2%252C4-oxadiazole%2520butanoic%2520acids%2520as%2520potent%2520and%2520selective%2520%25CE%25B1v%25CE%25B23%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D839%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Nagarajan, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devadas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malecha, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, H.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruminski, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rico, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marrufo, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleine, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lantz, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, N. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landis, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duffin, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engleman, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griggs, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickols, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shannon, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steininger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westlin, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nickols, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keene, J. L.</span><span> </span><span class="NLM_article-title"><i>R</i>-Isomers of Arg-Gly-Asp (RGD) mimics as potent αvβ3 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">3783</span><span class="NLM_x">–</span> <span class="NLM_lpage">3800</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=3783-3800&author=S.+R.+Nagarajanauthor=B.+Devadasauthor=J.+W.+Malechaauthor=H.-F.+Luauthor=P.+G.+Ruminskiauthor=J.+G.+Ricoauthor=T.+E.+Rogersauthor=L.+D.+Marrufoauthor=J.+T.+Collinsauthor=H.+P.+Kleineauthor=M.+K.+Lantzauthor=J.+Zhuauthor=N.+F.+Greenauthor=M.+A.+Russellauthor=B.+H.+Landisauthor=L.+M.+Millerauthor=D.+M.+Meyerauthor=T.+D.+Duffinauthor=V.+W.+Englemanauthor=M.+B.+Finnauthor=S.+K.+Freemanauthor=D.+W.+Griggsauthor=M.+L.+Williamsauthor=M.+A.+Nickolsauthor=J.+A.+Peggauthor=K.+E.+Shannonauthor=C.+Steiningerauthor=M.+M.+Westlinauthor=G.+A.+Nickolsauthor=J.+L.+Keene&title=R-Isomers+of+Arg-Gly-Asp+%28RGD%29+mimics+as+potent+%CE%B1v%CE%B23+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNagarajan%26aufirst%3DS.%2BR.%26aulast%3DDevadas%26aufirst%3DB.%26aulast%3DMalecha%26aufirst%3DJ.%2BW.%26aulast%3DLu%26aufirst%3DH.-F.%26aulast%3DRuminski%26aufirst%3DP.%2BG.%26aulast%3DRico%26aufirst%3DJ.%2BG.%26aulast%3DRogers%26aufirst%3DT.%2BE.%26aulast%3DMarrufo%26aufirst%3DL.%2BD.%26aulast%3DCollins%26aufirst%3DJ.%2BT.%26aulast%3DKleine%26aufirst%3DH.%2BP.%26aulast%3DLantz%26aufirst%3DM.%2BK.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DGreen%26aufirst%3DN.%2BF.%26aulast%3DRussell%26aufirst%3DM.%2BA.%26aulast%3DLandis%26aufirst%3DB.%2BH.%26aulast%3DMiller%26aufirst%3DL.%2BM.%26aulast%3DMeyer%26aufirst%3DD.%2BM.%26aulast%3DDuffin%26aufirst%3DT.%2BD.%26aulast%3DEngleman%26aufirst%3DV.%2BW.%26aulast%3DFinn%26aufirst%3DM.%2BB.%26aulast%3DFreeman%26aufirst%3DS.%2BK.%26aulast%3DGriggs%26aufirst%3DD.%2BW.%26aulast%3DWilliams%26aufirst%3DM.%2BL.%26aulast%3DNickols%26aufirst%3DM.%2BA.%26aulast%3DPegg%26aufirst%3DJ.%2BA.%26aulast%3DShannon%26aufirst%3DK.%2BE.%26aulast%3DSteininger%26aufirst%3DC.%26aulast%3DWestlin%26aufirst%3DM.%2BM.%26aulast%3DNickols%26aufirst%3DG.%2BA.%26aulast%3DKeene%26aufirst%3DJ.%2BL.%26atitle%3DR-Isomers%2520of%2520Arg-Gly-Asp%2520%2528RGD%2529%2520mimics%2520as%2520potent%2520%25CE%25B1v%25CE%25B23%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D3783%26epage%3D3800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Kubota, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hachisu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katano, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajito, K.</span><span> </span><span class="NLM_article-title">Tricyclic pharmacophore-based molecules as novel integrin αvβ3 antagonists. Part 1: design and synthesis of a lead compound exhibiting αvβ3/αIIbβ3 dual antagonistic activity</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2089</span><span class="NLM_x">–</span> <span class="NLM_lpage">2108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=2089-2108&author=D.+Kubotaauthor=M.+Ishikawaauthor=M.+Yamamotoauthor=S.+Murakamiauthor=M.+Hachisuauthor=K.+Katanoauthor=K.+Ajito&title=Tricyclic+pharmacophore-based+molecules+as+novel+integrin+%CE%B1v%CE%B23+antagonists.+Part+1%3A+design+and+synthesis+of+a+lead+compound+exhibiting+%CE%B1v%CE%B23%2F%CE%B1IIb%CE%B23+dual+antagonistic+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKubota%26aufirst%3DD.%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DMurakami%26aufirst%3DS.%26aulast%3DHachisu%26aufirst%3DM.%26aulast%3DKatano%26aufirst%3DK.%26aulast%3DAjito%26aufirst%3DK.%26atitle%3DTricyclic%2520pharmacophore-based%2520molecules%2520as%2520novel%2520integrin%2520%25CE%25B1v%25CE%25B23%2520antagonists.%2520Part%25201%253A%2520design%2520and%2520synthesis%2520of%2520a%2520lead%2520compound%2520exhibiting%2520%25CE%25B1v%25CE%25B23%252F%25CE%25B1IIb%25CE%25B23%2520dual%2520antagonistic%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D2089%26epage%3D2108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroda, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koyanagi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajito, K.</span><span> </span><span class="NLM_article-title">Tricyclic pharmacophore-based molecules as novel integrin αvβ3 antagonists. Part 2: synthesis of potent αvβ3/αIIbβ3 dual antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2109</span><span class="NLM_x">–</span> <span class="NLM_lpage">2130</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=2109-2130&author=M.+Ishikawaauthor=D.+Kubotaauthor=M.+Yamamotoauthor=C.+Kurodaauthor=M.+Iguchiauthor=A.+Koyanagiauthor=S.+Murakamiauthor=K.+Ajito&title=Tricyclic+pharmacophore-based+molecules+as+novel+integrin+%CE%B1v%CE%B23+antagonists.+Part+2%3A+synthesis+of+potent+%CE%B1v%CE%B23%2F%CE%B1IIb%CE%B23+dual+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DKubota%26aufirst%3DD.%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DKuroda%26aufirst%3DC.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKoyanagi%26aufirst%3DA.%26aulast%3DMurakami%26aufirst%3DS.%26aulast%3DAjito%26aufirst%3DK.%26atitle%3DTricyclic%2520pharmacophore-based%2520molecules%2520as%2520novel%2520integrin%2520%25CE%25B1v%25CE%25B23%2520antagonists.%2520Part%25202%253A%2520synthesis%2520of%2520potent%2520%25CE%25B1v%25CE%25B23%252F%25CE%25B1IIb%25CE%25B23%2520dual%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D2109%26epage%3D2130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Ishikawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubota, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ajito, K.</span><span> </span><span class="NLM_article-title">Synthesis of potent αvβ3/αIIbβ3 dual antagonists tricyclic pharmacophore-based molecules and their selectivity control</span> <span class="citation_source-journal">J. Synth. Org. Chem., Jpn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">1093</span><span class="NLM_x">–</span> <span class="NLM_lpage">1104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.5059%2Fyukigoseikyokaishi.66.1093" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlyrtL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2008&pages=1093-1104&author=M.+Ishikawaauthor=D.+Kubotaauthor=K.+Ajito&title=Synthesis+of+potent+%CE%B1v%CE%B23%2F%CE%B1IIb%CE%B23+dual+antagonists+tricyclic+pharmacophore-based+molecules+and+their+selectivity+control"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of potent αvβ3/αIIbβ3 dual antagonists tricyclic pharmacophore-based molecules and their selectivity control</span></div><div class="casAuthors">Ishikawa, Minoru; Kubota, Dai; Ajito, Keiichi</div><div class="citationInfo"><span class="NLM_cas:title">Yuki Gosei Kagaku Kyokaishi</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1093-1104</span>CODEN:
                <span class="NLM_cas:coden">YGKKAE</span>;
        ISSN:<span class="NLM_cas:issn">0037-9980</span>.
    
            (<span class="NLM_cas:orgname">Yuki Gosei Kagaku Kyokai</span>)
        </div><div class="casAbstract">The blockade of α11bβ3 binding to fibrinogen is known to provide a potent antiplatelet activity.  We have focused on the adhesion and migration of integrin αvβ3 in vascular smooth muscle cells and leukocytes.  An injectable αvβ3/α11bβ3 dual antagonist would be a novel drug candidate for acute ischemic diseases.  For the mol. design of novel non-peptide integrin αvβ3 antagonists, we focused on spatial screening and mimetics of the RGD tripeptide, which was a key recognition site.  The first piperazine analog (4) exhibited strong α11bβ3 activity, and replacement of piperazine by 4-aminopiperidine afforded the αvβ3/α11bβ3 dual antagonist (30).  Paying attention to enhancement of activity and improvement of soly., optimization of 30 gave some preliminary candidates modified at the central arom. or the C-terminus.  Backup compds. possessing the (3S)-aminopiperidine moiety with further improvement of soly. were synthesized.  These preliminary candidates exhibited preferable ADME in rats, and some of them showed acceptable water soly., which did not provide detectable toxicity in vitro or in mice.  We also generated αvβ3 selective antagonists with tricyclic pharmacophore, in order to prove that in vivo efficacy of the dual antagonist was superior to that of the αvβ3 selective antagonist.  Finally, excellent in vivo efficacy of the candidate (81) was demonstrated in both canine ACS and PTCA models by independent groups.  Regarding development of 81, a partnership was established in 2006, and a clin. trial of 81 is now being prepd. in the US and Canada.  The selection of an integrin research program, strategies for competing with big pharmaceutical companies, and speedy medicinal chem. are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA9RQmrFIRd7Vg90H21EOLACvtfcHk0lgAIrjSBmiDlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlyrtL7J&md5=7597e80137cc9857220d2a3804d47912</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.5059%2Fyukigoseikyokaishi.66.1093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5059%252Fyukigoseikyokaishi.66.1093%26sid%3Dliteratum%253Aachs%26aulast%3DIshikawa%26aufirst%3DM.%26aulast%3DKubota%26aufirst%3DD.%26aulast%3DAjito%26aufirst%3DK.%26atitle%3DSynthesis%2520of%2520potent%2520%25CE%25B1v%25CE%25B23%252F%25CE%25B1IIb%25CE%25B23%2520dual%2520antagonists%2520tricyclic%2520pharmacophore-based%2520molecules%2520and%2520their%2520selectivity%2520control%26jtitle%3DJ.%2520Synth.%2520Org.%2520Chem.%252C%2520Jpn.%26date%3D2008%26volume%3D66%26spage%3D1093%26epage%3D1104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Manzoni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bassanini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belvisi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scolastico, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castorina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pisano, C.</span><span> </span><span class="NLM_article-title">Nonpeptide integrin antagonists: RGD mimetics incorporating substituted azabicycloalkanes as amino acid replacements</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_fpage">1309</span><span class="NLM_x">–</span> <span class="NLM_lpage">1317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&pages=1309-1317&author=L.+Manzoniauthor=M.+Bassaniniauthor=L.+Belvisiauthor=I.+Mottoauthor=C.+Scolasticoauthor=M.+Castorinaauthor=C.+Pisano&title=Nonpeptide+integrin+antagonists%3A+RGD+mimetics+incorporating+substituted+azabicycloalkanes+as+amino+acid+replacements"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManzoni%26aufirst%3DL.%26aulast%3DBassanini%26aufirst%3DM.%26aulast%3DBelvisi%26aufirst%3DL.%26aulast%3DMotto%26aufirst%3DI.%26aulast%3DScolastico%26aufirst%3DC.%26aulast%3DCastorina%26aufirst%3DM.%26aulast%3DPisano%26aufirst%3DC.%26atitle%3DNonpeptide%2520integrin%2520antagonists%253A%2520RGD%2520mimetics%2520incorporating%2520substituted%2520azabicycloalkanes%2520as%2520amino%2520acid%2520replacements%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2007%26spage%3D1309%26epage%3D1317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Dayam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aiello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garofalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neamati, N.</span><span> </span><span class="NLM_article-title">Discovery of small molecule integrin αvβ3 antagonists as novel anticancer agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4526</span><span class="NLM_x">–</span> <span class="NLM_lpage">4534</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm051296s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4526-4534&author=R.+Dayamauthor=F.+Aielloauthor=J.+Dengauthor=Y.+Wuauthor=A.+Garofaloauthor=X.+Chenauthor=N.+Neamati&title=Discovery+of+small+molecule+integrin+%CE%B1v%CE%B23+antagonists+as+novel+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1021%2Fjm051296s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051296s%26sid%3Dliteratum%253Aachs%26aulast%3DDayam%26aufirst%3DR.%26aulast%3DAiello%26aufirst%3DF.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGarofalo%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DNeamati%26aufirst%3DN.%26atitle%3DDiscovery%2520of%2520small%2520molecule%2520integrin%2520%25CE%25B1v%25CE%25B23%2520antagonists%2520as%2520novel%2520anticancer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4526%26epage%3D4534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span> </span><span class="NLM_article-title">Discovery of small molecule inhibitors of integrin αvβ3 through structure-based virtual screening</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5878</span><span class="NLM_x">–</span> <span class="NLM_lpage">5882</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5878-5882&author=Y.+Zhouauthor=H.+Pengauthor=Q.+Jiauthor=J.+Qiauthor=Z.+Zhuauthor=C.+Yang&title=Discovery+of+small+molecule+inhibitors+of+integrin+%CE%B1v%CE%B23+through+structure-based+virtual+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DQ.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520small%2520molecule%2520inhibitors%2520of%2520integrin%2520%25CE%25B1v%25CE%25B23%2520through%2520structure-based%2520virtual%2520screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5878%26epage%3D5882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Pleiner-Duxneuner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwettler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paschalis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roschger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nell-Duxneuner, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaushofer, K.</span><span> </span><span class="NLM_article-title">Treatment of osteoporosis with parathyroid hormone and teriparatide</span> <span class="citation_source-journal">Calcif. Tissue Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">84</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1007%2Fs00223-009-9218-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19189037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVWksL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2009&pages=159-170&author=J.+Pleiner-Duxneunerauthor=E.+Zwettlerauthor=E.+Paschalisauthor=P.+Roschgerauthor=V.+Nell-Duxneunerauthor=K.+Klaushofer&title=Treatment+of+osteoporosis+with+parathyroid+hormone+and+teriparatide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of osteoporosis with parathyroid hormone and teriparatide</span></div><div class="casAuthors">Pleiner-Duxneuner, Johannes; Zwettler, Elisabeth; Paschalis, Eleftherios; Roschger, Paul; Nell-Duxneuner, Valerie; Klaushofer, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Calcified Tissue International</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">159-170</span>CODEN:
                <span class="NLM_cas:coden">CTINDZ</span>;
        ISSN:<span class="NLM_cas:issn">0171-967X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Nowadays osteoporosis treatment is based primarily on therapy with antiresorptive agents, like the bisphosphonates.  Parathyroid hormone (Preotact) and human recombinant parathyroid hormone peptide 1-34 (Teriparatide) are relatively new for the treatment of osteoporosis and belong to the group of anabolic agents.  Both agents demonstrated an increase in bone mineral d. and a significant redn. in vertebral fractures in postmenopausal women with osteoporosis when given for 18-24 mo.  Data on nonvertebral fractures are, however, not clear-cut, and so far only bisphosphonates and strontium ranelate have been demonstrated to reduce all types of fractures and therefore remain the front-line option for treatment of osteoporosis.  As the safety, tolerability, and cost of the therapy also influence the choice of therapy, Preotact and Teriparatide might be useful addns. to the armamentarium for (second-line) treatment of osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSlgQ_XUDVzLVg90H21EOLACvtfcHk0ljK-Irj5oMbdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVWksL4%253D&md5=0622adf720cd263638c0de2c2017ca3c</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1007%2Fs00223-009-9218-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00223-009-9218-x%26sid%3Dliteratum%253Aachs%26aulast%3DPleiner-Duxneuner%26aufirst%3DJ.%26aulast%3DZwettler%26aufirst%3DE.%26aulast%3DPaschalis%26aufirst%3DE.%26aulast%3DRoschger%26aufirst%3DP.%26aulast%3DNell-Duxneuner%26aufirst%3DV.%26aulast%3DKlaushofer%26aufirst%3DK.%26atitle%3DTreatment%2520of%2520osteoporosis%2520with%2520parathyroid%2520hormone%2520and%2520teriparatide%26jtitle%3DCalcif.%2520Tissue%2520Int.%26date%3D2009%26volume%3D84%26spage%3D159%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Frolik, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cain, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satterwhite, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown-Augsburger, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hock, J. M.</span><span> </span><span class="NLM_article-title">Anabolic and catabolic bone effects of human parathyroid hormone (1−34) are predicted by duration of hormone exposure</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2003&pages=372-379&author=C.+A.+Frolikauthor=E.+C.+Blackauthor=R.+L.+Cainauthor=J.+H.+Satterwhiteauthor=P.+L.+Brown-Augsburgerauthor=M.+Satoauthor=J.+M.+Hock&title=Anabolic+and+catabolic+bone+effects+of+human+parathyroid+hormone+%281%E2%88%9234%29+are+predicted+by+duration+of+hormone+exposure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrolik%26aufirst%3DC.%2BA.%26aulast%3DBlack%26aufirst%3DE.%2BC.%26aulast%3DCain%26aufirst%3DR.%2BL.%26aulast%3DSatterwhite%26aufirst%3DJ.%2BH.%26aulast%3DBrown-Augsburger%26aufirst%3DP.%2BL.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DHock%26aufirst%3DJ.%2BM.%26atitle%3DAnabolic%2520and%2520catabolic%2520bone%2520effects%2520of%2520human%2520parathyroid%2520hormone%2520%25281%25E2%2588%259234%2529%2520are%2520predicted%2520by%2520duration%2520of%2520hormone%2520exposure%26jtitle%3DBone%26date%3D2003%26volume%3D33%26spage%3D372%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Ma, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cain, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miles, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekhar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onyia, J. E.</span><span> </span><span class="NLM_article-title">Catabolic effects of continuous human PTH (1−38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">4047</span><span class="NLM_x">–</span> <span class="NLM_lpage">4054</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=2001&pages=4047-4054&author=Y.+L.+Maauthor=R.+L.+Cainauthor=D.+L.+Halladayauthor=X.+Yangauthor=Q.+Zengauthor=R.+R.+Milesauthor=S.+Chandrasekharauthor=T.+J.+Martinauthor=J.+E.+Onyia&title=Catabolic+effects+of+continuous+human+PTH+%281%E2%88%9238%29+in+vivo+is+associated+with+sustained+stimulation+of+RANKL+and+inhibition+of+osteoprotegerin+and+gene-associated+bone+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DY.%2BL.%26aulast%3DCain%26aufirst%3DR.%2BL.%26aulast%3DHalladay%26aufirst%3DD.%2BL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DMiles%26aufirst%3DR.%2BR.%26aulast%3DChandrasekhar%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DT.%2BJ.%26aulast%3DOnyia%26aufirst%3DJ.%2BE.%26atitle%3DCatabolic%2520effects%2520of%2520continuous%2520human%2520PTH%2520%25281%25E2%2588%259238%2529%2520in%2520vivo%2520is%2520associated%2520with%2520sustained%2520stimulation%2520of%2520RANKL%2520and%2520inhibition%2520of%2520osteoprotegerin%2520and%2520gene-associated%2520bone%2520formation%26jtitle%3DEndocrinology%26date%3D2001%26volume%3D142%26spage%3D4047%26epage%3D4054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Jilka, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinstein, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellido, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parfitt, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manolagas, S. C.</span><span> </span><span class="NLM_article-title">Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=1999&pages=439-446&author=R.+L.+Jilkaauthor=R.+S.+Weinsteinauthor=T.+Bellidoauthor=P.+Robersonauthor=A.+M.+Parfittauthor=S.+C.+Manolagas&title=Increased+bone+formation+by+prevention+of+osteoblast+apoptosis+with+parathyroid+hormone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJilka%26aufirst%3DR.%2BL.%26aulast%3DWeinstein%26aufirst%3DR.%2BS.%26aulast%3DBellido%26aufirst%3DT.%26aulast%3DRoberson%26aufirst%3DP.%26aulast%3DParfitt%26aufirst%3DA.%2BM.%26aulast%3DManolagas%26aufirst%3DS.%2BC.%26atitle%3DIncreased%2520bone%2520formation%2520by%2520prevention%2520of%2520osteoblast%2520apoptosis%2520with%2520parathyroid%2520hormone%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1999%26volume%3D104%26spage%3D439%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Jilka, R. L.</span><span> </span><span class="NLM_article-title">Molecular and cellular mechanisms of the anabolic effect of intermittent PTH</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1434</span><span class="NLM_x">–</span> <span class="NLM_lpage">1446</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=1434-1446&author=R.+L.+Jilka&title=Molecular+and+cellular+mechanisms+of+the+anabolic+effect+of+intermittent+PTH"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJilka%26aufirst%3DR.%2BL.%26atitle%3DMolecular%2520and%2520cellular%2520mechanisms%2520of%2520the%2520anabolic%2520effect%2520of%2520intermittent%2520PTH%26jtitle%3DBone%26date%3D2007%26volume%3D40%26spage%3D1434%26epage%3D1446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Rickard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez-Rojas, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trice, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votta, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroup, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuttall, M. E.</span><span> </span><span class="NLM_article-title">Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1361</span><span class="NLM_x">–</span> <span class="NLM_lpage">1372</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2006&pages=1361-1372&author=D.+J.+Rickardauthor=F.-L.+Wangauthor=A.-M.+Rodriguez-Rojasauthor=Z.+Wuauthor=W.+J.+Triceauthor=S.+J.+Hoffmanauthor=B.+Vottaauthor=G.+B.+Stroupauthor=S.+Kumarauthor=M.+E.+Nuttall&title=Intermittent+treatment+with+parathyroid+hormone+%28PTH%29+as+well+as+a+non-peptide+small+molecule+agonist+of+the+PTH1+receptor+inhibits+adipocyte+differentiation+in+human+bone+marrow+stromal+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRickard%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DF.-L.%26aulast%3DRodriguez-Rojas%26aufirst%3DA.-M.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DTrice%26aufirst%3DW.%2BJ.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DVotta%26aufirst%3DB.%26aulast%3DStroup%26aufirst%3DG.%2BB.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DNuttall%26aufirst%3DM.%2BE.%26atitle%3DIntermittent%2520treatment%2520with%2520parathyroid%2520hormone%2520%2528PTH%2529%2520as%2520well%2520as%2520a%2520non-peptide%2520small%2520molecule%2520agonist%2520of%2520the%2520PTH1%2520receptor%2520inhibits%2520adipocyte%2520differentiation%2520in%2520human%2520bone%2520marrow%2520stromal%2520cells%26jtitle%3DBone%26date%3D2006%26volume%3D39%26spage%3D1361%26epage%3D1372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Cowan, D. J.; Navas, F.,  III; Oplinger, J. A.</span><span> </span><span class="NLM_article-title">Preparation of Uracil-Derived Compounds as Parathyroid Hormone Type I Receptor Agonists for Use against Osteoporosis</span>. 2005-US3248, 2005077918, 20050203,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=D.+J.+Cowan&author=F.+Navas&author=J.+A.+Oplinger&title=Preparation+of+Uracil-Derived+Compounds+as+Parathyroid+Hormone+Type+I+Receptor+Agonists+for+Use+against+Osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCowan%26aufirst%3DD.%2BJ.%26atitle%3DPreparation%2520of%2520Uracil-Derived%2520Compounds%2520as%2520Parathyroid%2520Hormone%2520Type%2520I%2520Receptor%2520Agonists%2520for%2520Use%2520against%2520Osteoporosis%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Spearing, P. K.</span><span> </span><span class="NLM_article-title">Preparation of Isothiazolopyrimidinediones as Parathyroid Hormone Type I Receptor (PTH1R) Agonists for Treatment of Osteoporosis</span>. 2005-US3247, 005077959, 20050203,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=P.+K.+Spearing&title=Preparation+of+Isothiazolopyrimidinediones+as+Parathyroid+Hormone+Type+I+Receptor+%28PTH1R%29+Agonists+for+Treatment+of+Osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSpearing%26aufirst%3DP.%2BK.%26atitle%3DPreparation%2520of%2520Isothiazolopyrimidinediones%2520as%2520Parathyroid%2520Hormone%2520Type%2520I%2520Receptor%2520%2528PTH1R%2529%2520Agonists%2520for%2520Treatment%2520of%2520Osteoporosis%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delmar, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleason, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Calcilytic compounds: potent and selective Ca<sup>2+</sup> receptor antagonists that stimulate secretion of parathyroid hormone</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">299</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=11561095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFWltbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=299&publication_year=2001&pages=323-331&author=E.+F.+Nemethauthor=E.+G.+Delmarauthor=W.+L.+Heatonauthor=M.+A.+Millerauthor=L.+D.+Lambertauthor=R.+L.+Conklinauthor=M.+Gowenauthor=J.+G.+Gleasonauthor=P.+K.+Bhatnagarauthor=J.+Fox&title=Calcilytic+compounds%3A+potent+and+selective+Ca2%2B+receptor+antagonists+that+stimulate+secretion+of+parathyroid+hormone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone</span></div><div class="casAuthors">Nemeth, Edward F.; Delmar, Eric G.; Heaton, William L.; Miller, Michael A.; Lambert, Lyssa D.; Conklin, Rebecca L.; Gowen, Maxine; Gleason, John G.; Bhatnagar, Pradip K.; Fox, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">299</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">323-331</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Despite the discovery of many ions and mols. that activate the Ca2+ receptor, there are no known ligands that block this receptor.  Reported here are the pharmacodynamic properties of a small mol., NPS 2143, which acts as an antagonist at the Ca2+ receptor.  This compd. blocked (IC50 of 43 nM) increases in cytoplasmic Ca2+ concns. [Ca2+]i elicited by activating the Ca2+ receptor in HEK 293 cells expressing the human Ca2+ receptor.  NPS 2143, even when tested at much higher concns. (3 μM), did not affect the activity of a no. of other G protein-coupled receptors, including those most structurally homologous to the Ca2+ receptor.  NPS 2143 stimulated parathyroid hormone (PTH) secretion from bovine parathyroid cells (EC50 of 41 nM) over a range of extracellular Ca2+ concns. and reversed the effects of the calcimimetic compd. NPS R-467 on [Ca2+]i and on secretion of PTH.  When infused i.v. in normal rats, NPS 2143 caused a rapid and large increase in plasma levels of PTH.  Ca2+ receptor antagonists are termed calcilytics and NPS 2143 is the first substance (either at. or mol.) shown to possess such activity.  The pharmacodynamic properties of NPS 2143 together with the recently demonstrated effects of this compd. on bone formation support the view that orally active calcilytic compds. might provide a novel anabolic therapy for osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5irxzzwLOvbVg90H21EOLACvtfcHk0ljHgkVopdIJVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFWltbk%253D&md5=14cedbe167bc3f0de96cec16d9ce73b4</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DDelmar%26aufirst%3DE.%2BG.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DLambert%26aufirst%3DL.%2BD.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DGleason%26aufirst%3DJ.%2BG.%26aulast%3DBhatnagar%26aufirst%3DP.%2BK.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DCalcilytic%2520compounds%253A%2520potent%2520and%2520selective%2520Ca2%252B%2520receptor%2520antagonists%2520that%2520stimulate%2520secretion%2520of%2520parathyroid%2520hormone%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D299%26spage%3D323%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Marquis, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trout, R. E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelMar, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Wagenen, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimizu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roethke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P.</span><span> </span><span class="NLM_article-title">Antagonists of the calcium receptor I. Amino alcohol-based parathyroid hormone secretagogues</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3982</span><span class="NLM_x">–</span> <span class="NLM_lpage">3993</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900364m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmvVSgtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3982-3993&author=R.+W.+Marquisauthor=A.+M.+Lagoauthor=J.+F.+Callahanauthor=R.+E.+L.+Troutauthor=M.+Gowenauthor=E.+G.+DelMarauthor=B.+C.+Van+Wagenenauthor=S.+Loganauthor=S.+Shimizuauthor=J.+Foxauthor=E.+F.+Nemethauthor=Z.+Yangauthor=T.+Roethkeauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=J.+Leeauthor=R.+M.+Keenanauthor=P.+Bhatnagar&title=Antagonists+of+the+calcium+receptor+I.+Amino+alcohol-based+parathyroid+hormone+secretagogues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonists of the Calcium Receptor I. Amino Alcohol-Based Parathyroid Hormone Secretagogues</span></div><div class="casAuthors">Marquis, Robert W.; Lago, Amparo M.; Callahan, James F.; Trout, Robert E. Lee; Gowen, Maxine; DelMar, Eric G.; Van Wagenen, Bradford C.; Logan, Sarah; Shimizu, Scott; Fox, John; Nemeth, Edward F.; Yang, Zheng; Roethke, Theresa; Smith, Brian R.; Ward, Keith W.; Lee, John; Keenan, Richard M.; Bhatnagar, Pradip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3982-3993</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Functional screening of the former SmithKline Beecham compd. collection against the human calcium receptor (CaR) resulted in the identification of the amino alc.-based hit 2 (IC50 = 11 μM).  Structure-activity studies of 2 focused on the optimization of the right- and left-hand side arom. moieties as well as the amino alc. linker region.  Crit. to the optimization of this antagonist template was the discovery that the chirality of the C-2 secondary alc. played a key role in enhancing both CaR potency as well as selectivity over the β-adrenergic receptor subtypes.  These SAR studies ultimately led to the identification of 38 (NPS 2143; SB-262470A), a potent and orally active CaR antagonist.  Pharmacokinetic characterization of 38 in the rat revealed that this mol. had a large vol. of distribution (11 L/kg), which resulted in a prolonged systemic exposure, protracted increases in the plasma levels of PTH, and an overall lack of net bone formation effect in a rodent model of osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEH_JHFpGSM7Vg90H21EOLACvtfcHk0liJ4DWaFC7now"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmvVSgtL0%253D&md5=7737a92f22bb30886f925395753243fd</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fjm900364m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900364m%26sid%3Dliteratum%253Aachs%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DLago%26aufirst%3DA.%2BM.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DTrout%26aufirst%3DR.%2BE.%2BL.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DDelMar%26aufirst%3DE.%2BG.%26aulast%3DVan%2BWagenen%26aufirst%3DB.%2BC.%26aulast%3DLogan%26aufirst%3DS.%26aulast%3DShimizu%26aufirst%3DS.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DRoethke%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DKeenan%26aufirst%3DR.%2BM.%26aulast%3DBhatnagar%26aufirst%3DP.%26atitle%3DAntagonists%2520of%2520the%2520calcium%2520receptor%2520I.%2520Amino%2520alcohol-based%2520parathyroid%2520hormone%2520secretagogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3982%26epage%3D3993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroup, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodds, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, I. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votta, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelMar, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span> </span><span class="NLM_article-title">Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">1595</span><span class="NLM_x">–</span> <span class="NLM_lpage">1604</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2000&pages=1595-1604&author=M.+Gowenauthor=G.+B.+Stroupauthor=R.+A.+Doddsauthor=I.+E.+Jamesauthor=B.+J.+Vottaauthor=B.+R.+Smithauthor=P.+K.+Bhatnagarauthor=A.+M.+Lagoauthor=J.+F.+Callahanauthor=E.+G.+DelMarauthor=M.+A.+Millerauthor=E.+F.+Nemethauthor=J.+Fox&title=Antagonizing+the+parathyroid+calcium+receptor+stimulates+parathyroid+hormone+secretion+and+bone+formation+in+osteopenic+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DStroup%26aufirst%3DG.%2BB.%26aulast%3DDodds%26aufirst%3DR.%2BA.%26aulast%3DJames%26aufirst%3DI.%2BE.%26aulast%3DVotta%26aufirst%3DB.%2BJ.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DBhatnagar%26aufirst%3DP.%2BK.%26aulast%3DLago%26aufirst%3DA.%2BM.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DDelMar%26aufirst%3DE.%2BG.%26aulast%3DMiller%26aufirst%3DM.%2BA.%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26atitle%3DAntagonizing%2520the%2520parathyroid%2520calcium%2520receptor%2520stimulates%2520parathyroid%2520hormone%2520secretion%2520and%2520bone%2520formation%2520in%2520osteopenic%2520rats%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D105%26spage%3D1595%26epage%3D1604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Shcherbakova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghatak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span> </span><span class="NLM_article-title">3H-Quinazolin-4-ones as a new calcilytic template for the potential treatment of osteoporosis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1557</span><span class="NLM_x">–</span> <span class="NLM_lpage">1560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1557-1560&author=I.+Shcherbakovaauthor=M.+F.+Balandrinauthor=J.+Foxauthor=A.+Ghatakauthor=W.+L.+Heatonauthor=R.+L.+Conklin&title=3H-Quinazolin-4-ones+as+a+new+calcilytic+template+for+the+potential+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DGhatak%26aufirst%3DA.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26atitle%3D3H-Quinazolin-4-ones%2520as%2520a%2520new%2520calcilytic%2520template%2520for%2520the%2520potential%2520treatment%2520of%2520osteoporosis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1557%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Shcherbakova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoffroy, O. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nair, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swierczek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balandrin, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heaton, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conklin, R. L.</span><span> </span><span class="NLM_article-title">Design, new synthesis, and calcilytic activity of substituted 3H-pyrimidin-4-ones</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">2537</span><span class="NLM_x">–</span> <span class="NLM_lpage">2540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=2537-2540&author=I.+Shcherbakovaauthor=G.+Huangauthor=O.+J.+Geoffroyauthor=S.+K.+Nairauthor=K.+Swierczekauthor=M.+F.+Balandrinauthor=J.+Foxauthor=W.+L.+Heatonauthor=R.+L.+Conklin&title=Design%2C+new+synthesis%2C+and+calcilytic+activity+of+substituted+3H-pyrimidin-4-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DGeoffroy%26aufirst%3DO.%2BJ.%26aulast%3DNair%26aufirst%3DS.%2BK.%26aulast%3DSwierczek%26aufirst%3DK.%26aulast%3DBalandrin%26aufirst%3DM.%2BF.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DHeaton%26aufirst%3DW.%2BL.%26aulast%3DConklin%26aufirst%3DR.%2BL.%26atitle%3DDesign%252C%2520new%2520synthesis%252C%2520and%2520calcilytic%2520activity%2520of%2520substituted%25203H-pyrimidin-4-ones%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D2537%26epage%3D2540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Kirk, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arey, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seethala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feyen, J. H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, J. K.</span><span> </span><span class="NLM_article-title">Discovery and structure−activity relationships of trisubstituted pyrimidines/pyridines as novel calcium-sensing receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1204</span><span class="NLM_x">–</span> <span class="NLM_lpage">1208</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801178c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1204-1208&author=W.+Yangauthor=Z.+Ruanauthor=Y.+Wangauthor=K.+Van+Kirkauthor=Z.+Maauthor=B.+J.+Areyauthor=C.+B.+Cooperauthor=R.+Seethalaauthor=J.+H.+M.+Feyenauthor=J.+K.+Dickson&title=Discovery+and+structure%E2%88%92activity+relationships+of+trisubstituted+pyrimidines%2Fpyridines+as+novel+calcium-sensing+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Fjm801178c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801178c%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DW.%26aulast%3DRuan%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DVan%2BKirk%26aufirst%3DK.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DArey%26aufirst%3DB.%2BJ.%26aulast%3DCooper%26aufirst%3DC.%2BB.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DFeyen%26aufirst%3DJ.%2BH.%2BM.%26aulast%3DDickson%26aufirst%3DJ.%2BK.%26atitle%3DDiscovery%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%2520trisubstituted%2520pyrimidines%252Fpyridines%2520as%2520novel%2520calcium-sensing%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1204%26epage%3D1208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Hoffman, S. J.; Caprjotti, C. A.; Vasko, J. A.; Liang, X.; Stroup, G. B.; Casillas, L. N.; Marquis, R. W.; Kumar, S.</span><span> </span><span class="NLM_article-title">The bone-building effects of the oral calcium-sensing receptor antagonist, ronacaleret, in ovariectomized rats</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span>(S) S336, SEP 2008, abstract number Su372, volume 23.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+J.+Hoffman&author=C.+A.+Caprjotti&author=J.+A.+Vasko&author=X.+Liang&author=G.+B.+Stroup&author=L.+N.+Casillas&author=R.+W.+Marquis&author=S.+Kumar&title=The+bone-building+effects+of+the+oral+calcium-sensing+receptor+antagonist%2C+ronacaleret%2C+in+ovariectomized+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520bone-building%2520effects%2520of%2520the%2520oral%2520calcium-sensing%2520receptor%2520antagonist%252C%2520ronacaleret%252C%2520in%2520ovariectomized%2520rats%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Fitzpatrick, L. A.; Brennan, E.; Kumar, S.; Matheny, C.; Yi, B.; McLaughlin, M.; Phillips, J.; Skordos, L.; Ethgen, D.</span><span> </span><span class="NLM_article-title">Ronacaleret, a novel calcium-sensing receptor antagonist, demonstrates potential as an oral bone-forming therapy in healthy postmenopausal women</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span>(S) S50, SEP 2008, abstract number 1174, volume 23.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=L.+A.+Fitzpatrick&author=E.+Brennan&author=S.+Kumar&author=C.+Matheny&author=B.+Yi&author=M.+McLaughlin&author=J.+Phillips&author=L.+Skordos&author=D.+Ethgen&title=Ronacaleret%2C+a+novel+calcium-sensing+receptor+antagonist%2C+demonstrates+potential+as+an+oral+bone-forming+therapy+in+healthy+postmenopausal+women"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFitzpatrick%26aufirst%3DL.%2BA.%26atitle%3DRonacaleret%252C%2520a%2520novel%2520calcium-sensing%2520receptor%2520antagonist%252C%2520demonstrates%2520potential%2520as%2520an%2520oral%2520bone-forming%2520therapy%2520in%2520healthy%2520postmenopausal%2520women%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><a href="http://www.gsk.com/" class="extLink">http://www.gsk.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fwww.gsk.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Widler, L.; Gamse, R.; Seuwen, K.; Buhl, T.; Beerli, R.; Breitenstein, W.; Gyaw, S.; Reynolds, C.; Bruin, G.; Belleli, R.; Klickstein, L.; John, M. R.</span><span> </span><span class="NLM_article-title">A novel calcium-sensing receptor antagonist leads to dose-dependent transient release of parathyroid hormone after oral administration to healthy volunteers: an initial proof-of-concept for a potential new class of anabolic osteoporosis therapeutics</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span>(S) S49, SEP 2008, abstract number 1173, volume 23.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=L.+Widler&author=R.+Gamse&author=K.+Seuwen&author=T.+Buhl&author=R.+Beerli&author=W.+Breitenstein&author=S.+Gyaw&author=C.+Reynolds&author=G.+Bruin&author=R.+Belleli&author=L.+Klickstein&author=M.+R.+John&title=A+novel+calcium-sensing+receptor+antagonist+leads+to+dose-dependent+transient+release+of+parathyroid+hormone+after+oral+administration+to+healthy+volunteers%3A+an+initial+proof-of-concept+for+a+potential+new+class+of+anabolic+osteoporosis+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWidler%26aufirst%3DL.%26atitle%3DA%2520novel%2520calcium-sensing%2520receptor%2520antagonist%2520leads%2520to%2520dose-dependent%2520transient%2520release%2520of%2520parathyroid%2520hormone%2520after%2520oral%2520administration%2520to%2520healthy%2520volunteers%253A%2520an%2520initial%2520proof-of-concept%2520for%2520a%2520potential%2520new%2520class%2520of%2520anabolic%2520osteoporosis%2520therapeutics%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Kumar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matheny, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasko, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stroup, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaden, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haley, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DelMar, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lago, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatnagar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huffman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gowen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Danoff, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzpatrick, L. A.</span><span> </span><span class="NLM_article-title">An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">534</span><span class="NLM_x">–</span> <span class="NLM_lpage">542</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=534-542&author=S.+Kumarauthor=C.+J.+Mathenyauthor=S.+J.+Hoffmanauthor=R.+W.+Marquisauthor=M.+Schultzauthor=X.+Liangauthor=J.+A.+Vaskoauthor=G.+B.+Stroupauthor=V.+R.+Vadenauthor=H.+Haleyauthor=J.+Foxauthor=E.+G.+DelMarauthor=E.+F.+Nemethauthor=A.+M.+Lagoauthor=J.+F.+Callahanauthor=P.+Bhatnagarauthor=W.+F.+Huffmanauthor=M.+Gowenauthor=B.+Yiauthor=T.+M.+Danoffauthor=L.+A.+Fitzpatrick&title=An+orally+active+calcium-sensing+receptor+antagonist+that+transiently+increases+plasma+concentrations+of+PTH+and+stimulates+bone+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DMatheny%26aufirst%3DC.%2BJ.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DSchultz%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DVasko%26aufirst%3DJ.%2BA.%26aulast%3DStroup%26aufirst%3DG.%2BB.%26aulast%3DVaden%26aufirst%3DV.%2BR.%26aulast%3DHaley%26aufirst%3DH.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DDelMar%26aufirst%3DE.%2BG.%26aulast%3DNemeth%26aufirst%3DE.%2BF.%26aulast%3DLago%26aufirst%3DA.%2BM.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DBhatnagar%26aufirst%3DP.%26aulast%3DHuffman%26aufirst%3DW.%2BF.%26aulast%3DGowen%26aufirst%3DM.%26aulast%3DYi%26aufirst%3DB.%26aulast%3DDanoff%26aufirst%3DT.%2BM.%26aulast%3DFitzpatrick%26aufirst%3DL.%2BA.%26atitle%3DAn%2520orally%2520active%2520calcium-sensing%2520receptor%2520antagonist%2520that%2520transiently%2520increases%2520plasma%2520concentrations%2520of%2520PTH%2520and%2520stimulates%2520bone%2520formation%26jtitle%3DBone%26date%3D2010%26volume%3D46%26spage%3D534%26epage%3D542" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Balan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castrodad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphries, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapinos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khot, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazarra, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neagu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliver, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span> </span><span class="NLM_article-title">The discovery of novel calcium sensing receptor negative allosteric modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">3328</span><span class="NLM_x">–</span> <span class="NLM_lpage">3332</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=3328-3332&author=G.+Balanauthor=J.+Baumanauthor=S.+Bhattacharyaauthor=M.+Castrodadauthor=D.+R.+Healyauthor=M.+Herrauthor=P.+Humphriesauthor=S.+Jenningsauthor=A.+S.+Kalgutkarauthor=B.+Kapinosauthor=V.+Khotauthor=K.+Lazarraauthor=M.+Liauthor=Y.+Liauthor=C.+Neaguauthor=R.+Oliverauthor=D.+W.+Piotrowskiauthor=D.+Priceauthor=H.+Qiauthor=H.+A.+Simmonsauthor=J.+Southersauthor=L.+Weiauthor=Y.+Zhangauthor=V.+M.+Paralkar&title=The+discovery+of+novel+calcium+sensing+receptor+negative+allosteric+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBalan%26aufirst%3DG.%26aulast%3DBauman%26aufirst%3DJ.%26aulast%3DBhattacharya%26aufirst%3DS.%26aulast%3DCastrodad%26aufirst%3DM.%26aulast%3DHealy%26aufirst%3DD.%2BR.%26aulast%3DHerr%26aufirst%3DM.%26aulast%3DHumphries%26aufirst%3DP.%26aulast%3DJennings%26aufirst%3DS.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKapinos%26aufirst%3DB.%26aulast%3DKhot%26aufirst%3DV.%26aulast%3DLazarra%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DNeagu%26aufirst%3DC.%26aulast%3DOliver%26aufirst%3DR.%26aulast%3DPiotrowski%26aufirst%3DD.%2BW.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DSimmons%26aufirst%3DH.%2BA.%26aulast%3DSouthers%26aufirst%3DJ.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26atitle%3DThe%2520discovery%2520of%2520novel%2520calcium%2520sensing%2520receptor%2520negative%2520allosteric%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D3328%26epage%3D3332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Klaus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span> </span><span class="NLM_article-title">Wnt signalling and its impact on development and cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1038%2Fnrc2389" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18432252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltVGlu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=387-398&author=A.+Klausauthor=W.+Birchmeier&title=Wnt+signalling+and+its+impact+on+development+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt signalling and its impact on development and cancer</span></div><div class="casAuthors">Klaus, Alexandra; Birchmeier, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">387-398</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The Wnt signaling pathway is an ancient system that has been highly conserved during evolution.  It has a crucial role in the embryonic development of all animal species, in the regeneration of tissues in adult organisms and in many other processes.  Mutations or deregulated expression of components of the Wnt pathway can induce disease, most importantly cancer.  The first gene to be identified that encodes a Wnt signaling component, Int1 (integration 1), was molecularly characterized from mouse tumor cells 25 years ago.  In parallel, the homologous gene Wingless in Drosophila melanogaster, which produces developmental defects in embryos, was characterized.  Since then, further components of the Wnt pathway have been identified and their epistatic relationships have been defined.  This article is a Timeline of crucial discoveries about the components and functions of this essential pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXK8cE7Os02LVg90H21EOLACvtfcHk0likZ-pyd_Ti4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltVGlu7c%253D&md5=c76a4450035e4228c4da7a7c12a9c5ea</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1038%2Fnrc2389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2389%26sid%3Dliteratum%253Aachs%26aulast%3DKlaus%26aufirst%3DA.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3DWnt%2520signalling%2520and%2520its%2520impact%2520on%2520development%2520and%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2008%26volume%3D8%26spage%3D387%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Krishnan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDougald, O. A.</span><span> </span><span class="NLM_article-title">Regulation of bone mass by Wnt signaling</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">1202</span><span class="NLM_x">–</span> <span class="NLM_lpage">1209</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2006&pages=1202-1209&author=V.+Krishnanauthor=H.+U.+Bryantauthor=O.+A.+MacDougald&title=Regulation+of+bone+mass+by+Wnt+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnan%26aufirst%3DV.%26aulast%3DBryant%26aufirst%3DH.%2BU.%26aulast%3DMacDougald%26aufirst%3DO.%2BA.%26atitle%3DRegulation%2520of%2520bone%2520mass%2520by%2520Wnt%2520signaling%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2006%26volume%3D116%26spage%3D1202%26epage%3D1209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawadi, G.</span><span> </span><span class="NLM_article-title">Minireview: targeting the Wnt/β-catenin pathway to regulate bone formation in the adult skeleton</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">2635</span><span class="NLM_x">–</span> <span class="NLM_lpage">2643</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2007&pages=2635-2643&author=R.+Baronauthor=G.+Rawadi&title=Minireview%3A+targeting+the+Wnt%2F%CE%B2-catenin+pathway+to+regulate+bone+formation+in+the+adult+skeleton"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DRawadi%26aufirst%3DG.%26atitle%3DMinireview%253A%2520targeting%2520the%2520Wnt%252F%25CE%25B2-catenin%2520pathway%2520to%2520regulate%2520bone%2520formation%2520in%2520the%2520adult%2520skeleton%26jtitle%3DEndocrinology%26date%3D2007%26volume%3D148%26spage%3D2635%26epage%3D2643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohlmeier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.-Y.</span><span> </span><span class="NLM_article-title">Wnt signaling and skeletal development</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">999</span><span class="NLM_x">–</span> <span class="NLM_lpage">1009</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.cellsig.2007.11.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18164181" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsF2rtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2008&pages=999-1009&author=F.+Liuauthor=S.+Kohlmeierauthor=C.-Y.+Wang&title=Wnt+signaling+and+skeletal+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt signaling and skeletal development</span></div><div class="casAuthors">Liu, Fei; Kohlmeier, Sean; Wang, Cun-Yu</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">999-1009</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Wnt proteins are a family of secreted proteins that regulate many aspects of cellular functions.  The discovery that mutations in low-d. lipoprotein receptor-related protein 5, a putative Wnt coreceptor, could pos. and neg. affect bone mass in humans generated an enormous amt. of interest in the possible role of the Wnt signaling pathway in skeletal biol.  Over the last decade, considerable progress has been made in detg. the role of the canonical Wnt signaling pathway in various aspects of skeletal development.  Furthermore, recent evidence indicates the important role of non-canonical Wnt signaling in skeletal development.  In this review we discuss the current understanding of the role of Wnt signaling in chondrogenesis, osteoblastogenesis, and osteoclastogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGNSx986CCbLVg90H21EOLACvtfcHk0likZ-pyd_Ti4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsF2rtbY%253D&md5=40c495a0ebdcee11857205fa3a1c49d8</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2007.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2007.11.011%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DKohlmeier%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DC.-Y.%26atitle%3DWnt%2520signaling%2520and%2520skeletal%2520development%26jtitle%3DCell.%2520Signalling%26date%3D2008%26volume%3D20%26spage%3D999%26epage%3D1009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Macsai, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xian, C. J.</span><span> </span><span class="NLM_article-title">Roles of Wnt signalling in bone growth, remodelling, skeletal disorders and fracture repair</span> <span class="citation_source-journal">J. Cell. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">215</span><span class="NLM_x">, </span> <span class="NLM_fpage">578</span><span class="NLM_x">–</span> <span class="NLM_lpage">587</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1002%2Fjcp.21342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18247365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvVKgt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2008&pages=578-587&author=C.+E.+Macsaiauthor=B.+K.+Fosterauthor=C.+J.+Xian&title=Roles+of+Wnt+signalling+in+bone+growth%2C+remodelling%2C+skeletal+disorders+and+fracture+repair"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Roles of Wnt signalling in bone growth, remodelling, skeletal disorders and fracture repair</span></div><div class="casAuthors">Macsai, Carmen E.; Foster, Bruce K.; Xian, Cory J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Physiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">578-587</span>CODEN:
                <span class="NLM_cas:coden">JCLLAX</span>;
        ISSN:<span class="NLM_cas:issn">0021-9541</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Wnt signalling has an essential role in regulating bone formation and remodelling during embryonic development and throughout postnatal and adult life.  Specifically, Wnt signalling regulates bone formation by controlling embryonic cartilage development and postnatal chondrogenesis, osteoblastogenesis, osteoclastogenesis, endochondral bone formation, and bone remodelling.  Abnormalities in the function of Wnt genes give rise to or contribute to the development of several pathol. bone conditions, including abnormal bone mass, osteosarcomas and bone loss in multiple myeloma.  Furthermore, Wnt signalling is activated during bone fracture repair and plays a crucial role in regulating bone regeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEpVp497Paf7Vg90H21EOLACvtfcHk0likZ-pyd_Ti4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvVKgt70%253D&md5=d08c8707209661dc34628e98adc1773c</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1002%2Fjcp.21342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcp.21342%26sid%3Dliteratum%253Aachs%26aulast%3DMacsai%26aufirst%3DC.%2BE.%26aulast%3DFoster%26aufirst%3DB.%2BK.%26aulast%3DXian%26aufirst%3DC.%2BJ.%26atitle%3DRoles%2520of%2520Wnt%2520signalling%2520in%2520bone%2520growth%252C%2520remodelling%252C%2520skeletal%2520disorders%2520and%2520fracture%2520repair%26jtitle%3DJ.%2520Cell.%2520Physiol.%26date%3D2008%26volume%3D215%26spage%3D578%26epage%3D587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Glass, D. A.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karsenty, G.</span><span> </span><span class="NLM_article-title">Minireview: in vivo analysis of Wnt signaling in bone</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">2630</span><span class="NLM_x">–</span> <span class="NLM_lpage">2634</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2007&pages=2630-2634&author=D.+A.+Glassauthor=G.+Karsenty&title=Minireview%3A+in+vivo+analysis+of+Wnt+signaling+in+bone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlass%26aufirst%3DD.%2BA.%26aulast%3DKarsenty%26aufirst%3DG.%26atitle%3DMinireview%253A%2520in%2520vivo%2520analysis%2520of%2520Wnt%2520signaling%2520in%2520bone%26jtitle%3DEndocrinology%26date%3D2007%26volume%3D148%26spage%3D2630%26epage%3D2634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ominsky, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmington, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morony, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shalhoub, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tipton, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haldankar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winters, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boone, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niu, Q.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kostenuik, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonet, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacey, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paszty, C.</span><span> </span><span class="NLM_article-title">Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">578</span><span class="NLM_x">–</span> <span class="NLM_lpage">588</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1359%2Fjbmr.081206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19049336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksF2lu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=578-588&author=X.+Liauthor=M.+S.+Ominskyauthor=K.+S.+Warmingtonauthor=S.+Moronyauthor=J.+Gongauthor=J.+Caoauthor=Y.+Gaoauthor=V.+Shalhoubauthor=B.+Tiptonauthor=R.+Haldankarauthor=Q.+Chenauthor=A.+Wintersauthor=T.+Booneauthor=Z.+Gengauthor=Q.-T.+Niuauthor=H.+Z.+Keauthor=P.+J.+Kostenuikauthor=W.+S.+Simonetauthor=D.+L.+Laceyauthor=C.+Paszty&title=Sclerostin+antibody+treatment+increases+bone+formation%2C+bone+mass%2C+and+bone+strength+in+a+rat+model+of+postmenopausal+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis</span></div><div class="casAuthors">Li, Xiaodong; Ominsky, Michael S.; Warmington, Kelly S.; Morony, Sean; Gong, Jianhua; Cao, Jin; Gao, Yongming; Shalhoub, Victoria; Tipton, Barbara; Haldankar, Raj; Chen, Qing; Winters, Aaron; Boone, Tom; Geng, Zhaopo; Niu, Qing-Tian; Ke, Hua Zhu; Kostenuik, Paul J.; Simonet, W. Scott; Lacey, David L.; Paszty, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">578-588</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">The development of bone-rebuilding anabolic agents for potential use in the treatment of bone loss conditions, such as osteoporosis, has been a long-standing goal.  Genetic studies in humans and mice have shown that the secreted protein sclerostin is a key neg. regulator of bone formation, although the magnitude and extent of sclerostin's role in the control of bone formation in the aging skeleton is still unclear.  To study this unexplored area of sclerostin biol. and to assess the pharmacol. effects of sclerostin inhibition, we used a cell culture model of bone formation to identify a sclerostin neutralizing monoclonal antibody (Scl-AbII) for testing in an aged ovariectomized rat model of postmenopausal osteoporosis.  Six-month-old female rats were ovariectomized and left untreated for 1 yr to allow for significant estrogen deficiency-induced bone loss, at which point Scl-AbII was administered for 5 wk.  Scl-AbII treatment in these animals had robust anabolic effects, with marked increases in bone formation on trabecular, periosteal, endocortical, and intracortical surfaces.  This not only resulted in complete reversal, at several skeletal sites, of the 1 yr of estrogen deficiency-induced bone loss, but also further increased bone mass and bone strength to levels greater than those found in non-ovariectomized control rats.  Taken together, these preclin. results establish sclerostin's role as a pivotal neg. regulator of bone formation in the aging skeleton and, furthermore, suggest that antibody-mediated inhibition of sclerostin represents a promising new therapeutic approach for the anabolic treatment of bone-related disorders, such as postmenopausal osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqIMvgmEX9abVg90H21EOLACvtfcHk0lhmvHMRJ9Xv1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksF2lu7c%253D&md5=6ba21682e2f0a7aba4e95fede74808b0</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.081206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.081206%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DOminsky%26aufirst%3DM.%2BS.%26aulast%3DWarmington%26aufirst%3DK.%2BS.%26aulast%3DMorony%26aufirst%3DS.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DShalhoub%26aufirst%3DV.%26aulast%3DTipton%26aufirst%3DB.%26aulast%3DHaldankar%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DWinters%26aufirst%3DA.%26aulast%3DBoone%26aufirst%3DT.%26aulast%3DGeng%26aufirst%3DZ.%26aulast%3DNiu%26aufirst%3DQ.-T.%26aulast%3DKe%26aufirst%3DH.%2BZ.%26aulast%3DKostenuik%26aufirst%3DP.%2BJ.%26aulast%3DSimonet%26aufirst%3DW.%2BS.%26aulast%3DLacey%26aufirst%3DD.%2BL.%26aulast%3DPaszty%26aufirst%3DC.%26atitle%3DSclerostin%2520antibody%2520treatment%2520increases%2520bone%2520formation%252C%2520bone%2520mass%252C%2520and%2520bone%2520strength%2520in%2520a%2520rat%2520model%2520of%2520postmenopausal%2520osteoporosis%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2009%26volume%3D24%26spage%3D578%26epage%3D588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Eddleston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marenzana, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muzylak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, M. K.</span><span> </span><span class="NLM_article-title">A short treatment with an antibody to sclerostin can inhibit bone loss in an ongoing model of colitis</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">1662</span><span class="NLM_x">–</span> <span class="NLM_lpage">1671</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1359%2Fjbmr.090403" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19419292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlGgurfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=1662-1671&author=A.+Eddlestonauthor=M.+Marenzanaauthor=A.+R.+Mooreauthor=P.+Stephensauthor=M.+Muzylakauthor=D.+Marshallauthor=M.+K.+Robinson&title=A+short+treatment+with+an+antibody+to+sclerostin+can+inhibit+bone+loss+in+an+ongoing+model+of+colitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">A short treatment with an antibody to sclerostin can inhibit bone loss in an ongoing model of colitis</span></div><div class="casAuthors">Eddleston, Alison; Marenzana, Massimo; Moore, Adrian R.; Stephens, Paul; Muzylak, Mariusz; Marshall, Diane; Robinson, Martyn K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1662-1671</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">Chronic inflammation leads to bone loss, and increased fracture rates have been reported in a no. of human chronic inflammatory conditions.  The study reported here investigates the skeletal effects of dosing a neutralizing antibody to the bone regulatory protein sclerostin in a mouse model of chronic colitis.  When dosed prophylactically, an antibody to sclerostin (Scl-AbI) did not reduce the wt. loss or histol. changes assocd. with colitis but did prevent inflammation-induced bone loss.  At the end of the expt., Scl-AbI-treated animals had a significantly higher femoral BMD (+27%, p < 0.05) than control antibody (Cntrl-Ab)-treated animals.  In a second expt., treatment with Scl-AbI was delayed until colitis had developed, by which time the mech. properties of femurs in colitic animals were significantly worse than those of healthy age-matched control mice (max. load, -26%, p < 0.05; energy, -37%, p < 0.05; ultimate strength, -33%, p < 0.05; elastic modulus, -17%, p < 0.05).  A short treatment with Scl-AbI halted bone loss and reversed the decline of both intrinsic and extrinsic mech. properties of the femur such that, after 19 days of treatment, the bone mech. properties in the Scl-AbI-treated animals were not significantly different from those of noncolitic age-matched controls.  Serum markers of bone formation and resorption suggested that the antibody to sclerostin stimulated osteoblast activity and inhibited osteoclast-mediated bone resorption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorHiblBDi_6bVg90H21EOLACvtfcHk0lhmvHMRJ9Xv1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlGgurfM&md5=5aa298df22635caa3cffdeb5d9224581</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.090403&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.090403%26sid%3Dliteratum%253Aachs%26aulast%3DEddleston%26aufirst%3DA.%26aulast%3DMarenzana%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DA.%2BR.%26aulast%3DStephens%26aufirst%3DP.%26aulast%3DMuzylak%26aufirst%3DM.%26aulast%3DMarshall%26aufirst%3DD.%26aulast%3DRobinson%26aufirst%3DM.%2BK.%26atitle%3DA%2520short%2520treatment%2520with%2520an%2520antibody%2520to%2520sclerostin%2520can%2520inhibit%2520bone%2520loss%2520in%2520an%2520ongoing%2520model%2520of%2520colitis%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2009%26volume%3D24%26spage%3D1662%26epage%3D1671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Padhi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stouch, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glise, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posvar, E.</span><span> </span><span class="NLM_article-title">Anti-sclerostin antibody increases markers of bone formation in healthy postmenopausal women</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">S1</span><span class="NLM_x">–</span> <span class="NLM_lpage">S37</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=S1-S37&author=D.+Padhiauthor=B.+Stouchauthor=G.+Jangauthor=L.+Fangauthor=M.+Darlingauthor=H.+Gliseauthor=M.+Robinsonauthor=S.+Harrisauthor=E.+Posvar&title=Anti-sclerostin+antibody+increases+markers+of+bone+formation+in+healthy+postmenopausal+women"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPadhi%26aufirst%3DD.%26aulast%3DStouch%26aufirst%3DB.%26aulast%3DJang%26aufirst%3DG.%26aulast%3DFang%26aufirst%3DL.%26aulast%3DDarling%26aufirst%3DM.%26aulast%3DGlise%26aufirst%3DH.%26aulast%3DRobinson%26aufirst%3DM.%26aulast%3DHarris%26aufirst%3DS.%26aulast%3DPosvar%26aufirst%3DE.%26atitle%3DAnti-sclerostin%2520antibody%2520increases%2520markers%2520of%2520bone%2520formation%2520in%2520healthy%2520postmenopausal%2520women%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2007%26volume%3D22%26spage%3DS1%26epage%3DS37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Grisanti, M.; Niu, Q. T.; Fan, W.; Asuncion, F.; Lee, J.; Steavenson, S.; Chen, Q.; Li, J.; Geng, Z.; Kostenuik, P.; Lacey, D. L.; Simonet, W. S.; Ominsky, M.; Li, X.; Richards, W. G.</span><span> </span><span class="NLM_article-title">Dkk-1 inhibition increases bone mineral density in rodents</span>.  <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span>(1) S25, SEP 2006, abstract number 1089, volume 21.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Grisanti&author=Q.+T.+Niu&author=W.+Fan&author=F.+Asuncion&author=J.+Lee&author=S.+Steavenson&author=Q.+Chen&author=J.+Li&author=Z.+Geng&author=P.+Kostenuik&author=D.+L.+Lacey&author=W.+S.+Simonet&author=M.+Ominsky&author=X.+Li&author=W.+G.+Richards&title=Dkk-1+inhibition+increases+bone+mineral+density+in+rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrisanti%26aufirst%3DM.%26atitle%3DDkk-1%2520inhibition%2520increases%2520bone%2520mineral%2520density%2520in%2520rodents%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Diarra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polzer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwerina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ominsky, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwyer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korb, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smolen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheinecker, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Heide, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landewe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schett, G.</span><span> </span><span class="NLM_article-title">Dickkopf-1 is a master regulator of joint remodeling</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">156</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1038%2Fnm1538" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17237793" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVyktbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=156-163&author=D.+Diarraauthor=M.+Stolinaauthor=K.+Polzerauthor=J.+Zwerinaauthor=M.+S.+Ominskyauthor=D.+Dwyerauthor=A.+Korbauthor=J.+Smolenauthor=M.+Hoffmannauthor=C.+Scheineckerauthor=D.+van+der+Heideauthor=R.+Landeweauthor=D.+Laceyauthor=W.+G.+Richardsauthor=G.+Schett&title=Dickkopf-1+is+a+master+regulator+of+joint+remodeling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Dickkopf-1 is a master regulator of joint remodeling</span></div><div class="casAuthors">Diarra, Danielle; Stolina, Marina; Polzer, Karin; Zwerina, Jochen; Ominsky, Michael S.; Dwyer, Denise; Korb, Adelheid; Smolen, Josef; Hoffmann, Markus; Scheinecker, Clemens; van der Heide, Desiree; Landewe, Robert; Lacey, Dave; Richards, William G.; Schett, Georg</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">156-163</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Degenerative and inflammatory joint diseases lead to a destruction of the joint architecture.  Whereas degenerative osteoarthritis results in the formation of new bone, rheumatoid arthritis leads to bone resorption.  The mol. basis of these different patterns of joint disease is unknown.  By inhibiting Dickkopf-1 (DKK-1), a regulatory mol. of the Wnt pathway, the authors were able to reverse the bone-destructive pattern of a mouse model of rheumatoid arthritis to the bone-forming pattern of osteoarthritis.  In this way, no overall bone erosion resulted, although bony nodules, so-called osteophytes, did form.  The authors identified tumor necrosis factor-α (TNF) as a key inducer of DKK-1 in the mouse inflammatory arthritis model and in human rheumatoid arthritis.  These results suggest that the Wnt pathway is a key regulator of joint remodeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoctqLrJQzr7Vg90H21EOLACvtfcHk0ljjq8uIDqCBOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVyktbY%253D&md5=24e33f09eba01d2f5172b639d45549c4</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fnm1538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1538%26sid%3Dliteratum%253Aachs%26aulast%3DDiarra%26aufirst%3DD.%26aulast%3DStolina%26aufirst%3DM.%26aulast%3DPolzer%26aufirst%3DK.%26aulast%3DZwerina%26aufirst%3DJ.%26aulast%3DOminsky%26aufirst%3DM.%2BS.%26aulast%3DDwyer%26aufirst%3DD.%26aulast%3DKorb%26aufirst%3DA.%26aulast%3DSmolen%26aufirst%3DJ.%26aulast%3DHoffmann%26aufirst%3DM.%26aulast%3DScheinecker%26aufirst%3DC.%26aulast%3Dvan%2Bder%2BHeide%26aufirst%3DD.%26aulast%3DLandewe%26aufirst%3DR.%26aulast%3DLacey%26aufirst%3DD.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DSchett%26aufirst%3DG.%26atitle%3DDickkopf-1%2520is%2520a%2520master%2520regulator%2520of%2520joint%2520remodeling%26jtitle%3DNat.%2520Med.%26date%3D2007%26volume%3D13%26spage%3D156%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Fulciniti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tassone, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanjappa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ettenberg, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, Y.-t.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauhan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsiades, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhala, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stover, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, N. C.</span><span> </span><span class="NLM_article-title">Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2009&pages=371-379&author=M.+Fulcinitiauthor=P.+Tassoneauthor=T.+Hideshimaauthor=S.+Valletauthor=P.+Nanjappaauthor=S.+A.+Ettenbergauthor=Z.+Shenauthor=N.+Patelauthor=Y.-t.+Taiauthor=D.+Chauhanauthor=C.+Mitsiadesauthor=R.+Prabhalaauthor=N.+Rajeauthor=K.+C.+Andersonauthor=D.+R.+Stoverauthor=N.+C.+Munshi&title=Anti-DKK1+mAb+%28BHQ880%29+as+a+potential+therapeutic+agent+for+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFulciniti%26aufirst%3DM.%26aulast%3DTassone%26aufirst%3DP.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DVallet%26aufirst%3DS.%26aulast%3DNanjappa%26aufirst%3DP.%26aulast%3DEttenberg%26aufirst%3DS.%2BA.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DPatel%26aufirst%3DN.%26aulast%3DTai%26aufirst%3DY.-t.%26aulast%3DChauhan%26aufirst%3DD.%26aulast%3DMitsiades%26aufirst%3DC.%26aulast%3DPrabhala%26aufirst%3DR.%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DStover%26aufirst%3DD.%2BR.%26aulast%3DMunshi%26aufirst%3DN.%2BC.%26atitle%3DAnti-DKK1%2520mAb%2520%2528BHQ880%2529%2520as%2520a%2520potential%2520therapeutic%2520agent%2520for%2520multiple%2520myeloma%26jtitle%3DBlood%26date%3D2009%26volume%3D114%26spage%3D371%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Heath, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chantry, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckle, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulton, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaughnessy, J. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snowden, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stover, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderkerken, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croucher, P. I.</span><span> </span><span class="NLM_article-title">Inhibiting dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">436</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1359%2Fjbmr.081104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19016584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjslKru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=425-436&author=D.+J.+Heathauthor=A.+D.+Chantryauthor=C.+H.+Buckleauthor=L.+Coultonauthor=J.+D.+Shaughnessyauthor=H.+R.+Evansauthor=J.+A.+Snowdenauthor=D.+R.+Stoverauthor=K.+Vanderkerkenauthor=P.+I.+Croucher&title=Inhibiting+dickkopf-1+%28Dkk1%29+removes+suppression+of+bone+formation+and+prevents+the+development+of+osteolytic+bone+disease+in+multiple+myeloma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibiting dickkopf-1 (Dkk1) removes suppression of bone formation and prevents the development of osteolytic bone disease in multiple myeloma</span></div><div class="casAuthors">Heath, Deborah J.; Chantry, Andrew D.; Buckle, Clive H.; Coulton, Les; Shaughnessy, John D., Jr.; Evans, Holly R.; Snowden, John A.; Stover, David R.; Vanderkerken, Karin; Croucher, Peter I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">425-436</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">Multiple myeloma (MM) is assocd. with the development of osteolytic bone disease, mediated by increased osteoclastic bone resorption and impaired osteoblastic bone formation.  Dickkopf-1 (Dkk1), a sol. inhibitor of wingless/int (Wnt) signaling and osteoblastogenesis, is elevated in patients with MM and correlates with osteolytic bone disease.  In this study, we investigated the effect of inhibiting Dkk1 on the development of osteolytic lesions in the 5T2MM murine model of myeloma.  We showed that Dkk1 is expressed by murine 5T2MM myeloma cells.  Injection of 5T2MM cells into C57BL/KaLwRij mice resulted in the development of osteolytic bone lesions (p < 0.05), mediated by increased osteoclast nos. (p < 0.001) and a decrease in osteoblast nos. (p < 0.001) and mineralizing surface (p < 0.05).  Mice bearing 5T2MM cells were treated with an anti-Dkk1 antibody (BHQ880, 10 mg/kg, IV, twice weekly for 4 wk) from time of paraprotein detection.  Anti-Dkk1 treatment prevented 5T2MM-induced suppression of osteoblast nos. (p < 0.001) and surface (p < 0.001).  Treatment increased mineralizing surface by 28% and bone formation rate by 25%; however, there was no change in mineral apposition rate.  Inhibiting Dkk1 had no effect on osteoclast nos.  μCT anal. showed that anti-Dkk1 treatment significantly protected against 5T2MM-induced trabecular bone loss (p < 0.05) and reduced the development of osteolytic bone lesions (p < 0.05).  Treatment had no significant effect on tumor burden.  These data suggest that inhibiting Dkk1 prevents the suppression of bone formation and in doing so is effective in preventing the development of osteolytic bone disease in myeloma, offering an effective therapeutic approach to treating this clin. important aspect of myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSg4wcjmMeRLVg90H21EOLACvtfcHk0ljjq8uIDqCBOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjslKru78%253D&md5=fc15e5571454e63efa18581af393fe0a</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.081104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.081104%26sid%3Dliteratum%253Aachs%26aulast%3DHeath%26aufirst%3DD.%2BJ.%26aulast%3DChantry%26aufirst%3DA.%2BD.%26aulast%3DBuckle%26aufirst%3DC.%2BH.%26aulast%3DCoulton%26aufirst%3DL.%26aulast%3DShaughnessy%26aufirst%3DJ.%2BD.%26aulast%3DEvans%26aufirst%3DH.%2BR.%26aulast%3DSnowden%26aufirst%3DJ.%2BA.%26aulast%3DStover%26aufirst%3DD.%2BR.%26aulast%3DVanderkerken%26aufirst%3DK.%26aulast%3DCroucher%26aufirst%3DP.%2BI.%26atitle%3DInhibiting%2520dickkopf-1%2520%2528Dkk1%2529%2520removes%2520suppression%2520of%2520bone%2520formation%2520and%2520prevents%2520the%2520development%2520of%2520osteolytic%2520bone%2520disease%2520in%2520multiple%2520myeloma%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2009%26volume%3D24%26spage%3D425%26epage%3D436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Pelletier, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundquist, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bex, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleburn, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felix, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauze, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharode, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhead, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matteo, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehlmann, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murrills, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirrello, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unwalla, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vera, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobel, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaworsky, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodine, P. V. N.</span><span> </span><span class="NLM_article-title">(1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: a wingless β-catenin agonist that increases bone formation rate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6962</span><span class="NLM_x">–</span> <span class="NLM_lpage">6965</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9014197" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6962-6965&author=J.+C.+Pelletierauthor=J.+T.+Lundquistauthor=A.+M.+Gilbertauthor=N.+Alonauthor=F.+J.+Bexauthor=B.+M.+Bhatauthor=M.+G.+Bursavichauthor=V.+E.+Coleburnauthor=L.+A.+Felixauthor=D.+M.+Greenauthor=P.+Greenauthor=D.+B.+Hauzeauthor=Y.+P.+Kharodeauthor=H.-S.+Lamauthor=S.+R.+Lockheadauthor=R.+L.+Magoldaauthor=J.+J.+Matteoauthor=J.+F.+Mehlmannauthor=C.+Milliganauthor=R.+J.+Murrillsauthor=J.+Pirrelloauthor=S.+Selimauthor=M.+C.+Sharpauthor=R.+J.+Unwallaauthor=M.+D.+Veraauthor=J.+E.+Wrobelauthor=P.+Yaworskyauthor=P.+V.+N.+Bodine&title=%281-%284-%28Naphthalen-2-yl%29pyrimidin-2-yl%29piperidin-4-yl%29methanamine%3A+a+wingless+%CE%B2-catenin+agonist+that+increases+bone+formation+rate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Fjm9014197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9014197%26sid%3Dliteratum%253Aachs%26aulast%3DPelletier%26aufirst%3DJ.%2BC.%26aulast%3DLundquist%26aufirst%3DJ.%2BT.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DAlon%26aufirst%3DN.%26aulast%3DBex%26aufirst%3DF.%2BJ.%26aulast%3DBhat%26aufirst%3DB.%2BM.%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DColeburn%26aufirst%3DV.%2BE.%26aulast%3DFelix%26aufirst%3DL.%2BA.%26aulast%3DGreen%26aufirst%3DD.%2BM.%26aulast%3DGreen%26aufirst%3DP.%26aulast%3DHauze%26aufirst%3DD.%2BB.%26aulast%3DKharode%26aufirst%3DY.%2BP.%26aulast%3DLam%26aufirst%3DH.-S.%26aulast%3DLockhead%26aufirst%3DS.%2BR.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DMatteo%26aufirst%3DJ.%2BJ.%26aulast%3DMehlmann%26aufirst%3DJ.%2BF.%26aulast%3DMilligan%26aufirst%3DC.%26aulast%3DMurrills%26aufirst%3DR.%2BJ.%26aulast%3DPirrello%26aufirst%3DJ.%26aulast%3DSelim%26aufirst%3DS.%26aulast%3DSharp%26aufirst%3DM.%2BC.%26aulast%3DUnwalla%26aufirst%3DR.%2BJ.%26aulast%3DVera%26aufirst%3DM.%2BD.%26aulast%3DWrobel%26aufirst%3DJ.%2BE.%26aulast%3DYaworsky%26aufirst%3DP.%26aulast%3DBodine%26aufirst%3DP.%2BV.%2BN.%26atitle%3D%25281-%25284-%2528Naphthalen-2-yl%2529pyrimidin-2-yl%2529piperidin-4-yl%2529methanamine%253A%2520a%2520wingless%2520%25CE%25B2-catenin%2520agonist%2520that%2520increases%2520bone%2520formation%2520rate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6962%26epage%3D6965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Gilbert, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bex, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cain, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleburn, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gironda, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauze, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharode, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamurthy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirisits, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matteo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murrills, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unwalla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varadarajan, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaworsky, P. J.</span><span> </span><span class="NLM_article-title">Hit to lead studies on (hetero)arylpyrimidines—agonists of the canonical Wnt-β-catenin cellular messaging system</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=366-370&author=A.+M.+Gilbertauthor=M.+G.+Bursavichauthor=N.+Alonauthor=B.+M.+Bhatauthor=F.+J.+Bexauthor=M.+Cainauthor=V.+Coleburnauthor=V.+Girondaauthor=P.+Greenauthor=D.+B.+Hauzeauthor=Y.+Kharodeauthor=G.+Krishnamurthyauthor=M.+Kirisitsauthor=H.-S.+Lamauthor=Y.-B.+Liuauthor=S.+Lombardiauthor=J.+Matteoauthor=R.+Murrillsauthor=J.+A.+Robinsonauthor=S.+Selimauthor=M.+Sharpauthor=R.+Unwallaauthor=U.+Varadarajanauthor=W.+Zhaoauthor=P.+J.+Yaworsky&title=Hit+to+lead+studies+on+%28hetero%29arylpyrimidines%E2%80%94agonists+of+the+canonical+Wnt-%CE%B2-catenin+cellular+messaging+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DAlon%26aufirst%3DN.%26aulast%3DBhat%26aufirst%3DB.%2BM.%26aulast%3DBex%26aufirst%3DF.%2BJ.%26aulast%3DCain%26aufirst%3DM.%26aulast%3DColeburn%26aufirst%3DV.%26aulast%3DGironda%26aufirst%3DV.%26aulast%3DGreen%26aufirst%3DP.%26aulast%3DHauze%26aufirst%3DD.%2BB.%26aulast%3DKharode%26aufirst%3DY.%26aulast%3DKrishnamurthy%26aufirst%3DG.%26aulast%3DKirisits%26aufirst%3DM.%26aulast%3DLam%26aufirst%3DH.-S.%26aulast%3DLiu%26aufirst%3DY.-B.%26aulast%3DLombardi%26aufirst%3DS.%26aulast%3DMatteo%26aufirst%3DJ.%26aulast%3DMurrills%26aufirst%3DR.%26aulast%3DRobinson%26aufirst%3DJ.%2BA.%26aulast%3DSelim%26aufirst%3DS.%26aulast%3DSharp%26aufirst%3DM.%26aulast%3DUnwalla%26aufirst%3DR.%26aulast%3DVaradarajan%26aufirst%3DU.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DYaworsky%26aufirst%3DP.%2BJ.%26atitle%3DHit%2520to%2520lead%2520studies%2520on%2520%2528hetero%2529arylpyrimidines%25E2%2580%2594agonists%2520of%2520the%2520canonical%2520Wnt-%25CE%25B2-catenin%2520cellular%2520messaging%2520system%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D366%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Gopalsamy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billiard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponce-de-Leon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seestaller-Wehr, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamurthy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodine, P.</span><span> </span><span class="NLM_article-title">Identification of diarylsulfone sulfonamides as secreted frizzled related protein-1 (sFRP-1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7670</span><span class="NLM_x">–</span> <span class="NLM_lpage">7672</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801069w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7670-7672&author=A.+Gopalsamyauthor=M.+Shiauthor=B.+Staufferauthor=R.+Bahatauthor=J.+Billiardauthor=H.+Ponce-de-Leonauthor=L.+Seestaller-Wehrauthor=S.+Fukayamaauthor=A.+Mangineauthor=R.+Moranauthor=G.+Krishnamurthyauthor=P.+Bodine&title=Identification+of+diarylsulfone+sulfonamides+as+secreted+frizzled+related+protein-1+%28sFRP-1%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1021%2Fjm801069w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801069w%26sid%3Dliteratum%253Aachs%26aulast%3DGopalsamy%26aufirst%3DA.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DStauffer%26aufirst%3DB.%26aulast%3DBahat%26aufirst%3DR.%26aulast%3DBilliard%26aufirst%3DJ.%26aulast%3DPonce-de-Leon%26aufirst%3DH.%26aulast%3DSeestaller-Wehr%26aufirst%3DL.%26aulast%3DFukayama%26aufirst%3DS.%26aulast%3DMangine%26aufirst%3DA.%26aulast%3DMoran%26aufirst%3DR.%26aulast%3DKrishnamurthy%26aufirst%3DG.%26aulast%3DBodine%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520diarylsulfone%2520sulfonamides%2520as%2520secreted%2520frizzled%2520related%2520protein-1%2520%2528sFRP-1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7670%26epage%3D7672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Moore, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Commons, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goljer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamurthy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nogle, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trybulski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welmaker, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodine, P. V. N.</span><span> </span><span class="NLM_article-title">Modulation of Wnt signaling through inhibition of secreted frizzled-related protein I (sFRP-1) with N-substituted piperidinyl diphenylsulfonyl sulfonamides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">116</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801144h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=105-116&author=W.+J.+Mooreauthor=J.+C.+Kernauthor=R.+Bhatauthor=T.+J.+Commonsauthor=S.+Fukayamaauthor=I.+Goljerauthor=G.+Krishnamurthyauthor=R.+L.+Magoldaauthor=L.+Nogleauthor=K.+Pittsauthor=B.+Staufferauthor=E.+J.+Trybulskiauthor=G.+S.+Welmakerauthor=M.+Wilsonauthor=P.+V.+N.+Bodine&title=Modulation+of+Wnt+signaling+through+inhibition+of+secreted+frizzled-related+protein+I+%28sFRP-1%29+with+N-substituted+piperidinyl+diphenylsulfonyl+sulfonamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1021%2Fjm801144h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801144h%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DW.%2BJ.%26aulast%3DKern%26aufirst%3DJ.%2BC.%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DCommons%26aufirst%3DT.%2BJ.%26aulast%3DFukayama%26aufirst%3DS.%26aulast%3DGoljer%26aufirst%3DI.%26aulast%3DKrishnamurthy%26aufirst%3DG.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DNogle%26aufirst%3DL.%26aulast%3DPitts%26aufirst%3DK.%26aulast%3DStauffer%26aufirst%3DB.%26aulast%3DTrybulski%26aufirst%3DE.%2BJ.%26aulast%3DWelmaker%26aufirst%3DG.%2BS.%26aulast%3DWilson%26aufirst%3DM.%26aulast%3DBodine%26aufirst%3DP.%2BV.%2BN.%26atitle%3DModulation%2520of%2520Wnt%2520signaling%2520through%2520inhibition%2520of%2520secreted%2520frizzled-related%2520protein%2520I%2520%2528sFRP-1%2529%2520with%2520N-substituted%2520piperidinyl%2520diphenylsulfonyl%2520sulfonamides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D105%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Bodine, P. V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponce-de-Leon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seestaller-Wehr, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billiard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komm, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitts, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamurthy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalsamy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Commons, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodworth, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welmaker, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trybulski, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, W. J.</span><span> </span><span class="NLM_article-title">A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1063</span><span class="NLM_x">–</span> <span class="NLM_lpage">1068</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=1063-1068&author=P.+V.+N.+Bodineauthor=B.+Staufferauthor=H.+Ponce-de-Leonauthor=R.+A.+Bhatauthor=A.+Mangineauthor=L.+M.+Seestaller-Wehrauthor=R.+A.+Moranauthor=J.+Billiardauthor=S.+Fukayamaauthor=B.+S.+Kommauthor=K.+Pittsauthor=G.+Krishnamurthyauthor=A.+Gopalsamyauthor=M.+Shiauthor=J.+C.+Kernauthor=T.+J.+Commonsauthor=R.+P.+Woodworthauthor=M.+A.+Wilsonauthor=G.+S.+Welmakerauthor=E.+J.+Trybulskiauthor=W.+J.+Moore&title=A+small+molecule+inhibitor+of+the+Wnt+antagonist+secreted+frizzled-related+protein-1+stimulates+bone+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBodine%26aufirst%3DP.%2BV.%2BN.%26aulast%3DStauffer%26aufirst%3DB.%26aulast%3DPonce-de-Leon%26aufirst%3DH.%26aulast%3DBhat%26aufirst%3DR.%2BA.%26aulast%3DMangine%26aufirst%3DA.%26aulast%3DSeestaller-Wehr%26aufirst%3DL.%2BM.%26aulast%3DMoran%26aufirst%3DR.%2BA.%26aulast%3DBilliard%26aufirst%3DJ.%26aulast%3DFukayama%26aufirst%3DS.%26aulast%3DKomm%26aufirst%3DB.%2BS.%26aulast%3DPitts%26aufirst%3DK.%26aulast%3DKrishnamurthy%26aufirst%3DG.%26aulast%3DGopalsamy%26aufirst%3DA.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DKern%26aufirst%3DJ.%2BC.%26aulast%3DCommons%26aufirst%3DT.%2BJ.%26aulast%3DWoodworth%26aufirst%3DR.%2BP.%26aulast%3DWilson%26aufirst%3DM.%2BA.%26aulast%3DWelmaker%26aufirst%3DG.%2BS.%26aulast%3DTrybulski%26aufirst%3DE.%2BJ.%26aulast%3DMoore%26aufirst%3DW.%2BJ.%26atitle%3DA%2520small%2520molecule%2520inhibitor%2520of%2520the%2520Wnt%2520antagonist%2520secreted%2520frizzled-related%2520protein-1%2520stimulates%2520bone%2520formation%26jtitle%3DBone%26date%3D2009%26volume%3D44%26spage%3D1063%26epage%3D1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Shi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billiard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ponce-de-Leon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seestaller-Wehr, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mangine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnamurthy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bodine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gopalsamy, A.</span><span> </span><span class="NLM_article-title">Identification of iminooxothiazolidines as secreted frizzled related protein-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">6337</span><span class="NLM_x">–</span> <span class="NLM_lpage">6339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=6337-6339&author=M.+Shiauthor=B.+Staufferauthor=R.+Bhatauthor=J.+Billiardauthor=H.+Ponce-de-Leonauthor=L.+Seestaller-Wehrauthor=S.+Fukayamaauthor=A.+Mangineauthor=R.+Moranauthor=G.+Krishnamurthyauthor=P.+Bodineauthor=A.+Gopalsamy&title=Identification+of+iminooxothiazolidines+as+secreted+frizzled+related+protein-1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DM.%26aulast%3DStauffer%26aufirst%3DB.%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DBilliard%26aufirst%3DJ.%26aulast%3DPonce-de-Leon%26aufirst%3DH.%26aulast%3DSeestaller-Wehr%26aufirst%3DL.%26aulast%3DFukayama%26aufirst%3DS.%26aulast%3DMangine%26aufirst%3DA.%26aulast%3DMoran%26aufirst%3DR.%26aulast%3DKrishnamurthy%26aufirst%3DG.%26aulast%3DBodine%26aufirst%3DP.%26aulast%3DGopalsamy%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520iminooxothiazolidines%2520as%2520secreted%2520frizzled%2520related%2520protein-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D6337%26epage%3D6339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Hernandez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, J.</span><span> </span><span class="NLM_article-title">The role of glycogen synthase kinase 3 in the early stages of Alzheimer's disease</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">582</span><span class="NLM_x">, </span> <span class="NLM_fpage">3848</span><span class="NLM_x">–</span> <span class="NLM_lpage">3854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=582&publication_year=2008&pages=3848-3854&author=F.+Hernandezauthor=J.+Avila&title=The+role+of+glycogen+synthase+kinase+3+in+the+early+stages+of+Alzheimer%27s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez%26aufirst%3DF.%26aulast%3DAvila%26aufirst%3DJ.%26atitle%3DThe%2520role%2520of%2520glycogen%2520synthase%2520kinase%25203%2520in%2520the%2520early%2520stages%2520of%2520Alzheimer%2527s%2520disease%26jtitle%3DFEBS%2520Lett.%26date%3D2008%26volume%3D582%26spage%3D3848%26epage%3D3854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3 and cancer: good cop, bad cop?</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=351-353&author=S.+Patelauthor=J.+Woodgett&title=Glycogen+synthase+kinase-3+and+cancer%3A+good+cop%2C+bad+cop%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWoodgett%26aufirst%3DJ.%26atitle%3DGlycogen%2520synthase%2520kinase-3%2520and%2520cancer%253A%2520good%2520cop%252C%2520bad%2520cop%253F%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D14%26spage%3D351%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">MacAulay, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of type 2 diabetes</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1265</span><span class="NLM_x">–</span> <span class="NLM_lpage">1274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1517%2F14728222.12.10.1265" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18781825" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsrnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2008&pages=1265-1274&author=K.+MacAulayauthor=J.+R.+Woodgett&title=Targeting+glycogen+synthase+kinase-3+%28GSK-3%29+in+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes</span></div><div class="casAuthors">MacAulay, Katrina; Woodgett, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1265-1274</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: In spite of its rather specific name, glycogen synthase kinase-3 (GSK-3) is an eclectic cellular regulator that modulates an array of processes from nuclear transcription, to neurol. functions and metab.  The enzyme is also a focal point for diverse signaling pathways that act to suppress its activity.  Objectives: To review recent evidence supporting the important role GSK-3 plays in glucose homeostasis and discuss the therapeutic potential of inhibiting this enzyme in the treatment of diabetes and insulin resistance.  Results/conclusion: Despite its pleiotropic nature, GSK-3 has significant promise as a target for diabetes due to functional partitioning of the enzyme, tissue-selectivity and acute dosage-dependency of effects of inhibition, suggesting useful therapeutic windows.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGripu8iM9eVobVg90H21EOLACvtfcHk0lhnaJBdNwUhgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsrnP&md5=bddd77ada6a8b8ab3ba1b5d5f868cde1</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1517%2F14728222.12.10.1265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.12.10.1265%26sid%3Dliteratum%253Aachs%26aulast%3DMacAulay%26aufirst%3DK.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DTargeting%2520glycogen%2520synthase%2520kinase-3%2520%2528GSK-3%2529%2520in%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2008%26volume%3D12%26spage%3D1265%26epage%3D1274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Doble, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kockeritz, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">Functional redundancy of GSK-3α and GSK-3β in Wnt/β-catenin signaling shown by using an allelic series of embryonic stem cell lines</span> <span class="citation_source-journal">Dev. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">957</span><span class="NLM_x">–</span> <span class="NLM_lpage">971</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=957-971&author=B.+W.+Dobleauthor=S.+Patelauthor=G.+A.+Woodauthor=L.+K.+Kockeritzauthor=J.+R.+Woodgett&title=Functional+redundancy+of+GSK-3%CE%B1+and+GSK-3%CE%B2+in+Wnt%2F%CE%B2-catenin+signaling+shown+by+using+an+allelic+series+of+embryonic+stem+cell+lines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoble%26aufirst%3DB.%2BW.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DG.%2BA.%26aulast%3DKockeritz%26aufirst%3DL.%2BK.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DFunctional%2520redundancy%2520of%2520GSK-3%25CE%25B1%2520and%2520GSK-3%25CE%25B2%2520in%2520Wnt%252F%25CE%25B2-catenin%2520signaling%2520shown%2520by%2520using%2520an%2520allelic%2520series%2520of%2520embryonic%2520stem%2520cell%2520lines%26jtitle%3DDev.%2520Cell%26date%3D2007%26volume%3D12%26spage%3D957%26epage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Klein, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melton, D. A.</span><span> </span><span class="NLM_article-title">A molecular mechanism for the effect of lithium on development</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">8455</span><span class="NLM_x">–</span> <span class="NLM_lpage">8459</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1073%2Fpnas.93.16.8455" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=8710892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADyaK28XkvFyksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=8455-8459&author=P.+S.+Kleinauthor=D.+A.+Melton&title=A+molecular+mechanism+for+the+effect+of+lithium+on+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">A molecular mechanism for the effect of lithium on development</span></div><div class="casAuthors">Klein, Peter S.; Melton, Douglas A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">8455-8459</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Lithium, one of the most effective drugs for the treatment of bipolar (manic-depressive) disorder, also has dramatic effects on morphogenesis in the early development of numerous organisms.  How lithium exerts these diverse effects is unclear, but the favored hypothesis is that lithium acts through inhibition of inositol monophosphatase (IMPase).  We show here that complete inhibition of IMPase has no effect on the morphogenesis of Xenopus embryos and present a different hypothesis to explain the broad action of lithium.  Our results suggest that lithium acts through inhibition of glycogen synthase kinase-3β (GSK-3β), which regulates cell fate detn. in diverse organisms including dictyostelium, Drosophila, and Xenopus.  Lithium potently inhibits GSK-3β activity (Ki = 2 mM), but is not a general inhibitor of other protein kinases.  In support of this hypothesis, lithium treatment phenocopies loss of GSK-3β function of Xenopus and Dictyostelium.  These observations help explain the effect of lithium on cell-fate detn. and could provide insights into the pathogenesis and treatment of bipolar disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwmgF9XN0PabVg90H21EOLACvtfcHk0li6iMRs2a1osw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFyksLY%253D&md5=611ae73b9ec411df9ff84da5fdaffcfc</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.16.8455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.16.8455%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DP.%2BS.%26aulast%3DMelton%26aufirst%3DD.%2BA.%26atitle%3DA%2520molecular%2520mechanism%2520for%2520the%2520effect%2520of%2520lithium%2520on%2520development%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1996%26volume%3D93%26spage%3D8455%26epage%3D8459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Clement-Lacroix, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morvan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman-Roman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vayssiere, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belleville, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrera, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawadi, G.</span><span> </span><span class="NLM_article-title">Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">17406</span><span class="NLM_x">–</span> <span class="NLM_lpage">17411</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2005&pages=17406-17411&author=P.+Clement-Lacroixauthor=M.+Aiauthor=F.+Morvanauthor=S.+Roman-Romanauthor=B.+Vayssiereauthor=C.+Bellevilleauthor=K.+Estreraauthor=M.+L.+Warmanauthor=R.+Baronauthor=G.+Rawadi&title=Lrp5-independent+activation+of+Wnt+signaling+by+lithium+chloride+increases+bone+formation+and+bone+mass+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClement-Lacroix%26aufirst%3DP.%26aulast%3DAi%26aufirst%3DM.%26aulast%3DMorvan%26aufirst%3DF.%26aulast%3DRoman-Roman%26aufirst%3DS.%26aulast%3DVayssiere%26aufirst%3DB.%26aulast%3DBelleville%26aufirst%3DC.%26aulast%3DEstrera%26aufirst%3DK.%26aulast%3DWarman%26aufirst%3DM.%2BL.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DRawadi%26aufirst%3DG.%26atitle%3DLrp5-independent%2520activation%2520of%2520Wnt%2520signaling%2520by%2520lithium%2520chloride%2520increases%2520bone%2520formation%2520and%2520bone%2520mass%2520in%2520mice%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2005%26volume%3D102%26spage%3D17406%26epage%3D17411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Kulkarni, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onyia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halladay, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frolik, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kriauciunas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryant, H. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, Y. L.</span><span> </span><span class="NLM_article-title">Orally bioavailable GSK-3α/β dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">910</span><span class="NLM_x">–</span> <span class="NLM_lpage">920</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1359%2Fjbmr.060316" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16753022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvVamurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=910-920&author=N.+H.+Kulkarniauthor=J.+E.+Onyiaauthor=Q.+Zengauthor=X.+Tianauthor=M.+Liuauthor=D.+L.+Halladayauthor=C.+A.+Frolikauthor=T.+Englerauthor=T.+Weiauthor=A.+Kriauciunasauthor=T.+J.+Martinauthor=M.+Satoauthor=H.+U.+Bryantauthor=Y.+L.+Ma&title=Orally+bioavailable+GSK-3%CE%B1%2F%CE%B2+dual+inhibitor+increases+markers+of+cellular+differentiation+in+vitro+and+bone+mass+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Orally bioavailable GSK-3α/β dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo</span></div><div class="casAuthors">Kulkarni, Nalini H.; Onyia, Jude E.; Zeng, QingQiang; Tian, Xioayan; Liu, Min; Halladay, David L.; Frolik, Charles A.; Engler, Thomas; Wei, Tao; Kriauciunas, Aidas; Martin, T. John; Sato, Masahiko; Bryant, Henry U.; Ma, Yanfei L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">910-920</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">GSK-3, a component of the canonical Wnt signaling pathway, is implicated in regulation of bone mass.  The effect of a small mol. GSK-3 inhibitor was evaluated in pre-osteoblasts and in osteopenic rats.  GSK-3 inhibitor induced osteoblast differentiation in vitro and increased markers of bone formation in vitro and in vivo with concomitant increased bone mass and strength in rats.  Introduction: Inactivation of glycogen synthase kinase-3 (GSK-3) leads to stabilization, accumulation, and translocation of β-catenin into the nucleus to activate downstream Wnt target genes.  To examine whether GSK-3 directly regulates bone formation and mass we evaluated the effect of 603281-31-8, a small mol. GSK-3 α/β dual inhibitor in preosteoblastic cells and in osteopenic rats.  Materials and Methods: Murine mesenchymal C3H10T1/2 cells were treated with GSK-3 inhibitor (603281-31-8) and assayed for β-catenin levels, activity of Wnt-responsive promoter, expression of mRNA for bone formation, and adipogenic markers and alk. phosphatase activity.  In vivo, 6-mo-old rats were ovariectomized (OVX), allowed to lose bone for 1 mo, and treated with GSK-3 inhibitor at 3 mg/kg/day orally for 60 days.  At the end of treatment, BMD was measured by DXA, bone formation rate by histomorphometry, vertebral strength (failure in compression), and the expression levels of osteoblast-related genes by real-time PCR.  Results: Treatment of C3H10T1/2 cells with the GSK-3 inhibitor increased the levels of β-catenin accompanied by activation of Wnt-responsive TBE6-luciferase reporter gene.  This was assocd. with an increased expression of mRNA for bone sialoprotein (1.4-fold), collagen α1 (I) (∼2-fold), osteocalcin (1.2-fold), collagen α1 (V) (1.5-fold), alk. phosphatase (∼160-fold), and runx2 (1.6-fold), markers of the osteoblast phenotype and bone formation activity.  Alk. phosphatase mRNA expression paralleled alk. phosphatase activity.  The mRNA levels of collagens α1 (I), α1 (V), biglycan, osteonectin, and runx-2 increased on treatment with the GSK-3 inhibitor in rat femur compared with the OVX control.  DXA analyses revealed significant increases in BMC and BMD in cancellous and cortical bone of OVX rats treated with GSK-3 inhibitor.  This was assocd. with increased strength (peak load, energy, and stiffness) assessed by lumbar vertebra load to failure in compression.  Histomorphometric analyses showed that 603281-31-8 robustly increased bone formation but did not exclude a small effect on osteoclasts (resorption).  Conclusions: An orally active, small mol. GSK-3 inhibitor induced osteoblast differentiation and increased markers of bone formation in vitro, and increased markers of bone formation, bone mass, and strength in vivo, consistent with a role for the canonical Wnt pathway in osteogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQZCO5qxBPvrVg90H21EOLACvtfcHk0li6iMRs2a1osw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvVamurc%253D&md5=54520a35e9ef9b7238275f1780208d88</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.060316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.060316%26sid%3Dliteratum%253Aachs%26aulast%3DKulkarni%26aufirst%3DN.%2BH.%26aulast%3DOnyia%26aufirst%3DJ.%2BE.%26aulast%3DZeng%26aufirst%3DQ.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DHalladay%26aufirst%3DD.%2BL.%26aulast%3DFrolik%26aufirst%3DC.%2BA.%26aulast%3DEngler%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DT.%26aulast%3DKriauciunas%26aufirst%3DA.%26aulast%3DMartin%26aufirst%3DT.%2BJ.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DBryant%26aufirst%3DH.%2BU.%26aulast%3DMa%26aufirst%3DY.%2BL.%26atitle%3DOrally%2520bioavailable%2520GSK-3%25CE%25B1%252F%25CE%25B2%2520dual%2520inhibitor%2520increases%2520markers%2520of%2520cellular%2520differentiation%2520in%2520vitro%2520and%2520bone%2520mass%2520in%2520vivo%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2006%26volume%3D21%26spage%3D910%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Engler, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malhotra, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furness, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brozinick, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkholder, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clay, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diefenbacher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawkins, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iversen, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquart, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misener, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briere, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Toole, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queener, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reel, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owens, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brier, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eessalu, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaughn, R.</span><span> </span><span class="NLM_article-title">Substituted 3-imidazo[1,2-<i>a</i>]pyridin-3-yl-4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-<i>hi</i>]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3934</span><span class="NLM_x">–</span> <span class="NLM_lpage">3937</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049768a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3934-3937&author=T.+A.+Englerauthor=J.+R.+Henryauthor=S.+Malhotraauthor=B.+Cunninghamauthor=K.+Furnessauthor=J.+Brozinickauthor=T.+P.+Burkholderauthor=M.+P.+Clayauthor=J.+Claytonauthor=C.+Diefenbacherauthor=E.+Hawkinsauthor=P.+W.+Iversenauthor=Y.+Liauthor=T.+D.+Lindstromauthor=A.+L.+Marquartauthor=J.+McLeanauthor=D.+Mendelauthor=E.+Misenerauthor=D.+Briereauthor=J.+C.+O%27Tooleauthor=W.+J.+Porterauthor=S.+Queenerauthor=J.+K.+Reelauthor=R.+A.+Owensauthor=R.+A.+Brierauthor=T.+E.+Eessaluauthor=J.+R.+Wagnerauthor=R.+M.+Campbellauthor=R.+Vaughn&title=Substituted+3-imidazo%5B1%2C2-a%5Dpyridin-3-yl-4-%281%2C2%2C3%2C4-tetrahydro-%5B1%2C4%5Ddiazepino-%5B6%2C7%2C1-hi%5Dindol-7-yl%29pyrrole-2%2C5-diones+as+highly+selective+and+potent+inhibitors+of+glycogen+synthase+kinase-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Fjm049768a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049768a%26sid%3Dliteratum%253Aachs%26aulast%3DEngler%26aufirst%3DT.%2BA.%26aulast%3DHenry%26aufirst%3DJ.%2BR.%26aulast%3DMalhotra%26aufirst%3DS.%26aulast%3DCunningham%26aufirst%3DB.%26aulast%3DFurness%26aufirst%3DK.%26aulast%3DBrozinick%26aufirst%3DJ.%26aulast%3DBurkholder%26aufirst%3DT.%2BP.%26aulast%3DClay%26aufirst%3DM.%2BP.%26aulast%3DClayton%26aufirst%3DJ.%26aulast%3DDiefenbacher%26aufirst%3DC.%26aulast%3DHawkins%26aufirst%3DE.%26aulast%3DIversen%26aufirst%3DP.%2BW.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DMarquart%26aufirst%3DA.%2BL.%26aulast%3DMcLean%26aufirst%3DJ.%26aulast%3DMendel%26aufirst%3DD.%26aulast%3DMisener%26aufirst%3DE.%26aulast%3DBriere%26aufirst%3DD.%26aulast%3DO%2527Toole%26aufirst%3DJ.%2BC.%26aulast%3DPorter%26aufirst%3DW.%2BJ.%26aulast%3DQueener%26aufirst%3DS.%26aulast%3DReel%26aufirst%3DJ.%2BK.%26aulast%3DOwens%26aufirst%3DR.%2BA.%26aulast%3DBrier%26aufirst%3DR.%2BA.%26aulast%3DEessalu%26aufirst%3DT.%2BE.%26aulast%3DWagner%26aufirst%3DJ.%2BR.%26aulast%3DCampbell%26aufirst%3DR.%2BM.%26aulast%3DVaughn%26aufirst%3DR.%26atitle%3DSubstituted%25203-imidazo%255B1%252C2-a%255Dpyridin-3-yl-4-%25281%252C2%252C3%252C4-tetrahydro-%255B1%252C4%255Ddiazepino-%255B6%252C7%252C1-hi%255Dindol-7-yl%2529pyrrole-2%252C5-diones%2520as%2520highly%2520selective%2520and%2520potent%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3934%26epage%3D3937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Polakis, P.</span><span> </span><span class="NLM_article-title">The many ways of Wnt in cancer</span> <span class="citation_source-journal">Curr. Opin. Genet. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.gde.2006.12.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17208432" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslOnsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=45-51&author=P.+Polakis&title=The+many+ways+of+Wnt+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">The many ways of Wnt in cancer</span></div><div class="casAuthors">Polakis, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Genetics & Development</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-51</span>CODEN:
                <span class="NLM_cas:coden">COGDET</span>;
        ISSN:<span class="NLM_cas:issn">0959-437X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  More than 20 years ago, the oncogenicity of a Wnt ligand was revealed in a series of expts. originating with random proviral integration in mice.  The significance of Wnt signaling in human cancer has since been buttressed by the identification of mutations in genes coding for the Wnt pathway components Axin, APC, and β-catenin.  This review summarizes the reported genetic defects in the Wnt pathway, with an emphasis on their functional contribution to human tumor progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnNmcIi7W_97Vg90H21EOLACvtfcHk0lg5V4MQUyL9tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslOnsw%253D%253D&md5=5e82fbbbe4c3ae05c4ff96b339c5bbac</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2006.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2006.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DPolakis%26aufirst%3DP.%26atitle%3DThe%2520many%2520ways%2520of%2520Wnt%2520in%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2007%26volume%3D17%26spage%3D45%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Ougolkov, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernandez-Zapico, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilim, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smyrk, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chari, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billadeau, D. D.</span><span> </span><span class="NLM_article-title">Aberrant nuclear accumulation of glycogen synthase kinase-3β in human pancreatic cancer: association with kinase activity and tumor dedifferentiation</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5074</span><span class="NLM_x">–</span> <span class="NLM_lpage">5081</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1158%2F1078-0432.CCR-06-0196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16951223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28XovF2gsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=5074-5081&author=A.+V.+Ougolkovauthor=M.+E.+Fernandez-Zapicoauthor=V.+N.+Bilimauthor=T.+C.+Smyrkauthor=S.+T.+Chariauthor=D.+D.+Billadeau&title=Aberrant+nuclear+accumulation+of+glycogen+synthase+kinase-3%CE%B2+in+human+pancreatic+cancer%3A+association+with+kinase+activity+and+tumor+dedifferentiation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Aberrant Nuclear Accumulation of Glycogen Synthase Kinase-3{szligbeta} in Human Pancreatic Cancer: Association with Kinase Activity and Tumor Dedifferentiation</span></div><div class="casAuthors">Ougolkov, Andrei V.; Fernandez-Zapico, Martin E.; Bilim, Vladimir N.; Smyrk, Thomas C.; Chari, Suresh T.; Billadeau, Daniel D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5074-5081</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: We have shown recently that glycogen synthase kinase-3 (GSK-3) β regulates nuclear factor-κB (NF-κB)-mediated pancreatic cancer cell survival and proliferation in vitro.  Our objective was to det. the localization of GSK-3β in pancreatic cancer cells and assess the antitumor effect of GSK-3 inhibition in vivo to improve our understanding of the mechanism by which GSK-3β affects NF-κB activity in pancreatic cancer.  Exptl. Design: Immunohistochem. and cytosolic/nuclear fractionation were done to det. the localization of GSK-3β in human pancreatic tumors.  We studied the effect of GSK-3 inhibition on tumor growth, cancer cell proliferation, and survival in established CAPAN2 tumor xenografts using a tumor regrowth delay assay, Western blotting, bromodeoxyuridine incorporation, and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling.  RESULTS: We found nuclear accumulation of GSK-3β in pancreatic cancer cell lines and in 62 of 122 (51%) human pancreatic adenocarcinomas.  GSK-3β nuclear accumulation is significantly correlated with human pancreatic cancer dedifferentiation.  We have found that active GSK-3β can accumulate in the nucleus of pancreatic cancer cells and that inhibition of GSK-3 kinase activity represses its nuclear accumulation via proteasomal degrdn. within the nucleus.  Lastly, we have found that inhibition of GSK-3 arrests pancreatic tumor growth in vivo and decreases NF-κB-mediated pancreatic cancer cell survival and proliferation in established tumor xenografts.  CONCLUSIONS: Our results show the antitumor effect of GSK-3 inhibition in vivo, identify GSK-3β nuclear accumulation as a hallmark of poorly differentiated pancreatic adenocarcinoma, and provide new insight into the mechanism by which GSK-3β regulates NF-κB activity in pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCHtcOR2osCLVg90H21EOLACvtfcHk0lg5V4MQUyL9tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovF2gsr4%253D&md5=807ef4e512335f9c988b57e2fb8c1b22</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-0196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-0196%26sid%3Dliteratum%253Aachs%26aulast%3DOugolkov%26aufirst%3DA.%2BV.%26aulast%3DFernandez-Zapico%26aufirst%3DM.%2BE.%26aulast%3DBilim%26aufirst%3DV.%2BN.%26aulast%3DSmyrk%26aufirst%3DT.%2BC.%26aulast%3DChari%26aufirst%3DS.%2BT.%26aulast%3DBilladeau%26aufirst%3DD.%2BD.%26atitle%3DAberrant%2520nuclear%2520accumulation%2520of%2520glycogen%2520synthase%2520kinase-3%25CE%25B2%2520in%2520human%2520pancreatic%2520cancer%253A%2520association%2520with%2520kinase%2520activity%2520and%2520tumor%2520dedifferentiation%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D5074%26epage%3D5081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugs</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">773</span><span class="NLM_x">–</span> <span class="NLM_lpage">796</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1002%2Fmed.20119" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18271054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtV2qsLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=773-796&author=A.+Martinez&title=Preclinical+efficacy+on+GSK-3+inhibitors%3A+towards+a+future+generation+of+powerful+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugs</span></div><div class="casAuthors">Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">773-796</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  The renewed interest in glycogen synthase kinase-3 (GSK-3), involved in the mol. pathogenesis of human severe diseases, is focused on the potential of its inhibitors to treat diseases that have significant limitations in their current treatments.  During the last 5 years, a lot of literature discuss progress in the search and pharmacol. actions of GSK-3 inhibitors, but now, evidence have been accumulated showing preclin. efficacy for these new drugs, in very different models of several distinct pathologies.  These studies have been summarized in the present review offering promising examples for new therapies for diabetes, cancer, inflammation, Alzheimer's disease and other neurol. pathologies, and mood disorders.  Now, clin. human trials are awaiting to confirm the ray of hope that GSK-3 inhibitors are arising for the future treatment of severe unmet diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiNZASfEwzRLVg90H21EOLACvtfcHk0lhxDZlUoCtt8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtV2qsLvJ&md5=96cd9bc1d03273a8448f455c3cceb32c</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1002%2Fmed.20119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20119%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DPreclinical%2520efficacy%2520on%2520GSK-3%2520inhibitors%253A%2520towards%2520a%2520future%2520generation%2520of%2520powerful%2520drugs%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2008%26volume%3D28%26spage%3D773%26epage%3D796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">A small molecule with osteogenesis-inducing activity in multipotent mesenchymal progenitor cells</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">14520</span><span class="NLM_x">–</span> <span class="NLM_lpage">14521</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja0283908" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2002&pages=14520-14521&author=X.+Wuauthor=S.+Dingauthor=Q.+Dingauthor=N.+S.+Grayauthor=P.+G.+Schultz&title=A+small+molecule+with+osteogenesis-inducing+activity+in+multipotent+mesenchymal+progenitor+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Fja0283908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja0283908%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DQ.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DA%2520small%2520molecule%2520with%2520osteogenesis-inducing%2520activity%2520in%2520multipotent%2520mesenchymal%2520progenitor%2520cells%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2002%26volume%3D124%26spage%3D14520%26epage%3D14521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Wu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">Purmorphamine induces osteogenesis by activation of the hedgehog signaling pathway</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1229</span><span class="NLM_x">–</span> <span class="NLM_lpage">1238</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.chembiol.2004.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=15380183" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslGnu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=1229-1238&author=X.+Wuauthor=J.+Walkerauthor=J.+Zhangauthor=S.+Dingauthor=P.+G.+Schultz&title=Purmorphamine+induces+osteogenesis+by+activation+of+the+hedgehog+signaling+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Purmorphamine Induces Osteogenesis by Activation of the Hedgehog Signaling Pathway</span></div><div class="casAuthors">Wu, Xu; Walker, John; Zhang, Jie; Ding, Sheng; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1229-1238</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Previously, a small mol., purmorphamine, was identified that selectively induces osteogenesis in multipotent mesenchymal progenitor cells.  In order to gain insights into the mechanism of action of purmorphamine, high-d. oligonucleotide microarrays were used to profile gene expression in multipotent mesenchymal progenitor cells treated with either purmorphamine or bone morphogenetic protein-4 (BMP-4).  In contrast to BMP-4 treatment, purmorphamine activates the Hedgehog (Hh) signaling pathway, resulting in the up- and downregulation of its downstream target genes, including Gli1 and Patched.  Moreover, the known Hh signaling antagonists, cyclopamine and forskolin, completely block the osteogenesis and Glimediated transcription induced by purmorphamine.  These results demonstrate that purmorphamine is a small mol. agonist of Hedgehog signaling, and it may ultimately be useful in the treatment of bone-related disease and neurodegenerative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxYQ_VELcKaLVg90H21EOLACvtfcHk0lhxDZlUoCtt8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslGnu74%253D&md5=22d0d8da147f5c537b99c0ac07093d4f</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DX.%26aulast%3DWalker%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DS.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DPurmorphamine%2520induces%2520osteogenesis%2520by%2520activation%2520of%2520the%2520hedgehog%2520signaling%2520pathway%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26spage%3D1229%26epage%3D1238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Sinha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. K.</span><span> </span><span class="NLM_article-title">Purmorphamine activates the Hedgehog pathway by targeting Smoothened</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1038%2Fnchembio753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16408088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlSqu7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=29-30&author=S.+Sinhaauthor=J.+K.+Chen&title=Purmorphamine+activates+the+Hedgehog+pathway+by+targeting+Smoothened"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Purmorphamine activates the Hedgehog pathway by targeting Smoothened</span></div><div class="casAuthors">Sinha, Surajit; Chen, James K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-30</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hedgehog (Hh) signaling is an important regulator of embryonic patterning, tissue regeneration, stem cell renewal and cancer growth.  A purine deriv. named purmorphamine was previously found to activate the Hh pathway and affect osteoblast differentiation through an unknown mechanism.  The authors demonstrate here that purmorphamine directly targets Smoothened, a crit. component of the Hh signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3uCrERtgsx7Vg90H21EOLACvtfcHk0lh8NtU7IjxXxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlSqu7jM&md5=47a8e5bb03eb09c1c355dd3ee8022fda</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1038%2Fnchembio753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio753%26sid%3Dliteratum%253Aachs%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DJ.%2BK.%26atitle%3DPurmorphamine%2520activates%2520the%2520Hedgehog%2520pathway%2520by%2520targeting%2520Smoothened%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D29%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Han, C.-Y. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Jean, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babij, P.</span><span> </span><span class="NLM_article-title">Small molecules with potent osteogenic-inducing activity in osteoblast cells</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1442</span><span class="NLM_x">–</span> <span class="NLM_lpage">1445</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1442-1445&author=C.-Y.+E.+Hanauthor=Y.+Wangauthor=L.+Yuauthor=D.+Powersauthor=X.+Xiongauthor=V.+Yuauthor=Y.+Nguyenauthor=D.+J.+St.+Jeanauthor=P.+Babij&title=Small+molecules+with+potent+osteogenic-inducing+activity+in+osteoblast+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DC.-Y.%2BE.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DXiong%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DNguyen%26aufirst%3DY.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DBabij%26aufirst%3DP.%26atitle%3DSmall%2520molecules%2520with%2520potent%2520osteogenic-inducing%2520activity%2520in%2520osteoblast%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1442%26epage%3D1445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Karsenty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kronenberg, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Settembre, C.</span><span> </span><span class="NLM_article-title">Genetic control of bone formation</span> <span class="citation_source-journal">Annu. Rev. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">629</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2009&pages=629-648&author=G.+Karsentyauthor=H.+M.+Kronenbergauthor=C.+Settembre&title=Genetic+control+of+bone+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarsenty%26aufirst%3DG.%26aulast%3DKronenberg%26aufirst%3DH.%2BM.%26aulast%3DSettembre%26aufirst%3DC.%26atitle%3DGenetic%2520control%2520of%2520bone%2520formation%26jtitle%3DAnnu.%2520Rev.%2520Cell%2520Dev.%2520Biol.%26date%3D2009%26volume%3D25%26spage%3D629%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parlato, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mundy, G.</span><span> </span><span class="NLM_article-title">CREB induces BMP2 transcription in osteoblasts and CREB knockout reduces bone mass in mice</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">S27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=S27&author=M.+Zhaoauthor=J.+Edwardsauthor=S.+Koauthor=R.+Parlatoauthor=S.+Harrisauthor=G.+Mundy&title=CREB+induces+BMP2+transcription+in+osteoblasts+and+CREB+knockout+reduces+bone+mass+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DEdwards%26aufirst%3DJ.%26aulast%3DKo%26aufirst%3DS.%26aulast%3DParlato%26aufirst%3DR.%26aulast%3DHarris%26aufirst%3DS.%26aulast%3DMundy%26aufirst%3DG.%26atitle%3DCREB%2520induces%2520BMP2%2520transcription%2520in%2520osteoblasts%2520and%2520CREB%2520knockout%2520reduces%2520bone%2520mass%2520in%2520mice%26jtitle%3DBone%26date%3D2009%26volume%3D44%26spage%3DS27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Hojo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohba, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yano, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtler, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, J.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yonezawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, U.-I.</span><span> </span><span class="NLM_article-title">Development of high-throughput screening system for osteogenic drugs using a cell-based sensor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">376</span><span class="NLM_x">, </span> <span class="NLM_fpage">375</span><span class="NLM_x">–</span> <span class="NLM_lpage">379</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2008&pages=375-379&author=H.+Hojoauthor=K.+Igawaauthor=S.+Ohbaauthor=F.+Yanoauthor=K.+Nakajimaauthor=Y.+Komiyamaauthor=T.+Ikedaauthor=A.+C.+Lichtlerauthor=J.-T.+Wooauthor=T.+Yonezawaauthor=T.+Takatoauthor=U.-I.+Chung&title=Development+of+high-throughput+screening+system+for+osteogenic+drugs+using+a+cell-based+sensor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHojo%26aufirst%3DH.%26aulast%3DIgawa%26aufirst%3DK.%26aulast%3DOhba%26aufirst%3DS.%26aulast%3DYano%26aufirst%3DF.%26aulast%3DNakajima%26aufirst%3DK.%26aulast%3DKomiyama%26aufirst%3DY.%26aulast%3DIkeda%26aufirst%3DT.%26aulast%3DLichtler%26aufirst%3DA.%2BC.%26aulast%3DWoo%26aufirst%3DJ.-T.%26aulast%3DYonezawa%26aufirst%3DT.%26aulast%3DTakato%26aufirst%3DT.%26aulast%3DChung%26aufirst%3DU.-I.%26atitle%3DDevelopment%2520of%2520high-throughput%2520screening%2520system%2520for%2520osteogenic%2520drugs%2520using%2520a%2520cell-based%2520sensor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2008%26volume%3D376%26spage%3D375%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Liu, Z.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, X.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, H.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Si, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.-R.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 1-(benzo[<i>b</i>]thiophen-2-yl)ethanone analogues as novel anti-osteoporosis agents acting on BMP-2 promotor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4167</span><span class="NLM_x">–</span> <span class="NLM_lpage">4170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4167-4170&author=Z.-Y.+Liuauthor=X.-B.+Heauthor=Z.-Y.+Yangauthor=H.-Y.+Shaoauthor=X.+Liauthor=H.-F.+Guoauthor=Y.-Q.+Zhangauthor=S.-Y.+Siauthor=Z.-R.+Li&title=Synthesis+and+evaluation+of+1-%28benzo%5Bb%5Dthiophen-2-yl%29ethanone+analogues+as+novel+anti-osteoporosis+agents+acting+on+BMP-2+promotor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.-Y.%26aulast%3DHe%26aufirst%3DX.-B.%26aulast%3DYang%26aufirst%3DZ.-Y.%26aulast%3DShao%26aufirst%3DH.-Y.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DH.-F.%26aulast%3DZhang%26aufirst%3DY.-Q.%26aulast%3DSi%26aufirst%3DS.-Y.%26aulast%3DLi%26aufirst%3DZ.-R.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25201-%2528benzo%255Bb%255Dthiophen-2-yl%2529ethanone%2520analogues%2520as%2520novel%2520anti-osteoporosis%2520agents%2520acting%2520on%2520BMP-2%2520promotor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4167%26epage%3D4170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Mundy, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, G.</span><span> </span><span class="NLM_article-title">Stimulation of bone formation in vitro and in rodents by statins</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">1946</span><span class="NLM_x">–</span> <span class="NLM_lpage">1949</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1126%2Fscience.286.5446.1946" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=10583956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADyaK1MXnvFSiu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=1999&pages=1946-1949&author=G.+Mundyauthor=R.+Garrettauthor=S.+Harrisauthor=J.+Chanauthor=D.+Chenauthor=G.+Rossiniauthor=B.+Boyceauthor=M.+Zhaoauthor=G.+Gutierrez&title=Stimulation+of+bone+formation+in+vitro+and+in+rodents+by+statins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Stimulation of bone formation in vitro and in rodents by statins</span></div><div class="casAuthors">Mundy, G.; Garrett, R.; Harris, S.; Chan, J.; Chen, D.; Rossini, G.; Boyce, B.; Zhao, M.; Gutierrez, G.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">5446</span>),
    <span class="NLM_cas:pages">1946-1949</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Osteoporosis and other diseases of bone loss are a major public health problem.  Here it is shown that the statins, drugs widely used for lowering serum cholesterol, also enhance new bone formation in vitro and in rodents.  This effect was assocd. with increased expression of the bone morphogenetic protein-2 (BMP-2) gene in bone cells.  Lovastatin and simvastatin increased bone formation when injected s.c. over the calvaria of mice and increased cancelous bone vol. when orally administered to rats.  Thus, in appropriate doses, statins may have therapeutic applications for the treatment of osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGqsu8Ww1_x7Vg90H21EOLACvtfcHk0ljK3_h6Fso1jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnvFSiu78%253D&md5=6752eecfe7e6058ff4634b07817a7f53</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1126%2Fscience.286.5446.1946&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.286.5446.1946%26sid%3Dliteratum%253Aachs%26aulast%3DMundy%26aufirst%3DG.%26aulast%3DGarrett%26aufirst%3DR.%26aulast%3DHarris%26aufirst%3DS.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DRossini%26aufirst%3DG.%26aulast%3DBoyce%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DGutierrez%26aufirst%3DG.%26atitle%3DStimulation%2520of%2520bone%2520formation%2520in%2520vitro%2520and%2520in%2520rodents%2520by%2520statins%26jtitle%3DScience%26date%3D1999%26volume%3D286%26spage%3D1946%26epage%3D1949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Shimazaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kameo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanami, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiuchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichikawa, A.</span><span> </span><span class="NLM_article-title">Synthesis and structure−activity relationships of a new class of selective EP3 receptor agonist, 13,14-didehydro-16-phenoxy analogues of prostaglandin E1</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2000&pages=353-362&author=Y.+Shimazakiauthor=K.+Kameoauthor=T.+Tanamiauthor=H.+Tanakaauthor=N.+Onoauthor=Y.+Kiuchiauthor=S.+Okamotoauthor=F.+Satoauthor=A.+Ichikawa&title=Synthesis+and+structure%E2%88%92activity+relationships+of+a+new+class+of+selective+EP3+receptor+agonist%2C+13%2C14-didehydro-16-phenoxy+analogues+of+prostaglandin+E1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimazaki%26aufirst%3DY.%26aulast%3DKameo%26aufirst%3DK.%26aulast%3DTanami%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DN.%26aulast%3DKiuchi%26aufirst%3DY.%26aulast%3DOkamoto%26aufirst%3DS.%26aulast%3DSato%26aufirst%3DF.%26aulast%3DIchikawa%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520of%2520a%2520new%2520class%2520of%2520selective%2520EP3%2520receptor%2520agonist%252C%252013%252C14-didehydro-16-phenoxy%2520analogues%2520of%2520prostaglandin%2520E1%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2000%26volume%3D8%26spage%3D353%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Healy, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. D.</span><span> </span><span class="NLM_article-title">A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2033</span><span class="NLM_x">–</span> <span class="NLM_lpage">2042</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1359%2Fjbmr.2003.18.11.2033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=14606517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptVyiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=2033-2042&author=M.+Liauthor=H.+Z.+Keauthor=H.+Qiauthor=D.+R.+Healyauthor=Y.+Liauthor=D.+T.+Crawfordauthor=V.+M.+Paralkarauthor=T.+A.+Owenauthor=K.+O.+Cameronauthor=B.+A.+Lefkerauthor=T.+A.+Brownauthor=D.+D.+Thompson&title=A+novel%2C+non-prostanoid+EP2+receptor-selective+prostaglandin+E2+agonist+stimulates+local+bone+formation+and+enhances+fracture+healing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing</span></div><div class="casAuthors">Li, Mei; Ke, Hua Zhu; Qi, Hong; Healy, David R.; Li, Yan; Crawford, D. Todd; Paralkar, Vishwas M.; Owen, Thomas A.; Cameron, Kimberly O.; Lefker, Bruce A.; Brown, Thomas A.; Thompson, David D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2033-2042</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">CP-533,536, a newly discovered, non-prostanoid EP2 receptor-selective PGE2 agonist, stimulates local bone formation and enhances fracture healing in rat models.  There is a significant medical need for agents that can stimulate local bone formation and enhance fracture healing.  The authors tested the effects of CP-533,536, a newly discovered, non-prostanoid EP2 receptor-selective PGE2 agonist, in stimulating local bone formation and enhancing fracture healing in rat models.  In the first model, a single injection of CP-533,536 at doses of 0.3, 1, or 3 mg/kg to the proximal tibial metaphysis of 6-wk-old male rats was given on day 1, and the local bone anabolic effect was detd. on day 7.  The authors then tested the effects of this compd. in inducing bone formation on rat periosteum of the femur.  A single dose of 0.3 mg of CP-533,536 incorporated in a poly-(DL-lactide-co-glycolide) (PLGH) matrix was injected onto the periosteum of the femur in 3-wk-old male rats, and local bone formation was detd. on day 14.  Finally, the ability of CP-533,536 in PLGH matrix in enhancing fracture healing was tested using the rat femoral fracture model.  CP-533,536 in PLGH matrix at doses of 0.05, 0.5, or 5 mg was delivered to the local fracture site on the same day of fracture, and its efficacy was evaluated on day 21.  A single injection of CP-533,536 at doses of 0.3, 1, or 3 mg/kg to the proximal tibial metaphysis dose-dependently stimulated local lamellar bone formation on trabecular, endocortical, and periosteal surfaces, and thus increased bone mineral content and bone strength at the injected site.  Similarly, a single injection of 0.3 mg of CP-533,536 incorporated in PLGH matrix onto the periosteum of the femur induced significantly local bone formation.  In the rat femoral fracture model, CP-533,536 in PLGH matrix at doses of 0.05, 0.5, and 5 mg dose-dependently increased callus size, d., and strength compared with PLGH matrix alone.  These results show that CP-533,536 stimulates new bone formation on trabecular, endocortical, and periosteal surfaces and enhances fracture healing.  These data reveal that EP2 receptor-selective agonists provide therapeutic potential for local bone augmentation, bone repair, and bone healing in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-eB8GOoJsErVg90H21EOLACvtfcHk0ljK3_h6Fso1jQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptVyiu7o%253D&md5=96d5d5fca5c87a121edda85af9cdbb9b</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.2003.18.11.2033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.2003.18.11.2033%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DM.%26aulast%3DKe%26aufirst%3DH.%2BZ.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DHealy%26aufirst%3DD.%2BR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DCrawford%26aufirst%3DD.%2BT.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26aulast%3DOwen%26aufirst%3DT.%2BA.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DBrown%26aufirst%3DT.%2BA.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26atitle%3DA%2520novel%252C%2520non-prostanoid%2520EP2%2520receptor-selective%2520prostaglandin%2520E2%2520agonist%2520stimulates%2520local%2520bone%2520formation%2520and%2520enhances%2520fracture%2520healing%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2003%26volume%3D18%26spage%3D2033%26epage%3D2042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Scutt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeschnigk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertram, P.</span><span> </span><span class="NLM_article-title">PGE2 induces the transition from non-adherent to adherent bone marrow mesenchymal precursor cells via a cAMP/EP2-mediated mechanism</span> <span class="citation_source-journal">Prostaglandins</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1995&pages=383-95&author=A.+Scuttauthor=M.+Zeschnigkauthor=P.+Bertram&title=PGE2+induces+the+transition+from+non-adherent+to+adherent+bone+marrow+mesenchymal+precursor+cells+via+a+cAMP%2FEP2-mediated+mechanism"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScutt%26aufirst%3DA.%26aulast%3DZeschnigk%26aufirst%3DM.%26aulast%3DBertram%26aufirst%3DP.%26atitle%3DPGE2%2520induces%2520the%2520transition%2520from%2520non-adherent%2520to%2520adherent%2520bone%2520marrow%2520mesenchymal%2520precursor%2520cells%2520via%2520a%2520cAMP%252FEP2-mediated%2520mechanism%26jtitle%3DProstaglandins%26date%3D1995%26volume%3D49%26spage%3D383%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Woodiel, F. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fall, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raisz, L. G.</span><span> </span><span class="NLM_article-title">Anabolic effects of prostaglandins in cultured fetal rat calvariae: structure−activity relations and signal transduction pathway</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1249</span><span class="NLM_x">–</span> <span class="NLM_lpage">1255</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1002%2Fjbmr.5650110909" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=8864899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADyaK28Xls1ChtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1996&pages=1249-1255&author=F.+N.+Woodielauthor=P.+M.+Fallauthor=L.+G.+Raisz&title=Anabolic+effects+of+prostaglandins+in+cultured+fetal+rat+calvariae%3A+structure%E2%88%92activity+relations+and+signal+transduction+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Anabolic effects of prostaglandins in cultured fetal rat calvariae: Structure-activity relations and signal transduction pathway</span></div><div class="casAuthors">Woodiel, Florence N.; Fall, Pamela M.; Raisz, Lawrence G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1249-1255</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">Blackwell</span>)
        </div><div class="casAbstract">The structure-activity relations and signal transduction pathways for the anabolic effects of prostaglandins were examd. in cultured fetal rat calvariae.  In the presence of cortisol prostaglandins of the E and F series (10-9 to 10-5 M) produced a dose-related increase in [3H]thymidine incorporation up to 4-fold at 24 h.  Prostaglandin E2 (PGE2) was also effective in the absence of cortisol.  Butaprost (10-6 M), a selective EP-2 receptor agonist, produced partial stimulation.  Prostaglandin D2, prostacyclin, sulprostone, an EP-1 and EP-3 receptor agonist, and fluprostenol, an FP receptor agonist, were ineffective.  Forskolin (10-4 M) increased [3H]thymidine incorporation 3-fold, while phorbol myristate acetate (PMA) (10-6 M) produced a 1.8-fold increase.  Isobutylmethylxanthine (IBMX) increased [3H]thymidine incorporation in control cultures, in the absence of cortisol, and increased the response to PGE2 in control and cortisol-treated cultures.  [3H]proline incorporation into collagen and noncollagen protein was measured in the continuous presence of prostaglandins and cortisol for 72-96 h (continuous model) or when prostaglandins and cortisol were applied for 24 h, followed by culture for 48 h in control medium (on/off model).  The effects on collagen were greater than on noncollagen proteins, so that the percent of collagen synthesis increased.  The effects of prostaglandins and forskolin paralleled their mitogenic effects.  PMA increased only noncollagen protein.  Indomethacin did not diminish the anabolic response, while aphidicolin produced only partial inhibition.  We conclude that the anabolic effects of prostaglandins on replication and differentiation of osteoblasts are likely to be mediated by an EP-2 receptor that stimulates adenylate cyclase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTNtgUF7Itx7Vg90H21EOLACvtfcHk0lhYve2klcC0fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xls1ChtL0%253D&md5=772191cf873da2b4fba93727622f2be1</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1002%2Fjbmr.5650110909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjbmr.5650110909%26sid%3Dliteratum%253Aachs%26aulast%3DWoodiel%26aufirst%3DF.%2BN.%26aulast%3DFall%26aufirst%3DP.%2BM.%26aulast%3DRaisz%26aufirst%3DL.%2BG.%26atitle%3DAnabolic%2520effects%2520of%2520prostaglandins%2520in%2520cultured%2520fetal%2520rat%2520calvariae%253A%2520structure%25E2%2588%2592activity%2520relations%2520and%2520signal%2520transduction%2520pathway%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D1996%26volume%3D11%26spage%3D1249%26epage%3D1255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Yoshida, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuboyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugimoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ushikubi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohuchida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narumiya, S.</span><span> </span><span class="NLM_article-title">Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">4580</span><span class="NLM_x">–</span> <span class="NLM_lpage">4585</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=4580-4585&author=K.+Yoshidaauthor=H.+Oidaauthor=T.+Kobayashiauthor=T.+Maruyamaauthor=M.+Tanakaauthor=T.+Katayamaauthor=K.+Yamaguchiauthor=E.+Segiauthor=T.+Tsuboyamaauthor=M.+Matsushitaauthor=K.+Itoauthor=Y.+Itoauthor=Y.+Sugimotoauthor=F.+Ushikubiauthor=S.+Ohuchidaauthor=K.+Kondoauthor=T.+Nakamuraauthor=S.+Narumiya&title=Stimulation+of+bone+formation+and+prevention+of+bone+loss+by+prostaglandin+E+EP4+receptor+activation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoshida%26aufirst%3DK.%26aulast%3DOida%26aufirst%3DH.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DM.%26aulast%3DKatayama%26aufirst%3DT.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DSegi%26aufirst%3DE.%26aulast%3DTsuboyama%26aufirst%3DT.%26aulast%3DMatsushita%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DY.%26aulast%3DSugimoto%26aufirst%3DY.%26aulast%3DUshikubi%26aufirst%3DF.%26aulast%3DOhuchida%26aufirst%3DS.%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DNakamura%26aufirst%3DT.%26aulast%3DNarumiya%26aufirst%3DS.%26atitle%3DStimulation%2520of%2520bone%2520formation%2520and%2520prevention%2520of%2520bone%2520loss%2520by%2520prostaglandin%2520E%2520EP4%2520receptor%2520activation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D4580%26epage%3D4585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Graham, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamie, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polyzois, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narvani, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tzafetta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsiridis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heliotis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantalaris, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsiridis, E.</span><span> </span><span class="NLM_article-title">Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing: in vivo and in vitro evidence</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">766</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=749-766&author=S.+Grahamauthor=Z.+Gamieauthor=I.+Polyzoisauthor=A.+A.+Narvaniauthor=K.+Tzafettaauthor=E.+Tsiridisauthor=M.+Heliotisauthor=A.+Mantalarisauthor=E.+Tsiridis&title=Prostaglandin+EP2+and+EP4+receptor+agonists+in+bone+formation+and+bone+healing%3A+in+vivo+and+in+vitro+evidence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGraham%26aufirst%3DS.%26aulast%3DGamie%26aufirst%3DZ.%26aulast%3DPolyzois%26aufirst%3DI.%26aulast%3DNarvani%26aufirst%3DA.%2BA.%26aulast%3DTzafetta%26aufirst%3DK.%26aulast%3DTsiridis%26aufirst%3DE.%26aulast%3DHeliotis%26aufirst%3DM.%26aulast%3DMantalaris%26aufirst%3DA.%26aulast%3DTsiridis%26aufirst%3DE.%26atitle%3DProstaglandin%2520EP2%2520and%2520EP4%2520receptor%2520agonists%2520in%2520bone%2520formation%2520and%2520bone%2520healing%253A%2520in%2520vivo%2520and%2520in%2520vitro%2520evidence%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D749%26epage%3D766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Cameron, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu-Moyer, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jardine, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeNinno, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasser, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjoa, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawistoski, M. P.</span><span> </span><span class="NLM_article-title">Discovery of highly selective EP4 receptor agonists that stimulate new bone formation and restore bone mass in ovariectomized rats</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1799</span><span class="NLM_x">–</span> <span class="NLM_lpage">1802</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1799-1802&author=K.+O.+Cameronauthor=B.+A.+Lefkerauthor=M.+Y.+Chu-Moyerauthor=D.+T.+Crawfordauthor=P.+D.+Jardineauthor=S.+L.+DeNinnoauthor=S.+Gilbertauthor=W.+A.+Grasserauthor=H.+Keauthor=B.+Luauthor=T.+A.+Owenauthor=V.+M.+Paralkarauthor=H.+Qiauthor=D.+O.+Scottauthor=D.+D.+Thompsonauthor=C.+M.+Tjoaauthor=M.+P.+Zawistoski&title=Discovery+of+highly+selective+EP4+receptor+agonists+that+stimulate+new+bone+formation+and+restore+bone+mass+in+ovariectomized+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DChu-Moyer%26aufirst%3DM.%2BY.%26aulast%3DCrawford%26aufirst%3DD.%2BT.%26aulast%3DJardine%26aufirst%3DP.%2BD.%26aulast%3DDeNinno%26aufirst%3DS.%2BL.%26aulast%3DGilbert%26aufirst%3DS.%26aulast%3DGrasser%26aufirst%3DW.%2BA.%26aulast%3DKe%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DOwen%26aufirst%3DT.%2BA.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26aulast%3DTjoa%26aufirst%3DC.%2BM.%26aulast%3DZawistoski%26aufirst%3DM.%2BP.%26atitle%3DDiscovery%2520of%2520highly%2520selective%2520EP4%2520receptor%2520agonists%2520that%2520stimulate%2520new%2520bone%2520formation%2520and%2520restore%2520bone%2520mass%2520in%2520ovariectomized%2520rats%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1799%26epage%3D1802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Ke, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasser, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DaSilva-Jardine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jee, W. S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. D.</span><span> </span><span class="NLM_article-title">A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">575</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1359%2Fjbmr.051110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16598377" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1Kqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=565-575&author=H.+Z.+Keauthor=D.+T.+Crawfordauthor=H.+Qiauthor=H.+A.+Simmonsauthor=T.+A.+Owenauthor=V.+M.+Paralkarauthor=M.+Liauthor=B.+Luauthor=W.+A.+Grasserauthor=K.+O.+Cameronauthor=B.+A.+Lefkerauthor=P.+DaSilva-Jardineauthor=D.+O.+Scottauthor=Q.+Zhangauthor=X.+Y.+Tianauthor=W.+S.+S.+Jeeauthor=T.+A.+Brownauthor=D.+D.+Thompson&title=A+nonprostanoid+EP4+receptor+selective+prostaglandin+E2+agonist+restores+bone+mass+and+strength+in+aged%2C+ovariectomized+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats</span></div><div class="casAuthors">Ke, Hua Zhu; Crawford, D. Todd; Qi, Hong; Simmons, Hollis A.; Owen, Thomas A.; Paralkar, Vishwas M.; Li, Mei; Lu, Bihong; Grasser, William A.; Cameron, Kimberly O.; Lefker, Bruce A.; DaSilva-Jardine, Paul; Scott, Dennis O.; Zhang, Qing; Tian, Xiao Yan; Jee, Webster S. S.; Brown, Thomas A.; Thompson, David D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">565-575</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">CP432 is a newly discovered, nonprostanoid EP4 receptor selective prostaglandin E2 agonist.  CP432 stimulates trabecular and cortical bone formation and restores bone mass and bone strength in aged ovariectomized rats with established osteopenia.  Introduction: The purpose of this study was to det. whether a newly discovered, nonprostanoid EP4 receptor selective prostaglandin E2 (PGE2) agonist, CP432, could produce bone anabolic effects in aged, ovariectomized (OVX) rats with established osteopenia.  Materials and Methods: CP432 at 0.3, 1, or 3 mg/kg/day was given for 6 wk by s.c. injection to 12-mo-old rats that had been OVX for 8.5 mo.  The effects on bone mass, bone formation, bone resorption, and bone strength were detd.  Results: Total femoral BMD increased significantly in OVX rats treated with CP432 at all doses.  CP432 completely restored trabecular bone vol. of the third lumbar vertebral body accompanied with a dose-dependent decrease in osteoclast no. and osteoclast surface and a dose-dependent increase in mineralizing surface, mineral apposition rate, and bone formation rate-tissue ref. in OVX rats.  CP432 at 1 and 3 mg/kg/day significantly increased total tissue area, cortical bone area, and periosteal and endocortical bone formation in the tibial shafts compared with both sham and OVX controls.  CP432 at all doses significantly and dose-dependently increased ultimate strength in the fifth lumbar vertebral body compared with both sham and OVX controls.  At 1 and 3 mg/kg/day, CP432 significantly increased maximal load in a three-point bending test of femoral shaft compared with both sham and OVX controls.  Conclusions: CP432 completely restored trabecular and cortical bone mass and strength in established osteopenic, aged OVX rats by stimulating bone formation and inhibiting bone resorption on trabecular and cortical surfaces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSEcjkrLziTbVg90H21EOLACvtfcHk0liA5VGVq-tJZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1Kqs78%253D&md5=de11185b404b72c5063482ff4e5e388b</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.051110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.051110%26sid%3Dliteratum%253Aachs%26aulast%3DKe%26aufirst%3DH.%2BZ.%26aulast%3DCrawford%26aufirst%3DD.%2BT.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DSimmons%26aufirst%3DH.%2BA.%26aulast%3DOwen%26aufirst%3DT.%2BA.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DB.%26aulast%3DGrasser%26aufirst%3DW.%2BA.%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DDaSilva-Jardine%26aufirst%3DP.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTian%26aufirst%3DX.%2BY.%26aulast%3DJee%26aufirst%3DW.%2BS.%2BS.%26aulast%3DBrown%26aufirst%3DT.%2BA.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26atitle%3DA%2520nonprostanoid%2520EP4%2520receptor%2520selective%2520prostaglandin%2520E2%2520agonist%2520restores%2520bone%2520mass%2520and%2520strength%2520in%2520aged%252C%2520ovariectomized%2520rats%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2006%26volume%3D21%26spage%3D565%26epage%3D575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Cameron, K. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefker, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawistoski, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tjoa, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeNinno, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, D. D.</span><span> </span><span class="NLM_article-title">Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2075</span><span class="NLM_x">–</span> <span class="NLM_lpage">2078</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2075-2078&author=K.+O.+Cameronauthor=B.+A.+Lefkerauthor=H.+Z.+Keauthor=M.+Liauthor=M.+P.+Zawistoskiauthor=C.+M.+Tjoaauthor=A.+S.+Wrightauthor=S.+L.+DeNinnoauthor=V.+M.+Paralkarauthor=T.+A.+Owenauthor=L.+Yuauthor=D.+D.+Thompson&title=Discovery+of+CP-533536%3A+an+EP2+receptor+selective+prostaglandin+E2+%28PGE2%29+agonist+that+induces+local+bone+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DLefker%26aufirst%3DB.%2BA.%26aulast%3DKe%26aufirst%3DH.%2BZ.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DZawistoski%26aufirst%3DM.%2BP.%26aulast%3DTjoa%26aufirst%3DC.%2BM.%26aulast%3DWright%26aufirst%3DA.%2BS.%26aulast%3DDeNinno%26aufirst%3DS.%2BL.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26aulast%3DOwen%26aufirst%3DT.%2BA.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DThompson%26aufirst%3DD.%2BD.%26atitle%3DDiscovery%2520of%2520CP-533536%253A%2520an%2520EP2%2520receptor%2520selective%2520prostaglandin%2520E2%2520%2528PGE2%2529%2520agonist%2520that%2520induces%2520local%2520bone%2520formation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2075%26epage%3D2078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span>ClinicalTrials.gov. Identifier: NCT00533377. <a href="http://clinicaltrials.gov/ct2/show/NCT00533377" class="extLink">http://clinicaltrials.gov/ct2/show/NCT00533377</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ClinicalTrials.gov.+Identifier%3A+NCT00533377.+http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2FNCT00533377."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinagawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohuchida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of a highly selective EP4-receptor agonist. Part 2. 5-Thia and 9β-halo-PG derivatives with improved stability</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2033</span><span class="NLM_x">–</span> <span class="NLM_lpage">2035</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=2033-2035&author=T.+Maruyamaauthor=M.+Asadaauthor=T.+Shiraishiauthor=K.+Sakataauthor=A.+Sekiauthor=H.+Yoshidaauthor=Y.+Shinagawaauthor=T.+Maruyamaauthor=S.+Ohuchidaauthor=H.+Nakaiauthor=K.+Kondoauthor=M.+Toda&title=Design+and+synthesis+of+a+highly+selective+EP4-receptor+agonist.+Part+2.+5-Thia+and+9%CE%B2-halo-PG+derivatives+with+improved+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DAsada%26aufirst%3DM.%26aulast%3DShiraishi%26aufirst%3DT.%26aulast%3DSakata%26aufirst%3DK.%26aulast%3DSeki%26aufirst%3DA.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DShinagawa%26aufirst%3DY.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DOhuchida%26aufirst%3DS.%26aulast%3DNakai%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DToda%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520highly%2520selective%2520EP4-receptor%2520agonist.%2520Part%25202.%25205-Thia%2520and%25209%25CE%25B2-halo-PG%2520derivatives%2520with%2520improved%2520stability%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2001%26volume%3D11%26spage%3D2033%26epage%3D2035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwabe, S.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiraishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinagawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohuchida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toda, M.</span><span> </span><span class="NLM_article-title">Design and synthesis of a selective EP4-receptor agonist. Part 4: Practical synthesis and biological evaluation of a novel highly selective EP4-receptor agonist</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2103</span><span class="NLM_x">–</span> <span class="NLM_lpage">2110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=2103-2110&author=T.+Maruyamaauthor=S.-I.+Kuwabeauthor=Y.+Kawanakaauthor=T.+Shiraishiauthor=Y.+Shinagawaauthor=K.+Sakataauthor=A.+Sekiauthor=Y.+Kishidaauthor=H.+Yoshidaauthor=T.+Maruyamaauthor=S.+Ohuchidaauthor=H.+Nakaiauthor=S.+Hashimotoauthor=M.+Kawamuraauthor=K.+Kondoauthor=M.+Toda&title=Design+and+synthesis+of+a+selective+EP4-receptor+agonist.+Part+4%3A+Practical+synthesis+and+biological+evaluation+of+a+novel+highly+selective+EP4-receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DKuwabe%26aufirst%3DS.-I.%26aulast%3DKawanaka%26aufirst%3DY.%26aulast%3DShiraishi%26aufirst%3DT.%26aulast%3DShinagawa%26aufirst%3DY.%26aulast%3DSakata%26aufirst%3DK.%26aulast%3DSeki%26aufirst%3DA.%26aulast%3DKishida%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DH.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DOhuchida%26aufirst%3DS.%26aulast%3DNakai%26aufirst%3DH.%26aulast%3DHashimoto%26aufirst%3DS.%26aulast%3DKawamura%26aufirst%3DM.%26aulast%3DKondo%26aufirst%3DK.%26aulast%3DToda%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520selective%2520EP4-receptor%2520agonist.%2520Part%25204%253A%2520Practical%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520a%2520novel%2520highly%2520selective%2520EP4-receptor%2520agonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D2103%26epage%3D2110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Nakagawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohta, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaoka, K.</span><span> </span><span class="NLM_article-title">Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">543</span><span class="NLM_x">–</span> <span class="NLM_lpage">548</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2007&pages=543-548&author=K.+Nakagawaauthor=Y.+Imaiauthor=Y.+Ohtaauthor=K.+Takaoka&title=Prostaglandin+E2+EP4+agonist+%28ONO-4819%29+accelerates+BMP-induced+osteoblastic+differentiation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakagawa%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DOhta%26aufirst%3DY.%26aulast%3DTakaoka%26aufirst%3DK.%26atitle%3DProstaglandin%2520E2%2520EP4%2520agonist%2520%2528ONO-4819%2529%2520accelerates%2520BMP-induced%2520osteoblastic%2520differentiation%26jtitle%3DBone%26date%3D2007%26volume%3D41%26spage%3D543%26epage%3D548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Toyoda, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaoka, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaoka, K.</span><span> </span><span class="NLM_article-title">Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2005&pages=555-562&author=H.+Toyodaauthor=H.+Teraiauthor=R.+Sasaokaauthor=K.+Odaauthor=K.+Takaoka&title=Augmentation+of+bone+morphogenetic+protein-induced+bone+mass+by+local+delivery+of+a+prostaglandin+E+EP4+receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DToyoda%26aufirst%3DH.%26aulast%3DTerai%26aufirst%3DH.%26aulast%3DSasaoka%26aufirst%3DR.%26aulast%3DOda%26aufirst%3DK.%26aulast%3DTakaoka%26aufirst%3DK.%26atitle%3DAugmentation%2520of%2520bone%2520morphogenetic%2520protein-induced%2520bone%2520mass%2520by%2520local%2520delivery%2520of%2520a%2520prostaglandin%2520E%2520EP4%2520receptor%2520agonist%26jtitle%3DBone%26date%3D2005%26volume%3D37%26spage%3D555%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Ito, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, T.</span><span> </span><span class="NLM_article-title">Effects of a prostaglandin EP4 agonist, ONO-4819, and risedronate on trabecular microstructure and bone strength in mature ovariectomized rats</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">459</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2006&pages=453-459&author=M.+Itoauthor=K.+Nakayamaauthor=A.+Konakaauthor=K.+Sakataauthor=K.+Ikedaauthor=T.+Maruyama&title=Effects+of+a+prostaglandin+EP4+agonist%2C+ONO-4819%2C+and+risedronate+on+trabecular+microstructure+and+bone+strength+in+mature+ovariectomized+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIto%26aufirst%3DM.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DKonaka%26aufirst%3DA.%26aulast%3DSakata%26aufirst%3DK.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DMaruyama%26aufirst%3DT.%26atitle%3DEffects%2520of%2520a%2520prostaglandin%2520EP4%2520agonist%252C%2520ONO-4819%252C%2520and%2520risedronate%2520on%2520trabecular%2520microstructure%2520and%2520bone%2520strength%2520in%2520mature%2520ovariectomized%2520rats%26jtitle%3DBone%26date%3D2006%26volume%3D39%26spage%3D453%26epage%3D459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Ofek, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karsak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leclerc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frenkel, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attar-Namdar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kram, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shohami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bab, I.</span><span> </span><span class="NLM_article-title">Peripheral cannabinoid receptor, CB2, regulates bone mass</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">696</span><span class="NLM_x">–</span> <span class="NLM_lpage">701</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1073%2Fpnas.0504187103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16407142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVOhsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=696-701&author=O.+Ofekauthor=M.+Karsakauthor=N.+Leclercauthor=M.+Fogelauthor=B.+Frenkelauthor=K.+Wrightauthor=J.+Tamauthor=M.+Attar-Namdarauthor=V.+Kramauthor=E.+Shohamiauthor=R.+Mechoulamauthor=A.+Zimmerauthor=I.+Bab&title=Peripheral+cannabinoid+receptor%2C+CB2%2C+regulates+bone+mass"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Peripheral cannabinoid receptor, CB2, regulates bone mass</span></div><div class="casAuthors">Ofek, Orr; Karsak, Meliha; Leclerc, Nathalie; Fogel, Meirav; Frenkel, Baruch; Wright, Karen; Tam, Joseph; Attar-Namdar, Malka; Kram, Vardit; Shohami, Esther; Mechoulam, Raphael; Zimmer, Andreas; Bab, Itai</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">696-701</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The endogenous cannabinoids bind to and activate two G protein-coupled receptors, the predominantly central cannabinoid receptor type 1 (CB1) and peripheral cannabinoid receptor type 2 (CB2).  Whereas CB1 mediates the cannabinoid psychotropic, analgesic, and orectic effects, CB2 has been implicated recently in the regulation of liver fibrosis and atherosclerosis.  Here we show that CB2-deficient mice have a markedly accelerated age-related trabecular bone loss and cortical expansion, although cortical thickness remains unaltered.  These changes are reminiscent of human osteoporosis and may result from differential regulation of trabecular and cortical bone remodeling.  The CB2-/- phenotype is also characterized by increased activity of trabecular osteoblasts (bone-forming cells), increased osteoclast (the bone-resorbing cell) no., and a markedly decreased no. of diaphyseal osteoblast precursors.  CB2 is expressed in osteoblasts, osteocytes, and osteoclasts.  A CB2-specific agonist that does not have any psychotropic effects enhances endocortical osteoblast no. and activity and restrains trabecular osteoclastogenesis, apparently by inhibiting proliferation of osteoclast precursors and receptor activator of NF-κB ligand expression in bone marrow-derived osteoblasts/stromal cells.  The same agonist attenuates ovariectomy-induced bone loss and markedly stimulates cortical thickness through the resp. suppression of osteoclast no. and stimulation of endocortical bone formation.  These results demonstrate that the endocannabinoid system is essential for the maintenance of normal bone mass by osteoblastic and osteoclastic CB2 signaling.  Hence, CB2 offers a mol. target for the diagnosis and treatment of osteoporosis, the most prevalent degenerative disease in developed countries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUeW3SSIrXSbVg90H21EOLACvtfcHk0lizh3KeBKiD6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVOhsr4%253D&md5=222e7dfb53af21baf8c0bc4d7bb71eac</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0504187103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0504187103%26sid%3Dliteratum%253Aachs%26aulast%3DOfek%26aufirst%3DO.%26aulast%3DKarsak%26aufirst%3DM.%26aulast%3DLeclerc%26aufirst%3DN.%26aulast%3DFogel%26aufirst%3DM.%26aulast%3DFrenkel%26aufirst%3DB.%26aulast%3DWright%26aufirst%3DK.%26aulast%3DTam%26aufirst%3DJ.%26aulast%3DAttar-Namdar%26aufirst%3DM.%26aulast%3DKram%26aufirst%3DV.%26aulast%3DShohami%26aufirst%3DE.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DZimmer%26aufirst%3DA.%26aulast%3DBab%26aufirst%3DI.%26atitle%3DPeripheral%2520cannabinoid%2520receptor%252C%2520CB2%252C%2520regulates%2520bone%2520mass%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D696%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Bab, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, A.</span><span> </span><span class="NLM_article-title">Cannabinoid receptors and the regulation of bone mass</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">188</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1038%2Fsj.bjp.0707593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18071301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFClsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=182-188&author=I.+Babauthor=A.+Zimmer&title=Cannabinoid+receptors+and+the+regulation+of+bone+mass"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid receptors and the regulation of bone mass</span></div><div class="casAuthors">Bab, I.; Zimmer, A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-188</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  A functional endocannabinoid system is present in several mammalian organs and tissues.  Recently, endocannabinoids and their receptors have been reported in the skeleton.  Osteoblasts, the bone forming cells, and osteoclasts, the bone resorbing cells, produce the endocannabinoids anandamide and 2-arachidonoylglycerol and express CB2 cannabinoid receptors.  Although CB2 has been implicated in pathol. processes in the central nervous system and peripheral tissues, the skeleton appears as the main system physiol. regulated by CB2.  CB2-deficient mice show a markedly accelerated age-related bone loss and the CNR2 gene (encoding CB2) in women is assocd. with low bone mineral d.  The activation of CB2 attenuates ovariectomy-induced bone loss in mice by restraining bone resorption and enhancing bone formation.  Hence synthetic CB2 ligands, which are stable and orally available, provide a basis for developing novel anti-osteoporotic therapies.  Activation of CB1 in sympathetic nerve terminals in bone inhibits norepinephrine release, thus balancing the tonic sympathetic restrain of bone formation.  Low levels of CB1 were also reported in osteoclasts.  CB1-null mice display a skeletal phenotype that is dependent on the mouse strain, gender and specific mutation of the CB1 encoding gene, CNR1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe0y7uhkrEE7Vg90H21EOLACvtfcHk0lizh3KeBKiD6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFClsA%253D%253D&md5=c461a34365f7c258bbb9b422f8e0bd48</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707593%26sid%3Dliteratum%253Aachs%26aulast%3DBab%26aufirst%3DI.%26aulast%3DZimmer%26aufirst%3DA.%26atitle%3DCannabinoid%2520receptors%2520and%2520the%2520regulation%2520of%2520bone%2520mass%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D182%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Idris, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sophocleous, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landao-Bassonga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van't Hof, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralston, S. H.</span><span> </span><span class="NLM_article-title">Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">5619</span><span class="NLM_x">–</span> <span class="NLM_lpage">5626</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2008&pages=5619-5626&author=A.+I.+Idrisauthor=A.+Sophocleousauthor=E.+Landao-Bassongaauthor=R.+J.+van%27t+Hofauthor=S.+H.+Ralston&title=Regulation+of+bone+mass%2C+osteoclast+function%2C+and+ovariectomy-induced+bone+loss+by+the+type+2+cannabinoid+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIdris%26aufirst%3DA.%2BI.%26aulast%3DSophocleous%26aufirst%3DA.%26aulast%3DLandao-Bassonga%26aufirst%3DE.%26aulast%3Dvan%2527t%2BHof%26aufirst%3DR.%2BJ.%26aulast%3DRalston%26aufirst%3DS.%2BH.%26atitle%3DRegulation%2520of%2520bone%2520mass%252C%2520osteoclast%2520function%252C%2520and%2520ovariectomy-induced%2520bone%2520loss%2520by%2520the%2520type%25202%2520cannabinoid%2520receptor%26jtitle%3DEndocrinology%26date%3D2008%26volume%3D149%26spage%3D5619%26epage%3D5626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Tam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trembovler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Marzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrosino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexandrovich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casap, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shteyer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karsak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yirmiya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shohami, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bab, I.</span><span> </span><span class="NLM_article-title">The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">285</span><span class="NLM_x">–</span> <span class="NLM_lpage">294</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1096%2Ffj.06-7957com" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17704191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslWmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=285-294&author=J.+Tamauthor=V.+Trembovlerauthor=V.+Di+Marzoauthor=S.+Petrosinoauthor=G.+Leoauthor=A.+Alexandrovichauthor=E.+Regevauthor=N.+Casapauthor=A.+Shteyerauthor=C.+Ledentauthor=M.+Karsakauthor=A.+Zimmerauthor=R.+Mechoulamauthor=R.+Yirmiyaauthor=E.+Shohamiauthor=I.+Bab&title=The+cannabinoid+CB1+receptor+regulates+bone+formation+by+modulating+adrenergic+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling</span></div><div class="casAuthors">Tam, Joseph; Trembovler, Victoria; Di Marzo, Vincenzo; Petrosino, Stefania; Leo, Gabriella; Alexandrovich, Alex; Regev, Eran; Casap, Nardy; Shteyer, Arie; Ledent, Catherine; Karsak, Meliha; Zimmer, Andreas; Mechoulam, Raphael; Yirmiya, Raz; Shohami, Esther; Bab, Itai</div><div class="citationInfo"><span class="NLM_cas:title">FASEB Journal</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">285-294, 10.1096/fj.06-7957com</span>CODEN:
                <span class="NLM_cas:coden">FAJOEC</span>;
        ISSN:<span class="NLM_cas:issn">0892-6638</span>.
    
            (<span class="NLM_cas:orgname">Federation of American Societies for Experimental Biology</span>)
        </div><div class="casAbstract">We have recently reported that in bone the cannabinoid CB1 receptor is present in sympathetic terminals.  Here we show that traumatic brain injury (TBI), which in humans enhances peripheral osteogenesis and fracture healing, acutely stimulates bone formation in a distant skeletal site.  At this site we demonstrate (i) a high level of the main endocannabinoid, 2-arachidonoylglycerol (2-AG), and expression of diacylglycerol lipases, enzymes essential for 2-AG synthesis; (ii) that the TBI-induced increase in bone formation is preceded by elevation of the 2-AG and a decrease in norepinephrine (NE) levels.  The TBI stimulation of bone formation was absent in CB1-null mice.  In wild-type animals it could be mimicked, including the suppression of NE levels, by 2-AG administration.  The TBI- and 2-AG-induced stimulation of osteogenesis was restrained by the β-adrenergic receptor agonist isoproterenol.  NE from sympathetic terminals is known to tonically inhibit bone formation by activating osteoblastic β2-adrenergic receptors.  The present findings further demonstrate that the sympathetic control of bone formation is regulated through 2-AG activation of prejunctional CB1.  Elevation of bone 2-AG apparently suppresses NE release from bone sympathetic terminals, thus alleviating the inhibition of bone formation.  The involvement of osteoblastic CB2 signaling in this process is minimal, if any.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHBWEs2cC3IrVg90H21EOLACvtfcHk0li7IgM7SvTcvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslWmsw%253D%253D&md5=18848f3beebb92be4b7a354ba8d4ea4f</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1096%2Ffj.06-7957com&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.06-7957com%26sid%3Dliteratum%253Aachs%26aulast%3DTam%26aufirst%3DJ.%26aulast%3DTrembovler%26aufirst%3DV.%26aulast%3DDi%2BMarzo%26aufirst%3DV.%26aulast%3DPetrosino%26aufirst%3DS.%26aulast%3DLeo%26aufirst%3DG.%26aulast%3DAlexandrovich%26aufirst%3DA.%26aulast%3DRegev%26aufirst%3DE.%26aulast%3DCasap%26aufirst%3DN.%26aulast%3DShteyer%26aufirst%3DA.%26aulast%3DLedent%26aufirst%3DC.%26aulast%3DKarsak%26aufirst%3DM.%26aulast%3DZimmer%26aufirst%3DA.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DYirmiya%26aufirst%3DR.%26aulast%3DShohami%26aufirst%3DE.%26aulast%3DBab%26aufirst%3DI.%26atitle%3DThe%2520cannabinoid%2520CB1%2520receptor%2520regulates%2520bone%2520formation%2520by%2520modulating%2520adrenergic%2520signaling%26jtitle%3DFASEB%2520J.%26date%3D2008%26volume%3D22%26spage%3D285%26epage%3D294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group">Idris, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sophocleous, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landao-Bassonga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van't Hof, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralston, S. H.</span><span> </span><span class="NLM_article-title">Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.cmet.2009.07.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19656492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVChsLrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=139-47&author=A.+I.+Idrisauthor=A.+Sophocleousauthor=E.+Landao-Bassongaauthor=M.+Canalsauthor=G.+Milliganauthor=D.+Bakerauthor=R.+J.+van%27t+Hofauthor=S.+H.+Ralston&title=Cannabinoid+receptor+type+1+protects+against+age-related+osteoporosis+by+regulating+osteoblast+and+adipocyte+differentiation+in+marrow+stromal+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Cannabinoid receptor type 1 protects against age-related osteoporosis by regulating osteoblast and adipocyte differentiation in marrow stromal cells</span></div><div class="casAuthors">Idris, Aymen I.; Sophocleous, Antonia; Landao-Bassonga, Euphemie; Canals, Meritxell; Milligan, Graeme; Baker, David; van't Hof, Robert J.; Ralston, Stuart H.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Age-related osteoporosis is characterized by reduced bone formation and accumulation of fat in the bone marrow compartment.  Here, we report that the type 1 cannabinoid receptor (CB1) regulates this process.  Mice with CB1 deficiency (CB1-/-) had increased peak bone mass due to reduced bone resorption, but developed age-related osteoporosis with reduced bone formation and accumulation of adipocytes in the bone marrow space.  Marrow stromal cells from CB1-/- mice had an enhanced capacity for adipocyte differentiation, a reduced capacity for osteoblast differentiation, and increased expression of phosphorylated CREB (pCREB) and PPARγ.  Pharmacol. blockade of CB1 receptors stimulated adipocyte differentiation, inhibited osteoblast differentiation, and increased cAMP and pCREB in osteoblast and adipocyte precursors.  The CB1 receptor is therefore unique in that it regulates peak bone mass through an effect on osteoclast activity, but protects against age-related bone loss by regulating adipocyte and osteoblast differentiation of bone marrow stromal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNvLw59pncD7Vg90H21EOLACvtfcHk0li7IgM7SvTcvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVChsLrE&md5=feb740ebad00e3db6a076cf2f245d2d0</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2009.07.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2009.07.006%26sid%3Dliteratum%253Aachs%26aulast%3DIdris%26aufirst%3DA.%2BI.%26aulast%3DSophocleous%26aufirst%3DA.%26aulast%3DLandao-Bassonga%26aufirst%3DE.%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DMilligan%26aufirst%3DG.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3Dvan%2527t%2BHof%26aufirst%3DR.%2BJ.%26aulast%3DRalston%26aufirst%3DS.%2BH.%26atitle%3DCannabinoid%2520receptor%2520type%25201%2520protects%2520against%2520age-related%2520osteoporosis%2520by%2520regulating%2520osteoblast%2520and%2520adipocyte%2520differentiation%2520in%2520marrow%2520stromal%2520cells%26jtitle%3DCell%2520Metab.%26date%3D2009%26volume%3D10%26spage%3D139%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Rinaldi-Carmona, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pialot, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barth, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brelière, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soubrié, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Fur, G.</span><span> </span><span class="NLM_article-title">Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1239</span><span class="NLM_x">–</span> <span class="NLM_lpage">1247</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1996&pages=1239-1247&author=M.+Rinaldi-Carmonaauthor=F.+Pialotauthor=C.+Congyauthor=E.+Redonauthor=F.+Barthauthor=A.+Bachyauthor=J.+C.+Breli%C3%A8reauthor=P.+Soubri%C3%A9author=G.+Le+Fur&title=Characterization+and+distribution+of+binding+sites+for+%5B3H%5D-SR+141716A%2C+a+selective+brain+%28CB1%29+cannabinoid+receptor+antagonist%2C+in+rodent+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRinaldi-Carmona%26aufirst%3DM.%26aulast%3DPialot%26aufirst%3DF.%26aulast%3DCongy%26aufirst%3DC.%26aulast%3DRedon%26aufirst%3DE.%26aulast%3DBarth%26aufirst%3DF.%26aulast%3DBachy%26aufirst%3DA.%26aulast%3DBreli%25C3%25A8re%26aufirst%3DJ.%2BC.%26aulast%3DSoubri%25C3%25A9%26aufirst%3DP.%26aulast%3DLe%2BFur%26aufirst%3DG.%26atitle%3DCharacterization%2520and%2520distribution%2520of%2520binding%2520sites%2520for%2520%255B3H%255D-SR%2520141716A%252C%2520a%2520selective%2520brain%2520%2528CB1%2529%2520cannabinoid%2520receptor%2520antagonist%252C%2520in%2520rodent%2520brain%26jtitle%3DLife%2520Sci.%26date%3D1996%26volume%3D58%26spage%3D1239%26epage%3D1247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group">Lan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernando, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCallion, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makriyannis, A.</span><span> </span><span class="NLM_article-title">Structure−activity relationships of pyrazole derivatives as cannabinoid receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm980363y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=769-776&author=R.+Lanauthor=Q.+Liuauthor=P.+Fanauthor=S.+Linauthor=S.+R.+Fernandoauthor=D.+McCallionauthor=R.+Pertweeauthor=A.+Makriyannis&title=Structure%E2%88%92activity+relationships+of+pyrazole+derivatives+as+cannabinoid+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1021%2Fjm980363y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm980363y%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DFan%26aufirst%3DP.%26aulast%3DLin%26aufirst%3DS.%26aulast%3DFernando%26aufirst%3DS.%2BR.%26aulast%3DMcCallion%26aufirst%3DD.%26aulast%3DPertwee%26aufirst%3DR.%26aulast%3DMakriyannis%26aufirst%3DA.%26atitle%3DStructure%25E2%2588%2592activity%2520relationships%2520of%2520pyrazole%2520derivatives%2520as%2520cannabinoid%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D769%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Huffman, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liddle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aung, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abood, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">3-(1′,1′-Dimethylbutyl)-1-deoxy-Δ8-THC and related compounds: synthesis of selective ligands for the CB2 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2905</span><span class="NLM_x">–</span> <span class="NLM_lpage">2914</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=2905-2914&author=J.+W.+Huffmanauthor=J.+Liddleauthor=S.+Yuauthor=M.+M.+Aungauthor=M.+E.+Aboodauthor=J.+L.+Wileyauthor=B.+R.+Martin&title=3-%281%E2%80%B2%2C1%E2%80%B2-Dimethylbutyl%29-1-deoxy-%CE%948-THC+and+related+compounds%3A+synthesis+of+selective+ligands+for+the+CB2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuffman%26aufirst%3DJ.%2BW.%26aulast%3DLiddle%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DAung%26aufirst%3DM.%2BM.%26aulast%3DAbood%26aufirst%3DM.%2BE.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3D3-%25281%25E2%2580%25B2%252C1%25E2%2580%25B2-Dimethylbutyl%2529-1-deoxy-%25CE%25948-THC%2520and%2520related%2520compounds%253A%2520synthesis%2520of%2520selective%2520ligands%2520for%2520the%2520CB2%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D1999%26volume%3D7%26spage%3D2905%26epage%3D2914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Sophocleous, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landao-Bassonga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van't Hof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ralston, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Idris, A. I.</span><span> </span><span class="NLM_article-title">The type 2 cannabinoid receptor (CB2) protects against age-related osteoporosis by affecting bone formation and CB2 agonists exhibit anabolic activity in vivo</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">S219</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=S219&author=A.+Sophocleousauthor=E.+Landao-Bassongaauthor=R.+van%27t+Hofauthor=S.+H.+Ralstonauthor=A.+I.+Idris&title=The+type+2+cannabinoid+receptor+%28CB2%29+protects+against+age-related+osteoporosis+by+affecting+bone+formation+and+CB2+agonists+exhibit+anabolic+activity+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSophocleous%26aufirst%3DA.%26aulast%3DLandao-Bassonga%26aufirst%3DE.%26aulast%3Dvan%2527t%2BHof%26aufirst%3DR.%26aulast%3DRalston%26aufirst%3DS.%2BH.%26aulast%3DIdris%26aufirst%3DA.%2BI.%26atitle%3DThe%2520type%25202%2520cannabinoid%2520receptor%2520%2528CB2%2529%2520protects%2520against%2520age-related%2520osteoporosis%2520by%2520affecting%2520bone%2520formation%2520and%2520CB2%2520agonists%2520exhibit%2520anabolic%2520activity%2520in%2520vivo%26jtitle%3DBone%26date%3D2009%26volume%3D44%26spage%3DS219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Marriott, K.-S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huffman, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacology of 11-nor-1-methoxy-9-hydroxyhexahydrocannabinols and 11-nor-1-deoxy-9-hydroxyhexahydrocannabinols: new selective ligands for the cannabinoid CB2 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2386</span><span class="NLM_x">–</span> <span class="NLM_lpage">2397</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=2386-2397&author=K.-S.+C.+Marriottauthor=J.+W.+Huffmanauthor=J.+L.+Wileyauthor=B.+R.+Martin&title=Synthesis+and+pharmacology+of+11-nor-1-methoxy-9-hydroxyhexahydrocannabinols+and+11-nor-1-deoxy-9-hydroxyhexahydrocannabinols%3A+new+selective+ligands+for+the+cannabinoid+CB2+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarriott%26aufirst%3DK.-S.%2BC.%26aulast%3DHuffman%26aufirst%3DJ.%2BW.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3DSynthesis%2520and%2520pharmacology%2520of%252011-nor-1-methoxy-9-hydroxyhexahydrocannabinols%2520and%252011-nor-1-deoxy-9-hydroxyhexahydrocannabinols%253A%2520new%2520selective%2520ligands%2520for%2520the%2520cannabinoid%2520CB2%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D2386%26epage%3D2397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Hanus, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breuer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchilibon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiloah, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldenberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horowitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pertwee, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mechoulam, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fride, E.</span><span> </span><span class="NLM_article-title">HU-308: a specific agonist for CB2, a peripheral cannabinoid receptor</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">14228</span><span class="NLM_x">–</span> <span class="NLM_lpage">14233</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=14228-14233&author=L.+Hanusauthor=A.+Breuerauthor=S.+Tchilibonauthor=S.+Shiloahauthor=D.+Goldenbergauthor=M.+Horowitzauthor=R.+G.+Pertweeauthor=R.+A.+Rossauthor=R.+Mechoulamauthor=E.+Fride&title=HU-308%3A+a+specific+agonist+for+CB2%2C+a+peripheral+cannabinoid+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanus%26aufirst%3DL.%26aulast%3DBreuer%26aufirst%3DA.%26aulast%3DTchilibon%26aufirst%3DS.%26aulast%3DShiloah%26aufirst%3DS.%26aulast%3DGoldenberg%26aufirst%3DD.%26aulast%3DHorowitz%26aufirst%3DM.%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26aulast%3DRoss%26aufirst%3DR.%2BA.%26aulast%3DMechoulam%26aufirst%3DR.%26aulast%3DFride%26aufirst%3DE.%26atitle%3DHU-308%253A%2520a%2520specific%2520agonist%2520for%2520CB2%252C%2520a%2520peripheral%2520cannabinoid%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1999%26volume%3D96%26spage%3D14228%26epage%3D14233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Page, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balaux, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boisvert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milburn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaszewski, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walpole, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodzic, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Onge, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godbout, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salois, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payza, K.</span><span> </span><span class="NLM_article-title">Novel benzimidazole derivatives as selective CB2 agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3695</span><span class="NLM_x">–</span> <span class="NLM_lpage">3700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.bmcl.2008.05.073" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18522867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1Ohurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3695-3700&author=D.+Pageauthor=E.+Balauxauthor=L.+Boisvertauthor=Z.+Liuauthor=C.+Milburnauthor=M.+Tremblayauthor=Z.+Weiauthor=S.+Wooauthor=X.+Luoauthor=Y.-X.+Chengauthor=H.+Yangauthor=S.+Srivastavaauthor=F.+Zhouauthor=W.+Brownauthor=M.+Tomaszewskiauthor=C.+Walpoleauthor=L.+Hodzicauthor=S.+St-Ongeauthor=C.+Godboutauthor=D.+Saloisauthor=K.+Payza&title=Novel+benzimidazole+derivatives+as+selective+CB2+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Novel benzimidazole derivatives as selective CB2 agonists</span></div><div class="casAuthors">Page, Daniel; Balaux, Elise; Boisvert, Luc; Liu, Ziping; Milburn, Claire; Tremblay, Maxime; Wei, Zhongyong; Woo, Simon; Luo, Xuehong; Cheng, Yun-Xing; Yang, Hua; Srivastava, Sanjay; Zhou, Fei; Brown, William; Tomaszewski, Miroslaw; Walpole, Christopher; Hodzic, Leila; St-Onge, Stephane; Godbout, Claude; Salois, Dominic; Payza, Keymal</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3695-3700</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The prepn. and evaluation of a novel class of CB2 agonists based on a benzimidazole moiety, e.g., I, are reported.  They showed binding affinities up to 1 nM towards the CB2 receptor with partial to full agonist potencies.  They also demonstrated good to excellent selectivity (>1000-fold) over the CB1 receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbeiXe1I0Yg7Vg90H21EOLACvtfcHk0lhPHQJyizawhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1Ohurs%253D&md5=fa9e0921054b0d9f26044a1feb82a604</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.05.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.05.073%26sid%3Dliteratum%253Aachs%26aulast%3DPage%26aufirst%3DD.%26aulast%3DBalaux%26aufirst%3DE.%26aulast%3DBoisvert%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMilburn%26aufirst%3DC.%26aulast%3DTremblay%26aufirst%3DM.%26aulast%3DWei%26aufirst%3DZ.%26aulast%3DWoo%26aufirst%3DS.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DY.-X.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSrivastava%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DF.%26aulast%3DBrown%26aufirst%3DW.%26aulast%3DTomaszewski%26aufirst%3DM.%26aulast%3DWalpole%26aufirst%3DC.%26aulast%3DHodzic%26aufirst%3DL.%26aulast%3DSt-Onge%26aufirst%3DS.%26aulast%3DGodbout%26aufirst%3DC.%26aulast%3DSalois%26aufirst%3DD.%26aulast%3DPayza%26aufirst%3DK.%26atitle%3DNovel%2520benzimidazole%2520derivatives%2520as%2520selective%2520CB2%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3695%26epage%3D3700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Markt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rollinger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raduner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schuster, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirchmair, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Distinto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spitzer, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolber, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laggner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altmann, K.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gertsch, J.</span><span> </span><span class="NLM_article-title">Discovery of novel CB2 receptor ligands by a pharmacophore-based virtual screening workflow</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">369</span><span class="NLM_x">–</span> <span class="NLM_lpage">378</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm801044g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=369-378&author=P.+Marktauthor=C.+Feldmannauthor=J.+M.+Rollingerauthor=S.+Radunerauthor=D.+Schusterauthor=J.+Kirchmairauthor=S.+Distintoauthor=G.+M.+Spitzerauthor=G.+Wolberauthor=C.+Laggnerauthor=K.-H.+Altmannauthor=T.+Langerauthor=J.+Gertsch&title=Discovery+of+novel+CB2+receptor+ligands+by+a+pharmacophore-based+virtual+screening+workflow"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Fjm801044g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801044g%26sid%3Dliteratum%253Aachs%26aulast%3DMarkt%26aufirst%3DP.%26aulast%3DFeldmann%26aufirst%3DC.%26aulast%3DRollinger%26aufirst%3DJ.%2BM.%26aulast%3DRaduner%26aufirst%3DS.%26aulast%3DSchuster%26aufirst%3DD.%26aulast%3DKirchmair%26aufirst%3DJ.%26aulast%3DDistinto%26aufirst%3DS.%26aulast%3DSpitzer%26aufirst%3DG.%2BM.%26aulast%3DWolber%26aufirst%3DG.%26aulast%3DLaggner%26aufirst%3DC.%26aulast%3DAltmann%26aufirst%3DK.-H.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DGertsch%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520novel%2520CB2%2520receptor%2520ligands%2520by%2520a%2520pharmacophore-based%2520virtual%2520screening%2520workflow%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D369%26epage%3D378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group">Huffman, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padgett, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isherwood, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, B. R.</span><span> </span><span class="NLM_article-title">1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles: new high affinity ligands for the cannabinoid CB1 and CB2 receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5432</span><span class="NLM_x">–</span> <span class="NLM_lpage">5435</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5432-5435&author=J.+W.+Huffmanauthor=L.+W.+Padgettauthor=M.+L.+Isherwoodauthor=J.+L.+Wileyauthor=B.+R.+Martin&title=1-Alkyl-2-aryl-4-%281-naphthoyl%29pyrroles%3A+new+high+affinity+ligands+for+the+cannabinoid+CB1+and+CB2+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuffman%26aufirst%3DJ.%2BW.%26aulast%3DPadgett%26aufirst%3DL.%2BW.%26aulast%3DIsherwood%26aufirst%3DM.%2BL.%26aulast%3DWiley%26aufirst%3DJ.%2BL.%26aulast%3DMartin%26aufirst%3DB.%2BR.%26atitle%3D1-Alkyl-2-aryl-4-%25281-naphthoyl%2529pyrroles%253A%2520new%2520high%2520affinity%2520ligands%2520for%2520the%2520cannabinoid%2520CB1%2520and%2520CB2%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5432%26epage%3D5435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Whyte, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridge, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greasley, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, M. J.</span><span> </span><span class="NLM_article-title">The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">16511</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=16511-16516&author=L.+S.+Whyteauthor=E.+Rybergauthor=N.+A.+Simsauthor=S.+A.+Ridgeauthor=K.+Mackieauthor=P.+J.+Greasleyauthor=R.+A.+Rossauthor=M.+J.+Rogers&title=The+putative+cannabinoid+receptor+GPR55+affects+osteoclast+function+in+vitro+and+bone+mass+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWhyte%26aufirst%3DL.%2BS.%26aulast%3DRyberg%26aufirst%3DE.%26aulast%3DSims%26aufirst%3DN.%2BA.%26aulast%3DRidge%26aufirst%3DS.%2BA.%26aulast%3DMackie%26aufirst%3DK.%26aulast%3DGreasley%26aufirst%3DP.%2BJ.%26aulast%3DRoss%26aufirst%3DR.%2BA.%26aulast%3DRogers%26aufirst%3DM.%2BJ.%26atitle%3DThe%2520putative%2520cannabinoid%2520receptor%2520GPR55%2520affects%2520osteoclast%2520function%2520in%2520vitro%2520and%2520bone%2520mass%2520in%2520vivo%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2009%26volume%3D106%26spage%3D16511%26epage%3D16516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Pertwee, R. G.</span><span> </span><span class="NLM_article-title">The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta 9-tetrahydrocannabinol, cannabidiol and delta 9-tetrahydrocannabivarin</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1038%2Fsj.bjp.0707442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17828291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXovFCkuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=199-215&author=R.+G.+Pertwee&title=The+diverse+CB1+and+CB2+receptor+pharmacology+of+three+plant+cannabinoids%3A+delta+9-tetrahydrocannabinol%2C+cannabidiol+and+delta+9-tetrahydrocannabivarin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin</span></div><div class="casAuthors">Pertwee, R. G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">199-215</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cannabis sativa is the source of a unique set of compds. known collectively as plant cannabinoids or phytocannabinoids.  This review focuses on the manner with which three of these compds., (-)-trans-Δ9-tetrahydrocannabinol (Δ9-THC), (-)-cannabidiol (CBD) and (-)-trans-Δ9-tetrahydrocannabivarin (Δ9-THCV), interact with cannabinoid CB1 and CB2 receptors. Δ9-THC, the main psychotropic constituent of cannabis, is a CB1 and CB2 receptor partial agonist and in line with classical pharmacol., the responses it elicits appear to be strongly influenced both by the expression level and signalling efficiency of cannabinoid receptors and by ongoing endogenous cannabinoid release.  CBD displays unexpectedly high potency as an antagonist of CB1/CB2 receptor agonists in CB1- and CB2-expressing cells or tissues, the manner with which it interacts with CB2 receptors providing a possible explanation for its ability to inhibit evoked immune cell migration. Δ9-THCV behaves as a potent CB2 receptor partial agonist in vitro.  In contrast, it antagonizes cannabinoid receptor agonists in CB1-expressing tissues.  This it does with relatively high potency and in a manner that is both tissue and ligand dependent. Δ9-THCV also interacts with CB1 receptors when administered in vivo, behaving either as a CB1 antagonist or, at higher doses, as a CB1 receptor agonist.  Brief mention is also made in this review, first of the prodn. by Δ9-THC of pharmacodynamic tolerance, second of current knowledge about the extent to which Δ9-THC, CBD and Δ9-THCV interact with pharmacol. targets other than CB1 or CB2 receptors, and third of actual and potential therapeutic applications for each of these cannabinoids.  British Journal of Pharmacol. (2008) 153, 199-215; doi:10.1038/sj.bjp.0707442; published online 10 Sept. 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdNia0Z97Wz7Vg90H21EOLACvtfcHk0ljDxhWdRlSldg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXovFCkuw%253D%253D&md5=53187d5a54c048cbbd0d0b0143feb206</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0707442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0707442%26sid%3Dliteratum%253Aachs%26aulast%3DPertwee%26aufirst%3DR.%2BG.%26atitle%3DThe%2520diverse%2520CB1%2520and%2520CB2%2520receptor%2520pharmacology%2520of%2520three%2520plant%2520cannabinoids%253A%2520delta%25209-tetrahydrocannabinol%252C%2520cannabidiol%2520and%2520delta%25209-tetrahydrocannabivarin%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3D199%26epage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Soriano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geske, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, A.</span><span> </span><span class="NLM_article-title">Targeted disruption of the c-Src proto-oncogene leads to osteopetrosis in mice</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">702</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1991&pages=693-702&author=P.+Sorianoauthor=C.+Montgomeryauthor=R.+Geskeauthor=A.+Bradley&title=Targeted+disruption+of+the+c-Src+proto-oncogene+leads+to+osteopetrosis+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoriano%26aufirst%3DP.%26aulast%3DMontgomery%26aufirst%3DC.%26aulast%3DGeske%26aufirst%3DR.%26aulast%3DBradley%26aufirst%3DA.%26atitle%3DTargeted%2520disruption%2520of%2520the%2520c-Src%2520proto-oncogene%2520leads%2520to%2520osteopetrosis%2520in%2520mice%26jtitle%3DCell%26date%3D1991%26volume%3D64%26spage%3D693%26epage%3D702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Boyce, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoneda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mundy, G. R.</span><span> </span><span class="NLM_article-title">Requirement of pp60c-Src expression for osteoclasts to form ruffled borders and resorb bone in mice</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">1622</span><span class="NLM_x">–</span> <span class="NLM_lpage">1627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1992&pages=1622-1627&author=B.+F.+Boyceauthor=T.+Yonedaauthor=C.+Loweauthor=P.+Sorianoauthor=G.+R.+Mundy&title=Requirement+of+pp60c-Src+expression+for+osteoclasts+to+form+ruffled+borders+and+resorb+bone+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoyce%26aufirst%3DB.%2BF.%26aulast%3DYoneda%26aufirst%3DT.%26aulast%3DLowe%26aufirst%3DC.%26aulast%3DSoriano%26aufirst%3DP.%26aulast%3DMundy%26aufirst%3DG.%2BR.%26atitle%3DRequirement%2520of%2520pp60c-Src%2520expression%2520for%2520osteoclasts%2520to%2520form%2520ruffled%2520borders%2520and%2520resorb%2520bone%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1992%26volume%3D90%26spage%3D1622%26epage%3D1627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Marzia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voit, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliaccio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taranta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faraggiana, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoneda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mundy, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teti, A.</span><span> </span><span class="NLM_article-title">Decreased c-Src expression enhances osteoblast differentiation and bone formation</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2000&pages=311-320&author=M.+Marziaauthor=N.+A.+Simsauthor=S.+Voitauthor=S.+Migliaccioauthor=A.+Tarantaauthor=S.+Bernardiniauthor=T.+Faraggianaauthor=T.+Yonedaauthor=G.+R.+Mundyauthor=B.+F.+Boyceauthor=R.+Baronauthor=A.+Teti&title=Decreased+c-Src+expression+enhances+osteoblast+differentiation+and+bone+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarzia%26aufirst%3DM.%26aulast%3DSims%26aufirst%3DN.%2BA.%26aulast%3DVoit%26aufirst%3DS.%26aulast%3DMigliaccio%26aufirst%3DS.%26aulast%3DTaranta%26aufirst%3DA.%26aulast%3DBernardini%26aufirst%3DS.%26aulast%3DFaraggiana%26aufirst%3DT.%26aulast%3DYoneda%26aufirst%3DT.%26aulast%3DMundy%26aufirst%3DG.%2BR.%26aulast%3DBoyce%26aufirst%3DB.%2BF.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DTeti%26aufirst%3DA.%26atitle%3DDecreased%2520c-Src%2520expression%2520enhances%2520osteoblast%2520differentiation%2520and%2520bone%2520formation%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2000%26volume%3D151%26spage%3D311%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Hennequin, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curwen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fennell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert van der Brempt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgentin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivier, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otterbein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ple, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costello, G.</span><span> </span><span class="NLM_article-title"><i>N</i>-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2<i>H</i>-pyran-4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6465</span><span class="NLM_x">–</span> <span class="NLM_lpage">6488</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060434q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6465-6488&author=L.+F.+Hennequinauthor=J.+Allenauthor=J.+Breedauthor=J.+Curwenauthor=M.+Fennellauthor=T.+P.+Greenauthor=C.+Lambert+van+der+Bremptauthor=R.+Morgentinauthor=R.+A.+Normanauthor=A.+Olivierauthor=L.+Otterbeinauthor=P.+A.+Pleauthor=N.+Warinauthor=G.+Costello&title=N-%285-Chloro-1%2C3-benzodioxol-4-yl%29-7-%5B2-%284-methylpiperazin-1-yl%29ethoxy%5D-5-%28tetrahydro-2H-pyran-4-yloxy%29quinazolin-4-amine%2C+a+novel%2C+highly+selective%2C+orally+available%2C+dual-specific+c-Src%2FAbl+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1021%2Fjm060434q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060434q%26sid%3Dliteratum%253Aachs%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DBreed%26aufirst%3DJ.%26aulast%3DCurwen%26aufirst%3DJ.%26aulast%3DFennell%26aufirst%3DM.%26aulast%3DGreen%26aufirst%3DT.%2BP.%26aulast%3DLambert%2Bvan%2Bder%2BBrempt%26aufirst%3DC.%26aulast%3DMorgentin%26aufirst%3DR.%26aulast%3DNorman%26aufirst%3DR.%2BA.%26aulast%3DOlivier%26aufirst%3DA.%26aulast%3DOtterbein%26aufirst%3DL.%26aulast%3DPle%26aufirst%3DP.%2BA.%26aulast%3DWarin%26aufirst%3DN.%26aulast%3DCostello%26aufirst%3DG.%26atitle%3DN-%25285-Chloro-1%252C3-benzodioxol-4-yl%2529-7-%255B2-%25284-methylpiperazin-1-yl%2529ethoxy%255D-5-%2528tetrahydro-2H-pyran-4-yloxy%2529quinazolin-4-amine%252C%2520a%2520novel%252C%2520highly%2520selective%252C%2520orally%2520available%252C%2520dual-specific%2520c-Src%252FAbl%2520kinase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6465%26epage%3D6488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group">de Vries, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullender, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Duin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semeins, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everts, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein-Nulend, J.</span><span> </span><span class="NLM_article-title">The Src inhibitor AZD0530 reversibly inhibits the formation and activity of human osteoclasts</span> <span class="citation_source-journal">Mol. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">476</span><span class="NLM_x">–</span> <span class="NLM_lpage">488</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1158%2F1541-7786.MCR-08-0219" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19372577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXks1antb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=476-488&author=T.+J.+de+Vriesauthor=M.+G.+Mullenderauthor=M.+A.+van+Duinauthor=C.+M.+Semeinsauthor=N.+Jamesauthor=T.+P.+Greenauthor=V.+Evertsauthor=J.+Klein-Nulend&title=The+Src+inhibitor+AZD0530+reversibly+inhibits+the+formation+and+activity+of+human+osteoclasts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">The Src Inhibitor AZD0530 Reversibly Inhibits the Formation and Activity of Human Osteoclasts</span></div><div class="casAuthors">de Vries, Teun J.; Mullender, Margriet G.; van Duin, Marion A.; Semeins, Cornelis M.; James, Neil; Green, Tim P.; Everts, Vincent; Klein-Nulend, Jenneke</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">476-488</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Tumor cells in the bone microenvironment are able to initiate a vicious cycle of bone degrdn. by mobilizing osteoclasts, multinucleated cells specialized in bone degrdn.  C-Src is highly expressed both in tumors and in osteoclasts.  Therefore, drugs like AZD0530, designed to inhibit Src activity, could selectively interfere with both tumor and osteoclast activity.  Here we explored the effects of AZD0530 on human osteoclast differentiation and activity.  The effect on osteoclasts formed in vivo was assessed in mouse fetal calvarial explants and in isolated rabbit osteoclasts, where it dose-dependently inhibited osteoclast activity.  Its effect on formation and activity of human osteoclasts in vitro was detd. in cocultures of human osteoblasts and peripheral blood mononuclear cells.  AZD0530 was most effective in inhibiting osteoclast-like cell formation when present at the onset of osteoclastogenesis, suggesting that Src activity is important during the initial phase of osteoclast formation.  Formation of active phosphorylated c-Src, which was highly present in osteoclast-like cells in cocultures and in peripheral blood mononuclear cell monocultures, was significantly reduced by AZD0530.  Furthermore, it reversibly prevented osteoclast precursor migration from the osteoblast layer to the bone surface and subsequent formation of actin rings and resorption pits.  These data suggest that Src is pivotal for the formation and activity of human osteoclasts, probably through its effect on the distribution of the actin microfilament system.  The reversible effect of AZD0530 on osteoclast formation and activity makes it a promising candidate to temper osteoclastic bone degrdn. in bone diseases with enhanced osteoclast activity such as osteolytic metastatic bone disease. (Mol Cancer Res 2009;7(4):476-88).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXu-fotK4VKrVg90H21EOLACvtfcHk0lh9UywvBrqAoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXks1antb4%253D&md5=80c72d6afedef2ecf63cfcc4dfa05c5e</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-08-0219&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-08-0219%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BVries%26aufirst%3DT.%2BJ.%26aulast%3DMullender%26aufirst%3DM.%2BG.%26aulast%3Dvan%2BDuin%26aufirst%3DM.%2BA.%26aulast%3DSemeins%26aufirst%3DC.%2BM.%26aulast%3DJames%26aufirst%3DN.%26aulast%3DGreen%26aufirst%3DT.%2BP.%26aulast%3DEverts%26aufirst%3DV.%26aulast%3DKlein-Nulend%26aufirst%3DJ.%26atitle%3DThe%2520Src%2520inhibitor%2520AZD0530%2520reversibly%2520inhibits%2520the%2520formation%2520and%2520activity%2520of%2520human%2520osteoclasts%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2009%26volume%3D7%26spage%3D476%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group">Eastell, R.; Hannon, R. A.; Gallagher, N.; Clack, G.; Macpherson, M.; Marshall, A.</span><span> </span><span class="NLM_article-title">The effect of AZD0530, a highly selective, orally available Src/Abl kinase inhibitor, on biomarkers of bone resorption in healthy males</span>.  <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span>, Abstract 3041.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&author=R.+Eastell&author=R.+A.+Hannon&author=N.+Gallagher&author=G.+Clack&author=M.+Macpherson&author=A.+Marshall&title=The+effect+of+AZD0530%2C+a+highly+selective%2C+orally+available+Src%2FAbl+kinase+inhibitor%2C+on+biomarkers+of+bone+resorption+in+healthy+males"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEastell%26aufirst%3DR.%26atitle%3DThe%2520effect%2520of%2520AZD0530%252C%2520a%2520highly%2520selective%252C%2520orally%2520available%2520Src%252FAbl%2520kinase%2520inhibitor%252C%2520on%2520biomarkers%2520of%2520bone%2520resorption%2520in%2520healthy%2520males%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group">Chang, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosania, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherlin, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norman, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarohia, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leost, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">361</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2FS1074-5521%2899%2980048-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=10375538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFOgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1999&pages=361-375&author=Y.-T.+Changauthor=N.+S.+Grayauthor=G.+R.+Rosaniaauthor=D.+P.+Sutherlinauthor=S.+Kwonauthor=T.+C.+Normanauthor=R.+Sarohiaauthor=M.+Leostauthor=L.+Meijerauthor=P.+G.+Schultz&title=Synthesis+and+application+of+functionally+diverse+2%2C6%2C9-trisubstituted+purine+libraries+as+CDK+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors</span></div><div class="casAuthors">Chang, Young-Tae; Gray, Nathanael S.; Rosania, Gustavo R.; Sutherlin, Daniel P.; Kwon, Soojin; Norman, Thea C.; Sarohia, Radhika; Leost, Maryse; Meijer, Laurent; Schultz, Peter G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">361-375</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">Purines constitute a structural class of protein ligands involved in mediating an astonishing array of metabolic processes and signal pathways in all living organisms.  Synthesis of purine derivs. targeting specific purine-binding proteins in vivo could lead to versatile lead compds. for use as biol. probes or drug candidates.  We synthesized several libraries of 2,6,9-trisubstituted purines using both soln.- and solid-phase chem., and screened the compds. for inhibition of cyclin-dependent kinase (CDK) activity and human leukemic cell growth.  Lead compds. were optimized by iterative synthesis based on structure-activity relationships (SARs), as well as anal. of several CDK-inhibitor cocrystal structures, to afford several interesting compds. including one of the most potent CDK inhibitors known to date.  Unexpectedly, some compds. with similar CDK inhibitory activity arrested cellular proliferation at distinctly different phases of the cell cycle, and another inhibitor directly induced apoptosis, bypassing cell-cycle arrest.  Some of these compds. selectively inhibited growth of cells derived from specific tumors.  2,6,9-Trisubstituted purines have various and potent biol. activities, despite high concns. of competing endogenous purine ligands in living cells.  Purine libraries constitute a versatile source of small mols. that affect distinct biochem. pathways mediating different cellular functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGromOmpUr_CvbVg90H21EOLACvtfcHk0lh9UywvBrqAoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFOgtLo%253D&md5=67311217da8fecdddf96b9908a20c906</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2899%2980048-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252899%252980048-9%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DY.-T.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DRosania%26aufirst%3DG.%2BR.%26aulast%3DSutherlin%26aufirst%3DD.%2BP.%26aulast%3DKwon%26aufirst%3DS.%26aulast%3DNorman%26aufirst%3DT.%2BC.%26aulast%3DSarohia%26aufirst%3DR.%26aulast%3DLeost%26aufirst%3DM.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DSynthesis%2520and%2520application%2520of%2520functionally%2520diverse%25202%252C6%252C9-trisubstituted%2520purine%2520libraries%2520as%2520CDK%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D361%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group">Dalgarno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stehle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schelling, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Schravendijk, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keats, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacNeil, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, C.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shakespeare, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohacek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigele, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T.</span><span> </span><span class="NLM_article-title">Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">57</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1111%2Fj.1747-0285.2005.00316.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=16492148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=46-57&author=D.+Dalgarnoauthor=T.+Stehleauthor=S.+Narulaauthor=P.+Schellingauthor=M.+R.+van+Schravendijkauthor=S.+Adamsauthor=L.+Andradeauthor=J.+Keatsauthor=M.+Ramauthor=L.+Jinauthor=T.+Grossmanauthor=I.+MacNeilauthor=C.+Metcalfauthor=W.+Shakespeareauthor=Y.+Wangauthor=T.+Keenanauthor=R.+Sundaramoorthiauthor=R.+Bohacekauthor=M.+Weigeleauthor=T.+Sawyer&title=Structural+basis+of+Src+tyrosine+kinase+inhibition+with+a+new+class+of+potent+and+selective+trisubstituted+purine-based+compounds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds</span></div><div class="casAuthors">Dalgarno, David; Stehle, Thilo; Narula, Surinder; Schelling, Pierre; van Schravendijk, Marie Rose; Adams, Susan; Andrade, Lawrence; Keats, Jeff; Ram, Mary; Jin, Lei; Grossman, Trudy; MacNeil, Ian; Metcalf, Chester, III; Shakespeare, William; Wang, Yihan; Keenan, Terry; Sundaramoorthi, Raji; Bohacek, Regine; Weigele, Manfred; Sawyer, Tomi</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-57</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The tyrosine kinase pp60src (Src) is the prototypical member of a family of proteins that participate in a broad array of cellular signal transduction processes, including cell growth, differentiation, survival, adhesion, and migration.  Abnormal Src family kinase (SFK) signaling has been linked to several disease states, including osteoporosis and cancer metastases.  Src has thus emerged as a mol. target for the discovery of small-mol. inhibitors that regulate Src kinase activity by binding to the ATP pocket within the catalytic domain.  Here, we present crystal structures of the kinase domain of Src in complex with two purine-based inhibitors: AP23451, a small-mol. inhibitor designed to inhibit Src-dependent bone resorption, and AP23464, a small-mol. inhibitor designed to inhibit the Src-dependent metastatic spread of cancer.  In each case, a trisubstituted purine template core was elaborated using structure-based drug design to yield a potent Src kinase inhibitor.  These structures represent early examples of high affinity purine-based Src family kinase-inhibitor complexes, and they provide a detailed view of the specific protein-ligand interactions that lead to potent inhibition of Src.  In particular, the 3-hydroxyphenethyl N9 substituent of AP23464 forms unique interactions with the protein that are crit. to the picomolar affinity of this compd. for Src.  The comparison of these new structures with two relevant kinase-inhibitor complexes provides a structural basis for the obsd. kinase inhibitory selectivity.  Further comparisons reveal a concerted induced-fit movement between the N- and C-terminal lobes of the kinase that correlates with the affinity of the ligand.  Binding of the most potent inhibitor, AP23464, results in the largest induced-fit movement, which can be directly linked to interactions of the hydrophenethyl N9 substituent with a region at the interface between the two lobes.  A less pronounced induced-fit movement is also obsd. in the Src-AP23451 complex.  These new structures illustrate how the combination of structural, computational, and medicinal chem. can be used to rationalize the process of developing high affinity, selective tyrosine kinase inhibitors as potential therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqAcWZyLy8JrVg90H21EOLACvtfcHk0lgE2Hj0qOJD2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVSjt7Y%253D&md5=5a89de976e29e65aec0553c84e2e0b92</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2005.00316.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2005.00316.x%26sid%3Dliteratum%253Aachs%26aulast%3DDalgarno%26aufirst%3DD.%26aulast%3DStehle%26aufirst%3DT.%26aulast%3DNarula%26aufirst%3DS.%26aulast%3DSchelling%26aufirst%3DP.%26aulast%3Dvan%2BSchravendijk%26aufirst%3DM.%2BR.%26aulast%3DAdams%26aufirst%3DS.%26aulast%3DAndrade%26aufirst%3DL.%26aulast%3DKeats%26aufirst%3DJ.%26aulast%3DRam%26aufirst%3DM.%26aulast%3DJin%26aufirst%3DL.%26aulast%3DGrossman%26aufirst%3DT.%26aulast%3DMacNeil%26aufirst%3DI.%26aulast%3DMetcalf%26aufirst%3DC.%26aulast%3DShakespeare%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DKeenan%26aufirst%3DT.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DBohacek%26aufirst%3DR.%26aulast%3DWeigele%26aufirst%3DM.%26aulast%3DSawyer%26aufirst%3DT.%26atitle%3DStructural%2520basis%2520of%2520Src%2520tyrosine%2520kinase%2520inhibition%2520with%2520a%2520new%2520class%2520of%2520potent%2520and%2520selective%2520trisubstituted%2520purine-based%2520compounds%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2006%26volume%3D67%26spage%3D46%26epage%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group">Shakespeare, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohacek, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keenan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundaramoorthi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, C.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dilauro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roeloffzen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltmarsh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paramanathan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalgarno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradeepan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Schravendijk, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keats, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ram, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liou, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wardwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogus, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iuliucci, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weigele, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, T. K.</span><span> </span><span class="NLM_article-title">SAR of carbon-linked, 2-substituted purines: synthesis and characterization of AP23451 as a novel bone-targeted inhibitor of Src tyrosine kinase with in vivo anti-resorptive activity</span> <span class="citation_source-journal">Chem. Biol. Drug Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">97</span><span class="NLM_x">–</span> <span class="NLM_lpage">105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1111%2Fj.1747-0285.2007.00615.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=18179464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisFSntbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2008&pages=97-105&author=W.+C.+Shakespeareauthor=Y.+Wangauthor=R.+Bohacekauthor=T.+Keenanauthor=R.+Sundaramoorthiauthor=C.+Metcalfauthor=A.+Dilauroauthor=S.+Roeloffzenauthor=S.+Liuauthor=J.+Saltmarshauthor=G.+Paramanathanauthor=D.+Dalgarnoauthor=S.+Narulaauthor=S.+Pradeepanauthor=M.+R.+van+Schravendijkauthor=J.+Keatsauthor=M.+Ramauthor=S.+Liouauthor=S.+Adamsauthor=S.+Wardwellauthor=J.+Bogusauthor=J.+Iuliucciauthor=M.+Weigeleauthor=L.+Xingauthor=B.+Boyceauthor=T.+K.+Sawyer&title=SAR+of+carbon-linked%2C+2-substituted+purines%3A+synthesis+and+characterization+of+AP23451+as+a+novel+bone-targeted+inhibitor+of+Src+tyrosine+kinase+with+in+vivo+anti-resorptive+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">SAR of carbon-linked, 2-substituted purines: synthesis and characterization of AP23451 as a novel bone-targeted inhibitor of Src tyrosine kinase with in vivo anti-resorptive activity</span></div><div class="casAuthors">Shakespeare, William C.; Wang, Yihan; Bohacek, Regine; Keenan, Terry; Sundaramoorthi, Raji; Metcalf, Chet, III; Dilauro, Anne; Roeloffzen, Sonya; Liu, Shuangying; Saltmarsh, Jennifer; Paramanathan, Guru; Dalgarno, David; Narula, Surinder; Pradeepan, Selvi; van Schravendijk, Marie Rose; Keats, Jeff; Ram, Mary; Liou, Shuenn; Adams, Susan; Wardwell, Scott; Bogus, Julie; Iuliucci, John; Weigele, Manfred; Xing, Lianping; Boyce, Brendan; Sawyer, Tomi K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">97-105</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Targeted disruption of the pp60src (Src) gene has implicated this tyrosine kinase in osteoclast-mediated bone resorption and as a therapeutic target for the treatment of osteoporosis and other bone-related diseases.  Here, we describe structure activity relationships of a novel series of carbon-linked, 2-substituted purines that led to the identification of AP23451 as a potent inhibitor of Src tyrosine kinase with antiresorptive activity in vivo.  AP23451 features the use of an arylphosphinylmethylphosphinic acid moiety which confers bone-targeting properties to the mol., thereby increasing local concns. of the inhibitor to actively resorbing osteoclasts at the bone interface.  AP23451 exhibited an IC50 = 68 nM against Src kinase; an x-ray crystal structure of the mol. complexed with Src detailed the mol. interactions responsible for its Src inhibition.  In vivo, AP23451 demonstrated a dose-dependent decrease in PTH-induced hypercalcemia.  Moreover, AP23517, a structurally and biochem. similar mol. with comparable activity (IC50 = 73 nM) except devoid of the bone-targeting element, demonstrated significantly reduced in vivo efficacy, suggesting that Src activity was necessary but not sufficient for in vivo activity in this series of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMOkUhcT4xFrVg90H21EOLACvtfcHk0lgE2Hj0qOJD2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisFSntbs%253D&md5=256b265a9c89d3702881efdd357c31f9</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2007.00615.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2007.00615.x%26sid%3Dliteratum%253Aachs%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBohacek%26aufirst%3DR.%26aulast%3DKeenan%26aufirst%3DT.%26aulast%3DSundaramoorthi%26aufirst%3DR.%26aulast%3DMetcalf%26aufirst%3DC.%26aulast%3DDilauro%26aufirst%3DA.%26aulast%3DRoeloffzen%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DSaltmarsh%26aufirst%3DJ.%26aulast%3DParamanathan%26aufirst%3DG.%26aulast%3DDalgarno%26aufirst%3DD.%26aulast%3DNarula%26aufirst%3DS.%26aulast%3DPradeepan%26aufirst%3DS.%26aulast%3Dvan%2BSchravendijk%26aufirst%3DM.%2BR.%26aulast%3DKeats%26aufirst%3DJ.%26aulast%3DRam%26aufirst%3DM.%26aulast%3DLiou%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DS.%26aulast%3DWardwell%26aufirst%3DS.%26aulast%3DBogus%26aufirst%3DJ.%26aulast%3DIuliucci%26aufirst%3DJ.%26aulast%3DWeigele%26aufirst%3DM.%26aulast%3DXing%26aufirst%3DL.%26aulast%3DBoyce%26aufirst%3DB.%26aulast%3DSawyer%26aufirst%3DT.%2BK.%26atitle%3DSAR%2520of%2520carbon-linked%252C%25202-substituted%2520purines%253A%2520synthesis%2520and%2520characterization%2520of%2520AP23451%2520as%2520a%2520novel%2520bone-targeted%2520inhibitor%2520of%2520Src%2520tyrosine%2520kinase%2520with%2520in%2520vivo%2520anti-resorptive%2520activity%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2008%26volume%3D71%26spage%3D97%26epage%3D105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group">Kingsley, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirgwin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guise, T. A.</span><span> </span><span class="NLM_article-title">Breaking new ground to build bone</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">10753</span><span class="NLM_x">–</span> <span class="NLM_lpage">10754</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=10753-10754&author=L.+A.+Kingsleyauthor=J.+M.+Chirgwinauthor=T.+A.+Guise&title=Breaking+new+ground+to+build+bone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKingsley%26aufirst%3DL.%2BA.%26aulast%3DChirgwin%26aufirst%3DJ.%2BM.%26aulast%3DGuise%26aufirst%3DT.%2BA.%26atitle%3DBreaking%2520new%2520ground%2520to%2520build%2520bone%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D10753%26epage%3D10754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group">Gil-Henn, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Destaing, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alles, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neff, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanjay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruzzaniti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Camilli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span> </span><span class="NLM_article-title">Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2−/− mice</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">178</span><span class="NLM_x">, </span> <span class="NLM_fpage">1053</span><span class="NLM_x">–</span> <span class="NLM_lpage">1064</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2007&pages=1053-1064&author=H.+Gil-Hennauthor=O.+Destaingauthor=N.+A.+Simsauthor=K.+Aokiauthor=N.+Allesauthor=L.+Neffauthor=A.+Sanjayauthor=A.+Bruzzanitiauthor=P.+De+Camilliauthor=R.+Baronauthor=J.+Schlessinger&title=Defective+microtubule-dependent+podosome+organization+in+osteoclasts+leads+to+increased+bone+density+in+Pyk2%E2%88%92%2F%E2%88%92+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGil-Henn%26aufirst%3DH.%26aulast%3DDestaing%26aufirst%3DO.%26aulast%3DSims%26aufirst%3DN.%2BA.%26aulast%3DAoki%26aufirst%3DK.%26aulast%3DAlles%26aufirst%3DN.%26aulast%3DNeff%26aufirst%3DL.%26aulast%3DSanjay%26aufirst%3DA.%26aulast%3DBruzzaniti%26aufirst%3DA.%26aulast%3DDe%2BCamilli%26aufirst%3DP.%26aulast%3DBaron%26aufirst%3DR.%26aulast%3DSchlessinger%26aufirst%3DJ.%26atitle%3DDefective%2520microtubule-dependent%2520podosome%2520organization%2520in%2520osteoclasts%2520leads%2520to%2520increased%2520bone%2520density%2520in%2520Pyk2%25E2%2588%2592%252F%25E2%2588%2592%2520mice%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2007%26volume%3D178%26spage%3D1053%26epage%3D1064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group">Buckbinder, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ke, H. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnette, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumann, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hambor, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasser, W. A.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luzzio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hulford, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gebhard, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paralkar, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smock, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzman-Perez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span> </span><span class="NLM_article-title">Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">10619</span><span class="NLM_x">–</span> <span class="NLM_lpage">10624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1073%2Fpnas.0701421104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17537919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnt1Ohtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=10619-10624&author=L.+Buckbinderauthor=D.+T.+Crawfordauthor=H.+Qiauthor=H.+Z.+Keauthor=L.+M.+Olsonauthor=K.+R.+Longauthor=P.+C.+Bonnetteauthor=A.+P.+Baumannauthor=J.+E.+Hamborauthor=W.+A.+Grasserauthor=L.+C.+Panauthor=T.+A.+Owenauthor=M.+J.+Luzzioauthor=C.+A.+Hulfordauthor=D.+F.+Gebhardauthor=V.+M.+Paralkarauthor=H.+A.+Simmonsauthor=J.+C.+Kathauthor=W.+G.+Robertsauthor=S.+L.+Smockauthor=A.+Guzman-Perezauthor=T.+A.+Brownauthor=M.+Li&title=Proline-rich+tyrosine+kinase+2+regulates+osteoprogenitor+cells+and+bone+formation%2C+and+offers+an+anabolic+treatment+approach+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis</span></div><div class="casAuthors">Buckbinder, Leonard; Crawford, David T.; Qi, Hong; Ke, Hua Zhu; Olson, Lisa M.; Long, Kelly R.; Bonnette, Peter C.; Baumann, Amy P.; Hambor, John E.; Grasser, William A., III; Pan, Lydia C.; Owen, Thomas A.; Luzzio, Michael J.; Hulford, Catherine A.; Gebhard, David F.; Paralkar, Vishwas M.; Simmons, Hollis A.; Kath, John C.; Roberts, W. Gregory; Smock, Steven L.; Guzman-Perez, Angel; Brown, Thomas A.; Li, Mei</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">10619-10624</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Bone is accrued and maintained primarily through the coupled actions of bone-forming osteoblasts and bone-resorbing osteoclasts.  Cumulative in vitro studies indicated that proline-rich tyrosine kinase 2 (PYK2) is a pos. mediator of osteoclast function and activity.  However, our investigation of PYK2-/- mice did not reveal evidence supporting an essential function for PYK2 in osteoclasts either in vivo or in culture.  We find that PYK2-/- mice have high bone mass resulting from an unexpected increase in bone formation.  Consistent with the in vivo findings, mouse bone marrow cultures show that PYK2 deficiency enhances differentiation and activity of osteoprogenitor cells, as does expressing a PYK2-specific short hairpin RNA or dominantly interfering proteins in human mesenchymal stem cells.  Furthermore, the daily administration of a small-mol. PYK2 inhibitor increases bone formation and protects against bone loss in ovariectomized rats, an established preclin. model of postmenopausal osteoporosis.  In summary, we find that PYK2 regulates the differentiation of early osteoprogenitor cells across species and that inhibitors of the PYK2 have potential as a bone anabolic approach for the treatment of osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpENpFzA2DSTrVg90H21EOLACvtfcHk0ljywyEqG2dY4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnt1Ohtro%253D&md5=6327da043a470ce6c932d1f09c23fee8</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0701421104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0701421104%26sid%3Dliteratum%253Aachs%26aulast%3DBuckbinder%26aufirst%3DL.%26aulast%3DCrawford%26aufirst%3DD.%2BT.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DKe%26aufirst%3DH.%2BZ.%26aulast%3DOlson%26aufirst%3DL.%2BM.%26aulast%3DLong%26aufirst%3DK.%2BR.%26aulast%3DBonnette%26aufirst%3DP.%2BC.%26aulast%3DBaumann%26aufirst%3DA.%2BP.%26aulast%3DHambor%26aufirst%3DJ.%2BE.%26aulast%3DGrasser%26aufirst%3DW.%2BA.%26aulast%3DPan%26aufirst%3DL.%2BC.%26aulast%3DOwen%26aufirst%3DT.%2BA.%26aulast%3DLuzzio%26aufirst%3DM.%2BJ.%26aulast%3DHulford%26aufirst%3DC.%2BA.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DParalkar%26aufirst%3DV.%2BM.%26aulast%3DSimmons%26aufirst%3DH.%2BA.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DRoberts%26aufirst%3DW.%2BG.%26aulast%3DSmock%26aufirst%3DS.%2BL.%26aulast%3DGuzman-Perez%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DT.%2BA.%26aulast%3DLi%26aufirst%3DM.%26atitle%3DProline-rich%2520tyrosine%2520kinase%25202%2520regulates%2520osteoprogenitor%2520cells%2520and%2520bone%2520formation%252C%2520and%2520offers%2520an%2520anabolic%2520treatment%2520approach%2520for%2520osteoporosis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D10619%26epage%3D10624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group">Siu, L. L.; Burris, H. A.; Mileshkin, L.; Camidge, D. R.; Rischin, D.; Chen, E. X.; Jones, S.; Yin, D.; Fingert, H.</span><span> </span><span class="NLM_article-title">Phase 1 study of a focal adhesion kinase (FAK) inhibitor PF-00562271 in patients (pts) with advanced solid tumors</span>.  <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span>, Abstract 3527.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&author=L.+L.+Siu&author=H.+A.+Burris&author=L.+Mileshkin&author=D.+R.+Camidge&author=D.+Rischin&author=E.+X.+Chen&author=S.+Jones&author=D.+Yin&author=H.+Fingert&title=Phase+1+study+of+a+focal+adhesion+kinase+%28FAK%29+inhibitor+PF-00562271+in+patients+%28pts%29+with+advanced+solid+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DL.%2BL.%26atitle%3DPhase%25201%2520study%2520of%2520a%2520focal%2520adhesion%2520kinase%2520%2528FAK%2529%2520inhibitor%2520PF-00562271%2520in%2520patients%2520%2528pts%2529%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group">Han, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mistry, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnette, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrunyk, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aspnes, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brosius, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckbinder, L.</span><span> </span><span class="NLM_article-title">Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique (DFG-out) conformation and enables inhibitor design</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">13193</span><span class="NLM_x">–</span> <span class="NLM_lpage">13201</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1074%2Fjbc.M809038200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19244237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltlemtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=13193-13201&author=S.+Hanauthor=A.+Mistryauthor=J.+S.+Changauthor=D.+Cunninghamauthor=M.+Grifforauthor=P.+C.+Bonnetteauthor=H.+Wangauthor=B.+A.+Chrunykauthor=G.+E.+Aspnesauthor=D.+P.+Walkerauthor=A.+D.+Brosiusauthor=L.+Buckbinder&title=Structural+characterization+of+proline-rich+tyrosine+kinase+2+%28PYK2%29+reveals+a+unique+%28DFG-out%29+conformation+and+enables+inhibitor+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Characterization of Proline-rich Tyrosine Kinase 2 (PYK2) Reveals a Unique (DFG-out) Conformation and Enables Inhibitor Design</span></div><div class="casAuthors">Han, Seungil; Mistry, Anil; Chang, Jeanne S.; Cunningham, David; Griffor, Matt; Bonnette, Peter C.; Wang, Hong; Chrunyk, Boris A.; Aspnes, Gary E.; Walker, Daniel P.; Brosius, Arthur D.; Buckbinder, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">13193-13201</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Proline-rich tyrosine kinase 2 (PYK2) is a cytoplasmic, non-receptor tyrosine kinase implicated in multiple signaling pathways.  It is a neg. regulator of osteogenesis and considered a viable drug target for osteoporosis treatment.  The high-resoln. structures of the human PYK2 kinase domain with different inhibitor complexes establish the conventional bilobal kinase architecture and show the conformational variability of the DFG loop.  The basis for the lack of selectivity for the classical kinase inhibitor, PF-431396, within the FAK family is explained by our structural analyses.  Importantly, the novel DFG-out conformation with two diarylurea inhibitors (BIRB796, PF-4618433) reveals a distinct subclass of non-receptor tyrosine kinases identifiable by the gatekeeper Met-502 and the unique hinge loop conformation of Leu-504.  This is the first example of a leucine residue in the hinge loop that blocks the ATP binding site in the DFG-out conformation.  Our structural, biophys., and pharmacol. studies suggest that the unique features of the DFG motif, including Leu-504 hinge-loop variability, can be exploited for the development of selective protein kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRnQx5xeYf37Vg90H21EOLACvtfcHk0lh5I2hd3_4cjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltlemtr4%253D&md5=3fc4091566d670f2293f8424dd72243c</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M809038200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M809038200%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DS.%26aulast%3DMistry%26aufirst%3DA.%26aulast%3DChang%26aufirst%3DJ.%2BS.%26aulast%3DCunningham%26aufirst%3DD.%26aulast%3DGriffor%26aufirst%3DM.%26aulast%3DBonnette%26aufirst%3DP.%2BC.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DChrunyk%26aufirst%3DB.%2BA.%26aulast%3DAspnes%26aufirst%3DG.%2BE.%26aulast%3DWalker%26aufirst%3DD.%2BP.%26aulast%3DBrosius%26aufirst%3DA.%2BD.%26aulast%3DBuckbinder%26aufirst%3DL.%26atitle%3DStructural%2520characterization%2520of%2520proline-rich%2520tyrosine%2520kinase%25202%2520%2528PYK2%2529%2520reveals%2520a%2520unique%2520%2528DFG-out%2529%2520conformation%2520and%2520enables%2520inhibitor%2520design%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D13193%26epage%3D13201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group">Allen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, C.-Y. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Connor, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roveto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babij, P.</span><span> </span><span class="NLM_article-title">Identification of small molecule inhibitors of proline-rich tyrosine kinase 2 (Pyk2) with osteogenic activity in osteoblast cells</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4924</span><span class="NLM_x">–</span> <span class="NLM_lpage">4928</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4924-4928&author=J.+G.+Allenauthor=M.+R.+Leeauthor=C.-Y.+E.+Hanauthor=J.+Scherrerauthor=S.+Flynnauthor=C.+Boucherauthor=H.+Zhaoauthor=A.+B.+O%27Connorauthor=P.+Rovetoauthor=D.+Bauerauthor=R.+Graceffaauthor=W.+G.+Richardsauthor=P.+Babij&title=Identification+of+small+molecule+inhibitors+of+proline-rich+tyrosine+kinase+2+%28Pyk2%29+with+osteogenic+activity+in+osteoblast+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DJ.%2BG.%26aulast%3DLee%26aufirst%3DM.%2BR.%26aulast%3DHan%26aufirst%3DC.-Y.%2BE.%26aulast%3DScherrer%26aufirst%3DJ.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DO%2527Connor%26aufirst%3DA.%2BB.%26aulast%3DRoveto%26aufirst%3DP.%26aulast%3DBauer%26aufirst%3DD.%26aulast%3DGraceffa%26aufirst%3DR.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DBabij%26aufirst%3DP.%26atitle%3DIdentification%2520of%2520small%2520molecule%2520inhibitors%2520of%2520proline-rich%2520tyrosine%2520kinase%25202%2520%2528Pyk2%2529%2520with%2520osteogenic%2520activity%2520in%2520osteoblast%2520cells%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4924%26epage%3D4928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group">Liao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiipakka, R. A.</span><span> </span><span class="NLM_article-title">Green tea: biochemical and biological basis for health benefits</span> <span class="citation_source-journal">Vitam. Horm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2FS0083-6729%2801%2962001-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=11345896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktlenu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2001&pages=1-94&author=S.+Liaoauthor=Y.-H.+Kaoauthor=R.+A.+Hiipakka&title=Green+tea%3A+biochemical+and+biological+basis+for+health+benefits"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Green tea: biochemical and biological basis for health benefits</span></div><div class="casAuthors">Liao, Shutsung; Kao, Yung-Hsi; Hiipakka, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Vitamins and Hormones (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-94</span>CODEN:
                <span class="NLM_cas:coden">VIHOAQ</span>;
        ISSN:<span class="NLM_cas:issn">0083-6729</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review, with many refs., on the medical efficacy of green tea in the prevention and treatment of various diseases.  Pure green tea catechins have been used in a no. of studies examg. catechin effects on isolated enzyme systems and cells in cultures to det. the mol. mechanisms for the putative health benefits of green tea.  Topics discussed include: catechins and other constituents of green tea; structure, pharmacol., and metab. of catechins; chem. and biochem. properties of catechins; biol. activity of green tea catechins; and mol. and cellular bases for biol. effects of catechins.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBmXgIKSCIVLVg90H21EOLACvtfcHk0lh5I2hd3_4cjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktlenu7w%253D&md5=0ce9de01347e83b13ebf20460d37ee8f</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1016%2FS0083-6729%2801%2962001-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0083-6729%252801%252962001-6%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DS.%26aulast%3DKao%26aufirst%3DY.-H.%26aulast%3DHiipakka%26aufirst%3DR.%2BA.%26atitle%3DGreen%2520tea%253A%2520biochemical%2520and%2520biological%2520basis%2520for%2520health%2520benefits%26jtitle%3DVitam.%2520Horm.%26date%3D2001%26volume%3D62%26spage%3D1%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group">Delaisse, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eeckhout, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaes, G.</span><span> </span><span class="NLM_article-title">Inhibition of bone resorption in culture by (+)-catechin</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">3091</span><span class="NLM_x">–</span> <span class="NLM_lpage">3094</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1986&pages=3091-3094&author=J.+M.+Delaisseauthor=Y.+Eeckhoutauthor=G.+Vaes&title=Inhibition+of+bone+resorption+in+culture+by+%28%2B%29-catechin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelaisse%26aufirst%3DJ.%2BM.%26aulast%3DEeckhout%26aufirst%3DY.%26aulast%3DVaes%26aufirst%3DG.%26atitle%3DInhibition%2520of%2520bone%2520resorption%2520in%2520culture%2520by%2520%2528%252B%2529-catechin%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1986%26volume%3D35%26spage%3D3091%26epage%3D3094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group">Lin, R.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, M.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, I.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G.-J.</span><span> </span><span class="NLM_article-title">(−)-Epigallocatechin gallate inhibition of osteoclastic differentiation via NF-kB</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">379</span><span class="NLM_x">, </span> <span class="NLM_fpage">1033</span><span class="NLM_x">–</span> <span class="NLM_lpage">1037</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2009&pages=1033-1037&author=R.-W.+Linauthor=C.-H.+Chenauthor=Y.-H.+Wangauthor=M.-L.+Hoauthor=S.-H.+Hungauthor=I.-S.+Chenauthor=G.-J.+Wang&title=%28%E2%88%92%29-Epigallocatechin+gallate+inhibition+of+osteoclastic+differentiation+via+NF-kB"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DR.-W.%26aulast%3DChen%26aufirst%3DC.-H.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DHo%26aufirst%3DM.-L.%26aulast%3DHung%26aufirst%3DS.-H.%26aulast%3DChen%26aufirst%3DI.-S.%26aulast%3DWang%26aufirst%3DG.-J.%26atitle%3D%2528%25E2%2588%2592%2529-Epigallocatechin%2520gallate%2520inhibition%2520of%2520osteoclastic%2520differentiation%2520via%2520NF-kB%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2009%26volume%3D379%26spage%3D1033%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group">Chang, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S. W.</span><span> </span><span class="NLM_article-title">Proliferative effects of flavan-3-ols and propelargonidins from rhizomes of <i>Drynaria fortunei</i> on MCF-7 and osteoblastic cells</span> <span class="citation_source-journal">Arch. Pharmacal Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">620</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1007%2FBF02976711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=12967197" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1Wgtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2003&pages=620-630&author=E.+J.+Changauthor=W.+J.+Leeauthor=S.+H.+Choauthor=S.+W.+Choi&title=Proliferative+effects+of+flavan-3-ols+and+propelargonidins+from+rhizomes+of+Drynaria+fortunei+on+MCF-7+and+osteoblastic+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Proliferative effects of flavan-3-ols and propelargonidins from rhizomes of Drynaria fortunei on MCF-7 and osteoblastic cells</span></div><div class="casAuthors">Chang, Eun Ju; Lee, Won Jung; Cho, Sung Hee; Choi, Sang Won</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">620-630</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">The proliferative effects of thirty Oriental medicinal herbs on MCF-7 (estrogen-sensitive breast cancer cell line) and ROS 17/2.8 osteoblast-like cells were detd. using the MTT assay.  Methanol exts. from several herbs was found to show proliferative activity on the above two cell lines in the range of 5 to 100 μg/mL.  Among these active herbs, the methanol ext. from the rhizomes of Drynaria fortunei showed the most potent proliferative activity, and the cell proliferations were significantly increase by 136 and 158% in the MCF-7 and ROS 17/2.8 cells, resp., when treated with 100 μg/mL.  Through a bioassay-guided sepn., eight flavonoids, including four new flavan-3-ols and two propelargonidins, together with the known (-)-epiafzelechin and naringin, were isolated.  Their chem. structures were characterized as (-)-epiafzelechin (1), (-)-epiafzelechin-3-O-β-D-allopyranoside (2), (-)-epiafzelechin-3-O-(6''-O-acetyl)-β-D-allopyranoside (3), 4β-carboxymethyl-(-)-epiafzelechin Me ester (4), 4β-carboxymethyl-(-)-epiafzelechin sodium salt (5), naringin (6), (-)-epiafzelechin-(4β→8)-4β-carboxymethylepiafzelechin Me ester (7) and (-)-epiafzelechin-(4β→8, 2β→O→7)-epiafzelechin-(4β→8)-epiafzelechin (8) by extensive 1D and 2D NMR spectroscopy.  Most of these flavonoids, in the range of 10-15∼10-6 M, accelerated the proliferation of MCF-7 cell, with compds. 7 and 8, in the range of 10-15∼10-12 M, showing esp. potent proliferation effects.  Meanwhile, seven flavonoids, with the exception of compd. 4, stimulated the proliferation of ROS 17/2.8 cells in the range of 10-15∼10-6 M, with compds. 5-8 esp. accelerating the proliferation, in dose-dependent manners (10-15∼10-9 M), and their proliferative effect was much stronger than that of E2 and genistein.  These results suggest that propelargonidin dimers and trimers isolated from the rhizomes of Drynaria fortunei may be useful as potential phytoestrogens, which play important physiol. roles in the prevention of postmenopausal osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU4_vU_xYRybVg90H21EOLACvtfcHk0lglI_oWOZzl3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1Wgtro%253D&md5=870accea2a6555d556ff86d7d4cf77ac</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1007%2FBF02976711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02976711%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DE.%2BJ.%26aulast%3DLee%26aufirst%3DW.%2BJ.%26aulast%3DCho%26aufirst%3DS.%2BH.%26aulast%3DChoi%26aufirst%3DS.%2BW.%26atitle%3DProliferative%2520effects%2520of%2520flavan-3-ols%2520and%2520propelargonidins%2520from%2520rhizomes%2520of%2520Drynaria%2520fortunei%2520on%2520MCF-7%2520and%2520osteoblastic%2520cells%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2003%26volume%3D26%26spage%3D620%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group">Wang, X.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, N.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, W.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, M.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, X.-S.</span><span> </span><span class="NLM_article-title">Effects of eleven flavonoids from the osteoprotective fraction of <i>Drynaria fortunei</i> (Kunze) J. SM. on osteoblastic proliferation using an osteoblast-like cell line</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2008&pages=46-51&author=X.-L.+Wangauthor=N.-L.+Wangauthor=Y.+Zhangauthor=H.+Gaoauthor=W.-Y.+Pangauthor=M.-S.+Wongauthor=G.+Zhangauthor=L.+Qinauthor=X.-S.+Yao&title=Effects+of+eleven+flavonoids+from+the+osteoprotective+fraction+of+Drynaria+fortunei+%28Kunze%29+J.+SM.+on+osteoblastic+proliferation+using+an+osteoblast-like+cell+line"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.-L.%26aulast%3DWang%26aufirst%3DN.-L.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DPang%26aufirst%3DW.-Y.%26aulast%3DWong%26aufirst%3DM.-S.%26aulast%3DZhang%26aufirst%3DG.%26aulast%3DQin%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DX.-S.%26atitle%3DEffects%2520of%2520eleven%2520flavonoids%2520from%2520the%2520osteoprotective%2520fraction%2520of%2520Drynaria%2520fortunei%2520%2528Kunze%2529%2520J.%2520SM.%2520on%2520osteoblastic%2520proliferation%2520using%2520an%2520osteoblast-like%2520cell%2520line%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2008%26volume%3D56%26spage%3D46%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group">Lee, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. C.</span><span> </span><span class="NLM_article-title">Osteoblast differentiation stimulating activity of biflavonoids from <i>Cephalotaxus koreana</i></span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2850</span><span class="NLM_x">–</span> <span class="NLM_lpage">2854</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2850-2854&author=M.+K.+Leeauthor=S.+W.+Limauthor=H.+Yangauthor=S.+H.+Sungauthor=H.-S.+Leeauthor=M.+J.+Parkauthor=Y.+C.+Kim&title=Osteoblast+differentiation+stimulating+activity+of+biflavonoids+from+Cephalotaxus+koreana"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DM.%2BK.%26aulast%3DLim%26aufirst%3DS.%2BW.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSung%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DH.-S.%26aulast%3DPark%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BC.%26atitle%3DOsteoblast%2520differentiation%2520stimulating%2520activity%2520of%2520biflavonoids%2520from%2520Cephalotaxus%2520koreana%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2850%26epage%3D2854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group">Tung, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiem, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minh, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. H.</span><span> </span><span class="NLM_article-title">New anthracene glycosides from Rhodomyrtus tomentosa stimulate osteoblastic differentiation of MC3T3-E1 cells</span> <span class="citation_source-journal">Arch. Pharmacal Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1007%2Fs12272-009-1406-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19407968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Kjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=515-520&author=N.+H.+Tungauthor=Y.+Dingauthor=E.+M.+Choiauthor=P.+V.+Kiemauthor=C.+V.+Minhauthor=Y.+H.+Kim&title=New+anthracene+glycosides+from+Rhodomyrtus+tomentosa+stimulate+osteoblastic+differentiation+of+MC3T3-E1+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">New anthracene glycosides from Rhodomyrtus tomentosa stimulate osteoblastic differentiation of MC3T3-E1 cells</span></div><div class="casAuthors">Tung, Nguyen Huu; Ding, Yan; Choi, Eun Mi; Kiem, Phan Van; Minh, Chau Van; Kim, Young Ho</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Pharmacal Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">515-520</span>CODEN:
                <span class="NLM_cas:coden">APHRDQ</span>;
        ISSN:<span class="NLM_cas:issn">0253-6269</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Korea</span>)
        </div><div class="casAbstract">Two new anthracene glycosides (1-2) were isolated from aerial parts of Rhodomyrtus tomentosa, along with three known compds. (3-5).  The structures of two new compds. were established to be 4,8,9,10-tetrahydroxy-2,3,7-trimethoxyanthracene-6-O-β-D-glucopyranoside (1)and 2,4,7,8,9,10-hexahydroxy-3-methoxyanthracene-6-O-α-L-rhamnopyranoside (2) based on spectroscopic and chem. methods.  Among them, compd. 1, 2, and 5 significantly (P<0.05) increased the alk. phosphatase activity, collagen synthesis, and mineralization of the nodules of MC3T3-E1 osteoblastic cells compared to those of the control, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMcL5xMG8zu7Vg90H21EOLACvtfcHk0lglI_oWOZzl3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Kjs7g%253D&md5=b595a4670223d315c016a144d5bf92a7</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1007%2Fs12272-009-1406-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12272-009-1406-8%26sid%3Dliteratum%253Aachs%26aulast%3DTung%26aufirst%3DN.%2BH.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DChoi%26aufirst%3DE.%2BM.%26aulast%3DKiem%26aufirst%3DP.%2BV.%26aulast%3DMinh%26aufirst%3DC.%2BV.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DNew%2520anthracene%2520glycosides%2520from%2520Rhodomyrtus%2520tomentosa%2520stimulate%2520osteoblastic%2520differentiation%2520of%2520MC3T3-E1%2520cells%26jtitle%3DArch.%2520Pharmacal%2520Res.%26date%3D2009%26volume%3D32%26spage%3D515%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group">Kiem, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tri, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuong, L. V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, N. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quang, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, X. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minh, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. H.</span><span> </span><span class="NLM_article-title">Chemical constituents from the leaves of <i>Manglietia phuthoensis</i> and their effects on osteoblastic MC3T3-E1 cells</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1270</span><span class="NLM_x">–</span> <span class="NLM_lpage">1275</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2008&pages=1270-1275&author=P.+V.+Kiemauthor=M.+D.+Triauthor=L.+V.+D.+Tuongauthor=H.+T.+Nguyenauthor=N.+H.+Nguyenauthor=T.+H.+Quangauthor=X.+C.+Nguyenauthor=C.+V.+Minhauthor=E.-M.+Choiauthor=Y.+H.+Kim&title=Chemical+constituents+from+the+leaves+of+Manglietia+phuthoensis+and+their+effects+on+osteoblastic+MC3T3-E1+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKiem%26aufirst%3DP.%2BV.%26aulast%3DTri%26aufirst%3DM.%2BD.%26aulast%3DTuong%26aufirst%3DL.%2BV.%2BD.%26aulast%3DNguyen%26aufirst%3DH.%2BT.%26aulast%3DNguyen%26aufirst%3DN.%2BH.%26aulast%3DQuang%26aufirst%3DT.%2BH.%26aulast%3DNguyen%26aufirst%3DX.%2BC.%26aulast%3DMinh%26aufirst%3DC.%2BV.%26aulast%3DChoi%26aufirst%3DE.-M.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DChemical%2520constituents%2520from%2520the%2520leaves%2520of%2520Manglietia%2520phuthoensis%2520and%2520their%2520effects%2520on%2520osteoblastic%2520MC3T3-E1%2520cells%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2008%26volume%3D56%26spage%3D1270%26epage%3D1275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group">Cuong, N. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuan, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiem, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minh, C. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. H.</span><span> </span><span class="NLM_article-title">New cembranoid diterpenes from the Vietnamese soft coral <i>Sarcophyton mililatensis</i> stimulate osteoblastic differentiation in MC3T3-E1 cells</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">–</span> <span class="NLM_lpage">992</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2008&pages=988-992&author=N.+X.+Cuongauthor=T.+A.+Tuanauthor=P.+V.+Kiemauthor=C.+V.+Minhauthor=E.+M.+Choiauthor=Y.+H.+Kim&title=New+cembranoid+diterpenes+from+the+Vietnamese+soft+coral+Sarcophyton+mililatensis+stimulate+osteoblastic+differentiation+in+MC3T3-E1+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCuong%26aufirst%3DN.%2BX.%26aulast%3DTuan%26aufirst%3DT.%2BA.%26aulast%3DKiem%26aufirst%3DP.%2BV.%26aulast%3DMinh%26aufirst%3DC.%2BV.%26aulast%3DChoi%26aufirst%3DE.%2BM.%26aulast%3DKim%26aufirst%3DY.%2BH.%26atitle%3DNew%2520cembranoid%2520diterpenes%2520from%2520the%2520Vietnamese%2520soft%2520coral%2520Sarcophyton%2520mililatensis%2520stimulate%2520osteoblastic%2520differentiation%2520in%2520MC3T3-E1%2520cells%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D2008%26volume%3D56%26spage%3D988%26epage%3D992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S. X.</span><span> </span><span class="NLM_article-title">Skeleton-rearranged pentacyclic diterpenoids possessing a cyclobutane ring from Euphorbia wallichii</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2775</span><span class="NLM_x">–</span> <span class="NLM_lpage">2778</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0608552" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVCgsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=2775-2778&author=L.+Panauthor=P.+Zhouauthor=X.+Zhangauthor=S.+Pengauthor=L.+Dingauthor=S.+X.+Qiu&title=Skeleton-rearranged+pentacyclic+diterpenoids+possessing+a+cyclobutane+ring+from+Euphorbia+wallichii"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Skeleton-Rearranged Pentacyclic Diterpenoids Possessing a Cyclobutane Ring om Euphorbia wallichii</span></div><div class="casAuthors">Pan, Li; Zhou, Ping; Zhang, Xiaofeng; Peng, Shulin; Ding, Lisheng; Qiu, Samuel X.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2775-2778</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Two novel rearranged trachylobane diterpenoids, designated as wallichanol A (I) and wallichanol B, consisting of an unprecedented pentacyclic skeleton named wallichane with a cyclobutane ring, and a new ent-trachylobane diterpenoid, 3-oxo-ent-trachyloban-17-oic acid, were isolated om the roots of Euphorbia wallichii.  Their structures were elucidated by comprehensive anal. of 2D-NMR spectroscopic data, with the stereochem. of 1 confirmed by X-ray crystallog. study.  All of these compds. potently block osteoclastogenesis in vitro, suggesting a potential therapeutic application in prevention of osteoporosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRe_vVsVZyl7Vg90H21EOLACvtfcHk0lib45rKc2KlKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVCgsbc%253D&md5=40f5339cfe213dc4f509d5a2faa5ddfb</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1021%2Fol0608552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0608552%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DS.%2BX.%26atitle%3DSkeleton-rearranged%2520pentacyclic%2520diterpenoids%2520possessing%2520a%2520cyclobutane%2520ring%2520from%2520Euphorbia%2520wallichii%26jtitle%3DOrg.%2520Lett.%26date%3D2006%26volume%3D8%26spage%3D2775%26epage%3D2778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group">Qiu, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, L.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, S.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farnsworth, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span> </span><span class="NLM_article-title">A triterpene glycoside from black cohosh that inhibits osteoclastogenesis by modulating RANKL and TNFα signaling pathways</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">860</span><span class="NLM_x">–</span> <span class="NLM_lpage">869</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.chembiol.2007.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17656322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotlSnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=860-869&author=S.+X.+Qiuauthor=C.+Danauthor=L.-S.+Dingauthor=S.+Pengauthor=S.-N.+Chenauthor=N.+R.+Farnsworthauthor=J.+Noltaauthor=M.+L.+Grossauthor=P.+Zhou&title=A+triterpene+glycoside+from+black+cohosh+that+inhibits+osteoclastogenesis+by+modulating+RANKL+and+TNF%CE%B1+signaling+pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">A Triterpene Glycoside from Black Cohosh that Inhibits Osteoclastogenesis by Modulating RANKL and TNFα Signaling Pathways</span></div><div class="casAuthors">Qiu, Samuel X.; Dan, Chun; Ding, Li-Sheng; Peng, Shulin; Chen, Shao-Nong; Farnsworth, Norman R.; Nolta, Jan; Gross, Michael L.; Zhou, Ping</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">860-869</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Osteoporosis is a major age-related source of morbidity and mortality.  Increased bone resorption mediated by osteoclasts is central to its pathogenesis.  Cytokines, particularly RANKL and TNFα, are often increased under pathol. conditions, leading to enhanced osteoclastogenesis.  Black cohosh (Actaea/Cimicifuga racemosa L), a popular herbal supplement for the treatment of menopausal symptoms, was recently shown to have the beneficial effect of preventing bone loss.  Here, the authors demonstrate that 25-acetylcimigenol xylopyranoside (ACCX), a triterpenoid glycoside isolated from black cohosh, potently blocks in vitro osteoclastogenesis induced by either RANKL or TNFα.  This blockage of osteoclastogenesis elicited by ACCX results from abrogation of the NF-κB and ERK pathways induced by either RANKL or TNFα, resp.  Importantly, this compd. attenuates TNFα-induced bone loss in vivo.  Therefore, ACCX represents a potential lead for the development of a new class of antiosteoporosis agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUxbJizDoiZrVg90H21EOLACvtfcHk0lib45rKc2KlKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotlSnu7k%253D&md5=90148213836966465d286426ed907702</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2007.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2007.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DQiu%26aufirst%3DS.%2BX.%26aulast%3DDan%26aufirst%3DC.%26aulast%3DDing%26aufirst%3DL.-S.%26aulast%3DPeng%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DS.-N.%26aulast%3DFarnsworth%26aufirst%3DN.%2BR.%26aulast%3DNolta%26aufirst%3DJ.%26aulast%3DGross%26aufirst%3DM.%2BL.%26aulast%3DZhou%26aufirst%3DP.%26atitle%3DA%2520triterpene%2520glycoside%2520from%2520black%2520cohosh%2520that%2520inhibits%2520osteoclastogenesis%2520by%2520modulating%2520RANKL%2520and%2520TNF%25CE%25B1%2520signaling%2520pathways%26jtitle%3DChem.%2520Biol.%26date%3D2007%26volume%3D14%26spage%3D860%26epage%3D869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group">Khosla, S.</span><span> </span><span class="NLM_article-title">Increasing options for the treatment of osteoporosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">818</span><span class="NLM_x">–</span> <span class="NLM_lpage">820</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1056%2FNEJMe0905480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19671654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWltrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2009&pages=818-820&author=S.+Khosla&title=Increasing+options+for+the+treatment+of+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Increasing options for the treatment of osteoporosis</span></div><div class="casAuthors">Khosla, Sundeep</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">818-820</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbUHU7TMyG9rVg90H21EOLACvtfcHk0lgxcl1JFP3VjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWltrnL&md5=ef4cce192b0a1788053a59c765a81911</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1056%2FNEJMe0905480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMe0905480%26sid%3Dliteratum%253Aachs%26aulast%3DKhosla%26aufirst%3DS.%26atitle%3DIncreasing%2520options%2520for%2520the%2520treatment%2520of%2520osteoporosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2009%26volume%3D361%26spage%3D818%26epage%3D820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group">Canalis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giustina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bilezikian, J. P.</span><span> </span><span class="NLM_article-title">Mechanisms of anabolic therapies for osteoporosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">905</span><span class="NLM_x">–</span> <span class="NLM_lpage">916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1056%2FNEJMra067395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=17761594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvVylurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2007&pages=905-916&author=E.+Canalisauthor=A.+Giustinaauthor=J.+P.+Bilezikian&title=Mechanisms+of+anabolic+therapies+for+osteoporosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of anabolic therapies for osteoporosis</span></div><div class="casAuthors">Canalis, Ernesto; Giustina, Andrea; Bilezikian, John P.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">905-916</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review on mechanisms of anabolic therapies for osteoporosis.  The subtitles include: (1) bone remodeling and modeling; (2) signals that regulate bone formation; (3) clinic relevance of anabolic signaling mols.; (4) other candidate mols. for anabolic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryIE9xAuRdirVg90H21EOLACvtfcHk0lgxcl1JFP3VjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvVylurk%253D&md5=97d892443d8a7a2d581ee3990e892e7e</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1056%2FNEJMra067395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra067395%26sid%3Dliteratum%253Aachs%26aulast%3DCanalis%26aufirst%3DE.%26aulast%3DGiustina%26aufirst%3DA.%26aulast%3DBilezikian%26aufirst%3DJ.%2BP.%26atitle%3DMechanisms%2520of%2520anabolic%2520therapies%2520for%2520osteoporosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2007%26volume%3D357%26spage%3D905%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group">Yadav, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryu, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingrich, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glorieux, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajac, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insogna, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karsenty, G.</span><span> </span><span class="NLM_article-title">Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">825</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2008&pages=825-837&author=V.+K.+Yadavauthor=J.-H.+Ryuauthor=N.+Sudaauthor=K.+F.+Tanakaauthor=J.+A.+Gingrichauthor=G.+Schutzauthor=F.+H.+Glorieuxauthor=C.+Y.+Chiangauthor=J.+D.+Zajacauthor=K.+L.+Insognaauthor=J.+J.+Mannauthor=R.+Henauthor=P.+Ducyauthor=G.+Karsenty&title=Lrp5+controls+bone+formation+by+inhibiting+serotonin+synthesis+in+the+duodenum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DV.%2BK.%26aulast%3DRyu%26aufirst%3DJ.-H.%26aulast%3DSuda%26aufirst%3DN.%26aulast%3DTanaka%26aufirst%3DK.%2BF.%26aulast%3DGingrich%26aufirst%3DJ.%2BA.%26aulast%3DSchutz%26aufirst%3DG.%26aulast%3DGlorieux%26aufirst%3DF.%2BH.%26aulast%3DChiang%26aufirst%3DC.%2BY.%26aulast%3DZajac%26aufirst%3DJ.%2BD.%26aulast%3DInsogna%26aufirst%3DK.%2BL.%26aulast%3DMann%26aufirst%3DJ.%2BJ.%26aulast%3DHen%26aufirst%3DR.%26aulast%3DDucy%26aufirst%3DP.%26aulast%3DKarsenty%26aufirst%3DG.%26atitle%3DLrp5%2520controls%2520bone%2520formation%2520by%2520inhibiting%2520serotonin%2520synthesis%2520in%2520the%2520duodenum%26jtitle%3DCell%26date%3D2008%26volume%3D135%26spage%3D825%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group">Yadav, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oury, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, X.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Confavreux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klemenhagen, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingrich, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, X. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tecott, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karsenty, G.</span><span> </span><span class="NLM_article-title">A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">138</span><span class="NLM_x">, </span> <span class="NLM_fpage">976</span><span class="NLM_x">–</span> <span class="NLM_lpage">989</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2009&pages=976-989&author=V.+K.+Yadavauthor=F.+Ouryauthor=N.+Sudaauthor=Z.-W.+Liuauthor=X.-B.+Gaoauthor=C.+Confavreuxauthor=K.+C.+Klemenhagenauthor=K.+F.+Tanakaauthor=J.+A.+Gingrichauthor=X.+E.+Guoauthor=L.+H.+Tecottauthor=J.+J.+Mannauthor=R.+Henauthor=T.+L.+Horvathauthor=G.+Karsenty&title=A+serotonin-dependent+mechanism+explains+the+leptin+regulation+of+bone+mass%2C+appetite%2C+and+energy+expenditure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYadav%26aufirst%3DV.%2BK.%26aulast%3DOury%26aufirst%3DF.%26aulast%3DSuda%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DZ.-W.%26aulast%3DGao%26aufirst%3DX.-B.%26aulast%3DConfavreux%26aufirst%3DC.%26aulast%3DKlemenhagen%26aufirst%3DK.%2BC.%26aulast%3DTanaka%26aufirst%3DK.%2BF.%26aulast%3DGingrich%26aufirst%3DJ.%2BA.%26aulast%3DGuo%26aufirst%3DX.%2BE.%26aulast%3DTecott%26aufirst%3DL.%2BH.%26aulast%3DMann%26aufirst%3DJ.%2BJ.%26aulast%3DHen%26aufirst%3DR.%26aulast%3DHorvath%26aufirst%3DT.%2BL.%26aulast%3DKarsenty%26aufirst%3DG.%26atitle%3DA%2520serotonin-dependent%2520mechanism%2520explains%2520the%2520leptin%2520regulation%2520of%2520bone%2520mass%252C%2520appetite%252C%2520and%2520energy%2520expenditure%26jtitle%3DCell%26date%3D2009%26volume%3D138%26spage%3D976%26epage%3D989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group">Schwan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, P.</span><span> </span><span class="NLM_article-title">SSRIs, bone mineral density, and risk of fractures—a review</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">683</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1016%2Fj.euroneuro.2009.05.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19541458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVKrsbzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=683-692&author=S.+Schwanauthor=P.+Hallberg&title=SSRIs%2C+bone+mineral+density%2C+and+risk+of+fractures%E2%80%94a+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">SSRIs, bone mineral density, and risk of fractures - a review</span></div><div class="casAuthors">Schwan, Sofie; Hallberg, Paer</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">683-692</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A possibility for selective serotonin reuptake inhibitors (SSRIs) to increase the risk of bone fracture has been debated during recent years.  Proposed causes include an ability for the drugs to reduce bone mineral d. (BMD).  Exptl. data have identified a functional 5-HT system in bone, although its role is unclear.  Results from numerous epidemiol. studies are heterogeneous and several different assocns. have been suggested; between depression and low BMD, SSRIs and low BMD, depression and falls, SSRIs and falls, depression and fractures, and SSRIs and fractures.  In this paper, we review the available data and discuss the various study results.  Based on the current available data, we conclude that it is not possible to det. whether SSRIs may neg. influence bone regulation or are innocent bystanders.  It is likely that only a large, prospective, long-term study designed to investigate changes in BMD will be able to answer the question.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH8YDkzKzvgrVg90H21EOLACvtfcHk0li7tjRRiLcOvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVKrsbzE&md5=7617662d8e7583c7888a1f487e576c14</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2009.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2009.05.001%26sid%3Dliteratum%253Aachs%26aulast%3DSchwan%26aufirst%3DS.%26aulast%3DHallberg%26aufirst%3DP.%26atitle%3DSSRIs%252C%2520bone%2520mineral%2520density%252C%2520and%2520risk%2520of%2520fractures%25E2%2580%2594a%2520review%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2009%26volume%3D19%26spage%3D683%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group">Jones, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oukka, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofstaetter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glimcher, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glimcher, L. H.</span><span> </span><span class="NLM_article-title">Regulation of adult bone mass by the zinc finger adapter protein Schnurri-3</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">1223</span><span class="NLM_x">–</span> <span class="NLM_lpage">1227</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2006&pages=1223-1227&author=D.+C.+Jonesauthor=M.+N.+Weinauthor=M.+Oukkaauthor=J.+G.+Hofstaetterauthor=M.+J.+Glimcherauthor=L.+H.+Glimcher&title=Regulation+of+adult+bone+mass+by+the+zinc+finger+adapter+protein+Schnurri-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DD.%2BC.%26aulast%3DWein%26aufirst%3DM.%2BN.%26aulast%3DOukka%26aufirst%3DM.%26aulast%3DHofstaetter%26aufirst%3DJ.%2BG.%26aulast%3DGlimcher%26aufirst%3DM.%2BJ.%26aulast%3DGlimcher%26aufirst%3DL.%2BH.%26atitle%3DRegulation%2520of%2520adult%2520bone%2520mass%2520by%2520the%2520zinc%2520finger%2520adapter%2520protein%2520Schnurri-3%26jtitle%3DScience%26date%3D2006%26volume%3D312%26spage%3D1223%26epage%3D1227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group">Yamashita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ying, S.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, G.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, C.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. E.</span><span> </span><span class="NLM_article-title">Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">101</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2005&pages=101-113&author=M.+Yamashitaauthor=S.-X.+Yingauthor=G.-M.+Zhangauthor=C.+Liauthor=S.+Y.+Chengauthor=C.-X.+Dengauthor=Y.+E.+Zhang&title=Ubiquitin+ligase+Smurf1+controls+osteoblast+activity+and+bone+homeostasis+by+targeting+MEKK2+for+degradation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamashita%26aufirst%3DM.%26aulast%3DYing%26aufirst%3DS.-X.%26aulast%3DZhang%26aufirst%3DG.-M.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DCheng%26aufirst%3DS.%2BY.%26aulast%3DDeng%26aufirst%3DC.-X.%26aulast%3DZhang%26aufirst%3DY.%2BE.%26atitle%3DUbiquitin%2520ligase%2520Smurf1%2520controls%2520osteoblast%2520activity%2520and%2520bone%2520homeostasis%2520by%2520targeting%2520MEKK2%2520for%2520degradation%26jtitle%3DCell%26date%3D2005%26volume%3D121%26spage%3D101%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oyajobi, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mundy, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span> </span><span class="NLM_article-title">Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">12854</span><span class="NLM_x">–</span> <span class="NLM_lpage">12859</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=12854-12859&author=M.+Zhaoauthor=M.+Qiaoauthor=S.+E.+Harrisauthor=B.+O.+Oyajobiauthor=G.+R.+Mundyauthor=D.+Chen&title=Smurf1+inhibits+osteoblast+differentiation+and+bone+formation+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DQiao%26aufirst%3DM.%26aulast%3DHarris%26aufirst%3DS.%2BE.%26aulast%3DOyajobi%26aufirst%3DB.%2BO.%26aulast%3DMundy%26aufirst%3DG.%2BR.%26aulast%3DChen%26aufirst%3DD.%26atitle%3DSmurf1%2520inhibits%2520osteoblast%2520differentiation%2520and%2520bone%2520formation%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D12854%26epage%3D12859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group">Pearsall, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canalis, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cornwall-Brady, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underwood, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ucran, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pobre, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glatt, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadmeyer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seehra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouxsein, M. L.</span><span> </span><span class="NLM_article-title">A soluble activin type IIA receptor induces bone formation and improves skeletal integrity</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">7082</span><span class="NLM_x">–</span> <span class="NLM_lpage">7087</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=7082-7087&author=R.+S.+Pearsallauthor=E.+Canalisauthor=M.+Cornwall-Bradyauthor=K.+W.+Underwoodauthor=B.+Haigisauthor=J.+Ucranauthor=R.+Kumarauthor=E.+Pobreauthor=A.+Grinbergauthor=E.+D.+Wernerauthor=V.+Glattauthor=L.+Stadmeyerauthor=D.+Smithauthor=J.+Seehraauthor=M.+L.+Bouxsein&title=A+soluble+activin+type+IIA+receptor+induces+bone+formation+and+improves+skeletal+integrity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPearsall%26aufirst%3DR.%2BS.%26aulast%3DCanalis%26aufirst%3DE.%26aulast%3DCornwall-Brady%26aufirst%3DM.%26aulast%3DUnderwood%26aufirst%3DK.%2BW.%26aulast%3DHaigis%26aufirst%3DB.%26aulast%3DUcran%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DPobre%26aufirst%3DE.%26aulast%3DGrinberg%26aufirst%3DA.%26aulast%3DWerner%26aufirst%3DE.%2BD.%26aulast%3DGlatt%26aufirst%3DV.%26aulast%3DStadmeyer%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DSeehra%26aufirst%3DJ.%26aulast%3DBouxsein%26aufirst%3DM.%2BL.%26atitle%3DA%2520soluble%2520activin%2520type%2520IIA%2520receptor%2520induces%2520bone%2520formation%2520and%2520improves%2520skeletal%2520integrity%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2008%26volume%3D105%26spage%3D7082%26epage%3D7087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group">Ruckle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kramer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearsall, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Underwood, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seehra, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, M. L.</span><span> </span><span class="NLM_article-title">Single-dose, randomized, double-blind, placebo-controlled study of ACE-011 (ActRIIA-IgG1) in postmenopausal women</span> <span class="citation_source-journal">J. Bone Miner. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">744</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Fjm9018756&amp;key=10.1359%2Fjbmr.081208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Fjm9018756&amp;key=19049340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Fjm9018756&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksF2ksLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2009&pages=744-752&author=J.+Ruckleauthor=M.+Jacobsauthor=W.+Kramerauthor=A.+E.+Pearsallauthor=R.+Kumarauthor=K.+W.+Underwoodauthor=J.+Seehraauthor=Y.+Yangauthor=C.+H.+Condonauthor=M.+L.+Sherman&title=Single-dose%2C+randomized%2C+double-blind%2C+placebo-controlled+study+of+ACE-011+%28ActRIIA-IgG1%29+in+postmenopausal+women"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Single-dose, randomized, double-blind, placebo-controlled study of ACE-011 (ActRIIA-IgG1) in postmenopausal women</span></div><div class="casAuthors">Ruckle, Jon; Jacobs, Mark; Kramer, William; Pearsall, Amelia E.; Kumar, Ravindra; Underwood, Kathryn W.; Seehra, Jasbir; Yang, Yijun; Condon, Carolyn H.; Sherman, Matthew L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Bone and Mineral Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">744-752</span>CODEN:
                <span class="NLM_cas:coden">JBMREJ</span>;
        ISSN:<span class="NLM_cas:issn">0884-0431</span>.
    
            (<span class="NLM_cas:orgname">American Society for Bone and Mineral Research</span>)
        </div><div class="casAbstract">The effects of ACE-011 on safety, pharmacokinetics, and bone biomarkers were evaluated in healthy, postmenopausal women.  Our data indicate that ACE-011 results in a sustained increase in biomarkers of bone formation and redn. in markers of bone resorption.  The activin type IIA receptor (ActRIIA) is the high-affinity receptor for activin.  ACE-011 is a dimeric fusion protein consisting of the extracellular domain of the human ActRIIA linked to the Fc portion of human IgG1.  ACE-011 binds to activin, preventing activin from binding endogenous receptors.  A randomized, double-blind, placebo-controlled study was conducted to evaluate the safety and tolerability of ACE-011.  Forty-eight healthy, postmenopausal women were randomized to receive either a single dose of ACE-011 or placebo and were followed for 4 mo.  Dose levels ranged from 0.01 to 3.0 mg/kg i.v. and from 0.03 to 0.1 mg/kg s.c.  Safety and pharmacokinetic (PK) analyses and the biol. activity of ACE-011, as assessed by markers of bone turnover, and FSH levels were measured.  No serious adverse events (AEs) were reported.  AEs were generally mild and transient.  The PK of ACE-011 was linear over the dose range studied, with a mean half-life of 24-32 days.  The absorption after s.c. dosing was essentially complete.  ACE-011 caused a rapid and sustained dose-dependent increase in serum levels of bone-specific alk. phosphatase (BSALP) and a dose-dependent decrease in C-terminal type 1 collagen telopeptide (CTX) and TRACP-5b levels.  There was also a dose-dependent decrease in serum FSH levels consistent with inhibition of activin.  ACE-011 is a novel agent with biol. evidence of both an increase in bone formation and a decrease in bone resorption.  ACE-011 may be an effective therapy in a variety of diseases involving bone loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn_t2QS_ybO7Vg90H21EOLACvtfcHk0lgHxwVU2O2sZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksF2ksLg%253D&md5=e8df87da08ce88ccc103f36b8387a6b6</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1359%2Fjbmr.081208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1359%252Fjbmr.081208%26sid%3Dliteratum%253Aachs%26aulast%3DRuckle%26aufirst%3DJ.%26aulast%3DJacobs%26aufirst%3DM.%26aulast%3DKramer%26aufirst%3DW.%26aulast%3DPearsall%26aufirst%3DA.%2BE.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DUnderwood%26aufirst%3DK.%2BW.%26aulast%3DSeehra%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DCondon%26aufirst%3DC.%2BH.%26aulast%3DSherman%26aufirst%3DM.%2BL.%26atitle%3DSingle-dose%252C%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%2520study%2520of%2520ACE-011%2520%2528ActRIIA-IgG1%2529%2520in%2520postmenopausal%2520women%26jtitle%3DJ.%2520Bone%2520Miner.%2520Res.%26date%3D2009%26volume%3D24%26spage%3D744%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, S.</span><span> </span><span class="NLM_article-title">A chemical approach to stem-cell biology and regenerative medicine</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">453</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=453&publication_year=2008&pages=338-344&author=Y.+Xuauthor=Y.+Shiauthor=S.+Ding&title=A+chemical+approach+to+stem-cell+biology+and+regenerative+medicine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DS.%26atitle%3DA%2520chemical%2520approach%2520to%2520stem-cell%2520biology%2520and%2520regenerative%2520medicine%26jtitle%3DNature%26date%3D2008%26volume%3D453%26spage%3D338%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group">Chen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takanashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">Reversine increases the plasticity of lineage-committed mammalian cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">10482</span><span class="NLM_x">–</span> <span class="NLM_lpage">10487</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=10482-10487&author=S.+Chenauthor=S.+Takanashiauthor=Q.+Zhangauthor=W.+Xiongauthor=S.+Zhuauthor=E.+C.+Petersauthor=S.+Dingauthor=P.+G.+Schultz&title=Reversine+increases+the+plasticity+of+lineage-committed+mammalian+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%26aulast%3DTakanashi%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DXiong%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DPeters%26aufirst%3DE.%2BC.%26aulast%3DDing%26aufirst%3DS.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DReversine%2520increases%2520the%2520plasticity%2520of%2520lineage-committed%2520mammalian%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2007%26volume%3D104%26spage%3D10482%26epage%3D10487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group">Mukherjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoonmaker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hideshima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouxsein, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chhetri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aronson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulciniti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purton, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glimcher, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lian, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scadden, D. T.</span><span> </span><span class="NLM_article-title">Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2008&pages=491-504&author=S.+Mukherjeeauthor=N.+Rajeauthor=J.+A.+Schoonmakerauthor=J.+C.+Liuauthor=T.+Hideshimaauthor=M.+N.+Weinauthor=D.+C.+Jonesauthor=S.+Valletauthor=M.+L.+Bouxseinauthor=S.+Pozziauthor=S.+Chhetriauthor=Y.+D.+Seoauthor=J.+P.+Aronsonauthor=C.+Patelauthor=M.+Fulcinitiauthor=L.+E.+Purtonauthor=L.+H.+Glimcherauthor=J.+B.+Lianauthor=G.+Steinauthor=K.+C.+Andersonauthor=D.+T.+Scadden&title=Pharmacologic+targeting+of+a+stem%2Fprogenitor+population+in+vivo+is+associated+with+enhanced+bone+regeneration+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DS.%26aulast%3DRaje%26aufirst%3DN.%26aulast%3DSchoonmaker%26aufirst%3DJ.%2BA.%26aulast%3DLiu%26aufirst%3DJ.%2BC.%26aulast%3DHideshima%26aufirst%3DT.%26aulast%3DWein%26aufirst%3DM.%2BN.%26aulast%3DJones%26aufirst%3DD.%2BC.%26aulast%3DVallet%26aufirst%3DS.%26aulast%3DBouxsein%26aufirst%3DM.%2BL.%26aulast%3DPozzi%26aufirst%3DS.%26aulast%3DChhetri%26aufirst%3DS.%26aulast%3DSeo%26aufirst%3DY.%2BD.%26aulast%3DAronson%26aufirst%3DJ.%2BP.%26aulast%3DPatel%26aufirst%3DC.%26aulast%3DFulciniti%26aufirst%3DM.%26aulast%3DPurton%26aufirst%3DL.%2BE.%26aulast%3DGlimcher%26aufirst%3DL.%2BH.%26aulast%3DLian%26aufirst%3DJ.%2BB.%26aulast%3DStein%26aufirst%3DG.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DScadden%26aufirst%3DD.%2BT.%26atitle%3DPharmacologic%2520targeting%2520of%2520a%2520stem%252Fprogenitor%2520population%2520in%2520vivo%2520is%2520associated%2520with%2520enhanced%2520bone%2520regeneration%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2008%26volume%3D118%26spage%3D491%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group">Calvi, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weibrecht, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olson, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schipani, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Divieti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bringhurst, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milner, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kronenberg, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scadden, D. T.</span><span> </span><span class="NLM_article-title">Osteoblastic cells regulate the hematopoietic stem cell niche</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">425</span><span class="NLM_x">, </span> <span class="NLM_fpage">841</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=841-846&author=L.+M.+Calviauthor=G.+B.+Adamsauthor=K.+W.+Weibrechtauthor=J.+M.+Weberauthor=D.+P.+Olsonauthor=M.+C.+Knightauthor=R.+P.+Martinauthor=E.+Schipaniauthor=P.+Divietiauthor=F.+R.+Bringhurstauthor=L.+A.+Milnerauthor=H.+M.+Kronenbergauthor=D.+T.+Scadden&title=Osteoblastic+cells+regulate+the+hematopoietic+stem+cell+niche"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCalvi%26aufirst%3DL.%2BM.%26aulast%3DAdams%26aufirst%3DG.%2BB.%26aulast%3DWeibrecht%26aufirst%3DK.%2BW.%26aulast%3DWeber%26aufirst%3DJ.%2BM.%26aulast%3DOlson%26aufirst%3DD.%2BP.%26aulast%3DKnight%26aufirst%3DM.%2BC.%26aulast%3DMartin%26aufirst%3DR.%2BP.%26aulast%3DSchipani%26aufirst%3DE.%26aulast%3DDivieti%26aufirst%3DP.%26aulast%3DBringhurst%26aufirst%3DF.%2BR.%26aulast%3DMilner%26aufirst%3DL.%2BA.%26aulast%3DKronenberg%26aufirst%3DH.%2BM.%26aulast%3DScadden%26aufirst%3DD.%2BT.%26atitle%3DOsteoblastic%2520cells%2520regulate%2520the%2520hematopoietic%2520stem%2520cell%2520niche%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D841%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group">Adams, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alley, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chabner, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvi, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kronenberg, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scadden, D. T.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of a stem cell niche</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">238</span><span class="NLM_x">–</span> <span class="NLM_lpage">243</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=238-243&author=G.+B.+Adamsauthor=R.+P.+Martinauthor=I.+R.+Alleyauthor=K.+T.+Chabnerauthor=K.+S.+Cohenauthor=L.+M.+Calviauthor=H.+M.+Kronenbergauthor=D.+T.+Scadden&title=Therapeutic+targeting+of+a+stem+cell+niche"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DG.%2BB.%26aulast%3DMartin%26aufirst%3DR.%2BP.%26aulast%3DAlley%26aufirst%3DI.%2BR.%26aulast%3DChabner%26aufirst%3DK.%2BT.%26aulast%3DCohen%26aufirst%3DK.%2BS.%26aulast%3DCalvi%26aufirst%3DL.%2BM.%26aulast%3DKronenberg%26aufirst%3DH.%2BM.%26aulast%3DScadden%26aufirst%3DD.%2BT.%26atitle%3DTherapeutic%2520targeting%2520of%2520a%2520stem%2520cell%2520niche%26jtitle%3DNat.%2520Biotechnol.%26date%3D2007%26volume%3D25%26spage%3D238%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm9018756&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-11%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm9018756%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm9018756" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c3db1a2e3dbe","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
